Citrus Sinensis ID: 045214
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X996 | 443 | CBL-interacting protein k | yes | no | 0.951 | 0.966 | 0.691 | 1e-180 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.98 | 0.977 | 0.645 | 1e-172 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.984 | 0.969 | 0.651 | 1e-171 | |
| Q9C562 | 479 | CBL-interacting serine/th | yes | no | 0.98 | 0.920 | 0.615 | 1e-170 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.971 | 0.947 | 0.610 | 1e-164 | |
| Q6H7U5 | 493 | CBL-interacting protein k | no | no | 1.0 | 0.912 | 0.580 | 1e-159 | |
| Q2QYM3 | 439 | CBL-interacting protein k | no | no | 0.973 | 0.997 | 0.595 | 1e-158 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.964 | 0.988 | 0.616 | 1e-158 | |
| Q0JI49 | 502 | CBL-interacting protein k | no | no | 0.962 | 0.862 | 0.604 | 1e-157 | |
| Q2RBF0 | 434 | CBL-interacting protein k | no | no | 0.962 | 0.997 | 0.597 | 1e-155 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 630 bits (1626), Expect = e-180, Method: Compositional matrix adjust.
Identities = 300/434 (69%), Positives = 357/434 (82%), Gaps = 6/434 (1%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
E +G +LM+KYE+G+LLGQG FAKVY+AR+ T +SVAIK IDK+K+LK GL+DQ KREI
Sbjct: 3 EQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREI 62
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISA 121
SVM+L++HPN++Q+YEVMA+KTKIYFV+E+ KGGELF KV +G+LKED ARKYFQQLI A
Sbjct: 63 SVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICA 122
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+DFCHSRGVYHRDLKPENLLLDEN LKV+DFGLSALA CK QDGLLHTTCGTPAYVAPE
Sbjct: 123 VDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 182
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
VI+RRGYDG KADIWSCGVIL+VLLAGYLPFHD NLM MY+KI KA++K P+WF+ DVR+
Sbjct: 183 VINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRR 242
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSAS 301
LL RILDPNPSTRIS+ KIMENPWFRKGL++K + K++ VD+ F ++ +
Sbjct: 243 LLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAPT 302
Query: 302 TEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDIAR 361
E KP NLNAF IISLS+G DLSG F E D+KE KFTS +AS IISK+EDIA+
Sbjct: 303 LEK-----KPSNLNAFDIISLSTGLDLSGMFEESDKKES-KFTSTSTASTIISKIEDIAK 356
Query: 362 HLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLK 421
L++KLTKKDGGLLK E S GR G ID ++FE P+ HLVEL K++GD LEY+K+L
Sbjct: 357 GLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVLN 416
Query: 422 QEIRPALKDIVWAW 435
QE+RPALKDIVWAW
Sbjct: 417 QEMRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-172, Method: Compositional matrix adjust.
Identities = 288/446 (64%), Positives = 360/446 (80%), Gaps = 5/446 (1%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E KG +LM++YE+G+LLGQG+FAKVY+ R++ QSVAIK IDK+KILK L+DQ +RE
Sbjct: 2 VEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRRE 61
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM L++HP ++Q+YEVMA+KTKIYF++EY KGGELF KV +G+LKE+ ARKYFQQLIS
Sbjct: 62 ISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLIS 121
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
AIDFCHSRGVYHRDLKPENLLLDEN LK++DFGLSALA+CK QDGLLHTTCGTPAYVAP
Sbjct: 122 AIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVAP 181
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KAD+W+CGVILYVLLAGYLPF D N++ MY+KI KA++K+P+WFS+D+R
Sbjct: 182 EVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDIR 241
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNS---KSAKSKTAIKESSLVDVDAAFGPIE 297
KLL RILDPNP+TRIS+++IME+PWFR GLNS + + VD+D+ FG +
Sbjct: 242 KLLRRILDPNPATRISVSEIMEDPWFRVGLNSDLLNKTIPTDKVDKVVHVDMDSTFGNLS 301
Query: 298 NSASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLE 357
N+ + E + +LNAF IISLSSGFDLS F + + KEE KFTS +A+ I KLE
Sbjct: 302 NNIN-EGKQEAENLTSLNAFDIISLSSGFDLSAMFEDENSKEESKFTSTNTATTITKKLE 360
Query: 358 DIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQ 417
D+A++L++K KK+GGLLK E S GR G SI+ ++F+ P HLVE TK +GD LEYQ
Sbjct: 361 DVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKINGDTLEYQ 420
Query: 418 KMLKQEIRPALKDIVWAWQGDQHQVQ 443
K +KQE+RPALKDIVWAWQG+Q Q Q
Sbjct: 421 K-VKQEMRPALKDIVWAWQGEQPQPQ 445
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 601 bits (1550), Expect = e-171, Method: Compositional matrix adjust.
Identities = 291/447 (65%), Positives = 360/447 (80%), Gaps = 4/447 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E G +L+++YE+G+LLGQG FAKVY+ R++ T QSVAIK IDKDKI KVGL+DQ KRE
Sbjct: 4 LEKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKRE 63
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM+L++HPN++Q+YEVMA+K+KIYFV+EY KGGELF KV+KG+LKED ARKYFQQL+S
Sbjct: 64 ISVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVS 123
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLL+DENG LK+TDFGLSALA+ + QDGLLHTTCGTPAYVAP
Sbjct: 124 AVDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAP 183
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVISR+GYDG K D WSCGVIL+VL+AGYLPF DSNLM MYRKI KA++K P WFS+DVR
Sbjct: 184 EVISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVR 243
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE--SSLVDVDAAFGPIEN 298
KL+SRILDPNP +R+ I KIME WF+KGL+SK E ++L DV+ F + +
Sbjct: 244 KLVSRILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGS 303
Query: 299 SA--STEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKL 356
S+ TE + K NLNAF IISLS GFDLSG F E D+K+E +FTS SAS IISKL
Sbjct: 304 SSSKKTEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQSASAIISKL 363
Query: 357 EDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416
ED+A K+ + KK+GG+LK E + +GR G +ID ++FE PS HLVE+ K++GD LEY
Sbjct: 364 EDVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEY 423
Query: 417 QKMLKQEIRPALKDIVWAWQGDQHQVQ 443
Q + K++++PALKDIVWAWQG++ Q
Sbjct: 424 QHLWKEDMKPALKDIVWAWQGERQDQQ 450
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 597 bits (1540), Expect = e-170, Method: Compositional matrix adjust.
Identities = 280/455 (61%), Positives = 355/455 (78%), Gaps = 14/455 (3%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME K VL KY++GRLLGQG FAKVYY R + T QSVAIK IDK+K++KVGL++Q KRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMR+ +HPNV+++YEVMA+KT+IYFVMEY KGGELF KV+KGKL++D A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSR VYHRD+KPENLLLD+N LKV+DFGLSALA CK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGV+L+VLLAGYLPFHDSNLM MYRKI KAD+K P+WF+ +VR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAA-------- 292
+LL ++LDPNP TRI+IA+I E+ WFRKGL+ K K + +KE + V+ A
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 293 -----FGPIENSASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKY 347
GP EN +P NLNAF +I+LS+GFDL+G F + D K E +FTS+
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGD-DNKRESRFTSQK 359
Query: 348 SASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELT 407
ASVIISKLE++A+ LK+ + K++ GL K E+ +GR G S+D ++F+ P+ HLVE+
Sbjct: 360 PASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVK 419
Query: 408 KSSGDNLEYQKMLKQEIRPALKDIVWAWQGDQHQV 442
KS+GD LEYQK++ +++RPAL DIVW WQG++ ++
Sbjct: 420 KSNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDEL 454
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1490), Expect = e-164, Method: Compositional matrix adjust.
Identities = 270/442 (61%), Positives = 345/442 (78%), Gaps = 5/442 (1%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME K +LM +YELGR+LGQG FAKVY+AR+L + QSVAIK IDK+K+L+VG++DQ KRE
Sbjct: 1 MEKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
IS+MRL++HPN++Q++EVMASK+KIYF MEY +GGELF +V++G+LKED ARKYFQQLI
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLL+DENG LKV+DFGLSA +C+ QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
E+I++RGYDG KADIWSCGVIL+VLLAGYLPFHDSNLM MYRKI+K D KFP WF+ DVR
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGP--IEN 298
+LLSR+LDPNP+ RI++ K++E+PWF+KG S+ + ++L DV AF +N
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPN-ESNNLKDVHTAFSADHKDN 299
Query: 299 SASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFV-EHDQKEEVKFTSKYSASVIISKLE 357
+ P KP +LNAF IISLS GFDLSG F + +QK + +F ++ AS I+SKLE
Sbjct: 300 EGKAKEPASSLKPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAIVSKLE 359
Query: 358 DIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQ 417
IA K+ K+D GL+K + S +GR G +ID ++FE PS +VE+ KS+GD LEY+
Sbjct: 360 QIAETESFKVKKQD-GLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYE 418
Query: 418 KMLKQEIRPALKDIVWAWQGDQ 439
K + +RP+L+DI W Q +
Sbjct: 419 KFCNKGLRPSLRDICWDGQSEH 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6H7U5|CIPKQ_ORYSJ CBL-interacting protein kinase 26 OS=Oryza sativa subsp. japonica GN=CIPK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 562 bits (1449), Expect = e-159, Method: Compositional matrix adjust.
Identities = 277/477 (58%), Positives = 350/477 (73%), Gaps = 27/477 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M+ + +LM +YE+GR LGQGNFAKVYYAR+L +GQ+VAIK IDK+K+ +VGL+ Q KRE
Sbjct: 1 MDDRRTILMDRYEIGRQLGQGNFAKVYYARNLTSGQAVAIKMIDKEKVTRVGLMVQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
IS+MRL++HPN++Q++EVMASK+KIYFV+EYAKGGELFKK+SKGK ED AR+YF QLIS
Sbjct: 61 ISIMRLVKHPNILQLFEVMASKSKIYFVLEYAKGGELFKKISKGKFSEDVARRYFHQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
ID+CHSRGVYHRDLKPENLLLDEN LKV+DFGLSAL++ K DGLLHTTCGTPAYVAP
Sbjct: 121 GIDYCHSRGVYHRDLKPENLLLDENESLKVSDFGLSALSESKRHDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EV+SRRGYDG KADIWSCGVIL+VL++GYLPFHD+NL+ MYRKIAKA+YK P FSA+++
Sbjct: 181 EVLSRRGYDGAKADIWSCGVILFVLVSGYLPFHDTNLIEMYRKIAKAEYKCPRSFSAELK 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK--------------TAIKESSL 286
LL +ILDP+PSTRISI KI + W+RK + + KSK + E S+
Sbjct: 241 DLLYKILDPDPSTRISIPKIKRSAWYRKSSDVNALKSKHETGDKVYKGEATTSDTTECSI 300
Query: 287 VDVDAAF--------GPIENSASTEAPRPMTKP-----DNLNAFHIISLSSGFDLSGFFV 333
+ + A G S S E K NLNAF IISLS+GFDLS F
Sbjct: 301 FEGNRASSRDKVYTNGEATTSDSPECSNSDGKQASLSLPNLNAFDIISLSTGFDLSNLFE 360
Query: 334 EHDQKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQ 393
E + E +FT++ A+ I +KL ++AR K+K+ KK+ G+L+ +G G +D +
Sbjct: 361 ERYGRREERFTTRQPAAAIFAKLNELARRFKLKIKKKENGVLRLVAPKEGIKGLLELDAE 420
Query: 394 LFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPALKDIVWAWQGDQHQVQLQQVHSI 450
+FE PS HLVE KS+GD +EYQK++K++IRPALKDIVWAWQG QHQ Q + +
Sbjct: 421 VFELAPSFHLVEFKKSNGDTIEYQKLMKEDIRPALKDIVWAWQGGQHQQPEQSMQGM 477
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYM3|CIPKE_ORYSJ CBL-interacting protein kinase 14 OS=Oryza sativa subsp. japonica GN=CIPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1438), Expect = e-158, Method: Compositional matrix adjust.
Identities = 262/440 (59%), Positives = 339/440 (77%), Gaps = 2/440 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME++GK+LM++YELGRLLG+G F KV+YAR+L + QSVAIK +DK ++LKVGL +Q +RE
Sbjct: 1 MESRGKILMERYELGRLLGKGTFGKVHYARNLESNQSVAIKMMDKQQVLKVGLSEQIRRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLI 119
I+ MRL+ H N++Q++EVMA++ KIYFVMEY KGGELF+KV+K GKL E A KYFQQLI
Sbjct: 61 ITTMRLVAHKNIVQLHEVMATRNKIYFVMEYVKGGELFEKVAKRGKLTEVVAHKYFQQLI 120
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
SA+D+CHSRGVYHRDLKPENLLLDEN LKV+DFGLSAL++ K QDGLLHTTCGTPAYVA
Sbjct: 121 SAVDYCHSRGVYHRDLKPENLLLDENENLKVSDFGLSALSESKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239
PEVIS+ GYDG K+DIWSCGVIL+VL+AGYLPF NLM MYRKI +++ P WFS +
Sbjct: 181 PEVISKIGYDGAKSDIWSCGVILFVLVAGYLPFQGPNLMEMYRKIQHGEFRCPGWFSRKL 240
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENS 299
+KLL +I+DPNPSTRISI KI E+ WFRKG + + E++ +V G
Sbjct: 241 QKLLYKIMDPNPSTRISIQKIKESTWFRKGPEENRILKERTLNENTTKNVALVLGVRRKK 300
Query: 300 ASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
+ E +PM+ NLNAF IIS S GFDLSG F+ + + E +FTS SAS IISKLED+
Sbjct: 301 NAHEDVKPMS-VTNLNAFEIISFSKGFDLSGMFIVKEWRNEARFTSDKSASTIISKLEDV 359
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A+ L +++ KKD G++K + +GR G D+++FE S H++E+ ++SGD+LEY+++
Sbjct: 360 AKALNLRVRKKDNGVVKMQGRKEGRNGVLQFDIEIFEVTTSYHIIEMKQTSGDSLEYRQL 419
Query: 420 LKQEIRPALKDIVWAWQGDQ 439
L++ IRPALKDIV AW GD+
Sbjct: 420 LEEGIRPALKDIVLAWHGDE 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 280/454 (61%), Positives = 344/454 (75%), Gaps = 20/454 (4%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M+ G VLM+KYELGRLLGQG FAKVY+AR++ TG+SVAIK IDK K+ KVGL+DQ KRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRL++HP+V+ ++EVMASKTKIYF MEY KGGELF KVSKGKLKE+ ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
AID+CHSRGVYHRDLKPENLLLDENG LK++DFGLSAL + K QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI ++GYDG KAD+WSCGV+LYVLLAG+LPFH+ NL+ MYRKI K ++K P WF +V+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNS-KSAKSKTAIKESSLV-DVDAAFGPIEN 298
KLLSRILDPNP++RI I KIMEN WF+KG ++ KS + + SL+ DV AAF
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFS---- 296
Query: 299 SASTEAPRPMTKPDNLNAFHII-SLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLE 357
KP + NAF +I SLS GFDLSG F E +++ E KFT+K A I+SK E
Sbjct: 297 ----------VKPMSYNAFDLISSLSQGFDLSGLF-EKEERSESKFTTKKDAKEIVSKFE 345
Query: 358 DIARHL-KMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416
+IA + LTK D G +K E +GR G +IDV++FE S H+VE KS GD +EY
Sbjct: 346 EIATSSERFNLTKSDVG-VKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEY 404
Query: 417 QKMLKQEIRPALKDIVWAWQGDQHQVQLQQVHSI 450
++ +E+RP+LKDIVW WQG+ + +++ I
Sbjct: 405 KQFCDRELRPSLKDIVWKWQGNNNNSNNEKIEVI 438
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0JI49|CIPKB_ORYSJ CBL-interacting protein kinase 11 OS=Oryza sativa subsp. japonica GN=CIPK11 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 553 bits (1426), Expect = e-157, Method: Compositional matrix adjust.
Identities = 263/435 (60%), Positives = 347/435 (79%), Gaps = 2/435 (0%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
+LM +YE+G+ LGQG FAKVYYAR+L TGQ+VAIK I+KDK++KVGL++Q KREIS+MRL
Sbjct: 7 ILMGRYEVGKQLGQGTFAKVYYARNLTTGQAVAIKMINKDKVMKVGLMEQIKREISIMRL 66
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFC 125
++HPNV+Q++EVMASK+KIYFV+EYAKGGELF K++K GKL ED+AR+YF QLI+A+D+C
Sbjct: 67 VKHPNVLQLFEVMASKSKIYFVLEYAKGGELFNKIAKEGKLSEDSARRYFHQLINAVDYC 126
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
HSRGVYHRDLKPENLLLDEN LKV+DFGLSALA+ K QDGLLHTTCGTPAYVAPEV+SR
Sbjct: 127 HSRGVYHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAPEVLSR 186
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245
+GYDG KAD+WSCGVIL+VL+AGYLPFHD NL+ MYRKI +AD++ P +FSA+++ L+ +
Sbjct: 187 KGYDGAKADVWSCGVILFVLVAGYLPFHDPNLIEMYRKICRADFRCPRYFSAELKDLIHK 246
Query: 246 ILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSASTEAP 305
ILD +PSTRISI +I + W+RK + + S+ A S V G E S S E
Sbjct: 247 ILDSDPSTRISIPRIKRSTWYRKPVEINAKNSEAATTNSISSGVATTSGSAECSTSEENQ 306
Query: 306 RPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDIARHLKM 365
++ P NLNAF IISLS+GF+LSGFF + +E +FT++ + ++ KL+++A+ LK+
Sbjct: 307 GSLSLP-NLNAFDIISLSTGFNLSGFFEDTHGHQEERFTTRQPVTTVLGKLKELAKRLKL 365
Query: 366 KLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIR 425
K+ KKD G+L+ +G+ G +D ++FE PS LVEL K++GD +EY+K++K++IR
Sbjct: 366 KVKKKDNGVLRLAAPKEGKKGFLELDAEIFEVTPSFLLVELKKTNGDTMEYRKLVKEDIR 425
Query: 426 PALKDIVWAWQGDQH 440
PALKDIVW WQGD+H
Sbjct: 426 PALKDIVWVWQGDEH 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBF0|CIPKF_ORYSJ CBL-interacting protein kinase 15 OS=Oryza sativa subsp. japonica GN=CIPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 549 bits (1414), Expect = e-155, Method: Compositional matrix adjust.
Identities = 260/435 (59%), Positives = 335/435 (77%), Gaps = 2/435 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME++GK+LM++YELGRLLG+G F KV+YAR+L + QSVAIK +DK +ILKVGL +Q +RE
Sbjct: 1 MESRGKILMERYELGRLLGKGTFGKVHYARNLESNQSVAIKMMDKQQILKVGLSEQIRRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLI 119
I+ MRL+ H N++Q++EVMA++ KIYFVMEY KGGELF+KV+K GKL E A KYFQQLI
Sbjct: 61 ITTMRLVAHKNIVQLHEVMATRNKIYFVMEYVKGGELFEKVAKRGKLTEVVAHKYFQQLI 120
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
SA+D+CHSRGVYHRDLKPENLLLDEN LKV+DFGLSAL++ K QDGLLHTTCGTPAYVA
Sbjct: 121 SAVDYCHSRGVYHRDLKPENLLLDENENLKVSDFGLSALSESKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239
PEVIS+ GYDG K+DIWSCGVIL+VL+AGYLPF NLM MYRKI +++ P WFS +
Sbjct: 181 PEVISKIGYDGAKSDIWSCGVILFVLVAGYLPFQGPNLMEMYRKIQHGEFRCPGWFSRKL 240
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENS 299
+KLL +I+DPNPSTRISI KI E+ WFRKG + + E++ +V G
Sbjct: 241 QKLLYKIMDPNPSTRISIQKIKESTWFRKGPEENRILKERTLNENTTKNVAPVLGVRRKK 300
Query: 300 ASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
+ E +PM+ NLNAF IIS S GFDLSG F+ + + E +FTS SAS IISKLED+
Sbjct: 301 NAHEDVKPMS-VTNLNAFEIISFSKGFDLSGMFIVKEWRNEARFTSDKSASTIISKLEDV 359
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A+ L +++ KKD G++K + +GR G D+++FE S H++E+ ++SGD+LEY+++
Sbjct: 360 AKALNLRVRKKDNGVVKMQGRKEGRNGVLQFDIEIFEVTTSYHIIEMKQTSGDSLEYRQL 419
Query: 420 LKQEIRPALKDIVWA 434
L++ IRPALKDIV A
Sbjct: 420 LEEGIRPALKDIVLA 434
|
Involved in salt stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| 225448633 | 464 | PREDICTED: CBL-interacting protein kinas | 0.964 | 0.935 | 0.740 | 0.0 | |
| 225439641 | 462 | PREDICTED: CBL-interacting protein kinas | 0.966 | 0.941 | 0.729 | 0.0 | |
| 224139330 | 447 | predicted protein [Populus trichocarpa] | 0.988 | 0.995 | 0.706 | 0.0 | |
| 356496299 | 467 | PREDICTED: CBL-interacting protein kinas | 0.977 | 0.942 | 0.714 | 0.0 | |
| 116265960 | 470 | CBL-interacting protein kinase 22 [Popul | 0.971 | 0.929 | 0.710 | 0.0 | |
| 224145915 | 439 | predicted protein [Populus trichocarpa] | 0.973 | 0.997 | 0.712 | 0.0 | |
| 229609757 | 449 | CBL-interacting protein kinase 25 [Sorgh | 0.984 | 0.986 | 0.675 | 0.0 | |
| 255559649 | 457 | CBL-interacting serine/threonine-protein | 0.966 | 0.951 | 0.697 | 0.0 | |
| 359478333 | 437 | PREDICTED: CBL-interacting serine/threon | 0.944 | 0.972 | 0.694 | 0.0 | |
| 164471600 | 453 | serine-threonine kinase [Persea american | 0.977 | 0.971 | 0.691 | 1e-180 |
| >gi|225448633|ref|XP_002279331.1| PREDICTED: CBL-interacting protein kinase 2 [Vitis vinifera] gi|229609827|gb|ACQ83529.1| CBL-interacting protein kinase 13 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/440 (74%), Positives = 375/440 (85%), Gaps = 6/440 (1%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME KG VLMQ+Y++GRLLGQGNFAKVYY R L TGQSVAIK IDK+KI KVGL+DQTKRE
Sbjct: 1 MENKGNVLMQRYDVGRLLGQGNFAKVYYGRDLKTGQSVAIKVIDKEKIFKVGLIDQTKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM+L++HPNV+Q YEVMA+KTKIYFVMEYAKGGELF KV+KG+L ED AR YFQQLIS
Sbjct: 61 ISVMKLVKHPNVIQFYEVMATKTKIYFVMEYAKGGELFNKVAKGRLMEDFARNYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLLLDENG+LKVTDFGLSALA+ KHQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGVLKVTDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGVIL+VLLAGYLPFHDSNLM MYRKI KADYK P WF ++VR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKIGKADYKCPNWFPSEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LLS+ILDPNP+TRISIAKIM NPWFR+G K K+KT +K+ + D FGP EN++
Sbjct: 241 RLLSKILDPNPNTRISIAKIMVNPWFRRGFIPKPLKTKTEVKDLDPLGTDTVFGPCENNS 300
Query: 301 ST-----EAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISK 355
+ E +P T+P NLNAF IISLS+GFDLSG F +DQK+EV+FTS+ A+ IISK
Sbjct: 301 AAAGEMKELSKP-TQPTNLNAFDIISLSTGFDLSGLFATNDQKKEVQFTSRQPATAIISK 359
Query: 356 LEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLE 415
LE+IAR L++K+ KKDGGLLK E S +GR G SID ++FEF S HLVE+ KSSGD LE
Sbjct: 360 LEEIARRLRLKIKKKDGGLLKLEGSVEGRKGPLSIDAEIFEFTSSFHLVEMKKSSGDTLE 419
Query: 416 YQKMLKQEIRPALKDIVWAW 435
YQK+L+QEIRPALKDIVWAW
Sbjct: 420 YQKILRQEIRPALKDIVWAW 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439641|ref|XP_002269189.1| PREDICTED: CBL-interacting protein kinase 18 isoform 1 [Vitis vinifera] gi|147843535|emb|CAN81218.1| hypothetical protein VITISV_040419 [Vitis vinifera] gi|229609815|gb|ACQ83523.1| CBL-interacting protein kinase 07 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/436 (72%), Positives = 374/436 (85%), Gaps = 1/436 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME G +LMQ+YELG+LLGQG FAKV++AR+L TG SVAIK IDK+KILKVG+VDQ KRE
Sbjct: 1 MENNGSILMQRYELGKLLGQGTFAKVHHARNLKTGTSVAIKIIDKEKILKVGMVDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRL++HPNV+++YEVMASKTKIYFVMEYAKGGELF KV+KGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYAKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLLLDENG LKV+DFGLSALA+ KHQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGV+L+VLLAGYLPFHDSNLM +YRKI KA+Y+FP WF ++VR
Sbjct: 181 EVINRKGYDGAKADIWSCGVVLFVLLAGYLPFHDSNLMELYRKIGKAEYRFPNWFPSEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LLS+ILDPNP TRISI KIMEN WF+KGL+ ++T KE + ++V+A FG E+++
Sbjct: 241 RLLSKILDPNPKTRISITKIMENSWFQKGLDPVLRITETGEKEPADLEVEAVFGSNESAS 300
Query: 301 ST-EAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
+T EA + + NLNAF IIS S+GFDLSG F E+ QK+EV+FTS+ AS IISKLEDI
Sbjct: 301 TTAEAKQELATLSNLNAFDIISFSAGFDLSGLFEENKQKKEVRFTSRQPASAIISKLEDI 360
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A+ L +K+ KKDGGLLK E S +GR G SID ++FE PS HLVE+ KSSGD LEYQK+
Sbjct: 361 AKRLMLKVKKKDGGLLKMEGSKEGRKGVLSIDAEIFEVTPSFHLVEVKKSSGDTLEYQKI 420
Query: 420 LKQEIRPALKDIVWAW 435
+KQEIRPALKDIVWAW
Sbjct: 421 VKQEIRPALKDIVWAW 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139330|ref|XP_002323059.1| predicted protein [Populus trichocarpa] gi|222867689|gb|EEF04820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/446 (70%), Positives = 369/446 (82%), Gaps = 1/446 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME KG VLMQKYE+GRLLGQG FAKV++AR L TG SVAIK IDK+K+ KVG++DQ KRE
Sbjct: 1 MENKGNVLMQKYEIGRLLGQGTFAKVHHARDLKTGMSVAIKMIDKEKVFKVGMMDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRLI+HPNV+++YEVMA+KTKIYFVMEY KGGELF KV+KGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPNVVELYEVMATKTKIYFVMEYVKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+D+CHSRGV HRDLKPENLLLDEN LKV+DFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVSHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGVILYVLLAGYLPF D NLM MYRKIAK ++K P WF+ +VR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILYVLLAGYLPFRDPNLMEMYRKIAKGEFKCPNWFAPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENS- 299
KLLS+ILDPNP+TRIS+AKIMEN W RK L S+ + +KE + +D +A FG E S
Sbjct: 241 KLLSKILDPNPNTRISMAKIMENSWVRKDLQSRPCVLEAEVKEPAPLDSEAVFGINEISC 300
Query: 300 ASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
A+ E + + KP NLNAF IIS S+GFDLSG F E +QK+EV+FTS AS IISKLEDI
Sbjct: 301 AAVEPKQEVAKPCNLNAFDIISFSAGFDLSGLFEEKEQKKEVRFTSNKPASTIISKLEDI 360
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A+ L++K+ K DGGLLK E S +GR G ID ++FE P HLVE+ KSSGD +EYQK+
Sbjct: 361 AKRLRLKIKKNDGGLLKIEGSKEGRKGVMGIDAEIFEITPFFHLVEMKKSSGDTVEYQKV 420
Query: 420 LKQEIRPALKDIVWAWQGDQHQVQLQ 445
+KQ+IRPALKDIVW+WQG+Q + QLQ
Sbjct: 421 VKQDIRPALKDIVWSWQGEQQREQLQ 446
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496299|ref|XP_003517006.1| PREDICTED: CBL-interacting protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/441 (71%), Positives = 364/441 (82%), Gaps = 1/441 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME KG VLMQ+YELGRLLGQG FAKVY+AR++ TG SVAIK IDK+KILKVG++DQ KRE
Sbjct: 1 MEQKGGVLMQRYELGRLLGQGTFAKVYHARNIITGMSVAIKIIDKEKILKVGMIDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRLI+HP+V+++YEVMASKTKIYFVMEY KGGELF KVSKGKLK+D AR+YFQQLIS
Sbjct: 61 ISVMRLIRHPHVVELYEVMASKTKIYFVMEYVKGGELFNKVSKGKLKQDDARRYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+D+CHSRGV HRDLKPENLLLDENG LKVTDFGLSALA+ KHQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDENGNLKVTDFGLSALAETKHQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+RRGYDG KADIWSCGVILYVLLAG+LPF DSNLM MYRKI + ++KFP WF+ DVR
Sbjct: 181 EVINRRGYDGAKADIWSCGVILYVLLAGFLPFRDSNLMEMYRKIGRGEFKFPNWFAPDVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LLS+ILDPNP TRIS+AKIME+ WF+KGL K ++ +E + +D D FG EN
Sbjct: 241 RLLSKILDPNPKTRISMAKIMESSWFKKGL-EKPTITQNEDEELAPLDADGVFGACENGD 299
Query: 301 STEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDIA 360
E + +NLNAF IIS SSGFDLSG F E D+K+E +FTS AS+IISKLE+I
Sbjct: 300 PIEPAKNSKPCNNLNAFDIISYSSGFDLSGLFEETDRKKEERFTSDKPASIIISKLEEIC 359
Query: 361 RHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKML 420
R L++K+ KKDGGL K E S +GR G ID ++FE P HLVEL KSSGD LEYQK+L
Sbjct: 360 RRLRLKVKKKDGGLFKLEGSKEGRKGPLGIDAEIFEITPVFHLVELKKSSGDTLEYQKLL 419
Query: 421 KQEIRPALKDIVWAWQGDQHQ 441
KQE+RPALKDIVW WQG+Q Q
Sbjct: 420 KQEVRPALKDIVWNWQGEQPQ 440
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116265960|gb|ABJ91228.1| CBL-interacting protein kinase 22 [Populus trichocarpa] gi|118487767|gb|ABK95707.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/438 (71%), Positives = 363/438 (82%), Gaps = 1/438 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME KG VLMQKYE+GRLLGQG FAKV++AR L TG SVAIK IDK+K+ KVG++DQ KRE
Sbjct: 1 MENKGNVLMQKYEIGRLLGQGTFAKVHHARDLKTGMSVAIKMIDKEKVFKVGMMDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRLI+HPNV+++YEVMA+KTKIYFVMEY KGGELF KV+KGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPNVVELYEVMATKTKIYFVMEYVKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+D+CHSRGV HRDLKPENLLLDEN LKV+DFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVSHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGVILYVLLAGYLPF D NLM MYRKIAK ++K P WF+ +VR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILYVLLAGYLPFRDPNLMEMYRKIAKGEFKCPNWFAPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENS- 299
KLLS+ILDPNP+TRIS+AKIMEN W RK L S+ + +KE + +D +A FG E S
Sbjct: 241 KLLSKILDPNPNTRISMAKIMENSWVRKDLQSRPCVLEAEVKEPAPLDSEAVFGINEISC 300
Query: 300 ASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
A+ E + + KP NLNAF IIS S+GFDLSG F E +QK+EV+FTS AS IISKLEDI
Sbjct: 301 AAVEPKQEVAKPCNLNAFDIISFSAGFDLSGLFEEKEQKKEVRFTSNKPASTIISKLEDI 360
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A+ L++K+ K DGGLLK E S +GR G ID ++FE P HLVE+ KSSGD +EYQK+
Sbjct: 361 AKRLRLKIKKNDGGLLKIEGSKEGRKGVMGIDAEIFEITPFFHLVEMKKSSGDTVEYQKV 420
Query: 420 LKQEIRPALKDIVWAWQG 437
+KQ+IRPALKDIVW+WQG
Sbjct: 421 VKQDIRPALKDIVWSWQG 438
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145915|ref|XP_002325810.1| predicted protein [Populus trichocarpa] gi|222862685|gb|EEF00192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/439 (71%), Positives = 364/439 (82%), Gaps = 1/439 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME KG VLM++Y+ GRLLGQGNFAKVYY R+L TGQSVAIK IDK+K+LKVGL+DQ KRE
Sbjct: 1 MENKGNVLMERYDFGRLLGQGNFAKVYYGRNLKTGQSVAIKVIDKEKVLKVGLMDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRL++HPNV+Q+YEVMA+K KIYFV+EYAKGGELF KV+KG+LKED AR YFQQLIS
Sbjct: 61 ISVMRLVKHPNVLQLYEVMATKNKIYFVIEYAKGGELFNKVAKGRLKEDVARTYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
AIDFCHSRGV HRDLKPENLLLDENG LKV+DFGLSA A+ + QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDFCHSRGVSHRDLKPENLLLDENGGLKVSDFGLSAAAESRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI R+GYDG KADIWSCGV+L+VLLAGYLPFHD+NL+ MYRKI KA+YKFP WFS ++
Sbjct: 181 EVIYRKGYDGAKADIWSCGVVLFVLLAGYLPFHDANLILMYRKIRKAEYKFPNWFSPEMC 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIEN-S 299
+LLSR+LDPNP TRISI KIMEN WFRKGL+S + K + + D F EN S
Sbjct: 241 RLLSRMLDPNPKTRISITKIMENSWFRKGLDSNAVTIKNEVTGLDPLAADVTFDSCENDS 300
Query: 300 ASTEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
A EA + +++P +LNAF IISLSSGFDLSG F + +QK+E KF S +SAS I SKLEDI
Sbjct: 301 APAEAKKELSQPTSLNAFDIISLSSGFDLSGLFAKDNQKKEKKFISMHSASTITSKLEDI 360
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
AR LK+K+ KKDGGLLK E S+KGR G SID ++FEF PS HLVE+ SSGD LEY ++
Sbjct: 361 ARLLKLKVKKKDGGLLKLEGSEKGRKGALSIDTEIFEFTPSFHLVEVKSSSGDTLEYLQI 420
Query: 420 LKQEIRPALKDIVWAWQGD 438
L+ IRPALKDIVWAWQG+
Sbjct: 421 LENGIRPALKDIVWAWQGE 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229609757|gb|ACQ83494.1| CBL-interacting protein kinase 25 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/444 (67%), Positives = 365/444 (82%), Gaps = 1/444 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E KG VLM KYE+G+LLGQG FAKVY+AR+ T +SVAIK IDKDK++KVGL+DQ KRE
Sbjct: 2 VEHKGNVLMHKYEMGKLLGQGTFAKVYHARNTKTSESVAIKVIDKDKVMKVGLIDQIKRE 61
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM+L++HPN++Q+YEVMA+KTKIYFV+E+ KGGELF KV +G+LKED ARKYFQQLI
Sbjct: 62 ISVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLIC 121
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLLLDEN LKV+DFGLSALA+C+ QDGLLHTTCGTPAYVAP
Sbjct: 122 AVDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALAECQRQDGLLHTTCGTPAYVAP 181
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGVIL+VLLAGYLPFHD NLM MY+KI KA++K P WFS D R
Sbjct: 182 EVINRKGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPCWFSTDAR 241
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LL RILDPNPSTRIS+ KIMENPWFRKGL++K + K + VD +A + +
Sbjct: 242 RLLLRILDPNPSTRISMEKIMENPWFRKGLDAKLLRYNLQSKNAPQVDKNADSDSLSINI 301
Query: 301 STEAP-RPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDI 359
+ E+ + KP N+NAF IISLS+G DLSG F E D K E KFTS ++S I+SK+ED+
Sbjct: 302 TAESKQQEEKKPTNMNAFDIISLSTGLDLSGLFEESDNKREYKFTSTNTSSTIVSKIEDV 361
Query: 360 ARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKM 419
A++L++KLTKKDGGLLK E S GR G ID ++FE +P+ HLVE+ K++GD LEYQK+
Sbjct: 362 AKNLRLKLTKKDGGLLKMEASKPGRKGVMGIDAEIFEVSPNFHLVEIKKTNGDTLEYQKV 421
Query: 420 LKQEIRPALKDIVWAWQGDQHQVQ 443
L +E+RPALKDIVWAWQG+Q + Q
Sbjct: 422 LNREMRPALKDIVWAWQGEQSKQQ 445
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559649|ref|XP_002520844.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223539975|gb|EEF41553.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 305/437 (69%), Positives = 364/437 (83%), Gaps = 2/437 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME K VLMQ+Y+ GRLLGQGNFAKVYYAR++ TGQSVA+K IDK+KILKVGL++Q KRE
Sbjct: 1 MEHKRNVLMQRYDFGRLLGQGNFAKVYYARNIKTGQSVAVKIIDKEKILKVGLINQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM+L++HPNV+Q+YEVMASK KIYFV+EYAKGGELFKKV+KG+LKED AR YFQQLIS
Sbjct: 61 ISVMKLVKHPNVLQLYEVMASKAKIYFVIEYAKGGELFKKVAKGRLKEDAARNYFQQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLLLDENG+LKV+DFGLSAL + QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGILKVSDFGLSALVESNSQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVISR+GYDG KADIWSCGVILYVLLAG+LPFHD+NL+ +YRKI+KA+YKFP WFS +VR
Sbjct: 181 EVISRKGYDGAKADIWSCGVILYVLLAGFLPFHDANLILLYRKISKAEYKFPNWFSPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAF-GPIENS 299
KLLS+ILDPNP+TRISIAKIMEN WFRKG +K ++ +++ + D F P EN
Sbjct: 241 KLLSKILDPNPTTRISIAKIMENSWFRKGFTAKVFPARNDVQKFDSLVTDTTFLVPYENH 300
Query: 300 AST-EAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLED 358
+T E + + KP +LNAF IISLSSGF+LSGFF + Q++E FTS +SA+ IISK+ED
Sbjct: 301 TTTAENKKELGKPTSLNAFDIISLSSGFNLSGFFSRNYQEKETTFTSVHSATTIISKIED 360
Query: 359 IARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQK 418
AR L++++ KK GGLLK E S GR G SID ++FEF PS HLVE+ KS GD LEY
Sbjct: 361 TARDLRLEVKKKHGGLLKLEGSKGGRKGALSIDAEIFEFTPSFHLVEVKKSGGDTLEYLH 420
Query: 419 MLKQEIRPALKDIVWAW 435
+L++ +RPALKDIVW W
Sbjct: 421 ILEEGLRPALKDIVWVW 437
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478333|ref|XP_002269410.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 10 isoform 3 [Vitis vinifera] gi|229609823|gb|ACQ83527.1| CBL-interacting protein kinase 11 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 302/435 (69%), Positives = 364/435 (83%), Gaps = 10/435 (2%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
ME+KG VLM +YELGRLLGQG FAKVYYAR+L TGQSVAIK IDK+K++KVGL DQ KRE
Sbjct: 1 MESKGAVLMNRYELGRLLGQGTFAKVYYARNLKTGQSVAIKVIDKEKVVKVGLKDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVM+L +HPNV+Q+YEVMA+K+KIYFVMEYAKGGELFKKV+KGKLKE+ A KYF+QLI
Sbjct: 61 ISVMKLARHPNVLQLYEVMATKSKIYFVMEYAKGGELFKKVAKGKLKEEVAWKYFRQLID 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLLLDEN LKV+DFGLSA+A+CKHQDGLLHTTCGTP YVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENDNLKVSDFGLSAMAECKHQDGLLHTTCGTPTYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+++GYDG KADIWSCGV+L+VLLAGYLPFHDSNL+ MYRKI+KA++K P WFS DVR
Sbjct: 181 EVINKKGYDGAKADIWSCGVVLFVLLAGYLPFHDSNLIEMYRKISKAEFKCPNWFSPDVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LL +ILDPNP+TRISIAKI E+ WFR+GL SK KS+T K+ + +D DAA
Sbjct: 241 RLLQKILDPNPNTRISIAKIKESSWFRRGLKSKQIKSETGSKDMAPLDTDAA-------- 292
Query: 301 STEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDIA 360
A + + KP NLNAF IIS+S+GFDLSG F E QK++ FT + A+VIIS+LE+IA
Sbjct: 293 --SAKQELAKPTNLNAFDIISISAGFDLSGLFEEPCQKKKAIFTFRKPAAVIISRLEEIA 350
Query: 361 RHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKML 420
+HL++K+ KKD G +KFE +G+ G SID ++FE PS HLVE+ KS+GD LEYQK+L
Sbjct: 351 KHLRLKVMKKDAGFMKFEGLKEGKKGILSIDAEIFEVTPSFHLVEVKKSNGDTLEYQKLL 410
Query: 421 KQEIRPALKDIVWAW 435
K++IRPAL+DIVW W
Sbjct: 411 KEDIRPALQDIVWTW 425
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|164471600|gb|ABY58264.1| serine-threonine kinase [Persea americana] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1647), Expect = e-180, Method: Compositional matrix adjust.
Identities = 305/441 (69%), Positives = 364/441 (82%), Gaps = 1/441 (0%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M+ KG +LMQ++ELGRLLGQG FAKVY+AR+L + QSVAIK IDK+K+LKVG++DQ KRE
Sbjct: 1 MDNKGGILMQRFELGRLLGQGTFAKVYHARNLKSSQSVAIKVIDKEKVLKVGMIDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
I+ MRL HPNV+Q+YEVMA+KTKIYFV+EY KGGELF KV+KGKLKED ARKYFQQL+S
Sbjct: 61 IATMRLASHPNVVQLYEVMATKTKIYFVLEYVKGGELFNKVAKGKLKEDVARKYFQQLVS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRDLKPENLL+DEN LKVTDFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENENLKVTDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVISR+GYDG KADIWSCGVIL+VLLAGYLPFHDSNLM +YRK+ KA+YK P WF +VR
Sbjct: 181 EVISRKGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMELYRKVGKAEYKCPNWFPPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LL+RILDPNP+TRISIAKI +N WF++G +K AK +T KE + +D DAAF +
Sbjct: 241 RLLARILDPNPNTRISIAKIKDNSWFKRGFEAKFAKGETKSKELAPLDTDAAFASSDAGV 300
Query: 301 STEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYSASVIISKLEDIA 360
+ P + KP +LNAF IISLS+GFDLSG F + + ++E +F SK AS IISKLEDIA
Sbjct: 301 AARKPE-LVKPQHLNAFDIISLSAGFDLSGLFEDTNCRKEARFASKQPASTIISKLEDIA 359
Query: 361 RHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKML 420
+ L++K+ KKD G+LK E S +GR G SID ++F NPS HLVE+ KSSGD LEYQK+
Sbjct: 360 KRLRLKVKKKDEGILKLEGSKEGRKGVLSIDAEIFVVNPSFHLVEVKKSSGDTLEYQKLW 419
Query: 421 KQEIRPALKDIVWAWQGDQHQ 441
Q++RPAL DIVWAWQGDQ Q
Sbjct: 420 NQDMRPALTDIVWAWQGDQQQ 440
|
Source: Persea americana Species: Persea americana Genus: Persea Family: Lauraceae Order: Laurales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.971 | 0.912 | 0.594 | 2.9e-142 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.964 | 0.951 | 0.574 | 7.7e-135 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.94 | 0.963 | 0.594 | 7.7e-135 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.933 | 0.997 | 0.567 | 2.6e-127 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.951 | 0.877 | 0.525 | 7.4e-121 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.96 | 0.970 | 0.520 | 1.4e-117 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.924 | 0.943 | 0.533 | 1e-116 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.94 | 0.877 | 0.517 | 6.6e-113 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.584 | 0.509 | 0.636 | 7.1e-111 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.937 | 0.862 | 0.490 | 6.3e-108 |
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1391 (494.7 bits), Expect = 2.9e-142, P = 2.9e-142
Identities = 268/451 (59%), Positives = 337/451 (74%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKRE 60
ME K VL KY++GRLLGQG FAKVYY R + T QSV +KVGL++Q KRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMR+ +HPNV+++YEVMA+KT+IYFVMEY KGGELF KV+KGKL++D A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSR VYHRD+KPENLLLD+N LKV+DFGLSALA CK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GYDG KADIWSCGV+L+VLLAGYLPFHDSNLM MYRKI KAD+K P+WF+ +VR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAA------FG 294
+LL ++LDPNP TRI+IA+I E+ WFRKGL+ K K + +KE + V+ A G
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 295 PIENSAS-TEAPRPMTK------PDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKY 347
P EN A +E +T+ P NLNAF +I + D K E +FTS+
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGD-DNKRESRFTSQK 359
Query: 348 SASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELT 407
ASVIISKLE++A+ LK+ + K++ GL K E+ +GR G S+D ++F+ P+ HLVE+
Sbjct: 360 PASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVK 419
Query: 408 KSSGDNLEYQKMLKQEIRPALKDIVWAWQGD 438
KS+GD LEYQK++ +++RPAL DIVW WQG+
Sbjct: 420 KSNGDTLEYQKLVAEDLRPALSDIVWVWQGE 450
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1321 (470.1 bits), Expect = 7.7e-135, P = 7.7e-135
Identities = 254/442 (57%), Positives = 325/442 (73%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKRE 60
ME K VL ++YE+GRLLGQG FAKVY+ R T +SV ++VGL Q KRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMR+ +HPNV+++YEVMA+K++IYFV+EY KGGELF KV+KGKLKED A KYF QLIS
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGVYHRD+KPENLLLD+N LKV+DFGLSALA CK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI+R+GY+G KADIWSCGV+L+VLLAGYLPFHD+NLM MYRKI KAD+K P+WF+ +V+
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAK----SKTAIKESSLVDVDAAFGPI 296
+LL ++LDPN TRI+IAKI E+ WFRKGL+ K K K ++E++ G
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQN 300
Query: 297 ENSASTEAPRPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVIISKL 356
EN + E PR T LNAF II + K E +F S+ AS IISKL
Sbjct: 301 ENGENHEPPRLAT----LNAFDIIALSTGFGLAGLFGDVYDKRESRFASQKPASEIISKL 356
Query: 357 EDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416
++A+ LK+K+ K+ GL K E+ +G+ G ++D ++F+ P+ HLVE+ K +GD +EY
Sbjct: 357 VEVAKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEY 416
Query: 417 QKMLKQEIRPALKDIVWAWQGD 438
QK++++++RPAL DIVW WQG+
Sbjct: 417 QKLVEEDLRPALADIVWVWQGE 438
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1321 (470.1 bits), Expect = 7.7e-135, P = 7.7e-135
Identities = 262/441 (59%), Positives = 321/441 (72%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKRE 60
M+ G VLM+KYELGRLLGQG FAKVY+AR++ TG+SV KVGL+DQ KRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
ISVMRL++HP+V+ ++EVMASKTKIYF MEY KGGELF KVSKGKLKE+ ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
AID+CHSRGVYHRDLKPENLLLDENG LK++DFGLSAL + K QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVI ++GYDG KAD+WSCGV+LYVLLAG+LPFH+ NL+ MYRKI K ++K P WF +V+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNS-KSAKSKTAIKESSLV-DVDAAFGPIEN 298
KLLSRILDPNP++RI I KIMEN WF+KG ++ KS + + SL+ DV AAF
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFS---- 296
Query: 299 SASTEAPRPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVIISKLED 358
KP + NAF +I E +++ E KFT+K A I+SK E+
Sbjct: 297 ----------VKPMSYNAFDLISSLSQGFDLSGLFEKEERSESKFTTKKDAKEIVSKFEE 346
Query: 359 IARHL-KMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQ 417
IA + LTK D G+ K E +GR G +IDV++FE S H+VE KS GD +EY+
Sbjct: 347 IATSSERFNLTKSDVGV-KMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYK 405
Query: 418 KMLKQEIRPALKDIVWAWQGD 438
+ +E+RP+LKDIVW WQG+
Sbjct: 406 QFCDRELRPSLKDIVWKWQGN 426
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
Identities = 247/435 (56%), Positives = 315/435 (72%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKRE 60
ME KG VLM +YE+G+ LGQG FAKVY+ARHL TG SV LKVG+ +Q KRE
Sbjct: 1 MEKKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
IS MRL++HPN+++++EVMA+K+KIYFVME+ KGGELF KVS GKL+ED ARKYFQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+DFCHSRGV HRDLKPENLLLDE+G LK++DFGLSAL+ + QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVISR GYDG KAD+WSCGVIL+VLLAGYLPF DSNLM +Y+KI KA+ KFP W + +
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSA 300
+LL RILDPNP+TR+S KIM++ WFRKGL + K +++E + VD +A E +A
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEV---KESVEEETEVDAEA-----EGNA 292
Query: 301 STEAPRPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVIISKLEDIA 360
S E + + NLNAF II + ++KEE++FTS AS I KL +I
Sbjct: 293 SAEKEKK--RCINLNAFEIISLSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEIG 350
Query: 361 RHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKML 420
+ LKMK+ KK+ + + S + + ++ ++FE PS H+V L KS GD EY++++
Sbjct: 351 KDLKMKVRKKEHEW-RVKMSAEATV----VEAEVFEIAPSYHMVVLKKSGGDTAEYKRVM 405
Query: 421 KQEIRPALKDIVWAW 435
K+ IRPAL D V AW
Sbjct: 406 KESIRPALIDFVLAW 420
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 228/434 (52%), Positives = 307/434 (70%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKREISVMR 65
+VL KYE+GRLLG+G F KVYY + + TG+SV + G+++Q KREIS+MR
Sbjct: 37 RVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMR 96
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
L++HPN++++ EVMA+KTKI+F+MEY KGGELF K+ KGKLKED+ARKYFQQLISA+DFC
Sbjct: 97 LVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISAVDFC 156
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
HSRGV HRDLKPENLL+DENG LKV+DFGLSAL + QDGLLHT CGTPAYVAPEV+ +
Sbjct: 157 HSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRK 216
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245
+GYDG K DIWSCG+ILYVLLAG+LPF D NLM MYRKI K+++++P WFS + ++L+S+
Sbjct: 217 KGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISK 276
Query: 246 ILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSASTEAP 305
+L +P+ RISI IM PWFRK +NS + I E + +V+ + +T
Sbjct: 277 LLVVDPNKRISIPAIMRTPWFRKNINSPI---EFKIDELEIQNVEDETPTTTATTATTTT 333
Query: 306 RPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVIISKLEDIARHLKM 365
P++ P NAF I E +K FTS++SAS I+ KLE I + + M
Sbjct: 334 TPVS-PKFFNAFEFISSMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEGIGKEMNM 392
Query: 366 KLTK-KDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEI 424
K+ + KD + F K++ GR G ++ ++FE P + +VEL KS+GD LEY ++ ++ +
Sbjct: 393 KVKRTKDFKVKLFGKTE-GRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLYEEHV 451
Query: 425 RPALKDIVWAWQGD 438
RPAL++IVW+W GD
Sbjct: 452 RPALEEIVWSWHGD 465
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.4e-117, P = 1.4e-117
Identities = 230/442 (52%), Positives = 302/442 (68%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLK-VGLVDQTKR 59
ME + +VL KYE+GRLLG+G FAKVYY + + G+ V +K G+++Q KR
Sbjct: 1 MEEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKR 60
Query: 60 EISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
EIS+M+L++HPN++++ EVMA+KTKI+FVME+ KGGELF K+SKGKL ED AR+YFQQLI
Sbjct: 61 EISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLI 120
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
SA+D+CHSRGV HRDLKPENLLLDENG LK++DFGLSAL + QDGLLHT CGTPAYVA
Sbjct: 121 SAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVA 180
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239
PEV+ ++GYDG KADIWSCGV+LYVLLAG LPF D NLM MYRKI +AD++FP WFS +
Sbjct: 181 PEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEA 240
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSA-KSKTAI--KESSLVDVDAAFGPI 296
R+L+S++L +P RISI IM PW RK A K I + S + + G
Sbjct: 241 RRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDC 300
Query: 297 ENSASTEAPRPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVIISKL 356
EN TE P++ P NAF I E +K + FTS+ SA+ ++ K+
Sbjct: 301 ENQ--TE---PIS-PKFFNAFEFISSMSSGFDLSSLFESKRKVQSVFTSRSSATEVMEKI 354
Query: 357 EDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416
E + + + MK+ + +K E +GR G S+ ++FE P I +VE KS+GD LEY
Sbjct: 355 ETVTKEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEY 414
Query: 417 QKMLKQEIRPALKDIVWAWQGD 438
++ ++E+RPAL DIVW+W GD
Sbjct: 415 DRLYEEEVRPALNDIVWSWHGD 436
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
Identities = 229/429 (53%), Positives = 294/429 (68%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKREISVMRL 66
+L +YELGRLLG G FAKVY+AR++ TG+SV +KVG+VDQ KREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
++HPN+++++EVMASK+KIYF ME +GGELF KV+KG+L+ED AR YFQQLISA+DFCH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
SRGVYHRDLKPENLLLDE G LKVTDFGLSA + QDGLLHTTCGTPAYVAPEVI ++
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246
GYDG KAD+WSCGVIL+VLLAGYLPF D NL+ MYRKI + D+K P W S+D R+L++++
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 247 LDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPIENSASTEAPR 306
LDPNP+TRI+I K+M++PWF+K + A ++ DVD F ++ TE
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVD--FLVHKSKEETET-- 314
Query: 307 PMTKPDNLNAFHIIXXXXXXXXXXXXVEH--DQKEEVKFTSKYSASVIISKLEDIARHLK 364
LNAFHII E ++K E++F + AS +IS LE+ AR
Sbjct: 315 -------LNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGN 367
Query: 365 MKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEI 424
+K ++ E GR G +++ ++F PS +VE+ K GD LEY +
Sbjct: 368 KFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTAL 427
Query: 425 RPALKDIVW 433
RPALKDI W
Sbjct: 428 RPALKDIFW 436
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 6.6e-113, P = 6.6e-113
Identities = 225/435 (51%), Positives = 297/435 (68%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKREISVM 64
G+ + KYELGR LG+G FAKV +AR++ G +V LK ++ Q KREIS M
Sbjct: 24 GRTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTM 83
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAID 123
+LI+HPNV++++EVMASKTKIYFV+E+ GGELF K+S G+LKED ARKYFQQLI+A+D
Sbjct: 84 KLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVD 143
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+CHSRGVYHRDLKPENLLLD NG LKV+DFGLSAL + +DGLLHTTCGTP YVAPEVI
Sbjct: 144 YCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVI 203
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243
+ +GYDG KAD+WSCGVIL+VL+AGYLPF DSNL ++Y+KI KA++ P WFSA +KL+
Sbjct: 204 NNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLI 263
Query: 244 SRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAF---GPIENSA 300
RILDPNP+TRI+ A+++EN WF+KG K+ K + A + SL DVDA F G +N
Sbjct: 264 KRILDPNPATRITFAEVIENEWFKKGY--KAPKFENA--DVSLDDVDAIFDDSGESKNLV 319
Query: 301 STEAPRPMTKPDNLNAFHIIXXXXXXXXXXXXVEHDQ--KEEVKFTSKYSASVIISKLED 358
+ P +NAF +I + K + +FTSK SA+ I++K+E
Sbjct: 320 VERREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEA 379
Query: 359 IARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQK 418
A + + K + +K GR G ++ ++F+ PS+++VE+ KS GD LE+ K
Sbjct: 380 AAAPMGFDV-KTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHK 438
Query: 419 MLKQEIRPALKDIVW 433
K + LKDIVW
Sbjct: 439 FYKN-LTTGLKDIVW 452
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 7.1e-111, Sum P(2) = 7.1e-111
Identities = 168/264 (63%), Positives = 216/264 (81%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKREISVMRL 66
+L+ ++ELG+LLG G FAKV+ A+++ TG++V LK GLV KREIS++R
Sbjct: 21 LLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREISILRR 80
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
++HPN++Q++EVMA+KTKIYFVMEY +GGELF KV+KG+LKE+ ARKYFQQLI A++FCH
Sbjct: 81 VRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFCH 140
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
+RGV+HRD+KPENLLLDENG LKV+DFGLSA++ QDGL HT CGTPAYVAPEV+SR+
Sbjct: 141 ARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSRK 200
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245
GYDG K DIWSCGV+L+VL+AGYLPFHD +N+M MY+KI K D++ P WFS ++ LL+R
Sbjct: 201 GYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLTR 260
Query: 246 ILDPNPSTRISIAKIMENPWFRKG 269
+LD P TRISI +IMEN WF+ G
Sbjct: 261 LLDTKPQTRISIPEIMENRWFKIG 284
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 215/438 (49%), Positives = 289/438 (65%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVXXXXXXXXXXLKVGLVDQTKREISVMRL 66
+++ +YE+G+LLG G FAKVY AR++ T +SV LK GL+ KREIS++R
Sbjct: 21 LILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRR 80
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
++HPN++Q++EVMA+K KIYFVMEY +GGELF KV+KG+LKE+ ARKYFQQLISA+ FCH
Sbjct: 81 VRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCH 140
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
+RGVYHRDLKPENLLLDENG LKV+DFGLSA++ QDGL HT CGTPAYVAPEV++R+
Sbjct: 141 ARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 200
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246
GYD K DIWSCGVIL+VL+AGYLPFHD N+MAMY+KI + +++ P WFS ++ +LLS++
Sbjct: 201 GYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKL 260
Query: 247 LDPNPSTRISIAKIMENPWFRKGLNS-----KSAKSKTAIK----ESSLVDVDAAFGPIE 297
L+ NP R + +IMEN WF+KG + K + ES V+ D E
Sbjct: 261 LETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAASE 320
Query: 298 NSASTEAPRP----MTKPDNLNAFHIIXXXXXXXXXXXXVEHDQKEEVKFTSKYSASVII 353
+ PR + +P +LNAF II D E +F S S II
Sbjct: 321 SEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLF--DDDGEGSRFVSGAPVSKII 378
Query: 354 SKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDN 413
SKLE+IA+ + + KKD + E S +G G +I ++FE PS+ +VE+ K GD
Sbjct: 379 SKLEEIAKVVSFTVRKKDCRV-SLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGDK 437
Query: 414 LEYQKMLKQEIRPALKDI 431
EY+ E++P L+++
Sbjct: 438 TEYEDFCNNELKPKLQNL 455
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C562 | CIPKA_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6153 | 0.98 | 0.9206 | yes | no |
| Q7X996 | CIPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6912 | 0.9511 | 0.9661 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK13 | SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (464 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 450 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-109 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-94 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-84 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-83 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-73 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-71 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-69 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-64 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-62 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-61 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-52 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-52 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-51 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-51 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-50 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-50 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-49 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-48 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-48 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-47 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-47 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-47 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-46 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-46 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-46 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-46 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-45 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-44 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-44 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-43 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-43 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-42 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-42 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-42 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-42 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 1e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-41 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-41 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-40 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-40 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-40 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-40 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-40 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-39 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-39 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-39 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-39 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-39 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-39 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-38 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-38 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-38 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-38 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-37 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-37 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-36 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-35 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-34 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-33 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-33 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-31 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-31 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-31 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-30 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-30 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-29 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-28 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-27 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-25 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-25 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-24 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-10 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 321 bits (826), Expect = e-109
Identities = 112/260 (43%), Positives = 167/260 (64%), Gaps = 11/260 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YE+ LG+G+F KVY AR TG+ VAIK I K KI K ++ REI +++ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
++++Y+V + K+Y VMEY +GG+LF +G+L ED AR Y +Q++SA+++ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDG 190
HRDLKPEN+LLDE+G +K+ DFG LA+ L T GTP Y+APEV+ +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFG---LARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 191 DKADIWSCGVILYVLLAGYLPF-HDSNLMAMYRKIAKADYKFPTW---FSADVRKLLSRI 246
DIWS GVILY LL G PF D L+ +++KI K FP S + + L+ ++
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 247 LDPNPSTRISIAKIMENPWF 266
L +P R++ + +++P+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 4e-94
Identities = 104/263 (39%), Positives = 155/263 (58%), Gaps = 11/263 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YEL R LG G+F VY A+H GTG+ VA+K + K +REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS-KKDQTARREIRILRRLSHPN 59
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130
++++ + K +Y VMEY +GG+LF +S+ G L ED A+K Q++ +++ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDG 190
HRDLKPEN+LLDENG++K+ DFGL+ L T GTP Y+APEV+ G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 191 DKADIWSCGVILYVLLAGYLPF---HDSNLMAMYRKIAKADYKFPTWF----SADVRKLL 243
K D+WS GVILY LL G PF + + + + R+I +F S + + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 244 SRILDPNPSTRISIAKIMENPWF 266
+ L+ +PS R + +I+++PWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 1e-84
Identities = 101/264 (38%), Positives = 156/264 (59%), Gaps = 12/264 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+E + LG G+F +V RH G+G+ A+K + K KI+K+ V+ E +++ I+H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR 128
P ++ +Y + +Y VMEY GGELF + K G+ E AR Y Q++ A+++ HS
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ +RDLKPENLLLD +G +K+TDFG K G +T CGTP Y+APE+I +GY
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGF-----AKRVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 189 DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248
G D W+ G+++Y +LAGY PF D N + +Y KI + +FP++FS D + L+ +L
Sbjct: 176 -GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234
Query: 249 PNPSTRI-----SIAKIMENPWFR 267
+ + R+ + I +PWF
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 1e-83
Identities = 101/254 (39%), Positives = 157/254 (61%), Gaps = 9/254 (3%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G+F KV R TG+ A+K + K KI+K V+ T E +++ I HP +++++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
++ K+Y V+EYA GGELF +SK G+ E+ AR Y +++ A+++ HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKA-DI 195
PEN+LLD +G +K+TDFGL+ + +T CGTP Y+APEV+ +GY KA D
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY--GKAVDW 176
Query: 196 WSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRI 255
WS GV+LY +L G PF+ + +Y KI K +FP + S + R L+S +L +P+ R+
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
Query: 256 ---SIAKIMENPWF 266
+I +P+F
Sbjct: 237 GSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 9e-73
Identities = 94/250 (37%), Positives = 138/250 (55%), Gaps = 38/250 (15%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G F VY AR TG+ VAIK I K+ L+++ REI +++ + HPN++++Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135
V + +Y VMEY +GG L + + GKL ED + Q++ +++ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 136 KPENLLLDE-NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKAD 194
KPEN+LLD NG +K+ DFGLS L LL T GTPAY+APEV+ +GY +K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254
IWS GVILY L +++ L+ ++L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 255 ISIAKIMENP 264
S +I+E+
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 1e-71
Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 24/267 (8%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID------KDKILKVGLVDQTKREISVM 64
KYE+ + +G+G+F KVY R G+ +K ID K++ + E+ ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQLI 119
+ + HPN+++ YE K K+ VMEYA GG+L +K+ K K E+ +F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG-LLHTTCGTPAYV 178
A+ + HSR + HRD+KP+N+ L NG++K+ DFG+S K L T GTP Y+
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---KVLSSTVDLAKTVVGTPYYL 170
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSA 237
+PE+ + Y+ K+DIWS G +LY L PF NL+ + KI K Y P+ +S+
Sbjct: 171 SPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS 229
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENP 264
++R L+S +L +P R SIA+I+++P
Sbjct: 230 ELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 3e-69
Identities = 97/266 (36%), Positives = 146/266 (54%), Gaps = 14/266 (5%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+ +G + +V+ A+ TG AIK I K +++ VDQ E ++ Q P V+++Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
K +Y VMEY GG+L + G L ED AR Y +++ A+++ HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLL------HTTCGTPAYVAPEVISRRGYDG 190
P+N+L+D NG LK+TDFGLS + + Q L GTP Y+APEVI +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF--SADVRKLLSRILD 248
D WS G ILY L G PFH +++ I ++P S + L+S++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 249 PNPSTRI---SIAKIMENPWFRKGLN 271
P+P R+ SI +I +P+F KG++
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF-KGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 5e-69
Identities = 90/279 (32%), Positives = 150/279 (53%), Gaps = 25/279 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHP 70
++ G+++G+G+F+ V A+ T + AIK +DK +++K V K E V+ RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG 129
++++Y + +YFV+EYA GEL + + K G L E R Y +++ A+++ HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFG--------------LSALAKCKHQDGLLHTT---- 171
+ HRDLKPEN+LLD++ +K+TDFG Q
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF 231
GT YV+PE+++ G +D+W+ G I+Y +L G PF SN ++KI K +Y F
Sbjct: 183 VGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAK----IMENPWF 266
P F D + L+ ++L +P R+ + + + +P+F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-64
Identities = 83/262 (31%), Positives = 138/262 (52%), Gaps = 8/262 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
++ G LLG+G+F VY A TG+ +A+K+++ + L + +REI ++ +QHP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 71 NVMQIY--EVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
N+++ Y E K + +EY GG L + K GKL E RKY +Q++ + + HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
G+ HRD+K N+L+D +G++K+ DFG + + GTP ++APEVI
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYK--FPTWFSADVRKLLS 244
Y G ADIWS G + + G P+ + N MA KI + P S + + L
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 245 RILDPNPSTRISIAKIMENPWF 266
+ L +P R + +++++P+
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 93/259 (35%), Positives = 138/259 (53%), Gaps = 14/259 (5%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG G F +V + ++ A+K + K I++ G + E ++ HP ++++Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
K IY +MEY GGEL+ + G E TAR Y ++ A ++ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
PENLLLD NG +K+ DFG + K + T CGTP YVAPE+I +GYD D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 197 SCGVILYVLLAGYLPFHDSNL--MAMYRKIAKADYK--FPTWFSADVRKLLSRILDPNPS 252
S G++LY LL G PF + + M +Y I K + K FP + + L+ ++L NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 253 TRI-----SIAKIMENPWF 266
R+ I I ++ WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 5e-61
Identities = 100/265 (37%), Positives = 151/265 (56%), Gaps = 12/265 (4%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ +E+G LG G+F +V A+H GTG+ AIK + K +ILK+ V +E S++ +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
HP ++ + + ++YF++E+ GGELF + K G+ D A+ Y +L+ A ++ HS
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
+ + +RDLKPENLLLD G +KVTDFG + K T CGTP Y+APEVI +G
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFA-----KKVPDRTFTLCGTPEYLAPEVIQSKG 191
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
+ G D W+ GV+LY +AGY PF D +Y KI KFP WF R L+ +L
Sbjct: 192 H-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLL 250
Query: 248 DPNPSTRI-----SIAKIMENPWFR 267
+ + R+ +A + +P+F
Sbjct: 251 QTDHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-55
Identities = 89/276 (32%), Positives = 146/276 (52%), Gaps = 35/276 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID------KDKILKVGLVDQTKREISVM 64
YE+ +G+G+F V R G+ + K ID K+K LV E++++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ---LVS----EVNIL 53
Query: 65 RLIQHPNVMQIY--EVMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQ 117
R ++HPN+++ Y + S +Y VMEY +GG+L + + K K ++E+ + Q
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 118 LISAIDFCHSRG-----VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
L+ A+ CH+R V HRDLKP N+ LD N +K+ DFG LAK D T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG---LAKILGHDSSFAKTY 170
Query: 173 -GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF 231
GTP Y++PE ++ YD +K+DIWS G ++Y L A PF N + + KI + KF
Sbjct: 171 VGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KF 227
Query: 232 PTW---FSADVRKLLSRILDPNPSTRISIAKIMENP 264
+S+++ +++ +L+ +P R S ++++ P
Sbjct: 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 88/267 (32%), Positives = 141/267 (52%), Gaps = 26/267 (9%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI------DKDKILKVGLVDQTKREISVM 64
+E+ +G+G F +VY ARH TG+ VAIK I K+KI+ EI ++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---------NEIQIL 51
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAI 122
+ +HPN+++ Y K +++ VME+ GG L K + L E ++L+ +
Sbjct: 52 KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGL 111
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
++ HS G+ HRD+K N+LL +G +K+ DFGLSA +T GTP ++APEV
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEV 168
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD-YKF--PTWFSAD 238
I+ + YD KADIWS G+ L G P+ + M A++ KIA P +S +
Sbjct: 169 INGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDE 226
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPW 265
+ L + L NP R + +++++P+
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 80/258 (31%), Positives = 140/258 (54%), Gaps = 6/258 (2%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
Y+LG L+G+G F VY +L TG VAIK I +KI + + +EI +++ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG 129
N+++ + + +Y ++EYA+ G L + + K G E Y Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K N+L ++G++K+ DFG++ K + GTP ++APEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFPTWFSADVRKLLSRILD 248
+DIWS G + LL G P++D N M A++R + P S +++ L +
Sbjct: 178 -TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 249 PNPSTRISIAKIMENPWF 266
+P+ R + +++++PW
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 95/264 (35%), Positives = 149/264 (56%), Gaps = 20/264 (7%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
++LG+G+F KV A GT + A+K + KD IL+ V+ T E V+ L +HP + Q
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ +K +++FVMEY GG+L F G+ E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH-----TTCGTPAYVAPEVISRRGY 188
DLK +N+LLD G +K+ DFG+ CK +G+L T CGTP Y+APE++S + Y
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGM-----CK--EGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 189 DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248
G D W+ GV+LY +LAG PF + +++ I + + ++P W S + + +L L
Sbjct: 174 -GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 249 PNPSTRISI-----AKIMENPWFR 267
NP R+ I +P+FR
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 6e-52
Identities = 79/261 (30%), Positives = 142/261 (54%), Gaps = 10/261 (3%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+EL R++G+G F KV + T + A+K ++K K ++ G V E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
++ ++ + +Y V++ GG+L + K K E+ + + +++ A+++ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDG 190
HRD+KP+N+LLDE G + +TDF ++ D L +T GTP Y+APEV+ R+GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 191 DKADIWSCGVILYVLLAGYLPF--HDSNLMAMYR-KIAKADYKFPTWFSADVRKLLSRIL 247
D WS GV Y L G P+ H + R K AD +P +S + ++++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 248 DPNPSTRIS--IAKIMENPWF 266
+ +P R+ + + +P+F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 96/261 (36%), Positives = 147/261 (56%), Gaps = 15/261 (5%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LLG+G F KV R TG+ A+K + K+ I+ V T E V++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ ++ FVMEYA GGELF +S+ ED AR Y +++SA+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKH--QDG-LLHTTCGTPAYVAPEVISRRGYDGD 191
LK ENL+LD++G +K+TDFGL CK DG + T CGTP Y+APEV+ Y G
Sbjct: 121 LKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W GV++Y ++ G LPF++ + ++ I + +FP S + + LL+ +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 252 STRI-----SIAKIMENPWFR 267
R+ +IME+ +F
Sbjct: 235 KQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-51
Identities = 85/265 (32%), Positives = 140/265 (52%), Gaps = 12/265 (4%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+++ G +G G F KVY A +L TG+ +A+K I + + E+ V+ L++HP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRG 129
N+++ Y V + K+Y MEY GG L + + G+ L E R Y QL+ + + HS G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD---GLLHTTCGTPAYVAPEVISRR 186
+ HRD+KP N+ LD NG++K+ DFG A+ + + + GTPAY+APEVI+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 187 GYDGD--KADIWSCGVILYVLLAGYLPFH--DSNLMAMYRKIAKADYKFPT--WFSADVR 240
G ADIWS G ++ + G P+ D+ M+ A P S + +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 241 KLLSRILDPNPSTRISIAKIMENPW 265
L R L+ +P R + ++++++P+
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 7e-51
Identities = 100/347 (28%), Positives = 157/347 (45%), Gaps = 31/347 (8%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
Y + R LG+G+F +VY AR + VA+K + K K V++ REI ++ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 71 -NVMQIYEVMASKTKIYFVMEYAKGGELF----KKVSKGKLKEDTARKYFQQLISAIDFC 125
N++++Y+ + +Y VMEY GG L K KG L E A Q++SA+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 126 HSRGVYHRDLKPENLLLDENGM-LKVTDFGLSALAK----CKHQDGLLHTTCGTPAYVAP 180
HS+G+ HRD+KPEN+LLD +G +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 181 EVIS--RRGYDGDKADIWSCGVILYVLLAGYLPFH----DSNLMAMYRKIAKADYK---- 230
EV+ Y +DIWS G+ LY LL G PF S + I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 231 -----FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL---NSKSAKSKTAIK 282
P S LL ++L +P R+S + + + + S K
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 283 ESSLVDVDAAFGPIENSASTEAPRPMTKPDNLNAFHIISLSSGFDLS 329
+ + + + +S ++ A + + F +G S
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSS 344
|
Length = 384 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 9e-51
Identities = 78/265 (29%), Positives = 138/265 (52%), Gaps = 12/265 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
E + +G G F +V+ R + A+K + +++++ E V++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSR 128
P +++++ + +Y +MEY GGELF + + G+ T Y +++ A+++ HS+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ +RDLKPEN+LLD+ G +K+TDFG + K T CGTP Y+APEVI +G+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFA-----KKLRDRTWTLCGTPEYLAPEVIQSKGH 175
Query: 189 DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248
D W+ G+++Y +L GY PF D N +Y KI +FP + L+ ++L
Sbjct: 176 -NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234
Query: 249 PNPSTRISIAK-----IMENPWFRK 268
+ + R+ K + + WF+
Sbjct: 235 VDRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 94/258 (36%), Positives = 150/258 (58%), Gaps = 12/258 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
++LG+G+F KV A GT + AIKA+ KD +L+ V+ T E V+ L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ +K ++FVMEY GG+L F S G+ E AR Y ++I + F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQ---DGLLHTTCGTPAYVAPEVISRRGYDG 190
DLK +N+LLD++G +K+ DFG+ CK +G T CGTP Y+APE++ + Y+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGKASTFCGTPDYIAPEILKGQKYN- 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
+ D WS GV+LY +L G PFH + ++ I FP W S + + LS++ + +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234
Query: 251 PSTRISIA-KIMENPWFR 267
P+ R+ + I ++P+FR
Sbjct: 235 PTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-50
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 22/264 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR-----EISVMRL 66
+++ + LG+G++ VY + L Q A+K +D +G + Q +R EI ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD------LGSMSQKEREDAVNEIRILAS 55
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQLISA 121
+ HPN++ E K+ VMEYA G+L K +SK K + E + F QL+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ H + + HRDLK N+LL N ++K+ D G+S + K + T GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPE 171
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVR 240
V R Y K+DIWS G +LY + PF ++ + K+ + Y P +S D++
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 241 KLLSRILDPNPSTRISIAKIMENP 264
+ +L P R + KI+ +P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-50
Identities = 92/260 (35%), Positives = 139/260 (53%), Gaps = 22/260 (8%)
Query: 20 QGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ--HPNVMQIYE 77
+G F VY A+ TG AIK + K ++ V K E ++M +IQ P V ++Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYVAKLYY 64
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
SK +Y VMEY GG+ + G L ED A++Y +++ ++ H RG+ HRD+K
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRRGYDGDKA-D 194
PENLL+D+ G LK+TDFGLS ++GL + GTP Y+APE I G DK D
Sbjct: 125 PENLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETIL--GVGDDKMSD 175
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSADVRKLLSRILDPN 250
WS G +++ L GY PFH A++ I +P + S + L++R+L +
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 251 PSTRIS---IAKIMENPWFR 267
P+ R+ +I +P+F+
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 107/331 (32%), Positives = 166/331 (50%), Gaps = 36/331 (10%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
R+LG+G+F KV AR +G+ A+K + KD IL+ V+ T E ++ L HP + Q
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHR 133
+Y + +++FVME+ GG+L + K + E AR Y ++ SA+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQ--DGLLHTT-CGTPAYVAPEVISRRGYDG 190
DLK +N+LLD G K+ DFG+ CK +G +T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-G 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W+ GV+LY +L G+ PF N ++ I + +PTW S D +L + N
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234
Query: 251 PSTRI-SIAK-----IMENPWFR----KGLNSKSAKSKTAIKESSLVDV----------D 290
P+ R+ S+ I+ +P+F+ + LN + + + S DV D
Sbjct: 235 PTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKED 294
Query: 291 AAFGPIENSASTEAPRPMTKPDNLNAFHIIS 321
PIE E+ PM D F +
Sbjct: 295 PVLTPIE-----ESLLPMINQDEFRNFSYTA 320
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 102/313 (32%), Positives = 168/313 (53%), Gaps = 19/313 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LLG+G F KV R TG+ A+K + K+ I+ V T E V++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ ++ FVMEYA GGELF +S+ ++ E+ AR Y +++SA+++ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKH---QDGLLHTTCGTPAYVAPEVISRRGYDGD 191
+K ENL+LD++G +K+TDFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 121 IKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W GV++Y ++ G LPF++ + ++ I + +FP S + + LL+ +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 252 STRI-----SIAKIMENPWFRKGLNSKSAKSKTAI---KESSLVDVDAAFGPIENSASTE 303
R+ ++ME+ +F +N + K + K +VD + E +A +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFF-LSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSI 293
Query: 304 APRPMTKPDNLNA 316
P + D+L
Sbjct: 294 TITPPDRYDSLGL 306
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 9e-49
Identities = 107/310 (34%), Positives = 165/310 (53%), Gaps = 19/310 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LLG+G F KV R +G+ A+K + K+ I+ V T E V++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHSRGVYHRD 134
+K ++ FVMEY GGELF +S+ ++ ED R Y +++SA+D+ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKH---QDGLLHTTCGTPAYVAPEVISRRGYDGD 191
LK ENL+LD++G +K+TDFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 121 LKLENLMLDKDGHIKITDFGL-----CKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W GV++Y ++ G LPF++ + ++ I D KFP SAD + LLS +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234
Query: 252 STRI-----SIAKIMENPWFRKGLNSKSAKSKTAI---KESSLVDVDAAFGPIENSASTE 303
+ R+ +IM + +F G+N + K + K + D + E +A T
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF-TGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTI 293
Query: 304 APRPMTKPDN 313
P K D
Sbjct: 294 TITPPEKYDE 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 35/290 (12%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E+ +++G+G F +V+ R TGQ A+K + K ++K + + E ++ P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130
++++Y + +Y VMEY GG+L + + E+TAR Y +L+ A+D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL---------------------- 168
HRD+KP+N+L+D +G +K+ DFGL
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 169 -----HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK 223
++T GTP Y+APEV+ Y + D WS GVILY +L G+ PF+ L Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 224 IA--KADYKFPT--WFSADVRKLLSRILDPNPSTRISIAK-IMENPWFRK 268
I K +FP S + L+ R+L P R+ + I +P+F+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 91/255 (35%), Positives = 137/255 (53%), Gaps = 7/255 (2%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+F KV R T + A+K I K I+ V T E +V+ + P ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
S K+Y V+ + GGELF + + G+ AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
PEN+LLD G + + DFGL L D +T CGTP Y+APE++ GY D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 197 SCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRIS 256
+ GV+LY +L G PF+D N+ MYRKI + +FP F D + LL +L +P+ R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 257 IA---KIMENPWFRK 268
+I +P+F +
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 1e-47
Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 63/300 (21%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YE LG+G + VY AR TG+ VA+K I D + G+ REIS+++ ++HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59
Query: 72 VMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++++ +V+ ++ K+Y V EY K + G L + + QL+ + +CHS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA----------- 176
+ HRDLKP+N+L++ +G+LK+ DFGL+ G P
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTHEVVTLW 163
Query: 177 YVAPEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFH-DSN---LMAMYR--------- 222
Y APE++ + Y DIWS G I ++ G F DS L +++
Sbjct: 164 YRAPEILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 223 -----KIAKADYKFPTW-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
K+ FP + + LLS++L NP+ RIS + +++P+F
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 1e-47
Identities = 93/265 (35%), Positives = 148/265 (55%), Gaps = 19/265 (7%)
Query: 16 RLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGL-VDQTKREISVMRLIQHPN 71
++LG+G + KV+ R + TG+ A+K + K I++ TK E +++ ++HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130
++ + + K+Y ++EY GGELF + + G EDTA Y ++ A++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPAYVAPEVISRRG 187
+RDLKPEN+LLD G +K+TDFGL CK H+ + HT CGT Y+APE++ R G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGL-----CKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
+ G D WS G ++Y +L G PF N KI K P + + + R LL ++L
Sbjct: 177 H-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235
Query: 248 DPNPSTRI-----SIAKIMENPWFR 267
NPS+R+ A++ +P+FR
Sbjct: 236 KRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 7e-47
Identities = 96/261 (36%), Positives = 152/261 (58%), Gaps = 16/261 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LLG+G F KV + TG+ A+K + K+ I+ V T E V++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHS-RGVYHR 133
+ ++ FVMEYA GGELF +S+ ++ ED AR Y +++SA+D+ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKH--QDG-LLHTTCGTPAYVAPEVISRRGYDG 190
DLK ENL+LD++G +K+TDFGL CK +DG + T CGTP Y+APEV+ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGL-----CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W GV++Y ++ G LPF++ + ++ I + +FP S + + LLS +L +
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234
Query: 251 PSTRI-----SIAKIMENPWF 266
P R+ +IM++ +F
Sbjct: 235 PKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 8e-47
Identities = 88/244 (36%), Positives = 144/244 (59%), Gaps = 8/244 (3%)
Query: 16 RLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
++LGQG+F KV+ R + GQ A+K + K LKV +TK E ++ + HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-ATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHSRGVY 131
++++ ++ K+Y ++++ +GG+LF ++SK + E+ + Y +L A+D HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
+RDLKPEN+LLDE G +K+TDFGLS + + ++ CGT Y+APEV++RRG+
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
AD WS GV+++ +L G LPF + I KA P + S + + LL + NP
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 252 STRI 255
+ R+
Sbjct: 238 ANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 3e-46
Identities = 92/283 (32%), Positives = 155/283 (54%), Gaps = 18/283 (6%)
Query: 12 YELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI 67
+EL R+LG G + KV+ R +G G+ A+K + K I+ K + T+ E V+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 68 QH-PNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFC 125
+ P ++ ++ + TK++ +++Y GGELF + + E R Y +++ A+D
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
H G+ +RD+K EN+LLD G + +TDFGLS + ++ ++ CGT Y+APEVI R
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVI-R 179
Query: 186 RGYDG-DKA-DIWSCGVILYVLLAGYLPFH---DSNLMA-MYRKIAKADYKFPTWFSADV 239
G G DKA D WS GV+ + LL G PF + N + + R+I K+ FP SA+
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 240 RKLLSRILDPNPSTRI---SIAKIMENPWFRKGLNSKSAKSKT 279
R + ++L+ +P R+ +I +P+F +G++ +K
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFF-QGIDWDDLAAKR 281
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 4e-46
Identities = 92/259 (35%), Positives = 144/259 (55%), Gaps = 12/259 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
++LG+G+F KV+ A GT Q AIKA+ KD +L V+ T E V+ L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
+Y +K ++FVMEY GG+L F S K A Y ++I + F HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQ---DGLLHTTCGTPAYVAPEVISRRGYDG 190
DLK +N+LLD +G +K+ DFG+ CK D T CGTP Y+APE++ + Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGM-----CKENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D WS GV+LY +L G PFH + +++ I + +P W + + + +L ++
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 251 PSTRISI-AKIMENPWFRK 268
P R+ + I ++P+FR+
Sbjct: 235 PERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 85/262 (32%), Positives = 134/262 (51%), Gaps = 9/262 (3%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREISVMRLIQH 69
+ G+LLGQG F +VY + TG+ +A+K + D D V+ + EI +++ +QH
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR 128
++Q Y + + MEY GG + ++ G L E RKY +Q++ +++ HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
+ HRD+K N+L D G +K+ DFG S C G+ T GTP +++PEVIS
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGE 182
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADYKFPTWFSADVRKLLS 244
GY G KAD+WS G + +L P+ + MA KIA + + P+ S D R L
Sbjct: 183 GY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241
Query: 245 RILDPNPSTRISIAKIMENPWF 266
R N R S +++ + +
Sbjct: 242 RTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-46
Identities = 91/265 (34%), Positives = 144/265 (54%), Gaps = 18/265 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
++LG+G+F KV A GT + AIK + KD IL+ VD T E ++ L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ +K +++FVMEY GG+L ++ + K E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKH--QDGLLHTT-CGTPAYVAPEVISRRGYDG 190
DLK +N+LLD G K+ DFG+ CK +G+ TT CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGM-----CKEGILNGVTTTTFCGTPDYIAPEILQELEY-G 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W+ GV++Y ++AG PF N ++ I D +P W S + +L + N
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234
Query: 251 PSTRISIA-------KIMENPWFRK 268
P+ R+ I ++P+F++
Sbjct: 235 PNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 37/288 (12%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LLG+G+ +V+ R GTG+ A+K +DK +++K V + E ++ + HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
Y ++T + VM+Y GGELF ++ L E+ AR Y +++ A+++ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKC---------------KHQDGLLHTT------ 171
RDLKPEN+LL E+G + ++DF LS + + + T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 172 ------CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA 225
GT Y+APEVIS G+ D W+ G++LY +L G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 226 KADYKFP--TWFSADVRKLLSRILDPNPSTRISIAK----IMENPWFR 267
K + FP S+ R L+ ++L +PS R+ + I ++P+FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 92/285 (32%), Positives = 146/285 (51%), Gaps = 39/285 (13%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E +L+ G + VY RH T Q A+K I+K ++ + Q E ++ ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGE---LFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
V+ ++ +K + VMEY +GG+ L K + G L D AR YF + + A+++ H+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT----------------- 171
G+ HRDLKP+NLL+ G +K+TDFGLS + GL+ T
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLD 173
Query: 172 ---CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD 228
CGTP Y+APEVI R+GY G D W+ G+ILY L G +PF ++ ++ D
Sbjct: 174 KQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232
Query: 229 YKFPTW---FSADVRKLLSRILDPNPSTRI---SIAKIMENPWFR 267
++P AD + L+SR+L NP R+ ++ ++ +F
Sbjct: 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 90/271 (33%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YEL ++G G A VY A L + VAIK ID +K VD+ ++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPN 60
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFK----KVSKGKLKEDTARKYFQQLISAIDFCHS 127
V++ Y +++ VM Y GG L +G L E ++++ +++ HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSA-LAK-CKHQDGLLHTTCGTPAYVAPEVIS- 184
G HRD+K N+LL E+G +K+ DFG+SA LA + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK---------ADYKFPTWF 235
GYD KADIWS G+ L G P+ M + + ADYK +
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK---Y 236
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
S RK++S L +PS R + +++++ +F
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 89/265 (33%), Positives = 146/265 (55%), Gaps = 22/265 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR-----EISVMRL 66
+++ + +G+G F+ VY A L G+ VA+K + +I + ++D R EI +++
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV---QIFE--MMDAKARQDCLKEIDLLKQ 58
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGK--LKEDTARKYFQQLISA 121
+ HPNV++ ++ V+E A G+L K K K + E T KYF QL SA
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
++ HS+ + HRD+KP N+ + G++K+ D GL K H+ GTP Y++PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPE 176
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS--NLMAMYRKIAKADYK-FPT-WFSA 237
I GY+ K+DIWS G +LY + A PF+ NL ++ +KI K DY P +S
Sbjct: 177 RIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235
Query: 238 DVRKLLSRILDPNPSTRISIAKIME 262
++R L+SR ++P+P R I+ +++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-44
Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 17/261 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT---KREISVMRLIQHPNVMQ 74
LG+G+F KV A + TG+ AIKA+ K I+ V+ KR +HP ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
++ ++ + FVMEYA GG+L + E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CGTPAYVAPEVISRRGYDGD 191
LK +NLLLD G +K+ DFGL CK G T CGTP ++APEV++ Y
Sbjct: 127 LKLDNLLLDTEGFVKIADFGL-----CKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TR 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W GV++Y +L G PF + ++ I + ++P + S + ++ R+L NP
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
Query: 252 STRISIAK-----IMENPWFR 267
R+ + + + P+FR
Sbjct: 241 ERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 75/278 (26%), Positives = 135/278 (48%), Gaps = 27/278 (9%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAID--KDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+G+G +VY A TG+ VAIK + K + EI +M+ +HPN++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI------INEILIMKDCKHPNIVDY 80
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
Y+ +++ VMEY GG L + + ++ E ++++ +++ HS+ V HR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKA 193
D+K +N+LL ++G +K+ DFG +A + ++ GTP ++APEVI R+ Y K
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYG-PKV 197
Query: 194 DIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLSRILDPN 250
DIWS G++ + G P + L A++ K K P +S + + L++ L +
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257
Query: 251 PSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVD 288
P R S +++++P+ K A +
Sbjct: 258 PEKRPSAEELLQHPFL-----------KKACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 86/270 (31%), Positives = 143/270 (52%), Gaps = 13/270 (4%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHL-GTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
K K+ + + R LG G+F +V A + VAIK +K KI+K VD E
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISA 121
++ I HP + +Y ++ +Y V+E+ GGE F + + K D Y Q++
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
++ S + +RDLKPENLLLD++G +K+TDFG + + + +T CGTP Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPE 198
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
++ G+ G AD W+ G+ +Y +L G PF+ + + +Y+KI + FP + + +
Sbjct: 199 ILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257
Query: 242 LLSRILDPNPSTRISIAK-----IMENPWF 266
L+ ++L + + R K + E+PWF
Sbjct: 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 11/245 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
+++G+G+F KV A+H G+ A+K + K ILK E +V+ + ++HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ + K+YFV++Y GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKH---QDGLLHTTCGTPAYVAPEVISRRGYDG 190
DLKPEN+LLD G + +TDFGL CK T CGTP Y+APEV+ ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD- 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W G +LY +L G PF+ + MY I + S R LL +L +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234
Query: 251 PSTRI 255
+ R+
Sbjct: 235 RTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 17/261 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+GQG + +V+ A+ TG+ VA+K + K + K+ V E ++ + ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 78 VMASKTKIYFVMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
+Y MEY GG+ ++ G L ED AR Y ++ A+D H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
PEN L+D +G +K+TDFGLS ++ G+P Y+APEV+ +GYD D W
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIV-----TYANSVVGSPDYMAPEVLRGKGYD-FTVDYW 182
Query: 197 SCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFPTW------FSADVRKLLSRILD 248
S G +LY L G+ PF S + + K + P + S + L++++++
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN 242
Query: 249 PNPSTRI-SIAKIMENPWFRK 268
+PS R S+ I +P+F++
Sbjct: 243 -DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 84/295 (28%), Positives = 134/295 (45%), Gaps = 48/295 (16%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YE +G+G + +VY AR+ TG+ VA+K I + K G REI +++ ++HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59
Query: 72 VMQIYEVMASKTK--IYFVMEYAK---GGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
++++ E++ SK K IY V EY G L + K E + Y +QL+ + + H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH 117
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG--TPAYVAPEVI- 183
S G+ HRD+K N+L++ +G+LK+ DFG LA+ + T T Y PE++
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFG---LARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 184 -SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA----------DYKFP 232
+ R Y + D+WS G IL L G F S + KI +
Sbjct: 175 GATR-YGP-EVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232
Query: 233 TWF---------------------SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
WF LL ++L +P RIS + +++ +F
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 2e-42
Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 10/259 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
KYE R++G+G F V+ R + V IK I +++ K + E V++L+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFCHS 127
N+++ YE + VMEYA GG L + + K L EDT +F Q++ A+ H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 128 RGVYHRDLKPENLLLDENGM-LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
+ + HRDLK +N+LLD++ M +K+ DFG+S + K + +T GTP Y++PE+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGK 176
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSR 245
Y+ K+DIW+ G +LY L + F +NL A+ KI + +S D+R+L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 246 ILDPNPSTRISIAKIMENP 264
+L+ +PS R +++IM P
Sbjct: 236 MLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 80/259 (30%), Positives = 142/259 (54%), Gaps = 10/259 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
KY + +G+G+F K + G+ IK I+ K + +++++E++V+ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFCHS 127
N++Q E +Y VM+Y +GG+L+KK++ + ED +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC-GTPAYVAPEVISRR 186
R + HRD+K +N+ L ++G +K+ DFG +A+ + L TC GTP Y++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFG---IARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245
Y+ +K+DIW+ G +LY + F N+ + KI + Y + +S D+R L+S+
Sbjct: 177 PYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235
Query: 246 ILDPNPSTRISIAKIMENP 264
+ NP R S+ I+E
Sbjct: 236 LFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 85/258 (32%), Positives = 142/258 (55%), Gaps = 12/258 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
++LG+G+F KV A G G+ A+KA+ KD +L V+ T E V+ L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
+Y +K ++FVME+ GG+L F KG+ A Y +++ + F HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQ---DGLLHTTCGTPAYVAPEVISRRGYDG 190
DLK +N++LD +G +K+ DFG+ CK D T CGTP Y+APE++ Y
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGM-----CKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D WS GV+LY +L G PFH + ++ I +P W + + + +L ++ + +
Sbjct: 176 -SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 251 PSTRISI-AKIMENPWFR 267
P+ R+ + I +P+F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-42
Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 25/270 (9%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID----KDKILKVGLVDQTKREISVMR 65
+ + L +G+G+F +VY A T Q VAIK ID +D+I + ++EI +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
+ P + + Y +K++ +MEY GG + GKL E ++++ +++
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSA---LAKCKHQDGLLHTTCGTPAYVAPEV 182
H G HRD+K N+LL E G +K+ DFG+S K +T GTP ++APEV
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-----RNTFVGTPFWMAPEV 169
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSAD 238
I + GYD KADIWS G+ L G P D + M + I K P+ FS
Sbjct: 170 IKQSGYDE-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPPSLEGNKFSKP 226
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ +S L+ +P R S +++++ + +K
Sbjct: 227 FKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 57/116 (49%), Positives = 74/116 (63%), Gaps = 1/116 (0%)
Query: 315 NAFHIISLSSGFDLSGFFVEHD-QKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGG 373
NAF +ISLSSG DLSG F E D K E +FTS+ A II KLE+ A+ L ++ KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 374 LLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPALK 429
+K E GR G ++ V++FE PS+ +VE+ KS+GD LEY K K +RP LK
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 97/295 (32%), Positives = 145/295 (49%), Gaps = 47/295 (15%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTK-REISVMRLI 67
+YE G+ LG+G +A VY AR TG+ VAIK I + K K G ++ T REI +++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQEL 59
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDF 124
+HPN++ + +V K+ I V E+ +L +KV K K L + Y + +++
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG--TPAYVAPEV 182
HS + HRDLKP NLL+ +G+LK+ DFGL+ T T Y APE+
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA----RSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAG--YLPFHDSNLMAMYRKIAKA------------- 227
+ + G D+WS G I LL +LP DS++ + KI +A
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTPTEENWPGVT 231
Query: 228 ---DY----KFP-----TWFSA---DVRKLLSRILDPNPSTRISIAKIMENPWFR 267
DY FP F A D LL R+L NP+ RI+ + +E+P+F
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 81/259 (31%), Positives = 135/259 (52%), Gaps = 8/259 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIK--AIDKDKILKVGLVDQTKREISVMRLIQ 68
++ G LLG G+F VY +L G A+K ++ D V Q ++EI+++ +Q
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
HPN++Q + +Y +E GG L K + K G E R Y +Q++ +++ H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
R HRD+K N+L+D NG++K+ DFG +AK + + G+P ++APEVI+++G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFPTWFSADVRKLLSR 245
G ADIWS G + + G P+ +A KI K P S + + + +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 246 ILDPNPSTRISIAKIMENP 264
L +PS R + A+++E+P
Sbjct: 238 CLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 6e-41
Identities = 85/262 (32%), Positives = 146/262 (55%), Gaps = 11/262 (4%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+YE+ + +G+G+F K+Y A+ + IK ID K + V + +K+E+ ++ ++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFCHS 127
N++ + +++ VMEY GG+L K++++ + ED +F Q+ + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 128 RGVYHRDLKPENLLLDENGML-KVTDFGLSALAKCKHQDGLLHTTC-GTPAYVAPEVISR 185
R + HRD+K +N+ L +NGM+ K+ DFG +A+ + L TC GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLS 244
R Y+ +K DIWS G +LY L PF +NL + KI + + FS D+R L+S
Sbjct: 177 RPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 245 RILDPNPSTRISIAKIMENPWF 266
++ +P R SI I++ P+
Sbjct: 236 QLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 86/260 (33%), Positives = 139/260 (53%), Gaps = 13/260 (5%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT--KREISVMRLI-QHPNVMQ 74
+G+G F +VY R T + A+K + K +I+ V T +R I V L+ + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
+ + + +Y V +Y GGELF + K G+ ED A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV-ISRRGYDGDK 192
DLKPEN+LLD G + + DFGLS + +T CGT Y+APEV + +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-TWFSADVRKLLSRILDPNP 251
D WS GV+++ + G+ PF+ + MYR IA +FP S + R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 252 STRI----SIAKIMENPWFR 267
R+ ++ E+P+F
Sbjct: 238 QHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-40
Identities = 85/245 (34%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
+++G+G+F KV ARH + A+K + K ILK E +V+ + ++HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ + K+YFV++Y GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQ---DGLLHTTCGTPAYVAPEVISRRGYDG 190
DLKPEN+LLD G + +TDFGL CK +G T CGTP Y+APEV+ ++ YD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL-----CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD- 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W G +LY +L G PF+ N MY I + + R LL +L +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234
Query: 251 PSTRI 255
+ R+
Sbjct: 235 RTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 22/268 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRLIQH 69
E ++LGQG+ VY RH TG+ A+K I ++ K Q RE+ +R +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
P V++ Y + +I V+EY GG +L KKV GK+ E +Q++ +D+ H
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH 116
Query: 127 S-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
+ R + HRD+KP NLL++ G +K+ DFG+S + + +T GT Y++PE I
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQCNTFVGTVTYMSPERIQG 174
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAK-ADYKFP-TWFSADVR 240
ADIWS G+ L G PF + + I P FS + R
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268
+S L +P R S A+++++P+ +K
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 88/261 (33%), Positives = 140/261 (53%), Gaps = 16/261 (6%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM-QI 75
+LG+G+F KV A GT + AIK + KD I++ V+ T E V+ L P + Q+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ + ++YFVMEY GG+L + + GK KE A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQ---DGLLHTTCGTPAYVAPEVISRRGYDGD 191
LK +N++LD G +K+ DFG+ CK T CGTP Y+APE+I+ + Y G
Sbjct: 127 LKLDNVMLDAEGHIKIADFGM-----CKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W+ GV+LY +LAG PF + +++ I + + +P S + + +L +P
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
Query: 252 STRISIA-----KIMENPWFR 267
+ R+ I E+ +FR
Sbjct: 241 AKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 92/313 (29%), Positives = 144/313 (46%), Gaps = 47/313 (15%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E +++G+G F +V + TG A+K + K ++L+ V + E ++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
V+++Y + +Y +MEY GG++ + K E+ R Y + I AID H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKH-------------------------QD 165
HRD+KP+NLLLD G +K++DFGL K H
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 166 GLLHT-----------TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD 214
T T GTP Y+APEV + GY + D WS GVI+Y +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 215 SNLMAMYRKIA--KADYKFPT--WFSADVRKLLSRILDPNPSTRI---SIAKIMENPWFR 267
N YRKI K +FP S + + L+ R+ R+ + +I +P+F
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFF- 299
Query: 268 KGLNSKSAKSKTA 280
KG++ + + + A
Sbjct: 300 KGVDWEHIRERPA 312
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 86/287 (29%), Positives = 126/287 (43%), Gaps = 36/287 (12%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
Y+ +G+G + VY AR TG+ VAIK I K + G+ REI +++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 72 VMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ +V K +Y V E+ +L K +G L E + Y QL+ + FCHS G
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHG 118
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
+ HRDLKPENLL++ G+LK+ DFGL+ T Y APE++
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 190 GDKADIWSCGVILYVLLAG--------------------------YLPFHDSNLMAMYRK 223
DIWS G I LL+ P S
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 224 IAK-ADYKFPTWF---SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
K A P F S LLS++L +P RI+ + + +P+F
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 91/272 (33%), Positives = 143/272 (52%), Gaps = 22/272 (8%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAID--KDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
LG G F KVY A+H TG A K I ++ L+ +V EI ++ +HPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNIVGL 67
Query: 76 YEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
YE + K++ ++E+ GG L ++ +G L E R +Q++ A++F HS V H
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI-----SRRG 187
RDLK N+LL +G +K+ DFG+S AK K T GTP ++APEV+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRKLLS 244
YD KADIWS G+ L L P H+ N M + KI K++ P+ +S+ L
Sbjct: 185 YDY-KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 245 RILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
L +P R + A+++++P+ ++K+ K
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFVSDQSDNKAIK 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 41/291 (14%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y++ +G+G V+ A+ TG++VA+K + + L+ G+ +Q REI ++ QHP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHP 59
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
V+++ +V + VMEY E+ + + L E + Y + L+ + + H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT-TCGTPAYVAPEVI--SR 185
G+ HRDLKP NLL+ +G+LK+ DFGL+ L ++ L++ T Y APE++ +R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLF--SEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM------------------------Y 221
+ YD D+W+ G I LL G F N + Y
Sbjct: 177 K-YDP-GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 222 RKIAKADYKFPTW------FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
KI + K S + LL +L +PS R+S A+ + +P+F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 9e-40
Identities = 87/278 (31%), Positives = 142/278 (51%), Gaps = 18/278 (6%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
TK ++ + +++ +++G+G F +V RH + Q A+K + K +++K E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAI 122
+M ++Q++ +Y VMEY GG+L +S + E AR Y +++ A+
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC--KHQDGLLH--TTCGTPAYV 178
D HS G HRD+KP+N+LLD++G LK+ DFG C +G++ T GTP Y+
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-----TCMKMDANGMVRCDTAVGTPDYI 210
Query: 179 APEVISRRGYD---GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFPT 233
+PEV+ +G D G + D WS GV LY +L G PF+ +L+ Y KI K FP
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270
Query: 234 --WFSADVRKLLSRILDPNPST--RISIAKIMENPWFR 267
S + L+ L R + +I +P+F+
Sbjct: 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 89/262 (33%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM-QI 75
+LG+G+F KV A GT + AIK + KD +++ V+ T E V+ L P + Q+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ + ++YFVMEY GG+L + + GK KE A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQ--DGL-LHTTCGTPAYVAPEVISRRGYDGD 191
LK +N++LD G +K+ DFG+ CK DG+ T CGTP Y+APE+I+ + Y G
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W+ GV+LY +LAG PF + +++ I + + +P S + + ++ +P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240
Query: 252 STRISIAK-----IMENPWFRK 268
S R+ I E+ +FR+
Sbjct: 241 SKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 85/253 (33%), Positives = 134/253 (52%), Gaps = 12/253 (4%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
+++G+G+F KV A+ G A+K + K ILK + E +V+ + ++HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ + K+YFV++Y GGELF + + + E AR Y ++ SAI + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPAYVAPEVISRRGYDG 190
DLKPEN+LLD G + +TDFGL CK + T CGTP Y+APEV+ + YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD- 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
D W G +LY +L G PF+ ++ MY I + P + LL +L +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234
Query: 251 PSTRI-SIAKIME 262
R+ + A +E
Sbjct: 235 QRRRLGAKADFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 89/277 (32%), Positives = 157/277 (56%), Gaps = 21/277 (7%)
Query: 12 YELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI 67
+EL ++LG G + KV+ R + TG+ A+K + K ++ K V+ T+ E +V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 68 -QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFC 125
Q P ++ ++ ++ K++ +++Y GGE+F + + ED R Y ++I A++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD G + +TDFGLS L++ K + ++ CGT Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFH---DSNLMA-MYRKIAKADYKFPTWFSADV 239
+G G D WS G++++ LL G PF + N + + R+I K D FP++ +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 240 RKLLSRILDPNPSTRISIA-----KIMENPWFRKGLN 271
+ LL ++L +P R+ +I E+P+F KGL+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 82/255 (32%), Positives = 139/255 (54%), Gaps = 9/255 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y + R++G+G+F + +H+ + Q A+K I K V+ +++E ++ ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKL-KEDTARKYFQQLISAIDFCHS 127
N++ E + +Y VMEY GG+L +K+ +GKL EDT ++F Q+ + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
+ V HRD+K +N+ L +NG +K+ DFG + L T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRI 246
Y+ +K+DIWS G ILY L PF ++ + K+ + YK P+ +S ++R L+ ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 247 LDPNPSTRISIAKIM 261
NP +R S I+
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 7e-39
Identities = 86/269 (31%), Positives = 133/269 (49%), Gaps = 15/269 (5%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+++ L+G+G+F +V R TG A+K + K +L V + E ++ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
+ Q+ K +Y VMEY GG+L +++ + ED A+ Y +L+ AI H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPEVI----- 183
HRD+KPEN+L+D G +K+ DFG +A L K + L GTP Y+APEV+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL--PVGTPDYIAPEVLTTMNG 180
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFPT--WFSADV 239
+G G + D WS GVI Y ++ G PFH+ Y I + KFP S+D
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRK 268
L+ +L R+ + +P+F K
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 87/261 (33%), Positives = 143/261 (54%), Gaps = 16/261 (6%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM-QI 75
+LG+G+F KV A GT + AIK + KD +++ V+ T E V+ L P + Q+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ + ++YFVMEY GG+L ++ + G+ KE A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQ--DGLLHTT-CGTPAYVAPEVISRRGYDGD 191
LK +N++LD G +K+ DFG+ CK DG+ T CGTP Y+APE+I+ + Y G
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM-----CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251
D W+ GV+LY +LAG PF + +++ I + + +P S + + ++ +P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 252 STRISIA-----KIMENPWFR 267
R+ I E+ +FR
Sbjct: 241 GKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 87/262 (33%), Positives = 142/262 (54%), Gaps = 14/262 (5%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ + + + +G+G F++VY A L G VA+K + ++ +EI +++ +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL------FKKVSKGKLKEDTARKYFQQLISAI 122
HPNV++ Y ++ V+E A G+L FKK K + E T KYF QL SA+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSAL 119
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
+ HSR V HRD+KP N+ + G++K+ D GL K H+ GTP Y++PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS--NLMAMYRKIAKADY-KFPT-WFSAD 238
I GY+ K+DIWS G +LY + A PF+ NL ++ +KI + DY P+ +S +
Sbjct: 178 IHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 239 VRKLLSRILDPNPSTRISIAKI 260
+R+L++ ++P+P R I +
Sbjct: 237 LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 71/259 (27%), Positives = 128/259 (49%), Gaps = 12/259 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQH 69
+E+ +G+G+F V+ + A+K ID + K+ ++ + E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQID---LSKMNRREREEAIDEARVLAKLDS 58
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
+++ YE K K+ VMEYA+ G+L K L ED ++F Q++ + H
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
S+ + HRD+K NL LD +K+ D G++ L +T GTP Y++PE+ +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSR 245
Y+ +K+D+W+ GV+LY G PF +N A+ KI + + +S + +L+ +
Sbjct: 177 PYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 246 ILDPNPSTRISIAKIMENP 264
L + R +++ NP
Sbjct: 236 CLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 84/266 (31%), Positives = 142/266 (53%), Gaps = 21/266 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE-----ISVMRLIQHPNV 72
+G+G+ V A TG+ VA+K +D L Q +RE + +MR QHPN+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+++Y +++ VME+ +GG L V+ ++ E+ ++ A+ F H++GV H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138
Query: 133 RDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
RD+K +++LL +G +K++DFG A ++K + L GTP ++APEVISR Y G
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPEVISRLPY-GT 194
Query: 192 KADIWSCGVILYVLLAGYLP-FHDSNLMAM--YRKIAKADYKFPTWFSADVRKLLSRILD 248
+ DIWS G+++ ++ G P F++ L AM R K S +R L R+L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254
Query: 249 PNPSTRISIAKIMENPWFRKGLNSKS 274
+P+ R + A+++ +P+ K S
Sbjct: 255 RDPAQRATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 75/258 (29%), Positives = 133/258 (51%), Gaps = 10/258 (3%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
Y R+LG+G F + R V K ++ ++ + D EI ++ L+QHPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD-ALNEIVILSLLQHPN 60
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFCHSR 128
++ Y + MEYA GG L+ K+ + K +E+ Y Q++SA+ + H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC-GTPAYVAPEVISRRG 187
G+ HRD+K N+ L + G++K+ DFG+S K + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRI 246
Y+ K+DIW+ G +LY LL F +N + + KI + +Y + +S+++ L+ +
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 247 LDPNPSTRISIAKIMENP 264
L +P R + ++++ P
Sbjct: 237 LQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 8e-38
Identities = 71/204 (34%), Positives = 109/204 (53%), Gaps = 11/204 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIK---AIDKDKILKVGLVDQTKREISVMRL 66
KYE+ ++G+G + V R+ TG+ VAIK + D+ +K RE+ V+R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDF 124
++H N++ + E K ++Y V EY + EL + S G L D R Y QL+ AI +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAY 115
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
CHS + HRD+KPEN+L+ E+G+LK+ DFG + + + L T Y APE++
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPELLV 174
Query: 185 RRGYDGDKADIWSCGVILYVLLAG 208
G D+W+ G I+ LL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-38
Identities = 87/264 (32%), Positives = 143/264 (54%), Gaps = 14/264 (5%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ +++ + +G+G F++VY A L + VA+K + +++ +EI +++ +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL------FKKVSKGKLKEDTARKYFQQLISAI 122
HPNV++ + ++ V+E A G+L FKK K + E T KYF QL SA+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAV 119
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
+ HSR V HRD+KP N+ + G++K+ D GL K H+ GTP Y++PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS--NLMAMYRKIAKADY-KFPT-WFSAD 238
I GY+ K+DIWS G +LY + A PF+ NL ++ +KI + DY PT +S
Sbjct: 178 IHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 239 VRKLLSRILDPNPSTRISIAKIME 262
+R+L+S + P+P R I + +
Sbjct: 237 LRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 82/267 (30%), Positives = 140/267 (52%), Gaps = 23/267 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQS-VAIKAID-------KDKILKVGLVDQTKREISV 63
Y + LG G F VY R GQ+ +A+K I+ KDK + + E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 64 MR-LIQHPNVMQIYEVMASKTKIYFVMEYAKG---GELFK--KVSKGKLKEDTARKYFQQ 117
++ ++HPN+++ Y+ ++Y VM+ +G GE F K K + E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 118 LISAIDFCH-SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
++ A+ + H + + HRDL P N++L E+ + +TDFGL AK K + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTIL 178
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP---T 233
Y PE++ Y G+KAD+W+ G ILY + PF+ +N++++ KI +A Y+ P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEG 236
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKI 260
+S DV +++ L P+ R I ++
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 77/263 (29%), Positives = 133/263 (50%), Gaps = 15/263 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +++ LG+G++ VY A H TGQ VAIK + + + + +EIS+++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDS 57
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
P +++ Y T ++ VMEY G ++ K +K L E+ Q + +++ H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH 116
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
S HRD+K N+LL+E G K+ DFG+S + +T GTP ++APEVI
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKF--PTWFSADVRKLL 243
GY+ +KADIWS G+ + G P+ D + M A++ K P +S + +
Sbjct: 175 GYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 244 SRILDPNPSTRISIAKIMENPWF 266
+ L +P R S +++++P+
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 89/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE-----ISVM 64
+KY +GQG VY A + TGQ VAIK ++ L Q K+E I VM
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--------LQQQPKKELIINEILVM 70
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
R +HPN++ + +++ VMEY GG L V++ + E ++ + A++F
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HS V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIA---KADYKFPTWFSADVR 240
R+ Y G K DIWS G++ ++ G P+ + N L A+Y IA + + P SA R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFR 246
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFR 267
L+R L+ + R S +++++P+ +
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 95/284 (33%), Positives = 152/284 (53%), Gaps = 14/284 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY +GQG VY A + TGQ VAIK ++ + K L+ EI VMR ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKN 75
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
PN++ + +++ VMEY GG L V++ + E ++ + A+DF HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++R+ Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA--DYKFPTWFSADVRKLLSRI 246
G K DIWS G++ ++ G P+ + N L A+Y + + P SA R L+R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 247 LDPNPSTRISIAKIMENPWFR--KGLNSKSA---KSKTAIKESS 285
L+ + R S +++++P+ + K L+S + +K AIK SS
Sbjct: 253 LEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 15/260 (5%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
+++G+G+F KV A+ G+ A+K + K +L E +V+ + ++HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ + K+YFV+++ GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CGTPAYVAPEVISRRGYDG 190
DLKPEN+LLD G + +TDFGL CK TT CGTP Y+APEVI ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD- 174
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
+ D W G +LY +L G PF+ ++ MY I S +L +L+ +
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234
Query: 251 PSTRI----SIAKIMENPWF 266
R+ +I E+P+F
Sbjct: 235 RQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 85/274 (31%), Positives = 138/274 (50%), Gaps = 34/274 (12%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRL 66
+ YEL + +G G + VY AR + TG+ VAIK I D + ++EIS+++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKE 56
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDF 124
+HPN++ + + K++ VMEY GG L +V++G L E ++ + + +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCGTPAYVA 179
H G HRD+K N+LL E+G +K+ DFG+SA +AK K + GTP ++A
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-------SFIGTPYWMA 169
Query: 180 PEVI---SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--- 233
PEV + GYDG K DIW+ G+ L P D + M I+K+++ P
Sbjct: 170 PEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 234 ---WFSADVRKLLSRILDPNPSTRISIAKIMENP 264
W S + + L +P R + K++++P
Sbjct: 229 KEKW-SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 87/301 (28%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+ +G G F +V R + T A+K + K +L K E ++ + V+++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
Y K +YFVM+Y GG++ + G +ED AR Y +L AI+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGMLKVTDFGL------------------------------SALAKC--- 161
+KP+N+L+D +G +K+TDFGL S + +C
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 162 --------KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH 213
+HQ L H+ GTP Y+APEV+ R GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 214 DSNLMAMYRKIA--KADYKFPTW--FSADVRKLLSRILDPNPSTRI---SIAKIMENPWF 266
K+ + P+ S + L+ R L R+ +I +P+F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
Query: 267 R 267
+
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-37
Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 14/269 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ YE+ +++G+G F +V RH T + A+K + K +++K E +M
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
P V+Q++ +Y VMEY GG+L +S + E AR Y +++ A+D HS G
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH--TTCGTPAYVAPEVISRR- 186
HRD+KP+N+LLD++G LK+ DFG +++G++ T GTP Y++PEV+ +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 187 --GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFP--TWFSADVR 240
GY G + D WS GV LY +L G PF+ +L+ Y KI K FP S + +
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 241 KLLSRILDPNPST--RISIAKIMENPWFR 267
L+ L R + +I + +F+
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 72/267 (26%), Positives = 141/267 (52%), Gaps = 21/267 (7%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI------LKVGLVDQTKREISVMRLIQ 68
G L+G G+F VY + +G+ +A+K ++ + K ++D REI++++ +Q
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
H N++Q + +EY GG + ++ G +E R + +Q++ +++ H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--PA------YVA 179
RG+ HRD+K N+L+D G +K++DFG+S K + L T P+ ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISK----KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFPTWFSAD 238
PEV+ + Y KADIWS G ++ +L G PF D + A+++ A + P+ S++
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPW 265
L + + + + R + A+++++P+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 18/271 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ Y++ +++G+G F +V RH + + A+K + K +++K E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
P V+Q++ +Y VMEY GG+L +S + E A+ Y +++ A+D HS G
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--GLLH--TTCGTPAYVAPEVISR 185
+ HRD+KP+N+LLD++G LK+ DFG C D G++ T GTP Y++PEV+
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFG-----TCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 186 R---GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFP--TWFSAD 238
+ GY G + D WS GV L+ +L G PF+ +L+ Y KI K FP S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277
Query: 239 VRKLLSRILDPNPST--RISIAKIMENPWFR 267
+ L+ L R + +I ++P+F+
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 94/277 (33%), Positives = 160/277 (57%), Gaps = 25/277 (9%)
Query: 12 YELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI 67
+EL ++LG G + KV+ R + +G+ A+K + K I+ K + T+ E V+ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 68 -QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFC 125
Q P ++ ++ + TK++ +++Y GGELF +S + + KE + Y +++ A++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL--LHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD NG + +TDFGLS K H+D + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 184 SRRGYDG--DKA-DIWSCGVILYVLLAGYLPFH---DSNLMA-MYRKIAKADYKFPTWFS 236
RG DG DKA D WS GV++Y LL G PF + N A + R+I K++ +P S
Sbjct: 179 --RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 237 ADVRKLLSRILDPNPSTRISIA-----KIMENPWFRK 268
A + ++ R+L +P R+ +I ++P+F+K
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 92/285 (32%), Positives = 137/285 (48%), Gaps = 44/285 (15%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRLIQHPNVMQ 74
+G+G + VY AR TG+ VA+K I +D+ G+ REIS+++ + HPN+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDE----GVPSTAIREISLLKELNHPNIVR 62
Query: 75 IYEVMASKTKIYFVMEYAKGGELFK---KVSKGKLKEDTARKYFQQLISAIDFCHSRGVY 131
+ +V+ S+ K+Y V E+ +L K L + Y QL+ I +CHS V
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
HRDLKP+NLL+D G LK+ DFGL A A H T Y APE++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGL-ARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 192 KADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKA----------------DYK--FP 232
DIWS G I ++ F DS + ++R I + DYK FP
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSLPDYKPTFP 238
Query: 233 TWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPWF 266
W D+ K LLS++L +P+ RIS +++P+F
Sbjct: 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 50/294 (17%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK-----DKILKVGLVDQTKREI-SVMR 65
Y++ + LG G F VY AR+ TG+ VAIK + K ++ + + RE+ S+ +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-------REVKSLRK 53
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAID 123
L +HPN++++ EV ++YFV EY +G +L K E R Q++ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEV 182
H G +HRDLKPENLL+ ++K+ DFGL+ + + +T T Y APE+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEI 169
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI------------------ 224
+ R DIW+ G I+ L F S+ + KI
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229
Query: 225 -AKADYKFPTWF-----------SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
+K ++FP + S + L+ +L +P R + ++ +++P+F
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 86/274 (31%), Positives = 142/274 (51%), Gaps = 30/274 (10%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQ 74
R++G+G++AKV T + A+K I K+ + +D + E V HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ ++++++FV+E+ GG+L F + KL E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKH--QDGLLHTT-CGTPAYVAPEVISRRGYD- 189
DLK +N+LLD G +K+TD+G+ CK + G +T CGTP Y+APE++ RG D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGIRPGDTTSTFCGTPNYIAPEIL--RGEDY 173
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF----------PTWFSADV 239
G D W+ GV+++ ++AG PF D M+ DY F P S
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF-DIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 240 RKLLSRILDPNPSTRI------SIAKIMENPWFR 267
+L L+ +P R+ I +P+FR
Sbjct: 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 62/294 (21%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G +A VY R+ TG+ VA+K I D + G REIS+M+ ++H N++++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 78 VMASKTKIYFVMEYAKGGELFKKV----SKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
V+ ++ K+ V EY +L K + +G L +T + + QL+ I FCH V HR
Sbjct: 66 VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-----------YVAPEV 182
DLKP+NLL+++ G LK+ DFGL+ G P Y AP+V
Sbjct: 125 DLKPQNLLINKRGELKLADFGLA-------------RAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 183 I-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN------------------LMAMYRK 223
+ R Y DIWS G I+ ++ G F +N +
Sbjct: 172 LLGSRTYS-TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 224 IAKADYKFPTWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPWF 266
+ + FP + D+++ LL R+L NP RIS +++PWF
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 85/285 (29%), Positives = 147/285 (51%), Gaps = 24/285 (8%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM--- 64
L Q+ EL +G+G + VY +H+ TG+ VA+K I+ D V +RE++++
Sbjct: 2 LYQRLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQL 56
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
R Q PN+ + Y +++ +MEYA+GG + + G + E ++++ A+ +
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL---AKCKHQDGLLHTTCGTPAYVAPE 181
H GV HRD+K N+L+ G +K+ DFG++AL K T GTP ++APE
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-----TFVGTPYWMAPE 171
Query: 182 VISR-RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFP-TWFSAD 238
VI+ + YD KADIWS G+ +Y + G P+ D + AM + +S
Sbjct: 172 VITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL 230
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
+R+ ++ LD P R+S +++++ W + + S + +KE
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIK----AHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 85/276 (30%), Positives = 139/276 (50%), Gaps = 29/276 (10%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQH 69
+EL ++G+G + KVY ARH TGQ VAIK +D + + ++ K E +++R H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSNH 62
Query: 70 PNVMQIYEVMASKT------KIYFVMEYAKGG---ELFKKV--SKGKLKEDTARKYFQQL 118
PN+ Y K +++ VME GG +L K + +LKE+ ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
+ + + H V HRD+K +N+LL +N +K+ DFG+S A+ G +T GTP ++
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGTPYWM 180
Query: 179 APEVIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD---Y 229
APEVI+ YD ++D+WS G+ L G P D + M A++ KI +
Sbjct: 181 APEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPPTL 238
Query: 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265
K P +S +S L N R + +++E+P+
Sbjct: 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 67/261 (25%), Positives = 125/261 (47%), Gaps = 18/261 (6%)
Query: 13 ELGRLLGQGNFAKVYYARHLG----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
LG+ LG+G F +VY + G VA+K + +D + +++ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
HPNV+++ V + +Y VMEY +GG+L + + ++ KL + Q+ +++
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APEVI 183
S+ HRDL N L+ EN ++K++DFGLS D + G + APE +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 184 SRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRK 241
+ K+D+WS GV+L+ + G P+ + + + P ++
Sbjct: 176 KEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234
Query: 242 LLSRILDPNPSTRISIAKIME 262
L+ + +P R + ++++E
Sbjct: 235 LMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 68/242 (28%), Positives = 124/242 (51%), Gaps = 13/242 (5%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIK-------AIDKDKILKVGLVDQTKREISVMRLI 67
G L+G+G + +VY A ++ TG+ +A+K + + +V + EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCH 126
H N++Q ++ + +EY GG + + G+ +E R + +Q++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI--S 184
S+G+ HRDLK +NLL+D +G+ K++DFG+S + + + + G+ ++APEVI
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244
+GY K DIWS G ++ + AG P+ D +A K+ P DV LS
Sbjct: 186 SQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--IPPDVSMNLS 242
Query: 245 RI 246
+
Sbjct: 243 PV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN V H TG+ +A+K I + + + Q RE+ ++ P ++ Y
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 78 VMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHS-RGVYHRD 134
+ I MEY GG L K +G++ E K ++ + + H + HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKAD 194
+KP N+L++ G +K+ DFG+S + + L T GT +Y+APE I Y K+D
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SVKSD 181
Query: 195 IWSCGVILYVLLAGYLPF--HDSNLMAMY---RKIAKADY-KFPT-WFSADVRKLLSRIL 247
IWS G+ L L G P+ + ++ + I + P+ FS D + ++ L
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 248 DPNPSTRISIAKIMENPWFRK 268
+P R S +++E+P+ +K
Sbjct: 242 IKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 4e-34
Identities = 87/305 (28%), Positives = 132/305 (43%), Gaps = 58/305 (19%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMRL 66
+YEL + +G G + V A TG+ VAIK KI V L+D + REI ++R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRH 55
Query: 67 IQHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLI 119
++H N++ + +++ + +Y V E +L KV S L +D + + Q++
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDL-HKVIKSPQPLTDDHIQYFLYQIL 113
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG--TPAY 177
+ + HS V HRDLKP N+L++ N LK+ DFGL A +D T T Y
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLTEYVVTRWY 172
Query: 178 VAPEVI-SRRGYDGDKA-DIWSCGVILYVLLAG--YLPFHDS------------------ 215
APE++ S Y KA DIWS G I LL P D
Sbjct: 173 RAPELLLSSSRY--TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 216 ----------NLMAMYRKIAKADY--KFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263
N + K K FP S + LL ++L +P RI+ + + +
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 264 PWFRK 268
P+ +
Sbjct: 290 PYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G + VY AR+ TG+ VA+K I D + G+ REIS+++ + HPN++++ +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 78 VMASKTKIYFVMEYAKGGELFKK----VSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
V+ ++ K+Y V E+ + KK + + Y QL+ + FCHS V HR
Sbjct: 67 VIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKA 193
DLKP+NLL++ G +K+ DFGL A A H T Y APE++ Y
Sbjct: 125 DLKPQNLLINTEGAIKLADFGL-ARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 182
Query: 194 DIWSCGVILYVLLAGYLPF-HDSNLMAMYRKI---------------AKADYK--FPTW- 234
DIWS G I ++ F DS + ++R + DYK FP W
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242
Query: 235 ----------FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
D R LLS++L +P+ RIS + +P+F
Sbjct: 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-34
Identities = 90/285 (31%), Positives = 155/285 (54%), Gaps = 21/285 (7%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E+ +++G+G F +V + TGQ A+K ++K ++LK + E V+
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
+ ++ + +Y VM+Y GG+L +SK +L ED AR Y +++ AID H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEVISR-- 185
HRD+KP+N+LLD+NG +++ DFG S L DG + + GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLA--DGTVQSNVAVGTPDYISPEILQAME 179
Query: 186 --RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFP---TWFSAD 238
+G G + D WS GV +Y +L G PF+ +L+ Y KI K ++FP T S +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 239 VRKLLSRILDPNPSTRI---SIAKIMENPWFRKGLNSKSAKSKTA 280
+ L+ R++ P TR+ + ++P+F +G++ + ++ TA
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFF-EGIDWDNIRNSTA 282
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 83/261 (31%), Positives = 140/261 (53%), Gaps = 9/261 (3%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY +GQG V+ A + TGQ VAIK I+ K K L+ EI VM+ +++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKN 75
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
PN++ + +++ VMEY GG L V++ + E ++ + A++F H+
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++R+ Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA--DYKFPTWFSADVRKLLSRI 246
G K DIWS G++ ++ G P+ + N L A+Y + + P S R L+R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 247 LDPNPSTRISIAKIMENPWFR 267
L+ + R S +++++P+ +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 91/283 (32%), Positives = 150/283 (53%), Gaps = 14/283 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY +GQG VY A + TGQ VAI+ ++ + K L+ EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKN 76
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
PN++ + +++ VMEY GG L V++ + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++R+ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA--DYKFPTWFSADVRKLLSRI 246
G K DIWS G++ ++ G P+ + N L A+Y + + P SA R L+R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 247 LDPNPSTRISIAKIMENPWFR--KGLNSKS---AKSKTAIKES 284
LD + R S +++++ + + K L+S + A +K A K +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 84/284 (29%), Positives = 137/284 (48%), Gaps = 43/284 (15%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHPNVMQIY 76
+G+G F++V A+ TG+ AIK + K + V+ REI +R L HPN++++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNL-REIQALRRLSPHPNILRLI 64
Query: 77 EVMASKT--KIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
EV+ + ++ V E EL K K L E + Y QL+ ++D H G++H
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRRGYDGD 191
RD+KPEN+L+ ++ +LK+ DFG S +T T Y APE + GY G
Sbjct: 124 RDIKPENILIKDD-ILKLADFG-SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGP 178
Query: 192 KADIWSCGVILYVLLAGYLPF------------HD------SNLMAMYRKIAKADYKFP- 232
K DIW+ G + + +L+ + F HD + ++ +RK +Y FP
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238
Query: 233 ---TWF-------SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
T SA+ LL ++L +P RI+ + + +P+F
Sbjct: 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAID---KDKILKVGLVDQTKREISVMRLIQHPN 71
G+ LG G F+ Y AR + TG +A+K + + +V+ ++EI +M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130
++++ + +E+ GG + +SK G KE Y +QL+ + + H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 131 YHRDLKPENLLLDENG-MLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
HRD+K NLL+D G L++ DFG +A AK GT A++APEV+
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHD---SNLMAMYRKIAKADY--KFPTWFSADVRKL 242
Y G D+WS G ++ + P++ SN +A+ KIA A P S +R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 243 LSRILDPNPSTRISIAKIMENPWFR 267
R L+ P R +++++P FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 25/209 (11%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQ-----TKREISVMRL 66
YE +G+G + VY AR L TG+ VA+K + +V L ++ T REI++++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLREIALLKQ 54
Query: 67 IQ---HPNVMQIYEV-----MASKTKIYFVMEYAKG--GELFKKVSKGKLKEDTARKYFQ 116
++ HPN++++ +V + K+ V E+ K K L +T + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
QL+ +DF HS + HRDLKP+N+L+ +G +K+ DFG LA+ + L + T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG---LARIYSFEMALTSVVVTLW 171
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVL 205
Y APEV+ + Y D+WS G I L
Sbjct: 172 YRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 85/273 (31%), Positives = 145/273 (53%), Gaps = 28/273 (10%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
R++G+G++AKV R T + A+K + K+ + +D + E V + HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ ++++++FV+EY GG+L F + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CGTPAYVAPEVISRRGYD- 189
DLK +N+LLD G +K+TD+G+ CK TT CGTP Y+APE++ RG D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPNYIAPEIL--RGEDY 173
Query: 190 GDKADIWSCGVILYVLLAGYLPFH--------DSNLMA-MYRKIAKADYKFPTWFSADVR 240
G D W+ GV+++ ++AG PF D N +++ I + + P S
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233
Query: 241 KLLSRILDPNPSTRI------SIAKIMENPWFR 267
+L L+ +P R+ A I +P+FR
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 82/245 (33%), Positives = 126/245 (51%), Gaps = 11/245 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREISVMRLIQH 69
+ LG+LLGQG F +VY TG+ +A+K + D + V+ + EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 70 PNVMQIYEVM--ASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCH 126
++Q Y + + + ME+ GG + ++ S G L E+ RKY +Q++ + + H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK--CKHQDGLLHTTCGTPAYVAPEVIS 184
S + HRD+K N+L D G +K+ DFG S + C G+ T GTP +++PEVIS
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADYKFPTWFSADVRKL 242
GY G KADIWS G + +L P+ + MA KIA + P S R
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 243 LSRIL 247
L RI
Sbjct: 242 LKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 21/263 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLI 67
LG+ LG+G F +VY G G ++ A+ K LK +Q RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAV---KTLKEDASEQQIEEFLREARIMRKL 58
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDF 124
HPN++++ V + + VMEY GG+L +K +L + Q+ +++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APE 181
S+ HRDL N L+ EN ++K++DFGLS D + G + APE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 182 VISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADV 239
+ + K+D+WS GV+L+ + G P+ + + + K P ++
Sbjct: 175 SLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 240 RKLLSRILDPNPSTRISIAKIME 262
KL+ + +P R + ++++E
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 5e-33
Identities = 70/263 (26%), Positives = 127/263 (48%), Gaps = 21/263 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLI 67
ELG+ LG+G F +VY G G+ K A+ K LK G ++ + E S+M+ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAV---KTLKEGASEEEREEFLEEASIMKKL 58
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFC 125
HPN++++ V +Y V EY GG+L F + KL + Q+ +++
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEV 182
S+ HRDL N L+ EN ++K++DFGLS + ++D G ++APE
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLS---RDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 183 ISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY--KFPTWFSADV 239
+ + K+D+WS GV+L+ + G P+ + + + + Y P ++
Sbjct: 176 LKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDEL 233
Query: 240 RKLLSRILDPNPSTRISIAKIME 262
+L+ + +P R + ++++E
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 91/295 (30%), Positives = 142/295 (48%), Gaps = 63/295 (21%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G + VY R+ TGQ VA+K I + + + G+ REIS+++ +QHPN++ + +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 78 VMASKTKIYFVMEYAKGGELFKK----VSKGK-LKEDTARKYFQQLISAIDFCHSRGVYH 132
V+ ++++Y + E+ KK + KG+ + + + Y Q++ I FCHSR V H
Sbjct: 67 VLMQESRLYLIFEFLSMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-----------YVAPE 181
RDLKP+NLL+D G++K+ DFGL+ G P Y APE
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLA-------------RAFGIPVRVYTHEVVTLWYRAPE 171
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLP-FH-DS---NLMAMYRKIAKA--------- 227
V+ DIWS G I + +A P FH DS L ++R +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230
Query: 228 ---DYK--FPTWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPWF 266
DYK FP W +R LL ++L +P+ RIS K + +P+F
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 86/286 (30%), Positives = 149/286 (52%), Gaps = 26/286 (9%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID--KDKILKVGLVDQTKREISVMRLI 67
+ +E+ LG G F KVY A++ TG A K I+ ++ L+ +V EI ++
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATC 66
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGE---LFKKVSKGKLKEDTARKYFQQLISAIDF 124
HP ++++ K++ ++E+ GG + ++ +G L E + +Q++ A+ +
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQY 125
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPEV 182
HS + HRDLK N+LL +G +K+ DFG+SA + + +D + GTP ++APEV
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEV 181
Query: 183 I-----SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTW 234
+ YD KADIWS G+ L + P H+ N M + KIAK++ P+
Sbjct: 182 VMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTA 280
+S + R L LD +P TR S A+++E+P+ +++ + A
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVA 286
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI--LKVGLVDQTKREISVMRLIQ 68
+Y L + LG+G+F VY + +K + + + L Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQLISAID 123
HP +++ + + + EY +G +L K+ + K L E+ ++F QL+ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPAYVAPE 181
+ H R + HRDLK +N+ L N +LK+ DFG+S L C L T GTP Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATTFTGTPYYMSPE 175
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVR 240
+ +GYD K+DIWS G ILY + F N +++ +I + P +S +
Sbjct: 176 ALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234
Query: 241 KLLSRILDPNPSTRISIAKIMENPW 265
++ +L+ +PS R S A+I+ NP+
Sbjct: 235 SIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 84/243 (34%), Positives = 126/243 (51%), Gaps = 13/243 (5%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREISVMRLIQHPNV 72
G+LLGQG F +VY + TG+ +A K + D + V + EI +++ +QH +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 73 MQIYEVM---ASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSR 128
+Q Y + A KT F MEY GG + ++ + G L E RKY +Q++ + + HS
Sbjct: 67 VQYYGCLRDRAEKTLTIF-MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAK--CKHQDGLLHTTCGTPAYVAPEVISRR 186
+ HRD+K N+L D G +K+ DFG S + C G+ T GTP +++PEVIS
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSPEVISGE 184
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADYKFPTWFSADVRKLLS 244
GY G KAD+WS G + +L P+ + MA KIA + + P+ S R L
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLG 243
Query: 245 RIL 247
I
Sbjct: 244 CIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 79/243 (32%), Positives = 113/243 (46%), Gaps = 47/243 (19%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+ LG G F +V AR + T A+K + K +L V K E ++ + V+++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
Y K +YFVM+Y GG++ + + G ED AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGMLKVTDFGL--------------------------------SALAKC- 161
+KP+N+L+D +G +K+TDFGL A +C
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 162 ------------KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209
+HQ L H+ GTP Y+APEV+ R GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 210 LPF 212
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 78/252 (30%), Positives = 136/252 (53%), Gaps = 18/252 (7%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQ 74
R++G+G++AKV R Q A+K + K+ + +D + E V + +P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 75 IYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
++ + ++++ V+EY GG+L F + KL E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CGTPAYVAPEVISRRGYDG 190
DLK +N+LLD +G +K+TD+G+ CK G TT CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-G 174
Query: 191 DKADIWSCGVILYVLLAGYLPFH------DSNLMA-MYRKIAKADYKFPTWFSADVRKLL 243
D W+ GV+++ ++AG PF D N +++ I + + P + S +L
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
Query: 244 SRILDPNPSTRI 255
L+ +P R+
Sbjct: 235 KGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 83/258 (32%), Positives = 141/258 (54%), Gaps = 21/258 (8%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE-----ISVMRLIQHPNV 72
+G+G+ V AR +G+ VA+K +D L Q +RE + +MR QH NV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+++Y+ +++ +ME+ +GG L VS+ +L E+ + ++ A+ + HS+GV H
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 133 RDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
RD+K +++LL +G +K++DFG A ++K + L GTP ++APEVISR Y G
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GT 196
Query: 192 KADIWSCGVILYVLLAGYLP-FHDSNLMAM--YRKIAKADYKFPTWFSADVRKLLSRILD 248
+ DIWS G+++ ++ G P F DS + AM R K S +R L R+L
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 249 PNPSTRISIAKIMENPWF 266
P R + +++++P+
Sbjct: 257 REPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 16/263 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G F +V + TG+ A K +DK ++ K E ++ + ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 78 VMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+K + VM GG+L V + E A Y Q+I ++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKAD 194
LKPEN+LLD++G ++++D GL+ K + + GTP Y+APEV+ YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF-SVD 176
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTWFSADVRKLLSRILDPN 250
++ G LY ++AG PF + R+ + ++P FS + + L +L +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 251 PSTRI-----SIAKIMENPWFRK 268
P R+ S ++ E+P F+
Sbjct: 237 PEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-31
Identities = 77/244 (31%), Positives = 125/244 (51%), Gaps = 9/244 (3%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREISVMRLIQH 69
+ LG+LLG+G F +VY TG+ +A+K + D D V+ + EI +++ ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 70 PNVMQIYEVMASKT--KIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCH 126
++Q Y + K+ +EY GG + ++ + G L E+ R+Y +Q++ + + H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL-LHTTCGTPAYVAPEVISR 185
S + HRD+K N+L D G +K+ DFG S + G + + GTP +++PEVIS
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADVRKLL 243
GY G KAD+WS + +L P+ + MA KIA K P S R L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 244 SRIL 247
+I
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 90/354 (25%), Positives = 150/354 (42%), Gaps = 60/354 (16%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+++G+G F +V + TG+ A+K + K ++ K + K E V+ P V+ +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHSRGVYHRD 134
Y +Y +ME+ GG+L + K ED R Y + + AI+ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDG---------------------------- 166
+KP+N+L+D G +K++DFGLS +H
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 167 -----------------LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209
+ ++T GTP Y+APE+ ++GY G + D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 210 LPFHDSNLMAMYRKIA--KADYKFPT--WFSADVRKLLSRILDPNPSTRI---SIAKIME 262
PF N YRKI + FP S + L+ R++ N R+ +I
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304
Query: 263 NPWFRKGLNSKSAKSKTAIKESSLVDV-DAAFGP---IENSASTEAPRPMTKPD 312
+P+FR G++ + + A L + D ++ P +E A +
Sbjct: 305 HPFFR-GVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQ 357
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 78/251 (31%), Positives = 136/251 (54%), Gaps = 16/251 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +E+ +++G+G F +V + + A+K ++K ++LK + E V+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS 127
+ ++ + +Y VM+Y GG+L +SK +L ED AR Y +++ AID H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEVISR 185
HRD+KP+N+L+D NG +++ DFG S L +DG + ++ GTP Y++PE++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLM--EDGTVQSSVAVGTPDYISPEILQA 177
Query: 186 ----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFP---TWFS 236
+G G + D WS GV +Y +L G PF+ +L+ Y KI K ++FP T S
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 237 ADVRKLLSRIL 247
D + L+ R++
Sbjct: 238 EDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 78/249 (31%), Positives = 135/249 (54%), Gaps = 16/249 (6%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E+ +++G+G F +V + T + A+K ++K ++LK + E +V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
+ ++ + +Y VM+Y GG+L +SK +L ED AR Y +++ AI H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEVISR-- 185
HRD+KP+N+LLD NG +++ DFG S L +QDG + ++ GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLK--MNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 --RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFP---TWFSAD 238
G G + D WS GV +Y +L G PF+ +L+ Y KI + ++FP T S +
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 239 VRKLLSRIL 247
+ L+ R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 83/273 (30%), Positives = 142/273 (52%), Gaps = 24/273 (8%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMR 65
+KY + R+LG G V A+ + G+ A+K +D + G+ + K E+ +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLL 86
Query: 66 LIQHPNVMQIYEVMASKTK--------IYFVMEYAKGGELFKKV-SKGK----LKEDTAR 112
++++ +E A K I V++YA G+L +++ S+ K +E A
Sbjct: 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
F Q++ A+ HS+ + HRD+K N+LL NG++K+ DFG S + D + T C
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKF 231
GTP YVAPE+ R+ Y KAD++S GV+LY LL PF N+ M++ +A
Sbjct: 207 GTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKIMENP 264
P S +++++++ +L +P R S +K++ P
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 47/243 (19%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+ LG G F +V A + T A+K + K +L V K E ++ + V+++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
Y K +YFVM+Y GG++ + + E AR Y +L AI+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGMLKVTDFGLSA------------------------------------- 157
+KP+N+L+D +G +K+TDFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 158 --------LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209
A +HQ L H+ GTP Y+APEV+ R+GY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 210 LPF 212
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 86/296 (29%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI----DKDKILKVGLVDQTKREISVMR 65
+KYE L+G+G++ V +H TGQ VAIK D + K+ + REI +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLK 55
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAID 123
++H N++ + EV K ++Y V E+ L +K G L E RKY Q++ I+
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIE 114
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEV 182
FCHS + HRD+KPEN+L+ ++G++K+ DFG A+ G ++T T Y APE+
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFG---FARTLAAPGEVYTDYVATRWYRAPEL 171
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAG--YLP-------------------------FHDS 215
+ G DIW+ G ++ +L G P F +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 216 NLMAMYR-----KIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
L A R +I + +FP S V L + L +P R S ++++ + +F
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 33/270 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRLIQH 69
E +G G VY H TG+ A+K I +D + + Q REI ++R + H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
PNV++ +++ +I ++E+ GG L ++ + D AR Q++S I + H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLS-ALAK----CKHQDGLLHTTCGTPAYVAPEVI 183
+ HRD+KP NLL++ +K+ DFG+S LA+ C +++ GT AY++PE I
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-------NSSVGTIAYMSPERI 240
Query: 184 ----SRRGYDGDKADIWSCGVILYVLLAGYLPF---HDSNLMAMYRKIAKADY-KFPTWF 235
+ YDG DIWS GV + G PF + ++ I + + P
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPW 265
S + R +S L P+ R S +++++P+
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 73/253 (28%), Positives = 134/253 (52%), Gaps = 9/253 (3%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+ V A TG+ VA+K +D K + L+ E+ +MR H NV+ +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
+++ VME+ +GG L V+ ++ E+ ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
+++LL +G +K++DFG A+ + + GTP ++APEVISR Y G + DIWS
Sbjct: 147 DSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 198 CGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLSRILDPNPSTR 254
G+++ ++ G P+ + + R+I K S+ +R L +L PS R
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263
Query: 255 ISIAKIMENPWFR 267
+ +++++P+ +
Sbjct: 264 ATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 74/255 (29%), Positives = 136/255 (53%), Gaps = 9/255 (3%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+ V A +G+ VA+K +D K + L+ E+ +MR QH NV+++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
+++ VME+ +GG L V+ ++ E+ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
+++LL +G +K++DFG A+ + + GTP ++APE+ISR Y G + DIWS
Sbjct: 145 DSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 198 CGVILYVLLAGYLPFHDS---NLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254
G+++ ++ G P+ + M M R K S ++ L R+L +P+ R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 255 ISIAKIMENPWFRKG 269
+ A+++++P+ K
Sbjct: 262 ATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 75/247 (30%), Positives = 119/247 (48%), Gaps = 35/247 (14%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E +++G+G F +V + TG A+K + K +L+ V + E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSRGV 130
V++++ K +Y +ME+ GG++ + K L E+ + Y + + AID H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 131 YHRDLKPENLLLDENGMLKVTDFGL-SALAKC---------------------------- 161
HRD+KP+NLLLD G +K++DFGL + L K
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 162 ----KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL 217
K++ L ++T GTP Y+APEV + GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 218 MAMYRKI 224
YRK+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 80/264 (30%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-LKVG--LVDQTKREISVMRLIQHPNVM 73
++G+G F +VY R TG+ A+K +DK +I +K G L + +S++ P ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+ + K+ F+++ GG+L +S+ G E R Y ++I ++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR-RGYDGD 191
RDLKP N+LLDE+G ++++D GL+ C H + GT Y+APEV+ + YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYD-S 175
Query: 192 KADIWSCGVILYVLLAGYLPFH---DSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248
AD +S G +L+ LL G+ PF + + R + P FS ++R LL +L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 249 PNPSTRI-----SIAKIMENPWFR 267
+ + R+ ++ E+P+FR
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 54/297 (18%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRLI 67
KYE +G+G + V+ A++ T + VA+K + D D+ G+ REI +++ +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE----GVPSSALREICLLKEL 56
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV---SKGKLKEDTARKYFQQLISAIDF 124
+H N++++Y+V+ S K+ V EY + KK G + + + + QL+ + F
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL----AKCKHQDGLLHTTCGTPAYVAP 180
CHS V HRDLKP+NLL+++NG LK+ DFGL+ +C + + T Y P
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------TLWYRPP 168
Query: 181 EVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFH-----DSNLMAMYRKIAK-------- 226
+V+ + Y D+WS G I L P D L ++R +
Sbjct: 169 DVLFGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 227 ----ADYKF-------PTW------FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
DYK + ++ R LL +L NP RIS + +++P+F
Sbjct: 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 37/292 (12%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M +YE +G+G + VY AR T +++A+K I ++ G+ REIS+++ +Q
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKED--TARKYFQQLISAIDFC 125
H N++++ +V+ S+ ++Y V EY +L K + S ++ + Y Q++ I +C
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 126 HSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HS V HRDLKP+NLL+D LK+ DFGL A A H T Y APE++
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGL-ARAFGIPVRTFTHEVV-TLWYRAPEILL 176
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPF-HDSNLMAMYRKI---------------AKAD 228
+ DIWS G I ++ F DS + +++ + D
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 229 YK--FPTWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPWFR 267
YK FP W D+ LLS++L +PS RI+ +E+ +F+
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 58/292 (19%)
Query: 20 QGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM 79
+G + VY AR TG+ VA+K + +K K G + REI+++ +QHPN++ + EV+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 80 ASKT--KIYFVMEYAKGGELFKKVSKGKLKEDTARKYF---------QQLISAIDFCHSR 128
KIY VMEY + +L K + +T ++ F QL+S + H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DL-----KSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG--TPAYVAPEVISRR 186
+ HRDLK NLLL+ G+LK+ DFGL+ ++ L T T Y APE++
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM--------------------------AM 220
D+WS G I LL F + + A
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 221 YRKIAKADY-----KFPTWFSADVR-KLLSRILDPNPSTRISIAKIMENPWF 266
+ K Y KFP +D LL+R+L +P+ RIS +++P+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 16 RLLGQGNFAKVYYAR-HLGTGQS--VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+ LG+G F +VY + G++ VA+K + +D + +E VM+ + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKY---FQQLIS-AIDFC--- 125
+++ V + +Y V+EY +GG+L + K + + K + L+S AI
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 126 ---HSRGVYHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQDGLLHTTCGTPAY 177
S+ HRDL N L+ E+ ++K++DFGLS K G L +
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI-----RW 173
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYK--FPTW 234
+APE + + K+D+WS GV+L+ + G P+ + + + + Y+ P +
Sbjct: 174 MAPESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEY 231
Query: 235 FSADVRKLLSRILDPNPSTRISIAKI 260
++ +L+ +P R + +++
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 35/249 (14%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +E +++G+G F +V + TG A+K + K +L+ V + E ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSR 128
V++++ K +Y +ME+ GG++ + K L E+ + Y + + AID H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD----------------------- 165
G HRD+KP+NLLLD G +K++DFGL K H+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 166 ----------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS 215
L +T GTP Y+APEV + GY+ D WS GVI+Y +L GY PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 216 NLMAMYRKI 224
Y+K+
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 41/289 (14%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM 73
L R+ G+G + VY AR +G+ VA+K + D + G+ + REI+++ ++HPN++
Sbjct: 12 LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIV 69
Query: 74 QIYEVMASK--TKIYFVMEYAKG--GELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++ EV+ K I+ VMEY + L + E + QL+ + + H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYLHENF 128
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
+ HRDLK NLLL + G LK+ DFGL+ + T Y APE++
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 190 GDKADIWSCGVILYVLLAG--YLP----FHDSNLMA------------------MYRKIA 225
D+W+ G IL LLA LP +L+ + K
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 226 --KADY-----KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
K Y KFP W S +LL+ +L +P R + + +E+ +F+
Sbjct: 247 LPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 69/217 (31%), Positives = 115/217 (52%), Gaps = 9/217 (4%)
Query: 58 KREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARK---- 113
+ E+ + H +++ ++ S K+ +MEY GG+L K++ K +LKE +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEV 171
Query: 114 --YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT 171
F Q++ A+D HSR + HRDLK N+ L G++K+ DFG S + +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK- 230
CGTP Y+APE+ R+ Y KAD+WS GVILY LL + PF + + +++ Y
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
FP S+ ++ LL +L NP+ R + +++ + +
Sbjct: 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 80/301 (26%), Positives = 134/301 (44%), Gaps = 53/301 (17%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH- 69
YE +G+G + KVY AR TG+ VA+K + ++ + G+ REIS+++++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSES 60
Query: 70 PNVMQIYEVMASKTK-----IYFVMEY-----AKGGELFKKVSKGKLKEDTARKYFQQLI 119
++++ +V + K +Y V EY K + + L T + + QL+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 120 SAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLS-----ALAKCKHQDGLLHTTCG 173
+ CH GV HRDLKP+NLL+D + G+LK+ D GL + H+
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE-------IV 173
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF-HDS---NLMAMYRKIAKAD- 228
T Y APEV+ + DIWS G I + F DS L+ +++ +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 229 ------------YKFPTWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPW 265
++FP W D+ + LL ++L +P+ RIS + +P+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 266 F 266
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 74/246 (30%), Positives = 128/246 (52%), Gaps = 11/246 (4%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-LKVG--LVDQTKREISVMRLIQHPNVM 73
++G+G F +VY R TG+ A+K +DK +I +K G L + +S++ P ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+ + K+ F+++ GG+L +S+ G E R Y ++I ++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
RDLKP N+LLDE+G ++++D GL+ C H + GT Y+APEV+ +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMAMY---RKIAKADYKFPTWFSADVRKLLSRILDP 249
AD +S G +L+ LL G+ PF + R + + P FS +++ LL +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 250 NPSTRI 255
+ S R+
Sbjct: 237 DVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G G F V AR TGQ+VAIK I K V L +T RE+ +++ ++H N++ + +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHENIISLSD 76
Query: 78 VMAS-KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
+ S IYFV E G +L + ++ L++ + + Q++ + + HS GV HRDLK
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV-ISRRGYDGDKADI 195
P N+L++EN LK+ DFGL+ + QD + T Y APE+ ++ + YD + DI
Sbjct: 136 PSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYD-VEVDI 189
Query: 196 WSCGVILYVLLAG--YLPFHD-------------------------SNLMAMYRKIAKAD 228
WS G I +L G P D N + + + K +
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249
Query: 229 -----YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265
KF LL ++L +P RIS A+ + +P+
Sbjct: 250 PVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 77/269 (28%), Positives = 131/269 (48%), Gaps = 23/269 (8%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +EL + +G G + VY AR++ TG+ AIK I + +V Q EI +M+ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSR 128
N++ + + K++ ME+ GG L G L E ++ + + + HS+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCGTPAYVAPEV- 182
G HRD+K N+LL +NG +K+ DFG+SA +AK K + GTP ++APEV
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK-------SFIGTPYWMAPEVA 178
Query: 183 -ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW-----FS 236
+ R+G DIW+ G+ L P D + M + K++++ P +S
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238
Query: 237 ADVRKLLSRILDPNPSTRISIAKIMENPW 265
+ L NP R + K++++P+
Sbjct: 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 70/208 (33%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK-DKILKVGLVDQTKREISVMRLIQ 68
+Y+ +G+G + V A H TG VAIK I + +T REI ++R +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61
Query: 69 HPNVMQIYEVMASKT-----KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAID 123
H N++ I +++ + +Y V E + +L+K + L D + + Q++ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH-QDGLLHTTCGTPAYVAPEV 182
+ HS V HRDLKP NLLL+ N LK+ DFGL+ +A +H G L T Y APE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 183 -ISRRGYDGDKA-DIWSCGVILYVLLAG 208
++ +GY KA DIWS G IL +L+
Sbjct: 181 MLNSKGY--TKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 10/254 (3%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+F +V+ T Q VAIK ID ++ ++ ++EI+V+ P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
TK++ +MEY GG + G E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
N+LL E G +K+ DFG++ + +T GTP ++APEVI + YD KADIWS
Sbjct: 130 ANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWS 186
Query: 198 CGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW---FSADVRKLLSRILDPNPSTR 254
G+ L G P D + M + I K PT FS ++ + L+ +PS R
Sbjct: 187 LGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSFR 244
Query: 255 ISIAKIMENPWFRK 268
+ +++++ + K
Sbjct: 245 PTAKELLKHKFIVK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 75/260 (28%), Positives = 135/260 (51%), Gaps = 20/260 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG G F KVY A++ TG A K ID ++ + EI ++ HPN++++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPNIVKLLD 69
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGK--LKEDTARKYFQQLISAIDFCHSRGVYHRDL 135
+ ++ ++E+ GG + + + + L E R +Q + A+++ H + HRDL
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 136 KPENLLLDENGMLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPEVI-----SRRGY 188
K N+L +G +K+ DFG+SA + +D + GTP ++APEV+ R Y
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 185
Query: 189 DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRKLLSR 245
D KAD+WS G+ L + P H+ N M + KIAK++ P+ +S++ + L +
Sbjct: 186 DY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 246 ILDPNPSTRISIAKIMENPW 265
L+ N R + +++++P+
Sbjct: 245 CLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
EL RL G+G V R TG A+K I D L Q RE+ + + + P +
Sbjct: 5 ELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYI 61
Query: 73 MQIYE--VMASKTKIYFVMEYAKGGEL---FKKVSK--GKLKEDTARKYFQQLISAIDFC 125
++ Y + S + I MEY +GG L +KKV K G++ E K + ++ + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
HSR + HRD+KP N+LL G +K+ DFG+S L T GT Y+APE I
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMAPERIQG 177
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPF 212
+ Y +D+WS G+ L + PF
Sbjct: 178 KPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 73/266 (27%), Positives = 140/266 (52%), Gaps = 23/266 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE-------ISVM 64
Y R++G+G++ +V RH G+ IK K+ L + ++RE ++
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIK--------KLNLRNASRRERKAAEQEAQLL 53
Query: 65 RLIQHPNVMQIYEVMASKT-KIYFVMEYAKGGELFKKV--SKGKL-KEDTARKYFQQLIS 120
++HPN++ E + +Y VM + +GG+L+ K+ KGKL E+ ++F Q+
Sbjct: 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+ + H + + HRDLK +N+ L ++KV D G++ + ++Q + T GTP Y++P
Sbjct: 114 ALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSP 171
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM-YRKIAKADYKFPTWFSADV 239
E+ S + Y+ K+D+W+ G +Y + F+ ++ ++ YR I P +S ++
Sbjct: 172 ELFSNKPYNY-KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPEL 230
Query: 240 RKLLSRILDPNPSTRISIAKIMENPW 265
+L++ +L P R S+ I+ P+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 42/297 (14%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y+ +G G + V A +G+ VAIK I L +T RE+ ++R +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 71 NVMQIYEVMASKTK----IYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFC 125
N++ I +++ +Y VM+ +L + S L E+ R + QL+ + +
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEVI 183
HS V HRDLKP NLL++E+ L++ DFG++ + T T Y APE++
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 184 -SRRGYDGDKADIWSCGVILYVLLA------GYLPFHDSNLMAMY--------------- 221
S Y D+WS G I +L G H L+
Sbjct: 184 LSLPEYT-TAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 222 --RKI-----AKADYKFPTWF---SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
RK K + F S + LLS++L +P RI++ + +++P+ +
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 24/263 (9%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAI-DKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+LG+G + VY AR L T +AIK I ++D V EI++ ++H N++Q
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY 70
Query: 76 YEVMASKTKIYFVMEYAKGGELF----KKVSKGKLKEDTARKYFQQLISAIDFCHSRGVY 131
+ ME GG L K K E T Y +Q++ + + H +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 132 HRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQDGL---LHTTCGTPAYVAPEVISR-- 185
HRD+K +N+L++ +G++K++DFG K G+ T GT Y+APEVI +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFG-----TSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHD--SNLMAMYR-KIAKADYKFPTWFSADVRKL 242
RGY G ADIWS G + + G PF + AM++ + K + P SA+ +
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 243 LSRILDPNPSTRISIAKIMENPW 265
+ R +P+P R S ++++P+
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 72/254 (28%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR---EISVMRLIQHPN 71
G +LG+G + VY GQ +A+K ++ D + + ++ E+ +++ ++H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130
++Q I ME+ GG + +++ G L E KY +Q++ + + H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
HRD+K N++L NG++K+ DFG + H + +L + GTP ++APEVI+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-MLKSMHGTPYWMAPEVINE 182
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSAD---- 238
GY G K+DIWS G ++ + G P + +A I + P FSA
Sbjct: 183 SGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDF 241
Query: 239 VRKLLSRILDPNPS 252
V L+R PS
Sbjct: 242 VTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 83/321 (25%), Positives = 124/321 (38%), Gaps = 61/321 (19%)
Query: 1 METKGKVLMQKYE-LGRLLGQGNFAKVYYARHLGTGQSVAIKAI-----------DKDKI 48
M ++Y G LG+G + KV A TG+ VAIK + D+ +
Sbjct: 2 MSFSIS---ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV 58
Query: 49 LKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKL 106
G+ T RE+ +M I+H N+M + +V I VM+ KKV K +L
Sbjct: 59 GMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRL 116
Query: 107 KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS---------- 156
E + Q+++ ++ H HRDL P N+ ++ G+ K+ DFGL+
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 157 ALAKCKHQDGLLHTTCG--TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD 214
L+K + T T Y APE++ D+WS G I LL G F
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 215 SN---------------------------LMAMYRKIAKADYK--FPTWFSADVRKLLSR 245
N L + D K FP S D LL
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN-ASDDAIDLLQS 295
Query: 246 ILDPNPSTRISIAKIMENPWF 266
+L NP RIS + +++ +F
Sbjct: 296 LLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 77/245 (31%), Positives = 127/245 (51%), Gaps = 38/245 (15%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
G+ + +YE+ + +G G F +V+ +H T + KAI + LK Q E++VM
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVM 66
Query: 65 RLIQHPNVMQIYEVMASKT--KIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQ 117
R ++H N+++ + +K K+Y +ME+ G+L + + K GK++E +Q
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 118 LISAIDFCHS-------RGVYHRDLKPENLLLDE---------------NG--MLKVTDF 153
L+ A+ +CH+ V HRDLKP+N+ L NG + K+ DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLP 211
GLS K + + H+ GTP Y +PE++ + YD DK+D+W+ G I+Y L +G P
Sbjct: 187 GLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTP 242
Query: 212 FHDSN 216
FH +N
Sbjct: 243 FHKAN 247
|
Length = 1021 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 12/261 (4%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+F +V+ T + VAIK ID ++ ++ ++EI+V+ P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
TK++ +MEY GG + G L E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
N+LL E+G +K+ DFG++ L + + GTP ++APEVI + YD KADIW
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIKQSAYD-SKADIW 185
Query: 197 SCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW---FSADVRKLLSRILDPNPST 253
S G+ L G P + + M + I K + PT +S +++ + L+ PS
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--PTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 254 RISIAKIMENPWFRKGLNSKS 274
R + +++++ + + S
Sbjct: 244 RPTAKELLKHKFIVRFAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 16/206 (7%)
Query: 10 QKYE-LGRLLGQGNFAKVYYARHLGTGQSVAIKAI----DKDKILKVGLVDQTKREISVM 64
+KYE L ++ G+G++ V+ R+ TGQ VAIK D I K+ L REI ++
Sbjct: 1 EKYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRML 54
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAI 122
+ ++HPN++ + EV K K++ V EY L +K +G + E +K Q + A+
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAV 113
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
+FCH HRD+KPEN+L+ + G +K+ DFG + + T Y APE+
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPEL 171
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAG 208
+ G D+W+ G + LL G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK-----REISVM 64
+ + R +G G+F VY+AR + T + VAIK K+ G K +E+ +
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIK-----KMSYSGKQSNEKWQDIIKEVRFL 69
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAID 123
+ ++HPN ++ + + VMEY G +V K L+E + +
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+ HS HRD+K N+LL E G +K+ DFG SA + GTP ++APEVI
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPAN-----SFVGTPYWMAPEVI 183
Query: 184 ---SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-----WF 235
YDG K D+WS G+ L P + N M+ IA+ D PT W
Sbjct: 184 LAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDW- 239
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
S R + L P R S +++++ + +
Sbjct: 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
K+E+ ++G+G + V RH T + VAIK KD + + T RE+ ++R ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
N++++ E + K+Y V EY + EL +++ G + R Y QLI AI +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKN 119
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ HRD+KPENLL+ N +LK+ DFG A + + T Y +PE++ Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 189 DGDKADIWSCGVIL 202
G D+WS G IL
Sbjct: 179 -GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 76/270 (28%), Positives = 130/270 (48%), Gaps = 30/270 (11%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+GN+ VY H TG ++A+K I + L +Q E+ ++ P ++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 78 VMASKTKIYFVMEYAKGGELFK----KVSKGKLKEDTARKYFQQLISAIDFCHSR-GVYH 132
+ +Y MEY G L K V+ + ED R+ ++ + F + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 133 RDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
RD+KP N+L++ NG +K+ DFG+S +LAK T G +Y+APE I G
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK---------TNIGCQSYMAPERIKSGG 177
Query: 188 YDGD-----KADIWSCGVILYVLLAG---YLPFHDSNLMAMYRKIAKAD-YKFPTWFSAD 238
+ + ++D+WS G+ + + G Y P +N+ A I D P+ +S D
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ +++ L+ P+ R + A+++E+PW K
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 72/247 (29%), Positives = 125/247 (50%), Gaps = 6/247 (2%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+G+F +VY T + VAIK ID ++ ++ ++EI+V+ P + + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
TK++ +MEY GG + G L+E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
N+LL E G +K+ DFG++ + +T GTP ++APEVI + YD KADIWS
Sbjct: 130 ANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-KADIWS 186
Query: 198 CGVILYVLLAGYLPFHDSNLMAMYRKIAK-ADYKFPTWFSADVRKLLSRILDPNPSTRIS 256
G+ L G P D + M + I K + +S ++ + L+ +P R +
Sbjct: 187 LGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT 246
Query: 257 IAKIMEN 263
+++++
Sbjct: 247 AKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 75/300 (25%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK---DKILKVGLVDQTKREISVMRL 66
+Y+ +G G + +V A TG+ VAIK + + I +T RE+ +++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH----AKRTYRELRLLKH 70
Query: 67 IQHPNVMQIYEVMASKT------KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
+ H NV+ + +V + +Y V G +L V KL +D + Q++
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
+ + HS G+ HRDLKP N+ ++E+ LK+ DFGL+ +H D + T Y AP
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAP 184
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPF---------------------------- 212
E++ + DIWS G I+ LL G F
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 213 --HDSNLMAMYRKIAKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
N + ++ K D+K F + LL ++L +P RI+ A+ + +P+ +
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 70/222 (31%), Positives = 114/222 (51%), Gaps = 22/222 (9%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHP 70
+EL ++G G + +VY RH+ TGQ AIK +D + + ++ K EI++++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73
Query: 71 NVMQIYEVMASKT------KIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLISA 121
N+ Y K+ +++ VME+ G +L K LKED ++++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ H+ V HRD+K +N+LL EN +K+ DFG+S A+ G +T GTP ++APE
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 191
Query: 182 VIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM 218
VI+ YD ++DIWS G+ + G P D + M
Sbjct: 192 VIACDENPDATYDY-RSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 53/307 (17%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
GK + K+++ +G+G + +VY AR TG+ VA+K + D K G REI ++
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKIL 60
Query: 65 RLIQHPNVMQIYEVMASKTK----------IYFVMEYAKGGELFKKVSKG--KLKEDTAR 112
R + H N++ + E++ K Y V EY +L + G ED +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIK 119
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT- 171
+ +QL+ +++CH + HRD+K N+LL+ G +K+ DFGL+ L ++ +T
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY--NSEESRPYTNK 177
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVL---------------------LAGY- 209
T Y PE++ G D+WSCG IL L L G
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 210 ----------LP-FHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIA 258
LP F+ YR+ + ++ F LL +L +PS R +
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCTAE 294
Query: 259 KIMENPW 265
+ + +PW
Sbjct: 295 EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL----KVGLVDQTKREISVMRL 66
KYE +GQG F +V+ ARH T Q VA+K K+L K G REI +++L
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQL 67
Query: 67 IQHPNVMQIYEVMASKTK--------IYFVMEYAK---GGELFKKVSKGKLKEDTARKYF 115
++H NV+ + E+ +K Y V E+ + G L K K L E +K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVM 125
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS-ALAKCKHQDGLLHTT-CG 173
+ L++ + + H + HRD+K N+L+ ++G+LK+ DFGL+ A + K+ +T
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 174 TPAYVAPEV-ISRRGYDGDKADIWSCGVIL 202
T Y PE+ + R Y G D+W G I+
Sbjct: 186 TLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 80/272 (29%), Positives = 131/272 (48%), Gaps = 26/272 (9%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHP 70
+EL L+G G + +VY RH+ TGQ AIK +D + ++ K+EI++++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 71 NVMQIYEVMASKT------KIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLISA 121
N+ Y K +++ VME+ G +L K LKE+ ++++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ H V HRD+K +N+LL EN +K+ DFG+S A+ G +T GTP ++APE
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 181
Query: 182 VIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK---ADYKFPT 233
VI+ YD K+D+WS G+ + G P D + M I + K
Sbjct: 182 VIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPW 265
W S + + L N S R + ++M++P+
Sbjct: 241 W-SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-- 68
+YE +G G + VY AR +G VA+K++ + + + GL T RE+++++ ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 69 -HPNVMQIYEVMAS-----KTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLIS 120
HPN++++ +V A+ +TK+ V E+ KV L +T + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
+DF H+ + HRDLKPEN+L+ G +K+ DFGL+ + C+ L T Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176
Query: 181 EVISRRGYDGDKADIWSCGVIL 202
EV+ + Y D+WS G I
Sbjct: 177 EVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 83/308 (26%), Positives = 138/308 (44%), Gaps = 55/308 (17%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI------DKDKILKVGLVDQTKR 59
K +++KYE+ + LG+G + V+ A T + VA+K I D +T R
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-------AQRTFR 55
Query: 60 EISVMR-LIQHPNVMQIYEVMASK--TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ 116
EI ++ L HPN++++ V+ ++ IY V EY + +L + L++ R
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMY 114
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC---KHQDGLLHTTCG 173
QL+ A+ + HS V HRDLKP N+LL+ + +K+ DFGL+ ++ +L
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 174 TPAYVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI------- 224
T Y APE++ S R G D+WS G IL +L G F ++ + KI
Sbjct: 175 TRWYRAPEILLGSTRYTKG--VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232
Query: 225 AKAD---------------------YKFPTWF---SADVRKLLSRILDPNPSTRISIAKI 260
+ D S D LL ++L NP+ R++ +
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 261 MENPWFRK 268
+E+P+ +
Sbjct: 293 LEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 33/234 (14%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
MQ+Y++ RL+G+G +VY A + VA+K I +D L + RE + +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKG---GELFKKV-SKGKLKEDTARK--------YFQ 116
HP ++ +Y + + +Y+ M Y +G L K V K L ++ A K F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD----------G 166
++ + I++ HS+GV HRDLKP+N+LL G + + D+G A+ K ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDIDVDERN 179
Query: 167 LLHTT-------CGTPAYVAPEVISRRGYDG-DKADIWSCGVILYVLLAGYLPF 212
+ +++ GTP Y+APE G + DI++ GVILY +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-24
Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
YEL + +G G + VY AR+L TG+ A+K I + L+ Q EI +++ +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKH 65
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++ + S+ K++ MEY GG L V+ G L E ++ + + + HS
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHS 124
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCGTPAYVAPEV 182
+G HRD+K N+LL +NG +K+ DFG++A +AK K + GTP ++APEV
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK-------SFIGTPYWMAPEV 177
Query: 183 --ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-----TWF 235
+ + G DIW+ G+ L P D + M ++K++++ P T +
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237
Query: 236 SADVRKLLSRILDPNPSTRISIAKIM 261
S+ + L NP R + +++
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 33/267 (12%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGT--GQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
++ +LG +G+G F V LG GQ VA+K + D E SVM
Sbjct: 5 SKELKLGATIGKGEFGDVM----LGDYRGQKVAVKCLKDD----STAAQAFLAEASVMTT 56
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFC 125
++HPN++Q+ V+ +Y V EY G L + S+G+ A QQL A+D C
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGFALDVC 112
Query: 126 ------HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-YV 178
+ HRDL N+L+ E+ + KV+DFGL+ A G L P +
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWT 166
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF--PTWF 235
APE + R K+D+WS G++L+ + + G +P+ L + + K Y+ P
Sbjct: 167 APEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGC 224
Query: 236 SADVRKLLSRILDPNPSTRISIAKIME 262
+V K++ + +P+ R + ++ E
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 48/138 (34%), Positives = 77/138 (55%), Gaps = 1/138 (0%)
Query: 20 QGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM 79
+G F KVY R + A+K + K ++ +V Q + E + L + P ++ +Y +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 80 ASKTKIYFVMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPE 138
S +Y VMEY GG++ + G E+ A KY ++ A+D+ H G+ HRDLKP+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133
Query: 139 NLLLDENGMLKVTDFGLS 156
N+L+ G +K+TDFGLS
Sbjct: 134 NMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 36/291 (12%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH----PNV 72
+G G +VY R TG +A+K ++ + G ++ KR + + ++ P +
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 73 MQIYEVMASKTKIYFVME-YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR-GV 130
++ Y + + ++ ME + + K +G + ED K ++ A+ + + GV
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT-TCGTPAYVAPEVISRRGYD 189
HRD+KP N+LLD +G +K+ DFG+S + D T + G AY+APE I +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 190 GD---KADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYKFPTW---FSADVRKL 242
+AD+WS G+ L L G P+ + + KI + + FS D
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252
Query: 243 LSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAF 293
+ L + R +++++P+ R E++ VDV F
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIR-------------RYETAEVDVAGWF 290
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 16/204 (7%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTG-QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
Q+YE +G+G + KV+ AR L G + VA+K + + + + G+ T RE++V+R ++
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 59
Query: 69 ---HPNVMQIYEVMA-----SKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQL 118
HPNV+++++V +TK+ V E+ KV + + +T + QL
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
+ +DF HS V HRDLKP+N+L+ +G +K+ DFG LA+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQMALTSVVVTLWYR 176
Query: 179 APEVISRRGYDGDKADIWSCGVIL 202
APEV+ + Y D+WS G I
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 88/317 (27%), Positives = 141/317 (44%), Gaps = 70/317 (22%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--------DKDKILKVGLVDQTKREIS 62
+Y++ ++G+G++ V A TG+ VAIK I D +IL REI
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL---------REIK 51
Query: 63 VMRLIQHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ- 116
++RL++HP++++I +M ++ IY V E +L + + K +D ++ Q
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI---KANDDLTPEHHQF 107
Query: 117 ---QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-C 172
QL+ A+ + H+ V+HRDLKP+N+L + + LK+ DFGL+ +A + T
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 173 GTPAYVAPEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--------------- 216
T Y APE+ S DIWS G I +L G F N
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 217 ----------------LMAMYRKIAKA-DYKFPTWFSAD--VRKLLSRILDPNPSTRISI 257
L +M +K KFP +AD +LL R+L +P R +
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFP---NADPLALRLLERLLAFDPKDRPTA 284
Query: 258 AKIMENPWFRKGLNSKS 274
+ + +P+F KGL
Sbjct: 285 EEALADPYF-KGLAKVE 300
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAI---DKDKILKVGLVDQTKREISVMRLIQHPNV 72
R LG G+ V+ A + VA+K I D V REI ++R + H N+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNI 64
Query: 73 MQIYEVMASKTK--------------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQL 118
+++YEV+ +Y V EY + +L + +G L E+ AR + QL
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQL 123
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQ-DGLLHTTCGTPA 176
+ + + HS V HRDLKP N+ ++ E+ +LK+ DFGL+ + + G L T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 177 YVAPE-VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM 218
Y +P ++S Y D+W+ G I +L G F ++ +
Sbjct: 184 YRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 81/310 (26%), Positives = 130/310 (41%), Gaps = 63/310 (20%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL----KVGLVDQTKREISVMRLI 67
YE+ LG+G F +VY AR + TG+ VA+K KIL K G REI +++ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64
Query: 68 QHPNVMQIYEVMASKTK--------IYFVMEYAK---GGELFKKVSKGKLKEDTARKYFQ 116
+HPNV+ + ++ + +Y V Y G L KL E + Y
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYML 122
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQDGLL--- 168
QL+ I++ H + HRD+K N+L+D G+LK+ DFGL+ K G
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 169 HTTC-GTPAYVAPE-VISRRGYDGDKADIWSCGVILYVL------LAGYLPFHDSNL--- 217
+T T Y PE ++ R Y DIW G + + L G +L
Sbjct: 183 YTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 218 ---------MAMYRKI--AKADYKFPTW----------FSADVRKLLSRILDPNPSTRIS 256
+R + + + F + + LLS++L +P R++
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 257 IAKIMENPWF 266
+ +E+P+F
Sbjct: 302 ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 14/228 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+++ L R LG G F +V+ + VAIK + D +LK ++E+ ++ ++H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQ---QDFQKEVQALKRLRH 61
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQ-QLISAIDFCH 126
+++ ++ V + +Y + E + G L F + +G++ + Q+ + +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVISR 185
+ HRDL N+L+ E+ + KV DFGL+ L K +D L + P + APE S
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK---EDVYLSSDKKIPYKWTAPEAASH 178
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
+ K+D+WS G++LY + G +P+ N +Y +I A Y+ P
Sbjct: 179 GTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 16 RLLGQGNFAKVYYARHL----GTGQSVAIKAIDKDKILKVGLVDQT----KREISVMRLI 67
+ LG+G+F KV R+ TG+ VA+K+ L +Q +REI ++R +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS------LNHSGEEQHRSDFEREIEILRTL 63
Query: 68 QHPNVMQIYEVM--ASKTKIYFVMEYAKGGELFKKVSKGKLKEDTAR--KYFQQLISAID 123
H N+++ V + +MEY G L + + + + + R + Q+ +D
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-YVAPEV 182
+ S+ HRDL N+L++ ++K++DFGL+ + + +P + APE
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 183 ISRRGYDGDKADIWSCGVILYVLL 206
+ + +D+WS GV LY L
Sbjct: 184 LRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 63/265 (23%), Positives = 118/265 (44%), Gaps = 16/265 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R+LG+G F +V + TG+ A K ++K +I K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+K + V+ GG+L + E+ A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
RDLKPEN+LLD+ G ++++D GL+ + + GT Y+APEV+ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTWFSADVRKLLSRILD 248
D W G ++Y ++ G PF + R++ + ++ FS R + ++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 249 PNPSTRI-----SIAKIMENPWFRK 268
+P R+ ++ +P+FR
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 28/261 (10%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQHPN 71
+G+GNF VY L VA+K + L KR E +++ HPN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ V K IY VME GG L F + K +L + + +++ S+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP----AYVAPEVISR 185
HRDL N L+ EN +LK++DFG+S + + G+ + G + APE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEAL-N 168
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHD-SNLMAMYRKIAKADYKFPT--WFSADVRK 241
G ++D+WS G++L+ G P+ SN R+ ++ Y+ P ++ +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERIESGYRMPAPQLCPEEIYR 226
Query: 242 LLSRILDPNPSTRISIAKIME 262
L+ + +P R S ++I
Sbjct: 227 LMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 66/265 (24%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R+LG+G F +V + TG+ A K ++K +I K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 76 YEVMASKTKIYFVMEYAKGGEL-FKKVSKGK--LKEDTARKYFQQLISAIDFCHSRGVYH 132
+K + V+ GG+L F + G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG-LLHTTCGTPAYVAPEVISRRGYDGD 191
RDLKPEN+LLD+ G ++++D GL+ K +G + GT Y+APEV++ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTWFSADVRKLLSRIL 247
D W G ++Y ++ G PF + R++ + + + FS + + + +L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 248 DPNPSTRISI-----AKIMENPWFR 267
+P R+ ++ +P+FR
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-22
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 24/261 (9%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G F +V + TG+ A K +DK ++ K E ++ + P ++ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 78 VMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTAR--KYFQQLISAIDFCHSRGVYHRD 134
SKT + VM GG+L + + G+ + R Y Q+ I HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRRGYDGDKA 193
+KPEN+LLD+ G +++D GL+ K DG T GT Y+APE++ Y
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELK----DGKTITQRAGTNGYMAPEILKEEPYS-YPV 175
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW----------FSADVRKLL 243
D ++ G +Y ++AG PF D K+AK + K T F+ + + +
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHK-----EKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230
Query: 244 SRILDPNPSTRISIAKIMENP 264
L P R+ + ++P
Sbjct: 231 RLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 8e-22
Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 16/265 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R+LG+G F +V + TG+ A K ++K +I K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+K + V+ GG+L + + +E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
RDLKPEN+LLD++G ++++D GL+ + + GT Y+APEV+ Y
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERYTF-S 181
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLM----AMYRKIAKADYKFPTWFSADVRKLLSRILD 248
D W+ G +LY ++AG PF + R + + ++ FS D R L +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 249 PNPSTRI-----SIAKIMENPWFRK 268
+P R+ ++ E+P F++
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 21/266 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G F +V + TG+ A K ++K ++ K + E ++ + ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 78 VMASKTKIYFVMEYAKGGELFKKV-----SKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+KT + VM GG+L + E A Y Q+IS ++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEVISRRGYDG 190
RDLKPEN+LLD +G ++++D GL+ K DG T GTP ++APE++ YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 191 DKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTWFSADVRKLLSRI 246
D ++ GV LY ++A PF + ++I +P FS + +
Sbjct: 177 -SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 247 LDPNPSTRI-----SIAKIMENPWFR 267
L +P R+ + + +P FR
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-21
Identities = 34/58 (58%), Positives = 42/58 (72%), Gaps = 2/58 (3%)
Query: 314 LNAFHIISLSSGFDLSGFFVEHD--QKEEVKFTSKYSASVIISKLEDIARHLKMKLTK 369
LNAF +ISLSSG DLSG F E +K+E +FTS+ AS IISKLE+IA+ L K+ K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 70/256 (27%), Positives = 127/256 (49%), Gaps = 25/256 (9%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKD--KILKVGLVDQTKREISVMRLIQHPNVMQ 74
LLG+GNF +V+ L VA+K +D + LK+ + + + +++ HPN+++
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVK 56
Query: 75 IYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
+ V + IY VME GG+ F + K +LK K+ + + + S+ H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP----AYVAPEVISRRGY 188
RDL N L+ EN +LK++DFG+S + +D ++++ G + APE ++ Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMS-----RQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 189 DGDKADIWSCGVILYVLLA-GYLPFHD-SNLMAMYRKIAKADYKF--PTWFSADVRKLLS 244
+ +D+WS G++L+ + G P+ +N A R+ + Y+ P DV K++
Sbjct: 172 SSE-SDVWSYGILLWETFSLGVCPYPGMTNQQA--REQVEKGYRMSCPQKCPDDVYKVMQ 228
Query: 245 RILDPNPSTRISIAKI 260
R D P R +++
Sbjct: 229 RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHPN 71
L R LG G F +V+ GT + VA+K LK G + +E +M+ ++H
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVKT------LKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARK-YFQQLI-------SAID 123
++Q+Y V + + IY V EY G L LK +K QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDF-----LKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTP-AYV 178
+ SR HRDL N+L+ EN + K+ DFGL+ L + + P +
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF------PIKWT 171
Query: 179 APEVISRRGYDGDKADIWSCGVILY 203
APE + + K+D+WS G++L
Sbjct: 172 APEAANYGRFT-IKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM 73
+ LG G F V+ + G VAIK I + + + D E VM + HPN++
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62
Query: 74 QIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVY 131
Q+Y V + I+ V EY G L + + KGKL + + A+++ S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRRGY 188
HRDL N L+ E+ ++KV+DFGL+ D ++ GT + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 189 DGDKADIWSCGVILY-VLLAGYLPF 212
K+D+WS GV+++ V G +P+
Sbjct: 179 S-SKSDVWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
L ++Y + +G G + V A TG+ VAIK + + ++ + RE+++++ +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHM 71
Query: 68 QHPNVMQIYEVMASKT------KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISA 121
QH NV+ + +V S Y VM Y + +K+ L ED + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP NL ++E+ LK+ DFGL+ +H D + T Y APE
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPE 184
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK 226
VI + DIWS G I+ +L G F + + +I K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 7e-21
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R +G G+F VY+AR + T + VAIK + +E+ ++ I+HPN ++
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 76 YEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ + VMEY G +V K L+E + + + HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI---SRRGYDGD 191
+K N+LL E G +K+ DFG +++A ++ GTP ++APEVI YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG- 203
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK 226
K D+WS G+ L P + N M+ IA+
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 14/158 (8%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
++ Y+ LG+G++A VY R TGQ VA+K I + + G RE S+++ ++
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLK 61
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK------GKLKEDTARKYFQQLISAI 122
H N++ +++++ +K + V EY L + + G L R + QL+ +
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160
+CH R V HRDLKP+NLL+ E G LK+ DFGL A AK
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGL-ARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 71/253 (28%), Positives = 120/253 (47%), Gaps = 15/253 (5%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG G + +VY +VA+K + +D + V++ +E +VM+ I+HPN++Q+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ---QLISAIDFCHSRGVYHRD 134
V + Y + E+ G L + + +E A Q+ SA+++ + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVISRRGYDGDKA 193
L N L+ EN ++KV DFGLS L H P + APE ++ + K+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFS-IKS 186
Query: 194 DIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKF--PTWFSADVRKLLSRILDPN 250
D+W+ GV+L+ + G P+ +L +Y + K Y+ P V +L+ N
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYELMRACWQWN 245
Query: 251 PSTRISIAKIMEN 263
PS R S A+I +
Sbjct: 246 PSDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 19/260 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN VY A HL T + +A+K I D + V L Q E+ ++ P ++ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137
+ +I E+ GG L K+ E + ++ + + S + HRD+KP
Sbjct: 67 AFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
N+L++ G +K+ DFG+S + + + T GT AY+APE IS Y G +D+WS
Sbjct: 124 SNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVWS 178
Query: 198 CGVILYVLLAGYLPF-----HDSNLMAMYRKIAKADYKFPTW----FSADVRKLLSRILD 248
G+ L G P+ + +LM + D P FS +++ +
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238
Query: 249 PNPSTRISIAKIMENPWFRK 268
P R + +M++P+ +
Sbjct: 239 KQPKERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN V +H+ TG +A K + K + Q RE+ +M + P ++ Y
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSR-GVYHRD 134
++ I ME+ G L ++ K G + + K ++ + + ++ + HRD
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKAD 194
+KP N+L++ G +K+ DFG+S + + + T GT Y++PE I Y K+D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYT-VKSD 184
Query: 195 IWSCGVILYVLLAGYLPFHDSN------------LMAMYRKIAKADYKFPT-WFSADVRK 241
+WS G+ + L G PF SN L + + + + + P+ F D+R
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 242 LLSRILDPNPSTRISIAKIMENPWF 266
+ L +P+ R + ++ P F
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G+GNF +V+ R VA+K+ + L L + +E +++ HPN++++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE--TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 78 VMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135
V K IY VME +GG+ F + +LK + + + +++ S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP----AYVAPEVISRRGYDGD 191
N L+ E +LK++DFG+S + +DG+ +T G + APE ++ Y +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 192 KADIWSCGVILY 203
+D+WS G++L+
Sbjct: 177 -SDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 79/322 (24%), Positives = 131/322 (40%), Gaps = 72/322 (22%)
Query: 11 KYELGRLLGQGNFAKVYYARHL--GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
KYE+ +G+G + +VY A+ G+ AIK DK G+ REI+++R ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 69 HPNVMQIYEVMASKT--KIYFVMEYAKGGEL----FKKVSKGK-LKEDTARKYFQQLISA 121
H NV+ + EV +Y + +YA+ F + +K + + Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 122 IDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGL-----SALAKCKHQDGLLHTTC 172
+ + HS V HRDLKP N+L+ E G++K+ D GL + L D ++ T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 173 GTPAYVAPEVI-SRRGYDGDKA-DIWSCGVILYVLLA-------------GYLPFHD--- 214
Y APE++ R Y KA DIW+ G I LL PF
Sbjct: 181 ----YRAPELLLGARHY--TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 215 ------------------------SNLMAMYRKIAKADYKFPTWF------SADVRKLLS 244
LM ++ W + LL
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 245 RILDPNPSTRISIAKIMENPWF 266
++L+ +P+ RI+ + +E+P+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 13/215 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G G + V A TG VAIK + + ++ + RE+ +++ ++H NV+ + +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLD 81
Query: 78 VMASKTKI------YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVY 131
V + Y VM + G +L K + KL ED + Q++ + + H+ G+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
HRDLKP NL ++E+ LK+ DFGL+ + D + T Y APEVI +
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK 226
DIWS G I+ +L G F + + +I K
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 17/259 (6%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G G+F VY+A + T + VA+K + +E+ ++ ++HPN ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 78 VMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
+ + VMEY G +V K L+E + + + HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI---SRRGYDGDKA 193
N+LL E G +K+ DFG ++ + ++ GTP ++APEVI YDG K
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW----FSADVRKLLSRILDP 249
D+WS G+ L P + N M+ IA+ D PT ++ R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVDYCLQK 259
Query: 250 NPSTRISIAKIMENPWFRK 268
P R + A+++ + + R+
Sbjct: 260 IPQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 32/211 (15%)
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR 128
PN++ +++ + S+ ++ V+++A+GG+L+ +SK + E+ +++ +++ A+D H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA----YVAPEV-- 182
G+ RDL P N+LLD+ G +++T F + + +C A Y APEV
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFS---------RWSEVEDSCDGEAVENMYCAPEVGG 155
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAG--YLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
IS + + D WS G IL+ LL G + H S + P W S + R
Sbjct: 156 ISE---ETEACDWWSLGAILFELLTGKTLVECHPSGIN------THTTLNIPEWVSEEAR 206
Query: 241 KLLSRILDPNPSTRI-----SIAKIMENPWF 266
LL ++L NP+ R+ + I +P+F
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 35/280 (12%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G +A VY R T VA+K I + + G RE+S+++ ++H N++ +++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMASKTKIYFVMEYA-KGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136
++ ++ + V EY K + + + + + QL+ +++CH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
P+NLL++E G LK+ DFGL A AK + T Y P+++ + D+W
Sbjct: 132 PQNLLINERGELKLADFGL-ARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMW 189
Query: 197 SCGVILYVLLAGYLPFHDSNLMAMYRKIAK-------------------ADYKFPTWFS- 236
G I Y + G F S + I + Y +P + +
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249
Query: 237 ----------ADVRKLLSRILDPNPSTRISIAKIMENPWF 266
+D +LLS++L RIS + M++P+F
Sbjct: 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 84/297 (28%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 12 YELGRLLGQGNFAKVYYARHLGT--GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ- 68
YEL + LGQG + V AR+ T ++VAIK I + K L + RE+ ++R +
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRG 60
Query: 69 HPNVMQIYE---VMASK-TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYF-QQLISAID 123
H N+ +Y+ V ++Y E + +L + + G+ D + F Q++ +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA--LAKCKHQDGLLHTTCGTPAYVAPE 181
+ HS V HRDLKP NLL++ + LK+ DFGL+ G + T Y APE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 182 V-ISRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKI--------------- 224
+ +S + Y KA D+WS G IL LL F + + +I
Sbjct: 180 IMLSFQSY--TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 225 --AKA-DY----------KFPTWF---SADVRKLLSRILDPNPSTRISIAKIMENPW 265
KA +Y F + F + LL ++L +P+ RIS+ + +E+P+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 23/257 (8%)
Query: 16 RLLGQGNFAKVYYARHLGTGQS---VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+ LG G F V HLG ++ VAIKAI++ + + +++ K VM + HP +
Sbjct: 10 KELGSGQFGVV----HLGKWRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKL 61
Query: 73 MQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
+Q+Y V + +Y V E+ + G L + + +GKL +D Q + +++
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRRG 187
HRDL N L+ G++KV+DFG++ D ++ G + PEV +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 188 YDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKF-PTWFSADVRKLLSR 245
Y K+D+WS GV+++ V G +PF + + I++ + P S V +++
Sbjct: 178 YS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236
Query: 246 ILDPNPSTRISIAKIME 262
P R + A+++
Sbjct: 237 CWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMRL 66
KY + +G+G + V A++ T + VAIK KI +D +T REI ++R
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREIKLLRH 60
Query: 67 IQHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLIS 120
+ H NV+ I ++M + +Y V E +L + + S L +D + + QL+
Sbjct: 61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
+ + HS V HRDLKP NLLL+ N LK+ DFGL+ K + T Y AP
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAP 177
Query: 181 EVI-SRRGYDGDKADIWSCGVILYVLL 206
E++ + Y D+WS G I LL
Sbjct: 178 ELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 67/264 (25%), Positives = 118/264 (44%), Gaps = 16/264 (6%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R+LG+G F +V + TG+ A K ++K +I K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYAKGGEL-FKKVSKGK--LKEDTARKYFQQLISAIDFCHSRGVYH 132
+K + V+ GG+L F + G E A Y +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
RDLKPEN+LLD+ G ++++D GL+ + + GT Y+APEVI+ Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNEKYTF-S 181
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMAMY----RKIAKADYKFPTWFSADVRKLLSRILD 248
D W G ++Y ++ G PF R++ + ++ FS D + + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 249 PNPSTRISI-----AKIMENPWFR 267
NP R+ A + ++P F+
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 21/260 (8%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+QK LG ++G+G F V + TGQ VA+K I D + L E +VM +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFL-----EETAVMTKLH 57
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTAR--KYFQQLISAIDFC 125
H N++++ V+ +Y VME G L + ++G+ + ++ + +++
Sbjct: 58 HKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
S+ + HRDL N+L+ E+G+ KV+DFGL+ + + L + APE +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKH 171
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKF--PTWFSADVRKL 242
+ + K+D+WS GV+L+ V G P+ +L + + K Y+ P ADV L
Sbjct: 172 KKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVL 229
Query: 243 LSRILDPNPSTRISIAKIME 262
++ + P R S K+ E
Sbjct: 230 MTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+L R LG G F +V+ T VA+K LK G +D E +M+ ++HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNT-TPVAVKT------LKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++Q+Y V + IY V E K G L + + LK Q+ S + + +
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVIS 184
+ HRDL N+L+ EN + KV DFGL+ + K + + G + APE
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIK----EDIYEAREGAKFPIKWTAPEAAL 177
Query: 185 RRGYDGDKADIWSCGVILYVLLA-GYLPF 212
+ K+D+WS G++L ++ G +P+
Sbjct: 178 YNRFS-IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 11/215 (5%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
R +G G+F VY+AR + + VAIK + +E+ ++ ++HPN +Q
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 76 YEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ + VMEY G +V K L+E + + + HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI---SRRGYDGD 191
+K N+LL E G++K+ DFG +++ + GTP ++APEVI YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK 226
K D+WS G+ L P + N M+ IA+
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 73/282 (25%), Positives = 137/282 (48%), Gaps = 43/282 (15%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV-----MRLIQHPNV 72
LG+G + V RH+ TG +A+K I + + Q ++ + + MR + P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI------RATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 73 MQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKL--KEDTARKYFQQLISAIDFCHSR 128
+ Y + + ++ ME + +KKV L ED K ++ A+++ HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 129 -GVYHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQDGLLHTTCGTPAYVAPEV 182
V HRD+KP N+L++ NG +K+ DFG+S ++AK D G Y+APE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT--IDA------GCKPYMAPER 174
Query: 183 I----SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----- 233
I +++GYD K+D+WS G+ + L G P+ + ++++ K + P+
Sbjct: 175 INPELNQKGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQL-KQVVEEPSPQLPA 230
Query: 234 -WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
FS + + +++ L N R + +++++P+F L+ +
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 60/313 (19%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
++++Y+ + +G G V A TGQ+VAIK + + V + RE+ +M+L
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-PFQNVTHAKRAYRELVLMKL 71
Query: 67 IQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
+ H N++ + V + +Y VME +V + L + Q++
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLC 129
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
I HS G+ HRDLKP N+++ + LK+ DFG LA+ ++ T Y AP
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 186
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK-------------- 226
EVI GY + DIWS G I+ ++ G + F ++ + + KI +
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 227 -------------ADYKFPTWF----------------SADVRKLLSRILDPNPSTRISI 257
A Y F F ++ R LLS++L +P RIS+
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305
Query: 258 AKIMENP----WF 266
+++P W+
Sbjct: 306 DDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G G + V A TG VA+K + + + +T RE+ +++ ++H NV+ + +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 78 VMASKTKI-----YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
V + +++ + G +L V KL +D + Q++ + + HS + H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
RDLKP NL ++E+ LK+ DFGL+ +H D + T Y APE++ +
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 198
Query: 193 ADIWSCGVILYVLLAGYLPF 212
DIWS G I+ LL G F
Sbjct: 199 VDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 11/220 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
++Y+ +G G + V A Q VA+K + + + +T RE+ +++ ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73
Query: 70 PNVMQIYEVMASKTKI-----YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
NV+ + +V T I +++ G +L V KL ++ + QL+ + +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HS G+ HRDLKP N+ ++E+ L++ DFGL+ + D + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADDEMTGYVATRWYRAPEIML 188
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224
+ DIWS G I+ LL G F ++ + ++I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 61/234 (26%), Positives = 112/234 (47%), Gaps = 15/234 (6%)
Query: 34 TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQ-IYEVMASKTKIYFVMEYA 92
TG VAIK + D + + +RE ++ + HPN++ + A ++ V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 93 KGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---L 148
G L + + + G L + Q++ A+ H++G+ HRDLKP+N+++ + G+
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 149 KVTDFGLSALAKCKHQDGLLHTT-----CGTPAYVAPEVISRRGYD-GDKADIWSCGVIL 202
KV DFG+ L + T GTP Y APE + RG +D+++ G+I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIF 179
Query: 203 YVLLAGYLPFHDSNLM-AMYRKIAKADYKFPTWFSA-DVRKLLSRILDPNPSTR 254
L G +++ +Y++++ D P W + + ++L + L+ +P R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YE LG+G++A VY + G+ VA+K I + + G RE S+++ ++H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHAN 64
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
++ +++++ +K + V EY +L + + K G L + + + QL+ + + H R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRRGY 188
+ HRDLKP+NLL+ + G LK+ DFG LA+ K ++ T Y P+V+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFG---LARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 189 DGDKADIWSCGVILYVLLAGYLPF 212
D+W G I ++ G F
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 30/273 (10%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHP 70
+E+ +G+G + KV+ + G A+K +D + ++ + E ++++ L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSDHP 75
Query: 71 NVMQIYEVMASKT-----KIYFVMEYAKGGELFKKVSKGKLK------EDTARKYFQQLI 119
NV++ Y + K +++ V+E GG + + KG LK E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYV 178
+ H HRD+K N+LL G +K+ DFG+SA L + + +T+ GTP ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTPFWM 191
Query: 179 APEVIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK---ADYK 230
APEVI+ YD + D+WS G+ L G P D + M KI +
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263
P +S + + + L + R +++ ++++
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 42/285 (14%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G++A VY GQ VA+K I + G+ RE S+++ ++H N++ +++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135
++ +K + FV EY +L + + + G L R + QL+ + + H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADI 195
KP+NLL+ G LK+ DFGL+ Q + T Y P+V+ DI
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 196 WSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKA----------------DYKFPTWF--- 235
W G I +L G F S++ KI +YK P WF
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK-PEWFLPC 246
Query: 236 --------------SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
L S++L P RIS + +P+F
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG+G +A V+ R T VA+K I + + G RE+S+++ ++H N++ +++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ-QLISAIDFCHSRGVYHRDLK 136
++ ++ + V EY + G L K F QL+ + +CH R + HRDLK
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW 196
P+NLL++E G LK+ DFGL A AK + T Y P+V+ D+W
Sbjct: 131 PQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 197 SCGVILYVLLAG 208
G ILY + G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 37/291 (12%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+ Y LG+G +A V+ R T VA+K I + + G RE+S+++ ++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 69 HPNVMQIYEVMASKTKIYFVMEYA-KGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
H N++ +++++ + + V EY K + + + + + Q++ + +CH
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRR 186
R V HRDLKP+NLL++E G LK+ DFG LA+ K ++ T Y P+V+
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFG---LARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKA--------------- 227
+ D+W G I + + +G F S L ++R +
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 228 DYKFPTW-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
+Y FP + + +LL++ L RIS + M++ +FR
Sbjct: 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-18
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 13 ELGRLLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
LGR +G+G F VY Y +VA+K V ++ +E +MR H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDH 66
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
P+++++ V+ ++ ++ VME A GEL + +V+K L + Y QL +A+ + S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT-P-AYVAPEVISR 185
+ HRD+ N+L+ +K+ DFGLS + + G P ++APE I+
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESINF 182
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFH 213
R + +D+W GV ++ +L+ G PF
Sbjct: 183 RRFTS-ASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
+G G F V+ L + VAIK I + + + + E VM + HP ++Q+Y
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 78 VMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135
V ++ I V E+ + G L + + +GK ++T + + + S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRRGYDGDK 192
N L+ EN ++KV+DFG++ D ++ GT + +PEV S Y K
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 193 ADIWSCGVILY-VLLAGYLPFHD 214
+D+WS GV+++ V G P+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 56/301 (18%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ Y+LG ++G G+F VY A + T + VAIK + +D K RE+ +M+ + H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-------NRELLIMKNLNH 118
Query: 70 PNVMQIYE------VMASKTKIYF--VMEYAKGGELFKKVSKGKLKEDTA------RKYF 115
N++ + + ++ I+ VME+ + K K + + A + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQDGLLHTTCGT 174
QL A+ + HS+ + HRDLKP+NLL+D N LK+ DFG SA Q + + +
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYIC--S 233
Query: 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK-------- 226
Y APE++ D+WS G I+ ++ GY F + + +I +
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293
Query: 227 ---------ADYKFPTWFSADVRK------------LLSRILDPNPSTRISIAKIMENPW 265
AD KFP D++K +S+ L P R++ + + +P+
Sbjct: 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353
Query: 266 F 266
F
Sbjct: 354 F 354
|
Length = 440 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 26/275 (9%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHP 70
+E+ +G+G + KVY + G A+K +D + ++ + E ++++ L HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPNHP 79
Query: 71 NVMQIYEVMASKTK-----IYFVMEYAKGG---ELFKKVSK--GKLKEDTARKYFQQLIS 120
NV++ Y + K ++ V+E GG EL K + +L E +
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVA 179
+ H+ + HRD+K N+LL G +K+ DFG+SA L + + +T+ GTP ++A
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTPFWMA 196
Query: 180 PEVIS-RRGYDGD---KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK---ADYKFP 232
PEVI+ + YD + D+WS G+ L G P D + + KI + P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
+ +S+ L + R S+ ++E+P+ +
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 21 GNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVM 79
G F KV +H T + K I E V +L++ +PN +++Y +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNF--------NAIEPMVHQLMKDNPNFIKLYYSV 78
Query: 80 ASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPE 138
+ +M+Y K G+LF + +GKL E +K +QL+ A++ H + H D+K E
Sbjct: 79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138
Query: 139 NLLLDEN-GMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWS 197
N+L D + + D+GL K GT Y +PE I YD D W+
Sbjct: 139 NVLYDRAKDRIYLCDYGLC---KIIGTPSCYD---GTLDYFSPEKIKGHNYD-VSFDWWA 191
Query: 198 CGVILYVLLAGYLPFHDS-----NLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPS 252
GV+ Y LL G PF + +L ++ ++ K F S + + +L N +
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPFIKNVSKNANDFVQSMLKYNIN 250
Query: 253 TR-ISIAKIMENPWF 266
R + +I+++P+
Sbjct: 251 YRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 16 RLLGQGNFAKV----YYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
R+LG+G+F KV Y + GTG+ VA+K + ++ K+EI++++ + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHEN 67
Query: 72 VMQIYEVMASK---TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+++ Y+ S+ + +MEY G L + K KL + QQ+ + + HS+
Sbjct: 68 IVK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY-VAPEVISRRG 187
HRDL N+LLD + ++K+ DFGL+ H+ + +P + A E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 188 YDGDKADIWSCGVILYVLL 206
+ +D+WS GV LY LL
Sbjct: 187 FSY-ASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
Y + + L G+ +V+ A G V +LK+G T E +++ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPV---------VLKIGQKGTTLIEAMLLQNVNHPS 118
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
V+++ + + S V+ + +L+ ++K L D A +Q++ + + H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
+ HRD+K EN+ +++ + + D G A+ GT APEV++R Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG---AAQFPVVAPAFLGLAGTVETNAPEVLARDKYN 234
Query: 190 GDKADIWSCGVILYVLLA 207
KADIWS G++L+ +LA
Sbjct: 235 -SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 83/301 (27%), Positives = 128/301 (42%), Gaps = 53/301 (17%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVDQTK--REISVMRLIQ 68
E R +G G F V+ G+ VA+K K+ V LV + RE+ ++ +
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK-----KMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 69 HPNVMQIYEVMASK-----TKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAI 122
H NV+ +++ +IY V E + +L K VS L D + + Q++ +
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAP 180
+ HS G+ HRD+KP NLL++ N +LK+ DFG LA+ + D H T T Y AP
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFG---LARVEEPDESKHMTQEVVTQYYRAP 173
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFH----------------DSNLMAM---- 220
E++ + DIWS G I LL + F +L AM
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 221 -------YRKIAKAD-----YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
R K Y + + + LL R+L +P RIS A + +P+ +
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
Query: 269 G 269
G
Sbjct: 294 G 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M++ +L + +G+G F V + G VA+K I D + L E SVM ++
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLA-----EASVMTQLR 57
Query: 69 HPNVMQIYEVMAS-KTKIYFVMEYAKGGELFKKV-SKGK--LKEDTARKYFQQLISAIDF 124
H N++Q+ V+ K +Y V EY G L + S+G+ L D K+ + A+++
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
+ HRDL N+L+ E+ + KV+DFGL+ A G L + APE +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALR 172
Query: 185 RRGYDGDKADIWSCGVILYVLLA-GYLPF 212
+ + K+D+WS G++L+ + + G +P+
Sbjct: 173 EKKFS-TKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 74/311 (23%), Positives = 131/311 (42%), Gaps = 65/311 (20%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK-----REIS 62
++++Y+ + +G G V A G +VA+K + + +QT RE+
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP------FQNQTHAKRAYRELV 72
Query: 63 VMRLIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ 116
+++ + H N++ + V + +Y VME +V +L +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY 130
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
Q++ I HS G+ HRDLKP N+++ + LK+ DFG LA+ + ++ T
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRY 187
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA----------- 225
Y APEVI GY + DIWS G I+ L+ G + F ++ + + K+
Sbjct: 188 YRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246
Query: 226 -------------KADYK-------FPTWF-----------SADVRKLLSRILDPNPSTR 254
+ Y FP W ++ R LLS++L +P R
Sbjct: 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306
Query: 255 ISIAKIMENPW 265
IS+ + + +P+
Sbjct: 307 ISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+G+ V+ A+H T VA+K I+ D K L ++EI R +QHPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHPN 60
Query: 72 VMQIYEVMASKTKIYFV---MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
++ +++Y V M Y +L K L E + +++A+D+ HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 129 GVYHRDLKPENLLLDENGMLKVTDF--GLSALAKCKHQ----DGLLHTTCGTPAYVAPEV 182
G HR +K ++LL +G + ++ +S + K Q D + P +++PEV
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEV 179
Query: 183 ISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY 221
+ + +GY+ +K+DI+S G+ L G++PF D M
Sbjct: 180 LQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN V+ H +G +A K I + +K + +Q RE+ V+ P ++ Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDL 135
S +I ME+ GG L + + K G++ E K +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADI 195
KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 196 WSCGVILYVLLAGYLP 211
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 18/228 (7%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMRLIQHPN 71
+++G G F +V R G+ AI K LK G D+ + E S+M HPN
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAI---KTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ V+ + + EY + G L F + + GK + + S + +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG-TPA-YVAPEVISRRG 187
HRDL N+L++ N + KV+DFGLS + + T G P + APE I+ R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 188 YDGDKADIWSCGVILY-VLLAGYLPFHD-SNLMAMYRKIAKADYKFPT 233
+ +D+WS G++++ V+ G P+ D SN + K + Y+ P
Sbjct: 185 FT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVI--KAVEDGYRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG G F V Y + G VAIK I + + + +++ K VM + H ++Q+Y
Sbjct: 12 LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQLYG 66
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS-------AIDFCHSRGV 130
V + IY V EY G L L+E R QL+ + + S+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNY-----LREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APEVISRRG 187
HRDL N L+D+ G +KV+DFGLS D ++ G+ V PEV+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 188 YDGDKADIWSCGVILY-VLLAGYLPF 212
+ K+D+W+ GV+++ V G +P+
Sbjct: 178 FS-SKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN V +H +G +A K I + +K + +Q RE+ V+ P ++ Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG-------- 129
S +I ME+ GG L + LKE A++ ++++ + RG
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQV-----LKE--AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 130 -VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 189 DGDKADIWSCGVILYVLLAGYLP 211
++DIWS G+ L L G P
Sbjct: 180 S-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 15/226 (6%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQHPNV 72
++G G F +V R G+ AI K LK G ++ +R E S+M HPN+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAI---KTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 73 MQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
+ + V+ + + E+ + G L F + + G+ + + + + +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA---YVAPEVISRRG 187
HRDL N+L++ N + KV+DFGLS + D ++ G + APE I+ R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 188 YDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
+ +D+WS G++++ V+ G P+ D + + I + DY+ P
Sbjct: 188 FTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 71/306 (23%), Positives = 129/306 (42%), Gaps = 55/306 (17%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++++Y+ + +G G V A ++VAIK + + + RE+ +M+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 68 QHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISA 121
H N++ + V + +Y VME +V + +L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 131
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I HS G+ HRDLKP N+++ + LK+ DFGL+ A ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--------------- 226
VI GY + DIWS G I+ ++ + F + + + K+ +
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 227 ------------ADYKFPTWF---------------SADVRKLLSRILDPNPSTRISIAK 259
A FP F ++ R LLS++L +P+ RIS+ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 260 IMENPW 265
+++P+
Sbjct: 308 ALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 16 RLLGQGNFAKV----YYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
R LG+G+F KV Y TG+ VA+K++ + + K+EI ++R + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 72 VMQIYEVMASK---TKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
+++ Y+ + ++ I +ME+ G L + +K K+ KY Q+ +D+
Sbjct: 68 IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY-VAPE-VIS 184
SR HRDL N+L++ +K+ DFGL+ + + + +P + APE +I
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224
+ Y +D+WS GV LY LL Y +S+ M ++ K+
Sbjct: 187 SKFYIA--SDVWSFGVTLYELLT-YCD-SESSPMTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 16 RLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQ 68
+++G G F +V R G+ VAIK LK G ++ +R E S+M
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKT------LKAGYTEKQRRDFLSEASIMGQFD 63
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
HPN++ + V+ + V EY + G L F + G+ + + S + +
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA---YVAPEVI 183
G HRDL N+L++ N + KV+DFGLS + + + +TT G + APE I
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEAI 181
Query: 184 SRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
+ R + +D+WS G++++ V+ G P+ +
Sbjct: 182 AYRKFT-SASDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 51/193 (26%), Positives = 98/193 (50%), Gaps = 16/193 (8%)
Query: 53 LVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK-EDT- 110
Q + EI + + H N+++I E++ S+ Y + + +L+ + +D
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRP 264
Query: 111 ----ARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166
R +QL+ A+++ H + + HRD+K EN+ L+ +G + + DFG +A+ K ++
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREA 323
Query: 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDS------NLMA 219
+ GT A +PE+++ GY + DIWSCG+IL +L+ + P D L+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382
Query: 220 MYRKIAKADYKFP 232
+ ++ D +FP
Sbjct: 383 IIDSLSVCDEEFP 395
|
Length = 501 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 64/256 (25%), Positives = 115/256 (44%), Gaps = 14/256 (5%)
Query: 17 LLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM 73
LG G+F V ++ G VA+K + DK+ + +D +E ++M + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLI 59
Query: 74 QIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
++Y V+ + + V E A G L +K + G T Y Q+ + + + S+
Sbjct: 60 RLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVISRRGYD 189
HRDL N+LL + +K+ DFGL ++ P A+ APE + R +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 190 GDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF--PTWFSADVRKLLSRI 246
+D+W GV L+ + G P+ + + +KI K + P D+ ++ +
Sbjct: 179 -HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237
Query: 247 LDPNPSTRISIAKIME 262
NP+ R + A + E
Sbjct: 238 WAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 54/290 (18%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTG-----QSVAIK-----AIDKDKILKVGLVDQTKRE 60
+ LG+ LG+G F +V A +G +VA+K A +KD L D E
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD------LSDLVS-E 65
Query: 61 ISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGEL-----------------FKKVS 102
+ +M++I +H N++ + V + +Y V+EYA G L +
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 103 KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC- 161
+ L + + Q+ ++F S+ HRDL N+L+ E+ ++K+ DFGL+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 162 ----KHQDGLLHTTCGTPA-YVAPEVISRRGYDGDKADIWSCGVILY--VLLAGYLPFHD 214
K +G L P ++APE + R Y ++D+WS GV+L+ L G P+
Sbjct: 186 DYYRKTTNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS-PYPG 237
Query: 215 SNLMAMYRKIAKADYKF--PTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ ++ K+ K Y+ P + ++ L+ PS R + +++E
Sbjct: 238 IPVEELF-KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 29/232 (12%)
Query: 18 LGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
LG+G F KVY G + SVAIK + ++ + + + ++E +M +QHPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFK---------KVSKGKLKEDTARKYFQ------- 116
+ + V + + EY G+L + V E
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 117 -QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
Q+ + +++ S HRDL N L+ E +K++DFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVL----LAGYLPFHDSNLMAMYRK 223
++ PE I + + +DIWS GV+L+ + L Y F + ++ M R
Sbjct: 191 RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 72/306 (23%), Positives = 130/306 (42%), Gaps = 55/306 (17%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++++Y+ + +G G V A ++VAIK + + + RE+ +M+ +
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 80
Query: 68 QHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISA 121
H N++ + V + +Y VME +V + +L + Q++
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 138
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I HS G+ HRDLKP N+++ + LK+ DFGL+ A ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 195
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--------------- 226
VI GY + DIWS G I+ ++ G + F ++ + + K+ +
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 227 ------------ADYKFPTWF---------------SADVRKLLSRILDPNPSTRISIAK 259
A Y F F ++ R LLS++L + S RIS+ +
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 260 IMENPW 265
+++P+
Sbjct: 315 ALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 17 LLGQGNFAKVYYARH--LG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
LG+GNF V R+ L TG+ VA+K + L D +REI +++ +QH N+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-FEREIEILKSLQHDNI 67
Query: 73 MQIYEVM--ASKTKIYFVMEYAKGGELFKKVSKGKLKEDTAR--KYFQQLISAIDFCHSR 128
++ V A + + VMEY G L + K + + D + Y Q+ +++ S+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY-VAPEVISRRG 187
HRDL N+L++ +K+ DFGL+ + + + +P + APE ++
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 188 YDGDKADIWSCGVILYVL 205
+ +D+WS GV+LY L
Sbjct: 188 FS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 13 ELGRLLGQGNFAKV---YYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLI 67
+L + LG G F +V YY H VAIK+ LK G + E ++M+ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH----TKVAIKS------LKQGSMSPEAFLAEANLMKQL 58
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKG-KLKEDTARKYFQQLISAIDF 124
QHP ++++Y V+ ++ IY + EY + G L F K +G KL + Q+ + F
Sbjct: 59 QHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH---QDGLLHTTCGTPAYVAPE 181
+ HRDL+ N+L+ E K+ DFGL+ L + ++G + APE
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPE 173
Query: 182 VISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
I+ G K+D+WS G++L ++ G +P+
Sbjct: 174 AIN-YGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 7 VLMQKYELGRLLGQGNFAKVY--YARHLGTGQS---VAIKAI-------DKDKILKVGLV 54
+ +K L R LGQG+F VY A+ + G+ VAIK + ++ + L
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN---- 58
Query: 55 DQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKED----- 109
E SVM+ +V+++ V+++ VME G+L + + + +
Sbjct: 59 -----EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 110 ---TARKYFQ---QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-- 161
T +K+ Q ++ + + ++ HRDL N ++ E+ +K+ DFG++
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 162 ---KHQDGLLHTTCGTPA-YVAPEVISRRGYDGDKADIWSCGVILY 203
K GLL P ++APE + + G K+D+WS GV+L+
Sbjct: 174 YYRKGGKGLL------PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 61/298 (20%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LG GN V H +G +A K I + +K + +Q RE+ V+ P ++ Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 78 VMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG-------- 129
S +I ME+ GG L + + K A + + ++ I RG
Sbjct: 67 AFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLRGLTYLREKH 119
Query: 130 -VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 189 DGDKADIWSCGVILYVLLAGYLPF---HDSNLMAMYRKIAKA------------------ 227
++DIWS G+ L + G P L AM+ +
Sbjct: 176 -TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 228 ---------DY-------KFPT-WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
DY K P+ FS + + + + L NP R + ++ ++P+ ++
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 71/278 (25%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 12 YELGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ LGR+LG+G F V A+ G+ Q VA+K + D I +++ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59
Query: 69 HPNVMQIYEV-MASKTK-----IYFVMEYAKGGELFKKVSKGKLKED-------TARKYF 115
HPNV+++ V + S+ K ++ + K G+L + ++ E+ T ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
+ S +++ S+ HRDL N +L+EN + V DFGLS K + C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCASK 176
Query: 176 ---AYVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKAD-YK 230
++A E ++ Y +D+W+ GV ++ ++ G P+ +Y + K + K
Sbjct: 177 LPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235
Query: 231 FPTWFSADVRKLLSRILDPNPSTRISIAKI---MENPW 265
P DV +L+ + P P R S + +E W
Sbjct: 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGL--VDQTKREISVMRLIQHP 70
+L + LG G F +V+ + VA+K LK G V E ++M+ +QH
Sbjct: 9 KLVKKLGAGQFGEVWMG-YYNNSTKVAVKT------LKPGTMSVQAFLEEANLMKTLQHD 61
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++++Y V+ + IY + EY G L K GK+ + Q+ + +
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVIS 184
+ HRDL+ N+L+ E+ M K+ DFGL+ + +D G + APE I+
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAIN 177
Query: 185 RRGYDGDKADIWSCGVILY-VLLAGYLPF 212
G K+D+WS G++LY ++ G +P+
Sbjct: 178 -FGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHPNVMQI 75
LGQG F +V+ GT + VAIK LK G + +E VM+ ++H ++Q+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKT------LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 76 YEVMASKTKIYFVMEYAKGGEL--FKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYH 132
Y V+ S+ IY V EY G L F K GK L+ Q+ S + + H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRRGYD 189
RDL+ N+L+ EN + KV DFGL+ L +D G + APE + G
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRF 180
Query: 190 GDKADIWSCGVILYVLLA-GYLPF 212
K+D+WS G++L L G +P+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 77/321 (23%), Positives = 137/321 (42%), Gaps = 71/321 (22%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTG--QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+YE G +G+G + VY A+ + A+K I+ G+ REI+++R ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-----TGISMSACREIALLRELK 56
Query: 69 HPNVMQIYEVMASKT--KIYFVMEYAKGGEL----FKKVSKG-----KLKEDTARKYFQQ 117
HPNV+ + +V S + K++ + +YA+ F + SK +L + Q
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 118 LISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQD-GLLHTTC 172
++ I + H+ V HRDLKP N+L+ E G +K+ D G + L + L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL-------------PFHDSNLMA 219
T Y APE++ + DIW+ G I LL PFH L
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
Query: 220 MY--------------RKIA-----KADYKFPTWFSADVRK---------------LLSR 245
++ RK+ + D++ T+ ++ + K LL +
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296
Query: 246 ILDPNPSTRISIAKIMENPWF 266
+L +P+ RI+ + +++P+F
Sbjct: 297 LLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
E+GR G N VY ARH TG V ++ D + + L + E+ + +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 73 MQIYEVMASKTKIYFV---MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
M + V + + ++ + M Y L K + E + +++ H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH---------TTCGTPAYVAP 180
HR++K ++L+ +G++ ++ GLS L ++G +T P +++P
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHL-YSLVRNGQKAKVVYDFPQFSTSVLP-WLSP 177
Query: 181 EVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHD 214
E++ + GY+ K+DI+S G+ L G +PF D
Sbjct: 178 ELLRQDLYGYNV-KSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 32/220 (14%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQ-------SVAIKAIDKDKILKVGLVDQTKREISV 63
K LG+ LG+G F +V A LG + +VA+K + KD + L D E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEM 73
Query: 64 MRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKE-----DTAR----- 112
M++I +H N++ + +Y ++EYA G L + + + D AR
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 113 KYFQQLIS-------AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165
F+ L+S +++ S+ HRDL N+L+ EN ++K+ DFGL+ + D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--RDVNNID 191
Query: 166 GLLHTTCGT-PA-YVAPEVISRRGYDGDKADIWSCGVILY 203
TT G P ++APE + R Y ++D+WS GV+++
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK----VGLVDQTKREISVMRL 66
+YE G +G+G + VY A+ G+ D+D LK G+ REI+++R
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKR-KDGKD------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 67 IQHPNVMQIYEVMASKT--KIYFVMEYAKGGEL----FKKVSKG-----KLKEDTARKYF 115
++HPNV+ + +V S K++ + +YA+ F + SK +L +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQD-GLLHT 170
Q++ I + H+ V HRDLKP N+L+ E G +K+ D G + L + L
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH 213
T Y APE++ + DIW+ G I LL FH
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 14 LGRLLGQGNFAKVYYA--RHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMRLI 67
L R LG+G F KV+ HL + A+ K LK + + RE ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNF 65
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFK---------------KVSKGKLKEDTAR 112
QH N+++ Y V V EY + G+L K G+L
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT- 171
+ Q+ S + + S+ HRDL N L+ + ++K+ DFG+S +D ++TT
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RD--VYTTD 176
Query: 172 ----CGTPA----YVAPEVISRRGYDGDKADIWSCGVILY 203
G ++ PE I R + + +D+WS GV+L+
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTKREISVMRL 66
LG+ LG+G F +V A G +S VA+K + KD L D E+ +M+L
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 67 I-QHPNVMQIYEVMASKTKIYFVMEYAKGGEL-----------------FKKVSKGKLKE 108
I +H N++ + V + +Y ++EYA G L KV + +L
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 109 DTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ-DGL 167
Q+ +++ SR HRDL N+L+ E+ ++K+ DFG LA+ H D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG---LARGVHDIDYY 190
Query: 168 LHTTCG-TPA-YVAPEVISRRGYDGDKADIWSCGVILY 203
T+ G P ++APE + R Y ++D+WS G++++
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
V MQ Y + L G+ +V+ G + V +KA+ K REI ++
Sbjct: 90 VRMQ-YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG--------REIDIL 140
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAID 123
+ I H ++ + K+ + VM K +LF V G L + A ++L+ A+
Sbjct: 141 KTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALA 199
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC----GTPAYVA 179
+ H RG+ HRD+K EN+ LDE + DFG A CK C GT +
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFG----AACKLDAHPDTPQCYGWSGTLETNS 255
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPF 212
PE+++ Y K DIWS G++L+ + +
Sbjct: 256 PELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 64/269 (23%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 17 LLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
LG+G F +V+ A+ G + V +KA+ K K + + +RE+ + R + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
V+++ + Y ++EY G+L F + +K K ++ + A+ + G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 130 V--------YHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPA-Y 177
+ HRDL N L+ +KV S L+ K + + P +
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKV-----SLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 178 VAPEVISRRGYDGD---KADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKI--AKADYKF 231
+APE + + D K+D+WS GV+++ V G LPF+ + + ++ K +
Sbjct: 185 LAPEAV----QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKI 260
P + + KL++R NP R S +++
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 70/283 (24%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTKREISVMRL 66
LG+ LG+G F +V A +G + VA+K + D K L D E+ +M++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EMEMMKM 79
Query: 67 I-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKY----------- 114
I +H N++ + +Y ++EYA G L + + + + +Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQVPEEQ 136
Query: 115 --FQQLIS-------AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165
F+ L+S +++ S+ HRDL N+L+ E+ ++K+ DFGL+ H D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA--RDIHHID 194
Query: 166 GLLHTTCGT-PA-YVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYR 222
TT G P ++APE + R Y ++D+WS GV+L+ + G P+ + ++
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 252
Query: 223 KIAKADYKF--PTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263
K+ K ++ P+ + ++ ++ PS R + +++E+
Sbjct: 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REI-SVMRLIQH 69
+LG +G+G F V H +G +A+K I V +Q + ++ VMR
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRIR----STVDEKEQKRLLMDLDVVMRSSDC 62
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGG-ELFKK----VSKGKLKEDTARKYFQQLISAIDF 124
P +++ Y + + + ME + F K V K + E+ K + A+++
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 125 CHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEV 182
+ HRD+KP N+LLD NG +K+ DFG+S + D + T G Y+APE
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG----QLVDSIAKTRDAGCRPYMAPER 178
Query: 183 I---SRRGYDGDKADIWSCGVILYVLLAGYLPF 212
I +R GYD ++D+WS G+ LY + G P+
Sbjct: 179 IDPSARDGYD-VRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 19/227 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+L + LG G F +V+ G + VA+K + + ++ E +M+ ++H +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE----EAQIMKKLRHDKL 63
Query: 73 MQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGK-LKEDTARKYFQQLISAIDFCHSRG 129
+Q+Y V+ S+ IY V EY G L F K +G+ LK Q+ + + +
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRR 186
HRDL+ N+L+ + + K+ DFGL+ L +D G + APE +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALY 177
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFP 232
G K+D+WS G++L L+ G +P+ N + ++ + Y+ P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE 77
LGQG F +V+ GT + VAIK + ++ + E +M+ ++H ++ +Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 78 VMASKTKIYFVMEYAKGGEL--FKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRD 134
V+ S+ IY V E+ G L F K GK LK Q+ + + HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRRGYDGD 191
L+ N+L+ +N + K+ DFGL+ L +D G + APE + G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182
Query: 192 KADIWSCGVILYVLLA-GYLPF 212
K+D+WS G++L L+ G +P+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 31/245 (12%)
Query: 18 LGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
LG+ F KVY GT Q+VAIK + KDK + L ++ K E + +QHPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFK-----------------KVSKGKLKEDTARKYF 115
+ + V+ + + + Y +L + K K L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
Q+ + ++F S V H+DL N+L+ + +K++D GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPF-----HDSNLMAMYRKIAKADY 229
+++PE I + D +DIWS GV+L+ + + G P+ D M R++
Sbjct: 191 RWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 230 KFPTW 234
P W
Sbjct: 250 DCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 39/229 (17%)
Query: 11 KYELGRLLGQGNFAKVY--YARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVM 64
LG+ LG+G F KV A L A+ K+LK R E +++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAV---KMLKENASSSELRDLLSEFNLL 57
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL------FKKVSKGKLKEDTARK----- 113
+ + HP+V+++Y + + ++EYAK G L +KV L D R
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 114 --------------YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159
+ Q+ + + + HRDL N+L+ E +K++DFGLS
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--R 175
Query: 160 KCKHQDGLLHTTCG-TPA-YVAPEVISRRGYDGDKADIWSCGVILYVLL 206
+D + + G P ++A E + Y ++D+WS GV+L+ ++
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 73/286 (25%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQ-------SVAIKAIDKDKILKVGLVDQTKREISV 63
+ LG+ LG+G F +V A +G + +VA+K + D K L D E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVS-EMEM 70
Query: 64 MRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFK------------KVSKGKLKEDT 110
M++I +H N++ + +Y ++EYA G L + KL E+
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 111 ARKYFQQLIS-------AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163
F+ L+S +++ S+ HRDL N+L+ E+ ++K+ DFG LA+ H
Sbjct: 131 LT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG---LARDVH 185
Query: 164 Q-DGLLHTTCGT-PA-YVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMA 219
D TT G P ++APE + R Y ++D+WS GV+L+ + G P+ +
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 220 MYRKIAKADYKF--PTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263
++ K+ K ++ P + ++ ++ PS R + +++E+
Sbjct: 245 LF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 17 LLGQGNFAKVYYAR--HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQ 74
++G+GNF +V AR G AIK + K+ K D + +L HPN++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKE---------DTARKYF-QQLIS---- 120
+ + +Y +EYA G L + K ++ E TA QQL+
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 121 ---AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT-PA 176
+D+ + HRDL N+L+ EN + K+ DFGLS + Q+ + T G P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRLPV 187
Query: 177 -YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFPTW 234
++A E ++ Y + +D+WS GV+L+ +++ G P+ +Y K+ + Y+
Sbjct: 188 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP 245
Query: 235 FSAD--VRKLLSRILDPNPSTRISIAKIM 261
+ D V L+ + P R S A+I+
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 64/294 (21%), Positives = 109/294 (37%), Gaps = 73/294 (24%)
Query: 13 ELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAI-------DKDKILKVGLVDQTKRE 60
L R LG G F +VY + G VA+K + D+ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM---------E 59
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQL 118
+M H N++++ V + + ++E GG+L F + ++ + + ++ L
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 119 ISAIDF---CH---SRGVYHRDLKPENLLLDENG---MLKVTDFGLS------------- 156
A D C HRD+ N LL G + K+ DFG++
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 157 -ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDG---DKADIWSCGVILY-VLLAGYLP 211
A+ K ++ PE DG K D+WS GV+L+ + GY+P
Sbjct: 180 RAMLPIK--------------WMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
Query: 212 F---HDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ + +M + D P V ++++ P R + A I+E
Sbjct: 222 YPGRTNQEVMEFVTGGGRLDP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTK--REISVMRL 66
E ++LG G F VY + G+ VAIK + ++ + E VM
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMAS 65
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAIDF 124
+ HP+V+++ + S + + + G L V K + + Q+ + +
Sbjct: 66 VDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG-TP-AYVAPEV 182
+ + HRDL N+L+ +K+TDFGL+ L + H G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAEGGKVPIKWMALES 182
Query: 183 ISRRGYDGDKADIWSCGVILYVLLA-GYLPFHD 214
I R Y K+D+WS GV ++ L+ G P+
Sbjct: 183 ILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 17/228 (7%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQHPN 71
+++G G F +V+ G+ AI K LK G ++ ++ E S+M H N
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAI---KTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ V+ + EY + G L + + G+ + + + + +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA--YVAPEVISRRG 187
HRDL N+L++ N KV+DFGLS + + +G T+ G + APE I+ R
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 188 YDGDKADIWSCGVILY-VLLAGYLPFHD-SNLMAMYRKIAKADYKFPT 233
+ +D+WS G++++ V+ G P+ D SN M K ++ P
Sbjct: 187 F-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM--KAINDGFRLPA 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 16 RLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
R++G+G+F VY+ + G A+K++++ I + V+Q +E +M+ HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 73 MQIYEVMASKTKI-YFVMEYAKGGELFKKVSKGKLKEDTARK---YFQQLISAIDFCHSR 128
+ + + V+ Y K G+L + T + + Q+ +++ S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL-HTTCGTPA-YVAPEVISRR 186
HRDL N +LDE+ +KV DFGL+ K + HT P ++A E + +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPFHDSN 216
+ K+D+WS GV+L+ L+ G P+ D +
Sbjct: 178 KFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 14 LGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
LG++LG+G F V + G+ VA+K + D I +++ E + M+ HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHP 61
Query: 71 NVMQIYEV---MASKTKI---YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI----- 119
NVM++ V +S KI ++ + K G+L + +L + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 120 --SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-- 175
+++ +R HRDL N +L E+ + V DFGLS K +
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKMP 178
Query: 176 -AYVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
++A E ++ R Y K+D+W+ GV ++ + G P+
Sbjct: 179 VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 14 LGRLLGQGNFAKVYYAR--HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
L R LG+G F KV+ A +L Q + A+ K RE ++ +QH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFK----------KVSKG----KLKEDTARKYFQQ 117
+++ Y V + V EY K G+L K +++G +L + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 118 LISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
+ + + + S+ HRDL N L+ EN ++K+ DFG+S + T +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 178 VAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFH 213
+ PE I R + + +D+WS GV+L+ + G P++
Sbjct: 189 MPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 18 LGQGNFAKV---YYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQ 74
LG GNF V Y G VA+K + ++ I + RE SVM + HP +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVR 60
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
+ V + + VME A G L K + K ++ ++ Q+ + + S+ HR
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT-P-AYVAPEVISRRGYDGD 191
DL N+LL K++DFG+S A D TT G P + APE I+ +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINYGKFS-S 177
Query: 192 KADIWSCGVILY 203
K+D+WS GV L+
Sbjct: 178 KSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
L R LG+G F KV+ A + VA+KA+ KD L +RE ++ +Q
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQ 65
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFK-----------------KVSKGKLKEDTA 111
H ++++ Y V + V EY K G+L K + +KG+L
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 112 RKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT 171
Q+ S + + S+ HRDL N L+ N ++K+ DFG+S + T
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203
++ PE I R + + +D+WS GVIL+
Sbjct: 186 MLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 42/273 (15%)
Query: 17 LLGQGNFAKVYYA--RHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVM-RLIQH 69
++G+GNF +V A + G + AIK +LK + R E+ V+ +L H
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIK------MLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDT---ARKY-------FQQLI 119
PN++ + ++ +Y +EYA G L + K ++ E A+++ QQL+
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 120 -------SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
+ + + + HRDL N+L+ EN K+ DFGLS + ++ + T
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKTM 177
Query: 173 GT-PA-YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY 229
G P ++A E ++ Y K+D+WS GV+L+ +++ G P+ +Y K+ + Y
Sbjct: 178 GRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 235
Query: 230 KF--PTWFSADVRKLLSRILDPNPSTRISIAKI 260
+ P +V +L+ + P R A+I
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 7/190 (3%)
Query: 18 LGQGNFAKVY--YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
LG GNF V + + ++VA+K I K+ L D+ RE +VM+ + +P ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRD 134
+ +++ + VME A+ G L K + K K + E + Q+ + + HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 135 LKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-YVAPEVISRRGYDGDKA 193
L N+LL K++DFGLS T P + APE ++ + K+
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 194 DIWSCGVILY 203
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 48/235 (20%)
Query: 16 RLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTK----REISVMRLIQH 69
R +GQG F +V+ AR G + + A+ K+LK + RE ++M H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAEFDH 67
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELF--------KKVSKGKLKEDTARKYFQ---QL 118
PN++++ V A + + EY G+L + +ARK L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 119 ISAIDFCHSRGV------------YHRDLKPENLLLDENGMLKVTDFGLSA------LAK 160
C ++ V HRDL N L+ EN ++K+ DFGLS K
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 161 CKHQDGLLHTTCGTPA-YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFH 213
D + P ++ PE I Y ++D+W+ GV+L+ + + G P++
Sbjct: 188 ASENDAI-------PIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 42/273 (15%)
Query: 17 LLGQGNFAKVYYA--RHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVM-RLIQH 69
++G+GNF +V A + G AIK +K R E+ V+ +L H
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIK------RMKEYASKDDHRDFAGELEVLCKLGHH 55
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDT---ARKY-------FQQLI 119
PN++ + + +Y +EYA G L + K ++ E A QQL+
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 120 -------SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
+D+ + HRDL N+L+ EN + K+ DFGLS + Q+ + T
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTM 170
Query: 173 GT-PA-YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY 229
G P ++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K+ + Y
Sbjct: 171 GRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 228
Query: 230 KF--PTWFSADVRKLLSRILDPNPSTRISIAKI 260
+ P +V L+ + P R S A+I
Sbjct: 229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 4/158 (2%)
Query: 48 ILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK 107
++K G + E ++R + HP V+ + +V V+ + +L+ +
Sbjct: 198 VVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRP 256
Query: 108 EDTAR--KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165
A+ +QL+SAID+ H G+ HRD+K EN+L++ + + DFG + A+
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316
Query: 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203
+ GT APEV++ Y DIWS G++++
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 16 RLLGQGNFAKVYYARHL-----GTG-QSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
LG G F +VY G+G VA+K L+ G DQ K +E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT------LRKGATDQEKKEFLKEAHLMS 54
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKL-KEDTARKYFQQLIS-AID 123
HPN++++ V Y +ME +GG+L + ++ + ++L+ +D
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 124 FCHSRGVY-------HRDLKPENLLLDENG-----MLKVTDFGLSA-LAKC----KHQDG 166
VY HRDL N L+ E G ++K+ DFGL+ + K K +G
Sbjct: 115 VAKG-CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD-SNLMAMYRKI 224
LL ++APE + G ++D+WS GV+++ +L G P+ +N +
Sbjct: 174 LLPVR-----WMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 225 AKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
A + P + +L++ +PS R + +I E
Sbjct: 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 13 ELGRLLGQG--NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
EL ++G+G + V AR+ TG+ V ++ I+ + +V + E+ V +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHP 59
Query: 71 NVMQIYEVMASKTKIYFV---MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++ + +++ V M Y +L + E Q ++ A+D+ H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGL-SALAKCKH-------QDGLLHTTCGTPAYVA 179
G HR +K ++L+ +G KV GL S L+ H D ++ P +++
Sbjct: 120 MGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLS 176
Query: 180 PEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHD 214
PEV+ + +GYD K+DI+S G+ L G++PF D
Sbjct: 177 PEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 19/262 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-VAIK-AIDKDKILKVGLVDQTKR-----EISVM- 64
G+ LG G F KV A G +S +K A+ K+LK ++R E+ +M
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAV---KMLK-PTAHSSEREALMSELKIMS 93
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISA 121
L H N++ + I + EY G+L + + + L + + Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ F S+ HRDL N+LL ++K+ DFGL+ + ++APE
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 182 VISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF--PTWFSAD 238
I Y ++D+WS G++L+ + + G P+ + + + K+ K Y+ P A+
Sbjct: 214 SIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 239 VRKLLSRILDPNPSTRISIAKI 260
+ ++ D +P R + +I
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+L + LG G F +V+ A + VA+K + + + E +VM+ +QH +
Sbjct: 9 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 73 MQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKG-KLKEDTARKYFQQLISAIDFCHSRG 129
++++ V+ +K IY + E+ G L F K +G K + Q+ + F R
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP---AYVAPEVISRR 186
HRDL+ N+L+ + + K+ DFGL+ + +D G + APE I+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPF 212
+ K+D+WS G++L ++ G +P+
Sbjct: 179 SFT-IKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK-----REISVMRLIQ 68
LG+ LG+G F V + L S+ A+ K +K+ + +++ E M+
Sbjct: 3 LGKTLGEGEFGSVMEGQ-LNQDDSILKVAV---KTMKIAICTRSEMEDFLSEAVCMKEFD 58
Query: 69 HPNVMQIYEV--MASKTKIY----FVMEYAKGGELFKKVSKGKLKE-------DTARKYF 115
HPNVM++ V +++ Y ++ + K G+L + +L + K+
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---C 172
+ S +++ S+ HRDL N +L+EN + V DFGLS K +G +
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK----KIYNGDYYRQGRIA 174
Query: 173 GTPA-YVAPEVISRRGYDGDKADIWSCGVILY 203
P ++A E ++ R Y K+D+WS GV ++
Sbjct: 175 KMPVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 48 ILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK 107
++K G T E ++R I HP+++Q+ ++ K +K +
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA 180
Query: 108 EDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-- 165
+ ++ AI + H + HRD+K EN+ ++ G + + DFG A C D
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDIN 236
Query: 166 -GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS 215
+ GT A APE+++R Y G DIWS G++L+ + HDS
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC----HDS 282
|
Length = 391 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 52/206 (25%)
Query: 75 IYEVMASKTKIYFVMEYAKGGELFKKVS---KGKLKEDT-ARKYFQQLISAIDFCHSRGV 130
+ ++M SK Y V Y L KV KG +E+ + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 131 YHRDLKPENLLLDE-NGMLKVTDFGLSALAKC----KHQDGLLHTTCGTPAYVAPE--VI 183
HRD+KP+N++ E +G K+ D G +A + ++ LL P Y APE ++
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL-----DPRYAAPEQYIM 331
Query: 184 SRRGYDG-------------------DKADIWSCGVILYVLLAGYLPF--HDSNLMAMYR 222
S + D+ DI+S G+I L P DSNL+ R
Sbjct: 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI---FLQMAFPNLRSDSNLIQFNR 388
Query: 223 KIAKADYKFPTW-------FSADVRK 241
++ + DY W S D+R+
Sbjct: 389 QLKRNDYDLVAWRKLVEPRASPDLRR 414
|
Length = 566 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 29/232 (12%)
Query: 18 LGQGNFAKVY----YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM 73
LG+ F K+Y Y + Q VAIK + KD I + ++E S+M + HPN++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KD-INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKV--------------SKGKLKEDTARKYFQ--- 116
+ V+ + + + EY G+L + + G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 117 -QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
Q+ + +++ S H+DL N+L+ E +K++D GLS + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVL----LAGYLPFHDSNLMAMYRK 223
++ PE I + D +DIWS GV+L+ + L Y F + ++ M RK
Sbjct: 191 RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 24/234 (10%)
Query: 18 LGQGNFAKVYYAR-HLGTGQS-VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
+G G F KV H G ++ V +K + +E+ R + HPNV+Q
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 76 YEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQL----ISAIDFCHSRG 129
V+E+ G+L + + ++G + + + Q++ S + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTP-AYVAPEVISRR 186
H DL N L + +K+ D+G LA ++ + T P ++APE++ R
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYG---LALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 187 GYD------GDKADIWSCGVILYVLL-AGYLPFHD-SNLMAMYRKIAKADYKFP 232
G D K++IWS GV ++ L A P+ D S+ + + + + D K P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 14 LGRLLGQGNFAKVYYA----RHLGTGQSVAIKAI-DKDKILKVGLVDQTKREISVMRLIQ 68
L LL +G F +++Y G + V +K + D ++V L+ Q E ++ +
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLS 66
Query: 69 HPNVMQIYEVMASKTKIYFVME-YAKGGELFKKVSKGKLKEDTARKYFQ---------QL 118
H N++ I V + FV+ Y G L + + +L E + Q+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK--------CKHQDGLLHT 170
+ + H RGV H+D+ N ++DE +K+TD +AL++ C L
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHC------LGD 177
Query: 171 TCGTP-AYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFH--DSNLMAMYRK 223
P ++A E + + Y +D+WS GV+L+ L+ G P+ D MA Y K
Sbjct: 178 NENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 18 LGQGNFAKVYYAR--HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
LG+G F KV+ A +L Q + A+ K +RE ++ ++QH ++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 76 YEVMASKTKIYFVMEYAKGGEL----------------FKKVSKGKLKEDTARKYFQQLI 119
Y V + V EY + G+L + V+ G+L Q+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
S + + S HRDL N L+ + ++K+ DFG+S + T ++
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 180 PEVISRRGYDGDKADIWSCGVILY 203
PE I R + + +DIWS GV+L+
Sbjct: 193 PESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGT-GQSVAIKAIDKD---------KILKVGLVDQTK- 58
Q LG+G F +V+ G S A + + K+L+ D +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 59 ---REISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKY- 114
+E+ ++ + PN+ ++ V + +MEY + G+L + + K +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 115 ----FQQLI-------SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
F L+ S + + S HRDL N L+ +N +K+ DFG+S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTKREI----SVMRLIQHP 70
++LG G F VY + G+ V I AI K L+ + +EI VM + +P
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASVDNP 69
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ----QLISAIDFCH 126
+V ++ + + T + + + G L V + K ++ +Y Q+ +++
Sbjct: 70 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE 126
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSAL----AKCKHQDGLLHTTCGTP-AYVAPE 181
R + HRDL N+L+ +K+TDFGL+ L K H +G P ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-----GKVPIKWMALE 181
Query: 182 VISRRGYDGDKADIWSCGVILYVLLA-GYLPF 212
I R Y ++D+WS GV ++ L+ G P+
Sbjct: 182 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG----LVDQTKREISVMRLIQHPNVM 73
LG GNF V + + + + AI K+LK + D+ RE +M + +P ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-AI---KVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTAR---KYFQQLISAIDFCHSRGV 130
++ V ++ + VME A GG L K +S GK E T + Q+ + + +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPLNKFLS-GKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVISRRGYD 189
HRDL N+LL K++DFGLS + P + APE I+ R +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 190 GDKADIWSCGVILY 203
++D+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 8 LMQKYELGRL--LGQGNFAKVYYARHLGTGQSV----AIKAIDKDKILKVGLVDQTKREI 61
++++ EL R+ LG G F VY + G++V AIK +++ K + + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEA 60
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK--LKEDTARKYFQQLI 119
+M + HP+++++ V S T I V + G L V + K + + Q+
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA 119
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ + R + HRDL N+L+ +K+TDFGL+ L + ++ ++A
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLL 206
E I R + ++D+WS GV ++ L+
Sbjct: 180 LECIHYRKFT-HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 39/179 (21%)
Query: 10 QKYELGRLLGQGNFAKVYY------ARHLGTGQS--------VAIKAIDKDKILKVGLVD 55
Q+ L LG+G F +V+ A LG G VA+K + D V
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-------VT 57
Query: 56 QTKR-----EISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDT 110
+T R EI +M +++PN++++ V S + + EY + G+L + +S+ +++
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117
Query: 111 ARK------------YFQ-QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
Y Q+ S + + S HRDL N L+ + +K+ DFG+S
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 60/259 (23%), Positives = 104/259 (40%), Gaps = 72/259 (27%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI-SVMRLIQH-PN 71
LG+ LG+G F KV A G +S + + + K+LK G + + + ++++ H +
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTV-AVKMLKEGATASEYKALMTELKILIHIGH 69
Query: 72 VMQIYEVMASKTK----IYFVMEYAKGGEL-------------------------FKKVS 102
+ + ++ + TK + ++EY K G L K+
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 103 KGKLKEDTARK-------------------------------------YFQQLISAIDFC 125
K +L ++ + Y Q+ ++F
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVIS 184
SR HRDL N+LL EN ++K+ DFGL A K D + P ++APE I
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDARLPLKWMAPESIF 248
Query: 185 RRGYDGDKADIWSCGVILY 203
+ Y ++D+WS GV+L+
Sbjct: 249 DKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
Y Q+ ++F SR HRDL N+LL EN ++K+ DFGL A K D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 174 TP-AYVAPEVISRRGYDGDKADIWSCGVILY 203
P ++APE I + Y ++D+WS GV+L+
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
Y Q+ ++F SR HRDL N+LL EN ++K+ DFGL A K D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 174 TP-AYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPF 212
P ++APE I R Y ++D+WS GV+L+ + + G P+
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 31/83 (37%), Positives = 44/83 (53%), Gaps = 10/83 (12%)
Query: 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD 191
HR K N+LL +G+LK+ G S K Q P ++APEVI + Y +
Sbjct: 34 HRQAKSGNILLTWDGLLKL--DG-SVAFKTPEQSR------PDPYFMAPEVIQGQSYT-E 83
Query: 192 KADIWSCGVILYVLLAGYLPFHD 214
KADI+S G+ LY L LP+++
Sbjct: 84 KADIYSLGITLYEALDYELPYNE 106
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTKREI----SVMRLIQHP 70
++LG G F VY + G++V I AI K+L+ + +EI VM + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAI---KVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAIDFCHSR 128
V ++ + + T + V + G L V +K ++ + Q+ + +
Sbjct: 70 YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG-TP-AYVAPEVISRR 186
+ HRDL N+L+ +K+TDFGL+ L + H G P ++A E I R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHR 186
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPF 212
+ ++D+WS GV ++ L+ G P+
Sbjct: 187 RFT-HQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 51/253 (20%), Positives = 99/253 (39%), Gaps = 44/253 (17%)
Query: 35 GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIY----EVMASKTKIYFVME 90
+ V I+ K L+D T+ EI +R I N+++IY +++ ++ ++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVY---------HRDLKPENLL 141
Y G L + L ++ + +L AID C +G+Y +++L + L
Sbjct: 103 YCTRGYL-----REVLDKEKDLSFKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFL 155
Query: 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD---------GDK 192
+ EN LK+ G L +P + + Y K
Sbjct: 156 VTENYKLKIICHG-------------LEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSA--DVRKLLSRILDPN 250
DI+S GV+L+ + G +PF + +Y I + +++ ++ +
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262
Query: 251 PSTRISIAKIMEN 263
R +I +I+ N
Sbjct: 263 SIKRPNIKEILYN 275
|
Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 28/110 (25%), Positives = 54/110 (49%), Gaps = 12/110 (10%)
Query: 59 REISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKED--------- 109
+EI +M ++ PN++++ V + + + EY + G+L + +S+ + +E
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 110 ---TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
T Q+ S + + S HRDL N L+ +N +K+ DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 43/270 (15%)
Query: 18 LGQGNFAKVYYARHL------GTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQH 69
LGQG F +Y G + + K L D S+M + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQLSH 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYF--QQLISAIDFCHS 127
+++++Y V I V EY K G L + + K K +QL SA+ +
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 128 RGVYHRDLKPENLLLDENGM-------LKVTDFG--LSALAKCKHQDGLLHTTCGTPAYV 178
+ + H ++ +N+L+ G+ +K++D G ++ L++ + + + ++
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------PWI 171
Query: 179 APEVISRRGYDGDKA------DIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKF 231
APE +A D WS G L + G P + R +
Sbjct: 172 APEC-----IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RL 225
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKIM 261
P A++ L+++ +P+ R S I+
Sbjct: 226 PMPDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 39/178 (21%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 47 KILKVGLVDQTKR----EISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKK 100
L+ G D+ +R E + H N++++ V+ + V EY G L F +
Sbjct: 39 HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR 98
Query: 101 VSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160
+G+L L S + + G H+ L +L++ + + K++ F K
Sbjct: 99 KHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158
Query: 161 CKHQDGLLHTTCG--TPA-YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHD 214
+ ++TT +P + APE I + + +D+WS G++++ +++ G P+ D
Sbjct: 159 SE----AIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 50/219 (22%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTKRE 60
+V +K + R LGQG+F VY G + VAIK +++ ++ + + E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNE 59
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKED--------TAR 112
SVM+ +V+++ V++ +ME G+L + + + + + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 113 KYFQ---QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCKHQ 164
K Q ++ + + ++ HRDL N ++ E+ +K+ DFG++ K
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203
GLL +++PE + + G +D+WS GV+L+
Sbjct: 180 KGLLPVR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 60 EISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
EI+ M +QHPN++++ + S+ Y + EY +G L + + L + RK +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--NLSWERRRKIAIGIA 790
Query: 120 SAIDFCH---SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL---HTTCG 173
A+ F H S V +L PE +++D G GLL
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIID----------GKDEPHLRLSLPGLLCTDTKCFI 840
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP 211
+ AYVAPE + +K+DI+ G+IL LL G P
Sbjct: 841 SSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 29/156 (18%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDK------------DKILKVGLVDQTKREIS 62
+L+ +G A++Y LG IKA+ K D+ ++ ++T+RE
Sbjct: 1 MKLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 63 VMR--LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120
+M NV +Y V I VMEY +G L ++ + +++
Sbjct: 52 IMSRARKAGVNVPAVYFVDPENFII--VMEYIEGEPLKDLINSN---GMEELELSREIGR 106
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
+ HS G+ H DL N++L + + DFGL+
Sbjct: 107 LVGKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 6 KVLMQKYELGRLLGQGNFAKVY--YARHLGTGQS---VAIKAIDKDKILKVGLVDQTKRE 60
+V +K L R LGQG+F VY AR + G++ VA+K +++ L+ + + E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNE 59
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKED----------T 110
SVM+ +V+++ V++ VME G+L K L+ + T
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL--KSYLRSLRPEAENNPGRPPPT 117
Query: 111 ARKYFQ---QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS-----ALAKCK 162
++ Q ++ + + +++ HRDL N ++ + +K+ DFG++ K
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203
GLL ++APE + + G +D+WS GV+L+
Sbjct: 178 GGKGLLPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 32/140 (22%), Positives = 63/140 (45%), Gaps = 19/140 (13%)
Query: 31 HLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMRLIQH--PNVMQIYEVMASKTK 84
T + + D+D +LK+ + RE+++++L+ V ++ S
Sbjct: 8 GGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGW 67
Query: 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQL-----ISAIDFCHSRGVYHRDLKPEN 139
Y +ME+ +G L +VS+ + KED A + + L + + CH DL P N
Sbjct: 68 SYLLMEWIEGETL-DEVSEEE-KEDIAEQLAELLAKLHQLPLLVLCH------GDLHPGN 119
Query: 140 LLLDENGMLKVTDFGLSALA 159
+L+D+ +L + D+ +
Sbjct: 120 ILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 21/60 (35%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
GTP Y+APE++ + + G D W+ GV L+ L G PF+D +++ I D +P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 36/150 (24%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
Q+ + F S+ HRDL N+LL + K+ DFGL+ + + ++ P
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNARLPV 280
Query: 177 -YVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF--P 232
++APE I Y + +D+WS G++L+ + + G P+ + + + K+ K Y+ P
Sbjct: 281 KWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIME 262
+++ ++ D +P R + +I++
Sbjct: 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 19/46 (41%), Positives = 32/46 (69%), Gaps = 1/46 (2%)
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161
+Q+++ + H G+ HRD+KPENLL+ +G +K+ DFG +A+ C
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG-AAVDMC 360
|
Length = 507 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 20/118 (16%)
Query: 59 REISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ-- 116
+E+ ++ ++ PN++++ V + + + EY + G+L + +S L +
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 117 ------------------QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
Q+ S + + S HRDL N L+ EN +K+ DFG+S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 44/200 (22%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 15 GRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+LLG G F V+ + G S VAIK I +D+ + + T +++ L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMGSL-DHA 69
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAIDFCHSR 128
++++ + + V + + G L V + L + Q+ + +
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP-AYVAPEVISRRG 187
+ HR+L N+LL + ++++ DFG++ L + ++ TP ++A E I
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGR 187
Query: 188 YDGDKADIWSCGVILYVLLA 207
Y ++D+WS GV ++ +++
Sbjct: 188 YT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH--TTCGT 174
Q+ ++F S+ HRDL N+LL + ++K+ DFGL+ H + +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA--RDIMHDSNYVSKGSTFLP 302
Query: 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF-- 231
++APE I Y +D+WS G++L+ + + G P+ + + + K+ Y+
Sbjct: 303 VKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 232 PTWFSADVRKLLSRILDPNPSTRIS 256
P + +V ++ + + P R S
Sbjct: 362 PDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP- 175
Q+ + ++F S+ HRDL N+L+ E ++K+ DFGL A + + + + P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGL-ARDIMRDSNYISKGSTFLPL 305
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKF--P 232
++APE I Y +D+WS G++L+ + G P+ + + + K Y+ P
Sbjct: 306 KWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIM 261
S ++ +++ + + R ++++
Sbjct: 365 AHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 40/165 (24%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 10 QKYELGRLLGQGNFAKVY----YARHLGTGQSVA-IKAIDKDKILKVGLVDQTKREISVM 64
+++++ +L+G G F VY + H Q+VA I+ ++ + I+ LV +I +
Sbjct: 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKI 71
Query: 65 RL------IQHPNVMQIYEVMASK-TKIYF---VME--YAKGGELFKKVSKGKLKEDTAR 112
L I H + + Y + K ++Y+ ++E E+FK++ K K K+ +
Sbjct: 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKK-LIK 129
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157
+ +++ +++ H G+ H D+KPEN+++D N + D+G+++
Sbjct: 130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 56/251 (22%), Positives = 105/251 (41%), Gaps = 36/251 (14%)
Query: 33 GTGQSVAIKAIDKDKILKVGLVDQTKREISV--------MRLIQHPNVMQIYEVMASKTK 84
G IK I LKV +D + R+IS+ MR + H +++ +Y V +
Sbjct: 26 GYSYEKEIKVI-----LKV--LDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78
Query: 85 IYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL 142
V E+ + G +LF L K +QL SA+ + + + H ++ +N+LL
Sbjct: 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILL 138
Query: 143 DENGM-------LKVTDFG--LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKA 193
G+ +K++D G ++ L++ + + + ++APE + A
Sbjct: 139 AREGIDGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAA 190
Query: 194 DIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPS 252
D WS G L+ + G +P D L R + T ++ L++ ++ +P+
Sbjct: 191 DKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSCKELADLMTHCMNYDPN 249
Query: 253 TRISIAKIMEN 263
R IM +
Sbjct: 250 QRPFFRAIMRD 260
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHPNVMQI 75
+G G F KV + +G + A + + K+ + + +Q K E R +QH N++Q
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKLKED------TARKYFQQLISAIDFCHSRG 129
T VME+ G+L + + E T ++ ++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTP-AYVAPEVISRR 186
H DL N LL + +K+ D+GLS K+++ T P ++APE++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLS---HNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 187 G-----YDGDK-ADIWSCGVILYVLL 206
D K +++WS GV ++ L
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 25/234 (10%)
Query: 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHPNVMQI 75
+G G F KV + + T VA + + K+ +Q + ++ R++QHPN++Q
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVA-RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 76 YEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQ-----LISAIDFCHSRGV 130
V EY + G+L +S+ + ++ Q + + + H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT---TCGTPAYVAPEVISRRG 187
H DL N L + +KV D+G + ++++ + T C ++APE++
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRWLAPELVGEF- 176
Query: 188 YDG-------DKADIWSCGVILYVLLA-GYLPFHD-SNLMAMYRKIAKADYKFP 232
+ G +++W+ GV L+ L P+ S+ + I K
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 46/281 (16%)
Query: 18 LGQGNFAKVYYARHL--GTGQSVAIKAIDKDK-------------ILKVGLVDQTKREI- 61
LGQG +Y R G G+ + D+D +LKV +D + R+I
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKV--LDPSHRDIA 60
Query: 62 -------SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKY 114
S+M + H ++ ++ V ++ V E+ + G L + K K + A K
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI 120
Query: 115 F--QQLISAIDFCHSRGVYHRDLKPENLLLDENGM-------LKVTDFGLS--ALAKCKH 163
QQL SA+ + + + H ++ +N+LL G+ +K++D G+S AL++ +
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCG-VILYVLLAGYLPFHDSNLMAMYR 222
+ + ++APE + AD WS G +L + G +P + R
Sbjct: 181 VERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 223 KIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263
K ++ P ++ L+S+ L P+ R S I+ +
Sbjct: 233 FYEK-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 32/233 (13%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI-DKDKILKVGLVDQTKREISVMR 65
V Q++++ LLG+G F KV A + A+K + + K + K EI M
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR-----DAKIEIQFME 180
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAK--------GGELFKKVSK-GKLKEDTARKYFQ 116
++ + + +M K + YF E G L + K G +
Sbjct: 181 KVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIF 238
Query: 117 QLISAIDFCHSR-GVYHRDLKPENLLLD--ENGMLKVTDFGLSA---------LAKCKHQ 164
Q A+D+ H+ + H DLKPEN+L++ + + VT+ L L C +
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE 298
Query: 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF--HDS 215
T Y +PEV+ G+ D+WS G I+Y L G L + HD+
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDN 350
|
Length = 467 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 18 LGQGNFAKVYYA--RHLGTGQSVAIKAIDKDKILKVGLVDQTKREI--------SVMRLI 67
LGQG F K++ R +G + + +LKV +D++ R S+M +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEV----LLKV--LDKSHRNYSESFFEAASMMSQL 56
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKY--FQQLISAIDFC 125
H +++ Y V + V EY K G L + K K + + K +QL A+ F
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 126 HSRGVYHRDLKPENLLLDENG--------MLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
+G+ H ++ +N+LL +K++D G+S K + LL +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--EILLERI----PW 170
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAG 208
V PE I AD WS G L+ + +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.004
Identities = 18/66 (27%), Positives = 34/66 (51%), Gaps = 5/66 (7%)
Query: 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM 147
VMEY G EL + ++ ED + +++ I + G+ H DL N+L+D++
Sbjct: 109 VMEYIDGVEL----YRVRVLED-PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163
Query: 148 LKVTDF 153
+ + D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.34 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.74 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.67 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.92 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.61 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.54 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.29 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.63 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.44 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.72 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-63 Score=490.70 Aligned_cols=341 Identities=50% Similarity=0.879 Sum_probs=276.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCC-CCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK--VGLVDQTKREISVMRLIQ-HPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (450)
....++|++++.||+|+||+|++|.+..+++.||+|++++..... ....+++.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 367889999999999999999999999999999999888763331 135678889999999998 99999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFGls~~~~ 160 (450)
+++|+||||+.||+|++++.+ +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||+|....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998654
Q ss_pred cccCCCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCC-cHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF-SAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 238 (450)
.....+.+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||++.+...++.+|..+.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3556788999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc-cCCCccccchhhcccC-ccccccccCCCCCCC---CCCCCCCCCCCCCC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK-GLNSKSAKSKTAIKES-SLVDVDAAFGPIENS---ASTEAPRPMTKPDN 313 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 313 (450)
+++|+.+||.+||.+|+|+.+|+.||||+. ................ ...+......+.+.. .......+...+..
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLS 330 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999997 3322211111000000 000000000001000 00000011003456
Q ss_pred CcHHHHhh-hcCCC--CCCCccccccceeeeeeecccC
Q 045214 314 LNAFHIIS-LSSGF--DLSGFFVEHDQKEEVKFTSKYS 348 (450)
Q Consensus 314 ~~~~~~~~-~s~~~--~ls~~~~~~~~~~~~rf~s~~~ 348 (450)
.+++++++ ++.+. ++++++.....++..+|.+..+
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (370)
T KOG0583|consen 331 LNAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLTS 368 (370)
T ss_pred cChhhhcccccccccccccccccccccchhhhhhhccc
Confidence 78888777 67777 7899887654455667766543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-63 Score=469.98 Aligned_cols=261 Identities=38% Similarity=0.726 Sum_probs=233.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc----hHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG----LVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
+.+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+..... -...+.+|+++|++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 45778899999999999999999999999999999999987664321 23446899999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC---CCeEEeecCchh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN---GMLKVTDFGLSA 157 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~---~~vkl~DFGls~ 157 (450)
.+..|+||||++||+|++++-. +.+.|+..+.+++||+.||.|||++||+||||||||||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999999865 689999999999999999999999999999999999999766 679999999998
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCC--CCCccchhhHHHHHHHHhhCCCCCCCCcHHH-HHHHHhhcCCCCC--
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGY--DGDKADIWSCGVILYVLLAGYLPFHDSNLMA-MYRKIAKADYKFP-- 232 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~p-- 232 (450)
..+ ......+.||||.|.|||++...++ ++.++|||||||+||.+|+|++||.+..... +.++|.++.+.+-
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 654 4567789999999999999987664 4458899999999999999999999866554 8889999988764
Q ss_pred CC--CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 TW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 ~~--~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.| +|.++++||.+||..||++|||++|+|+||||+..
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 33 89999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-62 Score=482.71 Aligned_cols=262 Identities=36% Similarity=0.722 Sum_probs=247.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+....+....+.+.+||+|++.|+|||||++|++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 37999999999999999999999999999999999999888899999999999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|+|..++|..++++ ..++|.+++.|++||+.||.|||+++|+|||||..|+||+++.+|||+|||||+..... ....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc--cccc
Confidence 99999999999986 58999999999999999999999999999999999999999999999999999876533 2345
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
.+.||||.|.|||++...++ +..+||||+||+||.||.|++||...+..+.|.+|...++.+|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 68899999999999998877 59999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCccccccCCCcc
Q 045214 249 PNPSTRISIAKIMENPWFRKGLNSKS 274 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~~~~~~~ 274 (450)
+||.+|||+++||.|+||+.++.+..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999987776543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-61 Score=483.25 Aligned_cols=261 Identities=43% Similarity=0.812 Sum_probs=246.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.|-|+++++||.|+.|.|.+|++..||+.+|||++.+...........+++||-+|+.+.|||++++|++++++.++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35679999999999999999999999999999999988755555566789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|.||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+. ..+.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence 999999999999985 589999999999999999999999999999999999999999999999999998753 4567
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
++.+.||+|.|+|||++.+.+|+|.++||||||||||.||+|.+||++.|...++.++..+.+..|..+|+++++||++|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccccCC
Q 045214 247 LDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
|+.||++|+|.+||++|||++....
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999976543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-59 Score=440.33 Aligned_cols=260 Identities=37% Similarity=0.730 Sum_probs=241.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.+.|+++++||+|+||+||+++.+.|++.+|+|++++..+.+....++.+.|..||..++||+||+++..|++.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34678999999999999999999999999999999999998887778899999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+|+||+.||+|+..+++ +.++|+.++.|+..|+.||.|||+.||+||||||||||||.+|+++|+|||+|+... ...
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCC
Confidence 99999999999999985 799999999999999999999999999999999999999999999999999997432 233
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC-CCCcHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-TWFSADVRKLLS 244 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~ll~ 244 (450)
....+.|||+.|||||++.+.+|+ .++|.||||+++|+||+|.+||.+.+...++++|..+....+ ..++.+++++|+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 456678999999999999999986 899999999999999999999999999999999999995554 459999999999
Q ss_pred HccCCCCCCCC----CHHHHhcCcccccc
Q 045214 245 RILDPNPSTRI----SIAKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~----s~~eil~hp~f~~~ 269 (450)
++|..||++|. ++.+|.+||||..-
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999999996 78999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-59 Score=424.74 Aligned_cols=256 Identities=40% Similarity=0.793 Sum_probs=243.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.++|+++++||.|+||.|.+++++.+|..+|+|++++..+.+..+.++..+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++||+|+.++++ +++++..++.|+.|++.||+|||+++|++|||||||||||.+|.+||+|||+|... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999987 79999999999999999999999999999999999999999999999999998643 3
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
+.+.+.||||.|+|||++..++|. .++|.|||||++|||++|++||.+.+...+|++|..++..+|+.+++++++||.+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 446788999999999999999986 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 045214 246 ILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
+|+.|-.+|. ..++|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999995 4789999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-57 Score=444.31 Aligned_cols=260 Identities=36% Similarity=0.706 Sum_probs=240.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (450)
--..|.+++.||+|+|++|++|+++.+++.||||++.+..+.++.-.+-+.+|-.+|.+| .||.|++||..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346799999999999999999999999999999999999887777677788999999999 8999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+|+||+++|+|.++|.+ |.|++.-++.|+.||+.||+|||++|||||||||||||||.+|++||+|||.|.........
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999988 89999999999999999999999999999999999999999999999999998765433221
Q ss_pred -------C----CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCC
Q 045214 166 -------G----LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW 234 (450)
Q Consensus 166 -------~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (450)
. ...+.+||..|++||++.+... ++.+|||+||||||+|++|.+||.+.+...++++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1 1145789999999999987654 589999999999999999999999999999999999999999999
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+++.+++||.++|..||.+|+|+++|.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-56 Score=420.54 Aligned_cols=256 Identities=32% Similarity=0.545 Sum_probs=231.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-EEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-KIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 86 (450)
..+..+.+..||+|+.|+||+++|+.|++.+|+|++.... +....+|+.+|+++++.++|||||.+|+.|..+. .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 3446788999999999999999999999999999995432 3466789999999999999999999999999999 599
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+||+|.+.+.. ++++|.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.|...-.
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 99999999999999886 799999999999999999999995 9999999999999999999999999999876532
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-----cHHHHHHHHhhcC-CCCCCC-CcH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-----NLMAMYRKIAKAD-YKFPTW-FSA 237 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~ 237 (450)
....+..||-.|||||.+.+..|. .++||||||++++|+.+|+.||... +..+++..|..+. ..+|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 256788999999999999998875 8999999999999999999999875 5677888887754 456776 999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++++||..||++||.+|+|+.|+++|||+++..
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999998744
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=434.02 Aligned_cols=261 Identities=36% Similarity=0.682 Sum_probs=236.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.+.|++++.||+|+||.||+|+.+.||+.+|+|++++......+.++.++.|-.+|....+|+||++|..|.+..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 44678999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc--
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH-- 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~-- 163 (450)
|||||++||++..++.+ +.++|+.++.|+.+++.|+..+|+.|++||||||+|+|||..|++||+|||||+.....+
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999876 899999999999999999999999999999999999999999999999999985322200
Q ss_pred ------------------CC-------------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHH
Q 045214 164 ------------------QD-------------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGV 200 (450)
Q Consensus 164 ------------------~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGv 200 (450)
.+ ....+.+|||.|+|||++.+++|. ..+|.|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 00 011245799999999999999975 8999999999
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCCC--CcHHHHHHHHHccCCCCCCCCC---HHHHhcCcccccc
Q 045214 201 ILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPTW--FSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRKG 269 (450)
Q Consensus 201 il~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~ll~~~L~~dP~~R~s---~~eil~hp~f~~~ 269 (450)
||||||.|++||...++.+.+++|.... +.+|.. ++++++|||.+||. ||++|.. ++||.+||||+.-
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999999998765 566654 78999999999998 9999985 8999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-56 Score=421.53 Aligned_cols=262 Identities=42% Similarity=0.748 Sum_probs=246.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+..||++.++||+|+||+|.+|.....|+.||||.|+++++.+....-.+.+||+||..|+||||+.+|++|++.+++.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 35678999999999999999999999999999999999999988777888999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||||..+|+|.|+|.. +.++|.+++.+|+||++|+.|||.++++|||||.+|||||.|+++||+|||+|.++. ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cc
Confidence 99999999999999976 789999999999999999999999999999999999999999999999999998764 45
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
..+.+.||+|.|.+||++.+.+|.++.+|-||||++||.|..|..||++.+...+.++|..+.+.-|. -+.++.-||+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 67889999999999999999999999999999999999999999999999999999999999887766 46788999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
||-.||++|.|+++|-.|=|..-+++.
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy~~ 312 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGYNM 312 (668)
T ss_pred HHhcCcccchhHHHHhhhheeeccccc
Confidence 999999999999999999998766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=416.02 Aligned_cols=260 Identities=39% Similarity=0.709 Sum_probs=235.9
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|.+.+.||+|+||+||+|+++.++..||||.+.+.... ....+.+..||.+|+.++|||||.++++..+++.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 34567899999999999999999999999999999999988653 35567889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC------CCeEEeecCchhh
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN------GMLKVTDFGLSAL 158 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~------~~vkl~DFGls~~ 158 (450)
|+|||||+||+|.++|.+ ++++|..++.++.||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999987 699999999999999999999999999999999999999865 3589999999986
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWF 235 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 235 (450)
.. ......+.||||.|||||++....|+ .|+|+||+|+|+|+|++|+.||+..+..+++..+.++.. .+|.++
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 54 45567889999999999999988887 899999999999999999999999999999888876654 345668
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+..+.+|+...|..+|..|.+..+-+.|++.....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 89999999999999999999999999999987543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=419.19 Aligned_cols=269 Identities=35% Similarity=0.662 Sum_probs=237.2
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----------chHHHHHHHHHHHHhCCCCCcc
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----------GLVDQTKREISVMRLIQHPNVM 73 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv 73 (450)
+....++|++.+.||+|.||+|.+|++..+++.||||++.+...... .-.+++.+||.+|++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 45667899999999999999999999999999999999987543221 1246889999999999999999
Q ss_pred EEEEEEEeC--CEEEEEEeecCCCChhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 74 QIYEVMASK--TKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 74 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
+|+++..+. +.+|||+|||..|.+...-.... +++.+++.|+++++.||+|||.+||+||||||+|+||+++|.+||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999764 58999999999998876655555 999999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhccc---CCCCcccccCCCcccCchhccc---CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHH
Q 045214 151 TDFGLSALAKCKH---QDGLLHTTCGTPAYVAPEVISR---RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224 (450)
Q Consensus 151 ~DFGls~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i 224 (450)
+|||.|..+.... .+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||+|+.|++||.+....+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999987553221 1223455789999999999987 557789999999999999999999999999999999999
Q ss_pred hhcCCCCCCC--CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCCc
Q 045214 225 AKADYKFPTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273 (450)
Q Consensus 225 ~~~~~~~p~~--~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 273 (450)
......+|.. +..++++||.+||.+||++|+++.+|..|||........
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999998876 789999999999999999999999999999998765443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-56 Score=395.43 Aligned_cols=260 Identities=35% Similarity=0.692 Sum_probs=236.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
...+.+.|++.+.||+|.|+.||++.+..||+.+|+|+++..++... ..+.+++|++|.+.|+||||+++++.+.+...
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 56788899999999999999999999999999999999998776544 56889999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFGls~~~~ 160 (450)
.|+|+|+++|++|+.-|-. --++|..+-.+++||++||.|||.+||+|||+||+|+||-. .--+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999776654 46899999999999999999999999999999999999953 3369999999986543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCc
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFS 236 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (450)
.........|||.|||||++...+|. ..+|||+||++||-||.|++||.+.+...+|+.|..+.+.+|+ .++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 44556778999999999999988874 8999999999999999999999999999999999999887765 389
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++++|+++||..||.+|+|+.|+|+|||+++.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=428.27 Aligned_cols=262 Identities=32% Similarity=0.633 Sum_probs=244.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
..-.+.|.++++||+|.||+|++|..+.+++.+|||+++++.+.....++..+.|-+|+... +||.++.++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45577899999999999999999999999999999999999998888889999999999988 59999999999999999
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|+||||+.||++...+..+.++|..++.|+..++.||+|||++||+|||||.+|||||.+|.+||+|||+++.. ...
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CCC
Confidence 999999999999777777789999999999999999999999999999999999999999999999999998642 224
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
...+.+.||||.|+|||++.+..|. .++|.|||||+||+||.|..||.+.+.++++..|...+..+|.|+|.++.++++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 4567899999999999999999885 999999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCC-----HHHHhcCccccccC
Q 045214 245 RILDPNPSTRIS-----IAKIMENPWFRKGL 270 (450)
Q Consensus 245 ~~L~~dP~~R~s-----~~eil~hp~f~~~~ 270 (450)
++|..||++|.. +++|..||||+...
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 999999999996 58899999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=393.87 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=219.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
|++|+.+..+|+|+||.||+|+++.||+.||||.+.-.. .++...+-..|||++|++++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 578999999999999999999999999999999986443 2234445678999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+|||+.. +.+.+++ .+++++.++.|++|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... +..
T Consensus 80 FE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 9999874 4444543 5799999999999999999999999999999999999999999999999999987653 344
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------------- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (450)
.+...+.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|.+.+..+.+..|.+.-.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 566788999999999999866668999999999999999999999999876655555543211
Q ss_pred --CCCC------------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 230 --KFPT------------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 230 --~~p~------------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
.+|. .++.-+.+|+.+||..||.+|++.+|+|.||||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 2466789999999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=412.42 Aligned_cols=262 Identities=30% Similarity=0.555 Sum_probs=227.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKT 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (450)
-..+++||.+.+.||.|+||.||+|+...+|+.||||.+++....-++ -.-.||+..|++++ ||||+++.+++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 356899999999999999999999999999999999999776543221 12358999999998 999999999998888
Q ss_pred -EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 -KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 -~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+|+|||||+- .|.++++. ..|+|..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999965 89999865 469999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------- 227 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 227 (450)
. ...+..++.|.+|+|||++.+.++++.+.||||+|||++|+.+-++.|.+.+..+...+|...
T Consensus 162 S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 S---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred c---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 3 334566789999999999999999999999999999999999999999998876666665431
Q ss_pred ------CCCCCC-----------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 228 ------DYKFPT-----------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 228 ------~~~~p~-----------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
++.+|. ..++++.++|.+||.+||.+|||++|+|+||||+.....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 223332 257899999999999999999999999999999876543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=380.83 Aligned_cols=258 Identities=39% Similarity=0.735 Sum_probs=243.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+.-.++|++++.||+|-||.||+|+.+.++-.||+|++.++.+.+.+...++.||++|...|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34567899999999999999999999999999999999999988888889999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHh--c-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 86 YFVMEYAKGGELFKKVS--K-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
|+++||+.+|+|+..+. + .+++|..+..|+.|++.||.|||..+|+||||||+|+|++.+|.+|++|||-|....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999999998 3 369999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
.+...+.|||..|.+||+..+.+++ ..+|+|++|++.|+++.|..||...+..+.|++|.+.++.+|+.++.+++||
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 3445688999999999999999887 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|.+||..+|.+|.+..|++.|||+..
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=393.87 Aligned_cols=254 Identities=34% Similarity=0.640 Sum_probs=225.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEE-EEEeCC-
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE-VMASKT- 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~- 83 (450)
..-...|++.+.||+|+||+||++++..+|+.+|.|.++-+.. +....+.+..|+.+|++|+|||||++|+ .+..++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3344569999999999999999999999999999999985543 3345678899999999999999999998 454444
Q ss_pred EEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCcEEecCCCCeEEeecC
Q 045214 84 KIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHS--RG--VYHRDLKPENLLLDENGMLKVTDFG 154 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~--~g--i~HrDikp~NILl~~~~~vkl~DFG 154 (450)
.++||||||++|+|...|.. ..++|..+++++.||+.||.+||+ .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 49999999999999999853 469999999999999999999999 44 9999999999999999999999999
Q ss_pred chhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CC-
Q 045214 155 LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FP- 232 (450)
Q Consensus 155 ls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p- 232 (450)
+++++... ....++.+|||.||+||++.+.+|+ ++|||||+||++|||++-..||.+.+...+.++|..++++ +|
T Consensus 174 L~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 99887543 3346778999999999999999997 9999999999999999999999999999999999999886 66
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+|.++..||..|+.+||+.||+. +|++.+
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 5689999999999999999999997 555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=418.55 Aligned_cols=258 Identities=34% Similarity=0.642 Sum_probs=240.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+..-.+ .....+.+|++|++.++||||++++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999998865432 3467899999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
.|||.| +|+.++.. +.++|+.++.+..|++.||.|||+++|.|||+||.|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999976 6899999999999999999999999999999999999999999999999999986543 3345
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHcc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L 247 (450)
+....|||.|||||+..+.+|+ ..+|+||||||+|||++|++||-..+..++.+.|.......|+..|.++.+||..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6677899999999999988886 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccCC
Q 045214 248 DPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.+||.+|+|..+++.|||++....
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhh
Confidence 999999999999999999986543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-53 Score=403.07 Aligned_cols=258 Identities=31% Similarity=0.600 Sum_probs=220.7
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--EEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--KIYF 87 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~l 87 (450)
.+|..++.||+|+||.||++.+..+|+..|||.+....... .+.+.+|+.+|++++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 46899999999999999999999999999999998763222 677899999999999999999999754444 7999
Q ss_pred EEeecCCCChhhHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhc-cc
Q 045214 88 VMEYAKGGELFKKVSK-G-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKC-KH 163 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~-~~ 163 (450)
+|||++||+|.+++.+ + +++|+.++.|.+|+++||.|||++||+||||||+|||++. +|.+||+|||++..... ..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999987 4 6999999999999999999999999999999999999999 79999999999875543 11
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHhhcC--CCCCCCCcHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKAD--YKFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~ 240 (450)
.........|||.|||||++........++|||||||++.||+||..||.. .......-.+.... ..+|.++|.+++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 122334578999999999998633333599999999999999999999998 44444444444333 467889999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+||.+||..||++|||++++|+|||.+...
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999999997644
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=407.31 Aligned_cols=261 Identities=40% Similarity=0.744 Sum_probs=243.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.+=|.+.++||+|-|+.|.+|++.-||+.||||++++.+... -...++.+|++.|+.++|||||++|++..+.+++|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 46778999999999999999999999999999999999987654 33568899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe-cCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL-DENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl-~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+|+-+||+|+|+|.+ .++.|+.+++||.||+.|+.|||+..++||||||||+.+ ..-|-|||.|||++..+.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 99999999999999976 479999999999999999999999999999999999877 467899999999986554
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
+...+.+.||+..|-|||++.+..|+.+++||||||||||-|.+|++||...+..+.+..|..+.+..|..+|.++++||
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 34457889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
..||..||.+|.|+++|..|+|++..-.
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999999999986543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=404.57 Aligned_cols=255 Identities=38% Similarity=0.772 Sum_probs=232.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999987655444456778999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++||+|.+.+.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~-----~ 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----D 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC-----C
Confidence 9999999999999876 579999999999999999999999999999999999999999999999999986432 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.+++.++++||.+|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 22346899999999999887764 89999999999999999999999988888889998888899999999999999999
Q ss_pred cCCCCCCCCC-----HHHHhcCccccc
Q 045214 247 LDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
|+.||.+|++ +++++.||||+.
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999997 799999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-52 Score=403.35 Aligned_cols=259 Identities=32% Similarity=0.553 Sum_probs=228.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TK 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 84 (450)
...+.|+.++.||+|+||.||+|++..+|+.||+|.+..+... .+...-..|||.||++|+||||+++.++..+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 4566899999999999999999999999999999999887643 35667788999999999999999999998776 68
Q ss_pred EEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
+|+|+|||+. +|.-++... .|++.++..|++||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999987 788888774 7999999999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------CC---CCC
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------DY---KFP 232 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------~~---~~p 232 (450)
... .+...+-|.+|+|||.+.+..-++.++|+||+||||.||++|++.|.+.+..+.+.+|.+. .+ .+|
T Consensus 272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 433 3566788999999999999887889999999999999999999999999888777777442 01 112
Q ss_pred -------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 -------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 -------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++.+.+|+..||..||.+|.|+.++|+|+||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 126888999999999999999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=370.26 Aligned_cols=255 Identities=31% Similarity=0.525 Sum_probs=224.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|...+.||+|+||.||+|++..||+.||||.+...+.. .+......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 6899999999999999999999999999999999887543 355677889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++. +|...|+.. .++...++.|+.+++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+.+...+...
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 99976 899988763 69999999999999999999999999999999999999999999999999999887655432
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------------- 228 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------- 228 (450)
...+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|...-
T Consensus 159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 233789999999999998877899999999999999999999999887766666654321
Q ss_pred ---CCCC------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 ---YKFP------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 ---~~~p------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++.| +..+.++.+|+.+||..||.+|+|+.|+++|+||+.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 1111 113678899999999999999999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-51 Score=403.69 Aligned_cols=260 Identities=39% Similarity=0.762 Sum_probs=236.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 84 (450)
.-+...|++++.||+|.||.||.|+++.||+.+|+|++.+...........+.+|+.+|+.+. ||||+.+++.|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345678999999999999999999999999999999999887765445678999999999998 9999999999999999
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC----CCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN----GMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~----~~vkl~DFGls~~~~ 160 (450)
+|+|||+|.||+|++.|....++|..+..++.|++.+++|||+.||+||||||||+|+... +.+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999976459999999999999999999999999999999999999643 479999999997654
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC--CC--Cc
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP--TW--FS 236 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s 236 (450)
. .......||||.|+|||++...+|. ..+||||+|+++|.|++|..||.+.+......++..+.+.++ .| +|
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 3 4567889999999999999887775 899999999999999999999999998888889988887654 33 78
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..++++|.+||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=378.90 Aligned_cols=259 Identities=36% Similarity=0.684 Sum_probs=231.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-----cchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-----VGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
-+.++|+-.+.||+|..+.|-++.++.+|+.+|+|++....... ..+.+.-.+|+.||+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 36678999999999999999999999999999999997543221 13456667899999998 7999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
++...++|+|.|+-|+|+|++.. -.++|...+.+++||++|+.|||.++|+||||||+|||+|++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999987 48999999999999999999999999999999999999999999999999999765
Q ss_pred hcccCCCCcccccCCCcccCchhcccCC-----CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC--C
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRG-----YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--P 232 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--p 232 (450)
. ....+...||||+|.|||.+...- -++..+|+|+||+|||.||.|.+||......-+++.|..+++.+ |
T Consensus 174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred C---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 4 334466789999999999986432 23578999999999999999999999999999999999998876 5
Q ss_pred CC--CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 TW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ~~--~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.| +|.+.++||++||+.||.+|+|++|+|.||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 55 8899999999999999999999999999999965
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=395.78 Aligned_cols=253 Identities=30% Similarity=0.635 Sum_probs=229.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++||+|.+++.+ +.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999865421 12
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++.+++||.+||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 345799999999999887764 8999999999999999999999999888889999888888999999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 045214 249 PNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s-----~~eil~hp~f~~ 268 (450)
.||.+|++ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=397.77 Aligned_cols=251 Identities=36% Similarity=0.650 Sum_probs=225.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|++..+|+.||+|++.+..........++.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567789999999999999999999999999999999999999
Q ss_pred ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 96 ELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999876 5799999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999887764 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 045214 255 I-----SIAKIMENPWFRKG 269 (450)
Q Consensus 255 ~-----s~~eil~hp~f~~~ 269 (450)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=387.28 Aligned_cols=264 Identities=31% Similarity=0.556 Sum_probs=236.0
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+.+=.++|++++.||.|.-|+||+|+..+++..+|+|++++..+....-..++..|-.||.+++||.++.||..++++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34445689999999999999999999999999999999999988766667888899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 85 IYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.|++||||+||+|..+..+ ..++++.++.|+..++.||+|||..||++||||||||||.++|++-|+||.||.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999998875 3699999999999999999999999999999999999999999999999998731100
Q ss_pred ---------------------------------ccC---------------------CCCcccccCCCcccCchhcccCC
Q 045214 162 ---------------------------------KHQ---------------------DGLLHTTCGTPAYVAPEVISRRG 187 (450)
Q Consensus 162 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~l~~~~ 187 (450)
... +....+.+||-.|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 00123457999999999999988
Q ss_pred CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHccCCCCCCCCC----HHHHh
Q 045214 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW--FSADVRKLLSRILDPNPSTRIS----IAKIM 261 (450)
Q Consensus 188 ~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~ll~~~L~~dP~~R~s----~~eil 261 (450)
.. .++|.|+|||.+||||.|..||.+.+..+.+.+|......+|.. ++..++|||+++|.+||.+|+. ++||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 74 89999999999999999999999999999999999988888754 6899999999999999999998 99999
Q ss_pred cCcccccc
Q 045214 262 ENPWFRKG 269 (450)
Q Consensus 262 ~hp~f~~~ 269 (450)
+||||+.-
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=386.25 Aligned_cols=260 Identities=32% Similarity=0.543 Sum_probs=227.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.+.|++...||.|..++||+|+...+++.||||+++.++.... .+.+.+|+..|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 345689999999999999999999999999999999999887643 788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||.|+.+|++.+.+.. .+++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+...-...
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999975 579999999999999999999999999999999999999999999999999875432222
Q ss_pred -CCCCc-ccccCCCcccCchhcc--cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC-------
Q 045214 164 -QDGLL-HTTCGTPAYVAPEVIS--RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP------- 232 (450)
Q Consensus 164 -~~~~~-~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p------- 232 (450)
..... .+..|||+|||||++. ..+|+ .|+||||+|++..||.+|..||....++.++-.-..+..+.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 11112 5678999999999953 24565 999999999999999999999999988877655444544322
Q ss_pred ---CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 ---TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 ---~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..++..++.++..||+.||.+|||++++|+|+||++.
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1267789999999999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=396.99 Aligned_cols=258 Identities=32% Similarity=0.646 Sum_probs=231.8
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTG-QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
...-.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3455678999999999999999999976654 789999998765544445677889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
..|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 99999999999999999976 579999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++++.++
T Consensus 183 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 183 ---TRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ---CCcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 12245689999999999987666 48999999999999999999999999888889999888888999999999999
Q ss_pred HHHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 243 LSRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 243 l~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
|++||+.||.+|+ |++++++||||+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=401.80 Aligned_cols=253 Identities=34% Similarity=0.585 Sum_probs=228.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|...+.||+|+.|.||.|+...+++.||||.++.....+. +-+.+|+.+|+..+|+|||++++.|-..+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 468999999999999999999999999999999998775543 55789999999999999999999998899999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||++||+|.|.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++........ ...
T Consensus 350 Eym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~ 427 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS 427 (550)
T ss_pred eecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence 999999999999998999999999999999999999999999999999999999999999999999876543332 345
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~~~ 246 (450)
+.+|||+|||||+..++.| ++++||||||++++||+-|++||-..++......|... .+..|..+|+++++||.+|
T Consensus 428 TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred cccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 7799999999999999888 49999999999999999999999977776555555443 3456778999999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 045214 247 LDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|+.||++|+++.|+|+||||+.
T Consensus 507 L~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred hhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999964
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=390.37 Aligned_cols=254 Identities=30% Similarity=0.590 Sum_probs=225.9
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHH---HhCCCCCccEEEEEEEeCCEEEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM---RLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876543334456677777665 466899999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|||++|++|...+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998753221 12223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|..++.++.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 48999999999999999999999998888888888888888898999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 045214 249 PNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=389.18 Aligned_cols=249 Identities=37% Similarity=0.656 Sum_probs=223.7
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865544444456778999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCc
Q 045214 98 FKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176 (450)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~ 176 (450)
.+++.+ +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 6799999999999999999999999999999999999999999999999999864321 1222345679999
Q ss_pred ccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCC-
Q 045214 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRI- 255 (450)
Q Consensus 177 y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~- 255 (450)
|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||++||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887764 89999999999999999999999988888888888888889999999999999999999999997
Q ss_pred --CHHHHhcCcccccc
Q 045214 256 --SIAKIMENPWFRKG 269 (450)
Q Consensus 256 --s~~eil~hp~f~~~ 269 (450)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=394.93 Aligned_cols=258 Identities=32% Similarity=0.573 Sum_probs=222.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ---- 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~---- 164 (450)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999975 6899999999999999999999999999999999999999999999999999864321110
Q ss_pred -----------------------------CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 045214 165 -----------------------------DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS 215 (450)
Q Consensus 165 -----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 215 (450)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112345899999999999887775 8999999999999999999999998
Q ss_pred cHHHHHHHHhhc--CCCCCCC--CcHHHHHHHHHccCCCCC---CCCCHHHHhcCcccccc
Q 045214 216 NLMAMYRKIAKA--DYKFPTW--FSADVRKLLSRILDPNPS---TRISIAKIMENPWFRKG 269 (450)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~ll~~~L~~dP~---~R~s~~eil~hp~f~~~ 269 (450)
+..+.+.++... ...+|+. ++++++++|.+|+. +|. .||+++||++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 888888887653 3445543 78999999999775 444 46899999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=389.43 Aligned_cols=250 Identities=38% Similarity=0.672 Sum_probs=223.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567889999999999999999999999999999999999999
Q ss_pred ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 96 ELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99998866 5799999999999999999999999999999999999999999999999999764221 12223456899
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||++||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987766 48999999999999999999999988888888888778888999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 045214 255 I-----SIAKIMENPWFRK 268 (450)
Q Consensus 255 ~-----s~~eil~hp~f~~ 268 (450)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=400.08 Aligned_cols=262 Identities=42% Similarity=0.780 Sum_probs=244.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
..-.+.|.+.++||+|.|++|.+|++..++..||||++++...... ..+.+.+|+++|+.++|||||+++.+.+....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3456789999999999999999999999999999999998876543 345589999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+.||++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||+|..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999977 789999999999999999999999999999999999999999999999999998765 4
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
...+.+.||+|.|+|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+..+...+.+.+|-.++.++.++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 56678999999999999999999999999999999999999999999999999999889899999999999999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccccccCC
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
++|.++|.+|+++++++.|.|...+..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999876543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=375.33 Aligned_cols=263 Identities=37% Similarity=0.658 Sum_probs=243.8
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+.++-++.|+.+++||+|+||+|.+++.+.+++.+|||+++++-+........-..|-++|+..+||.+..+...|...+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34678999999999999999999999999999999999999988776666777888999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+||||+.||+|+-.+.+ ..++|+.++.|...|+.||.|||+++|++||||.+|+|||.+|++||+|||+++.. .
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 99999999999999999876 57999999999999999999999999999999999999999999999999998632 2
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
.......+.||||.|+|||++....| +.++|.|.+||+||+|++|++||...+...++..|..++..+|..++++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 23445678999999999999999888 49999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCC-----CHHHHhcCcccccc
Q 045214 243 LSRILDPNPSTRI-----SIAKIMENPWFRKG 269 (450)
Q Consensus 243 l~~~L~~dP~~R~-----s~~eil~hp~f~~~ 269 (450)
+..+|.+||.+|. .+.||+.|+||..-
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999998 48999999999753
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=385.35 Aligned_cols=251 Identities=32% Similarity=0.662 Sum_probs=220.6
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+|+.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876443333445667788888754 899999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV--FGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecc--cCCCceeccCC
Confidence 999998876 579999999999999999999999999999999999999999999999999875321 11223345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|.+++.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887764 899999999999999999999999888888888887778889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccc
Q 045214 254 RISI-AKIMENPWFRKG 269 (450)
Q Consensus 254 R~s~-~eil~hp~f~~~ 269 (450)
|+++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=393.39 Aligned_cols=257 Identities=34% Similarity=0.650 Sum_probs=222.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC---
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--- 165 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 165 (450)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999865 57999999999999999999999999999999999999999999999999998643211100
Q ss_pred ---------------------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCC
Q 045214 166 ---------------------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF 212 (450)
Q Consensus 166 ---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf 212 (450)
....+.+||+.|+|||++.+.++. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999887765 8999999999999999999999
Q ss_pred CCCcHHHHHHHHhhcC--CCCCC--CCcHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 045214 213 HDSNLMAMYRKIAKAD--YKFPT--WFSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRK 268 (450)
Q Consensus 213 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~ll~~~L~~dP~~R~s---~~eil~hp~f~~ 268 (450)
...+....+..+.... ..+|. .+++++++||.+||. +|.+|++ ++++++||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777765433 33343 368999999999996 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=388.24 Aligned_cols=250 Identities=36% Similarity=0.664 Sum_probs=223.8
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765443344567788999999999999999999999999999999999999
Q ss_pred ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 96 ELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99998866 5799999999999999999999999999999999999999999999999998764211 11223356799
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877664 8999999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 045214 255 I-----SIAKIMENPWFRK 268 (450)
Q Consensus 255 ~-----s~~eil~hp~f~~ 268 (450)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=392.84 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=220.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665554556788999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC-----
Q 045214 91 YAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ----- 164 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~----- 164 (450)
|++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999876 5799999999999999999999999999999999999999999999999998753211000
Q ss_pred ----------------------------------------CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHH
Q 045214 165 ----------------------------------------DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYV 204 (450)
Q Consensus 165 ----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ 204 (450)
.....+.+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999887765 89999999999999
Q ss_pred HhhCCCCCCCCcHHHHHHHHhh--cCCCCCC--CCcHHHHHHHHHcc--CCCCCCCCCHHHHhcCcccccc
Q 045214 205 LLAGYLPFHDSNLMAMYRKIAK--ADYKFPT--WFSADVRKLLSRIL--DPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 205 ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~ll~~~L--~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|++|..||...+......++.. .....|. .+++++.+||.+|| ..+|..|+++++++.||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998877666555543 2334444 47999999999955 4555669999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=388.70 Aligned_cols=253 Identities=30% Similarity=0.587 Sum_probs=224.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999976 5799999999999999999999999999999999999999999999999999864432 23
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC------CCcHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT------WFSADVR 240 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 240 (450)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.... ...|. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456799999999999887664 89999999999999999999999988877776665432 22232 3589999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+||.+||..+|.+||+++++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=386.01 Aligned_cols=250 Identities=35% Similarity=0.672 Sum_probs=223.3
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+.............+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456677888888876 799999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.+ +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998865 5799999999999999999999999999999999999999999999999998764221 1222345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 899999999999999999999999998889999988888899999999999999999999999
Q ss_pred CCCH------HHHhcCccccc
Q 045214 254 RISI------AKIMENPWFRK 268 (450)
Q Consensus 254 R~s~------~eil~hp~f~~ 268 (450)
||++ ++++.||||+.
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=393.32 Aligned_cols=257 Identities=32% Similarity=0.608 Sum_probs=220.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765444445677889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC---
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--- 165 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 165 (450)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 57999999999999999999999999999999999999999999999999998532110000
Q ss_pred ------------------------------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHH
Q 045214 166 ------------------------------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203 (450)
Q Consensus 166 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~ 203 (450)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 001135799999999999887764 8999999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHHhhc--CCCCCC--CCcHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 045214 204 VLLAGYLPFHDSNLMAMYRKIAKA--DYKFPT--WFSADVRKLLSRILDPNPSTR---ISIAKIMENPWFRK 268 (450)
Q Consensus 204 ~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~ll~~~L~~dP~~R---~s~~eil~hp~f~~ 268 (450)
+|++|..||...+....+..+... ...+|. .++.++.+||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777776542 344454 478999999999997 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=374.50 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=220.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-----C
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-----K 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 82 (450)
+..+|...+.||+|+||.|..|.++.+|+.||||.+.... ...-..++..||+++|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4557777899999999999999999999999999986332 233456788999999999999999999999855 4
Q ss_pred CEEEEEEeecCCCChhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+.+|+|+|++ +.+|...|+.++ ++++.++.++.|++.||+|+|+.||+||||||.|+|++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 558999999876 99999999999999999999999999999999999999999999999999987644
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------------- 227 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------- 227 (450)
....+.....+.|.+|+|||++.....++.+.||||+||||.|||+|++.|.+.+....++.|...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 333445567789999999999977666678999999999999999999999987755444443221
Q ss_pred ---------CCCCC--------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ---------DYKFP--------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ---------~~~~p--------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....| +..++.+.+|+.+||..||.+|+|++|+|+|||+...
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 2368899999999999999999999999999999764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=384.86 Aligned_cols=255 Identities=33% Similarity=0.610 Sum_probs=227.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP-NVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 89 (450)
.|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999876544444556778899999999765 5888999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999865 5799999999999999999999999999999999999999999999999998753221 12223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+......+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456799999999999887764 8999999999999999999999999888889999888888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCccccc
Q 045214 249 PNPSTRISI-----AKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s~-----~eil~hp~f~~ 268 (450)
+||.+|++. +++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.06 Aligned_cols=250 Identities=34% Similarity=0.642 Sum_probs=223.6
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456677888888866 899999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999998865 5799999999999999999999999999999999999999999999999998864321 1222345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|.+++.++.++|.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999877764 899999999999999999999999999899999988888899999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 045214 254 RI-------SIAKIMENPWFRK 268 (450)
Q Consensus 254 R~-------s~~eil~hp~f~~ 268 (450)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=382.59 Aligned_cols=250 Identities=36% Similarity=0.723 Sum_probs=219.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+.........+....|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543333445556677777654 899999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999999865 68999999999999999999999999999999999999999999999999998643221 223345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877664 899999999999999999999999888888888888777888999999999999999999999
Q ss_pred CCCH-HHHhcCccccc
Q 045214 254 RISI-AKIMENPWFRK 268 (450)
Q Consensus 254 R~s~-~eil~hp~f~~ 268 (450)
||++ .++++||||+.
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 9986 48889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=377.54 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=219.3
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+..|++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987654433334567889999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+++|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999888743 3689999999999999999999999999999999999999999999999999865321 122
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH----HHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM----AMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
.....||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.. .....+......++..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2345799999999999877765 8999999999999999999999875432 2333344445567778999999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 244 SRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
.+||+.||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=384.80 Aligned_cols=258 Identities=32% Similarity=0.622 Sum_probs=221.0
Q ss_pred CeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999765432 223356778999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC----cHHHHHHHHhhcCCCCCCCCcHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS----NLMAMYRKIAKADYKFPTWFSADVR 240 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (450)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335679999999999987654568999999999999999999999643 3344555666667778888999999
Q ss_pred HHHHHccCCCCCCCC-----CHHHHhcCcccccc
Q 045214 241 KLLSRILDPNPSTRI-----SIAKIMENPWFRKG 269 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~-----s~~eil~hp~f~~~ 269 (450)
++|.+||+.||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=393.34 Aligned_cols=257 Identities=33% Similarity=0.611 Sum_probs=221.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc-----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH----- 163 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~----- 163 (450)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999876 579999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHH
Q 045214 164 ----------------------------------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILY 203 (450)
Q Consensus 164 ----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~ 203 (450)
......+.+||+.|+|||++.+.++. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00111245799999999999888775 8999999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHHhhc--CCCCC--CCCcHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 045214 204 VLLAGYLPFHDSNLMAMYRKIAKA--DYKFP--TWFSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRK 268 (450)
Q Consensus 204 ~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~ll~~~L~~dP~~R~s---~~eil~hp~f~~ 268 (450)
+|++|..||...+..+...++... ...+| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988777666666542 23333 357999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=391.54 Aligned_cols=260 Identities=32% Similarity=0.548 Sum_probs=226.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999999999999999999986544433445567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-ccc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999986432111 112
Q ss_pred cccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC--CCcHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT--WFSADVR 240 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~ 240 (450)
....+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...+....+.++.... ..+|. .+|.++.
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence 23567999999999986543 34589999999999999999999999988888888876543 44554 4799999
Q ss_pred HHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 241 KLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 241 ~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
+||.+||+.+|.+ |+|++++++||||+.
T Consensus 280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=365.65 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=222.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 86 (450)
.+.|+.+..|++|+||.||+|+++.|++.||+|.++.++. +.++--...|||.+|..++|||||.+-++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3469999999999999999999999999999999987763 33444455799999999999999999998754 45799
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|||||+. +|..++.+ .++...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+..+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 99999986 89998876 479999999999999999999999999999999999999999999999999998776542
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-----------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA----------------- 227 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 227 (450)
......+-|.+|+|||.+.+...++.+.|+||+|||+.+|+++.+.|.+.+..+...+|...
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 23455678999999999999887789999999999999999999999998877666666431
Q ss_pred --CCCCCC------------C-CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 228 --DYKFPT------------W-FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 228 --~~~~p~------------~-~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
...+++ . ++....+|+..+|..||.+|.|++|.|+|+||.....+
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 011111 1 45788999999999999999999999999999875443
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=383.58 Aligned_cols=250 Identities=30% Similarity=0.585 Sum_probs=218.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444566788999999988 799999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.+ +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999998865 689999999999999999999999999999999999999999999999999885321 11223345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---------cHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---------NLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
|+.|+|||++.+..+. .++|+|||||++|+|++|..||... .....++.+......+|..++.++.++|.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 8999999999999999999999631 12335566677778889999999999999
Q ss_pred HccCCCCCCCCC------HHHHhcCccccc
Q 045214 245 RILDPNPSTRIS------IAKIMENPWFRK 268 (450)
Q Consensus 245 ~~L~~dP~~R~s------~~eil~hp~f~~ 268 (450)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=376.24 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=212.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46899999999999999999999999999999999754322 2235677899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++| +|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cc
Confidence 999986 89888864 35899999999999999999999999999999999999999999999999998643221 22
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------------ 228 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 228 (450)
......+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 23445789999999998765544689999999999999999999998877655444332210
Q ss_pred -CCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 -YKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 -~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+| +.++.++.+||.+||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=389.43 Aligned_cols=257 Identities=33% Similarity=0.650 Sum_probs=226.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc-----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH----- 163 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~----- 163 (450)
||++|++|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999976 589999999999999999999999999999999999999999999999999986543222
Q ss_pred ----------------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHH
Q 045214 164 ----------------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY 221 (450)
Q Consensus 164 ----------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 221 (450)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00122345799999999999887664 8999999999999999999999998887777
Q ss_pred HHHhh--cCCCCCCC--CcHHHHHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 045214 222 RKIAK--ADYKFPTW--FSADVRKLLSRILDPNPSTRIS-IAKIMENPWFRK 268 (450)
Q Consensus 222 ~~i~~--~~~~~p~~--~s~~~~~ll~~~L~~dP~~R~s-~~eil~hp~f~~ 268 (450)
.++.. ....+|.. +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 44445544 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=386.12 Aligned_cols=250 Identities=36% Similarity=0.659 Sum_probs=223.2
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|++..+++.||+|++.+.............+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444344567788999999999999999999999999999999999999
Q ss_pred ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 96 ELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
+|.+++.+ +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998876 579999999999999999999997 7999999999999999999999999998753221 1222345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999877664 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q 045214 254 RI-----SIAKIMENPWFRK 268 (450)
Q Consensus 254 R~-----s~~eil~hp~f~~ 268 (450)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=390.42 Aligned_cols=261 Identities=31% Similarity=0.568 Sum_probs=225.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.++||||+++++++.++..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997654443344566789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+||||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ce
Confidence 99999999999999988889999999999999999999999999999999999999999999999999986543211 11
Q ss_pred CcccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC--CCcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT--WFSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (450)
...+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++..+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 223567999999999997643 34589999999999999999999999988887887776533 44554 468999
Q ss_pred HHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 240 RKLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 240 ~~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
++++.+||..+|.+ |+|++++++||||+.
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999866654 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.39 Aligned_cols=254 Identities=29% Similarity=0.484 Sum_probs=212.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765432 234567789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++++.+..+... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877665543 579999999999999999999999999999999999999999999999999987543221 1122
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------C
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------Y 229 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (450)
....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345789999999999877764 89999999999999999999998765543332222110 0
Q ss_pred CCC-------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KFP-------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~p-------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..| ..+|.++.+||.+||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=389.49 Aligned_cols=257 Identities=33% Similarity=0.589 Sum_probs=220.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997665444444567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc-----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH----- 163 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~----- 163 (450)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999976 578999999999999999999999999999999999999999999999999975321100
Q ss_pred ------------------------------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh
Q 045214 164 ------------------------------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA 207 (450)
Q Consensus 164 ------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~ 207 (450)
........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999887764 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhhc--CCCCC--CCCcHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 045214 208 GYLPFHDSNLMAMYRKIAKA--DYKFP--TWFSADVRKLLSRILDPNPSTRI---SIAKIMENPWFRK 268 (450)
Q Consensus 208 g~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~ll~~~L~~dP~~R~---s~~eil~hp~f~~ 268 (450)
|..||.+.+.......+... ....| ..+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988876666555432 22333 357899999999987 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=380.64 Aligned_cols=252 Identities=36% Similarity=0.683 Sum_probs=222.3
Q ss_pred eceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 15 GRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 47899999999865432 22334567899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 91 YAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
|++|++|.+++.+ +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.... .......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc--cCCCccc
Confidence 9999999999875 578999999999999999999999999999999999999999999999999875322 1222334
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|+.+++++.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56799999999999877664 89999999999999999999999988888888888888889999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 045214 250 NPSTRI-----SIAKIMENPWFRKG 269 (450)
Q Consensus 250 dP~~R~-----s~~eil~hp~f~~~ 269 (450)
||++|| +++++++||||+..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=380.97 Aligned_cols=255 Identities=32% Similarity=0.603 Sum_probs=226.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.|++.+.||+|+||.||+|++..+++.||+|++.+..............|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544334455667788888777 5899999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++||+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999998864321 12223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+......+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456799999999999887765 8999999999999999999999999988899999888888999999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCccccc
Q 045214 249 PNPSTRISI-----AKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s~-----~eil~hp~f~~ 268 (450)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=380.62 Aligned_cols=250 Identities=33% Similarity=0.615 Sum_probs=219.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS-VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+|+.||+|++.+..........++.+|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333445555554 56789999999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc--cCCCccccccC
Confidence 999998876 579999999999999999999999999999999999999999999999999875421 12223345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++..+.......++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887764 899999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 045214 254 RISI----AKIMENPWFRK 268 (450)
Q Consensus 254 R~s~----~eil~hp~f~~ 268 (450)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=383.27 Aligned_cols=257 Identities=32% Similarity=0.586 Sum_probs=221.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|.+.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999976 5799999999999999999999999999999999999999999999999999865432211 12
Q ss_pred cccccCCCcccCchhccc-----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCC--CCCcHH
Q 045214 168 LHTTCGTPAYVAPEVISR-----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFP--TWFSAD 238 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 238 (450)
.....||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233589999999999999999999999888777777665432 2333 357899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.+||.+||. +|.+|||+++++.||||+.
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=379.50 Aligned_cols=251 Identities=35% Similarity=0.686 Sum_probs=224.0
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+++.||+|++.+.............+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456677899999888 799999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+.+.+ +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999999876 4899999999999999999999999999999999999999999999999998753211 1222344579
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..++.++.+||.+||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887765 899999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCH-----HHHhcCcccccc
Q 045214 254 RISI-----AKIMENPWFRKG 269 (450)
Q Consensus 254 R~s~-----~eil~hp~f~~~ 269 (450)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=387.17 Aligned_cols=257 Identities=33% Similarity=0.609 Sum_probs=222.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765444455678889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ---- 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~---- 164 (450)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999764321110
Q ss_pred -----------------------------CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 045214 165 -----------------------------DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS 215 (450)
Q Consensus 165 -----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 215 (450)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245799999999999888775 8999999999999999999999998
Q ss_pred cHHHHHHHHhhc--CCCCCCC--CcHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 045214 216 NLMAMYRKIAKA--DYKFPTW--FSADVRKLLSRILDPNPSTRI---SIAKIMENPWFRK 268 (450)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~ll~~~L~~dP~~R~---s~~eil~hp~f~~ 268 (450)
+....+.++... ...+|+. +++++++||.+|+ .||.+|+ +++++++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 888877777643 3344443 7899999999987 4999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=375.28 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=209.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|++..+++.||+|++...... .......+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+. ++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 477777754 5699999999999999999999999999999999999999999999999998864321 122
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhc--C---------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKA--D--------------- 228 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~--~--------------- 228 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655556889999999999999999999987432 2222222110 0
Q ss_pred ----CC--CCC---------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 ----YK--FPT---------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 ----~~--~p~---------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+. .|. .+++++.+||.+||++||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00 000 13568999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=365.45 Aligned_cols=257 Identities=32% Similarity=0.522 Sum_probs=221.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCC----
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKT---- 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 83 (450)
+..|+.++.||+|+||+||+|+++.+|+.||+|.+..+... ++.-....+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56788999999999999999999999999999999877543 234456689999999999999 999999998877
Q ss_pred --EEEEEEeecCCCChhhHHhc-C----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 84 --KIYFVMEYAKGGELFKKVSK-G----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 84 --~~~lv~E~~~gg~L~~~i~~-~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.+|+|+||++- +|..++.. + .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89888875 2 4778899999999999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---------
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--------- 227 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 227 (450)
+.+..+ ...+....+|.+|+|||++.+...++...||||+|||++||+++...|.+.+..+....|-+.
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 865433 233566789999999999999877779999999999999999999999998876666665331
Q ss_pred ---------CCCCCCC------------CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ---------DYKFPTW------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ---------~~~~p~~------------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...+|.| .+++..+++.+||+.+|.+|.|++.+|.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122222 23578999999999999999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.43 Aligned_cols=250 Identities=35% Similarity=0.685 Sum_probs=219.8
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL-IQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+++.||+|++.+..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987643322334556678888876 4999999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 5799999999999999999999999999999999999999999999999998753221 1122345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+....++.+......+|.+++.++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999877764 899999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHH-HHhcCccccc
Q 045214 254 RISIA-KIMENPWFRK 268 (450)
Q Consensus 254 R~s~~-eil~hp~f~~ 268 (450)
||++. ++++||||+.
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=377.39 Aligned_cols=255 Identities=33% Similarity=0.608 Sum_probs=226.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.|++.+.||+|+||.||+|++..+++.||+|++.+..............|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444444566778888988885 577889999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 6899999999999999999999999999999999999999999999999999864321 11223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999877664 8999999999999999999999999888888888888888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 045214 249 PNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s-----~~eil~hp~f~~ 268 (450)
.||.+|++ .+++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=379.00 Aligned_cols=250 Identities=30% Similarity=0.594 Sum_probs=217.3
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444556788899988776 899999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 5799999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC---------CcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD---------SNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. ......++.+......+|..++.++.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 899999999999999999999952 112335556667777889999999999999
Q ss_pred HccCCCCCCCCC------HHHHhcCccccc
Q 045214 245 RILDPNPSTRIS------IAKIMENPWFRK 268 (450)
Q Consensus 245 ~~L~~dP~~R~s------~~eil~hp~f~~ 268 (450)
+||+.||++||| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.52 Aligned_cols=250 Identities=33% Similarity=0.587 Sum_probs=219.1
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS-VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333445555554 67889999999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
++|...+.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988865 5799999999999999999999999999999999999999999999999998764221 1223345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877765 799999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 045214 254 RISI----AKIMENPWFRK 268 (450)
Q Consensus 254 R~s~----~eil~hp~f~~ 268 (450)
|+++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=383.34 Aligned_cols=261 Identities=33% Similarity=0.564 Sum_probs=224.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999999999999999997654433334456788999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+||||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Ccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998644211 111
Q ss_pred CcccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC--CCcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT--WFSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (450)
.....+||+.|+|||++.... ..+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 223567999999999987543 34589999999999999999999999988888888876533 33443 589999
Q ss_pred HHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 240 RKLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 240 ~~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
+++|.+||..+|.+ |++++++++||||+.
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99999999854443 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=383.64 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=227.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|...+.||+|+||.||+|.+..+++.||||+++.+... ..++.+.+|+.+|..++++||.++|+.+-.+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3688889999999999999999999999999999988754 34678899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSKGKL-KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l-~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|||.||++.+.++.+.+ .|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+....... ...
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh--hcc
Confidence 99999999999998765 999999999999999999999999999999999999999999999999986543322 223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHcc
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRIL 247 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~ll~~~L 247 (450)
.+..|||.|||||++...+|+ .++||||||++.++|++|.+||.+.+++.....|.+...+ +...+|+.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 8999999999999999999999998886555555443332 33458999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 045214 248 DPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.||+.|||+.++|.|+|++..
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999873
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=375.84 Aligned_cols=251 Identities=35% Similarity=0.653 Sum_probs=221.5
Q ss_pred eceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 15 GRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
++.||+|+||.||++++. .+|+.||+|++.+..... ....+..+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999873 578999999998654322 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccc
Q 045214 92 AKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT 170 (450)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 170 (450)
++||+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence 999999999975 5799999999999999999999999999999999999999999999999999864322 1122345
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCC
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~d 250 (450)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||++|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 6899999999999877664 899999999999999999999999888888888888888889999999999999999999
Q ss_pred CCCCCC-----HHHHhcCcccccc
Q 045214 251 PSTRIS-----IAKIMENPWFRKG 269 (450)
Q Consensus 251 P~~R~s-----~~eil~hp~f~~~ 269 (450)
|++||| +++++.||||+..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 7889999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=373.06 Aligned_cols=251 Identities=29% Similarity=0.569 Sum_probs=218.8
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++..+ +||||+.+++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555445567788999999888 699999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999998865 6899999999999999999999999999999999999999999999999998863211 1223345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-------cHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-------NLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
|+.|+|||++.+..+. .++|||||||++|+|++|..||... .....++.+......+|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999877764 8999999999999999999999631 2234566666677788888999999999999
Q ss_pred cCCCCCCCCC------HHHHhcCcccccc
Q 045214 247 LDPNPSTRIS------IAKIMENPWFRKG 269 (450)
Q Consensus 247 L~~dP~~R~s------~~eil~hp~f~~~ 269 (450)
|+.||.+|++ ++++++||||+..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999998 5799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=374.88 Aligned_cols=250 Identities=32% Similarity=0.597 Sum_probs=218.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS-VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998764433333445555654 46789999999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|..++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999998866 5799999999999999999999999999999999999999999999999999763211 1222345679
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+.......++..+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887765 899999999999999999999999888888888888777777789999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 045214 254 RISI----AKIMENPWFRK 268 (450)
Q Consensus 254 R~s~----~eil~hp~f~~ 268 (450)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.09 Aligned_cols=249 Identities=33% Similarity=0.610 Sum_probs=216.5
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
||+|+||+||+|++..+++.||+|++.+.............+|..++..+ +||||+++++.+.+.+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344555677777655 699999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999998865 6799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC-CCcHHHHHHHHHccCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-WFSADVRKLLSRILDPNPS 252 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~ll~~~L~~dP~ 252 (450)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+...++..+..+...+|. .+++++.+||.+||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976554468999999999999999999999998888888888877777775 4799999999999999999
Q ss_pred CCC----CHHHHhcCccccc
Q 045214 253 TRI----SIAKIMENPWFRK 268 (450)
Q Consensus 253 ~R~----s~~eil~hp~f~~ 268 (450)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=374.62 Aligned_cols=250 Identities=34% Similarity=0.608 Sum_probs=217.8
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHH-HHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI-SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999875443323333444444 456889999999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~--~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccc--cCCCCcccccC
Confidence 999999876 579999999999999999999999999999999999999999999999999986432 12223445689
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+......+++.++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887765 899999999999999999999999888888888887777788889999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 045214 254 RISIA----KIMENPWFRK 268 (450)
Q Consensus 254 R~s~~----eil~hp~f~~ 268 (450)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=379.80 Aligned_cols=257 Identities=30% Similarity=0.552 Sum_probs=236.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE-EEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK-IYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 87 (450)
+++|+.++.+|+|+||.+++++++..++.+++|.++....... ..+...+|+.++++++|||||.+++.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5789999999999999999999999999999999988775543 34578899999999999999999999998888 999
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||+||+||++.+.|.+ .-++|+.+..||.|++.||.|||+++|.|||||+.||+++.++.|||+|||+|+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 9999999999999975 25999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLL 243 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll 243 (450)
.....+..|||.|++||++.+.+|. .++|||||||++|+|++-+.+|...+...+..+|..+. .+.|..++.+++.+|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 2366788999999999999999986 99999999999999999999999999999999998877 578888999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..||..+|..||++.++|.+|.....
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999988643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=374.26 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=207.0
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK-----TKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 85 (450)
+|++.+.||+|+||.||+|++..+++.||||.+...... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753221 22345678999999999999999999987543 358
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 588888865 5799999999999999999999999999999999999999999999999999865432221
Q ss_pred C-CCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh----------------
Q 045214 165 D-GLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK---------------- 226 (450)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------- 226 (450)
. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 122345799999999998652 2335899999999999999999999987654332211110
Q ss_pred ----------cCC--CC---CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 227 ----------ADY--KF---PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 227 ----------~~~--~~---p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
... ++ .+.+++++.++|.+||+.||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000 00 0235788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=366.04 Aligned_cols=248 Identities=27% Similarity=0.472 Sum_probs=212.8
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||+|+||+||+|.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++..++..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999866544333446678899999999999999999999999999999999999999
Q ss_pred hhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 98 FKKVS-----KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 98 ~~~i~-----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
.+.+. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 88773 246899999999999999999999999999999999999999999999999998644322 12233457
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
||+.|+|||++.+..++ .++|||||||++|+|++|..||..... ......+......+|..++.++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999887765 899999999999999999999986532 2333444445556677899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 045214 249 PNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.||++|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=371.12 Aligned_cols=258 Identities=31% Similarity=0.568 Sum_probs=218.7
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.||+|++.+....+......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444444567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999965 479999999999999999999999999999999999999999999999999875432211 111
Q ss_pred cccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCC---CCCcHH
Q 045214 168 LHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFP---TWFSAD 238 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 238 (450)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+..+.+..+.... ..+| ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223479999999999863 2334578999999999999999999999888777777765432 3333 247899
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
++++|.+||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999765444 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.91 Aligned_cols=254 Identities=25% Similarity=0.463 Sum_probs=218.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999986554433334567789999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|++||+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999988753 3689999999999999999999999999999999999999999999999999864321 122
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH----HHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+......+|..++..+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 234579999999999987665 478999999999999999999998765432 233334444556677899999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 244 SRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.+||+.||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=370.82 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=216.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|++..++..+|+|++.... ......++.+|+.+++.++||||+++++++..++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997643 22345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 9999999999999976 5799999999999999999999986 699999999999999999999999999864321
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh-------------------
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK------------------- 226 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------- 226 (450)
.......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..++...+..
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 223455799999999999877664 899999999999999999999987655443222110
Q ss_pred ---------------------------cC-CCC-CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 227 ---------------------------AD-YKF-PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 227 ---------------------------~~-~~~-p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.. ... ...+++++++||.+||++||++|||++++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 011 11368899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=381.09 Aligned_cols=253 Identities=31% Similarity=0.461 Sum_probs=217.2
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-C-----CCccEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-H-----PNVMQIYEV 78 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~ 78 (450)
++++..+|++.+.||+|+||.|-+|.+..|++.||||+++..+ ....+...|+.+|..|+ | -|+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 4567779999999999999999999999999999999998765 45678889999999996 4 389999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC--CeEEeec
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG--MLKVTDF 153 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~--~vkl~DF 153 (450)
|...++.|||+|.++ .+|.++++. .+++...++.++.||+.||.+||+.||||+|||||||||.+.+ .|||+||
T Consensus 257 F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 999999999999995 489999976 3689999999999999999999999999999999999997543 7999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--- 230 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--- 230 (450)
|.|+... ....+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|......
T Consensus 336 GSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 336 GSSCFES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccccccC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9998643 223378899999999999999997 8999999999999999999999988876666555431110
Q ss_pred -------------------------------------------------CCCC-----------CcHHHHHHHHHccCCC
Q 045214 231 -------------------------------------------------FPTW-----------FSADVRKLLSRILDPN 250 (450)
Q Consensus 231 -------------------------------------------------~p~~-----------~s~~~~~ll~~~L~~d 250 (450)
.|+. -...+.+||.+||++|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 1100 0134789999999999
Q ss_pred CCCCCCHHHHhcCccccc
Q 045214 251 PSTRISIAKIMENPWFRK 268 (450)
Q Consensus 251 P~~R~s~~eil~hp~f~~ 268 (450)
|.+|+|..++|+||||..
T Consensus 490 P~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTG 507 (586)
T ss_pred chhcCCHHHHhcCccccc
Confidence 999999999999999974
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=374.46 Aligned_cols=258 Identities=27% Similarity=0.496 Sum_probs=210.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--- 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (450)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 578899999999999999999999999999999999975432 2233466789999999999999999999986443
Q ss_pred ---EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 ---KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 ---~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666554 358899999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh--------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK-------------- 226 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 226 (450)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 12223455789999999999887775 799999999999999999999987654333222111
Q ss_pred --------cCCC---------CCC-----------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 227 --------ADYK---------FPT-----------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 227 --------~~~~---------~p~-----------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.... +|. ..++++++||.+||++||++|||+.|+++||||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 111 13578999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.39 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=205.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK----- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (450)
..++|++++.||+|+||.||+|.+..+++.||||.+..+. ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999999999999886542 2235799999999999999999886432
Q ss_pred ---CEEEEEEeecCCCChhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeec
Q 045214 83 ---TKIYFVMEYAKGGELFKKVS-----KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDF 153 (450)
Q Consensus 83 ---~~~~lv~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DF 153 (450)
..+++||||+++ +|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999986 5666553 24799999999999999999999999999999999999999665 6999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------ 227 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------ 227 (450)
|+|...... ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 998754321 22234578999999999876554468999999999999999999999987655444333221
Q ss_pred -----------CC------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 -----------DY------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 -----------~~------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.. .+|...++++.+||.+||++||.+|||+.|+++||||..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01 123446789999999999999999999999999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=367.12 Aligned_cols=258 Identities=29% Similarity=0.534 Sum_probs=219.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444344556788999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999975 57999999999999999999999999999999999999999999999999987543211 1112
Q ss_pred cccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC---CCcHH
Q 045214 168 LHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT---WFSAD 238 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 238 (450)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2334589999999999999999999999988888887776543 23333 47899
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
+++||.+||..+|.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=361.11 Aligned_cols=251 Identities=33% Similarity=0.511 Sum_probs=206.7
Q ss_pred cCeeeeceEeecCCeEEEEEEEcC-CCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEE-----
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMA----- 80 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 80 (450)
++|++.+.||+|+||.||+|++.. +++.||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 47889999987654322 2334556777777766 6999999999875
Q ss_pred eCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
....+|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999997 488888864 358999999999999999999999999999999999999999999999999986
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-C------
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-K------ 230 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~------ 230 (450)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+.++..... +
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54322 233456799999999999877664 799999999999999999999998877666655543210 0
Q ss_pred --------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 231 --------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 231 --------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+.++..+++|+.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=388.05 Aligned_cols=260 Identities=30% Similarity=0.541 Sum_probs=225.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--- 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (450)
...++|++.+.||+|+||+||+|++..+++.||||++....... .....+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34579999999999999999999999999999999998765432 34567789999999999999999998765332
Q ss_pred -----EEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeec
Q 045214 84 -----KIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 84 -----~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DF 153 (450)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998853 36899999999999999999999999999999999999999999999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFP 232 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p 232 (450)
|++.............+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+..+.. ++|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 998765433333344567899999999999887765 899999999999999999999999888777777665544 467
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.+++++.+++.+||+.||.+|||+.++++|||++.
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 789999999999999999999999999999999865
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=363.88 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=213.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|.+.+.||+|+||.||+|++..+++.||+|.+...... .......+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999765432 2234567899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+++ +|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--cc
Confidence 999986 78877754 35899999999999999999999999999999999999999999999999998643221 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------- 227 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 227 (450)
......+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2234568999999999876554568999999999999999999999887654443333210
Q ss_pred CCCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 DYKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ~~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...+| +.+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 2368899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.82 Aligned_cols=251 Identities=36% Similarity=0.705 Sum_probs=219.4
Q ss_pred cccccCeeee-ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe--
Q 045214 6 KVLMQKYELG-RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS-- 81 (450)
Q Consensus 6 ~~l~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-- 81 (450)
.-+.+.|.+- ++||-|-.|+|-.|.++.|++.+|+|++.-. ...++|+++.-+. .|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3466778774 6799999999999999999999999998533 3457899887666 69999999999754
Q ss_pred --CCEEEEEEeecCCCChhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeec
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDF 153 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DF 153 (450)
..++.+|||.++||+|+..|.. + .++|.++..+++||..|+.|||+.+|+||||||||+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 5678999999999999999976 3 5999999999999999999999999999999999999975 447999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADY 229 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~ 229 (450)
|+|+... ....+.+.|-||+|+|||++....|+ ..+|+||+||++|.||+|++||..... ..+..+|..+.+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9986432 34667889999999999999888776 889999999999999999999986543 467888999988
Q ss_pred CCCC--C--CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 KFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 ~~p~--~--~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.||. | +|.+++++|+++|..+|.+|.|++++++|||+..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 8874 3 7899999999999999999999999999999865
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=359.52 Aligned_cols=253 Identities=40% Similarity=0.804 Sum_probs=229.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++.+...+|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||+++++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999976 57999999999999999999999999999999999999999999999999988654322 3
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccC
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....++.+..+...+|..++..+.++|.+||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999877655 48899999999999999999999988877778888888888888899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 045214 249 PNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=357.73 Aligned_cols=253 Identities=32% Similarity=0.539 Sum_probs=213.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-- 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (450)
....=.|+-.+++|.|+||.||.|...++++.||||.+-.+.-.+ -+|+.+|+.++|||||++..+|....
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 334457999999999999999999999999999999987765433 37999999999999999998875422
Q ss_pred ---EEEEEEeecCCCChhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecC
Q 045214 84 ---KIYFVMEYAKGGELFKKVS-----KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFG 154 (450)
Q Consensus 84 ---~~~lv~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFG 154 (450)
+..+||||++. +|.+.++ +.+++.-.++-|.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 45589999976 8888887 3579999999999999999999999999999999999999965 999999999
Q ss_pred chhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------
Q 045214 155 LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------- 227 (450)
Q Consensus 155 ls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------- 227 (450)
.|+......++ .+..-|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+..+....|.+.
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 98876543332 45567899999999998887789999999999999999999999998776665555331
Q ss_pred ----------CCCC------------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ----------DYKF------------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ----------~~~~------------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...+ ....++++.+|+.++|..+|.+|.++.|++.||||...
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 1111 12368999999999999999999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=367.34 Aligned_cols=247 Identities=30% Similarity=0.522 Sum_probs=212.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcE-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-EEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQS-VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-KIYF 87 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~l 87 (450)
....+.+.||.|+||+||+|... |.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.+.. ...+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 34566777999999999999984 455 999999876544333 678999999999999999999999998887 7999
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEecCCC-CeEEeecCchhhhhcc
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRG-VYHRDLKPENLLLDENG-MLKVTDFGLSALAKCK 162 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~g-i~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~ 162 (450)
||||+++|+|.+++.. +.++...+..++.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+|+.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999954 68999999999999999999999999 99999999999999998 9999999999764432
Q ss_pred cCCCCcccccCCCcccCchhcc--cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh--cCCCCCCCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVIS--RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADYKFPTWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~ 238 (450)
. .......||+.|||||++. ...|+ .++||||+|++||||+||..||.+.+..+....+.. ....+|..+++.
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~ 274 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH 274 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 1 2223367999999999999 44665 999999999999999999999999887655555543 334567779999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+..|+.+||..||.+||+..+|+.
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=384.29 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=222.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7889999875443 2234567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 88 VMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987742 36899999999999999999999999999999999999999999999999998755432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRK 241 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 241 (450)
.......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.. ++|..++.++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22223445689999999999987766 4899999999999999999999998888777777765554 356678999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+|.+||.+||++|||+++++.|||++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=366.01 Aligned_cols=258 Identities=29% Similarity=0.512 Sum_probs=219.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998654433344566788999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986442211 111
Q ss_pred cccccCCCcccCchhcccC----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCCC---CcHH
Q 045214 168 LHTTCGTPAYVAPEVISRR----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPTW---FSAD 238 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~---~s~~ 238 (450)
....+||+.|+|||++.+. +..+.++|||||||++|+|++|..||...+....+.++.... .++|.. ++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2235799999999998652 223578999999999999999999999888877777776543 334433 5899
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPST--RISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~--R~s~~eil~hp~f~~ 268 (450)
++++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=371.23 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=211.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 567999999999999999999999999999999996543 223456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 151 ~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPC 225 (353)
T ss_pred EecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cccc
Confidence 999999998653 24577888999999999999999999999999999999999999999999998654321 1122
Q ss_pred ccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH---HHHHHHh-hcCCCCCCCCcHHHH
Q 045214 169 HTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---AMYRKIA-KADYKFPTWFSADVR 240 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~ 240 (450)
....||+.|+|||++.. ..+.+.++|||||||++|+|++|..||...... .....+. ......+..++.++.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 34579999999998743 234557899999999999999999999753322 2222222 223345667899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||.+||+.||++|||+.|+++||||.+.
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=354.60 Aligned_cols=252 Identities=40% Similarity=0.696 Sum_probs=212.9
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|++++.||+|+||+||+|++..+++.||+|++........ ......+|+.+++.++||||+++++++......|++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999988764432 223345699999999999999999999999999999999
Q ss_pred cCCCChhhHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccc
Q 045214 92 AKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT 170 (450)
Q Consensus 92 ~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 170 (450)
+++++|.+++. .+.+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999998 578999999999999999999999999999999999999999999999999987542 122233456
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---HHHHHHHHhhcCCCCC----CCCcHHHHHHH
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADYKFP----TWFSADVRKLL 243 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~ll 243 (450)
..+++.|+|||++......+.++|+||||+++|+|++|..||...+ ......+........+ ...+.++.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 6789999999998733444689999999999999999999999873 3333333322221111 11248999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=373.77 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=204.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 4689999999999999999999999999999996532 3457899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+|++. ++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|...... ....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~ 239 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANK 239 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccc
Confidence 99995 578888765 57999999999999999999999999999999999999999999999999998643221 1122
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-------HHHHHHHH----------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-------LMAMYRKI---------------- 224 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i---------------- 224 (450)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345689999999999988766 489999999999999999998764321 01111111
Q ss_pred ----------hhcCC----CCCC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 225 ----------AKADY----KFPT-----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 225 ----------~~~~~----~~p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..... ..|. .++.++.+||.+||++||.+|||++|+|+||||+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 01100 1111 14668999999999999999999999999999976
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=370.30 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=212.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 4678999999999999999999999999999999998764322 12345677899999999999999999987533
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|+++|++ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999988 7799988888889999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
.......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 170 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred -----CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 1233457999999999997755556899999999999999999999987765544433322100
Q ss_pred ------------CCC--------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 ------------KFP--------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ------------~~p--------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..| ...++.+.+||.+||.+||.+|||+.|+++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 011 1245678999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=364.53 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=215.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 35679999999999999999999999999999999987643 2234567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ +++||||||+|||++.+|.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999999876 5789999999999999999999985 7999999999999999999999999998654221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHH--------------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI-------------------- 224 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-------------------- 224 (450)
......||+.|+|||++.+..+ +.++|+|||||++|+|++|..||...........+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2234578999999999987665 48999999999999999999999865443322111
Q ss_pred ------------------------hhcC-CCCC-CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 225 ------------------------AKAD-YKFP-TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 225 ------------------------~~~~-~~~p-~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.... ...+ ..++.++++||.+||+.||++|||++|++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 1111 13678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=349.77 Aligned_cols=256 Identities=32% Similarity=0.554 Sum_probs=219.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK--VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+.|++.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987653221 1234678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD- 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~- 165 (450)
++||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999875 57899999999999999999999999999999999999999999999999998643321111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll 243 (450)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+... ....|..++.++.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987765 48999999999999999999999887665554444333 3446677899999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=371.93 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=212.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-----KI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (450)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ......++.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999865321 2223467889999999999999999999998776 89
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 999999974 78777755 579999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh------------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK------------------ 226 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------ 226 (450)
........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12223456899999999998765556899999999999999999999988776554443321
Q ss_pred -----cCC---------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 227 -----ADY---------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 227 -----~~~---------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
... ......++++.+||.+||++||++|||+.|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223357899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.73 Aligned_cols=257 Identities=27% Similarity=0.461 Sum_probs=211.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4678999999999999999999999999999999999754322 23346678899999999999999999987543
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 458999999976 67666653 58899999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 1 2223445789999999999887765 899999999999999999999988766555444322100
Q ss_pred -----------C--------------C------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 230 -----------K--------------F------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 230 -----------~--------------~------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
. + +...+.++++||.+||+.||.+|||+.++|+||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0 0 011246789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=356.07 Aligned_cols=254 Identities=26% Similarity=0.472 Sum_probs=215.3
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987654433344567789999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3589999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH---HHHHH-HhhcCCCCCCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---AMYRK-IAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~-i~~~~~~~p~~~s~~~~~ll 243 (450)
.....||+.|+|||++.+..+. .++||||+||++|+|++|..||...... ..... ........+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877664 8999999999999999999999864321 11111 12223345667899999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 244 SRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
.+||+.||++||| ++|+++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=355.29 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=205.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEEe-----C
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMAS-----K 82 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 82 (450)
+|++.+.||+|+||.||+|++..+++.||+|.+....... .......+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987643222 2234456777777665 79999999998754 3
Q ss_pred CEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
..++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 78888764 35899999999999999999999999999999999999999999999999998754
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-----------
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD----------- 228 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 228 (450)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......++....
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 322 12234568999999999987766 489999999999999999999998876655444442210
Q ss_pred C----------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 Y----------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~----------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. ...+.++.++.+||.+||++||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.13 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=210.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 5678999999999999999999999999999999998754322 23346678899999999999999999988543
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 56666643 58899999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------- 227 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 227 (450)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 1 2223456799999999999887765 8999999999999999999999876654333222110
Q ss_pred ---------C-----CC---------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 228 ---------D-----YK---------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 228 ---------~-----~~---------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
. .. .+...+.++++||.+||+.||++|||+.|+++||||...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 00 0112356789999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=355.80 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=213.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 357899999999999999999999999999999999755422 223456789999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||+++ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 9999975 88888764 46899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------ 227 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------ 227 (450)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234467899999999876655568999999999999999999999887665444332211
Q ss_pred -CCCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 -DYKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 -~~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....| ..+++++++||.+||++||.+|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.11 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=202.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC------CCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH------PNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 82 (450)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 578999999999999999999999999999999996532 123445677877777754 4588899988764
Q ss_pred -CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCC-------------
Q 045214 83 -TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENG------------- 146 (450)
Q Consensus 83 -~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~------------- 146 (450)
.++|+|||++ |++|.+++.+ +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 6788888765 689999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH
Q 045214 147 ---MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK 223 (450)
Q Consensus 147 ---~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 223 (450)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|+.||...+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875321 223456899999999999887775 899999999999999999999988765444333
Q ss_pred HhhcCCCCCC------------------------------------------CCcHHHHHHHHHccCCCCCCCCCHHHHh
Q 045214 224 IAKADYKFPT------------------------------------------WFSADVRKLLSRILDPNPSTRISIAKIM 261 (450)
Q Consensus 224 i~~~~~~~p~------------------------------------------~~s~~~~~ll~~~L~~dP~~R~s~~eil 261 (450)
+......+|. ..++.+.+||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 3221111110 0134577999999999999999999999
Q ss_pred cCccccccC
Q 045214 262 ENPWFRKGL 270 (450)
Q Consensus 262 ~hp~f~~~~ 270 (450)
+||||++.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=395.74 Aligned_cols=260 Identities=32% Similarity=0.558 Sum_probs=232.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|+++++||+|+||.|.+++++.|++.||+|++++-...+......+..|-.+|.--+.+=|+.++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 46899999999999999999999999999999999986666666677888999999998999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|||++||+|..++.+ ++++|+.++.|+..++.||.-||+.|++||||||+|||||..|++||+|||.+--.. .++.-.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~-~dG~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD-ADGTVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC-CCCcEE
Confidence 999999999999987 579999999999999999999999999999999999999999999999999764332 122223
Q ss_pred cccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCC--CCCcHHH
Q 045214 168 LHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFP--TWFSADV 239 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~ 239 (450)
..+.+|||.|++||++.. .+.+|..+|.||+||++|+|+.|..||...+..+.|.+|..- .+.|| ..+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 456789999999999953 356689999999999999999999999999999999999654 67788 4589999
Q ss_pred HHHHHHccCCCCCCCCC---HHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRIS---IAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s---~~eil~hp~f~~~~ 270 (450)
++||.+++ -+|+.|.. ++++..||||....
T Consensus 313 kdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 313 KDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 99999999 67899998 99999999997543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=352.36 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=207.3
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||+|+||.||++++..+|+.||+|.+................|+.+++.++||||+++++.+.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred hhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 98 FKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 98 ~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
.+.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... .......||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCC
Confidence 988754 25889999999999999999999999999999999999999999999999998654321 122345789
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCC-CCCcHHHHHHHHHccCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFP-TWFSADVRKLLSRILDP 249 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~ll~~~L~~ 249 (450)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..............+ ..+++++.+|+.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999988775 4899999999999999999999976432 233333333333332 35899999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 045214 250 NPSTRISI----AKIMENPWFRK 268 (450)
Q Consensus 250 dP~~R~s~----~eil~hp~f~~ 268 (450)
||++||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.91 Aligned_cols=255 Identities=24% Similarity=0.464 Sum_probs=218.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|+..+.||+|+||+||+|.+..+++.+|+|.+.+...........+.+|+.+++.++|+||+.+++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999977654443444567889999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999998854321 112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH----HHHHhhcCCCCCCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM----YRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
.....|++.|+|||++.+..+. .++|+||+||++|+|++|..||........ ...+......++..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999876664 899999999999999999999987655433 23333344456667899999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCcccccc
Q 045214 244 SRILDPNPSTRIS-----IAKIMENPWFRKG 269 (450)
Q Consensus 244 ~~~L~~dP~~R~s-----~~eil~hp~f~~~ 269 (450)
.+||+.||++||+ +++++.||||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=376.11 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=226.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|+|+..||.|+||+||+|.++.++-..|.|+|.... .+..+.+.-||.||..++||+||++++.|...+.+||..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 46899999999999999999999999999999997654 345677889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|||.||-....+-. ..+++++++-+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.|.-... ....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 99999988877654 4799999999999999999999999999999999999999999999999998753221 1223
Q ss_pred cccccCCCcccCchhcc-----cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---CCCCCcHHH
Q 045214 168 LHTTCGTPAYVAPEVIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---FPTWFSADV 239 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 239 (450)
..+..|||+|||||+.. +.+|+ +++||||||++|.+|..+.+|-...+++..+-+|.+...+ -|+.++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 45778999999999874 45676 8999999999999999999999999999999888877654 477889999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.|||.+||.+||..||+++++++||||++.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999853
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=341.83 Aligned_cols=252 Identities=25% Similarity=0.551 Sum_probs=217.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-KTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 89 (450)
+|++.+.||+|++|.||++.+..+++.||+|.+....... ...+.+.+|+.++++++|||++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999997654322 334667899999999999999999998764 45789999
Q ss_pred eecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 90 EYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 99999999998864 35899999999999999999999999999999999999999999999999998654322 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~ 245 (450)
......+++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+..+.. ..+..+++++.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 23455789999999999877664 789999999999999999999998777666655555443 4566789999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 045214 246 ILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f 266 (450)
||++||++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=358.39 Aligned_cols=257 Identities=28% Similarity=0.502 Sum_probs=229.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-++.|+..++||+|+||+||-++.+.||+.+|+|.+++..+.+........+|-.+|.+++.+.||.+-..|++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 35678999999999999999999999999999999998877665555667889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||..|.||+|.-.|.+ | .++|..++.|+.+|+.||++||+.+|++|||||+|||||+.|+++|+|+|||......
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-- 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-- 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC--
Confidence 9999999999888865 4 7999999999999999999999999999999999999999999999999999755422
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCCCCCcHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFPTWFSADVR 240 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~ 240 (450)
.......||.+|||||++.+..|+ ...|.|||||++|+|+.|..||..... .++-+.+......+|..+|++++
T Consensus 341 -~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 -KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK 418 (591)
T ss_pred -CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence 233455899999999999988875 899999999999999999999987432 35556667777788999999999
Q ss_pred HHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 241 KLLSRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
+|.+.+|..||++|.. ++++.+||||+.
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999985 679999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=361.19 Aligned_cols=251 Identities=23% Similarity=0.408 Sum_probs=203.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.++|++++.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999853 3457899999875432 22346788999999999 899999999987654
Q ss_pred -CEEEEEEeecCCCChhhHHhcC---------------------------------------------------------
Q 045214 83 -TKIYFVMEYAKGGELFKKVSKG--------------------------------------------------------- 104 (450)
Q Consensus 83 -~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 104 (450)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988531
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCccc
Q 045214 105 ------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178 (450)
Q Consensus 105 ------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~ 178 (450)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 36778889999999999999999999999999999999999999999999986542211111122334667899
Q ss_pred CchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHH-HHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCC
Q 045214 179 APEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA-MYRKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRI 255 (450)
Q Consensus 179 aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~ 255 (450)
|||++.+..+. .++|||||||++|+|++ |..||.+..... ....+..+ ....|...++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999877664 89999999999999997 999998765433 33333332 2345667889999999999999999999
Q ss_pred CHHHHhc
Q 045214 256 SIAKIME 262 (450)
Q Consensus 256 s~~eil~ 262 (450)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.27 Aligned_cols=255 Identities=27% Similarity=0.573 Sum_probs=218.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc------cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK------VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+|.+++.||.|++|.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999899999999987654322 1234678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
.+++|||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 578999999999999999999999999999999999999999999999999886554211
Q ss_pred C----CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 164 Q----DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 164 ~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
. ........|++.|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+... ....|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1111234688999999999877664 7899999999999999999999887665544444333 33566678999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+.++|.+||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=343.28 Aligned_cols=258 Identities=33% Similarity=0.627 Sum_probs=222.2
Q ss_pred ccCeee-eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEE
Q 045214 9 MQKYEL-GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 9 ~~~y~~-~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (450)
.+-|++ .+.||+|+|+.|--|.+..+|..||||++++.. .....++.||++++..+ .|+||++++++|++++..|
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 334555 578999999999999999999999999998863 23467899999999999 5999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhhhhcc
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSALAKCK 162 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~~~~~ 162 (450)
+|||-+.||+|...|.+ ..++|.++..+.++|+.||.|||.+||+|||+||||||....+ -+|||||.+..-....
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 99999999999999977 4799999999999999999999999999999999999997655 4799999987543322
Q ss_pred c-----CCCCcccccCCCcccCchhcc----cCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---------------HH
Q 045214 163 H-----QDGLLHTTCGTPAYVAPEVIS----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---------------LM 218 (450)
Q Consensus 163 ~-----~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~ 218 (450)
+ ....+.+.||+..|||||+.. ...++..++|.||||+|||-||+|++||.+.- ..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 2 122345779999999999863 23344589999999999999999999997531 34
Q ss_pred HHHHHHhhcCCCCCCC----CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 219 AMYRKIAKADYKFPTW----FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 219 ~~~~~i~~~~~~~p~~----~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.++..|+.+.+.||.. +|.++++|++.+|..|+.+|.++.++++|||++..
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 6788899999999963 89999999999999999999999999999999753
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=347.89 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=208.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 489999999999999999999999999999998764322 2334677899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 91 YAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|++ ++|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.+|.++|+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 478887753 46899999999999999999999999999999999999999999999999998643221 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------C
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------D 228 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~ 228 (450)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554458999999999999999999999876543222111100 0
Q ss_pred C-----------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 Y-----------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~-----------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. .....+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=352.72 Aligned_cols=258 Identities=34% Similarity=0.634 Sum_probs=224.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+.+..|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544345567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-
Q 045214 90 EYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD- 165 (450)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~- 165 (450)
||+.|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999865 36899999999999999999999999999999999999999999999999987643221100
Q ss_pred --------------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH
Q 045214 166 --------------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA 219 (450)
Q Consensus 166 --------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~ 219 (450)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987765 489999999999999999999999888777
Q ss_pred HHHHHhhcCCCCCCC--CcHHHHHHHHHccCCCCCCCCC----HHHHhcCccccc
Q 045214 220 MYRKIAKADYKFPTW--FSADVRKLLSRILDPNPSTRIS----IAKIMENPWFRK 268 (450)
Q Consensus 220 ~~~~i~~~~~~~p~~--~s~~~~~ll~~~L~~dP~~R~s----~~eil~hp~f~~ 268 (450)
.+..+......++.. ++.++.++|.+||..||++||| +++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777766655555554 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=348.79 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=219.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
...+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999999765432 24667899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||||++|++|.+++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999987653221 112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~ 244 (450)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+... ....|..++..+.+++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987665 48999999999999999999999877654333222222 12345568899999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccc
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||.+||++|||+.++++||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.73 Aligned_cols=246 Identities=28% Similarity=0.473 Sum_probs=193.6
Q ss_pred eceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEEe
Q 045214 15 GRLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKIYFVME 90 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 90 (450)
++.||+|+||.||+|++.. +++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 5789999999999999764 678999999865432 2456789999999999999999998854 567899999
Q ss_pred ecCCCChhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe----cCCCCeEEeecCch
Q 045214 91 YAKGGELFKKVSK----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLS 156 (450)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----~~~~~vkl~DFGls 156 (450)
|+.+ +|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9865 78777642 248999999999999999999999999999999999999 45678999999998
Q ss_pred hhhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---------HHHHHHHhh
Q 045214 157 ALAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---------MAMYRKIAK 226 (450)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~i~~ 226 (450)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|..||...+. ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 75432211 12234567899999999998765556899999999999999999999974321 111111110
Q ss_pred c----------------------------CCCC----------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 227 A----------------------------DYKF----------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 227 ~----------------------------~~~~----------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. .... ....+.++.+||.+||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01134678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.33 Aligned_cols=253 Identities=27% Similarity=0.450 Sum_probs=207.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++..+|++++.||+|+||.||+|.... +++.||+|.+.... ...+|+.+++.++||||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 4566789999999999999999998654 56889999886432 3468999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
..|++||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 578888864 67999999999999999999999999999999999999999999999999998654432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---HHHHHHHhhc------------
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---MAMYRKIAKA------------ 227 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~------------ 227 (450)
..........||+.|+|||++....+. .++|||||||++|+|++|..||.+... ...+..+.+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222223356799999999999877765 899999999999999999999976431 1111111110
Q ss_pred -----------------CCCCCC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 -----------------DYKFPT-----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 -----------------~~~~p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+..|. .++.++.++|.+||..||++|||+.|+|.||||++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 011111 24678899999999999999999999999999976
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.93 Aligned_cols=252 Identities=30% Similarity=0.606 Sum_probs=222.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987655444456788999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 91 YAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 91 ~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
|+.|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 99999999999764 8999999999999999999999999999999999999999999999999987654322 1234
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---HHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
...|+..|+|||++....+ +.++|+||||+++|+|++|..||...+ ...............|..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 4568899999999987665 489999999999999999999999766 344444433355667778899999999999
Q ss_pred cCCCCCCCCCH--HHHhcCccc
Q 045214 247 LDPNPSTRISI--AKIMENPWF 266 (450)
Q Consensus 247 L~~dP~~R~s~--~eil~hp~f 266 (450)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=350.51 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=213.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..++..+|+|.+..+. ......++.+|+++++.++||||+++++.+.+++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++|++|.+++.+ +.+++..+..++.|++.||.|||+ +|++||||||+|||++.++.++|+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999976 679999999999999999999998 6999999999999999999999999998754321 22
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------------------- 227 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------- 227 (450)
....+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345578999999999877665 48999999999999999999999765543333222111
Q ss_pred -----------------CCCCC-CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 -----------------DYKFP-TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 -----------------~~~~p-~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....| ..++.++.+|+.+||..||++|||++++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 01111 1267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=349.40 Aligned_cols=258 Identities=34% Similarity=0.659 Sum_probs=221.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998765433344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC---
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--- 165 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 165 (450)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999966 67899999999999999999999999999999999999999999999999987532110000
Q ss_pred ----------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC--
Q 045214 166 ----------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-- 233 (450)
Q Consensus 166 ----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~-- 233 (450)
.......+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 01112467889999999877665 58999999999999999999999988877777777665544433
Q ss_pred -CCcHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 045214 234 -WFSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRK 268 (450)
Q Consensus 234 -~~s~~~~~ll~~~L~~dP~~R~s---~~eil~hp~f~~ 268 (450)
.++.++.++|.+||++||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=340.58 Aligned_cols=255 Identities=32% Similarity=0.533 Sum_probs=218.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++++.||.|+||.||+|....++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654332 4577899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 90 EYAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 90 E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|+++|++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999865 35899999999999999999999999999999999999999999999999998765443222
Q ss_pred --CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CC-----CCCcH
Q 045214 166 --GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FP-----TWFSA 237 (450)
Q Consensus 166 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 237 (450)
.......|++.|+|||++......+.++|+|||||++|+|++|..||...+....+.+....... ++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12334578999999999877644468999999999999999999999887766555554433221 11 24678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
++.+++.+||..||++|||+++++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.32 Aligned_cols=253 Identities=32% Similarity=0.540 Sum_probs=219.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+.+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999999875432 23467789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||++|++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (296)
T ss_pred EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999876433221 1223
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~~~ 246 (450)
...+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..+++.+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 4578999999999987665 47999999999999999999999987765444444332 2234556889999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 045214 247 LDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|..||++|||+.+++.||||+.
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhh
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=345.09 Aligned_cols=253 Identities=30% Similarity=0.510 Sum_probs=213.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|+ |++|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 4699999999999999999999999999999999999999999999999999875533221 223
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------C
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------Y 229 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (450)
....|++.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345789999999998766555689999999999999999998888766554443332210 0
Q ss_pred CC-----------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KF-----------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~-----------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+ .+..+.++.++|.+||++||++|||+++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 00 12356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=343.63 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=211.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998754321 223456789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++++.|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999888887755 579999999999999999999999999999999999999999999999999986543221 122
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------C
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------Y 229 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (450)
....++..|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+.... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 334578899999998765545689999999999999999999998766543332221100 0
Q ss_pred CCC------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KFP------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~p------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..| +.++..+.+|+.+||++||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.44 Aligned_cols=252 Identities=30% Similarity=0.531 Sum_probs=208.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976432 22334567789999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|+++ +|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 77777653 57999999999999999999999999999999999999999999999999998654321 1222
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCC-CCCcHHHHHHHHhhcC-------------------
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF-HDSNLMAMYRKIAKAD------------------- 228 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~------------------- 228 (450)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877655568999999999999999998885 4444444433332110
Q ss_pred C----------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 Y----------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~----------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. ...+.+++++++||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=383.34 Aligned_cols=263 Identities=28% Similarity=0.512 Sum_probs=217.7
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS- 81 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (450)
..|..+.++|++++.||.|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 357788999999999999999999999999999999999997654332 345678899999999999999999998854
Q ss_pred -CCEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCcEEecC----
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSR-------GVYHRDLKPENLLLDE---- 144 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~-------gi~HrDikp~NILl~~---- 144 (450)
...+|+||||+++++|.++|.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999998864 4699999999999999999999995 4999999999999964
Q ss_pred -------------CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCC
Q 045214 145 -------------NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYL 210 (450)
Q Consensus 145 -------------~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~ 210 (450)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++|||||||+||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999865432 2223456799999999998643 233589999999999999999999
Q ss_pred CCCCCcHH-HHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 211 PFHDSNLM-AMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 211 Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||...+.. .+...+...........+.++.+||.+||+.+|.+|||+.|+|.|||++..
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99865543 344443333222224478999999999999999999999999999999754
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=340.53 Aligned_cols=254 Identities=27% Similarity=0.506 Sum_probs=215.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc---ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL---KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+|++++.||.|+||.||+|.+ .+++.+|+|.+...... ......++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999987 47889999998754321 12234678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc---
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH--- 163 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~--- 163 (450)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 678999999999999999999999999999999999999999999999999986542211
Q ss_pred -CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHH
Q 045214 164 -QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADV 239 (450)
Q Consensus 164 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 239 (450)
.........|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345689999999999877664 8999999999999999999999876654443333322 224566689999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.++|.+||.++|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=343.69 Aligned_cols=255 Identities=31% Similarity=0.535 Sum_probs=222.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233466789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||+++++|.+++..+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999986543221 1223
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCC-CcHHHHHHHHHcc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTW-FSADVRKLLSRIL 247 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~ll~~~L 247 (450)
...+++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+..... ..+.. ++.++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4568899999999987765 4899999999999999999999988776665555544432 33444 7899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 045214 248 DPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..||++|||++++++||||++.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=345.87 Aligned_cols=255 Identities=33% Similarity=0.503 Sum_probs=219.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 57999999999999999999998899999999987543 233467788999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++++|.+++.+ ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence 99999999999865 469999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccCCCcccCchhcccC----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRR----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVR 240 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 240 (450)
.....+++.|+|||++... ...+.++|+|||||++|+|++|..||...+......++..... ..|..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 2345689999999998532 2224689999999999999999999998877666666655432 34556889999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++|.+||+.+|.+||+++++++||||.+.
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=366.45 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=204.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.++++++||||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45589999999999999999999999999999996422 234689999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||++. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 588888754 46999999999999999999999999999999999999999999999999998755332222
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC--------cHHHHHHHHhhcCCC-------
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS--------NLMAMYRKIAKADYK------- 230 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~~~------- 230 (450)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+... ....+.+.+......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223345799999999999887765 8999999999999999987654321 122233333222110
Q ss_pred ----------------------CCC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 ----------------------FPT-----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 ----------------------~p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 111 24568999999999999999999999999999974
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=349.07 Aligned_cols=256 Identities=32% Similarity=0.529 Sum_probs=218.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 347899999999999999999999999999999999754432 23567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||||++|++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...... ...
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--ccC
Confidence 999999999999998888999999999999999999999999999999999999999999999999987643221 112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~ 244 (450)
.....+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+.+|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987665 48999999999999999999999876553332222221 12245567899999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccc
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||..||++|||++++++||||+..
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.36 Aligned_cols=255 Identities=21% Similarity=0.379 Sum_probs=205.8
Q ss_pred eeeceEeec--CCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 13 ELGRLLGQG--NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 13 ~~~~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+++++||+| +|++||++.+..+|+.||+|.++.+... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 367889999 7889999999999999999999765432 2345678889999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC---
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ--- 164 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~--- 164 (450)
|+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999864 3589999999999999999999999999999999999999999999999986432211100
Q ss_pred --CCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-----------
Q 045214 165 --DGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK----------- 230 (450)
Q Consensus 165 --~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----------- 230 (450)
........++..|+|||++.+. ...+.++||||+||++|+|++|..||.................+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999998753 22358999999999999999999999875443322222111100
Q ss_pred -----------------------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 -----------------------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 -----------------------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....+++++.+||.+||+.||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=335.78 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=219.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999999865 36899999999999999999999999999999999999999999999999987644322 122
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRI 246 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~ll~~~ 246 (450)
....+|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+.....+ .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2345789999999999877664 8999999999999999999999988877777666655443 4446889999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 045214 247 LDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f 266 (450)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=342.52 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=212.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 35689999999999999999999999999999999875532 223567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999999999865 68999999999999999999999999999999999999999999999999987643221 11
Q ss_pred CcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC-----CCCcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-----TWFSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 239 (450)
......|++.|+|||++.. ....+.++|+|||||++|+|++|..||...................+ ..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 2234578999999999742 22234799999999999999999999976554443333333333222 1367889
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.+++.+||..||++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.68 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=210.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+..+.. ......+.+|+.++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999976532 223466889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.... .....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~----~~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc----ccccc
Confidence 99999988654 357899999999999999999999999999999999999999999999999986432 12234
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-------HHHHHHHhhcCC-CC-CCCCcHHHH
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-------MAMYRKIAKADY-KF-PTWFSADVR 240 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~ 240 (450)
..+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||..... ......+..... .. ...+++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5679999999999987766 4899999999999999999999975321 122222222221 12 234788999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++.+||+.||++||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=339.69 Aligned_cols=247 Identities=37% Similarity=0.716 Sum_probs=217.9
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||.|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.+++..|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876654445567899999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCc
Q 045214 98 FKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176 (450)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~ 176 (450)
.+++.+ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 468999999999999999999999999999999999999999999999999886543221 2234578999
Q ss_pred ccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc--HHHHHHHHh--hcCCCCCCCCcHHHHHHHHHccCCCCC
Q 045214 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--LMAMYRKIA--KADYKFPTWFSADVRKLLSRILDPNPS 252 (450)
Q Consensus 177 y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~ll~~~L~~dP~ 252 (450)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+.++. .....+|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 88999999999999999999998766 666666665 445567777899999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 045214 253 TRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 253 ~R~s-----~~eil~hp~f~~ 268 (450)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.13 Aligned_cols=259 Identities=31% Similarity=0.455 Sum_probs=218.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+....+.|++++.||.|+||.||+|++..+++.+++|.+.... ......+.+|+.+++.++||||+++++.+..++.
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence 3345578999999999999999999999999999999987543 2345678889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
+|+||||++|++|...+.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~- 162 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK- 162 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc-
Confidence 9999999999999887753 5689999999999999999999999999999999999999999999999998754221
Q ss_pred cCCCCcccccCCCcccCchhcccCC----CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCC
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRG----YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWF 235 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 235 (450)
.........+++.|+|||++.... ..+.++|+|||||++|+|++|..||...+....+.++..... ..+..+
T Consensus 163 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 163 -TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred -cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence 111223456889999999985321 124689999999999999999999988776655555543322 234567
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.++.++|.+||..||++||+++++++||||..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 899999999999999999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.94 Aligned_cols=256 Identities=27% Similarity=0.519 Sum_probs=213.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-------cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-------VGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999999999999999986432211 123456788999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+++||||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 68999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCC----CC
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPT----WF 235 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 235 (450)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...+.......+... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233456889999999987654 2358999999999999999999999876554444333222 222333 35
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=341.04 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=211.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35689999999999999999999999999999999975432 223567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999998865 67999999999999999999999999999999999999999999999999998644221 11
Q ss_pred CcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC-----CCCcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-----TWFSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 239 (450)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....+..+ ..++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1234568899999999853 22234789999999999999999999976554443333333332222 2367899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.+||.+||..||++|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.00 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=215.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
-|++.+.||+|+||.||+|.+..++..+++|.+..... .....+.+|+.+++.++||||+++++.+..++..|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 37889999999999999999999999999999865432 234667889999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|+++++|...+.+ +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 9999999888754 57999999999999999999999999999999999999999999999999998543211 1222
Q ss_pred ccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---CCCCCCCcHHHHH
Q 045214 169 HTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRK 241 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 241 (450)
....+++.|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999842 1222478999999999999999999998877665555554332 2345568899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||.+||++||.+|||++++++||||+..
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.25 Aligned_cols=248 Identities=29% Similarity=0.507 Sum_probs=203.6
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH---hCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR---LIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765432222233344444443 4479999999999999999999999999
Q ss_pred CCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 94 GGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
|++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998865 67999999999999999999999999999999999999999999999999998543221 123457
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---HHHHHHHhhcCCCCCCCCcHHHHHHHHHccCC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---MAMYRKIAKADYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
||+.|+|||.+......+.++||||+||++|+|++|..||..... .............+|..++.++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999986434345899999999999999999999975422 22222223334556777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccc
Q 045214 250 NPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 250 dP~~R~-----s~~eil~hp~f~~ 268 (450)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.27 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=213.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKI 85 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (450)
-.++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .......+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999999999999999987554222 2234556899999999999999999998655 578
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887764 568999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc----------------
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---------------- 227 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------- 227 (450)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 12223346888999999876554568999999999999999999999988776666554331
Q ss_pred ---CCCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ---DYKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ---~~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+..+ .++++++.+||.+||++||++|||+++++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 01111 2357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=344.46 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=215.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 1223467889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 90 EYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||++|++|..++..+ .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999888764 79999999999999999999997 599999999999999999999999999886432
Q ss_pred CCCcccccCCCcccCchhcccCCC-----CCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH---Hhhc-CCCCCCCC
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGY-----DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK---IAKA-DYKFPTWF 235 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~ 235 (450)
........+++.|+|||.+.+... .+.++|+|||||++|+|++|..||........+.. +... ....|+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 122334568899999999865432 24789999999999999999999987554443333 2222 23456668
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.++.+||.+||+.+|++||+++++++||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=344.71 Aligned_cols=254 Identities=30% Similarity=0.473 Sum_probs=213.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999987644322 34567789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++++.|.++... +.+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99999988887765 469999999999999999999999999999999999999999999999999986543222 222
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-------------------
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------------- 229 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------------- 229 (450)
....++..|+|||++.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 3456889999999987655556889999999999999999999987654443333221100
Q ss_pred C------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 K------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. .++.++..+.+|+.+||+++|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.32 Aligned_cols=252 Identities=31% Similarity=0.616 Sum_probs=219.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||.+.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999987643322 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 9999999998864 258999999999999999999999999999999999999999999999999886543211 11
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSRI 246 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~~ 246 (450)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+..+.. ..|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223458889999999877665 4799999999999999999999998877777766655544 35667899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 045214 247 LDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f 266 (450)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.71 Aligned_cols=256 Identities=28% Similarity=0.523 Sum_probs=214.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+|+.++.||+|+||.||.|.+..+++.+|+|++....... ......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999997543211 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccC-
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQ- 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~- 164 (450)
|+||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999876 6789999999999999999999999999999999999998776 599999999865433211
Q ss_pred -CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHH---h--hcCCCCCCCCcHH
Q 045214 165 -DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI---A--KADYKFPTWFSAD 238 (450)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 238 (450)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468899999999977665 48999999999999999999999765432222222 1 1233456678899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=342.96 Aligned_cols=256 Identities=34% Similarity=0.703 Sum_probs=227.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 88 (450)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+..|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544444577889999999998 99999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC--
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-- 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~-- 165 (450)
|||+++++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999977 48999999999999999999999999999999999999999999999999998655432211
Q ss_pred ----------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC
Q 045214 166 ----------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY 229 (450)
Q Consensus 166 ----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 229 (450)
.......++..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11223467899999999877654 4799999999999999999999998887777777777778
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCH----HHHhcCccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISI----AKIMENPWF 266 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~----~eil~hp~f 266 (450)
.+|..+++.+.++|.+||+.||.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.97 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=210.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS----- 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 81 (450)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3578999999999999999999999999999999987543 2235678899999998 79999999999865
Q ss_pred -CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
...+|++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+|+||||+||++++++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3578999999999999999875 358999999999999999999999999999999999999999999999999986
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccC----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC--CC
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRR----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--KF 231 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~ 231 (450)
..... ........|++.|+|||++... ...+.++|+||+||++|+|++|..||...........+..... ..
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 54321 1223456789999999998632 1234789999999999999999999987665544443333221 12
Q ss_pred CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 232 PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 232 p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+..++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.64 Aligned_cols=239 Identities=21% Similarity=0.310 Sum_probs=207.1
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEEEEEEee
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----KTKIYFVMEY 91 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 91 (450)
..||+|+++.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 789999999987654443445778899999999999999999999876 4578999999
Q ss_pred cCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 92 AKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
++||+|.+++.+ ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 999999999976 478999999999999999999998 49999999999999999999999999998654321 12
Q ss_pred cccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHHHH
Q 045214 170 TTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll~~ 245 (450)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... ..+.|...++++.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 344 58999999999999999999999998888877777443 344555689999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||+.||++|||++++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=332.88 Aligned_cols=252 Identities=29% Similarity=0.566 Sum_probs=220.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||.|+||.||.+++..+++.+++|.+....... ....++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999965 358999999999999999999999999999999999999999999999999886543222 12
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRI 246 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~ll~~~ 246 (450)
.....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+... .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 344578999999999877665 47899999999999999999999988887777776655443 3455789999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 045214 247 LDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f 266 (450)
|.++|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.34 Aligned_cols=257 Identities=32% Similarity=0.485 Sum_probs=214.6
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+..|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765533 123345677899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+ +++|.+++... .+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 88999999764 59999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------------- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (450)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||...+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345788999999986655556899999999999999999888887665554444422100
Q ss_pred ------C-----CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 230 ------K-----FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 230 ------~-----~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
. .....+.++.++|.+||++||++|||+.|++.||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 0122467899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=346.80 Aligned_cols=260 Identities=33% Similarity=0.612 Sum_probs=234.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+-...|..+.+||+|+||+|.+|..+++.+.+|||+++++-+......+--..|-++|... +-|.+++++..|.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4456799999999999999999999999999999999998766544444445667777766 578899999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+.||+|...|.+ |++.|..+..|+..|+-||-+||++||++||||.+|||||.+|++||+|||++.. ..-.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIFD 503 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cccC
Confidence 999999999999999987 8999999999999999999999999999999999999999999999999999853 2223
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
.....+.||||.|+|||++..++| +.++|.||+||+|||||+|+.||++.+..++++.|......+|..+|.++.++..
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICK 582 (683)
T ss_pred CcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence 445678899999999999998887 5899999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCCH-----HHHhcCcccccc
Q 045214 245 RILDPNPSTRISI-----AKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~s~-----~eil~hp~f~~~ 269 (450)
.+|.+.|.+|... .+|..||||+..
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999999864 789999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.81 Aligned_cols=247 Identities=29% Similarity=0.512 Sum_probs=211.4
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999865443333445667899999999999999999999999999999999999999
Q ss_pred hhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 98 FKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 98 ~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
.+++.+ + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 999865 3 699999999999999999999999999999999999999999999999998865432 1222345678
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFPTWFSADVRKLLSRILDPN 250 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~d 250 (450)
..|+|||++.+..+ +.++|+|||||++|+|++|..||..... ..+...+.......|..+++++.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999887665 4899999999999999999999987543 333333344455567778999999999999999
Q ss_pred CCCCC-----CHHHHhcCccccc
Q 045214 251 PSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 251 P~~R~-----s~~eil~hp~f~~ 268 (450)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.74 Aligned_cols=259 Identities=29% Similarity=0.501 Sum_probs=212.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999865432 223345677899999999999999999987543
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 788877654 9999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---------- 230 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (450)
. ........+++.|+|||++.+..+. .++|||||||++|+|++|..||...+....+.++......
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 1 1223345689999999999887765 8999999999999999999999876654433333210000
Q ss_pred --------------------------C-------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 231 --------------------------F-------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 231 --------------------------~-------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
+ +...+++++++|.+||+.||++|||+.|+|.||||+.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 11235678999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=336.04 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=213.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK--VGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (450)
..|++.+.||+|+||.||+|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36899999999999999999999999999999987553221 1234678899999999999999999998865 4678
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc-
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH- 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~- 163 (450)
|+++||+++++|.+++.. +.+++.....++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 578999999999999999999999999999999999999999999999999986443211
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (450)
.........++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+......++... ...+|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1111223468899999999987665 48999999999999999999999877655444433322 23456678899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
++ +||..+|++||+++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 56678999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.96 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=213.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (450)
..|++.+.||+|+||.||.|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998654321 12335678899999999999999999998866 3578
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999876 5789999999999999999999999999999999999999999999999998865432111
Q ss_pred -CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHH
Q 045214 165 -DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRK 241 (450)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (450)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 111234568999999999987665 48999999999999999999999876555444443322 23345667889999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
+|.+||. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999994 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=339.24 Aligned_cols=249 Identities=30% Similarity=0.512 Sum_probs=207.1
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHH---HHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE---ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
.||+|+||.||+|.+..+++.||+|.+.+..............| +..++...||||+++++.+.+.+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987543322211222233 344555689999999999999999999999999
Q ss_pred CCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 94 GGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
|++|.+++.+ +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999998865 5799999999999999999999999999999999999999999999999999864322 1223457
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKIAKADYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
|++.|+|||++.+....+.++||||+||++|+|++|..||... ................|..++.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875533458899999999999999999999876 3334444444455667777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 045214 250 NPSTRI-----SIAKIMENPWFRKG 269 (450)
Q Consensus 250 dP~~R~-----s~~eil~hp~f~~~ 269 (450)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.95 Aligned_cols=256 Identities=30% Similarity=0.572 Sum_probs=217.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCccEEEEEEEeCCEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ---HPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (450)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .....++.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58899999999999999999999999999999875432 233567889999999996 9999999999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+|||++|++|.+++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999886543322 22
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCC-CCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPT-WFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~ll~~ 245 (450)
.....|++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+.... ..++. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 2344689999999998765544689999999999999999999998876654443333222 12233 278899999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||+.||++||++.+++.||||++..
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=355.75 Aligned_cols=247 Identities=32% Similarity=0.664 Sum_probs=219.3
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
.++||+|.||+||-|.++.+|+.||||+|++..... ....++++|+.||..+.||.||.+--.+++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 578999999999999999999999999999987754 3348899999999999999999999999999999999999987
Q ss_pred CChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhhhhcccCCCCcc
Q 045214 95 GELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 95 g~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
.-|.-.+. +|+++|.....++.||+.||.|||-+||+|+|||||||||.... .+||||||+|+... ......
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---EksFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKSFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---hhhhhh
Confidence 55555554 48999999999999999999999999999999999999997544 79999999998754 334556
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC--C--CcHHHHHHHHH
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRKLLSR 245 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~ll~~ 245 (450)
+.+|||.|+|||++.+++|+ ..-|+||.|+|+|.-|.|..||... +++..+|++..+-+|+ | +++++.+||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78999999999999999997 7899999999999999999999764 3455677777776664 3 89999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccc
Q 045214 246 ILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+|+..-.+|+|+++.+.|||++.
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999975
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.21 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=204.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcC----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLG----------------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (450)
-.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998532 345799999876432 233567889999999999999
Q ss_pred ccEEEEEEEeCCEEEEEEeecCCCChhhHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 045214 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSKG--------------------KLKEDTARKYFQQLISAIDFCHSRGVY 131 (450)
Q Consensus 72 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--------------------~l~e~~~~~~~~qll~aL~~LH~~gi~ 131 (450)
|+++++++.+.+..|++|||+++|+|.+++... .++...+..++.|++.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988542 256778899999999999999999999
Q ss_pred ecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--CC
Q 045214 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA--GY 209 (450)
Q Consensus 132 HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~ 209 (450)
||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999864432221112233456788999999877665 489999999999999986 67
Q ss_pred CCCCCCcHHHHHHHHhh--------cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 210 LPFHDSNLMAMYRKIAK--------ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.||...+..+....+.. .....|+.++..+.+|+.+||+.||++|||+++|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88887665554433321 112235567899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=349.30 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=211.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK----- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (450)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4678999999999999999999999999999999986432 223456678899999999999999999886544
Q ss_pred CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 83 TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
...|+++||+.+ +|.+.+....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999975 8888888888999999999999999999999999999999999999999999999999998654322
Q ss_pred cC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh---------------
Q 045214 163 HQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--------------- 226 (450)
Q Consensus 163 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 226 (450)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223457899999999876544446899999999999999999999987654322221110
Q ss_pred c---------CC--C-----CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 227 A---------DY--K-----FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 227 ~---------~~--~-----~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
. .. . ..+..++++.++|.+||++||++|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 00 0 0123578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=332.80 Aligned_cols=250 Identities=31% Similarity=0.529 Sum_probs=215.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976532 24578899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 99999999998865 579999999999999999999999999999999999999999999999999986543221 12
Q ss_pred cccccCCCcccCchhcccC---CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-----CCCCCcHHH
Q 045214 168 LHTTCGTPAYVAPEVISRR---GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-----FPTWFSADV 239 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~ 239 (450)
.....++..|+|||.+... .++ .++|+|||||++|+|++|..||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345688899999998765 454 7899999999999999999999887665554444444222 233467889
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.+++.+||..+|..|||+.+++.|||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=332.11 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=216.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+|+..+.||+|+||+||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999889999999998754321 123456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+||++|++|.+++.+ +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999976 458999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh--cCCCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ll~~ 245 (450)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||...........+.. .....|..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34556899999999987665235899999999999999999999987665444444433 2234566788999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 045214 246 ILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f 266 (450)
||+.+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=331.48 Aligned_cols=251 Identities=35% Similarity=0.597 Sum_probs=217.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998654332 345778899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~~~ 166 (450)
|++|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999965 2489999999999999999999999999999999999998655 5799999988654322 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~ 245 (450)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... .+++..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2233568899999999987655 479999999999999999999999887766666655443 34566789999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 045214 246 ILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f 266 (450)
||.+||++|||++|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=342.28 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=207.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK----- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (450)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... ........+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 467899999999999999999999999999999998754322 22334567899999999999999999987654
Q ss_pred ---CEEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 83 ---TKIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 83 ---~~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
...|+||||+.+ +|.+.+... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 356999999975 787777653 68999999999999999999999999999999999999999999999999986
Q ss_pred hhhcccCC--CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------
Q 045214 158 LAKCKHQD--GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------ 229 (450)
Q Consensus 158 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------ 229 (450)
........ .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 54332211 1222346788999999987655445799999999999999999999987765443332222100
Q ss_pred -------------CCC-------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 -------------KFP-------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 -------------~~p-------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.09 Aligned_cols=248 Identities=29% Similarity=0.522 Sum_probs=216.1
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCC
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGE 96 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 96 (450)
+||+|+||+||.|++..|....|||.+.... ....+-+..||.+.+.++|.|||++.+.+..++++-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986443 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CCCCeEEeecCchhhhhcccCCCCcccc
Q 045214 97 LFKKVSK--GKL--KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTT 171 (450)
Q Consensus 97 L~~~i~~--~~l--~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~~~vkl~DFGls~~~~~~~~~~~~~~~ 171 (450)
|.++++. |++ +|...-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||.|+... ..+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence 9999976 777 8899999999999999999999999999999999996 57899999999886543 334456788
Q ss_pred cCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCC-cH-HHHHHH-HhhcCCCCCCCCcHHHHHHHHHcc
Q 045214 172 CGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDS-NL-MAMYRK-IAKADYKFPTWFSADVRKLLSRIL 247 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~-~~~~~~-i~~~~~~~p~~~s~~~~~ll~~~L 247 (450)
.||..|||||++..++ -+|.++|||||||++.||.||++||-.. ++ ..+++- +.+...++|..+|.+++.||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 8999999999996432 3468999999999999999999999763 23 333332 345566788899999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 045214 248 DPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+||..||++.++|.+||++.+
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 9999999999999999999876
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.96 Aligned_cols=254 Identities=25% Similarity=0.457 Sum_probs=212.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK---- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---- 82 (450)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4678999999999999999999999999999999986542 2235677899999998 899999999998643
Q ss_pred -CEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 83 -TKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 83 -~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+..|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999999999988752 46899999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCC----CCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---C
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY----DGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---Y 229 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~ 229 (450)
....... .......|++.|+|||++..... .+.++|||||||++|+|++|..||...+.......+.... .
T Consensus 176 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 6543211 11234568899999999864321 2479999999999999999999998876655555544332 2
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
..+..++.++.+||.+||++||++||++.++++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.44 Aligned_cols=246 Identities=25% Similarity=0.423 Sum_probs=198.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
..+|++.+.||+|+||.||+|.+..+++.||+|+..... ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 347999999999999999999999999999999854332 24689999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||++.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999965 78887754 4799999999999999999999999999999999999999999999999999864321 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCC-CCCCcH----------HHHHHHHhhcC---CCCC
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP-FHDSNL----------MAMYRKIAKAD---YKFP 232 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~----------~~~~~~i~~~~---~~~p 232 (450)
......||+.|+|||++.+..+. .++|||||||++|+|+++..| |..... ..+...+.... ..+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 22345799999999999887764 899999999999999986544 443211 11111111100 0111
Q ss_pred ------------------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 ------------------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ------------------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999975
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=340.13 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=214.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 467999999999999999999986655 6799999875432 233567889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
..|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998854 3478889999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHh
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 225 (450)
.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998644322222223345678899999998876664 89999999999999998 999999888877777776
Q ss_pred hcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 226 KADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 226 ~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.... ..|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5443 4566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=339.07 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=206.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57899999999999999999999989999999998764322 1224467899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 999985 89888864 468999999999999999999999999999999999999999999999999875432111 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhc------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA------------------ 227 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~------------------ 227 (450)
......+++.|+|||++.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12233578899999998765444589999999999999999999997654 22222221110
Q ss_pred -C--CCC---------CCCCc--HHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 228 -D--YKF---------PTWFS--ADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 228 -~--~~~---------p~~~s--~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. ... .+.++ .++.+++.+||+++|++|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.12 Aligned_cols=255 Identities=31% Similarity=0.542 Sum_probs=214.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999876433 2244578899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||++++.+..+..+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999777766655 5699999999999999999999999999999999999999999999999999865543221 123
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--------------------
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------- 228 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (450)
....+++.|+|||++......+.++|+||+|+++|+|++|..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345788999999999877344689999999999999999999998765544332221100
Q ss_pred ------------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 ------------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ------------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+|..++.++.+||.+||..+|++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.08 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=219.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|.....||+|+||.||++.+..+++.||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 3557778889999999999999999999999999865432 2346688999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|||+++++|.+++..+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 98 ~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR 175 (292)
T ss_pred EeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence 99999999999998888999999999999999999999999999999999999999999999999998643221 1222
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---CCCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ll~~ 245 (450)
....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+.... ...+..++..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 345789999999999776664 79999999999999999999998877665555544322 12223478899999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccCC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
||..||.+|||++++++||||+....
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCC
Confidence 99999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.92 Aligned_cols=250 Identities=37% Similarity=0.697 Sum_probs=219.6
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||.|+||.||+|++..+|+.+++|++.............+.+|+.+++.++||||+++++.+......|+++||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999776544445567889999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC------CCCccc
Q 045214 98 FKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ------DGLLHT 170 (450)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~------~~~~~~ 170 (450)
.+++.+ +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 6799999999999999999999999999999999999999999999999999865432211 012234
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCC--cHHHHHHHHHccC
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF--SADVRKLLSRILD 248 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~ll~~~L~ 248 (450)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||...........+.......|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 468889999999877664 4899999999999999999999998888888877777666666655 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCccccc
Q 045214 249 PNPSTRISI---AKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s~---~eil~hp~f~~ 268 (450)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.92 Aligned_cols=251 Identities=22% Similarity=0.391 Sum_probs=205.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.++|++++.||+|+||.||+|++..+ ++.||+|.+...... .....+.+|+.+++.+ +||||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999996543 357999999765322 2346788999999999 899999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-----------------------------------------------------------
Q 045214 83 TKIYFVMEYAKGGELFKKVSK----------------------------------------------------------- 103 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~----------------------------------------------------------- 103 (450)
+..|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999988743
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccc
Q 045214 104 ------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT 171 (450)
Q Consensus 104 ------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 171 (450)
.++++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||++...............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13678889999999999999999999999999999999999999999999998644322111111223
Q ss_pred cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHccC
Q 045214 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll~~~L~ 248 (450)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||........+...... ....|...++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 35667999999977666 489999999999999997 99999876544333333333 334566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 045214 249 PNPSTRISIAKIME 262 (450)
Q Consensus 249 ~dP~~R~s~~eil~ 262 (450)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=339.15 Aligned_cols=252 Identities=31% Similarity=0.530 Sum_probs=209.3
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||.|++|.||+|++..+++.||||.+..+... ......+.+|++++++++||||+++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998755322 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+. ++|.+++.. +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578888754 46899999999999999999999999999999999999999999999999998644321 122
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------CC
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------DY 229 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~ 229 (450)
.....+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 233457889999999877665568899999999999999999999876544332222110 00
Q ss_pred CC-----------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KF-----------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~-----------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+ .+.++++++++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=331.23 Aligned_cols=247 Identities=32% Similarity=0.614 Sum_probs=215.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||.|+||.||++.+..+++.+|+|.++..... ...+.+.+|+.+++.++||||+++++.+.+++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 589999999999999999999999999999998754322 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999998854 35899999999999999999999999999999999999999999999999988644322 112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSRI 246 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~~ 246 (450)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++.++.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999987765 4899999999999999999999998887777666655544 35667889999999999
Q ss_pred cCCCCCCCCCHHHHhc
Q 045214 247 LDPNPSTRISIAKIME 262 (450)
Q Consensus 247 L~~dP~~R~s~~eil~ 262 (450)
|+.||++|||+.+++.
T Consensus 236 l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 236 FKRNPRSRPSATTILS 251 (255)
T ss_pred HhCCcccCCCHHHHhh
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=337.62 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=218.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|+..+.||.|+||.||.|.+..++..||+|++...... .....+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 5688999999999999999999999999999998754322 23567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||++|++|.+++..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999986543221 1122
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...++..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 3468889999999977665 48999999999999999999999887665554444332 223344578899999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 045214 249 PNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+|++||++++++.||||.+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=332.36 Aligned_cols=249 Identities=30% Similarity=0.527 Sum_probs=214.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||.|+||.||+|.+..+++.+++|.+..... .+++.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999875432 578899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999864 468999999999999999999999999999999999999999999999999987543222 12
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~ 244 (450)
.....++..|+|||++.+..++ .++||||+|+++|+|++|..||...+.......+... ....+..++.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2344588999999999877664 8999999999999999999999876654433333221 22334457889999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 045214 245 RILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f 266 (450)
+||+.||++|||+.+++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=334.76 Aligned_cols=252 Identities=32% Similarity=0.508 Sum_probs=211.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC----
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT---- 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 83 (450)
.++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+++.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4799999999999999999999998999999999876542 246788999999999 7999999999986544
Q ss_pred --EEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 84 --KIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 84 --~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.+|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999988753 47899999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCC----CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRG----YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--- 229 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 229 (450)
...... ........|++.|+|||++.... ..+.++|||||||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 643221 12223456899999999985422 234789999999999999999999987665555555544322
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=353.90 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=205.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEE-----cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARH-----LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.++|++++.||+|+||.||+|.+ ..++..||+|++...... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 346778999999754322 2346788999999999 899999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhcC----------------------------------------------------------
Q 045214 83 TKIYFVMEYAKGGELFKKVSKG---------------------------------------------------------- 104 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 104 (450)
+..|+||||++||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999888531
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 105 ------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 105 ------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36778889999999999999999999999999999999999999999999986543221111
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHH-HHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLM-AMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...... ...+.+..+ ....|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 11223456679999999877664 89999999999999998 89999876543 333333333 2234566789999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||++||++|||+.++++
T Consensus 351 ~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHccCChhHCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=355.38 Aligned_cols=257 Identities=31% Similarity=0.585 Sum_probs=237.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-....+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-+||..++.|.||++|..|.+..++|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34567889999999999999999866666799999999988888888899999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
.||-|-||+|+..+.. |.+.+..++.|+..+++|++|||++||++|||||||++||.+|-+||.|||+|+.... ..
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---CC
Confidence 9999999999999975 7899999999999999999999999999999999999999999999999999976543 34
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll~ 244 (450)
.+-+.||||.|+|||++.+++.+ .++|.||||+++||||+|.+||.+.+++..|..|.++ .+.+|..++..+.+||.
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred ceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 45688999999999999999987 8999999999999999999999999999999999876 46789999999999999
Q ss_pred HccCCCCCCCCC-----HHHHhcCccccc
Q 045214 245 RILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 245 ~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
++...+|.+|.. +.+|..|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999986 899999999963
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=333.99 Aligned_cols=250 Identities=18% Similarity=0.285 Sum_probs=210.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++..... .....+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 457999999999999999999865 34678999999765322 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||+++|+|.+++.. +.+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999865 478999999999999999999999999999999999999999999999999765432111
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......+++.|+|||++.+..+. .++||||+||++|++++ |..||.+.+..+....+... ..+.|..++..+.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0 111123456789999999877664 89999999999999775 99999988877777666544 33556678899999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+||+++|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=336.31 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=209.6
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA------ 80 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 80 (450)
-.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3578999999999999999999999999999999986543 2235678899999988 7999999999984
Q ss_pred eCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
....+|++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35689999999999999998864 358899999999999999999999999999999999999999999999999976
Q ss_pred hhhcccCCCCcccccCCCcccCchhccc-----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-C-
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISR-----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-K- 230 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~- 230 (450)
..... ........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122334578999999999863 233 4789999999999999999999987655444333332221 1
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+..++.++.+||.+||..||.+|||+.|+++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.05 Aligned_cols=255 Identities=32% Similarity=0.606 Sum_probs=215.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
||.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++...+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999989999999999766533 3456889999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC--
Q 045214 91 YAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL-- 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~-- 167 (450)
|+++++|.+++.++ .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999774 689999999999999999999999999999999999999999999999999876533222111
Q ss_pred cccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHh-hcCCCCCCCC--cHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIA-KADYKFPTWF--SADVRK 241 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~--s~~~~~ 241 (450)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++|..||...+ .......+. .....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22356889999999987654 13489999999999999999999997653 222222222 2233455554 899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+|.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=339.62 Aligned_cols=254 Identities=32% Similarity=0.481 Sum_probs=212.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (450)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999765433 23345667899999999999999999998877 8999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
++|||+.+ +|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 88888865 358999999999999999999999999999999999999999999999999886543321
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC----------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---------------- 228 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------------- 228 (450)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 222344678899999998766555689999999999999999999998876655544432110
Q ss_pred ---------------CCCCCC-CcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 ---------------YKFPTW-FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ---------------~~~p~~-~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+|.. +++.+.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=332.50 Aligned_cols=246 Identities=35% Similarity=0.635 Sum_probs=208.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV-MRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+.||.|+||.||+|.+..+++.||+|++.+..............|..+ ....+||||+++++++...+.+|+++||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976543222223334455444 4455899999999999999999999999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 5799999999999999999999999999999999999999999999999998764321 224468
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHccCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSADVRKLLSRILDP 249 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ll~~~L~~ 249 (450)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+.......+ ..+++++.+++.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987764 5899999999999999999999998888777777665544332 34789999999999999
Q ss_pred CCCCCC---CHHHHhcCccccc
Q 045214 250 NPSTRI---SIAKIMENPWFRK 268 (450)
Q Consensus 250 dP~~R~---s~~eil~hp~f~~ 268 (450)
||++|| +++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 5589999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.09 Aligned_cols=254 Identities=31% Similarity=0.482 Sum_probs=207.7
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCE----
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTK---- 84 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 84 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4799999999999999999999999999999998765322 233466788999999995 6999999999877665
Q ss_pred -EEEEEeecCCCChhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCch
Q 045214 85 -IYFVMEYAKGGELFKKVSK------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLS 156 (450)
Q Consensus 85 -~~lv~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls 156 (450)
+|++|||+++ +|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887743 24799999999999999999999999999999999999998 889999999988
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-------
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------- 229 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------- 229 (450)
...... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+....+.++.....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 643221 11223346788999999987654446899999999999999999999987765544443322100
Q ss_pred ----------CCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 230 ----------KFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 230 ----------~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
..| +.++.++.+||.+||.+||.+|||++|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23688999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=343.55 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=192.2
Q ss_pred eceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEEe
Q 045214 15 GRLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA--SKTKIYFVME 90 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 90 (450)
+..||+|+||.||+|++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++. .+..+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999754 56889999986543 2245678999999999999999999884 4568999999
Q ss_pred ecCCCChhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe----cCCCCeEEeecCch
Q 045214 91 YAKGGELFKKVSK----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLS 156 (450)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----~~~~~vkl~DFGls 156 (450)
|+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 67776631 248899999999999999999999999999999999999 56679999999998
Q ss_pred hhhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH---------HHHHHHhh
Q 045214 157 ALAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---------AMYRKIAK 226 (450)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------~~~~~i~~ 226 (450)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 75432211 112234578999999999977655568999999999999999999999753211 00000000
Q ss_pred ----------------------------cCC----------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 227 ----------------------------ADY----------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 227 ----------------------------~~~----------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=334.77 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=215.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ....++.+|+.+++.++||||+++++.+...+.+|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4689999999999999999999999999999999765432 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||++|++|.+++.. ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999999975 578999999999999999999999 9999999999999999999999999999865432211
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-----cHHHHHHHHhhc-CCCCCCC-CcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-----NLMAMYRKIAKA-DYKFPTW-FSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~ 239 (450)
....+++.|+|||.+.+..+. .++|+||+|+++|+|++|..||... ...+..+.+... ....+.. ++.++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 126788999999999877654 8999999999999999999999764 223333333332 2234444 78999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=348.32 Aligned_cols=240 Identities=26% Similarity=0.489 Sum_probs=209.5
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
+.+++.||+|-||+||+|....+ ..||+|.+....... +.+.+|+++|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 45688999999999999998432 369999997754332 5567999999999999999999999998899999999
Q ss_pred cCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 92 AKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
++.|+|.+++.. +.+...+...++.||++|++||+++++|||||...||||++++.+||+|||||+... +...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~----d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG----DDEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC----CCce
Confidence 999999999986 469999999999999999999999999999999999999999999999999998322 1222
Q ss_pred cccc---CCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 169 HTTC---GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 169 ~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
.... -...|.|||.+....++ .+|||||+||+||||+| |+.||.+.+..+..+.+.++ ..+.|..+|+++.+++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 2222 23469999999988775 89999999999999999 99999999999988888765 5678899999999999
Q ss_pred HHccCCCCCCCCCHHHHh
Q 045214 244 SRILDPNPSTRISIAKIM 261 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil 261 (450)
..||..+|++|||.+.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999998665
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.54 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=219.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+-|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 3478899999999999999999889999999998654322 23467889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||+++++|.+++.++.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhc
Confidence 99999999999988889999999999999999999999999999999999999999999999999875433211 1122
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHccC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~~L~ 248 (450)
...++..|+|||.+.+.... .++|+||+||++|+|++|..||...+.......+..... ..+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688899999998766554 789999999999999999999988776655555544332 3455688999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 045214 249 PNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+|.+||++.+++.||||.+.
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=346.62 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=210.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK----- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (450)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 46899999999999999999999999999999999866543 3356788999999999999999999876543
Q ss_pred ---------CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEee
Q 045214 83 ---------TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTD 152 (450)
Q Consensus 83 ---------~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~D 152 (450)
...|++|||+++ +|.+.+..+.+++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 368999999974 8988888888999999999999999999999999999999999999974 55789999
Q ss_pred cCchhhhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---
Q 045214 153 FGLSALAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--- 228 (450)
Q Consensus 153 FGls~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 228 (450)
||++........ .+......++..|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999865422111 1122234678899999987664445689999999999999999999998766544433322110
Q ss_pred ----------------------C-----CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 ----------------------Y-----KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 ----------------------~-----~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
. .+.+.++.++.+||.+||++||.+|||+++++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 011246788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.53 Aligned_cols=248 Identities=31% Similarity=0.558 Sum_probs=204.8
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeC--CEEEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASK--TKIYFV 88 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 88 (450)
|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ......+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987543211 1223457888888885 99999999999887 899999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+++ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 77777764 46899999999999999999999999999999999999999 99999999998654322 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------C
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------D 228 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~ 228 (450)
......+++.|+|||.+....+.+.++|||||||++|+|++|..||...+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 1223468899999998766555668999999999999999999999887765544443221 1
Q ss_pred CCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 YKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+.+| +.++.++.++|.+||++||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.34 Aligned_cols=253 Identities=24% Similarity=0.455 Sum_probs=209.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE-----e
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA-----S 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~ 81 (450)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 5679999999999999999999999999999999886532 1235677899999999 7999999999873 4
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
++.+|++|||++|++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 5679999999999999987642 46889999999999999999999999999999999999999999999999997
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccC----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---C
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRR----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---Y 229 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~ 229 (450)
...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...+.......+.... .
T Consensus 172 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 172 AQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred eecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 644321 1122345689999999998532 112478999999999999999999998776544443332221 2
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..|..++.++.+++.+||+.||++|||+.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2345568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.95 Aligned_cols=251 Identities=33% Similarity=0.527 Sum_probs=210.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||.|++|.||+|++..+|+.||||.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999765422 224566789999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 91 YAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|+++ +|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9986 78887754 358999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------------ 228 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 228 (450)
......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+..+.+.++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22344678999999998765555689999999999999999999998876655444432110
Q ss_pred CC-----------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 YK-----------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~~-----------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.. ..+..++++.+++.+||+.||.+||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=334.24 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=218.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|.-.+.||+|++|.||+|.+..+++.+++|.++.... ...+.+.+|+.+++.++||||+++++++...+..|+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 356667899999999999999988999999999864332 22456789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||++|++|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999876433211 1223
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF---PTWFSADVRKLLSRI 246 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~ll~~~ 246 (450)
...|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+....... +..++..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4568999999999987665 489999999999999999999998877776666665543222 233788999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccccC
Q 045214 247 LDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
|+++|++|||+.++++||||++..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=329.78 Aligned_cols=252 Identities=31% Similarity=0.607 Sum_probs=218.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA--SKTKIYFV 88 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv 88 (450)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+++.+|+.+++.++||||+++++++. .+...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999999765432 233567889999999999999999999775 35578999
Q ss_pred EeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 89 MEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCH-----SRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH-----~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
|||+++++|.+++.. +.+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998853 47899999999999999999999 99999999999999999999999999999875
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcH
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSA 237 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 237 (450)
..... .......+++.|+|||++....+ +.++|+||||+++|+|++|..||...+.....+.+..... .+|..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 43222 11234578999999999987665 4889999999999999999999998887777777666554 35667899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
++.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.42 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=214.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--- 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 367899999999999999999999999999999999865432 2223456789999999999999999999987553
Q ss_pred ---EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 ---KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 ---~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+|+||||+ |++|.+++....+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999998 7799988888889999999999999999999999999999999999999999999999999886432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---------- 230 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (450)
. ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+....+.++......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 1 1223467899999999876444568999999999999999999999877655444433221110
Q ss_pred ---------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 ---------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ---------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+.+++++.++|.+||+.||++|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 123467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=339.66 Aligned_cols=252 Identities=27% Similarity=0.479 Sum_probs=222.0
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
-|.++..||+|+||.||+|.++.+|+.+|||.+..+. ..+.+.+||.||.+++.|++|++|+.|.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3788999999999999999999999999999987654 35678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||-.|+..|.++- ..++|+++..+++.-+.||+|||...-+|||||..||||+.+|..||+|||.|....... ...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence 9999999998864 579999999999999999999999999999999999999999999999999885433221 123
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---CCCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ll~~ 245 (450)
.+..|||.|||||++..-+|+ .++||||||++..+|..|++||.+-+++.....|-... +.-|..+|.++.+|+++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 567899999999999999997 79999999999999999999999888766554544332 22355689999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||.++|++|-|+-++++|||+++..
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999999998643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=347.07 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=215.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE--
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK-- 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (450)
.+.++|++.+.||+|++|.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4678999999999999999999999999999999998754322 2334667789999999999999999988765544
Q ss_pred ----EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 85 ----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ----~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.|+|+||+ |++|.+++....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 6699999988889999999999999999999999999999999999999999999999999986442
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---------- 230 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (450)
.. .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 21 234568899999999876444568999999999999999999999887765555444321100
Q ss_pred ---------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 ---------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ---------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....+++++.++|.+||++||++|||+.+++.||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 012358899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.06 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=217.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4688889999999999999999989999999998755322 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||++|++|.+++..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999886543211 1122
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHccC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~~L~ 248 (450)
...|+..|+|||.+.+..+. .++|+|||||++|+|++|..||...........+.... ...+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688899999999877654 79999999999999999999998765554444433322 22344578899999999999
Q ss_pred CCCCCCCCHHHHhcCccccc
Q 045214 249 PNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~ 268 (450)
.+|++|||+.++++||||.+
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.50 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=206.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKIY 86 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (450)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999875433334456778999999999999999999999888 8899
Q ss_pred EEEeecCCCChhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC----CCCeEEeecCch
Q 045214 87 FVMEYAKGGELFKKVSK------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE----NGMLKVTDFGLS 156 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~----~~~vkl~DFGls 156 (450)
+||||+++ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 66665532 26899999999999999999999999999999999999999 899999999998
Q ss_pred hhhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH---------HHHHH--
Q 045214 157 ALAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA---------MYRKI-- 224 (450)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------~~~~i-- 224 (450)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|..||...+... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 75433222 1122345688999999998765544589999999999999999999998643221 00000
Q ss_pred ------------------------hhcCCCCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 225 ------------------------AKADYKFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 225 ------------------------~~~~~~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
......++ ...+.++.+++.+||++||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.91 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=217.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..|+++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35567789999999999999998999999999865432 234668899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccc
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT 170 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 170 (450)
|+++++|.+.+....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 176 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence 9999999998887789999999999999999999999999999999999999999999999999886433211 12234
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHcc
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVRKLLSRIL 247 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ll~~~L 247 (450)
.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..... ..+..++..+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 578999999999987665 4899999999999999999999988776665555543322 223457889999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccC
Q 045214 248 DPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+.+|++||+++++++||||.+..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 99999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.83 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=203.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++++.++...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6799999999999999999999999999999999755322 22345678999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CC
Confidence 9996 567666543 468889999999999999999999999999999999999999999999999886432211 12
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhc-C-----------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKA-D----------------- 228 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~-~----------------- 228 (450)
.....+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234467899999999876543457899999999999999999999865432 222111100 0
Q ss_pred -----CCCCC---------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 -----YKFPT---------WFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 -----~~~p~---------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
...+. ..++++.+++.+||+.||.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.91 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=212.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 467899999875432 123567899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCe
Q 045214 84 KIYFVMEYAKGGELFKKVSK---------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~v 148 (450)
..|++|||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237888999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 227 (450)
+|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999988643221111112234567889999999877764 89999999999999998 99999888777777777655
Q ss_pred CCC-CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 228 DYK-FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 228 ~~~-~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
... .+..++.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543 35568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=325.65 Aligned_cols=252 Identities=37% Similarity=0.686 Sum_probs=221.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999999765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 91 YAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|++|++|.+.+.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999886543322
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLS 244 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~ 244 (450)
.......|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+............ ...|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233445789999999998777654 78999999999999999999999887777666665443 3456678899999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 045214 245 RILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f 266 (450)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=352.26 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=218.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|.=++.||.|+||.||.|++..+.+.||||.+........+-.+.+.+|++.|++++|||++.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36678999999999999999999999999999977655544556789999999999999999999999999999999999
Q ss_pred ecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||-| +-.|++. +.++.|.++..+..+.+.||+|||+++.||||||..||||++.|.|||+|||.|.+.. ..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence 9966 6777764 4579999999999999999999999999999999999999999999999999887543 24
Q ss_pred ccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCC-CCCcHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFP-TWFSADVRKLL 243 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p-~~~s~~~~~ll 243 (450)
.+.+|||+|||||++. .+.|+ -++|||||||+..+|...++|+...|.+..+..|..... .++ ..+|..+++|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 5789999999999985 34455 799999999999999999999888887766556655443 343 33789999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..||++-|..|||.++++.|+|+...
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999999999999999753
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.44 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=215.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ......++.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467999999999999999999999999999999987543 223457788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+++++|.+++.+ +.+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999999876 579999999999999999999997 6999999999999999999999999998754321 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-----------HHHHHHhhcC-CCCCCC
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-----------AMYRKIAKAD-YKFPTW 234 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~ 234 (450)
.....+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.. .....+.... ..++..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 1234578999999999877655 47999999999999999999999865431 2222332222 223333
Q ss_pred -CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 235 -FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 235 -~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++.++.+|+.+||++||++|||+.|+++||||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.11 Aligned_cols=252 Identities=33% Similarity=0.641 Sum_probs=216.0
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.+...+|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999997654322 234677899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC-eEEeecCchhhhhcccCCC
Q 045214 91 YAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM-LKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 91 ~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~-vkl~DFGls~~~~~~~~~~ 166 (450)
|+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||++++++. ++|+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 99999999998652 4799999999999999999999999999999999999998864 69999998865432 112
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~ 245 (450)
......|++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22344689999999998776654 899999999999999999999988776666555544333 3455678999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 045214 246 ILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f 266 (450)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.19 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=210.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
+..++|++.+.||+|+||.||.|.+.. ++..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998753 3567999998643221 234567899999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKG-----------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~-----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
.+..++||||+++++|.+++.+. .++...+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999998641 2467788999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD- 228 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 228 (450)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99998864322111111122355788999999987665 489999999999999999 799999887777666655544
Q ss_pred CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 229 YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 229 ~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
...|...+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=329.26 Aligned_cols=250 Identities=32% Similarity=0.600 Sum_probs=211.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987644444445567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 90 EYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988742 358999999999999999999999999999999999999999999999999886543221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc--HHHHHHHHhhcCCC-C-CCCCcHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--LMAMYRKIAKADYK-F-PTWFSADVR 240 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~~ 240 (450)
.......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.... .......+.....+ . +..++..+.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 122345688999999999877664 78999999999999999999997543 23444444433322 2 235778999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||..+|++|||++++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.15 Aligned_cols=255 Identities=33% Similarity=0.530 Sum_probs=217.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4789999999999999999999988999999999864432 2346678999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999876443221 122
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-C--CCCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-D--YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~~ll~~ 245 (450)
....|++.|+|||.+....+ +.++|+|||||++|+|++|..||...+.......+... . ...+..++..+++++.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34468899999999877665 47999999999999999999999876654433322221 1 22234467899999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccc
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||+.+|++||++.+++.||||+..
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcC
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=302.54 Aligned_cols=255 Identities=31% Similarity=0.540 Sum_probs=219.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|.-.+.||+|+||+||+|++..+++.||+|.++.+... .+.-....+||.+++.++|.|||+++++..++.++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 5678889999999999999999999999999999876533 355567789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|||.. +|..+... |.+..+.++.++.|++.||.|||++++.|||+||.|+|++.||.+|++|||+|+-++.+. ..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99965 78888865 789999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-------C----CCCC--
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-------Y----KFPT-- 233 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-------~----~~p~-- 233 (450)
.....-|.+|++|.++.+...++...|+||-|||+.|+.. |.+.|.+.+..+...+|...- + .+|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445679999999999998877889999999999999976 778899998888777764321 0 0111
Q ss_pred ----------------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 234 ----------------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 234 ----------------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.++..-++|++++|.-+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 13456789999999999999999999999999975
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.55 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=212.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
-.++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999997653 3558999988654322 2234567899999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEe
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~ 151 (450)
+..|++|||+++|+|.+++.+ ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999999864 124567889999999999999999999999999999999999999999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-C
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-Y 229 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~ 229 (450)
|||++................++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..+....+.... .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998864322111111122345678999999887665 489999999999999998 799999887777666665443 3
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc------Cccccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIME------NPWFRK 268 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~------hp~f~~ 268 (450)
..+...++++.+++.+||+.||++|||+.++++ ||||+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 456667899999999999999999999999986 888853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.83 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=212.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE----eCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA----SKT 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 83 (450)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 457899999999999999999999999999999998764322 234567788999999999999999998875 345
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 588888865 57999999999999999999999999999999999999999999999999998654322
Q ss_pred cC--CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------
Q 045214 163 HQ--DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------- 227 (450)
Q Consensus 163 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 227 (450)
.. ........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 112234578999999999876444568999999999999999999999876544332221110
Q ss_pred -----------C--CCC-----CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 -----------D--YKF-----PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 -----------~--~~~-----p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
. ... .+..+.++.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0 001 12368899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=328.32 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=211.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
++|++.+.||+|+||.||+|.+..+ ...||+|.+..... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5799999999999999999998654 45799999875432 233466788999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999865 4789999999999999999999999999999999999999999999999999876542111
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ..+.+...+..+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999999876654 89999999999999998 99999887776666666544 334556689999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 045214 243 LSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~h 263 (450)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=387.07 Aligned_cols=259 Identities=32% Similarity=0.586 Sum_probs=224.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.-||.-+..||.|.||.||.|.+..+|+..|+|-+...... ......+.+|..++..++|||+|++|++-...+..||.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34788999999999999999999999999999998755443 45567889999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc--CC
Q 045214 89 MEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH--QD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~--~~ 165 (450)
||||+||+|.+.++.++ .+|...+.|..|++.|+.|||++||+||||||+||+|+.+|.+|++|||.|....... -.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999999999864 6777888899999999999999999999999999999999999999999886443221 12
Q ss_pred CCcccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCCCcH--HHHHHHHhhcCCCCCCCCcHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSNL--MAMYRKIAKADYKFPTWFSADVRK 241 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~p~~~s~~~~~ 241 (450)
+.+....|||.|||||++.+.. -.+.++|||||||+..||.||+.||...+. .-||.--.....++|..+|++.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 3455778999999999997643 235789999999999999999999986443 345555455567789999999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
||.+||+.||++|+++.||++|.|-+.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=323.89 Aligned_cols=254 Identities=31% Similarity=0.561 Sum_probs=218.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKIYFV 88 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 88 (450)
+|.+.+.||+|++|.||.|.+..+++.+++|++...... ....+.+.+|+.++++++||||+++++.+... ..+|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999999766532 23457889999999999999999999999988 899999
Q ss_pred EeecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999999764 899999999999999999999999999999999999999999999999998876543332112
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHh--hcCCCCCCCCcHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIA--KADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~ll~ 244 (450)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||...+ .......+. ......|..++.++.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345578999999999877664 589999999999999999999998765 333333333 2334566678999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 045214 245 RILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f 266 (450)
+||+.||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.46 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=210.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
..|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999853 345679999886542 2335678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 85 IYFVMEYAKGGELFKKVSKG--------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~--------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
+|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 99999999999999998632 3899999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY 229 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 229 (450)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999864322111111223446788999999987665 489999999999999998 9999998877777777766553
Q ss_pred -CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 -KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 -~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+..++.++.+|+.+||++||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 445568899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.24 Aligned_cols=251 Identities=32% Similarity=0.515 Sum_probs=208.8
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|++.+.||.|++|.||+|.+..+|+.||+|++..+... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 78899999999999999999999999999999765432 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 92 AKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 92 ~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
++ ++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 5899888653 5899999999999999999999999999999999999999999999999998643221 1122
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--------------------
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------- 228 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (450)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 234568899999998765544588999999999999999999998776544333322110
Q ss_pred ---C------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 ---Y------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ---~------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. ...+.++.++.++|.+||++||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=330.81 Aligned_cols=245 Identities=27% Similarity=0.467 Sum_probs=203.5
Q ss_pred cccCeeeeceE--eecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 8 LMQKYELGRLL--GQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 8 l~~~y~~~~~L--G~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
+.+.|++.+.+ |+|+||.||++.+..+++.+|+|.+....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34678887777 99999999999999999999999987653221 122222222 79999999999999999
Q ss_pred EEEEEeecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~ 162 (450)
.|+||||++|++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 99999999999999999774 899999999999999999999999999999999999999998 999999998764321
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH----HHHHhhcCCCCCCCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM----YRKIAKADYKFPTWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~ 238 (450)
.....+++.|+|||++.+..+. .++|+||||+++|+|++|..||........ ...........++.+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 1234689999999999887764 789999999999999999999986433221 111123334555678999
Q ss_pred HHHHHHHccCCCCCCCCC-HHHHhcCcccc
Q 045214 239 VRKLLSRILDPNPSTRIS-IAKIMENPWFR 267 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s-~~eil~hp~f~ 267 (450)
+.+||.+||++||.+|++ ++++++||||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999996
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.89 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=210.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK----- 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (450)
+.++|.+.+.||+|+||.||+|++..+++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 5678999999999999999999999999999999987643222 2345677899999999999999999987544
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..+|+++||+. ++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 588888865 6799999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------------- 227 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------- 227 (450)
.. .......++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 22334568899999999876444568999999999999999999999876543322222110
Q ss_pred --------------CC---CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 --------------DY---KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 --------------~~---~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.. ...+.+++++.++|.+||++||++|||++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 012347889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=335.39 Aligned_cols=259 Identities=28% Similarity=0.532 Sum_probs=213.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT- 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (450)
|.+..++|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 567889999999999999999999999999999999999765322 223456778999999999999999999886654
Q ss_pred ---------EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 84 ---------KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 84 ---------~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
.+|+++||+++ ++.+.+.. ..+++..++.++.|++.||+|||++||+|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999987 67676654 4689999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-C-
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-K- 230 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~- 230 (450)
||++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+....+..+..... +
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999865432221 1122234678899999887654446899999999999999999999988766555444433100 0
Q ss_pred ----------------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 231 ----------------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 231 ----------------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
....++..+.+++.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=326.33 Aligned_cols=254 Identities=32% Similarity=0.556 Sum_probs=218.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+..+..++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 34577899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++++|.+++.. +.+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999999999976 689999999999999999999999 999999999999999999999999999886543221 11
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHHhhc-CCCCCCC-CcHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKIAKA-DYKFPTW-FSADVRKL 242 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~l 242 (450)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 224568899999999877654 58999999999999999999999876 344445444433 2334555 78999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|.+||.++|+.|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=326.29 Aligned_cols=244 Identities=24% Similarity=0.440 Sum_probs=202.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2234567889999999999999999999999999999999999999
Q ss_pred ChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 96 ELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3589999999999999999999999999999999999999999999999999764321110000011123
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDPNP 251 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP 251 (450)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||++||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999877665 478999999999999997 99999876665555544332 345666788999999999999999
Q ss_pred CCCCCHHHHhc
Q 045214 252 STRISIAKIME 262 (450)
Q Consensus 252 ~~R~s~~eil~ 262 (450)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=329.70 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=213.0
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
+..++|++.+.||+|+||.||+|.+... +..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3467899999999999999999998654 478999998654321 234567889999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
....|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999853 13678899999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-C
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-D 228 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~ 228 (450)
+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999865432222122234456789999999877665 489999999999999998 99999988777766666543 3
Q ss_pred CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 229 YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 229 ~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...|..++.++.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=325.25 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=213.0
Q ss_pred ceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeec
Q 045214 16 RLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.+...+|++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654332 4578899999999999999999999999999999999999
Q ss_pred CCCChhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 93 KGGELFKKVSK----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 93 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999865 56899999999999999999999999999999999999999999999999998755432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ....|..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334567889999999887655 489999999999999999 69999998887777777643 3456777899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcC
Q 045214 241 KLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+++.+||..||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=332.66 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=209.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998665322 23346678899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhcccC
Q 045214 89 MEYAKGGELFKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~~~~ 164 (450)
|||+++ +|.+.+.. . .+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999965 78777754 2 3688899999999999999999999999999999999985 557999999998643221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC----------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---------------- 228 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------------- 228 (450)
........+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+...++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1112334678999999998765544589999999999999999999998766554444332110
Q ss_pred -------CC------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -------YK------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -------~~------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.. ..+.+++++.+++.+||+.+|++||++.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 11346788999999999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=353.21 Aligned_cols=245 Identities=33% Similarity=0.588 Sum_probs=215.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.+.+.|++...+|.|+|+.|..+.+..+++.+++|++.+... +..+|+.++... +||||+++++++.++...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356789999999999999999999999999999999987632 234677666555 799999999999999999
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe-cCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL-DENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl-~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+|||.+.|+.|.+.+...+.....+..|+.||+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999999999999999987655558888999999999999999999999999999999 68999999999987654322
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
..+.|-|..|.|||++...+|+ .++|+||||++||+||+|..||...... +++.++..+.+. .++|.++++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 5567889999999999988886 9999999999999999999999875554 666666555444 88999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f 266 (450)
++||++||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.60 Aligned_cols=252 Identities=31% Similarity=0.600 Sum_probs=219.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+++++.++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 91 YAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
|+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 6899999999999999999999999999999999999999999999999999865433221 123
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHccC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA-KADYKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~ll~~~L~ 248 (450)
...+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+......+.. .....+|..++..+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999877664 589999999999999999999998766544443333 34445667789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 045214 249 PNPSTRISIAKIMENPWF 266 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f 266 (450)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=331.69 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=210.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
...|++.+.||+|+||.||+|.+. .+++.+|+|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 357999999999999999999863 3567899999875332 2234678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 85 IYFVMEYAKGGELFKKVSK------------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
.|++|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999998842 2377888999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHh
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 225 (450)
.+||+|||++................++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999865432222222234456778999999977665 489999999999999998 999998877665555554
Q ss_pred hcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 226 KAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 226 ~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
... .+.|..+++++.+++.+||++||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 433 44567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=325.54 Aligned_cols=246 Identities=40% Similarity=0.749 Sum_probs=220.4
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||.|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+..+|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999877655444567889999999999999999999999999999999999999999
Q ss_pred hhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCc
Q 045214 98 FKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176 (450)
Q Consensus 98 ~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~ 176 (450)
.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999764 78999999999999999999999999999999999999999999999999886543221 22344568899
Q ss_pred ccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCC
Q 045214 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRIS 256 (450)
Q Consensus 177 y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s 256 (450)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+......+|..++.++.+++.+||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877654 4789999999999999999999988887777778777778888889999999999999999999999
Q ss_pred H---HHHhcCccc
Q 045214 257 I---AKIMENPWF 266 (450)
Q Consensus 257 ~---~eil~hp~f 266 (450)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=334.52 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=215.5
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.....+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34556799999999999999999999999999999998755433334456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+|+||+.| +|.+.+. .+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 6666664 35799999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCC-CCCCcHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKF-PTWFSADV 239 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~ 239 (450)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.... ... +..++.++
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 123468889999998742 2233579999999999999999999998877655544444332 222 23467899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.++|.+||..||++||++.+++.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=340.90 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=210.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3568999999999999999999999999999999998764321 12345678899999999999999999987543
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|++++++ |++|.+.+....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3578888887 7799988887789999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
.......+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 1223456889999999987644445899999999999999999999987655443333221100
Q ss_pred ------------CCC--------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 ------------KFP--------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ------------~~p--------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..| ...++++.++|.+||++||.+|||+.+++.||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 001 1247889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.70 Aligned_cols=256 Identities=26% Similarity=0.456 Sum_probs=206.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (450)
...|++++.||+||.++||++...+.+- +|+|.+.... .+.....-+.+|+..|.+| .|.+||++|++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3469999999999999999999855444 5555443322 2335577889999999999 59999999999999999999
Q ss_pred EEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||-+ .+|...+.++ .++...++.|.+|++.|+.++|++||+|.||||.|+|+ -.|.+||+|||+|.........
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 999853 4899999874 34446899999999999999999999999999999998 6789999999999765544434
Q ss_pred CCcccccCCCcccCchhcccCCCC----------CCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhcC--CCCC
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYD----------GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKAD--YKFP 232 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~----------~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~--~~~p 232 (450)
-...+.+||+.||+||.+....+. +.++||||||||||+|+.|+.||.... ...-+..|...+ .++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 445677999999999998654432 578999999999999999999998643 333344444432 3555
Q ss_pred CCCcH-HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 TWFSA-DVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ~~~s~-~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..-+. ++.+++..||..||.+|||+.++|+|||.+-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 54333 3999999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=330.05 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=204.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV-MRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ...++..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46999999999999999999999999999999997653321 12345556654 6677999999999999999999999
Q ss_pred EeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 89 MEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
|||++| +|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999974 67666542 3689999999999999999999998 9999999999999999999999999998654211
Q ss_pred cCCCCcccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHHHHHh-hcCCCCC-CCCc
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIA-KADYKFP-TWFS 236 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~-~~~~~~p-~~~s 236 (450)
.......|+..|+|||++.+.. ..+.++|+||+||++|+|++|..||... ...+.+..+. ......| ..+|
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1122346889999999986421 1247899999999999999999999753 2222222322 2233333 3478
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.++.++|.+||..+|.+|||++++++||||++..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=326.30 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=212.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
...|.+.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++...+.++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 456999999999999999999999999999999987543 2245678899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999999864 35899999999999999999999999999999999999999999999999998654322111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+....+..+... ....|..++.++.+++
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 11122345679999998776664 78999999999999998 99999988877777766543 4456677899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=324.47 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=214.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI--LKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (450)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1223456788999999999999999999998664 568
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
++++||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999876 5789999999999999999999999999999999999999999999999999865432111
Q ss_pred C-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHH
Q 045214 165 D-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRK 241 (450)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (450)
. .......|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||..........++... ...+|..++.++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1 11223568999999999987665 48999999999999999999999887655544444332 23467778999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+|.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.04 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=210.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKIYF 87 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (450)
++|+..+.||.|++|.||+|.+..+++.+|+|.+...... ....++.+|+++++.++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5799999999999999999999999999999999765322 345678899999999999999999998854 447999
Q ss_pred EEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 88 VMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 46899999999999999999999999999999999999999999999999987543221
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-----cHHHHHHHHhhcCC-CCC----
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-----NLMAMYRKIAKADY-KFP---- 232 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~~-~~p---- 232 (450)
......++..|+|||.+.+..++ .++|+|||||++|+|++|..||... ...+....+..... .++
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 11234678899999999877664 7999999999999999999999865 22333333332111 111
Q ss_pred --CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 233 --TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 233 --~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
..+++++.++|.+||.+||.+|||+.|++.||||++...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 124678999999999999999999999999999976443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=334.87 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=206.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcE--EEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.+.|++.+.||+|+||.||+|.+..++.. +|+|.+.... .......+.+|+.++.++ +||||+++++++...+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 46799999999999999999999877765 5666654321 223456788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCe
Q 045214 86 YFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~v 148 (450)
|++|||+++++|.+++.+. .+++..++.++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999998632 47899999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 227 (450)
||+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+.+..+...
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999998753211111 111234567999999877655 489999999999999998 99999887777766666443
Q ss_pred -CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 228 -DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 228 -~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
....|..+++++.+|+.+||+.+|++||++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233455578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=338.71 Aligned_cols=261 Identities=28% Similarity=0.387 Sum_probs=213.5
Q ss_pred cccCeee-eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc-----------hHHHHHHHHHHHHhCCCCCccEE
Q 045214 8 LMQKYEL-GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG-----------LVDQTKREISVMRLIQHPNVMQI 75 (450)
Q Consensus 8 l~~~y~~-~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 75 (450)
+.++|.. .+.||+|+||.||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 6678875 57799999999999999999999999998754332110 11246789999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecC
Q 045214 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFG 154 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFG 154 (450)
++++...+..|++|||+.| +|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999999974 88888865 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccc------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH
Q 045214 155 LSALAKCKH------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222 (450)
Q Consensus 155 ls~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 222 (450)
++....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 986543111 01112234578899999998765555689999999999999999999999877665554
Q ss_pred HHhhcCC----------------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 223 KIAKADY----------------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 223 ~i~~~~~----------------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+..... ......+.++.++|.+||+++|++|||+++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 4432100 0012347889999999999999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.31 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=212.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45789999999999999999997543 57899999975432 234567889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999998742 2478888999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHh
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 225 (450)
.+||+|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998765432222222233456789999999877665 489999999999999998 889999888777777776
Q ss_pred hcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 226 KADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 226 ~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.... ..|..++..+.+|+.+||+.+|.+||++++|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6543 456778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=327.40 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=206.7
Q ss_pred eeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE----
Q 045214 12 YELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK---- 84 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 84 (450)
|.+++.||+|+||.||.|.... ++..||+|.+..+... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999999765 3478999998764332 2335678899999999999999999998765543
Q ss_pred --EEEEEeecCCCChhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 85 --IYFVMEYAKGGELFKKVSK-------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 85 --~~lv~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
.++++||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988732 2589999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPT 233 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (450)
+................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+.+..+... ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 865432221111222345678999999876665 489999999999999999 99999887777766666543 345677
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++.++.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.93 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=205.0
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------CC
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQ--SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------KT 83 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 83 (450)
|.+++.||+|+||.||+|.+..++. .+|+|.+...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 6999988764322 2335678899999999999999999997632 23
Q ss_pred EEEEEEeecCCCChhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 84 KIYFVMEYAKGGELFKKVSK-------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
..+++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999888732 24789999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTW 234 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 234 (450)
................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||........+..+..+. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 75432211111123346778999999987766 489999999999999999 899998877777777766544 345667
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++..+.++|.+||++||++|||+.++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=340.71 Aligned_cols=261 Identities=30% Similarity=0.458 Sum_probs=214.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK-- 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 82 (450)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 45788999999999999999999999989999999998653221 12235567899999999 999999999988643
Q ss_pred CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 83 TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
...|+||||+.+ +|.+++..+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999975 8999998778899999999999999999999999999999999999999999999999998755332
Q ss_pred cCC---CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-----------
Q 045214 163 HQD---GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD----------- 228 (450)
Q Consensus 163 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 228 (450)
... .......||+.|+|||++.+....+.++|+||||+++|+|++|..||..........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 223345689999999998765555689999999999999999999998765444333321110
Q ss_pred ----------------C----CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 ----------------Y----KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 ----------------~----~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
. ...+.++.++.++|.+||+.||++|||+.++++|||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 011226889999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=366.43 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=206.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++.+.||+|+||.||+|.+..+++.||+|++..+........+++.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765443334456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 89 MEYAKGGELFKKVSK------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
|||++|++|.+++.. ..++...+..++.|++.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998753 12455678899999999999999999999999999999999999999999998
Q ss_pred hhhhcccCC----------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH
Q 045214 157 ALAKCKHQD----------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM 220 (450)
Q Consensus 157 ~~~~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~ 220 (450)
......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 754211100 01123469999999999987766 4899999999999999999999987554332
Q ss_pred HHHH-hhcCCCC--CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKI-AKADYKF--PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i-~~~~~~~--p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.... ....... ...+++.+.+++.+||++||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2221 1111111 1347889999999999999999988666553
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=329.56 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=209.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999987 7788999988654321 22356788999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEee
Q 045214 84 KIYFVMEYAKGGELFKKVSKG--------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTD 152 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~D 152 (450)
..|++|||++|++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999998642 488899999999999999999999999999999999998765 599999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCC
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYK 230 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~ 230 (450)
||++.................++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999865421111111112234567999999977666 489999999999999997 99999987776666555433 345
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.|..++.++.+++.+||+.+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 667789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=336.09 Aligned_cols=251 Identities=21% Similarity=0.354 Sum_probs=208.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
..+|++.+.||+|+||.||+|.+..+++. ||+|++..... .....++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999998666554 89999864321 23356788999999999999999999998765 5
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.++++||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 36889999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
..........++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+....+....+... ..+.|..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221112223456789999999877664 89999999999999997 99999887766655444332 2345667889999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcC
Q 045214 241 KLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.85 Aligned_cols=248 Identities=30% Similarity=0.503 Sum_probs=206.5
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++.+|+++||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 44689999999999999999999999998875432 234678899999999999999999999999999999999999
Q ss_pred CCChhhHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhcccCCCCc
Q 045214 94 GGELFKKVSK--GKL--KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 94 gg~L~~~i~~--~~l--~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|++|.+.+.. ..+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++....... ...
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Ccc
Confidence 9999999875 345 88899999999999999999999999999999999986 6799999999886443211 222
Q ss_pred ccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHH--HHHHH-HhhcCCCCCCCCcHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLM--AMYRK-IAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~ll~ 244 (450)
....|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||...... ..+.. .......+|..+++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3346889999999986543 2357999999999999999999999764322 22211 123334567778999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 045214 245 RILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f 266 (450)
+||+++|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=360.46 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=197.9
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCC-CcEEEEEEee--------------cccccccchHHHHHHHHHHHHhCCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGT-GQSVAIKAID--------------KDKILKVGLVDQTKREISVMRLIQH 69 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i~--------------~~~~~~~~~~~~~~~Ei~il~~l~h 69 (450)
++.+.++|++++.||+|+||+||+|..+.. +...+.|.+. +..........++.+|+.+++.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 456778999999999999999999986543 3333333211 1111111234567899999999999
Q ss_pred CCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec
Q 045214 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKG------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD 143 (450)
Q Consensus 70 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~ 143 (450)
|||+++++++.+.+..|+++|++.+ +|.+++..+ ......++.++.||+.||+|||++||+||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 9999999999999999999999854 677766432 234677889999999999999999999999999999999
Q ss_pred CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCC-CCCCCc--H-HH
Q 045214 144 ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL-PFHDSN--L-MA 219 (450)
Q Consensus 144 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~--~-~~ 219 (450)
.++.+||+|||++....... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.. ||.... . ..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999987543221 1222346799999999999887765 89999999999999999875 454321 1 12
Q ss_pred HHHHHhhc---CCCCC----------------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 220 MYRKIAKA---DYKFP----------------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 220 ~~~~i~~~---~~~~p----------------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.+.+... ...+| ..++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 21111100 00011 124567888999999999999999999999999976
Q ss_pred c
Q 045214 269 G 269 (450)
Q Consensus 269 ~ 269 (450)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 4
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=334.11 Aligned_cols=253 Identities=23% Similarity=0.420 Sum_probs=210.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGT-------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
+..++|.+++.||+|+||.||+|++... ...+|+|.+..+.. ......+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4457899999999999999999987542 34699999976532 22346688899999999 79999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+...+..|+||||+++|+|.+++... .++...+..++.|++.||+|||++|++||||||+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 99999999999999999999998642 3788899999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999864432111111122234578999999977665 489999999999999998 8999988877777
Q ss_pred HHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.... ...|..++.++.+|+.+||..+|.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66665443 3556678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=361.53 Aligned_cols=245 Identities=32% Similarity=0.576 Sum_probs=204.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEE-E---eC---
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVM-A---SK--- 82 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~-~---~~--- 82 (450)
++++.+.|.+|||+.||+|++...|..||+|.+-.. +....+.+++||++|+.|+ |+|||.+++.. . ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 688999999999999999999888899999988655 3355788999999999996 99999999932 1 11
Q ss_pred CEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
-.++|.||||.||.|-|++.. .+|+|.++++||.|+++||++||... |||||||-|||||+.+|+.||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 247899999999999999974 46999999999999999999999998 9999999999999999999999999875
Q ss_pred hhhcccCCC--C--c---ccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc
Q 045214 158 LAKCKHQDG--L--L---HTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 158 ~~~~~~~~~--~--~---~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 227 (450)
-.-...... . . -...-|+.|+|||++. +.+. +.|+|||+|||+||-|+....||++.... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 322111000 0 0 0224699999999974 3443 58999999999999999999999987443 35677
Q ss_pred CCCCCC--CCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 228 DYKFPT--WFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 228 ~~~~p~--~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+.+|+ .++..+++||+.||++||.+||++-|++.+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 888776 589999999999999999999999998863
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.24 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=215.4
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|+....||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444578999999999999999999999999885432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccc
Q 045214 92 AKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT 171 (450)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 171 (450)
+++++|.+++..+.+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999998888889999999999999999999999999999999999999999999999999875432211 112335
Q ss_pred cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---CCCCCCCcHHHHHHHHHccC
Q 045214 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ll~~~L~ 248 (450)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ......+++++.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68899999999876655 489999999999999999999998876665554443322 22233478999999999999
Q ss_pred CCCCCCCCHHHHhcCccccccCC
Q 045214 249 PNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.||.+||++.+++.||||.+...
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=331.39 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=209.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCC----------------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTG----------------QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 72 (450)
.++|++++.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 56899998765422 345678899999999999999
Q ss_pred cEEEEEEEeCCEEEEEEeecCCCChhhHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 045214 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKG------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140 (450)
Q Consensus 73 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NI 140 (450)
+++++++..++..+++|||+++++|.+++... .+++..++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999999999999999999999999998652 489999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--CCCCCCCCcHH
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA--GYLPFHDSNLM 218 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~ 218 (450)
+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999865432222222234456788999999877655 489999999999999998 78899877666
Q ss_pred HHHHHHhhc--------CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 219 AMYRKIAKA--------DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 219 ~~~~~i~~~--------~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+...... ....|..++.++.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 655554322 12345567899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=328.84 Aligned_cols=252 Identities=31% Similarity=0.529 Sum_probs=210.7
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TKIYFVM 89 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 89 (450)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++.+. +..|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2234456778999999999999999999999888 8999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++ +|.+.+.+ ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 3799999999999999999999999999999999999999999999999999865433221 12
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------------ 229 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (450)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23346788999999877654446899999999999999999999988776555444432100
Q ss_pred -----C--------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 230 -----K--------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 230 -----~--------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
. +...++.++.+++.+||..+|.+||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 001137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.54 Aligned_cols=258 Identities=32% Similarity=0.584 Sum_probs=216.5
Q ss_pred CeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999999764432 223346778999999999 699999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999865 578999999999999999999999999999999999999999999999999886543221
Q ss_pred CCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCc----HHHHHHHHhhcCCCCCCCCcHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
........|+..|+|||.+.... ..+.++||||||+++|+|++|..||...+ .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 12223457899999999986532 33578999999999999999999997432 23444444455566777789999
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPSTRI-----SIAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~-----s~~eil~hp~f~~~ 269 (450)
.+++.+||+.||++|| ++++++.||||++.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=326.90 Aligned_cols=250 Identities=32% Similarity=0.623 Sum_probs=211.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..|++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654444344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 90 EYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998752 458999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH--HHHHHHHhhcCCC-C-CCCCcHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL--MAMYRKIAKADYK-F-PTWFSADVR 240 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~~ 240 (450)
......+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||..... ......+.....+ . +..++.++.
T Consensus 161 -~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred -cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 223345789999999999877664 789999999999999999999976433 3344444333322 2 235788999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+.||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.76 Aligned_cols=250 Identities=33% Similarity=0.632 Sum_probs=212.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999997654444444678899999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 90 EYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 35899999999999999999999999999999999999999999999999987644322
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc--HHHHHHHHhhcCC-CCCC-CCcHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--LMAMYRKIAKADY-KFPT-WFSADVR 240 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~ 240 (450)
........+++.|+|||.+.+..+. .++|+|||||++|+|++|..||.... .......+..+.. +.|. .++.++.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 1222345689999999999877664 79999999999999999999996543 3344444443332 2343 5788999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=345.57 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=204.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (450)
.++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45788999999999999999987543 34699999965432 233467889999999996 99999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-----------------------------------------------------------
Q 045214 83 TKIYFVMEYAKGGELFKKVSK----------------------------------------------------------- 103 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~----------------------------------------------------------- 103 (450)
+.+|+||||+++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988743
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC
Q 045214 104 --------------------------------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN 145 (450)
Q Consensus 104 --------------------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~ 145 (450)
..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136777888999999999999999999999999999999999
Q ss_pred CCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHH-HHHHH
Q 045214 146 GMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLM-AMYRK 223 (450)
Q Consensus 146 ~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~ 223 (450)
+.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999865432222112233457788999999987666 489999999999999997 99999875443 33333
Q ss_pred Hhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 224 IAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 224 i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+... ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3332 23455668899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.93 Aligned_cols=260 Identities=27% Similarity=0.479 Sum_probs=208.4
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe---
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--- 81 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 81 (450)
|-...++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .......+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 3344789999999999999999999999999999999987644322 223456789999999999999999988743
Q ss_pred -----CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecC
Q 045214 82 -----KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFG 154 (450)
Q Consensus 82 -----~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFG 154 (450)
...+|++|||+.+ +|...+.. ..+++..+..++.|+++||+|||++|++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 3357999999976 56666653 479999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCCC---------CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Q 045214 155 LSALAKCKHQDG---------LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 155 ls~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~ 225 (450)
++.......... ......+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 986543222111 11223568889999998765444689999999999999999999999877665554443
Q ss_pred hcCC-----------------------CCC-------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 226 KADY-----------------------KFP-------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 226 ~~~~-----------------------~~p-------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.... ..+ ..+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2100 000 1244678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.69 Aligned_cols=246 Identities=25% Similarity=0.437 Sum_probs=208.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++.+.||+|+||.||+|... ++..+|+|.+...... ..++.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999875 4567999988654322 356788999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 4689999999999999999999999999999999999999999999999998864321111 11
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~ 245 (450)
.....++..|+|||++....+. .++|+||||+++|+|++ |..||...+.......+..... ..|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345689999999876664 89999999999999999 9999998887777777765433 3456678899999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||+.||.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.15 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=211.6
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (450)
-.++|++.+.||+|+||.||+|.+... ...+|+|.+...... .....+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 346899999999999999999998644 378999998764321 2345688999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE 144 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~ 144 (450)
++.+|++|||+++|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999853 35889999999999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHH
Q 045214 145 NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRK 223 (450)
Q Consensus 145 ~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 223 (450)
++.+||+|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||...+..+.+..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999998754322211111222346679999998776654 89999999999999997 9999998887777766
Q ss_pred HhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 224 IAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 224 i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+.... ...|...+.++.+|+.+||.+||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 65443 34566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=340.07 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=203.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe-
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS- 81 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 81 (450)
.++|++.+.||+|+||.||+|.... +++.||+|++...... .....+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997543 4578999998754321 2345678899999999 89999999998754
Q ss_pred CCEEEEEEeecCCCChhhHHhc----------------------------------------------------------
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK---------------------------------------------------------- 103 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~---------------------------------------------------------- 103 (450)
+..+|++|||+++++|.+++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4678999999999999988743
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccC
Q 045214 104 ----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179 (450)
Q Consensus 104 ----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~a 179 (450)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1578889999999999999999999999999999999999999999999999875432211111223345678999
Q ss_pred chhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHH-HHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCC
Q 045214 180 PEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMY-RKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRIS 256 (450)
Q Consensus 180 PE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s 256 (450)
||++.+..+. .++|||||||++|+|++ |..||.+....+.. ..+... ....|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999887765 89999999999999998 99999875443332 333222 23345667899999999999999999999
Q ss_pred HHHHhcC
Q 045214 257 IAKIMEN 263 (450)
Q Consensus 257 ~~eil~h 263 (450)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.85 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=207.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 35899999999999999999885 5678999998654322 346778999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++|++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999998764321111 01
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~ 245 (450)
.....++..|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..+....+... ....|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112234579999999876664 79999999999999999 89999887777666666544 345566689999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||..+|++|||+.++++
T Consensus 237 cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 237 CWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=333.61 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=211.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-KTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 85 (450)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3578999999999999999999999999999999998754322 2345677899999999999999999999865 5679
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|+++||+ +++|.+.+..+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 9999998 5689888888889999999999999999999999999999999999999999999999999886422
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------ 227 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------ 227 (450)
.......+++.|+|||++.+....+.++|+|||||++|+|++|..||...+.......+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 11234467889999999866444468999999999999999999999876543222211110
Q ss_pred --------CCCCC-----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 --------DYKFP-----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 --------~~~~p-----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....| +.++.++.++|.+||+.+|++|||+++++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00111 2367899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=325.60 Aligned_cols=247 Identities=24% Similarity=0.423 Sum_probs=212.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
...|++++.||.|+||.||+|.+.. ++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4569999999999999999999987 88999999876542 2246788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 999999999999975 358999999999999999999999999999999999999999999999999986542211
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
.......++..|+|||++....+. .++||||||+++|+|++ |..||...+..+.+..+... ..+.|..+++++.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 112233456789999998876654 78999999999999998 89999888777777666543 3445667899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.15 Aligned_cols=250 Identities=31% Similarity=0.559 Sum_probs=219.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 334567789999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 91 YAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998665432
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLS 244 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~ 244 (450)
......+++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 23345689999999999876654 789999999999999999999998887776666655543 345568899999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 045214 245 RILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f 266 (450)
+||..+|++|||+.++++||+.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=321.94 Aligned_cols=262 Identities=28% Similarity=0.462 Sum_probs=211.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-CC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTG----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-KT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (450)
...|++...||+|+||.||+|..+.++ +.+|||.++.++.. .+......||+.+++.++|||++.+..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 457999999999999999999765543 37999999876543 2555778899999999999999999999876 88
Q ss_pred EEEEEEeecCCCChhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC----CCeEEeec
Q 045214 84 KIYFVMEYAKGGELFKKVSK------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN----GMLKVTDF 153 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~----~~vkl~DF 153 (450)
.+++++||++. +|...|.- ..++...++.++.||++|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 78888742 358999999999999999999999999999999999999877 89999999
Q ss_pred CchhhhhcccCCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---------HHHHHH
Q 045214 154 GLSALAKCKHQDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---------MAMYRK 223 (450)
Q Consensus 154 Gls~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~ 223 (450)
|+++.+...-..- .....+-|.+|+|||.+.+...++.+.||||.|||+.||||-++.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999886543321 234456799999999999988888999999999999999998888765321 122222
Q ss_pred Hhhc-------CC----CCCCC--------------------------CcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 224 IAKA-------DY----KFPTW--------------------------FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 224 i~~~-------~~----~~p~~--------------------------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
|.+. .+ ..|.+ -++...+|+.+||+.||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2211 00 11111 14558899999999999999999999999999
Q ss_pred cccCCC
Q 045214 267 RKGLNS 272 (450)
Q Consensus 267 ~~~~~~ 272 (450)
.+...+
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 875433
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.58 Aligned_cols=254 Identities=28% Similarity=0.528 Sum_probs=218.6
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..+.|++.+.||+|++|.||+|.+..+++.+++|++..... ....+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988899999999976542 34677899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999999874 79999999999999999999999999999999999999999999999999875443221
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-C--CCCCCcHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-K--FPTWFSADVRKL 242 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~~l 242 (450)
.......+++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.......+..... . .+..++.++.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 112334578899999998876664 899999999999999999999998776555444433322 2 223378899999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|.+||+.+|.+|||+.+++.||||++
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.17 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=210.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3579999999999999999998643 456799998865432 22356889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
..++||||+++++|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378899999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHh
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 225 (450)
.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998643322211122334568899999998876654 78999999999999998 999998887777776665
Q ss_pred hcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 226 KADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 226 ~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.... ..+..++.++.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5544 345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.33 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=209.9
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
.....++|++.+.||+|+||.||+|.+. .++..+|+|.+..... ....+.+.+|+.+++++ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3455678999999999999999999853 3456899999875432 23346788999999999 79999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
+...+..|++|||+.+|+|.+++... .+++..+..++.|++.||+|||++|++|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999998652 389999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC--CCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD--YKFP 232 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~p 232 (450)
+................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+......+..... ...|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 865432211111122346778999999877765 489999999999999998 999998766554444433332 2345
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...++++.+++.+||+++|++|||+.++++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.71 Aligned_cols=253 Identities=20% Similarity=0.363 Sum_probs=202.8
Q ss_pred ceEeec--CCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQG--NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
..||.| +||+||+|++..+|+.||+|++....... ...+.+++|+.+++.++||||+++++++..++..|+++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999997654332 345788999999999999999999999999999999999999
Q ss_pred CCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-CC--
Q 045214 94 GGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-GL-- 167 (450)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~-- 167 (450)
+++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++|||.+......... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 35899999999999999999999999999999999999999999999999865332211110 00
Q ss_pred --cccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---------------
Q 045214 168 --LHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--------------- 229 (450)
Q Consensus 168 --~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------------- 229 (450)
.....++..|+|||++.+.. ..+.++||||+||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 11123567799999987642 235899999999999999999999987654433322211110
Q ss_pred --------------------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 --------------------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 --------------------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.+..+++++.+||++||+.||++|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0112256789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=331.17 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=209.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVM 79 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (450)
-.++|.+++.||+|+||.||+|++.. ....+|+|.+..... ......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 45689999999999999999998642 345799999875432 23356788999999999 699999999999
Q ss_pred EeCCEEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe
Q 045214 80 ASKTKIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL 142 (450)
Q Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl 142 (450)
...+.+|++|||+++|+|.+++.. ..++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 999999999999999999999854 247888999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHH
Q 045214 143 DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMY 221 (450)
Q Consensus 143 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 221 (450)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+....+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999865432221111222334568999999987665 489999999999999999 89999988877777
Q ss_pred HHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 222 RKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 222 ~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+.... ...|..++.++.+++.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7665543 3456668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=316.34 Aligned_cols=248 Identities=33% Similarity=0.576 Sum_probs=213.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 245778899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 91 YAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 91 ~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|++|++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999998865433221 3
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCC--CCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFP--TWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p--~~~s~~~~~ll~~ 245 (450)
....++..|+|||.+....+ +.++|+||||+++|+|++|..||...+............ ...+ ..++.++.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578899999999877654 589999999999999999999998875444333333222 1222 2248899999999
Q ss_pred ccCCCCCCCCCHHHHhcCcc
Q 045214 246 ILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~ 265 (450)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=337.04 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=215.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-----KI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (450)
+|++.+.||.|++|.||+|++..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999998999999999876432 1234567889999999999999999999987765 89
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|++|||+.+ +|.+.+.+ +.+++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 78888876 4799999999999999999999999999999999999999999999999999875433221
Q ss_pred -CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-------------
Q 045214 165 -DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK------------- 230 (450)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------------- 230 (450)
........+++.|+|||++.+....+.++|+||||+++|+|++|..||...+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012334568999999999987744468999999999999999999999988776655554332110
Q ss_pred ------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 ------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+.+++++.++|.+||+++|.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 112367889999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=320.72 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=208.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+++.+|+.++++++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 457899999876432 235678999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||++|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999999652 5899999999999999999999999999999999999999999999999998755321111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
.......+..|+|||++.+..+ +.++|+||||+++|+|++ |..||.+.+.......+... ..+.+...+.++.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1111223457999999877665 489999999999999999 99999988777777666543 2345566789999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||+.+|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.43 Aligned_cols=248 Identities=23% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQ--SVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (450)
++|++.+.||+|+||.||+|....++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877764 46888776322 122346788999999999 7999999999999999999
Q ss_pred EEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeE
Q 045214 87 FVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLK 149 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vk 149 (450)
+++||+++++|.+++.+. .+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 378899999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA- 227 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 227 (450)
|+|||++........ ......+..|+|||++....+. .++|||||||++|+|++ |..||...+......++...
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999998753211100 1112234579999998776654 89999999999999997 99999988887777766544
Q ss_pred CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 228 DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 228 ~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
....|..++.++.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234566689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.26 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=202.2
Q ss_pred cccCe-eeeceEeecCCeEEEEEE----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-
Q 045214 8 LMQKY-ELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS- 81 (450)
Q Consensus 8 l~~~y-~~~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (450)
+.+|| ++.+.||+|+||+||++. ...+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred CChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35677 999999999999998865 335788999999876432 1234567889999999999999999998765
Q ss_pred -CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...+|++|||+++++|.+++....+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999988889999999999999999999999999999999999999999999999999986543
Q ss_pred cccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH--HHH-------------HHH
Q 045214 161 CKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM--AMY-------------RKI 224 (450)
Q Consensus 161 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~-------------~~i 224 (450)
..... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... ... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 22111 11122345677999999877665 48999999999999999999998653211 100 001
Q ss_pred h-hcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 225 A-KADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 225 ~-~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
. ....+.|..++.++.+++.+||++||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1122345667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=321.34 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=207.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++.+.||+|+||.||+|.... +..+|+|.+...... .+.+.+|+.++++++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 569999999999999999998754 456999998754321 356789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999865 3689999999999999999999999999999999999999999999999998764322111 01
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~ 245 (450)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..... ..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1122355679999999776654 79999999999999998 9999988777666666655433 3455578999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 045214 246 ILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~h 263 (450)
||++||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=313.52 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=205.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA-----SKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~ 83 (450)
.+||++.+.||+|||+.||++++..+++.+|+|.+..... ...+...+|+...++++|||+++++++.- ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3589999999999999999999999999999999976552 34678899999999999999999987642 334
Q ss_pred EEEEEEeecCCCChhhHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEeecCch
Q 045214 84 KIYFVMEYAKGGELFKKVSK----G-KLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~-~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
..|++++|...|+|.+.++. + -++|.++..|+.++++||++||+.. ++||||||.|||+.+.+..++.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999999864 3 5999999999999999999999998 999999999999999999999999988
Q ss_pred hhhhcccCCCC-------cccccCCCcccCchhcccCCCC--CCccchhhHHHHHHHHhhCCCCCCCCcH--HHHHHHHh
Q 045214 157 ALAKCKHQDGL-------LHTTCGTPAYVAPEVISRRGYD--GDKADIWSCGVILYVLLAGYLPFHDSNL--MAMYRKIA 225 (450)
Q Consensus 157 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~ 225 (450)
+.....-.... .....-|..|+|||.+.-+.+. +.++|||||||+||.|+.|..||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 65443222111 1122458899999999754432 5799999999999999999999974110 01111223
Q ss_pred hcCCCCC--CCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 226 KADYKFP--TWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 226 ~~~~~~p--~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+++.+| +.+|..+.++|..||++||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 4455555 3489999999999999999999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.07 Aligned_cols=257 Identities=32% Similarity=0.579 Sum_probs=222.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.-|..++.||-|+||+|.+++..+|...||+|.+++..+...+....++.|-.||..-..+-||+||..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35888999999999999999999999999999999988887788899999999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC----
Q 045214 90 EYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ---- 164 (450)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~---- 164 (450)
+|++||++..++-+ |-|.|+.++.|+..|..|+++.|..|+|||||||+|||||.+|++||.||||++-++-.+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999988755 8899999999999999999999999999999999999999999999999999863321110
Q ss_pred ------------------------------------CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC
Q 045214 165 ------------------------------------DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG 208 (450)
Q Consensus 165 ------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g 208 (450)
..+.+..+||+.|+|||++...+|. ..+|.||.|||||+|+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence 0112344699999999999999986 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhhc----CCCCCCCCcHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 045214 209 YLPFHDSNLMAMYRKIAKA----DYKFPTWFSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRK 268 (450)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~~ll~~~L~~dP~~R~s---~~eil~hp~f~~ 268 (450)
+.||.+..+.+...++..- .+..-..+|.++.++|.++. -+++.|.. ++++..||||+-
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999988776555444322 22333458999999999976 56888884 678999999974
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=321.76 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=206.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|.+..++ .||+|.+..... ..+++.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 3578999999999999999999986654 599999976432 2356789999999999999999999875 456899
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|||+++|+|.+++.+ ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999999975 3588999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
.......++..|+|||+..+..+ +.++|||||||++|+|++ |..||.+......+..+... ..+.+..++.++.++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred -ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 11223346678999999877666 489999999999999999 89999887776666665443 234455688999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||++||++|||++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.22 Aligned_cols=149 Identities=32% Similarity=0.648 Sum_probs=138.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|.+.+.||.|+||.||+|.+..+++.||||++............++.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555445567889999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
|||+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975 578999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=321.07 Aligned_cols=247 Identities=21% Similarity=0.394 Sum_probs=207.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 468999999999999999999974 566799998865432 246788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999999999864 4688999999999999999999999999999999999999999999999999865432111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ..+.+..++.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999877665 478999999999999998 99999887776666665543 2333455789999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||..+|++|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.32 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=207.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 356899999999999999999999999999999999876432 223345678999999999999999999998654
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..+|+|+||+.+ +|...+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 356999999964 6666543 468999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------ 228 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 228 (450)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 1 12234678899999998764444589999999999999999999999876554443332210
Q ss_pred -----------CCC--------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -----------YKF--------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -----------~~~--------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
... .+..++++.+||.+||+.||++||++++++.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 000 1235778999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=321.17 Aligned_cols=248 Identities=22% Similarity=0.391 Sum_probs=207.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999875 5567999998765432 356889999999999999999999875 45689
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+..+....+... ..+.|...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred c-ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 11112235567999999876655 489999999999999999 99999887777766666543 34456678899999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
|+.+||.+||++|||++++.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=326.68 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=207.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... ....++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999999754 2357999988654322 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 045214 86 YFVMEYAKGGELFKKVSK-------------------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NI 140 (450)
|+++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2367889999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHH
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA 219 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 219 (450)
|+++++.+||+|||++................++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999864322211111223356778999999876665 489999999999999998 999999887777
Q ss_pred HHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 220 MYRKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....+... ....|..++.++.+++.+||+++|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655443 33456678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.52 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=208.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
..+|.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457899999999999999999753 356789999876432 233567899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSKG----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM 147 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~ 147 (450)
..|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999998642 3788999999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhh
Q 045214 148 LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAK 226 (450)
Q Consensus 148 vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 226 (450)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999988643221111112233457889999999877764 89999999999999998 9999988776666655544
Q ss_pred c-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 227 A-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 227 ~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
. ....|..+++++.+++.+||+.||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 34556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=323.46 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=207.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
-..+|++.+.||+|+||.||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 34689999999999999999999877766 489999865432 23346788999999999999999999998654
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..++++||+++|+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999865 4689999999999999999999999999999999999999999999999999875532
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADV 239 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (450)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ..+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2211111223456789999999877664 89999999999999998 99999877666555555443 234556688999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 045214 240 RKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+++.+||+.||+.||++.++++
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=328.24 Aligned_cols=253 Identities=23% Similarity=0.426 Sum_probs=211.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
+..++|.+.+.||+|+||.||+|++.. .+..||+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 456789999999999999999998532 345799999875422 23356788999999999 89999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+......|++|||+++++|.+++.+. .++...+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998642 3677888999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+..++
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999998654322222222234567789999999776664 88999999999999998 8899998888777
Q ss_pred HHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.... ...|..++.++.+|+.+||.++|.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 77765443 2345668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.30 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=212.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|...+.||+|+||.||+|.+..+++.|++|.+.............+.+|+.+++.++|||++++++++.+....|++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 45778889999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+.| +|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.... .
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 99965 67777643 468999999999999999999999999999999999999999999999999875321 1
Q ss_pred cccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC--CCCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ll 243 (450)
.....|++.|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+.....+ ....++..+++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234578999999999842 233347899999999999999999999887665554444433222 1234678899999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+||+++|.+||++.+++.||||+..
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.07 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=204.1
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCC--------------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGT--------------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~--------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 75 (450)
++|++.+.||+|+||.||+|++..+ ...||+|.+..... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 5899999999999999999987543 23589999876432 2345678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCChhhHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe
Q 045214 76 YEVMASKTKIYFVMEYAKGGELFKKVSKG-------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL 142 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl 142 (450)
++++...+..|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999999999988542 26788899999999999999999999999999999999
Q ss_pred cCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--CCCCCCCCcHHHH
Q 045214 143 DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA--GYLPFHDSNLMAM 220 (450)
Q Consensus 143 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~~ 220 (450)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+.
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999864432211111223345678999999877665 589999999999999988 6789987666554
Q ss_pred HHHHhh--------cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAK--------ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~--------~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.. .....++.+++.+.+|+.+||+.||++|||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 443321 112235557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.51 Aligned_cols=259 Identities=31% Similarity=0.582 Sum_probs=232.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+-.+.|+++++||+|+|++|.+++.+.|.+.+|+|+++++-..+.+.++.+..|-.+..+. +||.+|-++.+|.++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3456899999999999999999999999999999999998877777788888888888766 799999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
++|.||++||+|.-.+.+ .+++|+.++.|...|+.||.|||++||++||||.+|+|+|..|++||.|+|+++. ....
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~ 404 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGP 404 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCC
Confidence 999999999999777765 6899999999999999999999999999999999999999999999999998753 2344
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-------Cc-HHHHHHHHhhcCCCCCCCCc
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-------SN-LMAMYRKIAKADYKFPTWFS 236 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-------~~-~~~~~~~i~~~~~~~p~~~s 236 (450)
.....+.||||.|.|||++.+..| ++.+|.|+||++|++|++|+.||+- .+ ..-+++-|...+..+|..+|
T Consensus 405 gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS 483 (593)
T ss_pred CcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence 556788999999999999999887 5999999999999999999999973 12 23456777888899999999
Q ss_pred HHHHHHHHHccCCCCCCCCC------HHHHhcCccccc
Q 045214 237 ADVRKLLSRILDPNPSTRIS------IAKIMENPWFRK 268 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s------~~eil~hp~f~~ 268 (450)
-.+..+++..|++||.+|.. .+++..|+||+.
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999999999999999974 689999999984
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=320.04 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=202.3
Q ss_pred eEeecCCeEEEEEEE--cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 17 LLGQGNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
.||+|+||.||+|.. ..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 45788999999865432 2234577889999999999999999999875 4567899999999
Q ss_pred CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC-Cccccc
Q 045214 95 GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG-LLHTTC 172 (450)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~~~ 172 (450)
++|.+++.. ..+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||++.......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999965 579999999999999999999999999999999999999999999999999986543221110 111223
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHccCCC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSRILDPN 250 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~d 250 (450)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+.... .+.|..+++++.++|.+||++|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 479999999999999998 999999877776666665543 4567779999999999999999
Q ss_pred CCCCCCHHHHhc
Q 045214 251 PSTRISIAKIME 262 (450)
Q Consensus 251 P~~R~s~~eil~ 262 (450)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.02 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=205.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 88 (450)
++|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..++..|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4577889999999999999999999999999998765432 33467789999999996 99999999999999999999
Q ss_pred EeecCCCChhhH---Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 89 MEYAKGGELFKK---VS---KGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 89 ~E~~~gg~L~~~---i~---~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
|||+.+ ++.++ +. ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 44433 21 25799999999999999999999975 999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccC--CCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcC-CCCC----C
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRR--GYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKAD-YKFP----T 233 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~-~~~p----~ 233 (450)
. .......|++.|+|||++.+. ...+.++||||+||++|+|++|..||...+. ......+.... ...+ .
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1 122344689999999999766 2345899999999999999999999976542 12222222221 1121 2
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.++.++.+|+.+||++||++|||+++++.||||+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37889999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.29 Aligned_cols=234 Identities=26% Similarity=0.492 Sum_probs=207.3
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
++-||.|+.|.||+|+. .++.||||.++. .-+.+|+-|+.|+||||+.+.+++....+++||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 67899999999999998 678999997742 224689999999999999999999999999999999999
Q ss_pred CChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 95 GELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 95 g~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
|.|...++.+ .++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+...... ....+.+|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 9999999875 7999999999999999999999999999999999999999999999999998754422 34567899
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHccCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLSRILDPNP 251 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll~~~L~~dP 251 (450)
|..|||||++.+.+.. .|+||||+||+|||||||..||.+-+...+.--+... .++.|..++..++-||++||+-.|
T Consensus 274 TVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 9999999999988765 9999999999999999999999987766554433333 346678899999999999999999
Q ss_pred CCCCCHHHHhcCc
Q 045214 252 STRISIAKIMENP 264 (450)
Q Consensus 252 ~~R~s~~eil~hp 264 (450)
..||++.+|+.|-
T Consensus 353 RNRPSFrqil~Hl 365 (904)
T KOG4721|consen 353 RNRPSFRQILLHL 365 (904)
T ss_pred CCCccHHHHHHHH
Confidence 9999999999874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=320.90 Aligned_cols=251 Identities=21% Similarity=0.378 Sum_probs=209.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4569999999999999999999887665 59999987542 223456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||+++++|.+++.. +.+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999865 468999999999999999999999999999999999999999999999999886543222
Q ss_pred CCCCccccc---CCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 164 QDGLLHTTC---GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 164 ~~~~~~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
......... .+..|+|||.+....+. .++|||||||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 24579999999877664 79999999999999886 99999887777666666433 23445567899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.+++.+||..+|.+||++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.78 Aligned_cols=251 Identities=32% Similarity=0.531 Sum_probs=210.7
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.++||||+++++++.+++.+|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999989999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 92 AKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
+++ +|.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 78877765 479999999999999999999999999999999999999999999999999886543322 1223
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------CC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------------------YK 230 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------~~ 230 (450)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+...++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578899999998776344689999999999999999999998877655544432210 00
Q ss_pred -----------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 231 -----------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 231 -----------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
..+.++.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=320.85 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=209.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 799999865432 22356788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|++|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999865 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCC-cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 164 QDGL-LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||...+..+....+... ..+.+..+++++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1111 111223568999999987665 489999999999999886 99999887776666666544 2334455789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+++|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.22 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=215.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++.++|||++++++++.+++..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45889999999999999999999999999999997654444445567889999999999999999999999999999999
Q ss_pred eecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+.| +|.+.+. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99976 6777664 35789999999999999999999999999999999999999999999999998754321
Q ss_pred cccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-C-CCCCcHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-F-PTWFSADVRKLL 243 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~ll 243 (450)
.....|++.|+|||.+.. .+..+.++|+||+||++|+|++|..||...+.......+...... . +..+++.+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234568899999999742 233457999999999999999999999887766666555544332 2 234788999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccccccC
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+||+.+|.+||++.++++|+|+....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=325.84 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=203.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG----------------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 72 (450)
.++|++.+.||+|+||.||+|++.. ++..+|+|.+.... ......++.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987543 12345678899999999999999
Q ss_pred cEEEEEEEeCCEEEEEEeecCCCChhhHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 045214 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSKG------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140 (450)
Q Consensus 73 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NI 140 (450)
+++++++...+..|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999998652 256778999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--CCCCCCCCcHH
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA--GYLPFHDSNLM 218 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~ 218 (450)
|++.++.++|+|||++................+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999864422211111222345678999998877665 489999999999999998 78999876655
Q ss_pred HHHHHHhh--------cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 219 AMYRKIAK--------ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 219 ~~~~~i~~--------~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+....... ...+.|..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54433211 122345667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=324.26 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=211.0
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998754 2223456778899999999999999999999999999999999
Q ss_pred cCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 92 AKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 92 ~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
+++ +|.+++.+. .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 985 899999764 79999999999999999999999999999999999999999999999999886543221 1223
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc------------------CCCC
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------DYKF 231 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~~~ 231 (450)
...++..|+|||.+.+....+.++|+|||||++|+|++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999877644568999999999999999999999887665544443221 0011
Q ss_pred C-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 232 P-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 232 p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+ +.++.++.++|.+||+.||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.58 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=208.7
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--CCC----ccEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ--HPN----VMQIYE 77 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpn----Iv~l~~ 77 (450)
.|+.+.+||.++.+||+|+||+|-.+.+..++..||||+++.-. ...+...-|+++|.++. .|+ ++.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 36888999999999999999999999999999999999997543 23355567999999983 333 788889
Q ss_pred EEEeCCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC----------
Q 045214 78 VMASKTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---------- 144 (450)
Q Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---------- 144 (450)
+|+..++++||+|.+ |-++++++.++ +++.+.++.+.+||+++++|||+.+++|.||||||||+-.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999988 66999999874 6899999999999999999999999999999999999832
Q ss_pred ----------CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC
Q 045214 145 ----------NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD 214 (450)
Q Consensus 145 ----------~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 214 (450)
+-.++|+|||.|+..... -.+.+.|..|+|||++.+-++. .++||||.||||+|+.+|...|..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceeccc
Confidence 235899999988754322 2456789999999999999996 899999999999999999999987
Q ss_pred CcHHH---HHHHHhh------------------cCCCCCCC-------------------------CcHHHHHHHHHccC
Q 045214 215 SNLMA---MYRKIAK------------------ADYKFPTW-------------------------FSADVRKLLSRILD 248 (450)
Q Consensus 215 ~~~~~---~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~ll~~~L~ 248 (450)
.+..+ +.+.|.. +....|.. -..++.|||.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 65433 3333321 01111110 01258899999999
Q ss_pred CCCCCCCCHHHHhcCccccc
Q 045214 249 PNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 249 ~dP~~R~s~~eil~hp~f~~ 268 (450)
.||.+|+|+.|+|.||||..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999999999975
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=324.01 Aligned_cols=258 Identities=32% Similarity=0.592 Sum_probs=214.7
Q ss_pred CeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.|++.+.||+|++|.||+|++. .+++.||+|++.+.... .......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 36789999999764332 223346678999999999 699999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++|++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCc----HHHHHHHHhhcCCCCCCCCcHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
.......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .....+.+.......|..++.++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999986543 23578999999999999999999996432 23344445555566777789999
Q ss_pred HHHHHHccCCCCCCCCC---HHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPSTRIS---IAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s---~~eil~hp~f~~~ 269 (450)
.++|.+||+.||++||| +.++++||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=331.78 Aligned_cols=255 Identities=22% Similarity=0.418 Sum_probs=210.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGT-------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
+...+|++++.||+|+||.||+|++... +..||+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445899999999999999999987542 2368999887542 123356788999999999 89999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+...+.+|+++||+++|+|.+++.+. .++...+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99999999999999999999998641 3677888999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999998654322111112223345679999999877664 78999999999999998 8999998887777
Q ss_pred HHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCc
Q 045214 221 YRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENP 264 (450)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp 264 (450)
...+.... ...|..++.++.+++.+||+.+|.+|||+.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77665543 345666889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=335.13 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=202.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe-
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS- 81 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 81 (450)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 368999999999999999999853 4678999999975432 12346688999999999 68999999998754
Q ss_pred CCEEEEEEeecCCCChhhHHhcC---------------------------------------------------------
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKG--------------------------------------------------------- 104 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 104 (450)
+..+|++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45789999999999999987531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 105 -----------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 105 -----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
.++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 256778889999999999999999999999999999999999999999999865422111111122345
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHH-HHHHHHhhc-CCCCCCCCcHHHHHHHHHccCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLM-AMYRKIAKA-DYKFPTWFSADVRKLLSRILDPN 250 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~d 250 (450)
++.|+|||++.+..+. .++||||||+++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999998776664 89999999999999997 99999875433 223333222 34556778899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 045214 251 PSTRISIAKIMEN 263 (450)
Q Consensus 251 P~~R~s~~eil~h 263 (450)
|++|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.99 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=205.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 357899999999999999999998655 4599998865432 2356788999999999999999999875 456899
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999999999965 2478999999999999999999999999999999999999999999999999865432111
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+... ..+.|..++..+.++
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 11122345678999999876655 489999999999999999 99999987776666666544 234556688999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.86 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=205.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCC--CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe----CC
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGT--GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS----KT 83 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 83 (450)
+|++.+.||+|+||.||+|++..+ +..||+|.+..... .......+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 89999999865322 122345678899999999 59999999987532 24
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+++||+. ++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 588888865 57999999999999999999999999999999999999999999999999998654322
Q ss_pred cC--CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------
Q 045214 163 HQ--DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------- 227 (450)
Q Consensus 163 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 227 (450)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998866433458999999999999999999999876543333222110
Q ss_pred ------------C---CCC---CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ------------D---YKF---PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ------------~---~~~---p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
. ..+ .+..+.++.+++.+||++||++|||+.+++.|||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 001 11257889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.20 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=207.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|... +++.||+|.+...... ..++.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 5788999998755432 357889999999999999999999874 55789
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999998864 368999999999999999999999999999999999999999999999999886543111
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......++..|+|||++....+ +.++||||||+++|+|++ |..||.+.+.......+... ..+.+...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122345678999999877665 489999999999999998 99999988777666665443 23455667899999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+||+.+|++|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.70 Aligned_cols=242 Identities=25% Similarity=0.469 Sum_probs=209.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 45799999999999999999987 488999999976542 356788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999999998653 58999999999999999999999999999999999999999999999999886542111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll 243 (450)
....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+... ....|..+++++.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 12334567999999876655 479999999999999997 99999888777666655443 3345667899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||..+|++|||++++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.85 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=202.6
Q ss_pred ceEeecCCeEEEEEEEcCCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeec
Q 045214 16 RLLGQGNFAKVYYARHLGTG---QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++. .+..+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876654 78999999866543 34567889999999999999999999876 45689999999
Q ss_pred CCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC-Cccc
Q 045214 93 KGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG-LLHT 170 (450)
Q Consensus 93 ~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~ 170 (450)
++++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999764 59999999999999999999999999999999999999999999999999986543221110 0111
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHccC
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~~L~ 248 (450)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..++..+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999977665 489999999999999998 999999877766666665443 35666789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 045214 249 PNPSTRISIAKIME 262 (450)
Q Consensus 249 ~dP~~R~s~~eil~ 262 (450)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=324.18 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=209.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... ......+.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999999753 678899999875432 223466889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 045214 84 KIYFVMEYAKGGELFKKVSKG-----------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NI 140 (450)
..|++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999998631 367888999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHH
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA 219 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 219 (450)
+++.++.++|+|||++.................++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987643221111111223456779999998877664 89999999999999997 889998877777
Q ss_pred HHHHHhhcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 220 MYRKIAKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 220 ~~~~i~~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....+..+.. ..|..++.++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7776665543 346678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.33 Aligned_cols=250 Identities=19% Similarity=0.328 Sum_probs=204.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.++|++.+.||+|+||.||+|.+..+++. +++|.+..... ......+..|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 46799999999999999999999877764 67777643221 123456778888999999999999999875 456
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.++++||+++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999964 46899999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (450)
..........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 21122233456778999999987666 489999999999999998 999998877665555554433 234455778999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||..||++|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.99 Aligned_cols=249 Identities=23% Similarity=0.409 Sum_probs=210.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+. +++.+|+|.+..... ....+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45678999999999999999999975 457899999876543 2356889999999999999999999999989999
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999965 368999999999999999999999999999999999999999999999999886543211
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+.......+... ..+.|...+.++.+
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 01112234568999999987665 489999999999999998 99999887777777766544 33455667899999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+||+.+|++||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.97 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=210.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4689999999999999999999877665 589998876542 2334678899999999999999999999887 78
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+++|||+++|+|.+++.+ +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999999875 46899999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (450)
..........++..|+|||.+....+. .++|+|||||++|++++ |..||...+..+....+.... .+.|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 111111122345689999998766654 89999999999999998 999999888777766665543 455666889999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||..||..|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=319.68 Aligned_cols=252 Identities=29% Similarity=0.551 Sum_probs=211.9
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
||.+.+.||+|+||.||++.+..++..+++|+++..... ......++.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887888877653322 122334567899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 89 MEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988752 46899999999999999999999999999999999999975 67999999988654221
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKL 242 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (450)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+.... ...|..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 2223345688999999998776664 78999999999999999999998877666666654443 23456688999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f 266 (450)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=341.68 Aligned_cols=253 Identities=23% Similarity=0.522 Sum_probs=219.1
Q ss_pred cCe-eeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE--E
Q 045214 10 QKY-ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK--I 85 (450)
Q Consensus 10 ~~y-~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~ 85 (450)
+|| +....||+|+|-+||+|.|..+|-.||--.+..+.+. .....+++..|+.+|+.|+||||+++|+.+.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 455 4467899999999999999999999987666554443 33456889999999999999999999999987665 8
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecC-CCCeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDE-NGMLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~-~~~vkl~DFGls~~~~~ 161 (450)
.+|.|.+.+|+|+.|+.+ ++++...++.|++||+.||.|||++. |+|||||.+||+|+. .|.|||+|+|||++.+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 899999999999999987 78999999999999999999999984 999999999999974 58999999999998754
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHhhcCCC--CCCCCcHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYK--FPTWFSAD 238 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~ 238 (450)
.. ..+..|||.|||||++. ..|+ ..+||||+|++|.||.|+..||.. .++.++|+++..+..+ +..--.++
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 33 23468999999999987 4576 899999999999999999999986 6788999999877543 22334689
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++||.+||.. .+.|+|+.|+|.||||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999999999864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.47 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=212.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
..+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34688899999999999999999999999999998764433334456778899999999999999999999999999999
Q ss_pred EeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+.| +|.+.+. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 999975 7777664 34689999999999999999999999999999999999999999999999998764321
Q ss_pred CcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC--CCCCCcHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADVRKL 242 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 242 (450)
.....+++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+.....+ .+..++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 123468899999999753 222347899999999999999999999876655444444433322 233578899999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|.+||+++|++||++++++.|||+...
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=327.46 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=199.4
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
+++.+| +++.||.+++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||++
T Consensus 6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhc--CCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 444444 4455666677779999999999865322 2346789999999999999999999999999999999999999
Q ss_pred CCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC-----C
Q 045214 94 GGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ-----D 165 (450)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~-----~ 165 (450)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999999875 4689999999999999999999999999999999999999999999999998753321111 1
Q ss_pred CCcccccCCCcccCchhcccC--CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHH-HHHhhc---------------
Q 045214 166 GLLHTTCGTPAYVAPEVISRR--GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY-RKIAKA--------------- 227 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~--------------- 227 (450)
.......++..|+|||++... .+ +.++|+||+||++|+|++|..||...+..... .++...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 112334578889999998653 34 47899999999999999999999875543322 222110
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ------------------DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ------------------~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....+..++.++.+|+.+||..||++|||++++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000111245688999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.15 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=204.3
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|++|||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998765432 24567889999999999999999999999999999999999999
Q ss_pred ChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 96 ELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999864 4689999999999999999999999999999999999999999999999998864321111111112234
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDPNP 251 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP 251 (450)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|..++.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 489999999999999999 89999887766666665443 334566788999999999999999
Q ss_pred CCCCCHHHHhc
Q 045214 252 STRISIAKIME 262 (450)
Q Consensus 252 ~~R~s~~eil~ 262 (450)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.55 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=205.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (450)
.++|.+++.||+|+||.||+|++. .+++.||+|++..... ....+.+.+|+.+|..+. ||||+++++.+...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 457889999999999999999964 3457899999976432 223456889999999997 99999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhcC----------------------------------------------------------
Q 045214 83 TKIYFVMEYAKGGELFKKVSKG---------------------------------------------------------- 104 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 104 (450)
+..|+||||+++|+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec
Q 045214 105 -----------------------------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD 143 (450)
Q Consensus 105 -----------------------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~ 143 (450)
.++...+..++.|++.||.|||+.|++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 245667888999999999999999999999999999999
Q ss_pred CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHH
Q 045214 144 ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYR 222 (450)
Q Consensus 144 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 222 (450)
.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999865432211111223467889999999987665 489999999999999998 899998755444333
Q ss_pred H-Hhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 K-IAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~-i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
. +..+ ....|..++.++.+|+.+||.++|.+||++++|++
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 3322 23456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.92 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=205.0
Q ss_pred ceEeecCCeEEEEEEEcC-CC--cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeec
Q 045214 16 RLLGQGNFAKVYYARHLG-TG--QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
+.||+|++|.||+|.+.. ++ ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36999999876543 456788999999999999999999999988 8999999999
Q ss_pred CCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-CCc
Q 045214 93 KGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-GLL 168 (450)
Q Consensus 93 ~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~ 168 (450)
++++|.+.+.+. .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999999663 5899999999999999999999999999999999999999999999999998765332111 111
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA--DYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ll~~ 245 (450)
....++..|+|||.+....+. .++|||||||++|+|++ |..||...+..+....+... ....|..++.++.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577889999998876664 78999999999999998 99999887777766666532 233455678999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=316.70 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=209.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|+..+.||+|+||.||+|.+..+++ .+|+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4579999999999999999999876654 799999865432 22346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|++|||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 578999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCc-ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHH
Q 045214 164 QDGLL-HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (450)
..... .....++.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+.... .+.+..++.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11223457999999987666 489999999999999997 999998877777776665432 233445789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.60 Aligned_cols=249 Identities=31% Similarity=0.509 Sum_probs=205.3
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEEeCCE----
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMASKTK---- 84 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 84 (450)
|++.+.||+|+||.||+|++..+++.||+|.+...... ......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78999999999999999999889999999999754332 22334566788777666 59999999999988776
Q ss_pred -EEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 85 -IYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 -~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
+|++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888765 258999999999999999999999999999999999999999999999999886543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----C-----
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-----K----- 230 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-----~----- 230 (450)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+.+.++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 12233457889999999987665 4899999999999999999999998776665555532100 0
Q ss_pred ------C-----------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 231 ------F-----------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 231 ------~-----------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
+ .+.+++.+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.53 Aligned_cols=241 Identities=27% Similarity=0.467 Sum_probs=204.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEE-EeCCEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM-ASKTKIYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~l 87 (450)
+.+|++.+.||+|+||.||++.. .|..+|+|.+..+. ..+.+.+|+.++++++|||++++++++ ..++..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 45799999999999999999987 47889999986432 245678999999999999999999975 55678999
Q ss_pred EEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|||+++++|.+++.+. .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 99999999999998652 478999999999999999999999999999999999999999999999998764321
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
......++..|+|||++....+. .++|||||||++|+|++ |..||...+.......+... ....++.+++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11233456789999998776654 78999999999999997 99999988777766666544 234556789999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.22 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=209.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcC----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-C
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLG----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-K 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 82 (450)
-.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35689999999999999999999876 36889999886432 22345678899999999999999999998655 5
Q ss_pred CEEEEEEeecCCCChhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeec
Q 045214 83 TKIYFVMEYAKGGELFKKVSK---------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DF 153 (450)
...++++||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 778999999999999999854 34889999999999999999999999999999999999999999999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKF 231 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~ 231 (450)
|+++...............++..|+|||++.+..+ +.++|||||||++|++++ |..||...+..+....+..+. ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99864422211111122345678999999987665 489999999999999999 999999887777666655432 234
Q ss_pred CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 232 PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 232 p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.05 Aligned_cols=247 Identities=30% Similarity=0.519 Sum_probs=202.3
Q ss_pred eeeceEeecCCeEEEEEEEc----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHL----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.+.||.|+||.||+|... ..+..|+||.+.... .....+.+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 346789999995432 223367889999999999999999999999988889999
Q ss_pred EeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||+++|+|.+++... .+++.....++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998654211111
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll 243 (450)
.......+...|+|||.+....+ +.++||||||+++|++++ |..||.+.+......++.... ...|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999987765 489999999999999999 789999988877777775443 345667899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.73 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=200.3
Q ss_pred eEeecCCeEEEEEEEc--CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 17 LLGQGNFAKVYYARHL--GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
.||+|+||.||+|.+. ..+..||+|++..... ....+.+.+|+.++++++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 3456799999875432 234567889999999999999999999875 4578999999999
Q ss_pred CChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC-Ccccc
Q 045214 95 GELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG-LLHTT 171 (450)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~~ 171 (450)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999853 579999999999999999999999999999999999999999999999999986443221111 11112
Q ss_pred cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCC
Q 045214 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+ ....|...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999877665 479999999999999996 99999988777666665543 3456777899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 045214 250 NPSTRISIAKIME 262 (450)
Q Consensus 250 dP~~R~s~~eil~ 262 (450)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=312.90 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=210.1
Q ss_pred eeeeceEeecCCeEEEEEEEcCCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTG----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+++.+.||.|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357899999999999999998766 89999999665422 245788999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcC-C--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSKG-K--LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~-~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+|||+++++|.+.+... . +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998653 2 99999999999999999999999999999999999999999999999999865433211
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 242 (450)
... ....+++.|+|||.+....+ +.++|+||||+++|+|++ |..||...+.....+.+..... ..+...+.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 01236789999999865554 589999999999999998 8999998877777777655433 4566689999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=317.29 Aligned_cols=241 Identities=25% Similarity=0.429 Sum_probs=199.8
Q ss_pred ceEeecCCeEEEEEEEcCCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEeec
Q 045214 16 RLLGQGNFAKVYYARHLGTGQ--SVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
+.||+|+||.||+|++..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988776 46888876432 123346788999999999 8999999999999999999999999
Q ss_pred CCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 93 KGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 93 ~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPT 233 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (450)
+........ ......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 742211100 111234567999999877665 489999999999999997 99999887777777666543 234555
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++.++.+++.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=313.18 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=208.4
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47899999999999999999885 4778999998654322 356789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++++|.+++.. +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999998764322111 11
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~ 245 (450)
.....++..|+|||.+.+..+. .++|+||||+++|+|++ |..||...+.......+..+. ...|...+.++.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1223356789999999876654 79999999999999998 999999888777777765543 23455678999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 237 CWKERPEDRPSFSLLLH 253 (256)
T ss_pred HcccChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=319.77 Aligned_cols=249 Identities=30% Similarity=0.509 Sum_probs=205.6
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 90 (450)
|.+.+.||+|++|+||+|....+++.||||.+...... .......+|+..++.++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999989999999998654321 11233457999999998 9999999999999999999999
Q ss_pred ecCCCChhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|+ +|+|.+.+.. . .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 7789888865 2 6899999999999999999999999999999999999999999999999988654321 12
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------------- 228 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------- 228 (450)
.....++..|+|||++......+.++|+||||+++++|++|..||...+..+.+.++....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2345688899999998655444689999999999999999999998776554443332110
Q ss_pred CC-----------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 229 YK-----------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 229 ~~-----------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.. ..+..+.++.++|.+||+.||++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=317.58 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=210.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|++.+.||+|+||.||+|+... +.+.+++|.+..... ......+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3679999999999999999999754 356799998865432 224567899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeec
Q 045214 84 KIYFVMEYAKGGELFKKVSK-G---------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~---------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DF 153 (450)
..|+||||+++++|.+++.. . .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999864 2 4899999999999999999999999999999999999999999999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC--C
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY--K 230 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~ 230 (450)
|++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..... .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 987533211 1111223356778999999877665 488999999999999998 8899987776666666654443 3
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=338.43 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=216.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..+...+++.||+|.||+||+|++.++ ||||+++.+.... +..+.+++|+.++++-+|.||+-+.+++..... .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3445677899999999999999999664 9999998876654 477899999999999999999999999988887 9
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||..+|+|.+|..++.- -+|.....+.|++|+++|+.|||.++|+|||||..||+|.+++.|||+||||++.......
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999999864 4788999999999999999999999999999999999999999999999999987665555
Q ss_pred CCCcccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC-----CCCCcH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF-----PTWFSA 237 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~ 237 (450)
..-+....|...|||||++.... .+++.+||||+||++|||++|.+||...+.+++...+..+.... -...+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 55566777999999999986422 23589999999999999999999999877777766655553221 223567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++++|+..||.+++++||+..+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=311.65 Aligned_cols=248 Identities=22% Similarity=0.396 Sum_probs=206.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 46789999999999999999999864 456699998875432 24678899999999999999999999887 7789
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
++|||+++++|.+++.+ ..++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999965 357888999999999999999999999999999999999999999999999886443211
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+... ..+.+...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 1 11112335667999999977655 478999999999999998 99999987776666655443 22345668899999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+||+++|++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.73 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=197.3
Q ss_pred ceEeecCCeEEEEEEEcCCCc-------EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 16 RLLGQGNFAKVYYARHLGTGQ-------SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999866544 38888876443 23346778899999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC--------eEEeecCchhh
Q 045214 89 MEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--------LKVTDFGLSAL 158 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--------vkl~DFGls~~ 158 (450)
|||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999753 5899999999999999999999999999999999999987765 69999998753
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhcCCCCCCCCcH
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKADYKFPTWFSA 237 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 237 (450)
... .....+++.|+|||++.+....+.++|||||||++|+|++| ..||...+...... .......+|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 321 12346888999999998755446899999999999999998 57776655544332 33445567777789
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
++.+|+.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=309.57 Aligned_cols=242 Identities=26% Similarity=0.448 Sum_probs=201.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+.||+|+||.||+|... +++.+|+|.+..... ......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 47899999999999864 688999999875432 123356788999999999999999999999999999999999999
Q ss_pred ChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccC
Q 045214 96 ELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173 (450)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~g 173 (450)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99998864 468899999999999999999999999999999999999999999999999875422111 111112244
Q ss_pred CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCC
Q 045214 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDPNP 251 (450)
Q Consensus 174 t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP 251 (450)
++.|+|||++....+ +.++||||||+++|++++ |..||...+.......+... ....+..++.++.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 667999999876655 479999999999999998 99999887776666555443 234566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 045214 252 STRISIAKIME 262 (450)
Q Consensus 252 ~~R~s~~eil~ 262 (450)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=306.76 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=206.5
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.+.+..||.|+.|.|++++.+.+|...|||.+..... .+...++.+.+.++.... .|+||+.+++|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4567889999999999999999999999999987643 234567777787776664 8999999999999999999999
Q ss_pred ecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
.+.. .+..++.+ ++++|..+-++...++.||.||.+ +||+|||+||+|||+|+.|++||||||+|...-. ...
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkA 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKA 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---ccc
Confidence 9854 33444433 679999999999999999999986 5999999999999999999999999999864321 112
Q ss_pred cccccCCCcccCchhcccC---CCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcCCC-CCC--CCcHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRR---GYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYK-FPT--WFSADVR 240 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~-~p~--~~s~~~~ 240 (450)
.....|.+.|||||.+.-. .|+ ..+||||||+++++|.||..||.+.+. -+++.++.....+ +|. .+|+++.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 2345789999999998532 344 789999999999999999999998543 4666777665443 222 3899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+|+..||.+|+.+||...++|+|||++.
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceee
Confidence 9999999999999999999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.74 Aligned_cols=228 Identities=27% Similarity=0.455 Sum_probs=192.4
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCChhhH
Q 045214 21 GNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK 100 (450)
Q Consensus 21 G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 100 (450)
|.+|+||+|++..+++.||+|.+.+... ..+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 22344455556799999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccC
Q 045214 101 VSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179 (450)
Q Consensus 101 i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~a 179 (450)
+.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 5799999999999999999999999999999999999999999999999997654322 1223456788999
Q ss_pred chhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCH--
Q 045214 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISI-- 257 (450)
Q Consensus 180 PE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~-- 257 (450)
||.+....+ +.++|+||+|+++|+|++|..||....... . ......+|.++++++.++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI-N---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc-c---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876665 478999999999999999999876532211 0 112345778899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 045214 258 ---AKIMENPWF 266 (450)
Q Consensus 258 ---~eil~hp~f 266 (450)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=318.03 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=207.5
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
..-.+.|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++... .||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34567899999999999999999999988999999999764322 2234556677766666 59999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.|++|||+.+ .|.+.+.. +.+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999854 67666654 578999999999999999999997 5999999999999999999999999999865422
Q ss_pred ccCCCCcccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcCC-CCC--CC
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADY-KFP--TW 234 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~p--~~ 234 (450)
. .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||..... .+.+..+..... ..+ ..
T Consensus 168 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 168 S---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred C---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 1 1122345788999999987543 234789999999999999999999976433 334444433322 222 23
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++.++.+|+.+||..||.+||++++++.||||+..
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 68899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=313.26 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=206.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
-.++|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999997654 45799998865432 2334678899999999999999999998875 45
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.|++|||+++++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999999999999975 35899999999999999999999999999999999999999999999999987643322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
.. .......+++.|+|||.+....+ +.++||||||+++|+|++ |..||...+..+....+... ....|..++.++.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 11 01112234568999999877665 489999999999999986 99999887776666655543 3456677899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||.++|.+|||+.+++.
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.34 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred ceEeecCCeEEEEEEEcCCC------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 16 RLLGQGNFAKVYYARHLGTG------QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.||+|+||.||+|.+.... +.+|+|.+..... ......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986543 7899998865421 123467788999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-----CeEEeecCch
Q 045214 90 EYAKGGELFKKVSK--------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-----MLKVTDFGLS 156 (450)
Q Consensus 90 E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-----~vkl~DFGls 156 (450)
||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999853 2378899999999999999999999999999999999999887 8999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTW 234 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 234 (450)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 64432211111223345788999999987665 589999999999999998 99999887766666655433 3455667
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++..+.+++.+||.++|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=313.32 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=191.3
Q ss_pred ceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
+.||+|+||.||+|.... ....+|+|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999997533 345788887754321 2234567889999999999999999999999999999999999
Q ss_pred CCChhhHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 94 GGELFKKVSKG------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+|+|.+++... ..++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246778899999999999999999999999999999999999999999998753221111111
Q ss_pred cccccCCCcccCchhcccC------CCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHH-hhcCCC-----CCCC
Q 045214 168 LHTTCGTPAYVAPEVISRR------GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKI-AKADYK-----FPTW 234 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i-~~~~~~-----~p~~ 234 (450)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+..... ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999997532 223578999999999999999 88999877655544443 333222 2335
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++..+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.25 Aligned_cols=238 Identities=21% Similarity=0.319 Sum_probs=193.6
Q ss_pred ceEeecCCeEEEEEEEcC------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 16 RLLGQGNFAKVYYARHLG------------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+.||+|+||.||+|.... ....+++|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358999876543 233456788999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC-------eEEeecC
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM-------LKVTDFG 154 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~-------vkl~DFG 154 (450)
..+++|||+++++|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 46899999999999999999999999999999999999987664 8999999
Q ss_pred chhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHh-hCCCCCCCCcHHHHHHHHhhcCCCCCC
Q 045214 155 LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLL-AGYLPFHDSNLMAMYRKIAKADYKFPT 233 (450)
Q Consensus 155 ls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (450)
++..... .....++..|+|||.+......+.++|||||||++|+|+ .|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8754321 123457889999999875454568999999999999998 589998876554432 22333334444
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
..+.++.+|+.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=354.15 Aligned_cols=255 Identities=29% Similarity=0.530 Sum_probs=209.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA------- 80 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------- 80 (450)
....|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||++|..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567899999999999999999999999999999998765 2345678999999999999999999982100
Q ss_pred -----------------------------------------------------------------------e--------
Q 045214 81 -----------------------------------------------------------------------S-------- 81 (450)
Q Consensus 81 -----------------------------------------------------------------------~-------- 81 (450)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -------------------------C--------CEEEEEEeecCCCChhhHHhcCCCC--HHHHHHHHHHHHHHHHHHH
Q 045214 82 -------------------------K--------TKIYFVMEYAKGGELFKKVSKGKLK--EDTARKYFQQLISAIDFCH 126 (450)
Q Consensus 82 -------------------------~--------~~~~lv~E~~~gg~L~~~i~~~~l~--e~~~~~~~~qll~aL~~LH 126 (450)
+ ..+||-||||+...|.+++..+.+. .+.++++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2379999999998999999887664 8899999999999999999
Q ss_pred HCCCeecCCCCCcEEecCCCCeEEeecCchhhhh----c------------ccCCCCcccccCCCcccCchhcccCC--C
Q 045214 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----C------------KHQDGLLHTTCGTPAYVAPEVISRRG--Y 188 (450)
Q Consensus 127 ~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~----~------------~~~~~~~~~~~gt~~y~aPE~l~~~~--~ 188 (450)
++||+||||||.||+||++++|||+|||+|+... . ....+......||-.|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999997622 0 01112344568999999999998766 3
Q ss_pred CCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHHHHHhhcCCCCCCCC----cHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 189 DGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIAKADYKFPTWF----SADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 189 ~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~p~~~----s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+..|+|+|||||+||||+. ||... ........+.++.++.|..+ -+.-..+|+.||+.||.+|||+.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 3489999999999999985 56542 33455666666666666332 2456789999999999999999999999
Q ss_pred cccc
Q 045214 264 PWFR 267 (450)
Q Consensus 264 p~f~ 267 (450)
.||-
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.37 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=205.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.++|+..+.||+|+||.||+|.+..+++ .+|+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3578999999999999999999887776 468888765432 12234678999999999999999999998654 4
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999865 36899999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
..........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+... ..+.+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22112223446778999999877665 489999999999999997 99999876655544444333 2334556789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcC
Q 045214 241 KLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=314.69 Aligned_cols=237 Identities=23% Similarity=0.312 Sum_probs=193.2
Q ss_pred eEeecCCeEEEEEEEcCC------------------------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 045214 17 LLGQGNFAKVYYARHLGT------------------------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 72 (450)
.||+|+||.||+|....+ ...||+|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999985322 23588998865432 234567789999999999999
Q ss_pred cEEEEEEEeCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----
Q 045214 73 MQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---- 146 (450)
Q Consensus 73 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---- 146 (450)
+++++++......|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998854 5789999999999999999999999999999999999997654
Q ss_pred ---CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHh-hCCCCCCCCcHHHHHH
Q 045214 147 ---MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLL-AGYLPFHDSNLMAMYR 222 (450)
Q Consensus 147 ---~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~ 222 (450)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998743211 122357888999999876444468999999999999984 7999998766544333
Q ss_pred HHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 223 KIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 223 ~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
. .......|...++++.++|.+||+.+|++|||+.+++++
T Consensus 233 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 F-YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 233445555567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.11 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=199.8
Q ss_pred CeeeeceEeecCCeEEEEEEE----cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CE
Q 045214 11 KYELGRLLGQGNFAKVYYARH----LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--TK 84 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 84 (450)
-|++.+.||+|+||.||+|.. ..+++.||+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368999999999999999984 45788999999875432 23346789999999999999999999998775 57
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.|+||||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999999865 35899999999999999999999999999999999999999999999999998754322
Q ss_pred cCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---------------HHHHHHHHhh
Q 045214 163 HQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---------------LMAMYRKIAK 226 (450)
Q Consensus 163 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~~~i~~ 226 (450)
... .......++..|+|||++.+..+. .++|||||||++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 211 112234567789999998776654 79999999999999999876643211 0111111111
Q ss_pred -cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 227 -ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 227 -~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.+..++.++.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 123345568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=330.62 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=213.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCc---E-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQ---S-VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
++-.+.+.||+|+||+||+|..+..+. . ||+|....+..........+.+|.++|+.++|||||++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344567999999999999999765422 3 899999865444446678889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+|||+|+||+|.+++.+. .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+|.......
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 9999999999999999874 49999999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC--CCCCCCcHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY--KFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 240 (450)
... ...--...|+|||.+...-| +.++||||+||++||+++ |..||.+....+...++....+ +.|...+.++.
T Consensus 317 ~~~--~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 317 MKK--FLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred ecc--ccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 110 01124568999999988755 599999999999999999 8889999999999999966554 45666788999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++.+|+..||+.|||+.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=312.73 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=198.3
Q ss_pred cCeeeeceEeecCCeEEEEEEE----cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Q 045214 10 QKYELGRLLGQGNFAKVYYARH----LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KT 83 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (450)
.+|++.+.||+|+||.||.|.. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999984 4578899999986543 2334678899999999999999999998643 45
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+|+||||+++++|.+++.+ +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999999999999865 4689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH----------------HHHHH
Q 045214 162 KHQDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----------------MYRKI 224 (450)
Q Consensus 162 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----------------~~~~i 224 (450)
..... ......++..|+|||++.+..+ +.++|||||||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 21110 1111223456999999977665 489999999999999999887765432110 11111
Q ss_pred hh-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 225 AK-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 225 ~~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.. ...+.+..++.++.+|+.+||.++|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 122345568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.60 Aligned_cols=244 Identities=20% Similarity=0.251 Sum_probs=192.5
Q ss_pred ceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
+.||+|+||.||+|.... ++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 468999999999998643 5678999988765422 223567889999999999999999999999999999999999
Q ss_pred CCChhhHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 94 GGELFKKVSKG------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998641 356678889999999999999999999999999999999999999999998854321111111
Q ss_pred cccccCCCcccCchhcccCC------CCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHH-hhcCCCCC-----CC
Q 045214 168 LHTTCGTPAYVAPEVISRRG------YDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKI-AKADYKFP-----TW 234 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i-~~~~~~~p-----~~ 234 (450)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||......+..... .......+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788899999986432 12578999999999999996 99999876655443332 22222222 23
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+..+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.29 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=196.7
Q ss_pred ceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEEEEEEee
Q 045214 16 RLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA-SKTKIYFVMEY 91 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 91 (450)
+.||+|+||.||+|.+.. .+..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999999754 34579999885432 1233567788999999999999999999764 56678999999
Q ss_pred cCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC--CC
Q 045214 92 AKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--GL 167 (450)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~--~~ 167 (450)
+.+++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999865 35677888899999999999999999999999999999999999999999998643221110 11
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~ 245 (450)
.....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+.... ...|..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112345678999999877665 489999999999999999 567787777666665554443 33455678999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 045214 246 ILDPNPSTRISIAKIME 262 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~ 262 (450)
||.++|++||++.+++.
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.28 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=203.8
Q ss_pred eeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----
Q 045214 12 YELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT----- 83 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (450)
|.+.+.||+|+||.||+|.... +++.||||++..+... ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998643 5789999999764322 234567889999999999999999999875432
Q ss_pred -EEEEEEeecCCCChhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 84 -KIYFVMEYAKGGELFKKVSK-------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 84 -~~~lv~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887632 2478899999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPT 233 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (450)
+................+++.|++||.+....+. .++|||||||++|+|++ |..||...+....+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8654321111111233456789999998777664 79999999999999999 89999887777766665543 344556
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++..+.+++.+||+.+|++|||+.+++.
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=307.26 Aligned_cols=240 Identities=28% Similarity=0.496 Sum_probs=202.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||++.. +++.+|+|.+..+. ....+.+|+.+++.++||||+++++++..+ ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 35799999999999999999864 78899999986532 235678999999999999999999998665 47999
Q ss_pred EeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999865 25899999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLL 243 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll 243 (450)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+.... ...+..++.++.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 122234567999999877665 489999999999999997 999999887776666654442 234556889999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 045214 244 SRILDPNPSTRISIAKIME 262 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (450)
.+||+.+|+.||+++++++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=308.55 Aligned_cols=249 Identities=28% Similarity=0.562 Sum_probs=208.6
Q ss_pred CeeeeceEeecCCeEEEEEEEcC-CCcEEEEEEeecccc-------cccchHHHHHHHHHHHHh-CCCCCccEEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKI-------LKVGLVDQTKREISVMRL-IQHPNVMQIYEVMAS 81 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 81 (450)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .......++.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999988 788999999864321 112234566788888865 799999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
++..|++|||++|++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988732 468999999999999999999996 7899999999999999999999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC-C-C
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF-P-T 233 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-p-~ 233 (450)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....... + .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 86543221 3345678999999999987665 589999999999999999999998887766666665544332 2 2
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+++++.+++.+||+.||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.56 Aligned_cols=235 Identities=22% Similarity=0.294 Sum_probs=192.7
Q ss_pred ceEeecCCeEEEEEEEcCCC----------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 16 RLLGQGNFAKVYYARHLGTG----------QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 35788877654321 4677899999999999999999999887 778
Q ss_pred EEEEeecCCCChhhHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-------CeEEeecCch
Q 045214 86 YFVMEYAKGGELFKKVSK-G-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-------MLKVTDFGLS 156 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-------~vkl~DFGls 156 (450)
|+||||+++|+|.+++.. . .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999975 3 689999999999999999999999999999999999999887 7999999988
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCCCCCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFPTW 234 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (450)
..... .....++..|+|||++... ...+.++|||||||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 64322 2234567889999998766 244589999999999999999 688887765433333222 22223333
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....+.+++.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3489999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=312.12 Aligned_cols=255 Identities=13% Similarity=0.196 Sum_probs=193.2
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccch--------HHHHHHHHHHHHhCCCCCcc
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGL--------VDQTKREISVMRLIQHPNVM 73 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv 73 (450)
.++..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......++..+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 356678999999999999999999999877 6778888754332110000 01122334455667899999
Q ss_pred EEEEEEEeCC----EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCe
Q 045214 74 QIYEVMASKT----KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 74 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~v 148 (450)
++++...... ..|+++|++.. ++.+.+.. ...++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9999765543 45788887744 56666655 347889999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccC-----CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HH---
Q 045214 149 KVTDFGLSALAKCKHQ-----DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MA--- 219 (450)
Q Consensus 149 kl~DFGls~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~--- 219 (450)
+|+|||+|+....... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999875532111 111223469999999999987776 4899999999999999999999987632 21
Q ss_pred -----HHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 220 -----MYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 220 -----~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....+......+ +..+.++.+++..|+..+|++||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333333 346789999999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=306.09 Aligned_cols=267 Identities=24% Similarity=0.417 Sum_probs=217.0
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-- 81 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (450)
++-...+.|+-...+|+|+||+||+|+.+.+|+.||+|++--+.. +.++-....+|+.+|..++|+|++.+++++..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 444567789999999999999999999999999999987644332 23444566799999999999999999987633
Q ss_pred ------CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeec
Q 045214 82 ------KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 82 ------~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DF 153 (450)
...+|+|+.+|+. +|+-++.+ -+++..++..+++++++||.|+|++.|+|||+||+|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3459999999976 78888876 37999999999999999999999999999999999999999999999999
Q ss_pred CchhhhhcccC--CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh--cCC
Q 045214 154 GLSALAKCKHQ--DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK--ADY 229 (450)
Q Consensus 154 Gls~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~ 229 (450)
|+++.+..... .......+-|.+|++||.+.+..-++++.|||+-||||.+|.++.+-+.+.+.......|.. +.+
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99965543321 12234456799999999999887778999999999999999999999988766554444422 100
Q ss_pred --------------------CCCCC-------------CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 230 --------------------KFPTW-------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 230 --------------------~~p~~-------------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
++|.. -.+++.+|+.+||..||.+|+++.++++|.||.+...+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 01110 14578999999999999999999999999999875443
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.84 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=203.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEc----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Q 045214 10 QKYELGRLLGQGNFAKVYYARHL----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KT 83 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (450)
..|++.+.||+|+||.||+|... .+++.+|+|++...... .....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 34889999999765432 345788999999999999999999999877 66
Q ss_pred EEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999764 499999999999999999999999999999999999999999999999999875432
Q ss_pred ccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH---------------HHHHHh
Q 045214 162 KHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA---------------MYRKIA 225 (450)
Q Consensus 162 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------------~~~~i~ 225 (450)
.... .......++..|+|||.+....+ +.++||||||+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 01112244567999999877665 489999999999999999999987542211 112222
Q ss_pred h-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 226 K-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 226 ~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
. ...+.+..++.++.+++.+||+++|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 123345567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.17 Aligned_cols=244 Identities=18% Similarity=0.286 Sum_probs=191.6
Q ss_pred ceEeecCCeEEEEEEEcCC--CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQGNFAKVYYARHLGT--GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
+.||+|+||.||+|+.... ...+++|.+...... ...+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999986433 345667776554321 235678899999999999999999999999999999999999
Q ss_pred CCChhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 94 GGELFKKVSKG-----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 94 gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
+|+|.+++.+. ..++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998642 3567788899999999999999999999999999999999999999999987532111111112
Q ss_pred ccccCCCcccCchhcccCC------CCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-C-----CCCCCC
Q 045214 169 HTTCGTPAYVAPEVISRRG------YDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-Y-----KFPTWF 235 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~ 235 (450)
...++++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... . ..+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12468999999999999997 578998776666555543322 1 223347
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+.+++..|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.11 Aligned_cols=241 Identities=33% Similarity=0.561 Sum_probs=198.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC------
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT------ 83 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 83 (450)
+-|..-+.||+||||.||+++++.+|+.||||.+++.... ...+..-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 5688899999999999999999999999999999886533 33577789999999999999999999865543
Q ss_pred EEEEEEeecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec--CCC--CeEEeecCc
Q 045214 84 KIYFVMEYAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD--ENG--MLKVTDFGL 155 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~--~~~--~vkl~DFGl 155 (450)
...+|||||.||+|+..+++ .+++|.+.+.++..+..||.|||++||+||||||+||++- .+| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 57899999999999999975 3799999999999999999999999999999999999994 334 469999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-----HHHHHHHHhhc---
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-----LMAMYRKIAKA--- 227 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~--- 227 (450)
|+-.. .+....+..||+.|.+||++.++.+++..+|.||+||++|++.||.+||.... ..-++..+.+.
T Consensus 171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 87543 34466788999999999999976666789999999999999999999997532 22333333221
Q ss_pred -----------------CCCCCCCCcHH----HHHHHHHccCCCCCCCC
Q 045214 228 -----------------DYKFPTWFSAD----VRKLLSRILDPNPSTRI 255 (450)
Q Consensus 228 -----------------~~~~p~~~s~~----~~~ll~~~L~~dP~~R~ 255 (450)
.+++|..+++. +-.+|..+|..+|++|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 12334444443 45788889999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=292.00 Aligned_cols=249 Identities=24% Similarity=0.504 Sum_probs=206.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCC--EE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKT--KI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~~ 85 (450)
.+.|++.+.+|+|.+++||.|.+..+++.++||++++-+ .+.++||+.||..|. ||||++++++..+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568999999999999999999999999999999997644 256899999999996 999999999987654 57
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~~~~ 164 (450)
.+++||++..+...+-. .++...++.|+.+|+.||.|||++||.|||+||.|+++|. ...++|+|+|+|.++. +
T Consensus 111 aLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH---p 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---P 185 (338)
T ss_pred hhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC---C
Confidence 79999998866554443 4888999999999999999999999999999999999995 4579999999997764 3
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHh-------------hcCCC
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIA-------------KADYK 230 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~-------------~~~~~ 230 (450)
.......+.+..|--||.+.+.+.+...-|+|||||+|..|+..+-||-. .+..+.+-+|. +-...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 34456678899999999998877767899999999999999999999853 32222222221 11222
Q ss_pred CCC-------------C-----------CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 FPT-------------W-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 ~p~-------------~-----------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+++ | .++++.|||.++|..|..+|+|+.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 221 1 4789999999999999999999999999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=314.69 Aligned_cols=264 Identities=28% Similarity=0.480 Sum_probs=219.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc----cchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK----VGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
.+|.+||.++.+||+|||++||+|.+....++||+|+-...+..+ .+..+...+|..|.+.|.||.||++|+++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 468889999999999999999999999999999999976655433 3456677899999999999999999999964
Q ss_pred -CCEEEEEEeecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCcEEec---CCCCeEEeecC
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSR--GVYHRDLKPENLLLD---ENGMLKVTDFG 154 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~--gi~HrDikp~NILl~---~~~~vkl~DFG 154 (450)
.+.+|-|+|||+|.+|.-++... -++|.+++.|+.||+.||.||.+. -|+|-||||.||||- .-|.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 55688999999999999999874 689999999999999999999986 599999999999994 34789999999
Q ss_pred chhhhhcccCC-----CCcccccCCCcccCchhcccC---CCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHH--H
Q 045214 155 LSALAKCKHQD-----GLLHTTCGTPAYVAPEVISRR---GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYR--K 223 (450)
Q Consensus 155 ls~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~--~ 223 (450)
+|........+ .+.....||-+|++||.+.-. +..+.++||||.|||+|.++.|+-||...... ++++ -
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99876543322 234456799999999988532 33467999999999999999999999875432 2222 1
Q ss_pred H-hhcCCCCC--CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 224 I-AKADYKFP--TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 224 i-~~~~~~~p--~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
| ......|| +.+++++++||++||++.-+.|..+.++-.||||...
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2 22234455 4589999999999999999999999999999999764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=328.43 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=222.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe-----C
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS-----K 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-----~ 82 (450)
.+.|++.+++|.|++|+||+++++.+++..|+|+.+.+... .+.++.|.++++.+ .|||++.+|++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 35799999999999999999999999999999999876533 36778899999888 69999999999853 5
Q ss_pred CEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
+++|+|||||.||+..|++++ .++.|+.+..|++.++.|+.+||.+.++|||||=.|||++.+|.|||+|||.|+..
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999976 47999999999999999999999999999999999999999999999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccC-----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---C
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRR-----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---F 231 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~ 231 (450)
.. ..+...+..|||.|||||++... .|+ ..+|+||||++..||-.|.+|+-+..++..+..|-....+ -
T Consensus 174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 32 23345678999999999999643 243 6899999999999999999999999988777777655432 2
Q ss_pred CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 232 PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 232 p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
|..++.++.++|..||.+|-.+||+..++++|||+....
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 555789999999999999999999999999999998544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.69 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=214.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.-++.+.||+|+||+||+|+... ....||||.++..... ....+++||++++..++|||||++++++..++..
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45778999999999999999643 3457999999766532 3568899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 86 YFVMEYAKGGELFKKVSK---------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
|+|+||+..|+|.+++.. .+++..+...++.||+.|+.||-++.++||||-..|+||.++-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 999999999999998742 12778899999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD- 228 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 228 (450)
+|||+++..-..+.-.......-..+|||||.+....|. .+|||||+||+|||+++ |..||.+.+..+..+.+..+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999998754322222222233446689999999988875 89999999999999998 999999999989888887765
Q ss_pred CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHh
Q 045214 229 YKFPTWFSADVRKLLSRILDPNPSTRISIAKIM 261 (450)
Q Consensus 229 ~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil 261 (450)
++.|..+|.++.+|+..||+.+|.+||++.||-
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 577899999999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.26 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=177.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCC----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEE-----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGT----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEV----- 78 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~----- 78 (450)
-.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 456899999999999999999999988 999999987643211 111111 1111222222222111
Q ss_pred -EEeCCEEEEEEeecCCCChhhHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 045214 79 -MASKTKIYFVMEYAKGGELFKKVSKGKL---------------------KEDTARKYFQQLISAIDFCHSRGVYHRDLK 136 (450)
Q Consensus 79 -~~~~~~~~lv~E~~~gg~L~~~i~~~~l---------------------~e~~~~~~~~qll~aL~~LH~~gi~HrDik 136 (450)
......+++|+||+.+++|.+++....+ .+..+..++.|++.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456689999999999999998865321 234567899999999999999999999999
Q ss_pred CCcEEecC-CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCC---------------------CCccc
Q 045214 137 PENLLLDE-NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD---------------------GDKAD 194 (450)
Q Consensus 137 p~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---------------------~~~~D 194 (450)
|+|||++. ++.+||+|||+|+..... ........++|+.|+|||.+...... +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 679999999998754321 12223456899999999976432211 23569
Q ss_pred hhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC-------CC--------------CCcHHHHHHHHHccCCCCCC
Q 045214 195 IWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF-------PT--------------WFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 195 iwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-------p~--------------~~s~~~~~ll~~~L~~dP~~ 253 (450)
||||||+||+|+++..|++.. .......+....... ++ ..+....+||.+||++||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999988775532 222222222211111 01 11234558999999999999
Q ss_pred CCCHHHHhcCccccc
Q 045214 254 RISIAKIMENPWFRK 268 (450)
Q Consensus 254 R~s~~eil~hp~f~~ 268 (450)
|||+.++|+||||+.
T Consensus 441 R~ta~e~L~Hpff~~ 455 (566)
T PLN03225 441 RISAKAALAHPYFDR 455 (566)
T ss_pred CCCHHHHhCCcCcCC
Confidence 999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.46 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=210.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCC-Cc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGT-GQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~-~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.-++.+.||+|+||.||.|...+. |. .||||.+.+.. +......+.+|..+|+.++|||||+++++.-+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 567899999999999999997763 32 38888886653 335567889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 86 YFVMEYAKGGELFKKVSKG--------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
+|++|||+||+|..+|++. .++......++.|++.|+.||++++++||||...|+||+....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999753 37888999999999999999999999999999999999999999999999998
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHH-HHhhcCCCCCCCC
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYR-KIAKADYKFPTWF 235 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~-~i~~~~~~~p~~~ 235 (450)
..-....-.......-...|||||.+.+..+ +.++||||+||+|||+++ |..||.+.+..+... -...+.++.|..+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 3221111000001122357999999998666 489999999999999999 999999988777666 4455677889999
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+..+.+++..||+.+|+.||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999997
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.81 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=194.5
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-EEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-KIYFV 88 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv 88 (450)
+.|.-...||+|+||.||+|.... |..||||.+....... ..++.+|+.++.+++|||+|++++++.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 467778899999999999999854 4899999876654321 355999999999999999999999999998 59999
Q ss_pred EeecCCCChhhHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 89 MEYAKGGELFKKVSK--G-KLKEDTARKYFQQLISAIDFCHSRG---VYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~-~l~e~~~~~~~~qll~aL~~LH~~g---i~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
+||++.|+|.+.+.. + .++.....+|+.+++.||+|||+.. |+||||||+|||||++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999965 3 7899999999999999999999854 999999999999999999999999999544321
Q ss_pred cCCCCcccc-cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc------HHH-HHHHHhhcC------
Q 045214 163 HQDGLLHTT-CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN------LMA-MYRKIAKAD------ 228 (450)
Q Consensus 163 ~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~-~~~~i~~~~------ 228 (450)
.....+. .||.+|+|||.+..... +.++||||+|++|.||++|+.|.+... ... ....+....
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 1112222 79999999999876444 589999999999999999998887532 111 111222211
Q ss_pred CCCC-CCCc--HH---HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 229 YKFP-TWFS--AD---VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 229 ~~~p-~~~s--~~---~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+. ..++ .+ +..+..+|++.+|..||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1223 22 456778999999999999999754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.36 Aligned_cols=254 Identities=30% Similarity=0.513 Sum_probs=215.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC------CCccEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH------PNVMQIYEV 78 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~ 78 (450)
|.+|.++|.+....|+|-|++|..|.+..-|..||||+|..+... ...-.+|++||++|+. -++++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 678999999999999999999999999998999999999876543 3445689999999952 479999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeec
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSK-G---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDF 153 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DF 153 (450)
|...+++|||+|.+. ..|.+.+.+ | ++....++.|++||+.||..|...||+|.||||+|||+++.. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999885 488888876 3 588999999999999999999999999999999999998765 5899999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT 233 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (450)
|.|...... ....+.-+..|.|||++.+.+|+ ...|+||.||+||||.||+..|.+.....|++.......++|.
T Consensus 582 GSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASEN----EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred ccccccccc----cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 988655432 23334456689999999999997 8999999999999999999999998777776655444434433
Q ss_pred CC------------------------------------------------------------cHHHHHHHHHccCCCCCC
Q 045214 234 WF------------------------------------------------------------SADVRKLLSRILDPNPST 253 (450)
Q Consensus 234 ~~------------------------------------------------------------s~~~~~ll~~~L~~dP~~ 253 (450)
.+ -..+++||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 10 124889999999999999
Q ss_pred CCCHHHHhcCccccc
Q 045214 254 RISIAKIMENPWFRK 268 (450)
Q Consensus 254 R~s~~eil~hp~f~~ 268 (450)
|.|+.++|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=286.83 Aligned_cols=239 Identities=44% Similarity=0.825 Sum_probs=206.7
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCChhhHH
Q 045214 22 NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV 101 (450)
Q Consensus 22 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 101 (450)
+||.||+|.+..+++.+|+|++........ .+.+.+|+..++.++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999976543321 578899999999999999999999999999999999999999999999
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCc
Q 045214 102 SKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180 (450)
Q Consensus 102 ~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aP 180 (450)
... .++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999886543221 23455688999999
Q ss_pred hhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHhhcCCCCCCC---CcHHHHHHHHHccCCCCCCCCC
Q 045214 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYKFPTW---FSADVRKLLSRILDPNPSTRIS 256 (450)
Q Consensus 181 E~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~ll~~~L~~dP~~R~s 256 (450)
|.+....++ .++|+||||+++++|++|..||.. .+.......+.......+.. ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999866665 699999999999999999999988 55556666555554443322 7899999999999999999999
Q ss_pred HHHHhcCccc
Q 045214 257 IAKIMENPWF 266 (450)
Q Consensus 257 ~~eil~hp~f 266 (450)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=292.70 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=210.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
+.-.||.-++.+|.|+- .|-.|.+..++++||+|.+.... ......++..+|..++..++|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 88899999999999999987663 2233457788999999999999999999998443
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|+|||++++ +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|....
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999976 7777766 457888999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------ 228 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 228 (450)
.+-.....+.|..|+|||++.+.+|. ..+||||+||++.+|++|...|.+.+..+.+.++....
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 22344567889999999999998864 89999999999999999999999876655554442210
Q ss_pred ---------------CC----CCCC-----------CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 229 ---------------YK----FPTW-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 229 ---------------~~----~p~~-----------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.. +|.. -+..+++++.+||..||++|.|++++|.|||++-++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 11 1211 134589999999999999999999999999998554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.02 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=188.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc----------------CCCcEEEEEEeeccccccc-----------chHHHHHH
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL----------------GTGQSVAIKAIDKDKILKV-----------GLVDQTKR 59 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~ 59 (450)
.-.++|++.+.||+|+||.||+|... ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34668999999999999999999752 2456799999865432100 01122335
Q ss_pred HHHHHHhCCCCCc-----cEEEEEEEe--------CCEEEEEEeecCCCChhhHHhc--C--------------------
Q 045214 60 EISVMRLIQHPNV-----MQIYEVMAS--------KTKIYFVMEYAKGGELFKKVSK--G-------------------- 104 (450)
Q Consensus 60 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~--~-------------------- 104 (450)
|+.++.+++|.++ +++++++.. .+..|+|+||+++++|.+++.. +
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766654 566666532 4568999999999999888753 1
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCch
Q 045214 105 ---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181 (450)
Q Consensus 105 ---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE 181 (450)
.++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 13456788999999999999999999999999999999999999999999986432211 11111234589999999
Q ss_pred hcccCCC--------------------C-CCccchhhHHHHHHHHhhCCC-CCCCCcH-----------HHHHHHHhhcC
Q 045214 182 VISRRGY--------------------D-GDKADIWSCGVILYVLLAGYL-PFHDSNL-----------MAMYRKIAKAD 228 (450)
Q Consensus 182 ~l~~~~~--------------------~-~~~~DiwSlGvil~~ll~g~~-Pf~~~~~-----------~~~~~~i~~~~ 228 (450)
++..... . ..+.|+||+||++|+|++|.+ ||.+... ...++.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9854221 1 124799999999999999986 7754211 11122222333
Q ss_pred CCCC--CCCcHHHHHHHHHccCCCC---CCCCCHHHHhcCccccc
Q 045214 229 YKFP--TWFSADVRKLLSRILDPNP---STRISIAKIMENPWFRK 268 (450)
Q Consensus 229 ~~~p--~~~s~~~~~ll~~~L~~dP---~~R~s~~eil~hp~f~~ 268 (450)
+.++ ...++.+++|+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3343 3478999999999999766 68999999999999965
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.77 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=203.7
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
+-+..||.|+||+|++..++.+|+..|||.++..... ....++..|.... +.-+.||||++|+..-.++..|+.||+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3467899999999999999999999999999877652 3346777787665 445899999999999999999999999
Q ss_pred cCCCChhhH------HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 92 AKGGELFKK------VSKGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 92 ~~gg~L~~~------i~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
++- +|..+ +.+..++|+.+-.+....+.||.||... .|+|||+||+||||+..|.+||||||++......
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 964 44332 1346799999999999999999999864 8999999999999999999999999998543211
Q ss_pred CCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhcCCCC---CCC---C
Q 045214 165 DGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKADYKF---PTW---F 235 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~---p~~---~ 235 (450)
-......|..+|||||.+.. .+|+ .+||+||||++|||+.||..||..-+ ..+....+..+..+. +.. +
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 11234468899999999864 4565 89999999999999999999998754 345555555555432 222 7
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+..+..+|.-||.+|-+.||...+++.+||++..
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 8999999999999999999999999999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.85 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=216.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcC-CCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLG-TGQ--SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
++..+.++||+|.||.|+.|.+.. +|+ .||||++..+.... ....+.+|+.+|.+|+|||+++||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 356778999999999999999865 344 58999998876543 56889999999999999999999999987 6788
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+|++++|+|.+.+.+ +.|.......|+.||+.|+.||.+++++||||-..|+||-....|||+||||.+-.....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999976 468889999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCc-ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 164 QDGLL-HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
..... ....-...|+|||.+....+. .++|+|++||++|||++ |+.||.+.+..+++++|..+ .++.|+.+|.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 21111 111234469999999888775 89999999999999998 89999999999999988643 4677888999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
+++..||..+|.+|||+..|.+.-+.+
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999997554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.76 Aligned_cols=134 Identities=28% Similarity=0.517 Sum_probs=118.0
Q ss_pred cccccc-cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CC---CccE
Q 045214 4 KGKVLM-QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-----HP---NVMQ 74 (450)
Q Consensus 4 ~g~~l~-~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hp---nIv~ 74 (450)
-|++|. +||-+.++||-|-|++||+|.+..+.+.||+|+.+.... ..+....||.+|++++ |+ +||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 478888 899999999999999999999999999999999986543 3456778999999883 33 6999
Q ss_pred EEEEEEe----CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEe
Q 045214 75 IYEVMAS----KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLL 142 (450)
Q Consensus 75 l~~~~~~----~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl 142 (450)
|++.|.. +.++++|+|++ |..|..+|.. .+++...++.|++|++.||.|||.. ||+|.||||||||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9999854 56899999998 7789888865 4799999999999999999999975 99999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=295.76 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=204.1
Q ss_pred eeeceEeecCCeEEEEEEEcCC----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGT----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.+.||+|.||.||.|..... .-.||||..+.+... ...+.+..|..+|+.++||||+++++++.+. ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 4567899999999999986432 345999998876543 3367889999999999999999999999754 58999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||+++-|+|..++.. ..++......|+.||+.||+|||+..++||||-..|||+.....|||+|||+|+..... .
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~---~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD---A 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc---c
Confidence 999999999999976 46888999999999999999999999999999999999999999999999999865432 2
Q ss_pred CcccccC--CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhh-cCCCCCCCCcHHHHHH
Q 045214 167 LLHTTCG--TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAK-ADYKFPTWFSADVRKL 242 (450)
Q Consensus 167 ~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~l 242 (450)
.+....| ..-|||||.+.-..+. .++|||-+||+|||+|. |.-||.+....+..-.+.+ ...+.|+.+++.+..|
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred hhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence 2333333 3459999999777664 89999999999999876 9999998665555545544 4578899999999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||+++|.+||.+.+|..
T Consensus 625 mskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHhccCcccCCcHHHHHH
Confidence 99999999999999877653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=293.93 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=207.0
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+-.+++.||+|-||+|.+|+-. .+..||+|.++.+... .....+.+||++|.+|+||||+++++++..++.+++++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 5678999999999999999974 3689999999887644 346789999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 91 YAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~---l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|++.|+|.+++.... ........++.||++|++||.+.+++||||.+.|+|+|.++++||+|||+|+..-....-..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999999997652 23455667999999999999999999999999999999999999999999874332222222
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--CCCCCCCCcHHHHHHHHhhc--------CCCCCCCCcH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA--GYLPFHDSNLMAMYRKIAKA--------DYKFPTWFSA 237 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~ 237 (450)
....+-..+|||||.+....+. .++|+|++|+++||+++ ...||...+..+..++...- ....|.-++.
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 2233456789999999887775 89999999999999754 78999987776665554321 2345677899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+++.+|+..+-++|||.+++..
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=279.93 Aligned_cols=255 Identities=25% Similarity=0.460 Sum_probs=207.7
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-----KIY 86 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 86 (450)
.+-.+.||-|+||.||.+.+..+|+.||+|.+..-. ..-...+++.+|+++|.-.+|.|++...++..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455788999999999999999999999999875322 22234578899999999999999999998875543 478
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
++.|.+.. +|...|-. ..++.+.+.-++.||++||+|||+.||.||||||.|+|++.|..+||||||+++........
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88888865 67776654 67999999999999999999999999999999999999999999999999999876544332
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhh-------------------
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK------------------- 226 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------- 226 (450)
. ....+-|-+|+|||++.+...++.+.||||.|||+.|||..+..|...++.+.++.|..
T Consensus 213 h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 N-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred h-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2 23446788999999999988778999999999999999999999988776555444421
Q ss_pred ----cCCCCCCC-----------CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 227 ----ADYKFPTW-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 227 ----~~~~~p~~-----------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+....|+. -..+...++.++|.+||.+|++.++.+.|++...+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 12222221 13467899999999999999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.44 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=216.1
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
.-.|.++||.|.||+|++|+.+..|+ .||||.++..... .....+..|..||.+.+||||++|.++......+.|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 45788999999999999999987764 5999999866533 446788999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
|.|||++|+|..+++. |.++.-++..+++.|+.|++||-+.|++||||...|||++.+-.+|++|||+|++..... .
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~ 786 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-E 786 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-C
Confidence 9999999999999975 689999999999999999999999999999999999999999999999999998765433 2
Q ss_pred CCcccccC--CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 166 GLLHTTCG--TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 166 ~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
....+.-| ..+|.|||.+....+. .+|||||+||+|||.++ |..||.+.+..+..+.|..+ .++.|..++..+.+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred ccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 22333323 3579999999888775 89999999999998765 99999998888888887654 45667789999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
|+..||++|-.+||.+.||+.
T Consensus 866 LMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHH
Confidence 999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=294.75 Aligned_cols=199 Identities=32% Similarity=0.579 Sum_probs=179.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHH-----HHHHHHHHHHhCC---CCCccEEEEEEEeC
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD-----QTKREISVMRLIQ---HPNVMQIYEVMASK 82 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~-----~~~~Ei~il~~l~---hpnIv~l~~~~~~~ 82 (450)
.|..++.||+|+||+|++|.++.+...|+||.|.++.+.-....+ .+-.||+||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 599999999999999999999999999999999988765433222 2457999999997 99999999999999
Q ss_pred CEEEEEEeec-CCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYA-KGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~-~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
+.+|++||-- +|-+|+++|+. ..++|.++..+|+|+..|+++||++||+|||||-||+.++.+|-+||+|||.|...+
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999999965 46699999986 579999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCC
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH 213 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 213 (450)
.+...+..||..|+|||++.+..|-+..-|||+||++||.+.....||.
T Consensus 722 ----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 ----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4456688999999999999999999999999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=301.78 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=223.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++++.+|.|+||.||+|+++.+++..|+|+++.+.-.. ..-+.+|+-+++.++||||+.+++.+-.....+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 468999999999999999999999999999999998765432 35567899999999999999999999999999999
Q ss_pred EeecCCCChhhHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVS-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||||.||+|.+.-. .+.++|.++....+..+.||+|||+.|-+|||||=.|||+++.|.+|++|||.+......- ..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--hh
Confidence 99999999998765 4899999999999999999999999999999999999999999999999999986543222 12
Q ss_pred cccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC-----CCcHHH
Q 045214 168 LHTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-----WFSADV 239 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~~~ 239 (450)
..+..|||+|||||+.. ..+|. ..+|||++|++..++-.-+.|-.+..++.....+.+..+..|. .+++.+
T Consensus 169 rksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 34668999999999863 34554 8999999999999999989998888888777777777666553 478999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+|++.+|.++|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999998653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=326.11 Aligned_cols=236 Identities=22% Similarity=0.352 Sum_probs=187.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
..|...+.||+|+||.||+|++..++..||+|.+...... ..+|+.++++++||||+++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566778999999999999999889999999998643321 135688999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH---SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH---~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||++||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 99999999999964 888999999999999999999 6699999999999999998888775 66543221
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-----HHHHHHHHhh---------cCC---
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-----LMAMYRKIAK---------ADY--- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~---------~~~--- 229 (450)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||+... .....+.... ...
T Consensus 834 ~~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 834 TDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred cCCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 11233688999999999877764 89999999999999999999986421 1111111000 000
Q ss_pred -CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 -KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 -~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 011111235778999999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.31 Aligned_cols=244 Identities=28% Similarity=0.476 Sum_probs=194.5
Q ss_pred eeeeceEeecCCeE-EEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Q 045214 12 YELGRLLGQGNFAK-VYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 12 y~~~~~LG~G~fg~-Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
|.--+.+|.|+.|+ ||+|.. .|+.||||.+-.+ ....+.|||..|+.. .|||||++|..-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34457789999985 899988 7899999987543 345678999999988 6999999999999999999999
Q ss_pred eecCCCChhhHHhcC-C----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CC--CeEEeecCchhhh
Q 045214 90 EYAKGGELFKKVSKG-K----LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NG--MLKVTDFGLSALA 159 (450)
Q Consensus 90 E~~~gg~L~~~i~~~-~----l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~--~vkl~DFGls~~~ 159 (450)
|.|.- +|.++++.. . ......+..+.|++.||++||+.+|+||||||.||||+. ++ .++|+|||+++..
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99965 899999873 1 111456788999999999999999999999999999976 34 6899999999755
Q ss_pred hcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhcCCCCC---CC
Q 045214 160 KCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKADYKFP---TW 234 (450)
Q Consensus 160 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~p---~~ 234 (450)
..... -....+..||-+|+|||++..... ..++|||||||++|+.++| ..||.+.-.. ..+|..+...+- +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccC
Confidence 43322 122445679999999999987655 4799999999999988885 9999875332 234444444321 11
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
-..++.+||.+||+++|..||++.++|.||+|=
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 112899999999999999999999999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.40 Aligned_cols=240 Identities=28% Similarity=0.468 Sum_probs=209.2
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeec
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
...+.||.|.||.||.|.++.-.-.||||.++.+... .+.+.+|..+|+.++|||+|++++++..+..+|||.|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3467899999999999999988889999999765432 567889999999999999999999999999999999999
Q ss_pred CCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 93 KGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 93 ~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
..|.|.+++++. .++.-....++.||.+|+.||..+++|||||-..|+|+.++..||++||||+++..... +.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT----YT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT----YT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc----ee
Confidence 999999999763 46667778888999999999999999999999999999999999999999998764321 11
Q ss_pred cccC---CCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHH
Q 045214 170 TTCG---TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 170 ~~~g---t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~ 244 (450)
...| ..-|.|||-+..+.+. .++|||++||+|||+.| |..||.+-+..+.|..+.++ ...-|..+++.+..|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 1122 3469999999877664 89999999999999988 89999999999988877654 35678889999999999
Q ss_pred HccCCCCCCCCCHHHHh
Q 045214 245 RILDPNPSTRISIAKIM 261 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil 261 (450)
.||+++|.+||+++||-
T Consensus 501 aCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHhcCCcccCccHHHHH
Confidence 99999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=275.00 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=203.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.+.+.|..++.||+|+|++||+|.+.. .++.||+|.+..... -.++.+|+++|..+ .+.||+++.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 456789999999999999999999887 788999999876543 25688999999999 699999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~~~vkl~DFGls~~~~~ 161 (450)
++..+|+||++..+..++... ++...++.|++.++.||.++|.+||+||||||.|+|.+ ..+.-.|+|||+|.....
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999887777766 67889999999999999999999999999999999997 456789999999861110
Q ss_pred cc-------------------------------CCCCc-----------ccccCCCcccCchhcccCCCCCCccchhhHH
Q 045214 162 KH-------------------------------QDGLL-----------HTTCGTPAYVAPEVISRRGYDGDKADIWSCG 199 (450)
Q Consensus 162 ~~-------------------------------~~~~~-----------~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 199 (450)
.. ..+.. -...||++|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00000 0124999999999999888888999999999
Q ss_pred HHHHHHhhCCCCCCCCcH-----HHH--------HHHHh---------------------------------hcCC---C
Q 045214 200 VILYVLLAGYLPFHDSNL-----MAM--------YRKIA---------------------------------KADY---K 230 (450)
Q Consensus 200 vil~~ll~g~~Pf~~~~~-----~~~--------~~~i~---------------------------------~~~~---~ 230 (450)
+|+..++++..||-.... .++ .++.. +... .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999853211 000 00000 0000 0
Q ss_pred ---CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 ---FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 ---~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....++..+.+|+.+||+.||.+|+|++++|.||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00124668999999999999999999999999999973
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=274.87 Aligned_cols=243 Identities=22% Similarity=0.351 Sum_probs=196.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH--hCCCCCccEEEEEEEeCC----E
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR--LIQHPNVMQIYEVMASKT----K 84 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~----~ 84 (450)
.-.+.+++|+|.||.||+|.. +++.||||++.... .+.+..|-+|.+ .++|+||+++++.-...+ .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 457789999999999999998 66999999996533 355666777766 458999999998865555 8
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS---------RGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~---------~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
++||+||.+.|+|.+++....++.....+++..+++||+|||+ -.|+|||||..||||..++...|+|||+
T Consensus 283 ywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999999999999999999999999999996 2599999999999999999999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCC-----CCccchhhHHHHHHHHhhC------------CCCCC-----
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD-----GDKADIWSCGVILYVLLAG------------YLPFH----- 213 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DiwSlGvil~~ll~g------------~~Pf~----- 213 (450)
|..+......+.....+||.+|||||++.+.--- -.+.||||+|.+||||++. ++||.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887766666667778999999999999763211 1357999999999999874 23444
Q ss_pred CCcHHHHHHHHhh--cCCCCCCC-----CcHHHHHHHHHccCCCCCCCCCHHHHh
Q 045214 214 DSNLMAMYRKIAK--ADYKFPTW-----FSADVRKLLSRILDPNPSTRISIAKIM 261 (450)
Q Consensus 214 ~~~~~~~~~~i~~--~~~~~p~~-----~s~~~~~ll~~~L~~dP~~R~s~~eil 261 (450)
.++..++...... .+..+|.. ....+.+.+..||+.||+-|.|+.=+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 2344555554433 33444432 235688999999999999999986443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=246.47 Aligned_cols=209 Identities=26% Similarity=0.483 Sum_probs=170.4
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
..-+..||+|++|.|-+.++..+|...|+|.+...-. .....++.+|+.+..+. .+|++|++|+.+.....+++.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3457789999999999999999999999999875432 23346777888876554 89999999999999999999999
Q ss_pred ecCCCChhhH----Hhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 91 YAKGGELFKK----VSK-GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 91 ~~~gg~L~~~----i~~-~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
.++. +|..+ +.+ +.++|..+-+++-.++.||.|||++ .++|||+||+|||++.+|++|+||||+|....
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---- 200 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---- 200 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh----
Confidence 9964 56444 334 4799999999999999999999987 89999999999999999999999999986543
Q ss_pred CCCccc-ccCCCcccCchhcc----cCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHhhcC
Q 045214 165 DGLLHT-TCGTPAYVAPEVIS----RRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKAD 228 (450)
Q Consensus 165 ~~~~~~-~~gt~~y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~ 228 (450)
+....+ ..|...|||||.+. ..+|+ -++||||||++++||.+++.||+. .++-+.++++.+..
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 222223 46888999999985 34564 899999999999999999999986 45556666665543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=246.39 Aligned_cols=212 Identities=44% Similarity=0.814 Sum_probs=186.5
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCCh
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL 97 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (450)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999998665321 346789999999999999999999999999999999999999999
Q ss_pred hhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhcccCCCCcccccCC
Q 045214 98 FKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174 (450)
Q Consensus 98 ~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~gt 174 (450)
.+++... .++...+..++.+++.++++||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999874 7999999999999999999999999999999999999999 89999999998865432211 12345678
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987753445899999999999999 678999999999999999
Q ss_pred CCHHHHhcCc
Q 045214 255 ISIAKIMENP 264 (450)
Q Consensus 255 ~s~~eil~hp 264 (450)
|++++++.|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.98 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=202.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE-EEeCCE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV-MASKTK 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~ 84 (450)
.+.+.|.+.+.||+|.||++.+|+++.++..+++|.+...... .+.+.+|...--.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4677899999999999999999999999999999999876533 46677887665445 68999998886 677888
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec--CCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD--ENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~--~~~~vkl~DFGls~~~~~~ 162 (450)
++++|||++-|+|...+...++.|.....++.|+++|+.|+|+.+++|||||.+||||- +...+||||||+++..+
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 99999999999999999998999999999999999999999999999999999999994 33489999999875322
Q ss_pred cCCCCcccccCCCcccCchhcccCC---C-CCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcC-CCCCC
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRG---Y-DGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKAD-YKFPT 233 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~---~-~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~-~~~p~ 233 (450)
........+..|.|||++.... + ..+.+|+|.+|+++|.+|||.+||..... ...+.++.... ...|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 1222333566899999875321 1 23578999999999999999999985432 23344443332 33443
Q ss_pred ---CCcHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 045214 234 ---WFSADVRKLLSRILDPNPSTR---ISIAKIMENPWFRK 268 (450)
Q Consensus 234 ---~~s~~~~~ll~~~L~~dP~~R---~s~~eil~hp~f~~ 268 (450)
.+|+.+..+.++-|.++|++| .++..-....|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 378999999999999999999 56666667777654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.83 Aligned_cols=247 Identities=25% Similarity=0.482 Sum_probs=193.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH--hCCCCCccEEEEEEEe---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR--LIQHPNVMQIYEVMAS--- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~--- 81 (450)
++..+-.+.+.||+|.||+||+|+. -|+.||||++.... .+...||.+|+. .|+|+||+.+++.-..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 5667889999999999999999999 67899999997543 245567777776 5599999999876432
Q ss_pred -CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEecCCCCeEEee
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR--------GVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDikp~NILl~~~~~vkl~D 152 (450)
-+++|+|.+|-+.|+|+|++.+..++.+...+++..++.||+|||.. .|+|||||..|||+..+|..-|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 24799999999999999999999999999999999999999999952 499999999999999999999999
Q ss_pred cCchhhhhccc--CCCCcccccCCCcccCchhcccCC----CCC-CccchhhHHHHHHHHhhC----------CCCCCC-
Q 045214 153 FGLSALAKCKH--QDGLLHTTCGTPAYVAPEVISRRG----YDG-DKADIWSCGVILYVLLAG----------YLPFHD- 214 (450)
Q Consensus 153 FGls~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~----~~~-~~~DiwSlGvil~~ll~g----------~~Pf~~- 214 (450)
+|||-...... .+-..+..+||.+|||||++...- +.+ ..+||||+|.++||+... .+||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99985443321 112235679999999999986421 111 368999999999999752 578864
Q ss_pred ----CcHHHHHHHHh--hcCCCCCC-CCcH----HHHHHHHHccCCCCCCCCCHHHHh
Q 045214 215 ----SNLMAMYRKIA--KADYKFPT-WFSA----DVRKLLSRILDPNPSTRISIAKIM 261 (450)
Q Consensus 215 ----~~~~~~~~~i~--~~~~~~p~-~~s~----~~~~ll~~~L~~dP~~R~s~~eil 261 (450)
++.++|.+-+. +....+|. |-+. .+..+++.||..||.-|.|+--|.
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 34445444332 23344454 3333 355788999999999999987664
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=285.76 Aligned_cols=247 Identities=24% Similarity=0.476 Sum_probs=206.2
Q ss_pred eeeeceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 12 YELGRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
..+.+.||+|+||.|++|.... ....||||.+...... ...+.+..|+++|+.+ +||||+.+.+.+...+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3567799999999999998542 1456999998765433 4567889999999999 6999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSKGK-----------------LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
.+++|+||+..|+|.+++...+ ++......++.||+.|++||++..++||||-..|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999997765 88999999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCC--cccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCc-HHHHHH
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTP--AYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSN-LMAMYR 222 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~--~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~-~~~~~~ 222 (450)
.+||+|||+|+.......- ......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++++
T Consensus 456 ~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred EEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 9999999999743221110 001122223 4999999998666 489999999999999998 899999854 556666
Q ss_pred HHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+..+. ...|..+++++.+++..||+.+|++||+..++.+
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 665554 4678889999999999999999999999999886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=246.21 Aligned_cols=218 Identities=42% Similarity=0.741 Sum_probs=185.7
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999875433 2457888999999999999999999999999999999999
Q ss_pred cCCCChhhHHhcC-C-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 92 AKGGELFKKVSKG-K-LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 92 ~~gg~L~~~i~~~-~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
+++++|.+++... . +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 9999999999764 4 89999999999999999999999999999999999999999999999998865543221 1233
Q ss_pred cccCCCcccCchhc-ccCCCCCCccchhhHHHHHHHHhhCCCCCCC--CcHHHHHHHHhhcCCCCCC
Q 045214 170 TTCGTPAYVAPEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHD--SNLMAMYRKIAKADYKFPT 233 (450)
Q Consensus 170 ~~~gt~~y~aPE~l-~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~p~ 233 (450)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788899999998 444444 699999999999999999999987 4445777777776644443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=276.70 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=208.2
Q ss_pred eeeceEeecCCeEEEEEEEcCCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+..++||+|+||+||+|...-.|+ +||||++...... .....+.+|.-+|..++|||+++++++..... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 456889999999999999765554 6899988766543 23567889999999999999999999987766 8899
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
++|+++|.|.|+++. +.+.......|..||++|+.|||.++++||||-..|+|+..-..+|+.|||++.+.......-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999965 679999999999999999999999999999999999999999999999999998765433322
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~ 244 (450)
......-.+.|||=|.+....|. .++||||+||++||++| |..|+.+....++-..+..+ +++.|+..+-++..++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22222234569999999887775 89999999999999998 99999998877766665443 46788889999999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 045214 245 RILDPNPSTRISIAKIME 262 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~ 262 (450)
+||..|+..||+++++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=295.31 Aligned_cols=260 Identities=28% Similarity=0.525 Sum_probs=212.2
Q ss_pred cccCe-eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecc---cccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 8 LMQKY-ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKD---KILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 8 l~~~y-~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+...| ...+.+|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..+.|||++.....+.+..
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 5688899999999999988777777777765421 1111122233677888888999999988877776666
Q ss_pred EEEEEEeecCCCChhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
..+-.||||++ +|+.++... .++..++..+++||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66667999999 999999885 8999999999999999999999999999999999999999999999999999888766
Q ss_pred cCC--CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHH--HHHhh-------cCCCC
Q 045214 163 HQD--GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY--RKIAK-------ADYKF 231 (450)
Q Consensus 163 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~--~~i~~-------~~~~~ 231 (450)
... ......+|+.+|+|||++.+..|++...||||+|++++.|.+|+.||......+.. ..... +...+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 665 45667899999999999999999999999999999999999999999875443221 11111 11112
Q ss_pred CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 232 PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 232 p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
-..++...+.+|.+||++||.+|.|+++|++++||+.
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 2237888999999999999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=290.10 Aligned_cols=198 Identities=14% Similarity=0.205 Sum_probs=145.3
Q ss_pred CCC-CCccEEEEEE-------EeCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 045214 67 IQH-PNVMQIYEVM-------ASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK 136 (450)
Q Consensus 67 l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDik 136 (450)
++| +||.++++.+ .....++.++|++ +++|.+++.. ..+++..++.+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777766 2334677888987 5599999975 469999999999999999999999999999999
Q ss_pred CCcEEecCC-------------------CCeEEeecCchhhhhcccC--------------CCCcccccCCCcccCchhc
Q 045214 137 PENLLLDEN-------------------GMLKVTDFGLSALAKCKHQ--------------DGLLHTTCGTPAYVAPEVI 183 (450)
Q Consensus 137 p~NILl~~~-------------------~~vkl~DFGls~~~~~~~~--------------~~~~~~~~gt~~y~aPE~l 183 (450)
|+||||+.. +.+|++|||+++....... .......+||+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4456666666543211000 0001124689999999999
Q ss_pred ccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 184 ~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+..| +.++|||||||+||||++|..|+..... ....+.....+ .+..-.++..+++.+||++||.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88877 4899999999999999999988764321 11222111111 11112456789999999999999999999999
Q ss_pred Cccccc
Q 045214 263 NPWFRK 268 (450)
Q Consensus 263 hp~f~~ 268 (450)
||||.+
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=236.06 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=207.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-e
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA-S 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~ 81 (450)
-..|+++.-++-+|+||.||.|...+. .+.|-+|.++.... +-....+..|.-.+..+.|||+..+.++.. +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 345788899999999999999976543 24466666643321 223566778888899999999999999864 5
Q ss_pred CCEEEEEEeecCCCChhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK---------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
....++++.+..-|+|..++.. ..++..+...++.|+..|++|||++|++|.||-..|.+||+.-++||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 5678888899988999998861 1366778888999999999999999999999999999999999999999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CC
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YK 230 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~ 230 (450)
=.+|+..-..+...+-........||+||.+.+..|. .++|+||+|++||||+| |+.||-+-++.+++..+..+. ..
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 9998755444433333344456689999999988886 89999999999999998 999999999999998887663 45
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
-|-.+++++..++..||..+|++||+.+|+..
T Consensus 519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 67789999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-27 Score=228.23 Aligned_cols=254 Identities=35% Similarity=0.619 Sum_probs=212.7
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CccEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP-NVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 90 (450)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999997 78999999877655433567889999999999988 79999999988888999999
Q ss_pred ecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccCC
Q 045214 91 YAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 91 ~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~~ 165 (450)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999877764 699999999999999999999999999999999999999998 7999999998744332221
Q ss_pred C----CcccccCCCcccCchhcccC--CCCCCccchhhHHHHHHHHhhCCCCCCCCc----HHHHHHHHhhcCCC-CCCC
Q 045214 166 G----LLHTTCGTPAYVAPEVISRR--GYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKADYK-FPTW 234 (450)
Q Consensus 166 ~----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~-~p~~ 234 (450)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||.... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34667899999999999874 355689999999999999999999988765 34555555555433 2222
Q ss_pred Cc--------HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 235 FS--------ADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 235 ~s--------~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.. ..+.+++.+++..+|..|.+..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 47899999999999999999999998877654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=221.82 Aligned_cols=157 Identities=24% Similarity=0.284 Sum_probs=127.5
Q ss_pred CChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 95 GELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
|+|.+++.. ..+++..++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 689999975 46999999999999999999999999 999999999999999 998765432 1236
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcCCCC-------CCCCcH--HHHHH
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYKF-------PTWFSA--DVRKL 242 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~l 242 (450)
||+.|+|||++.+..+. .++||||+||++|+|++|..||..... ...+..+....... +..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 899999999999999999999976543 23333332221111 122333 69999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
+.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=238.58 Aligned_cols=171 Identities=20% Similarity=0.244 Sum_probs=135.5
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcC-CCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCccE-EEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKI--LKVGLVDQTKREISVMRLIQHPNVMQ-IYEVMA 80 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~ 80 (450)
-..+.++|.+.+.||+|+||+||+|++.. +++.+|||.+..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 45788999999999999999999999876 678889998763311 12234567899999999999999985 5442
Q ss_pred eCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcEEecCCCCeEEeecCchhhh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDL-KPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDi-kp~NILl~~~~~vkl~DFGls~~~ 159 (450)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 458999999999999732 21 11 1468899999999999999999999 999999999999999999999865
Q ss_pred hcccCCCC------cccccCCCcccCchhccc
Q 045214 160 KCKHQDGL------LHTTCGTPAYVAPEVISR 185 (450)
Q Consensus 160 ~~~~~~~~------~~~~~gt~~y~aPE~l~~ 185 (450)
........ ....++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 43322111 235678999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=254.21 Aligned_cols=241 Identities=33% Similarity=0.588 Sum_probs=209.4
Q ss_pred eEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEeec
Q 045214 17 LLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
++|.|+||.|++++.. ..|..+|+|+..+....... ....+.|-.++..++ ||.+++++..+..++..|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999998743 35788999999876544322 225567888888886 999999999999999999999999
Q ss_pred CCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccc
Q 045214 93 KGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT 171 (450)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 171 (450)
.||+|+..+.+ ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999998876 468889999999999999999999999999999999999999999999999987653222 12
Q ss_pred cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCC
Q 045214 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNP 251 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP 251 (450)
|||..|||||++. ++ ..++|.||+|+++|+|++|..||.. +....|.+..+..|..+++.+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 33 3789999999999999999999998 677788888999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccccCC
Q 045214 252 STRIS-----IAKIMENPWFRKGLN 271 (450)
Q Consensus 252 ~~R~s-----~~eil~hp~f~~~~~ 271 (450)
.+|.- +.++++|++|+....
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHHhccCcchhHHHhccchheeeeH
Confidence 99985 589999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-26 Score=225.29 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=194.7
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCC----CCccEEEEEE-EeCCE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTG-QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH----PNVMQIYEVM-ASKTK 84 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 84 (450)
+|.+.+.||+|+||.||++.+..++ +.+|+|+......... ..++.|+.++..+.. +++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998774 6799998876543221 257889999988863 6899999999 58889
Q ss_pred EEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-----CCeEEeecCch
Q 045214 85 IYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-----GMLKVTDFGLS 156 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-----~~vkl~DFGls 156 (450)
-|+||+.+ |.+|.++... +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999987 7899998743 579999999999999999999999999999999999999865 36999999999
Q ss_pred hhhhcccCCC-------C-cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHH---h
Q 045214 157 ALAKCKHQDG-------L-LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI---A 225 (450)
Q Consensus 157 ~~~~~~~~~~-------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i---~ 225 (450)
+.+......+ . .....||..|+++....+... +.+.|+||++.++.+|+.|.+||..........+. .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8333211111 0 123459999999999887765 58999999999999999999999875532222222 2
Q ss_pred hcCC-C-CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 226 KADY-K-FPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 226 ~~~~-~-~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.... . +....+.++.++...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 1 233355778888888888899999998887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=204.45 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=197.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 84 (450)
-+..++|.+++.||+|+||.+|+|....+|+.||||+-....- ..++..|..+.+.|+ -..|+.+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3567899999999999999999999999999999998754432 145678999999996 4789999999999999
Q ss_pred EEEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecCchhhh
Q 045214 85 IYFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFGLSALA 159 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFGls~~~ 159 (450)
-.+||+.. |.+|.++.. +..++-..+..++.|++.-++|+|.++++||||||+|+|..- ...+.++|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 889999875 467999999999999999999999999999999999999863 346999999999766
Q ss_pred hcccCCC-----CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHHhhcCCCC
Q 045214 160 KCKHQDG-----LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKIAKADYKF 231 (450)
Q Consensus 160 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~ 231 (450)
....... .-....||.+|++--...+... +...|+-|+|.+|.++.-|.+||.+- +..+-|++|.+.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 5432211 1123469999998766554433 46789999999999999999999984 3456777887777665
Q ss_pred CC-----CCcHHHHHHHHHccCCCCCCCCC
Q 045214 232 PT-----WFSADVRKLLSRILDPNPSTRIS 256 (450)
Q Consensus 232 p~-----~~s~~~~~ll~~~L~~dP~~R~s 256 (450)
|. .+|.++...+.-|=..--++-|+
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 53 47888888888776665556665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=207.74 Aligned_cols=243 Identities=20% Similarity=0.354 Sum_probs=193.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+..-.|++++.||+|+||++++|.+.-++++||||.-.... ...++..|.+.++.| ..++|...|.+...+-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 44558999999999999999999999999999999764332 236788999999988 579999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-----CeEEeecCchhh
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-----MLKVTDFGLSAL 158 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-----~vkl~DFGls~~ 158 (450)
.+|||++ |.+|.|+.+- .+|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 8899998864 5799999999999999999999999999999999999997543 589999999987
Q ss_pred hhcccCCC-----CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC---CcHHHHHHHHhhcCCC
Q 045214 159 AKCKHQDG-----LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD---SNLMAMYRKIAKADYK 230 (450)
Q Consensus 159 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~ 230 (450)
+..+.... ...+..||.+||+=-...+... +...|+-|||-++++.|-|.+||.+ .+..+-|++|....-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 75443222 1224479999999877776654 4789999999999999999999987 4556778888655443
Q ss_pred CCC-----CCcHHHHHHHHHccCCCCCCCCC
Q 045214 231 FPT-----WFSADVRKLLSRILDPNPSTRIS 256 (450)
Q Consensus 231 ~p~-----~~s~~~~~ll~~~L~~dP~~R~s 256 (450)
.|. .+|.++..-+.-.=..+-.+-|+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 332 35556555554433333344444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=207.61 Aligned_cols=176 Identities=15% Similarity=0.181 Sum_probs=138.0
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHH------HHHHHHHHHhCCCCCccEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQ------TKREISVMRLIQHPNVMQIYEVM 79 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~ 79 (450)
+.+.++|++.+.||.|+||.||++.. ++..+|+|+++......+..... +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 56889999999999999999999765 46789999998665444333333 57999999999999999999886
Q ss_pred EeC--------CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEe
Q 045214 80 ASK--------TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 80 ~~~--------~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~ 151 (450)
... +..+++|||++|.+|.+... +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 543 35899999999999987732 333 2456999999999999999999999999999988 9999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHh
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLL 206 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll 206 (450)
|||.+........ ...+.....|. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 9997643311100 01133445566 7999999999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=235.99 Aligned_cols=220 Identities=32% Similarity=0.649 Sum_probs=177.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
.-..|+.++++..|+||-||+.+++.+.+.+|+ .+++..+.- |. ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lil--------Rn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLIL--------RN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchhh--------hc--cccccCCccee--------------
Confidence 446799999999999999999999999999999 455443221 11 44444555554
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|+-...++. +.++.+. +.+++|||+-||+|||+||+|++|+.-|++|+.|||++..........
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 455555554 5566555 779999999999999999999999999999999999985422111000
Q ss_pred -------------CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC
Q 045214 167 -------------LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT 233 (450)
Q Consensus 167 -------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (450)
.-...||||.|+|||++..++| +..+|.|++|+|+|+.+-|..||.+..+++++.........+|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 1123499999999999999998 58999999999999999999999999999999998888777765
Q ss_pred C---CcHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 045214 234 W---FSADVRKLLSRILDPNPSTRI---SIAKIMENPWFRK 268 (450)
Q Consensus 234 ~---~s~~~~~ll~~~L~~dP~~R~---s~~eil~hp~f~~ 268 (450)
. +++++++++.++|+.+|..|. .+-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 789999999999999999997 4678889999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=195.80 Aligned_cols=141 Identities=21% Similarity=0.276 Sum_probs=112.9
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCCC
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG-----------------------LVDQTKREISVMRLIQHPN 71 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 71 (450)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999865321111 0123456999999998887
Q ss_pred ccEEEEEEEeCCEEEEEEeecCCCChhhH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEecCCCCeE
Q 045214 72 VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFC-HSRGVYHRDLKPENLLLDENGMLK 149 (450)
Q Consensus 72 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~-i~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDikp~NILl~~~~~vk 149 (450)
+...+.+.... .|+||||++|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75444333222 3899999999877655 4556899999999999999999999 799999999999999998 57899
Q ss_pred EeecCchhhh
Q 045214 150 VTDFGLSALA 159 (450)
Q Consensus 150 l~DFGls~~~ 159 (450)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=201.45 Aligned_cols=233 Identities=26% Similarity=0.349 Sum_probs=151.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC----------CCccEEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH----------PNVMQIYEVMA 80 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 80 (450)
....++.||.|+++.||.+.+.+||+.+|+|++...........+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45778999999999999999999999999999976654444557778877765555432 23333333322
Q ss_pred e------------CCE-----EEEEEeecCCCChhhHHhc----CCC---CHHHH-HHHHHHHHHHHHHHHHCCCeecCC
Q 045214 81 S------------KTK-----IYFVMEYAKGGELFKKVSK----GKL---KEDTA-RKYFQQLISAIDFCHSRGVYHRDL 135 (450)
Q Consensus 81 ~------------~~~-----~~lv~E~~~gg~L~~~i~~----~~l---~e~~~-~~~~~qll~aL~~LH~~gi~HrDi 135 (450)
- .+. .+++|+-+. ++|.+.+.- ... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 112 356777764 478776532 222 12233 334489999999999999999999
Q ss_pred CCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCC-------CCCCccchhhHHHHHHHHhhC
Q 045214 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG-------YDGDKADIWSCGVILYVLLAG 208 (450)
Q Consensus 136 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~~DiwSlGvil~~ll~g 208 (450)
+|+|++++.+|.++|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999986432221 111134557799999875431 124688999999999999999
Q ss_pred CCCCCCCcHHHHHH-HHhhcCCCCCCCCcHHHHHHHHHccCCCCCCC
Q 045214 209 YLPFHDSNLMAMYR-KIAKADYKFPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 209 ~~Pf~~~~~~~~~~-~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
.+||.......... .+. .+. .++..+++||.++|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEWDFS----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGGGGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccccch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99998764432111 111 223 678999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=189.72 Aligned_cols=142 Identities=19% Similarity=0.274 Sum_probs=115.1
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCC
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG-----------------------LVDQTKREISVMRLIQHP 70 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hp 70 (450)
+...||+|+||.||+|.+. +|+.||||+++........ .....++|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999999875321000 022346899999999999
Q ss_pred CccEEEEEEEeCCEEEEEEeecCCCChhh-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCe
Q 045214 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK-KVSKGKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~v 148 (450)
+|.....+.... .|+||||++|+++.. .+....+++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555444333 489999999986544 3556778999999999999999999999 9999999999999998 8999
Q ss_pred EEeecCchhhh
Q 045214 149 KVTDFGLSALA 159 (450)
Q Consensus 149 kl~DFGls~~~ 159 (450)
+|+|||+|...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-26 Score=236.94 Aligned_cols=259 Identities=31% Similarity=0.545 Sum_probs=220.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (450)
...|.+.+.||+|+|+.|-++.+.. +...+|.|.+.... .......++..|..+-+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5579999999999999999998855 45567777776543 23344567778999888887 999999999999999999
Q ss_pred EEEeecCCCChhhHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhc
Q 045214 87 FVMEYAKGGELFKKV-SKG--KLKEDTARKYFQQLISAIDFCH-SRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKC 161 (450)
Q Consensus 87 lv~E~~~gg~L~~~i-~~~--~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~ 161 (450)
++++|..|+++++.+ ..+ ..+...+..++.|+..++.|+| ..++.|+||||+|.+++.++ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 654 6888899999999999999999 99999999999999999999 999999999998877
Q ss_pred -ccCCCCcccccC-CCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH-HHHHHhhc--C--CCCCCC
Q 045214 162 -KHQDGLLHTTCG-TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA-MYRKIAKA--D--YKFPTW 234 (450)
Q Consensus 162 -~~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~--~--~~~p~~ 234 (450)
..........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||....... .+..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 555666777899 9999999999988888899999999999999999999998765432 22222222 1 223345
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++....+++.++|..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=195.38 Aligned_cols=197 Identities=27% Similarity=0.418 Sum_probs=147.5
Q ss_pred CCCCccEEEEEEEe---------------------------CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHH
Q 045214 68 QHPNVMQIYEVMAS---------------------------KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLIS 120 (450)
Q Consensus 68 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~ 120 (450)
+|||||++...|.+ ...+|+||...+. +|..++.....+....+-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 69999999866532 3458999987754 8999999888899999999999999
Q ss_pred HHHHHHHCCCeecCCCCCcEEec--CCC--CeEEeecCchhhhhcccCC-----CCcccccCCCcccCchhcccCCC---
Q 045214 121 AIDFCHSRGVYHRDLKPENLLLD--ENG--MLKVTDFGLSALAKCKHQD-----GLLHTTCGTPAYVAPEVISRRGY--- 188 (450)
Q Consensus 121 aL~~LH~~gi~HrDikp~NILl~--~~~--~vkl~DFGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~--- 188 (450)
|+.|||++||.|||+|.+|||+. +++ .+.|+|||.+- ......- ......-|.-.-||||+....+-
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL-Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL-ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee-eccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999994 333 58999999763 2211111 11123357778999999864331
Q ss_pred --CCCccchhhHHHHHHHHhhCCCCCCCCcHHHH--HHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCH---HHHh
Q 045214 189 --DGDKADIWSCGVILYVLLAGYLPFHDSNLMAM--YRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISI---AKIM 261 (450)
Q Consensus 189 --~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~---~eil 261 (450)
+-.++|.|++|.+.||+++...||.....+.+ .......-..+|+.+++.+++++..+|+.||++|++. +.++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 22589999999999999999999987432211 1111123345788899999999999999999999984 4555
Q ss_pred cCccc
Q 045214 262 ENPWF 266 (450)
Q Consensus 262 ~hp~f 266 (450)
+-..|
T Consensus 512 ~LsLw 516 (598)
T KOG4158|consen 512 NLSLW 516 (598)
T ss_pred HHHHh
Confidence 53333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=181.34 Aligned_cols=190 Identities=18% Similarity=0.257 Sum_probs=141.1
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccch-HHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEe
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGL-VDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678999999999997766 67778877776544321111 225789999999995 5889999886 34799999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcEEecCCCCeEEeecCchhhhhcccCC----
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDL-KPENLLLDENGMLKVTDFGLSALAKCKHQD---- 165 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDi-kp~NILl~~~~~vkl~DFGls~~~~~~~~~---- 165 (450)
|+.|.+|...+..+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999987654321 1357889999999999999999999 799999999999999999998743321110
Q ss_pred ---C----CcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCC
Q 045214 166 ---G----LLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHD 214 (450)
Q Consensus 166 ---~----~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~ 214 (450)
. ..+-...++.|++|+...-.. ..-...+.++.|+-+|.++|+.+|+-.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011123688899998643221 111467888999999999999988644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=182.66 Aligned_cols=133 Identities=20% Similarity=0.288 Sum_probs=109.0
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-----CCCCccEEEEEEEeCC---EE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-----QHPNVMQIYEVMASKT---KI 85 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~ 85 (450)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 6666665 6999876432 2346789999999999 5799999999998874 44
Q ss_pred E-EEEee--cCCCChhhHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCcEEecCC----CCeEEeecC
Q 045214 86 Y-FVMEY--AKGGELFKKVSKGKLKEDTARKYFQQLISAI-DFCHSRGVYHRDLKPENLLLDEN----GMLKVTDFG 154 (450)
Q Consensus 86 ~-lv~E~--~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL-~~LH~~gi~HrDikp~NILl~~~----~~vkl~DFG 154 (450)
| +|+|| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 557999999988777776 35678888777 99999999999999999999743 379999954
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-23 Score=217.78 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=179.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccc-ccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDK-ILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
.|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-.-..+..+|++ ...+++||.+.+.-+...+..-|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999984 344 9999986543 222222344445566 56679999999998888888899999
Q ss_pred eecCCCChhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh--hhcccCCC
Q 045214 90 EYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDG 166 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~--~~~~~~~~ 166 (450)
+|+.. +|.|++..++ +.+-+.+.|+.||+.||..||..||+|||||.|||||+.=+=+.|+||.--+. ....++..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99976 8999998765 67778889999999999999999999999999999999888899999974211 11111111
Q ss_pred C---cccccCCCcccCchhcccCC----------CCCCccchhhHHHHHHHHhh-CCCCCCCCcH-----------HHHH
Q 045214 167 L---LHTTCGTPAYVAPEVISRRG----------YDGDKADIWSCGVILYVLLA-GYLPFHDSNL-----------MAMY 221 (450)
Q Consensus 167 ~---~~~~~gt~~y~aPE~l~~~~----------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~-----------~~~~ 221 (450)
. ..+...-..|.|||.+.... .-.++.||||+||+++||++ |.+||.-... ...+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 1 11222334699999986522 12367899999999999988 6888863221 1111
Q ss_pred HHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 222 RKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 222 ~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
++| -+..++++|..|++.||++|.++++.|+.
T Consensus 260 e~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 13479999999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=179.61 Aligned_cols=142 Identities=19% Similarity=0.252 Sum_probs=114.6
Q ss_pred eeeeceEeecCCeEEEEEE-EcCCCcEEEEEEeeccccccc---------------------chHHHHHHHHHHHHhCCC
Q 045214 12 YELGRLLGQGNFAKVYYAR-HLGTGQSVAIKAIDKDKILKV---------------------GLVDQTKREISVMRLIQH 69 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~-~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~Ei~il~~l~h 69 (450)
|.+.+.||+|+||.||+|. +..+|+.||+|+++....... .....+.+|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999999 667999999999986532100 012346789999999975
Q ss_pred C--CccEEEEEEEeCCEEEEEEeecCCCChhhHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEecCC
Q 045214 70 P--NVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSRG-VYHRDLKPENLLLDEN 145 (450)
Q Consensus 70 p--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i-~~~~l~e~~~~~~~~qll~aL~~LH~~g-i~HrDikp~NILl~~~ 145 (450)
. .++++++. . ..|+||||++|.+|.... ....+.+..+..++.|++.+|.+||++| ++||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 34455543 2 358999999998887665 3455677778899999999999999999 99999999999999 8
Q ss_pred CCeEEeecCchhh
Q 045214 146 GMLKVTDFGLSAL 158 (450)
Q Consensus 146 ~~vkl~DFGls~~ 158 (450)
+.++|+|||.|..
T Consensus 185 ~~i~LiDFg~a~~ 197 (237)
T smart00090 185 GKVVIIDVSQSVE 197 (237)
T ss_pred CCEEEEEChhhhc
Confidence 8999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=206.47 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=166.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-...|.|-+.||+|+||+||.|.+.. |+.||+|+-.+..........++...++ ... -+.|+.+...+...+.-+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCcce
Confidence 335689999999999999999999876 9999999998887776666666655554 211 356777777777888889
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-------CCCeEEeecCchhh
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-------NGMLKVTDFGLSAL 158 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-------~~~vkl~DFGls~~ 158 (450)
+|+||.+-|+|.+++.. ..+++..+..+..|++..|++||..||||+||||+|.||.. +-.++|+|||.|--
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999999999999986 57999999999999999999999999999999999999942 33589999998855
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL 210 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~ 210 (450)
.............++|-.+-++|+..++++. +.+|.|.+..+++.||.|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 4443333345567899999999999999996 99999999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=166.98 Aligned_cols=138 Identities=22% Similarity=0.338 Sum_probs=116.0
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc-----hHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG-----LVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++.||+|++|.||+|.. .|..+++|+.......... ...++.+|+.++..+.|++|+....++...+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 7788999987643322111 1245788999999999999888777777778899999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999876432 7889999999999999999999999999999999 88999999998753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=174.87 Aligned_cols=240 Identities=20% Similarity=0.379 Sum_probs=193.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+...+..+|.+.-.|+.|+|+. .|..++.|++....... ...+.+..|.-.|+...||||+.+++.+.....+.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3456677889999999999998 45577888887654432 23456778888899999999999999999999999999
Q ss_pred eecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEe--ecCchhhhhcc
Q 045214 90 EYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVT--DFGLSALAKCK 162 (450)
Q Consensus 90 E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~--DFGls~~~~~~ 162 (450)
.|++-|+|+..+..+ ..+..++.+++.+++.|++|||+.. |----|....+++|++-..+|+ |--+|- +
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q-- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e--
Confidence 999999999999774 3678899999999999999999974 3344688889999998766654 322211 1
Q ss_pred cCCCCcccccCCCcccCchhcccCCCC--CCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYD--GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~ 238 (450)
. ....-+|.||+||.+.+++-+ -.++|+||+.+++|||.|...||.+.++++.--++.-. ...+|+.++..
T Consensus 343 e-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 E-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred c-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1 122357899999999877644 34799999999999999999999998888766666544 45689999999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHh
Q 045214 239 VRKLLSRILDPNPSTRISIAKIM 261 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil 261 (450)
...|+.-|++.||.+||....|+
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999987764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=163.23 Aligned_cols=138 Identities=21% Similarity=0.298 Sum_probs=109.6
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-------------------chHHHHHHHHHHHHhCCCCC-
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-------------------GLVDQTKREISVMRLIQHPN- 71 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 71 (450)
|.+.+.||+|+||.||+|... +|+.||||+++....... .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999875 799999999875431000 01123578999999998774
Q ss_pred -ccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 72 -VMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 72 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
++..++ ....+++|||++|++|...... .....++.+++.++.++|+.|++||||||+||++++++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999988765431 345678899999999999999999999999999999999999
Q ss_pred eecCchhhh
Q 045214 151 TDFGLSALA 159 (450)
Q Consensus 151 ~DFGls~~~ 159 (450)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999987533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=162.14 Aligned_cols=133 Identities=21% Similarity=0.303 Sum_probs=108.4
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEee
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----GLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (450)
.||+|+||.||+|.. ++..+++|.......... ....++.+|+.+++.+.|+++....-++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 678899998654332111 1235678899999999988765555555566678999999
Q ss_pred cCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 92 AKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765322 7899999999999999999999999999999 89999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=181.96 Aligned_cols=139 Identities=20% Similarity=0.268 Sum_probs=112.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-----KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
..|...+.||+|+||.||++.... ..+++|........ .....+++.+|+.+++.++|++++..+.+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445678999999999999998743 34555543322111 11123567899999999999999988877777778
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
.++||||++|++|.+++. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998876 356789999999999999999999999999999 678999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=153.95 Aligned_cols=138 Identities=20% Similarity=0.323 Sum_probs=101.3
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHH---------------------HHHHHHHHHHhCCCC--
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD---------------------QTKREISVMRLIQHP-- 70 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp-- 70 (450)
+++.||+|+||.||+|.+. +++.||||++............ ....|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 8999999998764321111111 114566667666444
Q ss_pred CccEEEEEEEeCCEEEEEEeecCCCChhh-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCe
Q 045214 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK-KVSKGKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~v 148 (450)
.+.++++. ...+++|||++|+.+.. .+...... ..++.++.+++.++.++|+ +||+|+||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 35555553 23589999999954432 22221111 6788999999999999999 9999999999999999 8999
Q ss_pred EEeecCchhh
Q 045214 149 KVTDFGLSAL 158 (450)
Q Consensus 149 kl~DFGls~~ 158 (450)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-19 Score=177.67 Aligned_cols=178 Identities=26% Similarity=0.419 Sum_probs=134.7
Q ss_pred CCEEEEEEeecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
..++||.|++|+-.+|.+++... ..+......++.|+..|++| +|.+|+|+||.||+...++.+||.|||+.+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 34689999999999999999642 45667889999999999999 999999999999999999999999999975
Q ss_pred hhhccc----CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCCCCC
Q 045214 158 LAKCKH----QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFP 232 (450)
Q Consensus 158 ~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~p 232 (450)
-..... .........||+.||+||.+.+..|. .++||||||++|++|+. =..+|.. ......+..+.++.-
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPE 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChH
Confidence 433222 01122345799999999999998885 99999999999999997 2222221 222333333333211
Q ss_pred CCC-cHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 233 TWF-SADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 233 ~~~-s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+. -++-..|+.+||.+.|..||++.+.--|+|.
T Consensus 481 ~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222 2455689999999999999987777666664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=171.57 Aligned_cols=199 Identities=25% Similarity=0.401 Sum_probs=154.8
Q ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCcE
Q 045214 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGV-YHRDLKPENL 140 (450)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi-~HrDikp~NI 140 (450)
|+.+.|.|+.++++...++...++|.+||.-|+|.|.+... +++..-...+.+.++.||.|+|...| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45689999999999999999999999999999999999875 45666677788999999999998765 9999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCC------CCCccchhhHHHHHHHHhhCCCCCCC
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY------DGDKADIWSCGVILYVLLAGYLPFHD 214 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DiwSlGvil~~ll~g~~Pf~~ 214 (450)
++|....+||+|||+.............+...-...|.|||.+..... -+.+.||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999765532111111122233456999999976422 24579999999999999999999986
Q ss_pred C----cHHHHHHHHhh-cCCCC-CC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 215 S----NLMAMYRKIAK-ADYKF-PT-----WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 215 ~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
. +..+...++.+ +...+ |. .+.+++..++.+||.-+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 22345555554 22212 21 24457999999999999999999988753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=156.25 Aligned_cols=138 Identities=19% Similarity=0.330 Sum_probs=107.4
Q ss_pred eceEe-ecCCeEEEEEEEcCCCcEEEEEEeecccc----c------ccchHHHHHHHHHHHHhCCCCCc--cEEEEEEEe
Q 045214 15 GRLLG-QGNFAKVYYARHLGTGQSVAIKAIDKDKI----L------KVGLVDQTKREISVMRLIQHPNV--MQIYEVMAS 81 (450)
Q Consensus 15 ~~~LG-~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~ 81 (450)
...|| .|+.|+||.+.. .+..+++|.+..... . ......++.+|+.++..+.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34677 788888888877 478899998864321 0 11223567899999999998875 677766433
Q ss_pred C-C---EEEEEEeecCC-CChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 82 K-T---KIYFVMEYAKG-GELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 82 ~-~---~~~lv~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
. . ..++|||+++| .+|.+++..+.+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 23599999998 6899888877777654 568999999999999999999999999999999999999976
Q ss_pred hh
Q 045214 157 AL 158 (450)
Q Consensus 157 ~~ 158 (450)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 53
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-18 Score=120.62 Aligned_cols=59 Identities=63% Similarity=0.919 Sum_probs=48.1
Q ss_pred CCCCcHHHHhhhcCCCCCCCccccccc---eeeeeeecccCHHHHHHHHHHHHHHcCcEEEE
Q 045214 311 PDNLNAFHIISLSSGFDLSGFFVEHDQ---KEEVKFTSKYSASVIISKLEDIARHLKMKLTK 369 (450)
Q Consensus 311 ~~~~~~~~~~~~s~~~~ls~~~~~~~~---~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~ 369 (450)
|..+|||+|||+|+|||||+||+.... +|++||+|+.||++|+++||++|+.+||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 668999999999999999999986543 58999999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=137.07 Aligned_cols=131 Identities=22% Similarity=0.332 Sum_probs=112.7
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCccEEEEEEEeCCEEEEEEee
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH--PNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 91 (450)
+++.||+|.++.||++... +..+++|....... ...+.+|+.+++.+.| +++++++......+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999984 37899999865432 3567899999999976 5899999998888899999999
Q ss_pred cCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 92 AKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR---GVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~---gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
++|+.+... +......++.+++.+++++|.. +++|+|++|+||+++..+.++++|||.+.
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999877654 5566778899999999999985 79999999999999998999999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7e-18 Score=178.33 Aligned_cols=262 Identities=25% Similarity=0.437 Sum_probs=210.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.+.+.+.+-+.+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|.++....-+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44567888899999999999999988998888887765443332233334444444444456766665555556778999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc---
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH--- 163 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~--- 163 (450)
+++|..|++|...+.+ +..+++.++.++..+..+++|||+..+.|+|++|.|++...+|..+++|||.........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999987 568888999999999999999999999999999999999999999999998432111100
Q ss_pred --------------------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH
Q 045214 164 --------------------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL 217 (450)
Q Consensus 164 --------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~ 217 (450)
.....+...||+.|.+||.+.+... +..+|.|+.|+++++.++|..||....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0011234468999999999988765 5889999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC---CCcHHHHHHHHHccCCCCCCCCCHH---HHhcCccccccC
Q 045214 218 MAMYRKIAKADYKFPT---WFSADVRKLLSRILDPNPSTRISIA---KIMENPWFRKGL 270 (450)
Q Consensus 218 ~~~~~~i~~~~~~~p~---~~s~~~~~ll~~~L~~dP~~R~s~~---eil~hp~f~~~~ 270 (450)
...++.+.....+.|. ..+.++++++.++|..+|.+|..+. ++..||||+...
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 9999999888877664 4789999999999999999999987 899999998644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.2e-16 Score=155.84 Aligned_cols=257 Identities=19% Similarity=0.225 Sum_probs=194.7
Q ss_pred ccccCeeeeceEee--cCCeEEEEEEE--cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQ--GNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~--G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (450)
.+..++.+.+.+|. |.+|.||.+.. ..++..+|+|.-+..... .....+-.+|+...+.+ .|+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCccccc
Confidence 34557888999999 99999999998 888999999974322110 11123335677777777 59999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-CC-CCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-GK-LKEDTARKYFQQLIS----AIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFG 154 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-~~-l~e~~~~~~~~qll~----aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFG 154 (450)
.+..|+-+|++. .+|..+... .. +++..++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999995 678777765 44 899999999999999 9999999999999999999999999 889999999
Q ss_pred chhhhhcccCCCCc---ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHH-HHHHHHhhcCC
Q 045214 155 LSALAKCKHQDGLL---HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLM-AMYRKIAKADY 229 (450)
Q Consensus 155 ls~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~-~~~~~i~~~~~ 229 (450)
+........-.... ....|...|++||...+. .+..+||+|+|.++.+-.+|..+.... +.. ...+.+. ...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~ 345 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPL 345 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cch
Confidence 87655433322211 122577889999998654 458999999999999988876654432 111 1111111 111
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+-...+.++...+..|++.+|..|++.+.++.|+++..
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 222235677888999999999999999999999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.9e-15 Score=149.35 Aligned_cols=138 Identities=22% Similarity=0.357 Sum_probs=96.1
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-------------------------------chHH------HHH
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-------------------------------GLVD------QTK 58 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-------------------------------~~~~------~~~ 58 (450)
+.||+|++|.||+|+.. +|+.||||+.++.-.... +... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999974 789999999876421100 0001 133
Q ss_pred HHHHHHHhC----C-CCCc--cEEEEEEEeCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHH-HHHHHHHC
Q 045214 59 REISVMRLI----Q-HPNV--MQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLIS-AIDFCHSR 128 (450)
Q Consensus 59 ~Ei~il~~l----~-hpnI--v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~-aL~~LH~~ 128 (450)
+|...+.++ + ++++ +++|. ...+..++||||++|++|.+.... .... ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 455555544 2 3332 23332 334457999999999999887643 2222 2345555555 46889999
Q ss_pred CCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 129 gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
|++|+|+||.||+++.+|.++++|||++...
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999997544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-15 Score=158.24 Aligned_cols=144 Identities=20% Similarity=0.348 Sum_probs=100.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc---------------------------c----chHHH
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---------------------------V----GLVDQ 56 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~---------------------------~----~~~~~ 56 (450)
+...|+. +.||+|++|.||.|+.+.+|+.||||+.++.-... . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 89999999999999998889999999998652100 0 11222
Q ss_pred HHH------HHHHHHhC----CCCCccEEEEEEE-eCCEEEEEEeecCCCChhhH--Hhc-C----CCCHHHHHHHHHHH
Q 045214 57 TKR------EISVMRLI----QHPNVMQIYEVMA-SKTKIYFVMEYAKGGELFKK--VSK-G----KLKEDTARKYFQQL 118 (450)
Q Consensus 57 ~~~------Ei~il~~l----~hpnIv~l~~~~~-~~~~~~lv~E~~~gg~L~~~--i~~-~----~l~e~~~~~~~~ql 118 (450)
+.+ |...+.++ .+.+.+.+-.++. ..+..++||||++|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333 44333333 2333343333332 25567899999999999774 333 2 25555666666666
Q ss_pred HHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCchhhh
Q 045214 119 ISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGLSALA 159 (450)
Q Consensus 119 l~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGls~~~ 159 (450)
+ ..|++|+|+||.||+++.+| .++++|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5 58999999999999999888 9999999987543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-13 Score=141.00 Aligned_cols=172 Identities=17% Similarity=0.309 Sum_probs=132.7
Q ss_pred EEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCC
Q 045214 28 YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK 107 (450)
Q Consensus 28 ~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~ 107 (450)
.|..+.++.+|.|.+.+.... +....+++-++.|+.++||||+++++.++..+.+|+|+|.+. .|..++++ ++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--hH
Confidence 456677899999999876653 345677888999999999999999999999999999999985 56667765 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccC
Q 045214 108 EDTARKYFQQLISAIDFCH-SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186 (450)
Q Consensus 108 e~~~~~~~~qll~aL~~LH-~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 186 (450)
...+..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6777778899999999997 67899999999999999999999999987653322221 11111122246667655332
Q ss_pred CCCCCccchhhHHHHHHHHhhCCCC
Q 045214 187 GYDGDKADIWSCGVILYVLLAGYLP 211 (450)
Q Consensus 187 ~~~~~~~DiwSlGvil~~ll~g~~P 211 (450)
. -..|.|-|||++++++.|.++
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred c---cchhhhhHHHHHHHHhCcccC
Confidence 2 346999999999999999443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-13 Score=123.76 Aligned_cols=139 Identities=18% Similarity=0.221 Sum_probs=104.3
Q ss_pred eceEeecCCeEEEEEEEcC------CCcEEEEEEeecccc-------------------cccchHH----HHHHHHHHHH
Q 045214 15 GRLLGQGNFAKVYYARHLG------TGQSVAIKAIDKDKI-------------------LKVGLVD----QTKREISVMR 65 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~~~~vaiK~i~~~~~-------------------~~~~~~~----~~~~Ei~il~ 65 (450)
...||.|--+.||.|.... .+..+|||+.+.... .+.+... ..++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 357999999864210 0011122 3348999999
Q ss_pred hCCC--CCccEEEEEEEeCCEEEEEEeecCCCChh-hHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEE
Q 045214 66 LIQH--PNVMQIYEVMASKTKIYFVMEYAKGGELF-KKVSKGKLKEDTARKYFQQLISAIDFC-HSRGVYHRDLKPENLL 141 (450)
Q Consensus 66 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~-~~i~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDikp~NIL 141 (450)
++.. -++++++++ ..-++||||+.++.+. ..+....+++..+..++.|++.+|..| |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9853 567777765 4568999999875443 234444566777888899999999999 8999999999999999
Q ss_pred ecCCCCeEEeecCchhh
Q 045214 142 LDENGMLKVTDFGLSAL 158 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~ 158 (450)
++ ++.+.|+|||.|-.
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 96 57899999997743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=121.23 Aligned_cols=127 Identities=20% Similarity=0.287 Sum_probs=96.8
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEEEEEeecC
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~ 93 (450)
.+.|+.|.++.||+++. .++.|++|+...... ......+|+.+++.+.+.+ +++++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478899999865431 1134578999999886544 445655443 33579999999
Q ss_pred CCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCcEEecCCCCeEEeecCchh
Q 045214 94 GGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGV-----YHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 94 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi-----~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
|.++.+. ......++.+++.+|+.||+.++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123467899999999999985 9999999999998 6789999999753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.2e-14 Score=142.49 Aligned_cols=253 Identities=18% Similarity=0.204 Sum_probs=189.0
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEc-CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHL-GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
.....+|.++..||.|.|+.|+..... .++..|++|.....-...... ..-..|+.+...+ .|.+++.++..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 355678999999999999999998755 577889999876554333221 1223566666555 6999999999998888
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFGls~~~~~ 161 (450)
..|+-.|||+++++...+.- ..+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||..+....
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 89999999999988766632 468889999999999999999999999999999999999876 7789999998753111
Q ss_pred ccCCCCcccccCCCccc-CchhcccCCCCCCccchhhHHHHHHHHhhCCC-CCCCCcHHHHHHHHhhcCCCCCCCCcHHH
Q 045214 162 KHQDGLLHTTCGTPAYV-APEVISRRGYDGDKADIWSCGVILYVLLAGYL-PFHDSNLMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
.. ....+.-++. .+|++........++|++|||..+.+..+|.. ++.... ...+..+..+..+..+.++
T Consensus 420 ~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 SS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred ec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHhh
Confidence 11 1122333444 35555444444589999999999999999863 333322 2234455555555566889
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+...+..+++..|+.+.++..|+-|..
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999999988877643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-12 Score=111.59 Aligned_cols=134 Identities=22% Similarity=0.316 Sum_probs=101.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccch-----HHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGL-----VDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
..+++|+-+.+|.+.. -|..+++|.-.+.....+.. ..+..+|..++.+++--.|...+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 44557777644332222221 3456789999999876666555555556677789999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
|++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898876 245666777778889999999999999999996654 99999999753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-13 Score=125.47 Aligned_cols=200 Identities=17% Similarity=0.305 Sum_probs=140.6
Q ss_pred HHhCCCCCccEEEEEEEeC-----CEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CCe
Q 045214 64 MRLIQHPNVMQIYEVMASK-----TKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSR--GVY 131 (450)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~--gi~ 131 (450)
+-.+-|.|||+++.++.+. ....++.||+..|++..++++ ..+......+|+-||++||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3445799999999987543 458899999999999999865 2588889999999999999999998 499
Q ss_pred ecCCCCCcEEecCCCCeEEeecCchhhhhcccC--CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCC
Q 045214 132 HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ--DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209 (450)
Q Consensus 132 HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~ 209 (450)
|+++..+.|++..+|-+|+.--.-......... ........+-++|.|||.=.-... ..++|||++|....+|..+.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 999999999999999888753221111000000 001112346788999996433333 36899999999999998887
Q ss_pred CCCC-CCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 210 LPFH-DSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 210 ~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
.--. ..+.......+...-+... .+--++++.+||+..|..||++.+++-||..-
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 5422 2222222222222211111 12245789999999999999999999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-11 Score=108.28 Aligned_cols=144 Identities=19% Similarity=0.232 Sum_probs=110.3
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----GLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
....|-+|+-+.|+.+.. .|+.+.||.--......+ -...+.++|+++|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677889999999999988 788888886433222111 1245678999999998766666666666677777889
Q ss_pred EeecCC-CChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhhh
Q 045214 89 MEYAKG-GELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSALA 159 (450)
Q Consensus 89 ~E~~~g-g~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~~ 159 (450)
|||++| .++.+++.. ..........+++++-+.+.-||.++|+|+||..+||+|..+| .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 467777754 2333344478999999999999999999999999999997665 3589999998643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=113.31 Aligned_cols=139 Identities=21% Similarity=0.326 Sum_probs=108.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCccEEEEEEEeC---CEEEEEEe
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH--PNVMQIYEVMASK---TKIYFVME 90 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 90 (450)
+.|+.|..+.||++... +|+.+++|+....... .....+.+|..+++.+.+ .++++++.+.... +..|++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3688999998654321 124567899999999975 4467777776654 36789999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS------------------------------------------- 127 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~------------------------------------------- 127 (450)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776644567777888888888888888884
Q ss_pred -------------CCCeecCCCCCcEEecC--CCCeEEeecCchh
Q 045214 128 -------------RGVYHRDLKPENLLLDE--NGMLKVTDFGLSA 157 (450)
Q Consensus 128 -------------~gi~HrDikp~NILl~~--~~~vkl~DFGls~ 157 (450)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23599999999999998 5668999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.3e-10 Score=111.01 Aligned_cols=211 Identities=18% Similarity=0.267 Sum_probs=156.5
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE----eCCEEEEEEeecCC-CC
Q 045214 22 NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA----SKTKIYFVMEYAKG-GE 96 (450)
Q Consensus 22 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~g-g~ 96 (450)
--.+.|+|....+|..|++|.++-++....+ ..-.-++.++++.|+|||++.+++. .+..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3468999999999999999999655443321 2234577889999999999999986 34579999999986 46
Q ss_pred hhhHH----------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 97 LFKKV----------------SKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 97 L~~~i----------------~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
|.++- ...+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+..|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 66542 11247889999999999999999999999999999999999998899999888654332
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCC-CCCCcHHHH-HHHHhhcCCCCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP-FHDSNLMAM-YRKIAKADYKFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~ 238 (450)
... + |-+... .+-|.=.||.+++.|.||..- +........ ... +...+|.+
T Consensus 445 ~d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D 497 (655)
T KOG3741|consen 445 EDP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTD 497 (655)
T ss_pred CCC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHH
Confidence 111 1 112221 356999999999999999643 222222222 222 22347899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
++++|.-+...+++. -++.+++.|
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999988887 788888864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-10 Score=103.06 Aligned_cols=126 Identities=24% Similarity=0.397 Sum_probs=84.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecccc-----------------------cccchHHHHHHHHHHHHhCCCC--CccEEEEEE
Q 045214 25 KVYYARHLGTGQSVAIKAIDKDKI-----------------------LKVGLVDQTKREISVMRLIQHP--NVMQIYEVM 79 (450)
Q Consensus 25 ~Vy~a~~~~~~~~vaiK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 79 (450)
.||.|.. ..|..+|+|+...... ...-.....++|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 4677999999864210 0001235578999999999765 577777653
Q ss_pred EeCCEEEEEEeecC--CCChhhHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 80 ASKTKIYFVMEYAK--GGELFKKVSKGKLKEDTARKYFQQLISAIDF-CHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 80 ~~~~~~~lv~E~~~--gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~-LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.-++||||++ |..+.. +....++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.++|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 655544 433333355677788888885555 579999999999999999877 9999999976
Q ss_pred h
Q 045214 157 A 157 (450)
Q Consensus 157 ~ 157 (450)
.
T Consensus 154 v 154 (188)
T PF01163_consen 154 V 154 (188)
T ss_dssp E
T ss_pred e
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.3e-11 Score=125.16 Aligned_cols=152 Identities=19% Similarity=0.385 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhccc------CCCCc-ccccCCCcccCchhcccCCC
Q 045214 117 QLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH------QDGLL-HTTCGTPAYVAPEVISRRGY 188 (450)
Q Consensus 117 qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~------~~~~~-~~~~gt~~y~aPE~l~~~~~ 188 (450)
+...|+.|+|.. +++|++|.|++|.++.+|..||+.|+.+....... .+... ....-...|.|||++... .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 344899999976 99999999999999999999999999864332211 11111 112345679999999874 4
Q ss_pred CCCccchhhHHHHHHHHh-hCCCCCCCCcHHHHHHHHh----hcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 189 DGDKADIWSCGVILYVLL-AGYLPFHDSNLMAMYRKIA----KADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 189 ~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+.++|++|+||++|.+. .|..-+...+....+..-. ......+..+++++++=|.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 568999999999999998 5555555543333222211 11233456789999999999999999999999999999
Q ss_pred cccccc
Q 045214 264 PWFRKG 269 (450)
Q Consensus 264 p~f~~~ 269 (450)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.5e-09 Score=102.11 Aligned_cols=138 Identities=16% Similarity=0.088 Sum_probs=96.5
Q ss_pred EeecCCeEEEEEEEcCCCcEEEEEEeeccccc---cc-----chHHHHHHHHHHHHhCCCCCc--cEEEEEEEe-----C
Q 045214 18 LGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL---KV-----GLVDQTKREISVMRLIQHPNV--MQIYEVMAS-----K 82 (450)
Q Consensus 18 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~ 82 (450)
+-......|..... .|+.|.||........ +. .-.....+|...+..|..-+| +.+..+++. .
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 33333344555544 6778999976432210 00 001136789988888843333 334444432 2
Q ss_pred CEEEEEEeecCCC-ChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-------CCCeEEe
Q 045214 83 TKIYFVMEYAKGG-ELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-------NGMLKVT 151 (450)
Q Consensus 83 ~~~~lv~E~~~gg-~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-------~~~vkl~ 151 (450)
..-|+|+|+++|. +|.+++.. ...++.....++.++...+.-||+.||+|+|++|.|||++. ++.+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999986 78888753 45677788899999999999999999999999999999975 4679999
Q ss_pred ecCchh
Q 045214 152 DFGLSA 157 (450)
Q Consensus 152 DFGls~ 157 (450)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.9e-09 Score=101.32 Aligned_cols=234 Identities=18% Similarity=0.224 Sum_probs=149.7
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEE------EEEeCC-E
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYE------VMASKT-K 84 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~------~~~~~~-~ 84 (450)
..++.||+|+-+.+|-.- .-...+.|++++..... ..+ .+..|... .||-+-.=+. +..+.. .
T Consensus 14 ~~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~---~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAA---QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecc---hhhchhheeecCCCchH---HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 457889999999999543 33345678887654321 111 12223222 4553322011 112222 3
Q ss_pred EEEEEeecCCCC-hhhHHhc----C---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 85 IYFVMEYAKGGE-LFKKVSK----G---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 85 ~~lv~E~~~gg~-L~~~i~~----~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+-+.|..++|.. ..++... . ....+-+.+..+.|+.+.+.||..|..-+|++++|+|+++++.|.|.|=..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs- 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS- 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc-
Confidence 778888888753 2222221 1 255677888999999999999999999999999999999999999998542
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCC----CCccchhhHHHHHHHHhhC-CCCCCCCc-----HHHHHHHHhh
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD----GDKADIWSCGVILYVLLAG-YLPFHDSN-----LMAMYRKIAK 226 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~----~~~~DiwSlGvil~~ll~g-~~Pf~~~~-----~~~~~~~i~~ 226 (450)
+.....+......+|.+.|.+||...-..+. ....|.|.||+++|++|.| ..||.+-. +......|..
T Consensus 164 --fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 --FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred --eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 1222223334456799999999976522221 3578999999999999886 99997521 1111112222
Q ss_pred c----------CC-CCC---CC--CcHHHHHHHHHccCC--CCCCCCCHH
Q 045214 227 A----------DY-KFP---TW--FSADVRKLLSRILDP--NPSTRISIA 258 (450)
Q Consensus 227 ~----------~~-~~p---~~--~s~~~~~ll~~~L~~--dP~~R~s~~ 258 (450)
+ .. +.| +| +++++..|..+|+.. ++.-|||++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 11 112 11 688999999999865 356899964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-09 Score=98.63 Aligned_cols=136 Identities=24% Similarity=0.344 Sum_probs=103.2
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc------------c--cc-----chHHHHHHHHHHHHhCCCC--
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI------------L--KV-----GLVDQTKREISVMRLIQHP-- 70 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~------------~--~~-----~~~~~~~~Ei~il~~l~hp-- 70 (450)
+.++..||-|--|.||.|.+. .|..+|||.=+.... . .. -.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999985 789999996532100 0 00 0134568999999999655
Q ss_pred CccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
.+++.+++ +.-.+|||+++|-.|...- ++...+..++..|+.-+.-+-..|++|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 77777765 4568999999997775432 234555666777777777777899999999999999999999999
Q ss_pred eecCch
Q 045214 151 TDFGLS 156 (450)
Q Consensus 151 ~DFGls 156 (450)
+||-.+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 999744
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.3e-08 Score=89.15 Aligned_cols=103 Identities=21% Similarity=0.370 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHhCCCC--CccEEEEEEEeC----CEEEEEEeecCCC-ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 045214 55 DQTKREISVMRLIQHP--NVMQIYEVMASK----TKIYFVMEYAKGG-ELFKKVSK-GKLKEDTARKYFQQLISAIDFCH 126 (450)
Q Consensus 55 ~~~~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH 126 (450)
.+..+|...+..|..- .+++.+.+.+.. ..-|+|+|+++|. +|.+++.. ...+......++.++...++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4677888888877433 344555555442 2458999999985 78888876 34777788899999999999999
Q ss_pred HCCCeecCCCCCcEEecCCC---CeEEeecCchh
Q 045214 127 SRGVYHRDLKPENLLLDENG---MLKVTDFGLSA 157 (450)
Q Consensus 127 ~~gi~HrDikp~NILl~~~~---~vkl~DFGls~ 157 (450)
++||+|+|++|.|||++.++ .+.++||+-+.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999999887 89999999654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.7e-08 Score=89.22 Aligned_cols=141 Identities=21% Similarity=0.293 Sum_probs=94.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHH------HHHHHHHHHHhCC---CCCccEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD------QTKREISVMRLIQ---HPNVMQIY 76 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~---hpnIv~l~ 76 (450)
+.+.++|.+.+++-......|.+..- +|+.+++|.............. ...+++..+..+. -..+..++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 45778999999999988888887765 7789999988654322111111 1233444343332 22222322
Q ss_pred EE-----EEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEe
Q 045214 77 EV-----MASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 77 ~~-----~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~ 151 (450)
-+ +......+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|++++++ .++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 22 223345678999999988866532 233 244567788999999999999999999999855 49999
Q ss_pred ecCch
Q 045214 152 DFGLS 156 (450)
Q Consensus 152 DFGls 156 (450)
||+..
T Consensus 177 D~~~k 181 (229)
T PF06176_consen 177 DTQGK 181 (229)
T ss_pred ECccc
Confidence 99853
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-07 Score=85.05 Aligned_cols=136 Identities=13% Similarity=0.142 Sum_probs=98.4
Q ss_pred eecCCeEEEEEEEcCCCcEEEEEEeecc--cccc-cchHHHHHHHHHHHHhCCCCC--ccEEEEE--EEe--CCEEEEEE
Q 045214 19 GQGNFAKVYYARHLGTGQSVAIKAIDKD--KILK-VGLVDQTKREISVMRLIQHPN--VMQIYEV--MAS--KTKIYFVM 89 (450)
Q Consensus 19 G~G~fg~Vy~a~~~~~~~~vaiK~i~~~--~~~~-~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~--~~~--~~~~~lv~ 89 (450)
|+||-+.|+.... .|+.+-+|.-... .... +.-...+.+|+..+..+..-+ ++++... ... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5699999998776 4446888865411 1111 223466789999998884332 4444421 111 22467899
Q ss_pred eecCC-CChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC--eEEeecCch
Q 045214 90 EYAKG-GELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--LKVTDFGLS 156 (450)
Q Consensus 90 E~~~g-g~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--vkl~DFGls 156 (450)
|-+.| -+|.+++.+. +.++.....++.++...+.-||+.|+.|+|+.+.||+++.+|. +.++||--+
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97765 4888888663 4577788899999999999999999999999999999987777 999999754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.8e-08 Score=100.92 Aligned_cols=135 Identities=21% Similarity=0.353 Sum_probs=91.4
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc---------------------------c----chHHH------HH
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---------------------------V----GLVDQ------TK 58 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~---------------------------~----~~~~~------~~ 58 (450)
+.|+.++-|.||.|+.. +|+.||||+.++.-... . +..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999985 49999999997631100 0 01111 23
Q ss_pred HHHHHHHhC-----CCCCccEEEEEEEeCCEEEEEEeecCCCChhhH--HhcCCCCHHH-----HHHHHHHHHHHHHHHH
Q 045214 59 REISVMRLI-----QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK--VSKGKLKEDT-----ARKYFQQLISAIDFCH 126 (450)
Q Consensus 59 ~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~l~e~~-----~~~~~~qll~aL~~LH 126 (450)
+|...+.++ +.|++.-..=+++..+.-.++|||++|-.+.+. +...+++... +..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 444444444 234433333333445667899999999888877 4445555333 333344443
Q ss_pred HCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 127 ~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
..|++|+|.+|.||+++.+|.+.+.|||+...
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceec
Confidence 38999999999999999999999999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.2e-07 Score=83.96 Aligned_cols=145 Identities=17% Similarity=0.215 Sum_probs=102.2
Q ss_pred ccCeeeec---eEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---------------------chHHHHHHHHHHH
Q 045214 9 MQKYELGR---LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---------------------GLVDQTKREISVM 64 (450)
Q Consensus 9 ~~~y~~~~---~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~Ei~il 64 (450)
..+..+.. .|+.|--+.||+|.. .++..+|+|++......-. -......+|...|
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL 122 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNL 122 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHH
Confidence 33444444 555677789999986 5789999999965322110 0123346788888
Q ss_pred HhCC--CCCccEEEEEEEeCCEEEEEEeecCCC-ChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcE
Q 045214 65 RLIQ--HPNVMQIYEVMASKTKIYFVMEYAKGG-ELFKKVSKGKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENL 140 (450)
Q Consensus 65 ~~l~--hpnIv~l~~~~~~~~~~~lv~E~~~gg-~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NI 140 (450)
+++. +-.+++.+.+.. -.+||||+... .-.-.+..-++...++..+..++++.+.-|-. .|++|+||..-||
T Consensus 123 ~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNi 198 (268)
T COG1718 123 KRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNI 198 (268)
T ss_pred HHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhhe
Confidence 8883 455666666653 46899998653 11222333344455788999999999998877 8999999999999
Q ss_pred EecCCCCeEEeecCchhhh
Q 045214 141 LLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~ 159 (450)
|+. +|.+.++|||.|...
T Consensus 199 L~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 199 LVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred EEE-CCeEEEEECcccccc
Confidence 998 889999999977543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.4e-07 Score=84.13 Aligned_cols=132 Identities=15% Similarity=0.168 Sum_probs=84.5
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 93 (450)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567889876432 2345789999999886433 5788888888888899999999
Q ss_pred CCC-hh--------------hH-------Hhc---CCCCHHH-HHHHHHH----------HHHH-HHHHH----HCCCee
Q 045214 94 GGE-LF--------------KK-------VSK---GKLKEDT-ARKYFQQ----------LISA-IDFCH----SRGVYH 132 (450)
Q Consensus 94 gg~-L~--------------~~-------i~~---~~l~e~~-~~~~~~q----------ll~a-L~~LH----~~gi~H 132 (450)
|.+ +. .. +.. ...+... ...+..+ +... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 11 111 0011100 0111100 1111 12222 124789
Q ss_pred cCCCCCcEEecCCCCeEEeecCchh
Q 045214 133 RDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 133 rDikp~NILl~~~~~vkl~DFGls~ 157 (450)
+|+.|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.4e-09 Score=105.10 Aligned_cols=238 Identities=19% Similarity=0.170 Sum_probs=165.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~ 89 (450)
-|...+.+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+..++..++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4677888999999999999886655444 5555432 33456889999999999 777777778888999999
Q ss_pred eecCCC-ChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 90 EYAKGG-ELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 90 E~~~gg-~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+++.++ +-..... .-.+.+-+.....+.-..+++++|+.-=+|+| ||+..+ +..+..||+........ .
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---~ 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---M 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---c
Confidence 999887 2222221 12345556666777888999999998778898 777654 78999999976433221 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCC---CCCCcHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKF---PTWFSADVRK 241 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~---p~~~s~~~~~ 241 (450)
...+..+|+.++|||+.....+. ...|.|++|.--.+|--|.+|-..+ ......+..+. ..+ ..|-+..-.+
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccC
Confidence 34567899999999999888776 7899999998777777777664331 11110111000 000 0111122234
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+...|+..-|..|+....++-|.+|..
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhcc
Confidence 778899999999999999998888854
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.7e-06 Score=79.01 Aligned_cols=135 Identities=21% Similarity=0.311 Sum_probs=82.2
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CccEEEEEE---EeCCEEEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP--NVMQIYEVM---ASKTKIYFVM 89 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~ 89 (450)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999999854 58999997654 2346677888888888433 356666643 3344689999
Q ss_pred eecCCCChhh----------------HHh---cC-----CCCHHH------HHH---H------------HHHHHH-HHH
Q 045214 90 EYAKGGELFK----------------KVS---KG-----KLKEDT------ARK---Y------------FQQLIS-AID 123 (450)
Q Consensus 90 E~~~gg~L~~----------------~i~---~~-----~l~e~~------~~~---~------------~~qll~-aL~ 123 (450)
++++|..+.. .+. .- .+.... ... . ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 10 001000 000 0 111222 333
Q ss_pred HHHH-------CCCeecCCCCCcEEec-CCCCeEEeecCch
Q 045214 124 FCHS-------RGVYHRDLKPENLLLD-ENGMLKVTDFGLS 156 (450)
Q Consensus 124 ~LH~-------~gi~HrDikp~NILl~-~~~~vkl~DFGls 156 (450)
.+++ ..++|+|+.|.|||++ .++.+.|+||+.+
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 3332 4699999999999999 6677789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=81.19 Aligned_cols=74 Identities=14% Similarity=0.177 Sum_probs=53.6
Q ss_pred eEeecCC-eEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 17 LLGQGNF-AKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 17 ~LG~G~f-g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
.|..|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+++++.+....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 78999875 34678888875442 234678998888883 44577888888777788999999999
Q ss_pred CChh
Q 045214 95 GELF 98 (450)
Q Consensus 95 g~L~ 98 (450)
.++.
T Consensus 77 ~~l~ 80 (244)
T cd05150 77 VPAA 80 (244)
T ss_pred ccHh
Confidence 7665
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.8e-06 Score=86.76 Aligned_cols=139 Identities=20% Similarity=0.251 Sum_probs=90.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc----------------------------cchHHHHH------HHH
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK----------------------------VGLVDQTK------REI 61 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~----------------------------~~~~~~~~------~Ei 61 (450)
+.||.-+.|.||+|+.+. |+.||||+-++.-... .+..+.+. +|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 678999999999999875 9999999986631100 01111122 233
Q ss_pred HHH----HhCCCCC------ccEEEEEEEeCCEEEEEEeecCCCChhh--HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 045214 62 SVM----RLIQHPN------VMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRG 129 (450)
Q Consensus 62 ~il----~~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~--~i~~~~l~e~~~~~~~~qll~aL~~LH~~g 129 (450)
+.. +.+.|-+ |+++|-. ..+...++|||++|..+.| .|++.+++...+...+.+... ..+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 222 2334444 4444433 3456789999999987755 466667777655544443322 2223468
Q ss_pred CeecCCCCCcEEecC----CCCeEEeecCchhhh
Q 045214 130 VYHRDLKPENLLLDE----NGMLKVTDFGLSALA 159 (450)
Q Consensus 130 i~HrDikp~NILl~~----~~~vkl~DFGls~~~ 159 (450)
++|+|=+|.||+++. ++.+.+-|||+....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 999999999999984 568999999986543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-05 Score=72.88 Aligned_cols=131 Identities=21% Similarity=0.326 Sum_probs=98.0
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccc-------------cccchHHHHHHHHHHHHhCC------CCCccEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-------------LKVGLVDQTKREISVMRLIQ------HPNVMQI 75 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l 75 (450)
...||+|+.-.||. | ......+||+...... .......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999995 3 2445589999987660 11123466778888777776 7889999
Q ss_pred EEEEEeCCEEEEEEeecCC------CChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---
Q 045214 76 YEVMASKTKIYFVMEYAKG------GELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG--- 146 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~--- 146 (450)
|++.+++--.-+|+|.+.. .+|.+++.++.+++ ..... +-+-.+||-+++|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998643 36888888887877 44443 44455688899999999999999996432
Q ss_pred -CeEEee
Q 045214 147 -MLKVTD 152 (450)
Q Consensus 147 -~vkl~D 152 (450)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.9e-06 Score=90.88 Aligned_cols=203 Identities=19% Similarity=0.256 Sum_probs=140.8
Q ss_pred HHHHHHHHHHhCCCCCccEEEEEEEeCC----EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 045214 56 QTKREISVMRLIQHPNVMQIYEVMASKT----KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGV 130 (450)
Q Consensus 56 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi 130 (450)
..+-|+..+....|+|++.++.+.-..- ...+..|++...++...+.. +..+.+.++.+..+++.||.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3455677778889999999999874433 23455688999999999877 789999999999999999999999965
Q ss_pred eecCCCCC---cEEecCCCCeEEe--ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCC-CCccchhhHHHHHHH
Q 045214 131 YHRDLKPE---NLLLDENGMLKVT--DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD-GDKADIWSCGVILYV 204 (450)
Q Consensus 131 ~HrDikp~---NILl~~~~~vkl~--DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~~DiwSlGvil~~ 204 (450)
.|.-+... +--.+..+.+..+ ||+.+........ .....-+..+.|||....+.+. +...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55544444 3333455566666 8887654332221 2233345567888877655443 223699999999999
Q ss_pred HhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 205 LLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 205 ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+..|..+-.... ....+ .+.....+..+.+.+|+.-++++|+++.+++.|||.+...
T Consensus 385 ~~~~~~i~~~~~---~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhcCccccccc---chhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 988765422111 00011 1111222788999999999999999999999999987543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=89.47 Aligned_cols=81 Identities=20% Similarity=0.383 Sum_probs=58.4
Q ss_pred eeceEeecCCeEEEEEEEcCCC--cEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCc--cEEEEEEEeC---CEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTG--QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNV--MQIYEVMASK---TKI 85 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 85 (450)
-++.|+.|.+..+|+......+ ..+++|......... ....+.+|..+|+.+. |+++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998765432 467777765433211 2346789999999995 6665 7888877654 468
Q ss_pred EEEEeecCCCC
Q 045214 86 YFVMEYAKGGE 96 (450)
Q Consensus 86 ~lv~E~~~gg~ 96 (450)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 99999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.2e-06 Score=71.61 Aligned_cols=129 Identities=22% Similarity=0.333 Sum_probs=93.3
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEEEee
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~ 91 (450)
+..+.|++|++|.||++.. .|..+|+|+-..+.. ...+..|.++|..+.--++ .++|.+..+ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 3467899999999999998 567999998876643 3678899999999976655 456665443 345999
Q ss_pred cCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC-CCcEEecCCCCeEEeecCchhh
Q 045214 92 AKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK-PENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDik-p~NILl~~~~~vkl~DFGls~~ 158 (450)
+.|-+|.+.-..+ + ++-+..+++.-.-|-..||-|+.|. |...+|-.++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887665433 2 2333445566555667899999996 4444444555999999997763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3e-05 Score=70.19 Aligned_cols=128 Identities=19% Similarity=0.263 Sum_probs=90.5
Q ss_pred cCeeeeceEeecCC-eEEEEEEEcCCCcEEEEEEeec---cc-------ccc-c-------chHHHHHHHHHHHHhCC--
Q 045214 10 QKYELGRLLGQGNF-AKVYYARHLGTGQSVAIKAIDK---DK-------ILK-V-------GLVDQTKREISVMRLIQ-- 68 (450)
Q Consensus 10 ~~y~~~~~LG~G~f-g~Vy~a~~~~~~~~vaiK~i~~---~~-------~~~-~-------~~~~~~~~Ei~il~~l~-- 68 (450)
..++.++.||.|+- |.||+++. .|+.+|+|++.. .. ... . .....+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999998 788999999321 10 000 0 12345667887777764
Q ss_pred -CCCc--cEEEEEEEeC------------------CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 045214 69 -HPNV--MQIYEVMASK------------------TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS 127 (450)
Q Consensus 69 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~ 127 (450)
+.++ +++|++..-. ....||-||++... .++. .-+.++++-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHH
Confidence 4556 8999987322 12457777776543 2233 334567777888999
Q ss_pred CCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 128 RGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 128 ~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.||+-+|+++.|.. .-+|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999985 3489999853
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=74.41 Aligned_cols=73 Identities=10% Similarity=0.096 Sum_probs=46.7
Q ss_pred eceEeecCCe-EEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC---CccEEEEEEEeC---CEEEE
Q 045214 15 GRLLGQGNFA-KVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP---NVMQIYEVMASK---TKIYF 87 (450)
Q Consensus 15 ~~~LG~G~fg-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 87 (450)
++.++.|+.. .||.. +..+++|+..... ....+.+|..+++.+... .+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567766666 58875 2357778754321 235788999999887532 355555544332 24588
Q ss_pred EEeecCCCCh
Q 045214 88 VMEYAKGGEL 97 (450)
Q Consensus 88 v~E~~~gg~L 97 (450)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00022 Score=64.55 Aligned_cols=96 Identities=20% Similarity=0.298 Sum_probs=77.2
Q ss_pred HHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEeecCCCChhhH---H-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 045214 59 REISVMRLIQH-PNVMQIYEVMASKTKIYFVMEYAKGGELFKK---V-SKGKLKEDTARKYFQQLISAIDFCHS---RGV 130 (450)
Q Consensus 59 ~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i-~~~~l~e~~~~~~~~qll~aL~~LH~---~gi 130 (450)
.|.-+++.+.+ ++++++++.+. .+++.||...+++... + .-...+.....+++.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888888866 69999999873 3678899987766421 1 11346788899999999999999997 357
Q ss_pred eecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 131 YHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 131 ~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
.-+|++|+|+-++++|++|++|......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 7799999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00016 Score=67.75 Aligned_cols=75 Identities=15% Similarity=0.258 Sum_probs=49.3
Q ss_pred eceEeecCCeEEEEEEEcC-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CccEEEEEEEeCCEEEEEEeec
Q 045214 15 GRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP-NVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E~~ 92 (450)
++.|..|-...+|++.... .++.|++|+....... .....+|+.+++.+... -.++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788888999987643 3578999977643211 12335788888888433 3455554432 2 3799999
Q ss_pred CCCCh
Q 045214 93 KGGEL 97 (450)
Q Consensus 93 ~gg~L 97 (450)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00034 Score=68.15 Aligned_cols=78 Identities=10% Similarity=0.114 Sum_probs=55.8
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC---CCccEEEEEEEe---CCEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH---PNVMQIYEVMAS---KTKIY 86 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 86 (450)
.-.+.||.|..+.||..... ++ .+.+|..+... ....+.+|...|+.+.. ..++++++++.. .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999998652 23 47778743211 12467889999988843 467888887754 46789
Q ss_pred EEEeecCCCCh
Q 045214 87 FVMEYAKGGEL 97 (450)
Q Consensus 87 lv~E~~~gg~L 97 (450)
+|||+++|.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00043 Score=69.75 Aligned_cols=80 Identities=20% Similarity=0.216 Sum_probs=55.8
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccc--cc--cchHHHHHHHHHHHHhCC---CCCccEEEEEEEeCCEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI--LK--VGLVDQTKREISVMRLIQ---HPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~--~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (450)
.+.||.|.+..||++.....++.++||.-.+... .. .-..++...|...|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864446899998542110 01 113466777888888762 3467888877 4455789
Q ss_pred EEeecCCCC
Q 045214 88 VMEYAKGGE 96 (450)
Q Consensus 88 v~E~~~gg~ 96 (450)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=69.70 Aligned_cols=131 Identities=18% Similarity=0.250 Sum_probs=77.8
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEEEeecCCC
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 95 (450)
.+..|-.+.+|+... +++.+++|........ ..-...+|..+++.+...++ ++++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456788889998873 5678889876543211 10134678999988854333 44554432 36899999986
Q ss_pred Chhh--------------HH---hcC-----CCC-HHHHHHHHHHH---------HHHHHHHHH--------CCCeecCC
Q 045214 96 ELFK--------------KV---SKG-----KLK-EDTARKYFQQL---------ISAIDFCHS--------RGVYHRDL 135 (450)
Q Consensus 96 ~L~~--------------~i---~~~-----~l~-e~~~~~~~~ql---------l~aL~~LH~--------~gi~HrDi 135 (450)
.+.. .+ ..- +++ ...+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 11 111 111 11222332222 111222221 25899999
Q ss_pred CCCcEEecCCCCeEEeecCchh
Q 045214 136 KPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 136 kp~NILl~~~~~vkl~DFGls~ 157 (450)
.|.||++++++ +.|+||..|.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999877 8899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.1e-06 Score=97.69 Aligned_cols=208 Identities=16% Similarity=0.080 Sum_probs=143.2
Q ss_pred HHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEEeecCCCChhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC-C
Q 045214 58 KREISVMRLIQHPNVMQIYEVMA--SKTKIYFVMEYAKGGELFKKVSKG-----KLKEDTARKYFQQLISAIDFCHSR-G 129 (450)
Q Consensus 58 ~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~~LH~~-g 129 (450)
..|..-++...|+++...+.-.. +....|..++|+.+|.+++.|-+| .+.+.-+....++.+.+..-+|+. |
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555556678999888776553 344678999999999999999764 244555555556667888888864 2
Q ss_pred ----CeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHH
Q 045214 130 ----VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVL 205 (450)
Q Consensus 130 ----i~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~l 205 (450)
.+|+++|+-|.+|..+.++|+.++|+.+.. .+.........+++.|++|++...-.+. .++|+|..|+.+|..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHH
Confidence 689999999999999999999999997621 1122233455788899999998776664 559999999999999
Q ss_pred hhCCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 206 LAGYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 206 l~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..|..+|..-....+...+... ....+...|.++-.....+|-+.-..||.-...+.-+.|-.
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9988876532222222222222 12334444555555555555566677888777777666643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00029 Score=68.38 Aligned_cols=135 Identities=16% Similarity=0.187 Sum_probs=82.9
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEEE------EEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIYE------VMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (450)
.+.|..|....+|+... .+..+++|+.... ...++..|+.++..+.+.+ +++++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56677788889999865 3457899987641 1245677888887774322 445443 223456789
Q ss_pred EEEeecCCCChhh-----------HH---hc--CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 045214 87 FVMEYAKGGELFK-----------KV---SK--GKLKE--------DTAR------------KYFQQLISAIDFCHS--- 127 (450)
Q Consensus 87 lv~E~~~gg~L~~-----------~i---~~--~~l~e--------~~~~------------~~~~qll~aL~~LH~--- 127 (450)
++++|++|..+.. .+ .. ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999976421 01 10 00100 0000 011112233444443
Q ss_pred ----CCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 128 ----RGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 128 ----~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00032 Score=68.62 Aligned_cols=135 Identities=17% Similarity=0.203 Sum_probs=79.9
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEEEE------EEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIYEV------MASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 86 (450)
.+.++.|....+|++.. ++..+++|+.+... ..+.+..|+.++..|...+ +++++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998865 33457889875532 1234556677776663222 3444431 22356789
Q ss_pred EEEeecCCCChh-----------hHH---hc--CCCC--------HHH----HH-----------HHHHHHHHHHHHHHH
Q 045214 87 FVMEYAKGGELF-----------KKV---SK--GKLK--------EDT----AR-----------KYFQQLISAIDFCHS 127 (450)
Q Consensus 87 lv~E~~~gg~L~-----------~~i---~~--~~l~--------e~~----~~-----------~~~~qll~aL~~LH~ 127 (450)
+++||++|.++. ..+ .. ..++ ... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 111 10 0110 000 00 001122334555532
Q ss_pred -------CCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 128 -------RGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 128 -------~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.+++|+|+++.||+++.++.+.|+||+.+
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 68999999999999998887789999965
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00014 Score=49.62 Aligned_cols=42 Identities=17% Similarity=0.379 Sum_probs=35.6
Q ss_pred eeEEEEEEEEEEe-CceEEEEEEecCCCcHHHHHHHHHhhhhhc
Q 045214 386 GTFSIDVQLFEFN-PSIHLVELTKSSGDNLEYQKMLKQEIRPAL 428 (450)
Q Consensus 386 g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l 428 (450)
..+.|.+||+++. ++++.|+|+|.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 3578999999998 899999999999999999999998 55544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00051 Score=67.16 Aligned_cols=140 Identities=22% Similarity=0.311 Sum_probs=98.9
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-------------------cc---ch-HHHHHHHHHHHHhCCCC
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-------------------KV---GL-VDQTKREISVMRLIQHP 70 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-------------------~~---~~-~~~~~~Ei~il~~l~hp 70 (450)
+-..|..|--+.||.|.. .+|..+|||+++.+-+. +. .+ .-...+|++.|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445577788899999876 57888999998653110 00 11 23457889999888665
Q ss_pred CccEEEEEEEeCCEEEEEEeecCC-CChhhHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEecCCCCe
Q 045214 71 NVMQIYEVMASKTKIYFVMEYAKG-GELFKKVSKGKLKEDTARKYFQQLISAIDFC-HSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDikp~NILl~~~~~v 148 (450)
.|.-.--+.- ..-.|||+|+.. |--.-.+..-.++...+..+..|++.-+.-| |.++++|.||.--|+|+ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 5433222221 124689999953 2223345556788889999999999888887 56799999999999998 67899
Q ss_pred EEeecCchh
Q 045214 149 KVTDFGLSA 157 (450)
Q Consensus 149 kl~DFGls~ 157 (450)
.++|-+.|-
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=3.6e-05 Score=73.75 Aligned_cols=134 Identities=18% Similarity=0.284 Sum_probs=96.0
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc------------cc--c-c----hHHHHHHHHHHHHhCCCC--
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI------------LK--V-G----LVDQTKREISVMRLIQHP-- 70 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~------------~~--~-~----~~~~~~~Ei~il~~l~hp-- 70 (450)
|.+++.||-|.-+.||.+-+ ..|.+.++|+=+.... .. . . ..-...+|...|+.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67899999999999999987 4688899986432110 00 0 0 012346799999988532
Q ss_pred CccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
-+++.++ .+..++|||++.|..|...-.- ..+..+...++.-+--|-.+|++|+|..-=||++++++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 3445544 3567899999999877644321 123345566666677788999999999999999999999999
Q ss_pred eecCc
Q 045214 151 TDFGL 155 (450)
Q Consensus 151 ~DFGl 155 (450)
+||-.
T Consensus 244 IDFPQ 248 (465)
T KOG2268|consen 244 IDFPQ 248 (465)
T ss_pred eechH
Confidence 99964
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00056 Score=66.67 Aligned_cols=75 Identities=16% Similarity=0.204 Sum_probs=49.1
Q ss_pred eceEeecCCeEEEEEEEcC------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLG------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKIYF 87 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 87 (450)
++.|..|-...+|++.... +++.+++|+...... ......+|..+++.+...+ ..+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556677778999987643 267899999765421 1234578888888884333 3455655532 35
Q ss_pred EEeecCCCCh
Q 045214 88 VMEYAKGGEL 97 (450)
Q Consensus 88 v~E~~~gg~L 97 (450)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0034 Score=61.68 Aligned_cols=135 Identities=13% Similarity=0.175 Sum_probs=74.1
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CccEEEE------EEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP--NVMQIYE------VMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 86 (450)
.+.|+.|....+|.... ++..+++|++.... .+.+..|+.+++.|... .+.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~~~------~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFERLT------AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEeccCC------hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35566777789999875 23368999875211 12334455555554211 1333332 223456789
Q ss_pred EEEeecCCCChh-----------hHHh---c--CCC--------CH----HHHH-----------HHHHHHH-HHHHHHH
Q 045214 87 FVMEYAKGGELF-----------KKVS---K--GKL--------KE----DTAR-----------KYFQQLI-SAIDFCH 126 (450)
Q Consensus 87 lv~E~~~gg~L~-----------~~i~---~--~~l--------~e----~~~~-----------~~~~qll-~aL~~LH 126 (450)
+++||++|..+. ..+. . ..+ .. .... ..+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999996431 1111 0 001 00 0000 1111111 1122222
Q ss_pred -------HCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 127 -------SRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 127 -------~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
..|++|+|++|.||+++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0022 Score=62.59 Aligned_cols=140 Identities=20% Similarity=0.293 Sum_probs=86.4
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CccEEEEEEEeCC--EEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP--NVMQIYEVMASKT--KIYF 87 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~--~~~l 87 (450)
..+++....|....+|..... ++.+++. .. .............+|..+++.+.-- -+...++++.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 345555545555566666553 7788888 32 1222234456778899999887542 3344455554444 7799
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHH-HHHHHHHHHHHH---------------------------------------
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYF-QQLISAIDFCHS--------------------------------------- 127 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~-~qll~aL~~LH~--------------------------------------- 127 (450)
||+|++|..+.+........ ..+. ..+...|+-||+
T Consensus 103 v~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99999995433322221111 1112 244444444442
Q ss_pred -------------------CCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 128 -------------------RGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 128 -------------------~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
..++|+|+++.||+++.++-+-|.||+++.+.
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 13599999999999999999999999988653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0051 Score=61.96 Aligned_cols=77 Identities=19% Similarity=0.124 Sum_probs=52.9
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc----chHHHHHHHHHHHHhCC---CCCccEEEEEEEeCCEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV----GLVDQTKREISVMRLIQ---HPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 86 (450)
-.+.||.|....||+..+ .++.++||.-........ ....+...|...|+.+. ..+++++|.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999887 345699997652211110 12455566777777663 247888888876 4457
Q ss_pred EEEeecCC
Q 045214 87 FVMEYAKG 94 (450)
Q Consensus 87 lv~E~~~g 94 (450)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0043 Score=61.44 Aligned_cols=76 Identities=18% Similarity=0.110 Sum_probs=50.2
Q ss_pred eEeecCCeEEEEEEEcCCCcEEEEEEeecccc----cccchHHHHHHHHHHHHhCC--CC-CccEEEEEEEeCCEEEEEE
Q 045214 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI----LKVGLVDQTKREISVMRLIQ--HP-NVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~----~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~ 89 (450)
.+|.|....||++.+...++.++||.-..--- .-+-..++..-|...|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999854447899997532111 01123456677888887663 23 56666654 455566999
Q ss_pred eecCC
Q 045214 90 EYAKG 94 (450)
Q Consensus 90 E~~~g 94 (450)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0038 Score=62.13 Aligned_cols=136 Identities=15% Similarity=0.228 Sum_probs=80.9
Q ss_pred eeceEeecCCeEEEEEEEcC----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLG----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFV 88 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv 88 (450)
-++.|..|-...+|++.... +++.|++|+..... ...+++ .+|..+++.+..-++ .++++.+... .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34556568888999987532 34789999886543 122233 678999988854443 4566665332 47
Q ss_pred EeecCCCChhhH--------------H---hcCC------CC-HHHHHHHHHHH-----------------HHHHHHH--
Q 045214 89 MEYAKGGELFKK--------------V---SKGK------LK-EDTARKYFQQL-----------------ISAIDFC-- 125 (450)
Q Consensus 89 ~E~~~gg~L~~~--------------i---~~~~------l~-e~~~~~~~~ql-----------------l~aL~~L-- 125 (450)
.||++|.+|... + .... .. .+.+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 899987665311 1 1101 11 12233333222 1111112
Q ss_pred --H----HCCCeecCCCCCcEEecC-CCCeEEeecCchh
Q 045214 126 --H----SRGVYHRDLKPENLLLDE-NGMLKVTDFGLSA 157 (450)
Q Consensus 126 --H----~~gi~HrDikp~NILl~~-~~~vkl~DFGls~ 157 (450)
. ...++|+|+++.|||+++ ++.+.++||..|.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 236899999999999986 4689999998764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0023 Score=65.17 Aligned_cols=163 Identities=23% Similarity=0.256 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 045214 55 DQTKREISVMRLIQHPNVMQIYEVMASK-TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133 (450)
Q Consensus 55 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~Hr 133 (450)
.++.-...+++.+.|+|...+.++.... ....+|||++ +.+|.+....+.+-..... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee
Confidence 3455668889999999999999887543 3578899998 5588888876543222111 1222221
Q ss_pred CCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCC
Q 045214 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH 213 (450)
Q Consensus 134 Dikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 213 (450)
|+ ++.+| -+++ .| |- ..++++||||+|.++.++.-|...|.
T Consensus 92 -----~~-------~~~td-~~~t------------------~~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----NI-------IYITD-HFLT------------------KY--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----hh-------hhccc-cccc------------------cC--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 11 22333 0000 00 10 11259999999999999999987776
Q ss_pred CCcHHHHHHHHhhcCCCCC------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 214 DSNLMAMYRKIAKADYKFP------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~p------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.....+....+.+-..... ...+..+.+++.+|+...|..||...++++++-|...+.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 5544444444333221111 114556778999999999999999999999999976643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0055 Score=60.63 Aligned_cols=135 Identities=16% Similarity=0.232 Sum_probs=78.8
Q ss_pred eceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEEEe
Q 045214 15 GRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFVME 90 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E 90 (450)
++.|..|=...+|+....+. +..|++|+...... ..+ .-.+|..+++.+..-++ +++++++. .+ ++.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 44555577788998875432 34799998765321 112 23678888888865444 45666553 22 4889
Q ss_pred ecCCCChhh----------H----H---hcCC------CC-HHHHHHHHHHH----------------------HHHHHH
Q 045214 91 YAKGGELFK----------K----V---SKGK------LK-EDTARKYFQQL----------------------ISAIDF 124 (450)
Q Consensus 91 ~~~gg~L~~----------~----i---~~~~------l~-e~~~~~~~~ql----------------------l~aL~~ 124 (450)
|++|..|.. . + .... .+ ...+..++.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 988765421 1 1 1111 11 12233333222 111222
Q ss_pred HH----HCC----CeecCCCCCcEEecC-CCCeEEeecCchh
Q 045214 125 CH----SRG----VYHRDLKPENLLLDE-NGMLKVTDFGLSA 157 (450)
Q Consensus 125 LH----~~g----i~HrDikp~NILl~~-~~~vkl~DFGls~ 157 (450)
+. +.+ ++|+|+.|.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21 122 799999999999975 5789999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.017 Score=56.36 Aligned_cols=28 Identities=36% Similarity=0.603 Sum_probs=24.9
Q ss_pred CCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 128 RGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 128 ~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.+++|+|+++.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57899999999999987 67899999854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0088 Score=57.56 Aligned_cols=29 Identities=28% Similarity=0.489 Sum_probs=24.5
Q ss_pred CCeecCCCCCcEEecCCCC-eEEeecCchh
Q 045214 129 GVYHRDLKPENLLLDENGM-LKVTDFGLSA 157 (450)
Q Consensus 129 gi~HrDikp~NILl~~~~~-vkl~DFGls~ 157 (450)
.++|+|++|.|||+++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.012 Score=58.95 Aligned_cols=78 Identities=21% Similarity=0.221 Sum_probs=53.1
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc---ccchHHHHHHHHHHHHhCC--CC-CccEEEEEEEeCCEEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL---KVGLVDQTKREISVMRLIQ--HP-NVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 88 (450)
.+.||.|.-..||++.+...++.++||.-..---. -+-..++..-|..+|+... -| .++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67889999999999998444678999965321111 1123567778888888763 33 56677665 45556788
Q ss_pred EeecCC
Q 045214 89 MEYAKG 94 (450)
Q Consensus 89 ~E~~~g 94 (450)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.029 Score=54.26 Aligned_cols=75 Identities=13% Similarity=0.181 Sum_probs=48.1
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEEeCCEEEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+-.+.++.|....+|... .+++.+.+|+-.... ...+..|..-|+.| .--.+++++.+....+.-|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 446778999999999887 578899999876221 23456778777777 3446889999988877789999
Q ss_pred eecCCC
Q 045214 90 EYAKGG 95 (450)
Q Consensus 90 E~~~gg 95 (450)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.041 Score=53.84 Aligned_cols=29 Identities=21% Similarity=0.208 Sum_probs=26.8
Q ss_pred CCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 129 GVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 129 gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
+++|+|+.+.|+|++.++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0059 Score=56.17 Aligned_cols=30 Identities=33% Similarity=0.656 Sum_probs=21.3
Q ss_pred CCCeecCCCCCcEEe-cCCCCeEEeecCchh
Q 045214 128 RGVYHRDLKPENLLL-DENGMLKVTDFGLSA 157 (450)
Q Consensus 128 ~gi~HrDikp~NILl-~~~~~vkl~DFGls~ 157 (450)
..++|+|+.|.|||+ +.++.++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358999999999999 889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.034 Score=56.04 Aligned_cols=76 Identities=18% Similarity=0.252 Sum_probs=46.5
Q ss_pred eeceEeecCCeEEEEEEEcCC-CcE-----EEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGT-GQS-----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKIY 86 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (450)
..+.|..|-...+|++..... +.. |.+++.... ....-.-.+|+.+++.+...+ -.++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 445666688899999975433 222 444432111 111122367899999996544 4566776643 5
Q ss_pred EEEeecCCCCh
Q 045214 87 FVMEYAKGGEL 97 (450)
Q Consensus 87 lv~E~~~gg~L 97 (450)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.015 Score=57.94 Aligned_cols=62 Identities=23% Similarity=0.265 Sum_probs=46.7
Q ss_pred EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEecCC
Q 045214 84 KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC-HSRGVYHRDLKPENLLLDEN 145 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDikp~NILl~~~ 145 (450)
...++-+|..|-++..+++....+|....++..--.+|+--+ --.+++|.|++|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 456777899999999999876677766666666555555443 34689999999999999644
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.015 Score=57.09 Aligned_cols=89 Identities=22% Similarity=0.340 Sum_probs=61.8
Q ss_pred HhCCCCCccEEEEEE-EeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEe
Q 045214 65 RLIQHPNVMQIYEVM-ASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLL 142 (450)
Q Consensus 65 ~~l~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl 142 (450)
+....++..+.+-+- .+..+.|++|++- |+++. .+.. -..+++..++++.+..++-+... ..-|||+.-.||||
T Consensus 280 ~~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 280 RECGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred hhccchhhhcceEEecCCceEEEEEEecC-Cceee-eeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 334444444444443 3344667777764 44442 2222 24567778899988888777765 78999999999999
Q ss_pred cCCCCeEEeecCchhh
Q 045214 143 DENGMLKVTDFGLSAL 158 (450)
Q Consensus 143 ~~~~~vkl~DFGls~~ 158 (450)
+ +|++.|+||-+|++
T Consensus 356 d-~GnvtLIDfklsRl 370 (488)
T COG5072 356 D-EGNVTLIDFKLSRL 370 (488)
T ss_pred e-cCceEEEEeeeeec
Confidence 9 99999999999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.35 Score=47.69 Aligned_cols=71 Identities=13% Similarity=0.083 Sum_probs=43.0
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEE---E--EEEeCCEEEEEEeecC
Q 045214 21 GNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIY---E--VMASKTKIYFVMEYAK 93 (450)
Q Consensus 21 G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~ 93 (450)
+.-..||.... .++..+++|+.+.... ...++..|+..+..|.... ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44567888865 3567799998864331 2355667777777663211 22211 1 2233567889999998
Q ss_pred CCC
Q 045214 94 GGE 96 (450)
Q Consensus 94 gg~ 96 (450)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 864
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.055 Score=49.70 Aligned_cols=100 Identities=17% Similarity=0.165 Sum_probs=63.3
Q ss_pred EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHH
Q 045214 37 SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ 116 (450)
Q Consensus 37 ~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~ 116 (450)
+..+|.+..-...- ....+..+.+++.++. .|+++..- +.-.+-+++|+|--.. .. -..++.
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~-~~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------IN-FSNFIT 148 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cc-hhHHHH
Confidence 34555554433321 1234467788887763 67777632 3445668899884321 11 111111
Q ss_pred HHHHHHHHHHH--CCCeecCCCCCcEEecCCCCeEEeecC
Q 045214 117 QLISAIDFCHS--RGVYHRDLKPENLLLDENGMLKVTDFG 154 (450)
Q Consensus 117 qll~aL~~LH~--~gi~HrDikp~NILl~~~~~vkl~DFG 154 (450)
-=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|-+
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 12466777884 479999999999999999999999977
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.18 Score=48.81 Aligned_cols=75 Identities=15% Similarity=0.108 Sum_probs=45.6
Q ss_pred eecCCeEEEEEEEcC----C----CcEEEEEEeeccccccc--chHHHHHHHHHHHHhCC-------------CCCccEE
Q 045214 19 GQGNFAKVYYARHLG----T----GQSVAIKAIDKDKILKV--GLVDQTKREISVMRLIQ-------------HPNVMQI 75 (450)
Q Consensus 19 G~G~fg~Vy~a~~~~----~----~~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-------------hpnIv~l 75 (450)
|.|-.|.+|++.-.. + ...++||....+..... .....+.+|+.+++.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 566778888877533 2 23588888763322211 12355678888876551 1235667
Q ss_pred EEEEEeCCEEEEEEeecC
Q 045214 76 YEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~ 93 (450)
|....+....+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 776666667889998653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 450 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-61 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-61 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-61 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-60 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-60 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-59 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-58 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-58 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-57 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-57 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-56 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-56 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-56 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-56 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-55 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-55 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-55 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-53 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-50 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-50 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-50 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-49 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-49 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-49 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-49 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-49 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-49 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-48 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-48 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-48 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-48 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-48 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-48 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-48 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-48 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-48 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-48 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-48 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-48 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-48 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-48 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-48 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-48 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-48 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-48 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-48 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-48 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-48 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-48 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-48 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-48 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-47 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-47 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-47 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-47 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-47 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-47 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-46 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-45 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-44 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-43 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-43 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-42 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-42 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-42 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-42 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-42 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-42 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-42 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-42 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-42 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-42 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-42 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-41 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-41 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-41 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-41 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-41 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-41 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-41 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-41 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-41 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-41 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-41 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-41 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-41 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-41 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-41 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-41 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-40 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-40 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-40 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-40 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-40 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-40 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-40 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-40 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-40 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-40 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-40 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-40 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-40 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-40 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-40 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-40 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-40 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-40 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-40 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-40 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-40 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-40 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-40 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-40 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-40 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-40 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-40 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-40 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-40 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-40 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-40 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-40 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-39 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-39 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-39 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-39 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-39 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-39 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-39 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-39 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-39 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-39 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-39 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-39 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-39 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-39 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-39 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-39 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-39 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-39 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-39 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-39 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-39 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-39 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-39 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-39 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-39 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-39 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-39 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-39 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-39 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-39 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-39 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-39 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-39 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-39 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-39 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-39 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-39 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-39 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-39 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-39 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-38 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-38 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-38 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-38 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-38 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-38 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-38 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-38 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-38 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-38 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-38 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-37 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-37 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-37 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-37 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-37 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-37 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-37 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-37 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-36 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-36 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-36 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-36 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-36 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-35 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-35 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-35 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-35 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-35 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-35 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-35 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-35 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-35 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-34 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-34 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-34 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-34 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-34 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-34 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-34 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-34 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-34 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-34 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-34 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-34 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-34 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-33 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-32 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-32 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-32 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-32 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-31 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-31 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-31 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-31 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-31 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-31 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-31 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-31 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-31 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-30 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-30 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-30 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-29 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-29 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-29 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-28 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-28 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-28 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-28 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-27 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-27 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-26 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-25 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-25 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-25 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-25 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-25 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-25 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-25 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-25 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-24 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-24 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-24 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-24 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-23 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-23 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-23 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-22 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-21 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 494 bits (1274), Expect = e-174
Identities = 132/471 (28%), Positives = 221/471 (46%), Gaps = 59/471 (12%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ G+V + Y LG LG G F KV +H TG VA+K +++ KI + +V + +REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLIS 120
++L +HP+++++Y+V+++ + I+ VMEY GGELF G+L E +R+ FQQ++S
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
+D+CH V HRDLKPEN+LLD + K+ DFGLS + L T+CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAP 184
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVIS R Y G + DIWS GVILY LL G LPF D ++ +++KI + P + + V
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNS-----KSAKSKTAIKESSLVDVDAAFG- 294
LL +L +P R +I I E+ WF++ L + S T I + +L +V F
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304
Query: 295 ------------------------------------------PIENSASTEAPRPMTKPD 312
+S + P+
Sbjct: 305 SEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPE 364
Query: 313 NLNAFHIISLSSGFDLSGFFVEHDQKEEVK-------FTSKYSASVIISKLEDIARHLKM 365
+ + + L + + + V+ S+ + I++++ + L
Sbjct: 365 RVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDY 424
Query: 366 KLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416
+ + L+ + + + +QL++ + +L++ + LE
Sbjct: 425 EWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-171
Identities = 117/272 (43%), Positives = 169/272 (62%), Gaps = 4/272 (1%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ G+V + Y LG LG G F KV H TG VA+K +++ KI + +V + KREI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLIS 120
++L +HP+++++Y+V+++ T + VMEY GGELF G+++E AR+ FQQ++S
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+D+CH V HRDLKPEN+LLD + K+ DFGLS + L T+CG+P Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAP 179
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
EVIS R Y G + DIWSCGVILY LL G LPF D ++ +++KI + P + + V
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272
LL +L +P R +I I E+ WF++ L S
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 483 bits (1246), Expect = e-171
Identities = 120/359 (33%), Positives = 181/359 (50%), Gaps = 24/359 (6%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
++ +Y+ + +G GNF R T + VA+K I++ + + +RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQRE 66
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLI 119
I R ++HPN+++ EV+ + T + +MEYA GGEL+++ + G+ ED AR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGM--LKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
S + +CHS + HRDLK EN LLD + LK+ DFG S + +T GTPAY
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAY 183
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK----IAKADYKFP- 232
+APEV+ R+ YDG AD+WSCGV LYV+L G PF D YRK I Y P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 233 -TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDA 291
S + L+SRI +P+TRISI +I + WF K L + + S + +
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNE--SNTGSQFQEPEQ 301
Query: 292 AFGPIENSA--STEAPRPMTKPDNLNAFHIISLSSGFDLSGFFVEHDQKEEVKFTSKYS 348
++ +EA P + L+ F ++ DL + D + E+ S
Sbjct: 302 PMQSLDTIMQIISEATIPAVRNRCLDDF----MTDNLDLDDDMDDFDSESEIDIDSSGE 356
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-171
Identities = 92/274 (33%), Positives = 153/274 (55%), Gaps = 9/274 (3%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M ++ ++L + LG+G + +V A + T ++VA+K +D + + + K+E
Sbjct: 1 MAVP---FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKE 55
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLI 119
I + +++ H NV++ Y Y +EY GGELF + + E A+++F QL+
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 115
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ + + H G+ HRD+KPENLLLDE LK++DFGL+ + + +++ LL+ CGT YVA
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYKFPTW--FS 236
PE++ RR + + D+WSCG++L +LAG LP+ S+ Y + W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270
+ LL +IL NPS RI+I I ++ W+ K L
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-170
Identities = 92/287 (32%), Positives = 156/287 (54%), Gaps = 6/287 (2%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++ ++L + LG+G + +V A + T ++VA+K +D + + + K+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCH 126
H NV++ Y Y +EY GGELF + + E A+++F QL++ + + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
G+ HRD+KPENLLLDE LK++DFGL+ + + +++ LL+ CGT YVAPE++ RR
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYKFPTW--FSADVRKLL 243
+ + D+WSCG++L +LAG LP+ S+ Y + W + LL
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVD 290
+IL NPS RI+I I ++ W+ K L + + + S
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG 289
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-168
Identities = 92/270 (34%), Positives = 144/270 (53%), Gaps = 6/270 (2%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD-QTKREISVMRL 66
L+ KY +G LLG+G++ KV T A+K + K K+ ++ + K+EI ++R
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 67 IQHPNVMQIYEVM--ASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAI 122
++H NV+Q+ +V+ K K+Y VMEY G E+ V + + A YF QLI +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
++ HS+G+ H+D+KP NLLL G LK++ G++ D T+ G+PA+ PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 183 IS-RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
+ + G K DIWS GV LY + G PF N+ ++ I K Y P +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLN 271
LL +L+ P+ R SI +I ++ WFRK
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 460 bits (1185), Expect = e-162
Identities = 111/271 (40%), Positives = 169/271 (62%), Gaps = 5/271 (1%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
K + Y + LG+G+F KV A H T Q VA+K I + + K + + +REIS
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISA 121
++L++HP+++++Y+V+ + T I V+EYA GGELF V K ++ ED R++FQQ+I A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I++CH + HRDLKPENLLLD+N +K+ DFGLS + L T+CG+P Y APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPE 177
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
VI+ + Y G + D+WSCG++LYV+L G LPF D + +++K+ Y P + S +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNS 272
L+ R++ +P RI+I +I +PWF L
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-161
Identities = 91/276 (32%), Positives = 159/276 (57%), Gaps = 5/276 (1%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+ T ++ +++G LLG+G+FA VY A + TG VAIK IDK + K G+V + + E
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQL 118
+ + ++HP+++++Y +Y V+E GE+ + K E+ AR + Q+
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
I+ + + HS G+ HRDL NLLL N +K+ DFGL+ K +T CGTP Y+
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYI 179
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSAD 238
+PE+ +R + G ++D+WS G + Y LL G PF + K+ ADY+ P++ S +
Sbjct: 180 SPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+ L+ ++L NP+ R+S++ ++++P+ + ++KS
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-161
Identities = 82/262 (31%), Positives = 135/262 (51%), Gaps = 4/262 (1%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
++Y GR LG+G FAK + T + A K + K +LK ++ EIS+ R +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHS 127
H +V+ + ++ V+E + L + + L E AR Y +Q++ + H
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
V HRDLK NL L+E+ +K+ DFGL+ ++ CGTP Y+APEV+S++G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
+ + D+WS G I+Y LL G PF S L Y +I K +Y P + L+ ++L
Sbjct: 192 HSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250
Query: 248 DPNPSTRISIAKIMENPWFRKG 269
+P+ R +I +++ + +F G
Sbjct: 251 QTDPTARPTINELLNDEFFTSG 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-161
Identities = 94/296 (31%), Positives = 158/296 (53%), Gaps = 31/296 (10%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---------- 51
+ V + +Y L +G+G++ V A + A+K + K K+++
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 52 -------------GLVDQTKREISVMRLIQHPNVMQIYEVM--ASKTKIYFVMEYAKGGE 96
G ++Q +EI++++ + HPNV+++ EV+ ++ +Y V E G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 97 LFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
+ + + L ED AR YFQ LI I++ H + + HRD+KP NLL+ E+G +K+ DFG+S
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 157 ALAKCKHQDGLLHTTCGTPAYVAPEVIS--RRGYDGDKADIWSCGVILYVLLAGYLPFHD 214
K D LL T GTPA++APE +S R+ + G D+W+ GV LY + G PF D
Sbjct: 185 NE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 215 SNLMAMYRKIAKADYKFPTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+M ++ KI +FP + D++ L++R+LD NP +RI + +I +PW +
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-161
Identities = 94/281 (33%), Positives = 153/281 (54%), Gaps = 6/281 (2%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
K K + +++GR LG+G F VY AR +A+K + K ++ K G+ Q +REI
Sbjct: 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISA 121
+ ++HPN++++Y + +IY ++E+A GEL+K++ K G+ E + + ++L A
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ +CH R V HRD+KPENLL+ G LK+ DFG S A T CGT Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRTMCGTLDYLPPE 182
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
+I + +D K D+W GV+ Y L G PF + +R+I D KFP + S +
Sbjct: 183 MIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIK 282
L+S++L +P R+ + +ME+PW + + +
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-160
Identities = 82/262 (31%), Positives = 135/262 (51%), Gaps = 4/262 (1%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
++Y GR LG+G FAK + T + A K + K +LK ++ EIS+ R +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHS 127
H +V+ + ++ V+E + L + + L E AR Y +Q++ + H
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
V HRDLK NL L+E+ +K+ DFGL+ ++ CGTP Y+APEV+S++G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
+ + D+WS G I+Y LL G PF S L Y +I K +Y P + L+ ++L
Sbjct: 218 HSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276
Query: 248 DPNPSTRISIAKIMENPWFRKG 269
+P+ R +I +++ + +F G
Sbjct: 277 QTDPTARPTINELLNDEFFTSG 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 447 bits (1151), Expect = e-158
Identities = 95/277 (34%), Positives = 155/277 (55%), Gaps = 6/277 (2%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
K + ++ +E+GR LG+G F VY AR + +A+K + K ++ K G+ Q +RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISA 121
+ ++HPN++++Y T++Y ++EYA G +++++ K K E Y +L +A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ +CHS+ V HRD+KPENLLL G LK+ DFG S A CGT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLPPE 177
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
+I R +D K D+WS GV+ Y L G PF + Y++I++ ++ FP + + R
Sbjct: 178 MIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
L+SR+L NPS R + +++E+PW + S
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 425 bits (1096), Expect = e-149
Identities = 90/291 (30%), Positives = 139/291 (47%), Gaps = 20/291 (6%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT---KR 59
+ +Y LG LLG+G F V+ L VAIK I ++++L + +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 60 EISVMRLI----QHPNVMQIYEVMASKTKIYFVMEYA-KGGELFKK-VSKGKLKEDTARK 113
E++++ + HP V+++ + ++ V+E +LF KG L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
+F Q+++AI CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFD 199
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
GT Y PE ISR Y A +WS G++LY ++ G +PF ++I +A+ FP
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFP 253
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
S D L+ R L P PS+R S+ +I+ +PW +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA 304
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-148
Identities = 110/276 (39%), Positives = 166/276 (60%), Gaps = 5/276 (1%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
+ + Y L + +G+GNFAKV ARH+ TG+ VAIK IDK ++ L + RE+
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVR 66
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISA 121
+M+++ HPN+++++EV+ ++ +Y +MEYA GGE+F V+ G++KE AR F+Q++SA
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ +CH + + HRDLK ENLLLD + +K+ DFG S G L CG P Y APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPE 183
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
+ + YDG + D+WS GVILY L++G LPF NL + ++ + Y+ P + S D
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKS 277
LL R L NP R ++ +IM++ W G K
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 419 bits (1078), Expect = e-146
Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 16/278 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD----- 55
+ QKY LG G F V+ A + V +K I K+K+L+ ++
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 56 QTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME-YAKGGELFKK-VSKGKLKEDTARK 113
+ EI+++ ++H N++++ ++ ++ VME + G +LF +L E A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
F+QL+SA+ + + + HRD+K EN+++ E+ +K+ DFG +A + + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFCG 191
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT 233
T Y APEV+ Y G + ++WS GV LY L+ PF + + +A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271
S ++ L+S +L P P R ++ K++ +PW + +N
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-144
Identities = 81/275 (29%), Positives = 135/275 (49%), Gaps = 18/275 (6%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD---QTKRE 60
+ + L +Y++G LLG G F VY + VAIK ++KD+I G + + E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 61 ISVMRLIQH--PNVMQIYEVMASKTKIYFVMEYAKG-GELFKK-VSKGKLKEDTARKYFQ 116
+ +++ + V+++ + ++E + +LF +G L+E+ AR +F
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGM-LKVTDFGLSALAKCKHQDGLLHTTCGTP 175
Q++ A+ CH+ GV HRD+K EN+L+D N LK+ DFG AL +D + GT
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 212
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235
Y PE I Y G A +WS G++LY ++ G +PF +I + F
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV 266
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270
S++ + L+ L PS R + +I +PW + L
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 395 bits (1016), Expect = e-136
Identities = 65/312 (20%), Positives = 127/312 (40%), Gaps = 51/312 (16%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK----------- 50
+ + Y + R L QG F K+ + A+K +K + K
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 51 ---VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK---- 103
D K E+ ++ I++ + ++ + ++Y + EY + + K
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 104 -----GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSA 157
+ + + ++++ + H+ + + HRD+KP N+L+D+NG +K++DFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHD-S 215
D + + GT ++ PE S Y+G K DIWS G+ LYV+ +PF
Sbjct: 201 YM----VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 216 NLMAMYRKIAKADYKFPT-------------------WFSADVRKLLSRILDPNPSTRIS 256
+L+ ++ I + ++P + S + L L NP+ RI+
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 257 IAKIMENPWFRK 268
+++ W
Sbjct: 317 SEDALKHEWLAD 328
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-112
Identities = 72/304 (23%), Positives = 133/304 (43%), Gaps = 39/304 (12%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+E +LGQG F +V AR+ + AIK I + + E+ ++ + H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 70 PNVMQIYEV-------------MASKTKIYFVMEYAKGGELFKKVSKGKLK--EDTARKY 114
V++ Y + K+ ++ MEY + G L+ + L D +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 115 FQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL------------AKCK 162
F+Q++ A+ + HS+G+ HRDLKP N+ +DE+ +K+ DFGL+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222
L + GT YVA EV+ G+ +K D++S G+I + ++ Y + + +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 223 KIAKADYKFPTWF----SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
K+ +FP F +K++ ++D +P+ R ++ + W + K
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH--QDEVIK 297
Query: 279 TAIK 282
A+K
Sbjct: 298 EALK 301
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-109
Identities = 96/294 (32%), Positives = 150/294 (51%), Gaps = 22/294 (7%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT--- 57
M K L +Y + + LG G +V A T + VAIK I K K +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 58 --KREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKY 114
+ EI +++ + HP +++I ++ Y V+E +GGELF K V +LKE T + Y
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 115 FQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTT 171
F Q++ A+ + H G+ HRDLKPEN+LL +E+ ++K+TDFG S K + L+ T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTL 176
Query: 172 CGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKA 227
CGTP Y+APEV+ GY D WS GVIL++ L+GY PF + +++ +I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 228 DYKFPT--WF--SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKS 277
Y F W S L+ ++L +P R + + + +PW + + +
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-106
Identities = 93/277 (33%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
Y++ LG+G F+ V H TG A K I+ K L + +RE + R +QH
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 64
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN++++++ + ++ Y V + GGELF+ V++ E A QQ++ +I +CHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
G+ HR+LKPENLLL + +K+ DFGL+ H GTP Y++PEV+ +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKK 181
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRK 241
Y DIW+CGVILY+LL GY PF D + +Y +I Y +P+ W + + +
Sbjct: 182 DPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
L+ +L NP RI+ + ++ PW SA +
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-106
Identities = 94/293 (32%), Positives = 149/293 (50%), Gaps = 22/293 (7%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT---- 57
K L +Y + + LG G +V A T + VAI+ I K K +
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN 186
Query: 58 -KREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYF 115
+ EI +++ + HP +++I ++ Y V+E +GGELF K V +LKE T + YF
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
Q++ A+ + H G+ HRDLKPEN+LL +E+ ++K+TDFG S K + L+ T C
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLC 302
Query: 173 GTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKAD 228
GTP Y+APEV+ GY D WS GVIL++ L+GY PF + +++ +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
Query: 229 YKFPT--WF--SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKS 277
Y F W S L+ ++L +P R + + + +PW + + +
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-106
Identities = 102/271 (37%), Positives = 148/271 (54%), Gaps = 16/271 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
Q Y L +G+G++ +V A GT A K I K + V D+ K+EI +M+ + H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDH 65
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN++++YE T IY VME GGELF++ V K +E A + + ++SA+ +CH
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
V HRDLKPEN L + LK+ DFGL+A K ++ T GTP YV+P+V+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGKMMRTKVGTPYYVSPQVL-E 181
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRK 241
Y G + D WS GV++YVLL GY PF + KI + + FP W S
Sbjct: 182 GLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNS 272
L+ R+L +P RI+ + +E+ WF K L+S
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 317 bits (813), Expect = e-105
Identities = 89/282 (31%), Positives = 149/282 (52%), Gaps = 21/282 (7%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-----LKVGLVDQTK 58
K QKY+ ++G+G + V H TG A+K ++ + + T+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 59 REISVMR-LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQ 116
RE ++R + HP+++ + + S + ++ V + + GELF K L E R +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
L+ A+ F H+ + HRDLKPEN+LLD+N ++++DFG S + L CGTP
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPG 264
Query: 177 YVAPEVISR------RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK 230
Y+APE++ GY G + D+W+CGVIL+ LLAG PF + M R I + Y+
Sbjct: 265 YLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323
Query: 231 FPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
F + W S+ V+ L+SR+L +P R++ + +++P+F +
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 18/271 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ R LG G F V+ +G IK I+KD+ ++Q + EI V++ + H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELF-----KKVSKGKLKEDTARKYFQQLISAIDF 124
PN+++I+EV +Y VME +GGEL + L E + +Q+++A+ +
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 125 CHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
HS+ V H+DLKPEN+L + +K+ DFGL+ L K D GT Y+APE
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEHSTNAAGTALYMAPE 196
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF---SAD 238
V +R K DIWS GV++Y LL G LPF ++L + +K + + +
Sbjct: 197 VF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
LL ++L +P R S A+++ + WF++
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 94/282 (33%), Positives = 143/282 (50%), Gaps = 22/282 (7%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD------QTKREISV 63
+ YE +LG+G + V H T + A+K ID + T +E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 64 MR-LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISA 121
+R + HPN++Q+ + + T + V + K GELF K L E RK + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I H + HRDLKPEN+LLD++ +K+TDFG S L CGTP+Y+APE
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPE 193
Query: 182 VI------SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-- 233
+I + GY G + D+WS GVI+Y LLAG PF M M R I +Y+F +
Sbjct: 194 IIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 234 W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273
W +S V+ L+SR L P R + + + +P+F++ + +
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-104
Identities = 90/272 (33%), Positives = 153/272 (56%), Gaps = 14/272 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
++Y + +LG+G+F +V + T Q A+K I+K K RE+ +++ + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDH 80
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN+M+++E++ + Y V E GGELF + + + + E A + +Q+ S I + H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
+ HRDLKPEN+LL +++ +K+ DFGLS + Q+ + GT Y+APEV+ R
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVL-R 196
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRK 241
Y +K D+WS GVILY+LL+G PF+ N + +++ Y F W S D +
Sbjct: 197 GTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273
L+ ++L +PS RI+ + +E+PW +K + +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-104
Identities = 91/268 (33%), Positives = 143/268 (53%), Gaps = 13/268 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
Y++ LG+G F+ V H TG A K I+ K L + +RE + R +QH
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 87
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN++++++ + ++ Y V + GGELF+ V++ E A QQ++ +I +CHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
G+ HR+LKPENLLL + +K+ DFGL+ H GTP Y++PEV+ +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKK 204
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRK 241
Y DIW+CGVILY+LL GY PF D + +Y +I Y +P+ W + + +
Sbjct: 205 DPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKG 269
L+ +L NP RI+ + ++ PW
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 72/294 (24%), Positives = 135/294 (45%), Gaps = 20/294 (6%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
V + Y + + +G G +KV+ + Q AIK ++ ++ L D + EI+ +
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL-DSYRNEIAYLN 81
Query: 66 LIQHPN--VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAI 122
+Q + ++++Y+ + IY VME +L K + + Y++ ++ A+
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
H G+ H DLKP N L+ +GMLK+ DFG++ + + + GT Y+ PE
Sbjct: 141 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 183 ISRRGYD----------GDKADIWSCGVILYVLLAGYLPFHD--SNLMAMYRKI-AKADY 229
I K+D+WS G ILY + G PF + + ++ I +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
+FP D++ +L L +P RISI +++ +P+ + + + +K +E
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-103
Identities = 92/268 (34%), Positives = 150/268 (55%), Gaps = 16/268 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ + +LG G F++V+ + TG+ A+K I K + + EI+V++ I+H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKH 65
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
N++ + ++ S T Y VM+ GGELF + + +G E A QQ++SA+ + H
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
G+ HRDLKPENLL +EN + +TDFGLS + + +G++ T CGTP YVAPEV+++
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQ 181
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRK 241
+ Y D WS GVI Y+LL GY PF++ ++ KI + Y+F + W S +
Sbjct: 182 KPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKG 269
+ +L+ +P+ R + K + +PW
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-102
Identities = 91/275 (33%), Positives = 152/275 (55%), Gaps = 12/275 (4%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
++Y+L LG+G F+ V + GQ A I+ K L + +RE
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREAR 62
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISA 121
+ RL++HPN++++++ ++ + Y + + GGELF+ V++ E A QQ++ A
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 122 IDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
+ CH GV HR+LKPENLLL + +K+ DFGL+ + + + GTP Y+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYL 180
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W-- 234
+PEV+ + Y G D+W+CGVILY+LL GY PF D + +Y++I Y FP+ W
Sbjct: 181 SPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ + + L++++L NPS RI+ A+ +++PW
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-100
Identities = 82/283 (28%), Positives = 145/283 (51%), Gaps = 18/283 (6%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQ--TK 58
M + YEL ++G+G F+ V + TGQ A+K +D K + K
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 59 REISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELF-----KKVSKGKLKEDTARK 113
RE S+ +++HP+++++ E +S +Y V E+ G +L + + E A
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHT 170
Y +Q++ A+ +CH + HRD+KP +LL + + +K+ FG++ + +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGG 192
Query: 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK 230
GTP ++APEV+ R Y G D+W CGVIL++LL+G LPF+ + ++ I K YK
Sbjct: 193 RVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYK 250
Query: 231 FPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
W S + L+ R+L +P+ RI++ + + +PW ++
Sbjct: 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 80/338 (23%), Positives = 151/338 (44%), Gaps = 21/338 (6%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
V + Y + + +G G +KV+ + Q AIK ++ ++ L D + EI+ +
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL-DSYRNEIAYLN 62
Query: 66 LIQHPN--VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAI 122
+Q + ++++Y+ + IY VME +L K + + Y++ ++ A+
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
H G+ H DLKP N L+ +GMLK+ DFG++ + + + GT Y+ PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 183 ISRRGYD----------GDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADY-- 229
I K+D+WS G ILY + G PF N ++ I ++
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDV 289
+FP D++ +L L +P RISI +++ +P+ + + + +K +E V +
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV-L 299
Query: 290 DAAFGPIENSASTEAPRPMTKPDNLNAFHIISLSSGFD 327
G ++ +A + + + + H S S F+
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 337
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 66/317 (20%), Positives = 112/317 (35%), Gaps = 52/317 (16%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M ++ + L +LGQG A V+ RH TG AIK + L+ VD RE
Sbjct: 1 MGSQS-TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMRE 57
Query: 61 ISVMRLIQHPNVMQIYEVMASKTK--IYFVMEYAKGGELF----KKVSKGKLKEDTARKY 114
V++ + H N+++++ + T +ME+ G L+ + + L E
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHT 170
+ ++ ++ G+ HR++KP N++ D + K+TDFG A+ D +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVS 174
Query: 171 TCGTPAYVAPEVISRRGYD-------GDKADIWSCGVILYVLLAGYLPFHDS----NLMA 219
GT Y+ P++ R G D+WS GV Y G LPF
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 MYRKIAKADY-------------------KFPTW------FSADVRKLLSRILDPNPSTR 254
+ KI P + +L+ IL+ +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 255 ISIAKIMENPWFRKGLN 271
+
Sbjct: 295 WGFDQFFAETSDILHRG 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 299 bits (766), Expect = 6e-99
Identities = 88/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REI 61
L +KY L +GQG++ V A T AIK ++K+KI ++ D + E+
Sbjct: 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK------------------ 103
+M+ + HPN+ ++YEV + I VME GG L K++
Sbjct: 80 RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 104 -----------------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140
+E +Q+ SA+ + H++G+ HRD+KPEN
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 141 LL--DENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPAYVAPEVIS--RRGYDGDKAD 194
L +++ +K+ DFGLS + + T GTP +VAPEV++ Y G K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCD 258
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT--W--FSADVRKLLSRILDPN 250
WS GV+L++LL G +PF N ++ F + S R LLS +L+ N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318
Query: 251 PSTRISIAKIMENPWFRK 268
R + +++PW +
Sbjct: 319 VDERFDAMRALQHPWISQ 336
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 8e-99
Identities = 87/281 (30%), Positives = 150/281 (53%), Gaps = 17/281 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQTKREISVMRL 66
YE+G LG G FA V R GTG+ A K I K ++ ++ +RE++++R
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFC 125
I+HPN++ ++++ +KT + ++E GGELF K L ED A ++ +Q++ + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 126 HSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
HS+ + H DLKPEN++L N +K+ DFG++ + GTP +VAPE
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPE 181
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSA 237
+++ G +AD+WS GVI Y+LL+G PF I+ +Y F + S
Sbjct: 182 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
+ + R+L +P R++IA+ +E+ W K + ++ + +
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWI-KAIRRRNVRGE 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 8e-99
Identities = 78/338 (23%), Positives = 150/338 (44%), Gaps = 21/338 (6%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
V + Y + + +G G +KV+ + Q AIK ++ ++ L D + EI+ +
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL-DSYRNEIAYLN 109
Query: 66 LIQHPN--VMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAI 122
+Q + ++++Y+ + IY VME +L K + + Y++ ++ A+
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
H G+ H DLKP N L+ +GMLK+ DFG++ + + + G Y+ PE
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 183 ISRRGYD----------GDKADIWSCGVILYVLLAGYLPFHD--SNLMAMYRKI-AKADY 229
I K+D+WS G ILY + G PF + + ++ I +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDV 289
+FP D++ +L L +P RISI +++ +P+ + + + +K +E V +
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV-L 346
Query: 290 DAAFGPIENSASTEAPRPMTKPDNLNAFHIISLSSGFD 327
G ++ +A + + + + H S S F+
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 6e-98
Identities = 94/287 (32%), Positives = 158/287 (55%), Gaps = 14/287 (4%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++Y + +LG+G+F +V + T Q A+K I+K K RE+ +++ +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL 78
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCH 126
HPN+M+++E++ + Y V E GGELF + + + + E A + +Q+ S I + H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 127 SRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+ HRDLKPEN+LL +++ +K+ DFGLS + Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVL 195
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSADV 239
R Y +K D+WS GVILY+LL+G PF+ N + +++ Y F P W S D
Sbjct: 196 -RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSL 286
+ L+ ++L +PS RI+ + +E+PW +K + S ES++
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM 300
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 7e-98
Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 23/273 (8%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQ 68
YE+ +G G+++ H T A+K IDK K EI ++ R Q
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQ 74
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHS 127
HPN++ + +V +Y V E KGGEL K + + E A + +++ H+
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 128 RGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+GV HRDLKP N+L +++ DFG + + + ++GLL T C T +VAPEV+
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLMTPCYTANFVAPEVL 192
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFH---DSNLMAMYRKIAKADYKFPT--W--FS 236
R+GYD DIWS GV+LY +L GY PF D + +I + W S
Sbjct: 193 ERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ L+S++L +P R++ A ++ +PW
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 2e-97
Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 18/268 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+E+ LG+G + VY + GT + A+K + K + EI V+ + H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN++++ E+ + T+I V+E GGELF + V KG E A +Q++ A+ + H
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 129 GVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
G+ HRDLKPENLL + LK+ DFGLS K L+ T CGTP Y APE++
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRG 224
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKADYKFPT--W--FSADVR 240
Y G + D+WS G+I Y+LL G+ PF+D M+R+I +Y F + W S + +
Sbjct: 225 CAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268
L+ +++ +P R++ + +++PW
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 3e-97
Identities = 65/311 (20%), Positives = 111/311 (35%), Gaps = 52/311 (16%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M ++ + L +LGQG A V+ RH TG AIK + L+ VD RE
Sbjct: 1 MGSQS-TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMRE 57
Query: 61 ISVMRLIQHPNVMQIYEVMASKTK--IYFVMEYAKGGELFKKVSK----GKLKEDTARKY 114
V++ + H N+++++ + T +ME+ G L+ + + L E
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHT 170
+ ++ ++ G+ HR++KP N++ D + K+TDFG A+ D +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVS 174
Query: 171 TCGTPAYVAPEVISRRGYD-------GDKADIWSCGVILYVLLAGYLPFHD----SNLMA 219
GT Y+ P++ R G D+WS GV Y G LPF
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 MYRKIAKADY-------------------------KFPTWFSADVRKLLSRILDPNPSTR 254
+ KI + +L+ IL+ +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 255 ISIAKIMENPW 265
+
Sbjct: 295 WGFDQFFAETS 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-97
Identities = 92/291 (31%), Positives = 155/291 (53%), Gaps = 13/291 (4%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
++ + +Y+ R+LG+G+F +V + TGQ A+K I K ++ + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLI 119
+ +++ + HPN+M++YE K Y V E GGELF + +S+ + E A + +Q++
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 120 SAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
S I + H + HRDLKPENLLL ++ +++ DFGLS + + GT
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAY 193
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW 234
Y+APEV+ Y +K D+WS GVILY+LL+G PF+ +N + +K+ K Y F P W
Sbjct: 194 YIAPEVL-HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251
Query: 235 --FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
S + L+ ++L PS RIS +++ W + + + ++
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = 7e-97
Identities = 73/275 (26%), Positives = 115/275 (41%), Gaps = 20/275 (7%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+E+ LG G F V H TG+ VAIK ++ K ++ EI +M+ + HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72
Query: 71 NVMQIYEVMASKTKI------YFVMEYAKGGELFKKVSK----GKLKEDTARKYFQQLIS 120
NV+ EV K+ MEY +GG+L K +++ LKE R + S
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
A+ + H + HRDLKPEN++L + K+ D G + K Q L GT Y
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGTLQY 189
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSA 237
+APE++ ++ Y D WS G + + + G+ PF + + +
Sbjct: 190 LAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 238 DVRKLLSRILD-PNPSTRISIAKIMENPWFRKGLN 271
D+ + P P+ I W + L
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 1e-95
Identities = 81/288 (28%), Positives = 140/288 (48%), Gaps = 16/288 (5%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQTKRE 60
K + + Y++G LG G FA V R TG A K I K + ++ +RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLI 119
+S++R + H NV+ +++V ++T + ++E GGELF K L E+ A + +Q++
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 SAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
+++ H++ + H DLKPEN++L +K+ DFGL+ + GTP
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PT 233
+VAPE+++ G +AD+WS GVI Y+LL+G PF I Y F
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 234 W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKT 279
+ S + + ++L R++I + + +PW N ++ +
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-95
Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 16/272 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQTKREISVMRL 66
Y+ G LG G FA V R TG A K I K + + +RE+S+++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFC 125
IQHPNV+ ++EV +KT + ++E GGELF K L E+ A ++ +Q+++ + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 126 HSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
HS + H DLKPEN++L +K+ DFGL+ GTP +VAPE
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPE 187
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSA 237
+++ G +AD+WS GVI Y+LL+G PF ++ +Y+F + SA
Sbjct: 188 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ + R+L +P R++I +++PW +
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 3e-95
Identities = 88/289 (30%), Positives = 151/289 (52%), Gaps = 23/289 (7%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGL----------VDQT 57
+ + Y R LG G + +V + AIK I K + K ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 58 KREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQ 116
EIS+++ + HPN++++++V K Y V E+ +GGELF++ +++ K E A +
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
Q++S I + H + HRD+KPEN+LL + +K+ DFGLS+ +D L G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLG 210
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF-- 231
T Y+APEV+ ++ Y +K D+WSCGVI+Y+LL GY PF N + +K+ K Y F
Sbjct: 211 TAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 232 PTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
W S + ++L+ +L + + R + + + + W +K N+ + +
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQ 317
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-95
Identities = 93/285 (32%), Positives = 151/285 (52%), Gaps = 28/285 (9%)
Query: 4 KGKVLMQKYELG---RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
K Q Y+L + LG+G+F+ H + Q+ A+K I K T++E
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKE 55
Query: 61 ISVMRLIQ-HPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQL 118
I+ ++L + HPN+++++EV + + VME GGELF++ K E A ++L
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 119 ISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTP 175
+SA+ H GV HRDLKPENLL ++N +K+ DFG + L + L T C T
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTL 173
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-------LMAMYRKIAKAD 228
Y APE++++ GYD + D+WS GVILY +L+G +PF + + + +KI K D
Sbjct: 174 HYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 229 YKFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ F W S + + L+ +L +P+ R+ ++ + N W + G
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 9e-95
Identities = 83/292 (28%), Positives = 143/292 (48%), Gaps = 17/292 (5%)
Query: 1 MET-KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQ 56
MET K + + Y++G LG G FA V R TG A K I K + ++
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 57 TKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYF 115
+RE+S++R + HPN++ +++V ++T + ++E GGELF K L E+ A +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCKHQDGLLHTT 171
+Q++ +++ H++ + H DLKPEN++L +K+ DFGL+ +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNI 178
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF 231
GTP +VAPE+++ G +AD+WS GVI Y+LL+G PF I Y F
Sbjct: 179 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 232 --PTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKT 279
+ S + + ++L R++I + + +PW ++ +
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-94
Identities = 97/287 (33%), Positives = 156/287 (54%), Gaps = 14/287 (4%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
L + Y+ + LG G + +V R T AIK I K + + E++V++L+
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLL 93
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCH 126
HPN+M++Y+ K Y VME KGGELF + + + K E A +Q++S + + H
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 127 SRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+ HRDLKPENLLL +++ ++K+ DFGLSA+ + + GT Y+APEV+
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPEVL 210
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSADV 239
R+ Y +K D+WS GVIL++LLAGY PF + RK+ K Y F P W S
Sbjct: 211 -RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSL 286
+ L+ ++L + RIS + +E+PW ++ + K + + +++
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-93
Identities = 56/311 (18%), Positives = 101/311 (32%), Gaps = 54/311 (17%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-- 68
G +LGQ + A TG+S + + + Q K E+ +RL++
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 69 -----------------------HPNVMQIYEVMASKT--KIYFVMEYAK------GGEL 97
++++ +F+ + G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 98 FKKVSKGKLKEDTARKY-FQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
S K AR Q+I + H G+ H L+P +++LD+ G + +T F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRG----------YDGDKADIWSCGVILYVLL 206
+DG + + + PE+ +RR D W+ G+++Y +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 207 AGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
LP + I ++ VR LL L R+ + ME P +
Sbjct: 308 CADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 267 RKGLNSKSAKS 277
+ SA
Sbjct: 364 EQLRTELSAAL 374
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 1e-92
Identities = 88/300 (29%), Positives = 142/300 (47%), Gaps = 39/300 (13%)
Query: 10 QKYELGR-LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
Y+L +LG+G A+V +L T Q A+K I+K + RE+ ++ Q
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQ 68
Query: 69 -HPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKGKLKEDTARKYFQQLISAIDFCH 126
H NV+++ E + + Y V E +GG + + E A Q + SA+DF H
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 127 SRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAK-----CKHQDGLLHTTCGTPAYV 178
++G+ HRDLKPEN+L ++ +K+ DF L + K L T CG+ Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 179 APEVI-----SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---------------M 218
APEV+ YD + D+WS GVILY+LL+GY PF
Sbjct: 189 APEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 219 AMYRKIAKADYKFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
++ I + Y+FP W S + L+S++L + R+S A+++++PW + +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-92
Identities = 92/288 (31%), Positives = 142/288 (49%), Gaps = 33/288 (11%)
Query: 2 ETKGKVLMQKYELGR-LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
E K + Y+L + +LG G KV H TGQ A+K + + +E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR--------QE 71
Query: 61 ISVM-RLIQHPNVMQIYEV----MASKTKIYFVMEYAKGGELFKK-VSKGKLK--EDTAR 112
+ + P+++ I +V K + +ME +GGELF + +G E A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLH 169
+ + + +AI F HS + HRD+KPENLL +++ +LK+TDFG + L
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQ 187
Query: 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIA 225
T C TP YVAPEV+ YD D+WS GVI+Y+LL G+ PF+ + M R+I
Sbjct: 188 TPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 226 KADYKFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
Y FP W S D ++L+ +L +P+ R++I + M +PW +
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 17/289 (5%)
Query: 10 QKYEL-GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
Y L + LG+G FA V TGQ A K + K + + EI+V+ L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAK 86
Query: 69 H-PNVMQIYEVMASKTKIYFVMEYAKGGELFKKV---SKGKLKEDTARKYFQQLISAIDF 124
P V+ ++EV + ++I ++EYA GGE+F + E+ + +Q++ + +
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 125 CHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
H + H DLKP+N+LL G +K+ DFG+S L GTP Y+APE
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPE 203
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSA 237
+++ D+W+ G+I Y+LL PF + Y I++ + + T+ S
Sbjct: 204 ILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSL 286
+ +L NP R + + + W ++ + S
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 2e-91
Identities = 66/281 (23%), Positives = 128/281 (45%), Gaps = 16/281 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY + LG+G F V+ + ++ K + + K+EIS++ + +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKG-KLKEDTARKYFQQLISAIDFCHS 127
N++ ++E S ++ + E+ G ++F++ + +L E Y Q+ A+ F HS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 128 RGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
+ H D++PEN++ + +K+ +FG + K P Y APEV
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQH 177
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSADVRK 241
D+WS G ++YVLL+G PF + I A+Y F + S +
Sbjct: 178 DVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIK 282
+ R+L +R++ ++ +++PW ++ + S K +K
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-91
Identities = 93/289 (32%), Positives = 146/289 (50%), Gaps = 32/289 (11%)
Query: 1 METKGKVLMQKYEL-GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR 59
++ K ++ Y++ ++LG G KV + T + A+K + + R
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------R 103
Query: 60 EISVM-RLIQHPNVMQIYEV----MASKTKIYFVMEYAKGGELFKK-VSKGKLK--EDTA 111
E+ + R Q P++++I +V A + + VME GGELF + +G E A
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 112 RKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLL 168
+ + + AI + HS + HRD+KPENLL N +LK+TDFG + K L
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSL 220
Query: 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKI 224
T C TP YVAPEV+ YD D+WS GVI+Y+LL GY PF+ ++ +A M +I
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279
Query: 225 AKADYKFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
Y+FP W S +V+ L+ +L P+ R++I + M +PW +
Sbjct: 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 5e-91
Identities = 90/274 (32%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
K + ++ G++LG+G+F+ V AR L T + AIK ++K I+K V RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISA 121
VM + HP +++Y K+YF + YAK GEL K + K G E R Y +++SA
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+++ H +G+ HRDLKPEN+LL+E+ +++TDFG + + + + ++ GT YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 182 VISRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
+++ + K+ D+W+ G I+Y L+AG PF N +++KI K +Y FP F R
Sbjct: 203 LLTEKSA--CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 260
Query: 241 KLLSRILDPNPSTRI------SIAKIMENPWFRK 268
L+ ++L + + R+ + +P+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 9e-90
Identities = 72/290 (24%), Positives = 138/290 (47%), Gaps = 15/290 (5%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
E K + Y++ LG G F V+ TG+ K I+ L V K EI
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEI 99
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKG-KLKEDTARKYFQQLI 119
S+M + HP ++ +++ K ++ ++E+ GGELF + ++ K+ E Y +Q
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 120 SAIDFCHSRGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
+ H + H D+KPEN++ + +K+ DFGL+ D ++ T T +
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEF 216
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW- 234
APE++ R G D+W+ GV+ YVLL+G PF + + + + + D++F +
Sbjct: 217 AAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275
Query: 235 -FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
S + + + +L P R+++ +E+PW + ++ +++ ++
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 325
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-89
Identities = 86/315 (27%), Positives = 157/315 (49%), Gaps = 16/315 (5%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+KY + +G+G+F K + G+ IK I+ + + ++++RE++V+ ++
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMK 81
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK---LKEDTARKYFQQLISAIDFC 125
HPN++Q E +Y VM+Y +GG+LFK+++ K +ED +F Q+ A+
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
H R + HRD+K +N+ L ++G +++ DFG++ + L GTP Y++PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICEN 199
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-FPTWFSADVRKLLS 244
+ Y+ +K+DIW+ G +LY L F ++ + KI + +S D+R L+S
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 245 RILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESSLVDVDAAFGPI-------- 296
++ NP R S+ I+E + K + + A + PI
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASG 318
Query: 297 ENSASTEAPRPMTKP 311
+NS S + +TKP
Sbjct: 319 QNSISVMPAQKITKP 333
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-89
Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 15/283 (5%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
E K ++ Y++ LG G F V+ TG + A K + + ++EI
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEI 205
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLI 119
M +++HP ++ +++ ++ + E+ GGELF+KV K+ ED A +Y +Q+
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 120 SAIDFCHSRGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
+ H H DLKPEN++ + LK+ DFGL+A + T GT +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEF 322
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW- 234
APEV + G D+WS GV+ Y+LL+G PF N R + D+ +
Sbjct: 323 AAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381
Query: 235 -FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
S D + + ++L +P+TR++I + +E+PW G
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 7e-89
Identities = 83/286 (29%), Positives = 147/286 (51%), Gaps = 21/286 (7%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M ++ + YE+ +G G++ + R G+ + K +D + E
Sbjct: 1 MPSR----AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSE 55
Query: 61 ISVMRLIQHPNVMQIYE--VMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARK 113
++++R ++HPN+++ Y+ + + T +Y VMEY +GG+L ++KG L E+ +
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 114 YFQQLISAIDFCHSRG-----VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168
QL A+ CH R V HRDLKP N+ LD +K+ DFGL+ + H
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFA 173
Query: 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD 228
T GTP Y++PE ++R Y+ +K+DIWS G +LY L A PF + + KI +
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 229 YKF-PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273
++ P +S ++ ++++R+L+ R S+ +I+ENP + +
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 9e-89
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 35/303 (11%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
++ + + R+L +G FA VY A+ +G+G+ A+K + ++ K +E+
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 63 VMR-LIQHPNVMQIY-------EVMASKTKIYFVMEYAKGGELF----KKVSKGKLKEDT 110
M+ L HPN++Q E + + ++ G+L K S+G L DT
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 111 ARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDFGLSA-------LAKC 161
K F Q A+ H + + HRDLK ENLLL G +K+ DFG + +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 162 KHQDGLLH---TTCGTPAYVAPEVIS--RRGYDGDKADIWSCGVILYVLLAGYLPFHDSN 216
+ L+ T TP Y PE+I G+K DIW+ G ILY+L PF D
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 217 LMAMYRKIAKADYKFPTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+ I Y P L+ +L NP R+SIA+++ + +
Sbjct: 258 KLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
Query: 275 AKS 277
KS
Sbjct: 314 PKS 316
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 3e-88
Identities = 87/286 (30%), Positives = 130/286 (45%), Gaps = 18/286 (6%)
Query: 10 QKYELGRL--LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
Y + + LG G F +V+ TG +A K I + V K EISVM +
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQL 143
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKK-VSKG-KLKEDTARKYFQQLISAIDFC 125
H N++Q+Y+ SK I VMEY GGELF + + + L E + +Q+ I
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 126 HSRGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
H + H DLKPEN+L + +K+ DFGL+ K L GTP ++APEV+
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTPEFLAPEVV 260
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW--FSADV 239
+ D+WS GVI Y+LL+G PF N I + + S +
Sbjct: 261 NYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKESS 285
++ +S++L S RIS ++ +++PW S S K
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWL-SDHKLHSRLSAQKKKNRG 364
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 3e-87
Identities = 89/273 (32%), Positives = 151/273 (55%), Gaps = 14/273 (5%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
++ + +++ + LG G+F +V +H +G A+K +DK K++K+ ++ T E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLIS 120
+++ + P ++++ + +Y VMEY GGE+F + + G+ E AR Y Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
++ HS + +RDLKPENLL+D+ G ++VTDFG K G T CGTP +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAP 207
Query: 181 EVISRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239
E+I +GY +KA D W+ GV++Y + AGY PF + +Y KI +FP+ FS+D+
Sbjct: 208 EIILSKGY--NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 240 RKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
+ LL +L + + R + I + WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 6e-87
Identities = 95/268 (35%), Positives = 163/268 (60%), Gaps = 12/268 (4%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
K +Q +++ R LG G+F +V+ R G+ A+K + K+ ++++ V+ T E ++
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDF 124
++ HP +++++ +I+ +M+Y +GGELF + K + A+ Y ++ A+++
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HS+ + +RDLKPEN+LLD+NG +K+TDFG K+ + +T CGTP Y+APEV+S
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AKYVPDVTYTLCGTPDYIAPEVVS 176
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244
+ Y D WS G+++Y +LAGY PF+DSN M Y KI A+ +FP +F+ DV+ LLS
Sbjct: 177 TKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235
Query: 245 RILDPNPSTRI-----SIAKIMENPWFR 267
R++ + S R+ + +PWF+
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 1e-85
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 24/281 (8%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ Y + LG+G F+ V L G A+K I + ++ +RE + RL H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNH 85
Query: 70 PNVMQIYEV----MASKTKIYFVMEYAKGGELFK-----KVSKGKLKEDTARKYFQQLIS 120
PN++++ +K + + ++ + K G L+ K L ED +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-------GLLHTTCG 173
++ H++G HRDLKP N+LL + G + D G A +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 174 TPAYVAPEVISRRGYD--GDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYK 230
T +Y APE+ S + + ++ D+WS G +LY ++ G P+ +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 231 FPTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
P S+ + +LL+ ++ +P R I ++ +
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 3e-82
Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
K ++ L+G G F +V+ A+H G++ IK + + ++ +RE+ +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 66 LIQHPNVMQIYE----------------VMASKTKIYFVMEYAKGGELFKKVSKGK---L 106
+ H N++ + ++ ME+ G L + + K + L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 107 KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166
+ A + F+Q+ +D+ HS+ + +RDLKP N+ L + +K+ DFGL K DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDG 176
Query: 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK 226
+ GT Y++PE IS + Y + D+++ G+IL LL +++ + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 227 ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
F + LL ++L P R + ++I+ K
Sbjct: 234 --GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-81
Identities = 60/268 (22%), Positives = 108/268 (40%), Gaps = 11/268 (4%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
Q ++ LG G++ +V+ R G+ A+K + S
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISA 121
++ QHP +++ + +Y E G L + L E Y + + A
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
+ HS+G+ H D+KP N+ L G K+ DFG L G G P Y+APE
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG---LLVELGTAGAGEVQEGDPRYMAPE 226
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGY-LPFHDSNLMAMYRKIAKADYKFPTWFSADVR 240
++ + Y AD++S G+ + + LP + + +F S+++R
Sbjct: 227 LL-QGSYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSSELR 282
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268
+L +L+P+P R + ++ P R+
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-81
Identities = 82/277 (29%), Positives = 143/277 (51%), Gaps = 12/277 (4%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ + + + +G+G F++VY A L G VA+K + ++ +EI +++ +
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQLISAID 123
HPNV++ Y ++ V+E A G+L + + K + E T KYF QL SA++
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
HSR V HRD+KP N+ + G++K+ D GL + H+ GTP Y++PE I
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 208
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFH--DSNLMAMYRKIAKADYK--FPTWFSADV 239
GY+ K+DIWS G +LY + A PF+ NL ++ +KI + DY +S ++
Sbjct: 209 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
R+L++ ++P+P R + + + + S +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-80
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 52/285 (18%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
K ++ ++LG G KV + T + A+K + + RE+ +
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVEL 63
Query: 64 M-RLIQHPNVMQIYEV----MASKTKIYFVMEYAKGGELFKK-VSKGKLK--EDTARKYF 115
R Q P++++I +V A + + VME GGELF + +G E A +
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 116 QQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
+ + AI + HS + HRD+KPENLL N +LK+TDFG
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKAD 228
A E YD D+WS GVI+Y+LL GY PF+ ++ +A M +I
Sbjct: 167 ------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
Query: 229 YKFPT--W--FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
Y+FP W S +V+ L+ +L P+ R++I + M +PW +
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-80
Identities = 46/314 (14%), Positives = 87/314 (27%), Gaps = 48/314 (15%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+K +L L G+ + V+ R + + A+K +++ +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 70 PNVMQIYEVM--------------------------ASKTKIYFVMEYAKG-----GELF 98
+ + + + +M A
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 99 KKV--SKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156
V +G QLI S+G+ H P+NL + +G L + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD-KADIWSCGVILYVLLAGYLPFHDS 215
+ Y E ++ + W G+ +Y + +LPF
Sbjct: 242 -----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 216 N-------LMAMYRKIAKADYKFPTW--FSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
R F + V+ L+ R L+ + R+ + ME P F
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
Query: 267 RKGLNSKSAKSKTA 280
+ N S+ T
Sbjct: 357 LQLQNEISSSLSTG 370
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-79
Identities = 76/273 (27%), Positives = 143/273 (52%), Gaps = 10/273 (3%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ V +E+ R +G+G+F KV + T + A+K ++K K ++ V +E+
Sbjct: 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLIS 120
+M+ ++HP ++ ++ + ++ V++ GG+L + + KE+T + + +L+
Sbjct: 67 QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
A+D+ ++ + HRD+KP+N+LLDE+G + +TDF +A ++ + T GT Y+AP
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN---IAAMLPRETQITTMAGTKPYMAP 183
Query: 181 EVISRRGYDG-DKA-DIWSCGVILYVLLAGYLPFH---DSNLMAMYRKIAKADYKFPTWF 235
E+ S R G A D WS GV Y LL G P+H ++ + +P+ +
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
Query: 236 SADVRKLLSRILDPNPSTRISIAK-IMENPWFR 267
S ++ LL ++L+PNP R S + P+
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 243 bits (624), Expect = 1e-77
Identities = 91/280 (32%), Positives = 149/280 (53%), Gaps = 19/280 (6%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQT 57
K+ + +EL R+LG+G + KV+ R + TG+ A+K + K I+ T
Sbjct: 9 RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 58 KREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQ 116
K E +++ ++HP ++ + + K+Y ++EY GGELF ++ + G EDTA Y
Sbjct: 69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCG 173
++ A+ H +G+ +RDLKPEN++L+ G +K+TDFGL CK H + HT CG
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CKESIHDGTVTHTFCG 183
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT 233
T Y+APE++ R G+ D WS G ++Y +L G PF N KI K P
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242
Query: 234 WFSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268
+ + + R LL ++L N ++R+ ++ +P+FR
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-77
Identities = 95/271 (35%), Positives = 152/271 (56%), Gaps = 15/271 (5%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
KV M ++ +LLG+G F KV R TG+ A+K + K+ I+ V T E V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDF 124
+HP + + + ++ FVMEYA GGELF +S+ E+ AR Y +++SA+++
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPAYVAPE 181
HSR V +RD+K ENL+LD++G +K+TDFGL CK + T CGTP Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPE 175
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
V+ Y G D W GV++Y ++ G LPF++ + ++ I + +FP S + +
Sbjct: 176 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 242 LLSRILDPNPSTRI-----SIAKIMENPWFR 267
LL+ +L +P R+ ++ME+ +F
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-77
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 23/273 (8%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQH 69
+ +LG G + Y R + + VA+K I + RE+ ++R +H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS 127
PNV++ + + Y +E L + V + QQ S + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 128 RGVYHRDLKPENLLLDENGM-----LKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPE 181
+ HRDLKP N+L+ ++DFGL LA +H GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 182 VISRRGYD--GDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFPTWF--- 235
++S + DI+S G + Y +++ G PF S +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
R+L+ +++ +P R S ++++P+F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 7e-77
Identities = 85/275 (30%), Positives = 135/275 (49%), Gaps = 15/275 (5%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ + +++G+G+F KV ARH A+K + K ILK E
Sbjct: 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER 89
Query: 62 SVM-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLI 119
+V+ + ++HP ++ ++ + K+YFV++Y GGELF + + E AR Y ++
Sbjct: 90 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPA 176
SA+ + HS + +RDLKPEN+LLD G + +TDFGL CK + T CGTP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKENIEHNSTTSTFCGTPE 204
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFS 236
Y+APEV+ ++ Y D W G +LY +L G PF+ N MY I + +
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 237 ADVRKLLSRILDPNPSTRI----SIAKIMENPWFR 267
R LL +L + + R+ +I + +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 9e-77
Identities = 59/334 (17%), Positives = 102/334 (30%), Gaps = 44/334 (13%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL----- 66
G +LGQ + A TG+S + + + Q K E+ +RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 67 -----------------IQHPNVMQIYEVMASKTKI-----YFVMEYAKG------GELF 98
++ P ++ V + + +F+ + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 99 KKVSKGKLKEDTARKYF-QQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157
S K AR Q+I + H G+ H L+P +++LD+ G + +T F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK----ADIWSCGVILYVLLAGYLPFH 213
+ P A ++ + D W+ G+ +Y + LP
Sbjct: 260 RDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 214 DSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273
D + I ++ P VR LL L R+ + ME P + +
Sbjct: 319 DDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374
Query: 274 SAKSKTAIKESSLVDVDAAFGPIENSASTEAPRP 307
SA + P S EA
Sbjct: 375 SAALPLYQTDGEPTREG-GAPPSGTSQPDEAGAA 407
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-76
Identities = 91/271 (33%), Positives = 146/271 (53%), Gaps = 12/271 (4%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
+ K+ ++ + L ++LG+G+F KV+ A T Q AIKA+ KD +L V+ T E
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 63 VMRL-IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLIS 120
V+ L +HP + ++ +K ++FVMEY GG+L + K A Y ++I
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPAY 177
+ F HS+G+ +RDLK +N+LLD++G +K+ DFG+ CK D +T CGTP Y
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAKTNTFCGTPDY 184
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSA 237
+APE++ + Y D WS GV+LY +L G PFH + ++ I + +P W
Sbjct: 185 IAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 243
Query: 238 DVRKLLSRILDPNPSTRI-SIAKIMENPWFR 267
+ + LL ++ P R+ I ++P FR
Sbjct: 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 3e-76
Identities = 90/279 (32%), Positives = 151/279 (54%), Gaps = 19/279 (6%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTK 58
E K ++EL ++LGQG+F KV+ + + Q A+K + K + V TK
Sbjct: 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TK 74
Query: 59 REISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQ 117
E ++ + HP +++++ ++ K+Y ++++ +GG+LF ++SK E+ + Y +
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 118 LISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGT 174
L A+D HS G+ +RDLKPEN+LLDE G +K+TDFGL K + ++ CGT
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKKAYSFCGT 189
Query: 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW 234
Y+APEV++RRG+ AD WS GV+++ +L G LPF + I KA P +
Sbjct: 190 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248
Query: 235 FSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268
S + + LL + NP+ R+ + +I + +F
Sbjct: 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 7e-76
Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 60/303 (19%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQ 68
++LG G+ V + G+ VA+K + D D EI ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDD 67
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--------GKLKEDTARKYFQQLIS 120
HPNV++ Y + +Y +E L V KE +Q+ S
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 121 AIDFCHSRGVYHRDLKPENLLLD-------------ENGMLKVTDFGLSALAKCKHQDG- 166
+ HS + HRDLKP+N+L+ EN + ++DFGL CK D
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL-----CKKLDSG 181
Query: 167 ------LLHTTCGTPAYVAPEVIS-------RRGYDGDKADIWSCGVILYVLL-AGYLPF 212
L+ GT + APE++ +R DI+S G + Y +L G PF
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPF 240
Query: 213 HDSNLMAMYRKIAKADYKFPTW-------FSADVRKLLSRILDPNPSTRISIAKIMENPW 265
D + I + + A+ L+S+++D +P R + K++ +P
Sbjct: 241 GDKY--SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 266 FRK 268
F
Sbjct: 299 FWP 301
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-75
Identities = 92/278 (33%), Positives = 147/278 (52%), Gaps = 17/278 (6%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+ + ++ + +E R+LG+G+F KV AR TG A+K + KD IL+ V+ T E
Sbjct: 14 VNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 61 ISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQL 118
++ L HP + Q++ + +++FVME+ GG+L + K + E AR Y ++
Sbjct: 74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI 133
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTP 175
ISA+ F H +G+ +RDLK +N+LLD G K+ DFG+ CK T CGTP
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVTTATFCGTP 188
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235
Y+APE++ Y G D W+ GV+LY +L G+ PF N ++ I + +PTW
Sbjct: 189 DYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247
Query: 236 SADVRKLLSRILDPNPSTRI------SIAKIMENPWFR 267
D +L + NP+ R+ I+ +P+F+
Sbjct: 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-75
Identities = 82/277 (29%), Positives = 144/277 (51%), Gaps = 16/277 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+ ++ + + +LG+G+F KV + GT + A+K + KD +++ V+ T E
Sbjct: 11 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 61 ISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQL 118
V+ L + P + Q++ + ++YFVMEY GG+L + + G+ KE A Y ++
Sbjct: 71 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTP 175
+ F S+G+ +RDLK +N++LD G +K+ DFG+ CK T CGTP
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVTTKTFCGTP 185
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235
Y+APE+I+ + Y G D W+ GV+LY +LAG PF + +++ I + + +P
Sbjct: 186 DYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244
Query: 236 SADVRKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
S + + ++ +P R+ I E+ +FR
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 9e-75
Identities = 86/275 (31%), Positives = 139/275 (50%), Gaps = 12/275 (4%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
++ + YE+ +++G+G F +V RH T + A+K + K +++K E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAI 122
+M P V+Q++ +Y VMEY GG+L +S + E AR Y +++ A+
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
D HS G HRD+KP+N+LLD++G LK+ DFG + T GTP Y++PEV
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEV 240
Query: 183 ISRRGYDG--DKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKI--AKADYKFP--TWF 235
+ +G DG + D WS GV LY +L G PF+ +L+ Y KI K FP
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300
Query: 236 SADVRKLLSRILDPNPSTRI---SIAKIMENPWFR 267
S + + L+ L + R+ + +I + +F+
Sbjct: 301 SKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 1e-74
Identities = 97/276 (35%), Positives = 154/276 (55%), Gaps = 16/276 (5%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ K +V M ++E +LLG+G F KV + TG+ A+K + K+ I+ V T E
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 62 SVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLIS 120
V++ +HP + + + ++ FVMEYA GGELF +S+ ED AR Y +++S
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 121 AIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPA 176
A+D+ HS + V +RDLK ENL+LD++G +K+TDFGL CK + T CGTP
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGATMKTFCGTPE 314
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFS 236
Y+APEV+ Y G D W GV++Y ++ G LPF++ + ++ I + +FP
Sbjct: 315 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 237 ADVRKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
+ + LLS +L +P R+ +IM++ +F
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-73
Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 32/288 (11%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ +E + LG+G F V+ A++ + AIK I ++ RE+ + ++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLE 61
Query: 69 HPNVMQIYEV------------MASKTKIYFVMEYAKGGELFKKVSKGKLK----EDTAR 112
HP +++ + + K +Y M+ + L ++
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL----------AKCK 162
F Q+ A++F HS+G+ HRDLKP N+ + ++KV DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222
GT Y++PE I Y K DI+S G+IL+ LL Y +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRTLT 238
Query: 223 KIAKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ + T ++ +L P+P R I+EN F
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-73
Identities = 81/282 (28%), Positives = 145/282 (51%), Gaps = 26/282 (9%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
+ +Q ++L R++G+G++AKV R T + A+K + K+ + +D + E V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 66 LI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAID 123
HP ++ ++ ++++++FV+EY GG+L + + KL E+ AR Y ++ A++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPAYVAP 180
+ H RG+ +RDLK +N+LLD G +K+TD+G+ CK T CGTP Y+AP
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPNYIAP 179
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA---------MYRKIAKADYKF 231
E++ Y G D W+ GV+++ ++AG PF +++ I + +
Sbjct: 180 EILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 232 PTWFSADVRKLLSRILDPNPSTRI------SIAKIMENPWFR 267
P S +L L+ +P R+ A I +P+FR
Sbjct: 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 1e-72
Identities = 47/311 (15%), Positives = 103/311 (33%), Gaps = 35/311 (11%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQ 56
+T+ ++ + + LLG+G FA+VY A Q +K +
Sbjct: 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YI 113
Query: 57 TKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELF------KKVSKGKLKEDT 110
+ + ++ M+ Y + V E G L K + + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 111 ARKYFQQLISAIDFCHSRGVYHRDLKPENLLL-----------DENGMLKVTDFGLSALA 159
+ +++ I+ H + H D+KP+N +L D + L + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLM 218
K + + C T + E++S + ++ + D + +Y +L G Y+ +
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 219 AMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIA---KIMENPWFRKGLNSKSA 275
+ + W + +L+ + + F++ +K
Sbjct: 293 CKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR 347
Query: 276 KSKTAIKESSL 286
+ + L
Sbjct: 348 ALRNRLIVLLL 358
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-72
Identities = 80/286 (27%), Positives = 146/286 (51%), Gaps = 26/286 (9%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ + +Q ++L R++G+G++AKV R T + A++ + K+ + +D + E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 62 SVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLI 119
V HP ++ ++ ++++++FV+EY GG+L + + KL E+ AR Y ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTPA 176
A+++ H RG+ +RDLK +N+LLD G +K+TD+G+ CK T CGTP
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPN 218
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA---------MYRKIAKA 227
Y+APE++ Y G D W+ GV+++ ++AG PF +++ I +
Sbjct: 219 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 228 DYKFPTWFSADVRKLLSRILDPNPSTRI------SIAKIMENPWFR 267
+ P S +L L+ +P R+ A I +P+FR
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-72
Identities = 87/286 (30%), Positives = 153/286 (53%), Gaps = 25/286 (8%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTK 58
KV ++ +EL ++LG G + KV+ R + TG+ A+K + K I+ K + T+
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 59 REISVMRLIQH-PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQ 116
E V+ I+ P ++ ++ ++TK++ +++Y GGELF +S+ + E + Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK----HQDGLLHTTC 172
+++ A++ H G+ +RD+K EN+LLD NG + +TDFGL K + + C
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SKEFVADETERAYDFC 221
Query: 173 GTPAYVAPEVISRRGYDGDKA-DIWSCGVILYVLLAGYLPFH----DSNLMAMYRKIAKA 227
GT Y+AP+++ DKA D WS GV++Y LL G PF ++ + R+I K+
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 228 DYKFPTWFSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268
+ +P SA + L+ R+L +P R+ +I E+ +F+K
Sbjct: 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-72
Identities = 76/280 (27%), Positives = 139/280 (49%), Gaps = 18/280 (6%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
+ ++ + +E+ +++G+G F +V + + A+K ++K ++LK + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLIS 120
V+ + ++ +Y VM+Y GG+L +SK +L E+ AR Y +++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
AID H HRD+KP+N+L+D NG +++ DFG + GTP Y++P
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISP 245
Query: 181 EVI-----SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI--AKADYKFPT 233
E++ + Y G + D WS GV +Y +L G PF+ +L+ Y KI K ++FPT
Sbjct: 246 EILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 234 W---FSADVRKLLSRILDPNPSTRI---SIAKIMENPWFR 267
S + + L+ R++ + R+ I ++P+F
Sbjct: 305 QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-71
Identities = 82/277 (29%), Positives = 144/277 (51%), Gaps = 16/277 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+ ++ + + +LG+G+F KV + GT + A+K + KD +++ V+ T E
Sbjct: 332 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 61 ISVMRLI-QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQL 118
V+ L + P + Q++ + ++YFVMEY GG+L + + G+ KE A Y ++
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK---HQDGLLHTTCGTP 175
+ F S+G+ +RDLK +N++LD G +K+ DFG+ CK T CGTP
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVTTKTFCGTP 506
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235
Y+APE+I+ + Y G D W+ GV+LY +LAG PF + +++ I + + +P
Sbjct: 507 DYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
Query: 236 SADVRKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
S + + ++ +P R+ I E+ +FR
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 22/282 (7%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
+ ++ +E+ +++G+G F++V + TGQ A+K ++K +LK G V + E V
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISA 121
+ + Q++ + +Y VMEY GG+L +SK ++ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL--HTTCGTPAYVA 179
ID H G HRD+KP+N+LLD G +++ DFG DG + GTP Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC---LKLRADGTVRSLVAVGTPDYLS 231
Query: 180 PEVISRRGYD------GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI--AKADYKF 231
PE++ G G + D W+ GV Y + G PF+ + Y KI K
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 232 PT---WFSADVRKLLSRILDPNPSTRI---SIAKIMENPWFR 267
P + R + R+L P TR+ +P+F
Sbjct: 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-70
Identities = 65/281 (23%), Positives = 121/281 (43%), Gaps = 23/281 (8%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
+ + R+LG+G F +V+ + TG+ A K ++K ++ K E +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELF-----KKVSKGKLKEDTARKYFQQL 118
+ + ++ + +KT + VM GG++ +E A Y Q+
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH---QDGLLHTTCGTP 175
+S ++ H R + +RDLKPEN+LLD++G ++++D GL GTP
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL-----AVELKAGQTKTKGYAGTP 353
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKF 231
++APE++ Y D ++ GV LY ++A PF + +++ + +
Sbjct: 354 GFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 232 PTWFSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
P FS + +L +P R+ S + +P FR
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-69
Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 20/278 (7%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
+ V + R+LG+G F +V + TG+ A K ++K +I K E +
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLIS 120
+ + V+ + +K + V+ GG+L + + E A Y ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH--QDGLLHTTCGTPAYV 178
++ H + +RDLKPEN+LLD++G ++++D GL H + + GT Y+
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTIKGRVGTVGYM 352
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKIAKADYKFPTW 234
APEV+ Y D W+ G +LY ++AG PF + R + + ++
Sbjct: 353 APEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 235 FSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFR 267
FS R L S++L +P+ R+ S ++ E+P F+
Sbjct: 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 229 bits (584), Expect = 4e-68
Identities = 79/280 (28%), Positives = 138/280 (49%), Gaps = 16/280 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E + M + + R++G+G F +VY R TG+ A+K +DK +I E
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 61 ISVMRLI---QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQ 116
++ L+ P ++ + + K+ F+++ GG+L +S+ G E R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
++I ++ H+R V +RDLKP N+LLDE+G ++++D GL+ C H + GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---AMYRKIAKADYKFPT 233
Y+APEV+ + AD +S G +L+ LL G+ PF + R + P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 234 WFSADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268
FS ++R LL +L + + R+ ++ E+P+FR
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-64
Identities = 52/284 (18%), Positives = 97/284 (34%), Gaps = 34/284 (11%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
++ +G G F V+ G AIK K V + + + L QH
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDF 124
+V++ + A + EY GG L +S+ KE + Q+ + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 125 CHSRGVYHRDLKPENLLLDENG-------------------MLKVTDFGLSALAKCKHQD 165
HS + H D+KP N+ + M K+ D G +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------RI 184
Query: 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA 225
G ++A EV+ KADI++ + + + + +I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 226 KADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ + P S + +LL ++ P+P R S ++++
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 59/265 (22%), Positives = 106/265 (40%), Gaps = 17/265 (6%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ +G+G+F +V+ + TG A+K + L E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLS 108
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
P ++ +Y + + ME +GG L + + + G L ED A Y Q + +++ H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 128 RGVYHRDLKPENLLLDENG-MLKVTDFGLSA---LAKCKHQDGLLHTTCGTPAYVAPEVI 183
R + H D+K +N+LL +G + DFG + GT ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVR 240
+ D K DIWS ++ +L G P+ + KIA + P +
Sbjct: 229 MGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 241 KLLSRILDPNPSTRISIAKIMENPW 265
+ + L P R S ++
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-59
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 23/293 (7%)
Query: 2 ETKGKVLMQKYEL-----GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQ 56
+ + +L YE +LG+G + VY R L +AIK I +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQP 65
Query: 57 TKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLK--EDTAR 112
EI++ + ++H N++Q + I ME GG L + G LK E T
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTT 171
Y +Q++ + + H + HRD+K +N+L++ +G+LK++DFG S + + T
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS--KRLAGINPCTETF 183
Query: 172 CGTPAYVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLM-AMYRKIAKA 227
GT Y+APE+I RGY ADIWS G + + G PF++ AM+ K+
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMF 241
Query: 228 DY--KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
+ P SA+ + + + +P+P R ++ + + + K + K
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-55
Identities = 62/268 (23%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+ +G+G+F VY T VA + K+ K + K E +++ +QHPN
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPN 86
Query: 72 VMQIY----EVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCH 126
+++ Y + K I V E G L + + +K R + +Q++ + F H
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 127 SRG--VYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+R + HRDLK +N+ + G +K+ D GL+ L + GTP ++APE+
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMY 202
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKAD--YKFPTWFSADVR 240
YD + D+++ G+ + + P+ + N +YR++ F +V+
Sbjct: 203 -EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRK 268
+++ + N R SI ++ + +F++
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 62/330 (18%), Positives = 116/330 (35%), Gaps = 73/330 (22%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAI-------KAIDKDKILK----------- 50
+ +E + +G+G F V+ A++ + AI + + ++K+++
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 51 -------------------------------------VGLVDQTKREISVMRLIQHPNVM 73
+D +I M N +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKVSKGK----LKEDTARKYFQQLISAIDFCHSRG 129
+ + K +Y M+ + L +++ + F Q+ A++F HS+G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSA----------LAKCKHQDGLLHTTCGTPAYVA 179
+ HRDLKP N+ + ++KV DFGL + GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSAD 238
PE I Y K DI+S G+IL+ LL + + + + + T
Sbjct: 245 PEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268
++ +L P+P+ R I+EN F
Sbjct: 302 EHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-53
Identities = 75/276 (27%), Positives = 137/276 (49%), Gaps = 13/276 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ + +G+G+F +V+ T + VAIK ID ++ ++ ++EI+V+
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 79
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
P V + Y TK++ +MEY GG + G L E ++++ +D+ HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
HRD+K N+LL E+G +K+ DFG++ + +T GTP ++APEVI + YD
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADY-KFPTWFSADVRKLLSRIL 247
KADIWS G+ L G P + + M ++ I K + +S +++ + L
Sbjct: 198 S-KADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 248 DPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
+ PS R + +++++ + ++AK + + E
Sbjct: 256 NKEPSFRPTAKELLKHKFIL-----RNAKKTSYLTE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 16/259 (6%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+ +G G+F V+ A G VA+K + + V++ RE+++M+ ++HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELF----KKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+ + + V EY G L+ K ++ +L E + +++ H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 129 G--VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISR 185
+ HR+LK NLL+D+ +KV DFGLS + K L + GTP ++APEV+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS---RLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADVRKLL 243
+ +K+D++S GVIL+ L P+ + N + + + P + V ++
Sbjct: 214 EPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 244 SRILDPNPSTRISIAKIME 262
P R S A IM+
Sbjct: 273 EGCWTNEPWKRPSFATIMD 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 22/266 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
E+G L+G+G F +VY+ R G VAI+ ID ++ + + KRE+ R +H NV
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENV 91
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
+ S + + KG L+ + +K L + R+ Q+++ + + H++G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLS---ALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
H+DLK +N+ D NG + +TDFGL + + ++ L G ++APE+I +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 188 YDGD--------KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF---PTWFS 236
D + +D+++ G I Y L A PF A+ ++ K
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-GMKPNLSQIGMG 269
Query: 237 ADVRKLLSRILDPNPSTRISIAKIME 262
++ +L R + K+M+
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMD 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 85/269 (31%), Positives = 140/269 (52%), Gaps = 11/269 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY +GQG VY A + TGQ VAI+ ++ + K L+ EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
PN++ + +++ VMEY GG L V++ + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++R+ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKAD---YKFPTWFSADVRKLLSR 245
K DIWS G++ ++ G P+ + N L A+Y IA + P SA R L+R
Sbjct: 195 P-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNR 252
Query: 246 ILDPNPSTRISIAKIMENPWFRKGLNSKS 274
L+ + R S +++++ + + S
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-52
Identities = 75/269 (27%), Positives = 142/269 (52%), Gaps = 11/269 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +G+G+ V AR +G+ VA+K +D K + L+ E+ +MR QH
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQH 101
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
NV+++Y+ +++ +ME+ +GG L VS+ +L E+ + ++ A+ + H++G
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +++LL +G +K++DFG A+ + GTP ++APEVISR Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKAD---YKFPTWFSADVRKLLSR 245
+ DIWS G+++ ++ G P+ + + AM R + + K S +R L R
Sbjct: 220 T-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 246 ILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+L +P R + +++++P+ + +
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQTGLPEC 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 71/263 (26%), Positives = 117/263 (44%), Gaps = 30/263 (11%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
E+ ++G+G F V A+ + VAIK I+ + K E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELF----KKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+++Y A + VMEYA+GG L+ A + Q + + HS
Sbjct: 64 VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 129 ---GVYHRDLKPENLLLDENGM-LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
+ HRDLKP NLLL G LK+ DFG + + G+ A++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFE 176
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-----FPTWFSADV 239
Y +K D++S G+IL+ ++ PF + A +I A + +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPI 233
Query: 240 RKLLSRILDPNPSTRISIAKIME 262
L++R +PS R S+ +I++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 84/276 (30%), Positives = 138/276 (50%), Gaps = 18/276 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +E+ LG G F KVY A++ TG A K I+ ++ EI ++ H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY---IVEIEILATCDH 75
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
P ++++ K++ ++E+ GG + L E + +Q++ A++F HS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR- 186
+ + HRDLK N+L+ G +++ DFG+S AK + GTP ++APEV+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 187 ----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD---YKFPTWFSAD 238
YD KADIWS G+ L + P H+ N M + KIAK+D P+ +S +
Sbjct: 194 MKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVE 251
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
R L LD NP TR S A+++E+P+ ++K+
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 87/295 (29%), Positives = 140/295 (47%), Gaps = 32/295 (10%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
YEL ++G G A V A + VAIK I+ +K +D+ +EI M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELF---------KKVSKGKLKEDTARKYFQQLISAI 122
++ Y K +++ VM+ GG + + G L E T ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLL--HTTCGTPAYVA 179
++ H G HRD+K N+LL E+G +++ DFG+SA LA T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 180 PEVISR-RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK----------AD 228
PEV+ + RGYD KADIWS G+ L G P+H M + + D
Sbjct: 195 PEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 229 YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
+ + RK++S L +P R + A+++ + +F+K AK+K ++E
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK------AKNKEFLQE 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-51
Identities = 58/260 (22%), Positives = 119/260 (45%), Gaps = 15/260 (5%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
+G+ +G G+F VY + G VA+K ++ + K E+ V+R +H N+
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNI 82
Query: 73 MQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRGV 130
+ + ++ V ++ +G L+ S+ K + +Q +D+ H++ +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 131 YHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD- 189
HRDLK N+ L E+ +K+ DFGL+ G+ ++APEVI + +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 190 -GDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAK-----ADYKFPTWFSADVRKL 242
++D+++ G++LY L+ G LP+ + +N + + + K + +++L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 243 LSRILDPNPSTRISIAKIME 262
++ L R S +I+
Sbjct: 262 MAECLKKKRDERPSFPRILA 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-51
Identities = 59/269 (21%), Positives = 110/269 (40%), Gaps = 27/269 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAI----DKDKILKVGLVDQTKREISVMRLIQ 68
E + +G+G F V+ R + VAIK++ + + + + +RE+ +M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCH 126
HPN++++Y VME+ G+L+ +K + + I++
Sbjct: 82 HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SRG--VYHRDLKPENLLLDENGM-----LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
++ + HRDL+ N+ L KV DFGLS + + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNFQWMA 194
Query: 180 PEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK----FPT 233
PE I Y +KAD +S +ILY +L G PF + + + + P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIME 262
+R ++ +P R + I++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 83/300 (27%), Positives = 142/300 (47%), Gaps = 54/300 (18%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI----DKDKILKVGLVDQTKREISVM 64
MQKYE +G+G + V+ A++ T + VA+K + D + G+ REI ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-----GVPSSALREICLL 55
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLIS 120
+ ++H N++++++V+ S K+ V E+ K + G L + + + QL+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLK 112
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC-GTPAYVA 179
+ FCHSR V HRDLKP+NLL++ NG LK+ +FGL A+ ++ T Y
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL---ARAFGIPVRCYSAEVVTLWYRP 169
Query: 180 PEVI--SRRGYDGDKADIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAKA--------- 227
P+V+ ++ Y D+WS G I L P F +++ ++I +
Sbjct: 170 PDVLFGAKL-Y-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 228 -------DYK-FPTW------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
DYK +P + +A R LL +L NP RIS + +++P+F
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 69/308 (22%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREISVMRL 66
++YE LG+G FA VY AR T Q VAIK I K G+ REI +++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLISAI 122
+ HPN++ + + K+ I V ++ + K + L + Y + +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA------ 176
++ H + HRDLKP NLLLDENG+LK+ DFGL AK G+P
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGL---AKSF----------GSPNRAYTHQ 172
Query: 177 -----YVAPEVI--SRRGYDGDKADIWSCGVILYVLLAG--YLPFHDSNLMAMYRKIAKA 227
Y APE++ +R Y G D+W+ G IL LL +LP DS+L + +I +
Sbjct: 173 VVTRWYRAPELLFGARM-Y-GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLT-RIFET 228
Query: 228 ----------------DYK-FPTW-----------FSADVRKLLSRILDPNPSTRISIAK 259
DY F ++ D+ L+ + NP RI+ +
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288
Query: 260 IMENPWFR 267
++ +F
Sbjct: 289 ALKMKYFS 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-50
Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 39/293 (13%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+KYE L+G+G++ V R+ TG+ VAIK + + REI +++ ++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLR 82
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCH 126
H N++ + EV K + Y V E+ + ++ L +KY Q+I+ I FCH
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
S + HRD+KPEN+L+ ++G++K+ DFG A + T Y APE++
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGF-ARTLAAPGEVYDDEVA-TRWYRAPELLVGD 199
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKA----------------DY 229
G D+W+ G ++ + G F DS++ +Y I +
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY-HIMMCLGNLIPRHQELFNKNPVF 258
Query: 230 K---FPTW------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
P S V L + L +P R A+++ + +F+
Sbjct: 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-50
Identities = 74/264 (28%), Positives = 133/264 (50%), Gaps = 21/264 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG-LVDQTKREISVMRLIQHPN 71
L ++G G F KVY A +G VA+KA D + ++ ++E + +++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVY 131
++ + V + + VME+A+GG L + +S ++ D + Q+ +++ H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 132 ---HRDLKPENLLLDE--------NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
HRDLK N+L+ + N +LK+TDFGL+ + H+ + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---REWHRTTKM-SAAGAYAWMAP 183
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--KFPTWFSAD 238
EVI + +D+WS GV+L+ LL G +PF + +A+ +A P+
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 239 VRKLLSRILDPNPSTRISIAKIME 262
KL+ +P+P +R S I++
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILD 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-50
Identities = 71/302 (23%), Positives = 130/302 (43%), Gaps = 55/302 (18%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
+M+KYE +G+G++ V+ R+ TGQ VAIK + + REI +++ +
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL 59
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFC 125
+HPN++ + EV K +++ V EY + + + E + Q + A++FC
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV------A 179
H HRD+KPEN+L+ ++ ++K+ DFG A+ + V +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFG---FARLLTGPSDYYDD-----EVATRWYRS 170
Query: 180 PEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKA--------- 227
PE++ + Y G D+W+ G + LL+G + S++ +Y I K
Sbjct: 171 PELLVGDTQ-Y-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQ 227
Query: 228 ----------DYKFPTW------------FSADVRKLLSRILDPNPSTRISIAKIMENPW 265
K P S LL L +P+ R++ +++ +P+
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 266 FR 267
F
Sbjct: 288 FE 289
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 83/309 (26%), Positives = 142/309 (45%), Gaps = 74/309 (23%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI----DKDKILKVGLVDQTKREISVM 64
M+KY +G+G + VY A++ G++ A+K I + + G+ T REIS++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-----GIPSTTIREISIL 54
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLIS 120
+ ++H N++++Y+V+ +K ++ V E+ K V +G L+ TA+ + QL++
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLN 111
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA---- 176
I +CH R V HRDLKP+NLL++ G LK+ DFGL A+ G P
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL---ARAF----------GIPVRKYT 158
Query: 177 -------YVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA 227
Y AP+V+ S++ Y DIWS G I ++ G F + +I +
Sbjct: 159 HEIVTLWYRAPDVLMGSKK-Y-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
Query: 228 ----------------DYK--FPTWFSADVRK-----------LLSRILDPNPSTRISIA 258
Y F + LLS++L +P+ RI+
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 259 KIMENPWFR 267
+ +E+ +F+
Sbjct: 277 QALEHAYFK 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 70/312 (22%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+++ LG G +A VY + TG VA+K + D + G REIS+M+ ++
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK 61
Query: 69 HPNVMQIYEVMASKTKIYFVMEYA----KG--GELFKKVSKGKLKEDTARKYFQQLISAI 122
H N++++Y+V+ ++ K+ V E+ K + L+ + + + QL+ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA------ 176
FCH + HRDLKP+NLL+++ G LK+ DFGL A+ G P
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGL---ARAF----------GIPVNTFSSE 168
Query: 177 -----YVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-- 227
Y AP+V+ SR Y DIWSCG IL ++ G F +N + I
Sbjct: 169 VVTLWYRAPDVLMGSRT-Y-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
Query: 228 --------------DYK--FPTWFSADVRK----------------LLSRILDPNPSTRI 255
Y D+R+ L +L NP R+
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 256 SIAKIMENPWFR 267
S + + +PWF
Sbjct: 287 SAKQALHHPWFA 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 17/272 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID-KDKILKVGLVDQTKREISVMRLIQ 68
+ +++ LG+G++ VY A H TGQ VAIK + + + ++ +EIS+M+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI------IKEISIMQQCD 82
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
P+V++ Y T ++ VMEY G + ++ L ED Q + +++ H
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
HRD+K N+LL+ G K+ DFG++ + +T GTP ++APEVI
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD---YKFPTWFSADVRKL 242
GY+ ADIWS G+ + G P+ D + M A++ I ++ P +S +
Sbjct: 201 GYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDF 258
Query: 243 LSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+ + L +P R + +++++P+ R
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 58/316 (18%), Positives = 120/316 (37%), Gaps = 60/316 (18%)
Query: 11 KYELGRLLGQG--NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
YEL ++G+G + V AR+ TG+ V ++ I+ + +V + E+ V +L
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFN 84
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
HPN++ + +++ V + G +L + E Q ++ A+D+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCGTPAYVAP 180
H G HR +K ++L+ +G + ++ + + + + +++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 181 EVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK------------ 226
EV+ + +GYD K+DI+S G+ L G++PF D M +
Sbjct: 205 EVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 227 ----------------------------------ADYKFPTWFSADVRKLLSRILDPNPS 252
+ + FS + + L NP
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 253 TRISIAKIMENPWFRK 268
R S + ++ + +F++
Sbjct: 324 ARPSASTLLNHSFFKQ 339
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-49
Identities = 83/310 (26%), Positives = 132/310 (42%), Gaps = 67/310 (21%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
+ LM+KY+ +G+G + VY A+ G+ VA+K I D G+ REIS++
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLL 73
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLIS 120
+ + HPN++ + +V+ S+ + V E+ K +K L++ + Y QL+
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLR 130
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA---- 176
+ CH + HRDLKP+NLL++ +G LK+ DFGL A+ G P
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL---ARAF----------GIPVRSYT 177
Query: 177 -------YVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA 227
Y AP+V+ S++ Y DIWS G I ++ G F KI
Sbjct: 178 HEVVTLWYRAPDVLMGSKK-Y-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235
Query: 228 ----------------DYK---FPTWFSADVRK-----------LLSRILDPNPSTRISI 257
+K F + LLS +L +P+ RIS
Sbjct: 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295
Query: 258 AKIMENPWFR 267
M +P+F+
Sbjct: 296 RDAMNHPYFK 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 45/295 (15%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+ Y LG+G +A VY + T VA+K I + + G RE+S+++ ++
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 58
Query: 69 HPNVMQIYEVMASKTKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
H N++ +++++ ++ + V EY K + + + + QL+ + +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI- 183
CH + V HRDLKP+NLL++E G LK+ DFGL A AK + T Y P+++
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGL-ARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 184 -SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--------------- 227
S Y + D+W G I Y + G F S + I +
Sbjct: 174 GSTD-Y-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 228 -DYK---FPTWFSADVRK-----------LLSRILDPNPSTRISIAKIMENPWFR 267
++K +P + + + LL+++L RIS M++P+F
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 49/261 (18%), Positives = 102/261 (39%), Gaps = 21/261 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
L + + +++ R G + +K + D E +R+ HPNV
Sbjct: 13 NFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNV 69
Query: 73 MQIYEVMAS--KTKIYFVMEYAKGGELFK---KVSKGKLKEDTARKYFQQLISAIDFCHS 127
+ + S + + G L+ + + + + A K+ + + F H+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 128 RG--VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
+ L ++++DE+ +++ + + PA+VAPE + +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQK 182
Query: 186 RGYDGD--KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--KFPTWFSADVRK 241
+ D + AD+WS V+L+ L+ +PF D + M + K+A P S V K
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 242 LLSRILDPNPSTRISIAKIME 262
L+ ++ +P+ R I+
Sbjct: 243 LMKICMNEDPAKRPKFDMIVP 263
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 3e-48
Identities = 77/315 (24%), Positives = 124/315 (39%), Gaps = 67/315 (21%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI--DKDKILKVGLVDQTKREIS 62
G + +YE +G G + VY AR +G VA+K++ GL T RE++
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 63 VMRLIQ---HPNVMQIYEVMASK-----TKIYFVMEYA----KGGELFKKVSKGKLKEDT 110
++R ++ HPNV+++ +V A+ K+ V E+ + K L +T
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAET 121
Query: 111 ARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT 170
+ +Q + +DF H+ + HRDLKPEN+L+ G +K+ DFGL A+
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL---AR---------- 168
Query: 171 TCGTPA----------YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM 220
Y APEV+ + Y D+WS G I + F ++
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227
Query: 221 YRKIAKA----------------DYKFPTWFSADVRK-----------LLSRILDPNPST 253
KI FP V+ LL +L NP
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 254 RISIAKIMENPWFRK 268
RIS + +++ + K
Sbjct: 288 RISAFRALQHSYLHK 302
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 84/309 (27%), Positives = 138/309 (44%), Gaps = 68/309 (22%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ +Y LG+G + +VY A T ++VAIK I + + G+ RE+S+++ +Q
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQ 91
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAIDFCH 126
H N++++ V+ +++ + EYA+ +L KK + + + QLI+ ++FCH
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 127 SRGVYHRDLKPENLLLD-----ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA----- 176
SR HRDLKP+NLLL E +LK+ DFGL A+ G P
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL---ARAF----------GIPIRQFTH 196
Query: 177 ------YVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA- 227
Y PE++ SR Y DIWS I +L F + + KI +
Sbjct: 197 EIITLWYRPPEILLGSRH-Y-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 228 ---------------DYK--FPTWFSADVRK------------LLSRILDPNPSTRISIA 258
D+K FP + +++ LL+ +L+ +P RIS
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314
Query: 259 KIMENPWFR 267
+E+P+F
Sbjct: 315 NALEHPYFS 323
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-48
Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ + R +G G+F VY+AR + + VAIK + +E+ ++ ++H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN +Q + + VMEY G +V K L+E + + + HS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVAPEVIS--- 184
+ HRD+K N+LL E G++K+ DFG ++ +A ++ GTP ++APEVI
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMD 226
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD---YKFPTWFSADVR 240
YDG K D+WS G+ L P + N M A+Y IA+ + + W S R
Sbjct: 227 EGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFR 283
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+ L P R + ++++ + +
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 81/288 (28%), Positives = 137/288 (47%), Gaps = 30/288 (10%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQ 68
+EL L+G G + +VY RH+ TGQ AIK +D + ++ K+EI++++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 69 HPNVMQIYE------VMASKTKIYFVMEYAKGG---ELFKKVSKGKLKEDTARKYFQQLI 119
H N+ Y +++ VME+ G +L K LKE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ H V HRD+K +N+LL EN +K+ DFG+S A+ G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 197
Query: 180 PEVISRR-----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFPT 233
PEVI+ YD K+D+WS G+ + G P D + M A++ I + P
Sbjct: 198 PEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNP--APR 253
Query: 234 W----FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKS 277
+S + + L N S R + ++M++P+ R N + +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRI 301
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 75/259 (28%), Positives = 123/259 (47%), Gaps = 14/259 (5%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
GK++ ++Y++ LG G + VY A VAIKAI K + + +RE+
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAI 122
+ H N++ + +V Y VMEY +G L + S G L DTA + Q++ I
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGI 124
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC--GTPAYVAP 180
H + HRD+KP+N+L+D N LK+ DFG +AK + L T GT Y +P
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG---IAKALSETSLTQTNHVLGTVQYFSP 181
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKADYKFPTWFSADV 239
E + + DI+S G++LY +L G PF+ ++ + + I + T D+
Sbjct: 182 EQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240
Query: 240 ----RKLLSRILDPNPSTR 254
++ R + + + R
Sbjct: 241 PQSLSNVILRATEKDKANR 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 25/269 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK--DKILKVGLVDQTKREISVMRLIQHP 70
G +LG+G F + H TG+ + +K + + ++ + +E+ VMR ++HP
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR-----TFLKEVKVMRCLEHP 67
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSR 128
NV++ V+ ++ F+ EY KGG L K + + + + S + + HS
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSAL------------AKCKHQDGLLHTTCGTPA 176
+ HRDL N L+ EN + V DFGL+ L + K +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADY--KFPT 233
++APE+I+ R YD +K D++S G++L ++ D + + P
Sbjct: 188 WMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIME 262
+ R D +P R S K+
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 28/284 (9%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
+ + + E +G G +V+ R TG +A+K + + + + ++
Sbjct: 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDL 74
Query: 62 SV-MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG-ELFKKVSKGKLKEDTARKYFQQLI 119
V ++ P ++Q + + T ++ ME E KK +G + E K ++
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 120 SAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCG 173
A+ + GV HRD+KP N+LLDE G +K+ DFG+S AK + G
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--------RSAG 186
Query: 174 TPAYVAPEVI-----SRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKA 227
AY+APE I ++ YD +AD+WS G+ L L G P+ + + K+ +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDI-RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 228 D---YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ FS D + + L + R K++E+ + ++
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 64/262 (24%), Positives = 103/262 (39%), Gaps = 32/262 (12%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLG-TGQSVAIK----AIDKDKILKVGLVDQT 57
G ++ +YE+ + G +Y A G+ V +K + D +
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMA 126
Query: 58 KREISVMRLIQHPNVMQIYEV-----MASKTKIYFVMEYAKGGELFKKVSKGKLKEDTAR 112
E + + HP+++QI+ Y VMEY G L K+ KL A
Sbjct: 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAI 185
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
Y +++ A+ + HS G+ + DLKPEN++L E LK+ D G + G L
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG---AVSRINSFGYL---Y 238
Query: 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
GTP + APE++ R DI++ G L L + + +
Sbjct: 239 GTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK---- 292
Query: 233 TWFSADVRKLLSRILDPNPSTR 254
+LL R +DP+P R
Sbjct: 293 --TYDSYGRLLRRAIDPDPRQR 312
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 86/312 (27%), Positives = 139/312 (44%), Gaps = 56/312 (17%)
Query: 1 METKGKV-LMQKYELGRLLGQGNFAKVYYARHL-GTGQSVAIKAI----DKDKILKVGLV 54
ME G Q+YE +G+G + KV+ AR L G+ VA+K + ++ G+
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-----GMP 55
Query: 55 DQTKREISVMRLIQ---HPNVMQIYEV-----MASKTKIYFVMEYA----KGGELFKKVS 102
T RE++V+R ++ HPNV+++++V +TK+ V E+ KV
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVP 113
Query: 103 KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162
+ + +T + QL+ +DF HS V HRDLKP+N+L+ +G +K+ DFGL A+
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL---ARIY 170
Query: 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222
L + T Y APEV+ + Y D+WS G I + F S+ +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 229
Query: 223 KIAKA----------------DYKFPTWFSADVRK-----------LLSRILDPNPSTRI 255
KI F + + + K LL + L NP+ RI
Sbjct: 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 256 SIAKIMENPWFR 267
S + +P+F+
Sbjct: 290 SAYSALSHPYFQ 301
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLV-DQT-----KRE-ISVM 64
Y L RL+G+G VY A + VA+K ++ L D +RE +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK------LMSETLSSDPVFRTRMQREARTAG 89
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAI 122
RL Q P+V+ I++ ++Y M G +L + +G L A +Q+ SA+
Sbjct: 90 RL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT--TCGTPAYVAP 180
D H+ G HRD+KPEN+L+ + + DFG +A + L T GT Y+AP
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMAP 204
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222
E S +ADI++ +LY L G P+ L M
Sbjct: 205 ERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGA 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 80/307 (26%), Positives = 131/307 (42%), Gaps = 72/307 (23%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
Y +++G G+F VY A+ +G+ VAIK + +DK RE+ +MR + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 107
Query: 71 NVMQIYEVMASKT------KIYFVMEYAKGGELFKKV------SKGKLKEDTARKYFQQL 118
N++++ S + V++Y E +V +K L + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAKCKHQDGLLHTTCGTP-- 175
++ + HS G+ HRD+KP+NLLLD + +LK+ DFG AK G P
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAK--------QLVRGEPNV 214
Query: 176 AYV------APEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK-- 226
+Y+ APE+I Y D+WS G +L LL G F + + +I K
Sbjct: 215 SYICSRYYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 227 ---------------ADYKFPTW----FSADVRK--------LLSRILDPNPSTRISIAK 259
++KFP ++ R L SR+L+ P+ R++ +
Sbjct: 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333
Query: 260 IMENPWF 266
+ +F
Sbjct: 334 ACAHSFF 340
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLV-DQT---- 57
T L +YELG +LG G ++V+ AR L + VA+K +L+ L D +
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK------VLRADLARDPSFYLR 58
Query: 58 -KRE-ISVMRLIQHPNVMQIY---EVMASKTKIYF-VMEYAKGGELFKKV--SKGKLKED 109
+RE + L HP ++ +Y E + + VMEY G L + + ++G +
Sbjct: 59 FRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPK 116
Query: 110 TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169
A + A++F H G+ HRD+KP N+++ +KV DFG+ A A + +
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQ 175
Query: 170 TTC--GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF 212
T GT Y++PE R ++D++S G +LY +L G PF
Sbjct: 176 TAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPF 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREI 61
E + + +G+G + V H +GQ +A+K I + Q ++
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDL 71
Query: 62 SV-MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGG-----ELFKKVSKGKLKEDTARKYF 115
V MR P ++Q Y + + + ME + V + E+ K
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 116 QQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLH 169
+ A++ + HRD+KP N+LLD +G +K+ DFG+S +AK
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT-------- 183
Query: 170 TTCGTPAYVAPEVI----SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR--- 222
G Y+APE I SR+GYD ++D+WS G+ LY L G P+ N +++
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDV-RSDVWSLGITLYELATGRFPYPKWN--SVFDQLT 240
Query: 223 KIAKAD-----YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
++ K D FS ++ L + S R +++++P+
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 4e-43
Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 5/125 (4%)
Query: 310 KPDNLNAFHIISLSSGFDLSGFF-VEHDQKEEVKFTSKYSASVIISKLEDIARHLKMKLT 368
+NAF IIS S GF+LSG F +F S ++A ++ +LE+I + +
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 369 KKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPAL 428
KK+ +K E G+ G F++ V++ + + ++E+ K + + +RP
Sbjct: 62 KKETWGMKIE----GQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFF 117
Query: 429 KDIVW 433
++V
Sbjct: 118 VELVH 122
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 54/307 (17%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ KYE +GQG F +V+ ARH TGQ VA+K + + K G REI +++L++
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLK 74
Query: 69 HPNVMQIYEVMASK--------TKIYFVMEYA----KGGELFKKVSKGKLKEDTARKYFQ 116
H NV+ + E+ +K IY V ++ G K ++ Q
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQ 131
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG--T 174
L++ + + H + HRD+K N+L+ +G+LK+ DFGL+ T T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 175 PAYVAPEVI--SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA----- 227
Y PE++ R Y G D+W G I+ + + I++
Sbjct: 192 LWYRPPELLLGERD-Y-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 228 --------------DYKFPTWFSADVRK-------------LLSRILDPNPSTRISIAKI 260
+ V+ L+ ++L +P+ RI
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 261 MENPWFR 267
+ + +F
Sbjct: 310 LNHDFFW 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 61/256 (23%), Positives = 110/256 (42%), Gaps = 9/256 (3%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+ G++ +E LG GN V+ H +G +A K I + +K + +Q RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRE 81
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLI 119
+ V+ P ++ Y S +I ME+ GG L + + K G++ E K +I
Sbjct: 82 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 141
Query: 120 SAIDFCHSRG-VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
+ + + + HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y+
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYM 197
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSAD 238
+PE + Y ++DIWS G+ L + G P + +
Sbjct: 198 SPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 239 VRKLLSRILDPNPSTR 254
R + +R
Sbjct: 257 PRTPGRPLNKFGMDSR 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 84/313 (26%), Positives = 138/313 (44%), Gaps = 73/313 (23%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
G+ Y +++G G+F V+ A+ + + + VAIK + +DK RE+ +M
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIM 86
Query: 65 RLIQHPNVMQIYEVMAS------KTKIYFVMEYAKGGELFKKV------SKGKLKEDTAR 112
R+++HPNV+ + S + + V+EY E + K + +
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIK 144
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAKCKHQDGLLHTT 171
Y QL+ ++ + HS G+ HRD+KP+NLLLD G+LK+ DFG AK
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG---SAK--------ILI 193
Query: 172 CGTP--AYV------APEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222
G P +Y+ APE+I Y DIWS G ++ L+ G F + +
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 223 KIAK-----------------ADYKFPTW----FSADVRK--------LLSRILDPNPST 253
+I K ++KFP FS R L+SR+L+ PS
Sbjct: 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312
Query: 254 RISIAKIMENPWF 266
R++ + + +P+F
Sbjct: 313 RLTAIEALCHPFF 325
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 4e-42
Identities = 36/137 (26%), Positives = 72/137 (52%), Gaps = 4/137 (2%)
Query: 310 KPDNLNAFHIISLSSGFDLSGFFVEHD--QKEEVKFTSKYSASVIISKLEDIARHLKMKL 367
P +NAF +I+LS G +LS F K + +F S+ S II+ +E +A + K
Sbjct: 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKS 62
Query: 368 TKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPA 427
++ + E + G ++ ++++E PS+ +V++ K++G+ LEY K K ++
Sbjct: 63 HTRNFKT-RLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSK 120
Query: 428 LKDIVWAWQGDQHQVQL 444
L++I+W + ++
Sbjct: 121 LENIIWRATEGIPKSEI 137
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV-MRLIQHP 70
E LG+G + V RH+ +GQ +A+K I + + ++ + MR + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCP 66
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSK--GKLKEDTARKYFQQLISAIDFCH 126
+ Y + + ++ ME + +K+V + ED K ++ A++ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 127 S-RGVYHRDLKPENLLLDENGMLKVTDFGLSA-----LAKCKHQDGLLHTTCGTPAYVAP 180
S V HRD+KP N+L++ G +K+ DFG+S +AK G Y+AP
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--------IDAGCKPYMAP 178
Query: 181 EVI----SRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKAD--YKFPT 233
E I +++GY K+DIWS G+ + L P+ +++ +
Sbjct: 179 ERINPELNQKGYSV-KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
FSA+ S+ L N R + ++M++P+F
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 58/291 (19%), Positives = 112/291 (38%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
L +G+G + +V+ G ++VA+K + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKS----WFRETELYNTVMLRHENI 64
Query: 73 MQIY----EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+ S T+++ + Y + G L+ + L + + + S + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 129 --------GVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPAYV 178
+ HRDLK +N+L+ +NG + D GL+ + D + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 179 APEVISRRGYDGD-----KADIWSCGVILYVLLAGY----------LPFHDSN-----LM 218
APEV+ + DIW+ G++L+ + PF+D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 219 AMYRKIAKADY--KFP-TWFSADVRKLLSRIL----DPNPSTRISIAKIME 262
M + + P WFS L++++ NPS R++ +I +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 72/336 (21%), Positives = 125/336 (37%), Gaps = 77/336 (22%)
Query: 1 METKGKVLMQKYE-LGRLLGQGNFAKVYYAR--HLGTGQSVAIKAIDKDKILKVGLVDQT 57
+ ++ + + +E G +G+G + VY A+ + A+K I+ G+
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSA 65
Query: 58 KREISVMRLIQHPNVMQIYEVMASKT--KIYFVMEYA---------KGGELFKKVSKGKL 106
REI+++R ++HPNV+ + +V S K++ + +YA +L
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 107 KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTDFGLSALAKCK 162
+ Q++ I + H+ V HRDLKP N+L+ E G +K+ D G A
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNS 184
Query: 163 HQDGLLHTTCG--TPAYVAPEVI--SRRGYDGDKADIWSCGVILYVLLAG---------- 208
L T Y APE++ +R Y DIW+ G I LL
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARH-Y-TKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 209 ---YLPFHDSNLMAMYR------------------------KIAKADY----------KF 231
P+H L ++ + Y K
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
+ LL ++L +P RI+ + M++P+F
Sbjct: 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 42/257 (16%), Positives = 85/257 (33%), Gaps = 38/257 (14%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
++ +Y L G + + A + VA+ +D +L ++ +T +
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
I P V ++ +V+ ++ V E+ +GG L ++V+ A + Q L +A D
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADA 144
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
H GV P + + +G + + PA +
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA--- 179
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT-------WFSA 237
+ DI G LY LL P ++ + + + P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 238 DVRKLLSRILDPNPSTR 254
+ + +R + + R
Sbjct: 235 QISAVAARSVQGDGGIR 251
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 67/302 (22%), Positives = 133/302 (44%), Gaps = 57/302 (18%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LI 67
Y+L R LG+G +++V+ A ++ + V +K + K K KREI ++ L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLR 88
Query: 68 QHPNVMQIYEVM--ASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
PN++ + +++ V E+ + K++ + L + R Y +++ A+D+C
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQ-TLTDYDIRFYMYEILKALDYC 146
Query: 126 HSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI- 183
HS G+ HRD+KP N+++D E+ L++ D+G LA+ H + + + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 184 SRRGYDGDKA-DIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAK--------------- 226
+ Y D + D+WS G +L ++ P FH + +IAK
Sbjct: 204 DYQMY--DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 227 ----ADYK--FPTW--------FSADVRK--------LLSRILDPNPSTRISIAKIMENP 264
+ ++ + L ++L + +R++ + ME+P
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 265 WF 266
+F
Sbjct: 322 YF 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 60/291 (20%), Positives = 121/291 (41%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
++ + +G+G + +V+ + G + VA+K + + EI L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEAS----WFRETEIYQTVLMRHENI 93
Query: 73 MQIY----EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+ + S T++Y + +Y + G L+ + L + K +S + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 129 --------GVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPAYV 178
+ HRDLK +N+L+ +NG + D GL+ + D +T GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 179 APEVISRRGYDGD-----KADIWSCGVILYVLLAGY----------LPFH-----DSNLM 218
PEV+ AD++S G+IL+ + LP+H D +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 219 AMYRKIAKADY--KFP-TWFSADVRKLLSRIL----DPNPSTRISIAKIME 262
M + FP W S + + + +++ NP++R++ ++ +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 57/291 (19%), Positives = 121/291 (41%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV 72
L +G+G F +V+ + G+ VA+K + + EI +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENI 98
Query: 73 MQIY----EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+ + + T+++ V +Y + G LF +++ + + K S + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 129 --------GVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPAYV 178
+ HRDLK +N+L+ +NG + D GL+ + D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 179 APEVISRRGYDGD-----KADIWSCGVILYVLLAGY----------LPFH-----DSNLM 218
APEV+ +ADI++ G++ + + LP++ D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 219 AMYRKIAKADY--KFP-TWFSADVRKLLSRIL----DPNPSTRISIAKIME 262
M + + + P W S + +++++I+ N + R++ +I +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 67/311 (21%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL-- 66
M ++++ R+ GQG F V + TG SVAIK + +D + RE+ +M+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLA 74
Query: 67 -IQHPNVMQIYEVMASKTK-------IYFVMEYAKGGELFKKV------SKGKLKEDTAR 112
+ HPN++Q+ + + + VMEY + + + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 113 KYFQQLISAIDFCH--SRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKC-KHQDGLL 168
+ QLI +I H S V HRD+KP N+L++ +G LK+ DFG AK + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG---SAKKLSPSEPNV 189
Query: 169 HTTCGTPAYVAPEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK- 226
C + Y APE+I + Y DIWS G I ++ G F N +I +
Sbjct: 190 AYIC-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 227 ----------------ADYKFPTW--------FSADVRK-------LLSRILDPNPSTRI 255
D FS K LLS +L P R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 256 SIAKIMENPWF 266
+ + +P+F
Sbjct: 308 KPYEALCHPYF 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 57/300 (19%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
+ Y +G G + V A +G+ VAIK K+ + + + RE+ +++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78
Query: 66 LIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
+QH NV+ + +V + Y VM + +L +K+ K E+ + Q++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQML 136
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ + HS GV HRDLKP NL ++E+ LK+ DFGL+ +H D + T Y A
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRA 191
Query: 180 PEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI-------------- 224
PEVI S Y+ DIWS G I+ +L G F + + +I
Sbjct: 192 PEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 225 ----------------AKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
+ D+ FP S LL ++L+ + R++ A+ + +P+F
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 75/336 (22%), Positives = 129/336 (38%), Gaps = 90/336 (26%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
+KY LG+ LG G+F V + +G+ A+K + +D K RE+ +M++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKV 56
Query: 67 IQHPNVMQIYEVMASKTK--------------------------------------IYFV 88
+ H N++++ + + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 89 MEYAKGGELFKKV------SKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL 142
MEY + KV S + + Y QL A+ F HS G+ HRD+KP+NLL+
Sbjct: 117 MEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 143 D-ENGMLKVTDFGLSALAKCKHQDG-LLHTTCGTPAYVAPEVI-SRRGYDGDKADIWSCG 199
+ ++ LK+ DFG AK + C + Y APE++ Y D+WS G
Sbjct: 175 NSKDNTLKLCDFG---SAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIG 229
Query: 200 VILYVLLAGYLPFHDSNLMAMYRKIAK-----------------ADYKFPTW----FSAD 238
+ L+ G F + +I + + +FPT +
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289
Query: 239 VRK--------LLSRILDPNPSTRISIAKIMENPWF 266
+ + LL +IL P RI+ + M +P+F
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 56/300 (18%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
Y + +G G + V A TG VAIK K+ + + + RE+ +++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79
Query: 66 LIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
++H NV+ + +V Y VM + G +L K + KL ED + Q++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ + H+ G+ HRDLKP NL ++E+ LK+ DFGL+ + D + T Y A
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRA 193
Query: 180 PEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK------------ 226
PEVI + Y DIWS G I+ ++ G F S+ + ++I K
Sbjct: 194 PEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 227 ------ADY--------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
+Y S LL ++L + R++ + + +P+F
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 47/233 (20%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV----GLVDQTKREISV 63
+ +YE+ L+G G++ V A + VAIK KIL+V + REI++
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAI 105
Query: 64 MRLIQHPNVMQIYEVMASKT-----KIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQ 116
+ + H +V+++ +++ K ++Y V+E A + KK+ + L E +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLY 163
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
L+ + + HS G+ HRDLKP N L++++ +KV DFGL+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 177 -------------------YV------APEVI-SRRGYDGDKA-DIWSCGVIL 202
+V APE+I + Y +A D+WS G I
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 60/308 (19%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAID--KDKILKVGLVDQTKREISVMRLI 67
++L LLG+G + V A H TG+ VAIK I+ + +T REI +++
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF----ALRTLREIKILKHF 66
Query: 68 QHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAI 122
+H N++ I+ + + +Y + E +L + +S L +D + + Q + A+
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA---YV- 178
H V HRDLKP NLL++ N LKV DFGL A + T +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL-ARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 179 -----APEVI-SRRGYDGDKA-DIWSCGVILYVLLAG--------YL------------P 211
APEV+ + Y +A D+WSCG IL L Y P
Sbjct: 185 TRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 212 FHDS-----------NLMAMYRKIAKADYK--FPTWFSADVRKLLSRILDPNPSTRISIA 258
D+ + A + FP + LL R+L +P+ RI+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAK 301
Query: 259 KIMENPWF 266
+ +E+P+
Sbjct: 302 EALEHPYL 309
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 56/302 (18%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
++Y+ +G G + V A TG VA+K K+ + ++ +T RE+ +++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLK 83
Query: 66 LIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
++H NV+ + +V +Y V G +L V KL +D + Q++
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ + HS + HRDLKP NL ++E+ LK+ DFGL+ +H + T Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRWYRA 197
Query: 180 PEVI-SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI-------------- 224
PE++ + Y+ DIWS G I+ LL G F ++ + + I
Sbjct: 198 PEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 225 ----------------AKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWF 266
K ++ F + LL ++L + RI+ A+ + + +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 267 RK 268
+
Sbjct: 316 AQ 317
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 63/309 (20%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
++Y+ + +G G V A ++VAIK K+ + + RE+ +M+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMK 116
Query: 66 LIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
+ H N++ + V + +Y VME L +V + +L + Q++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQML 174
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
I HS G+ HRDLKP N+++ + LK+ DFG LA+ ++ T Y A
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRA 231
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI--------------- 224
PEVI GY + DIWS G I+ ++ + F + + + K+
Sbjct: 232 PEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 225 ---------------------------AKADYKFPTWFSADVRKLLSRILDPNPSTRISI 257
AD + ++ R LLS++L +P+ RIS+
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 258 AKIMENPWF 266
+++P+
Sbjct: 351 DDALQHPYI 359
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 56/302 (18%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+Y +G+G + V A VAIK I +T REI ++ +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRH 84
Query: 70 PNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
N++ I +++ + T +Y V + +L+K + L D + Q++ + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV------ 178
HS V HRDLKP NLLL+ LK+ DFGL+ +A H T YV
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVATRWYR 198
Query: 179 APEVI-SRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKI------------ 224
APE++ + +GY K+ DIWS G IL +L+ F + + I
Sbjct: 199 APEIMLNSKGY--TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 225 ------------------AKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIMENP 264
K + FP + LL ++L NP RI + + + +P
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 265 WF 266
+
Sbjct: 316 YL 317
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 63/311 (20%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISV 63
++++Y+ + +G G V A ++VAIK K+ + + RE+ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVL 77
Query: 64 MRLIQHPNVMQIYEVMASKTK------IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQ 117
M+ + H N++ + V + +Y VME L +V + +L + Q
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQ 135
Query: 118 LISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY 177
++ I HS G+ HRDLKP N+++ + LK+ DFG LA+ ++ T Y
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 192
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI------------- 224
APEVI GY + DIWS G I+ ++ G + F ++ + + K+
Sbjct: 193 RAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 225 -----------------------------AKADYKFPTWFSADVRKLLSRILDPNPSTRI 255
AD + ++ R LLS++L + S RI
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 256 SIAKIMENPWF 266
S+ + +++P+
Sbjct: 312 SVDEALQHPYI 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 54/295 (18%), Positives = 106/295 (35%), Gaps = 51/295 (17%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD--QTKREISVMRLIQ 68
+L + +G F V+ A+ + VA+K I + Q + E+ + ++
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVK------IFPIQDKQSWQNEYEVYSLPGMK 76
Query: 69 HPNVMQIY----EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
H N++Q + ++ + + + G L + + + + + + +
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 125 CHSRGVY----------HRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174
H HRD+K +N+LL N + DFGL+ + G H GT
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 175 PAYVAPEVISRRGYDGD----KADIWSCGVILYVLLAG-----------YLPFHDS---- 215
Y+APEV+ + D+++ G++L+ L + LPF +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 216 -NLMAMYRKIA--KADYKFP-TWFSADVRKLLSRIL----DPNPSTRISIAKIME 262
+L M + K W +L + D + R+S + E
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 54/290 (18%), Positives = 105/290 (36%), Gaps = 46/290 (15%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL--IQHP 70
+L L+G+G + VY + VA+K + E ++ R+ ++H
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVK------VFSFANRQNFINEKNIYRVPLMEHD 67
Query: 71 NVMQIY-----EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
N+ + + + VMEY G L K +S ++ + + + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 126 HS---------RGVYHRDLKPENLLLDENGMLKVTDFGLS------ALAKCKHQDGLLHT 170
H+ + HRDL N+L+ +G ++DFGLS L + +D +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 171 TCGTPAYVAPEVISRR------GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224
GT Y+APEV+ + D+++ G+I + + + Y ++
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY-QM 246
Query: 225 AKADYKFPTWFSADVRKL---------LSRILDPNPSTRISIAKIMENPW 265
A D++ L N S+ + +E+ W
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 58/309 (18%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG------LVD--QTKREI 61
Y + R + G++ V G VAIK + + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 62 SVMRLIQHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFK--KVSKGKLKEDTARKY 114
++ HPN++ + ++ + +Y V E +L + + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 115 FQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT 174
++ + H GV HRDL P N+LL +N + + DF LA+ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 175 PAYVAPEVI-SRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSN---------------- 216
Y APE++ +G+ K D+WS G ++ + F S
Sbjct: 197 RWYRAPELVMQFKGF--TKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 217 ---------------LMAMYRKIAKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAK 259
L + + PT L++++L+ NP RIS +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 260 IMENPWFRK 268
+ +P+F
Sbjct: 314 ALRHPYFES 322
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 70/313 (22%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD--QTKREISVMRLI 67
+Y + LG G V+ A + VAIK KI+ REI ++R +
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRL 65
Query: 68 QHPNVMQIYEVMASKTK--------------IYFVMEYAKGGELFKKVSKGKLKEDTARK 113
H N+++++E++ +Y V EY +L + +G L E+ AR
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARL 124
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
+ QL+ + + HS V HRDLKP NL ++ E+ +LK+ DFGL+ + + +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE- 183
Query: 173 GTPAYV------APEVI-SRRGYDGDKA-DIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224
+ +P ++ S Y KA D+W+ G I +L G F ++ + + I
Sbjct: 184 ----GLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 225 AK-----------------ADY--------------KFPTWFSADVRKLLSRILDPNPST 253
+ Y P S + L +IL +P
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMD 296
Query: 254 RISIAKIMENPWF 266
R++ + + +P+
Sbjct: 297 RLTAEEALSHPYM 309
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
Y + L+G+G++ VY A T ++VAIK K+ ++ L+D + REI+++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITILN 80
Query: 66 LIQHPNVMQIYEVMASKTK-----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ-QLI 119
++ ++++Y+++ +Y V+E A +L K + K L+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA--- 176
+F H G+ HRDLKP N LL+++ +KV DFGL+ + +++
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 177 -----------YV------APEVI-SRRGYDGDKA-DIWSCGVILYVLLAG 208
+V APE+I + Y K+ DIWS G I LL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNM 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 78/335 (23%), Positives = 124/335 (37%), Gaps = 85/335 (25%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVD--QTKREISVMR 65
+KYEL + LG+G + V+ + TG+ VA+K KI D +T REI ++
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMILT 63
Query: 66 -LIQHPNVMQIYEVMASKTK--IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ-QLISA 121
L H N++ + V+ + +Y V +Y +L V + + E ++Y QLI
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKV 121
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA----- 176
I + HS G+ HRD+KP N+LL+ +KV DFGLS +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 177 --------YV------APEVI-SRRGYDGDKA-DIWSCGVILYVLLAG------------ 208
YV APE++ Y K D+WS G IL +L G
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 209 --------------------------YL---------PFHDSNLMAMYRKIAKADYKFPT 233
+ + + K
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ + LL ++L NP+ RIS +++P+
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/263 (24%), Positives = 115/263 (43%), Gaps = 25/263 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMRLIQ 68
LG +G+GNF +V+ R VA+K + L K +E +++
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVK------SCRETLPPDLKAKFLQEARILKQYS 170
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
HPN++++ V K IY VME +GG+ F + +L+ T + + +++
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY----VAPEV 182
S+ HRDL N L+ E +LK++DFG+S DG+ + G APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE----ADGVYAASGGLRQVPVKWTAPEA 286
Query: 183 ISRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADV 239
++ Y ++D+WS G++L+ G P+ + + + K + P V
Sbjct: 287 LNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPELCPDAV 344
Query: 240 RKLLSRILDPNPSTRISIAKIME 262
+L+ + P R S + I +
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+ LG G + +VY +VA+K LK ++ + +E +VM+ I+HP
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAAVMKEIKHP 276
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++Q+ V + Y + E+ G L ++ ++ ++ Q+ SA+++
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY--VAPEVISR 185
+ HR+L N L+ EN ++KV DFG L++ D APE ++
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
+ K+D+W+ GV+L+ + G P+ +L +Y + K
Sbjct: 394 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+ LG G + +VY +VA+K LK ++ + +E +VM+ I+HP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAAVMKEIKHP 69
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++Q+ V + Y + E+ G L ++ ++ ++ Q+ SA+++
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YVAPEV 182
+ HRDL N L+ EN ++KV DFGLS L H P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF------PIKWTAPES 183
Query: 183 ISRRGYDGDKADIWSCGVILY 203
++ + K+D+W+ GV+L+
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLW 203
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 32/271 (11%)
Query: 13 ELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTK---REISVMR 65
+ + LG+GNF V R TG+ VA+K L+ + + REI +++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILK 66
Query: 66 LIQHPNVMQIYEVMASKTK--IYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISA 121
+QH N+++ V S + + +MEY G L + + K ++ +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV--- 178
+++ ++ HRDL N+L++ +K+ DFGL K QD P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEFFKV-KEPGESPIF 182
Query: 179 --APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFS 236
APE ++ + +D+WS GV+LY L Y+ S R I
Sbjct: 183 WYAPESLTESKFS-VASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQ--GQMIV 238
Query: 237 ADVRKLLSR--ILDPNPSTRISIAKIMENPW 265
+ +LL L I IM W
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECW 269
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 77/353 (21%), Positives = 129/353 (36%), Gaps = 89/353 (25%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI-DKDKILKVGLVDQTKREIS 62
+ +YE+ +++G+G+F +V A Q VA+K + ++ + + Q EI
Sbjct: 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-----QAAEEIR 145
Query: 63 VMRLIQH------PNVMQIYEVMASKTKIYFVME------YAKGGELFKKVSKGKLKEDT 110
++ ++ NV+ + E + I E Y EL KK
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY----ELIKKNKFQGFSLPL 201
Query: 111 ARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG--MLKVTDFGLSALAKCKHQDGLL 168
RK+ ++ +D H + H DLKPEN+LL + G +KV DFG S C ++ +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----C-YEHQRV 256
Query: 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF--HDSNLM-------- 218
+T + Y APEVI Y D+WS G IL LL GY D
Sbjct: 257 YTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315
Query: 219 -----AMYRKIAKADYKF-----PTWFSADVRK--------------------------- 241
+ +A P + +
Sbjct: 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375
Query: 242 ------------LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIK 282
L + L+ +P+ R++ + + +PW R+ L KT++K
Sbjct: 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVK 428
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-27
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+ +G G F V+ L + VAIK ++ G + + E VM + HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIK------TIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
++Q+Y V + I V E+ + G L + + +G +T + + +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YVAPEVI 183
V HRDL N L+ EN ++KV+DFG++ P + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------PVKWASPEVF 177
Query: 184 SRRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
S Y K+D+WS GV+++ V G +P+ + + + I+
Sbjct: 178 SFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLI 67
+ ++LG G F VY + G+ V I AI K L+ + E VM +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASV 74
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFC 125
+P+V ++ + + + + + G L + + K + + Q+ +++
Sbjct: 75 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEV 182
R + HRDL N+L+ +K+TDFGL+ K + + G P ++A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLA---KLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 183 ISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
I R Y ++D+WS GV ++ ++ G P+
Sbjct: 191 ILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDG 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 32/271 (11%)
Query: 13 ELGRLLGQGNFAKVYYARHLG----TGQSVAIKAIDKDKILKVGLVDQTK---REISVMR 65
+ + LG+GNF V R+ TG+ VA+K L+ + + REI +++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILK 97
Query: 66 LIQHPNVMQIYEVMASKTK--IYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISA 121
+QH N+++ V S + + +MEY G L + + K ++ +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV--- 178
+++ ++ HRDL N+L++ +K+ DFGL K QD + P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEYYKV-KEPGESPIF 213
Query: 179 --APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFS 236
APE ++ + +D+WS GV+LY L Y+ S R I
Sbjct: 214 WYAPESLTESKFS-VASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQ--GQMIV 269
Query: 237 ADVRKLLSR--ILDPNPSTRISIAKIMENPW 265
+ +LL L I IM W
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECW 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 13 ELGRLLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
L LG G+F V + G SVA+K + D + + +D RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++++Y V + V E A G L + +G T +Y Q+ + + S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEVIS 184
+ HRDL NLLL ++K+ DFGL D P A+ APE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 185 RRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADYKFP 232
R + +D W GV L+ + G P+ N + KI K + P
Sbjct: 198 TRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 34/272 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHL----GTGQSVAIKAIDKDKILKVGLVDQTK----REISVM 64
+ R LG+G+F KV R+ TG+ VA+K+ LK +EI ++
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS------LKPESGGNHIADLKKEIEIL 77
Query: 65 RLIQHPNVMQIYEVMASKTK--IYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLIS 120
R + H N+++ + I +ME+ G L + +K K+ KY Q+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV-- 178
+D+ SR HRDL N+L++ +K+ DFG L K D +T
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG---LTKAIETDKEYYTV-KDDRDSPV 193
Query: 179 ---APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235
APE + + + +D+WS GV L+ LL + DS+ M +
Sbjct: 194 FWYAPECLMQSKFY-IASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMT 248
Query: 236 SADVRKLLSR--ILDPNPSTRISIAKIMENPW 265
+ L L P+ + ++M W
Sbjct: 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHPN 71
L + LG G F V + G VA+K ++K G + + + +E M + HP
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQ-YDVAVK------MIKEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
+++ Y V + + IY V EY G L + + L+ + + + F S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YVAPEVIS 184
HRDL N L+D + +KV+DFG++ P + APEV
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------PVKWSAPEVFH 178
Query: 185 RRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
Y K+D+W+ G++++ V G +P+ + K+++
Sbjct: 179 YFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT-KREISVMRLIQHPN 71
+L + +G+G F V + G VA+K +K Q E SVM ++H N
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGN--KVAVK------CIKNDATAQAFLAEASVMTQLRHSN 75
Query: 72 VMQIYEV-MASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++Q+ V + K +Y V EY G L + + L D K+ + A+++
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APEVIS 184
HRDL N+L+ E+ + KV+DFGL+ A G L P V APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALR 187
Query: 185 RRGYDGDKADIWSCGVILY 203
+ + K+D+WS G++L+
Sbjct: 188 EKKFS-TKSDVWSFGILLW 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLI 67
+ ++LG G F VY + G+ V I AI K L+ + E VM +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASV 74
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFC 125
+P+V ++ + + + + + G L + + K + + Q+ +++
Sbjct: 75 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEV 182
R + HRDL N+L+ +K+TDFG LAK + + G P ++A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFG---LAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 183 ISRRGYDGDKADIWSCGVILY 203
I R Y ++D+WS GV ++
Sbjct: 191 ILHRIYT-HQSDVWSYGVTVW 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+ LG G F V Y + G VAIK ++K G + + + E VM + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ-YDVAIK------MIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
++Q+Y V + I+ + EY G L + + + + + + + + A+++ S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--PA-YVAPEVISR 185
HRDL N L+++ G++KV+DFGLS D ++ G+ P + PEV+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPF 212
+ K+DIW+ GV+++ + G +P+
Sbjct: 196 SKFS-SKSDIWAFGVLMWEIYSLGKMPY 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKR----EISVMRL 66
+ +++G G F +V R + SVAIK LKVG ++ +R E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT------LKVGYTEKQRRDFLGEASIMGQ 102
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDF 124
HPN++++ V+ + V EY + G L F + + + + S + +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APE 181
G HRDL N+L++ N + KV+DFGL + + +TT G + +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 182 VISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
I+ R + +D+WS G++L+ V+ G P+ +
Sbjct: 221 AIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTK----REISVMR 65
+ +++G G+ +V Y R GQ VAIKA LK G ++ + E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA------LKAGYTERQRRDFLSEASIMG 105
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAID 123
HPN++++ V+ V EY + G L F + G+ + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---AP 180
+ G HRDL N+L+D N + KV+DFGLS + + +TT G + AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAP 223
Query: 181 EVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
E I+ R + +D+WS GV+++ VL G P+ +
Sbjct: 224 EAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 18/201 (8%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLI 67
++LG G F V+ + G+S+ I I K+++ Q+ + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFC 125
H +++++ + + + V +Y G L + +G L + Q+ + +
Sbjct: 73 DHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEV 182
G+ HR+L N+LL ++V DFG +A D P ++A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFG---VADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 183 ISRRGYDGDKADIWSCGVILY 203
I Y ++D+WS GV ++
Sbjct: 189 IHFGKYTH-QSDVWSYGVTVW 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK---REISVMRLIQ 68
+ LG+GNF V R+ G + A+ K L+ DQ + REI +++ +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAV---KQLQHSGPDQQRDFQREIQILKALH 82
Query: 69 HPNVMQIYEVMASKTK--IYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDF 124
+++ V + + VMEY G L F + + +L Y Q+ +++
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC------KHQDGLLHTTCGTP-AY 177
SR HRDL N+L++ +K+ DFGL+ L + G P +
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIFW 196
Query: 178 VAPEVISRRGYDGDKADIWSCGVILY 203
APE +S + ++D+WS GV+LY
Sbjct: 197 YAPESLSDNIFS-RQSDVWSFGVVLY 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQSVAIK-AIDKDKILKVGLVDQTK----REISVMRLIQ 68
+++G G F +VY + + AI K LK G ++ + E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI---KTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCH 126
H N++++ V++ + + EY + G L F + G+ + + + + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV---APEVI 183
+ HRDL N+L++ N + KV+DFGLS + + +TT G + APE I
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 184 SRRGYDGDKADIWSCGVILY-VLLAGYLPFHD-SN 216
S R + +D+WS G++++ V+ G P+ + SN
Sbjct: 223 SYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
L LGQG F +V+ GT + VAIK LK G + +E VM+ ++H
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++Q+Y V S+ IY V EY G L K + L+ Q+ S + +
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY--VAPEVISR 185
HRDL+ N+L+ EN + KV DFG LA+ + APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
+ K+D+WS G++L + G +P+ + ++ +
Sbjct: 439 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+L LG G F +V+ + G + VA+K LK G + E ++M+ +QH
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVK------SLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKG-KLKEDTARKYFQQLISAIDFCHS 127
++++Y V ++ IY + EY + G L F K G KL + Q+ + F
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YVAPEV 182
R HRDL+ N+L+ + K+ DFGL+ L + + P + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKWTAPEA 181
Query: 183 ISRRGYDGDKADIWSCGVILY 203
I+ + K+D+WS G++L
Sbjct: 182 INYGTFT-IKSDVWSFGILLT 201
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
L LGQG F +V+ GT + VAIK LK G + +E VM+ ++H
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGK-LKEDTARKYFQQLISAIDFCHS 127
++Q+Y V S+ IY V EY G L F K GK L+ Q+ S + +
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAY--VAPEVISR 185
HRDL+ N+L+ EN + KV DFG LA+ + APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 186 RGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
+ K+D+WS G++L + G +P+ + ++ +
Sbjct: 356 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 13 ELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVM 64
+ R LG+G+F KV + GTG+ VA+K LK Q + +EI ++
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------ALKADAGPQHRSGWKQEIDIL 87
Query: 65 RLIQHPNVMQIYEVMASKTK--IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAI 122
R + H ++++ + VMEY G L + + + + QQ+ +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK------CKHQDGLLHTTCGTP- 175
+ H++ HRDL N+LLD + ++K+ DFGL+ +DG P
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PV 201
Query: 176 AYVAPEVISRRGYDGDKADIWSCGVILY 203
+ APE + + +D+WS GV LY
Sbjct: 202 FWYAPECLKEYKFY-YASDVWSFGVTLY 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 13 ELGRLLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
ELGR +G+G F V+ Y +VAIK K D + +E MR
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIK------TCKNCTSDSVREKFLQEALTMR 71
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAID 123
HP+++++ V ++ ++ +ME GEL F +V K L + Y QL +A+
Sbjct: 72 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YV 178
+ S+ HRD+ N+L+ N +K+ DFGLS + K G L P ++
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 184
Query: 179 APEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
APE I+ R + +D+W GV ++ +L+ G PF
Sbjct: 185 APESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQG 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 13 ELGRLLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
L R+LG+G F +VY Y H G +VA+K K K E +M+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVK------TCKKDCTLDNKEKFMSEAVIMK 68
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAID 123
+ HP+++++ ++ + + +ME GEL + + +K LK T Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTP-AYV 178
+ S HRD+ N+L+ +K+ DFGLS + K L P ++
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWM 181
Query: 179 APEVISRRGYDGDKADIWSCGVILY-VLLAGYLPFHD 214
+PE I+ R + +D+W V ++ +L G PF
Sbjct: 182 SPESINFRRFTT-ASDVWMFAVCMWEILSFGKQPFFW 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT-KREISVMRLIQHPN 71
+L + +G+G F V + G VA+K +K Q E SVM ++H N
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGN--KVAVK------CIKNDATAQAFLAEASVMTQLRHSN 247
Query: 72 VMQIYEV-MASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCHS 127
++Q+ V + K +Y V EY G L + + L D K+ + A+++
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA-YVAPEVISRR 186
HRDL N+L+ E+ + KV+DFGL+ A G L P + APE + +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 187 GYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAK 226
+ K+D+WS G++L+ + G +P+ L + ++ K
Sbjct: 362 KFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/346 (18%), Positives = 124/346 (35%), Gaps = 98/346 (28%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-- 68
+Y L R LG G+F+ V+ A+ + VA+K + DK+ + + EI +++ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 69 ---------HPNVMQIYEVMASKTKIYFVMEYAKGG--------------ELFKKVSKGK 105
+++++ + +F + G L KK
Sbjct: 76 DNTKEDSMGANHILKLLD--------HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 127
Query: 106 LKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDE------NGMLKVTDFGLSAL 158
+ ++ +QL+ +D+ H R G+ H D+KPEN+L++ +K+ D G +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC- 186
Query: 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF------ 212
D + T Y +PEV+ + ADIWS +++ L+ G F
Sbjct: 187 ----WYDEHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGH 241
Query: 213 ---HDSNLMA------------MYRKIAKADYKF------------------------PT 233
D + +A + R F
Sbjct: 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 301
Query: 234 WFSADVRK---LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
+ + ++ LS +L +P R ++ +PW + L + +
Sbjct: 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 13 ELGRLLGQGNFAKVY---YARHLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
ELGR +G+G F V+ Y +VAIK K D + +E MR
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK------TCKNCTSDSVREKFLQEALTMR 446
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAID 123
HP+++++ V ++ ++ +ME GEL F +V K L + Y QL +A+
Sbjct: 447 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YV 178
+ S+ HRD+ N+L+ N +K+ DFGLS + K G L P ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 559
Query: 179 APEVISRRGYDGDKADIWSCGVILY 203
APE I+ R + +D+W GV ++
Sbjct: 560 APESINFRRFTS-ASDVWMFGVCMW 583
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
G+ M +YE+ L+G+G+F +V A + VAIK I K +Q + E+ +
Sbjct: 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRL 103
Query: 64 MRLIQHP------NVMQIYEVMASKTKIYFVME------YAKGGELFKKVSKGKLKEDTA 111
+ L+ ++ + + + V E Y +L + + + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLT 159
Query: 112 RKYFQQLISAIDFCHSR--GVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGL 167
RK+ QQ+ +A+ F + + H DLKPEN+LL + +K+ DFG S+ C
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SS---C-QLGQR 214
Query: 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA 227
++ + Y +PEV+ YD D+WS G IL + G F +N + KI +
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDL-AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
Query: 228 DYKFPTWF 235
P
Sbjct: 274 LGIPPAHI 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 21/197 (10%)
Query: 18 LGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTK----REISVMRLIQHPN 71
LG GNF V + + VAIK +LK G RE +M + +P
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ V ++ + VME A GG L F + ++ + Q+ + + +
Sbjct: 72 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEVISRR 186
HRDL N+LL K++DFGLS D P + APE I+ R
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 187 GYDGDKADIWSCGVILY 203
+ ++D+WS GV ++
Sbjct: 189 KFSS-RSDVWSYGVTMW 204
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 65/345 (18%), Positives = 122/345 (35%), Gaps = 98/345 (28%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAI-DKDKILKVGLVDQTKREISV 63
G +L + + R +G G F +V +H+ + A+K + + K K E +
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-----YTRSAKIEADI 84
Query: 64 MRLIQH-----PNVMQIYEVMASKTKIYFVME------YAKGGELFKKVSKGKLKEDTAR 112
++ IQ+ N+++ + + + E Y E+ + + + +
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIK 140
Query: 113 KYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM------------------------- 147
Y +++ A+++ + H DLKPEN+LLD+
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 148 LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA 207
+K+ DFG A + + T Y APEVI G+D +D+WS G +L L
Sbjct: 201 IKLIDFG-CA---T-FKSDYHGSIINTRQYRAPEVILNLGWDV-SSDMWSFGCVLAELYT 254
Query: 208 GYLPF--HDSN-LMAM-------------------------YRKIAKADYKFPTWFSADV 239
G L F H+ +AM + K + +
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 240 RK------------------LLSRILDPNPSTRISIAKIMENPWF 266
+ L IL +P+ R S A+++++ +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 21/201 (10%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTK-----REISVMRL 66
+ LG GNF V + VA+K ILK D E +VM+
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK------ILKNEANDPALKDELLAEANVMQQ 74
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFC 125
+ +P ++++ + VME A+ G L K + + + +K+ + Q+ + +
Sbjct: 75 LDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEV 182
HRDL N+LL K++DFGLS + + P + APE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYAPEC 191
Query: 183 ISRRGYDGDKADIWSCGVILY 203
I+ + K+D+WS GV+++
Sbjct: 192 INYYKFSS-KSDVWSFGVLMW 211
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK--REISVMRLIQHP 70
+L + LG G F +V+ A + + VA+K +K G + E +VM+ +QH
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVK------TMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGK-LKEDTARKYFQQLISAIDFCHS 127
+++++ V +K IY + E+ G L F K +G + Q+ + F
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAK----CKHQDGLLHTTCGTPA-YVAPEV 182
R HRDL+ N+L+ + + K+ DFGL+ + + + P + APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------PIKWTAPEA 356
Query: 183 ISRRGYDGDKADIWSCGVILY 203
I+ + K+D+WS G++L
Sbjct: 357 INFGSFT-IKSDVWSFGILLM 376
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 52/221 (23%), Positives = 88/221 (39%), Gaps = 36/221 (16%)
Query: 13 ELGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
++G+G+F VY+ + G A+K+ L E +M+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 81
Query: 66 LIQHPNVMQIYEVMA-SKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAI 122
HPNV+ + + S+ V+ Y K G+L F + + Q+ +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL-------AKCKHQDGLLHTTCGTP 175
+ S+ HRDL N +LDE +KV DFGL+ + L P
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P 195
Query: 176 AYV---APEVISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
V A E + + + K+D+WS GV+L+ ++ G P+
Sbjct: 196 --VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 233
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS---VAIKAIDKDKILKVGLVDQTK----REISVMR 65
R++G+G+F VY+ ++ Q+ AIK+ L Q RE +MR
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS------LSRITEMQQVEAFLREGLLMR 77
Query: 66 LIQHPNVMQIYEV-MASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAI 122
+ HPNV+ + + + + + ++ Y G+L F + + + Q+ +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL-------AKCKHQDGLLHTTCGTP 175
++ + HRDL N +LDE+ +KV DFGL+ + +H+ L P
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P 191
Query: 176 AYV---APEVISRRGYDGDKADIWSCGVILY 203
V A E + + K+D+WS GV+L+
Sbjct: 192 --VKWTALESLQTYRFT-TKSDVWSFGVLLW 219
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 73/353 (20%), Positives = 121/353 (34%), Gaps = 92/353 (26%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYAR-HLGTGQSVAIKAI-DKDKILKVGLVDQTKREI 61
G L ++YE+ LG+G F KV H VA+K I + K + + EI
Sbjct: 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEI 67
Query: 62 SVMRLIQHP------NVMQIYEVMASKTKIYFVME------YAKGGELFKKVSKGKLKED 109
+V++ I+ + + + + E + E K+ +
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF----EFLKENNFQPYPLP 123
Query: 110 TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM-------------------LKV 150
R QL A+ F H + H DLKPEN+L + ++V
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL 210
DFG SA T T Y PEVI G+ D+WS G IL+ G+
Sbjct: 184 ADFG-SA---T-FDHEHHTTIVATRHYRPPEVILELGWAQ-PCDVWSIGCILFEYYRGFT 237
Query: 211 PF--HDSNLM-------------AMYRKIAKADYKF---PTW------------------ 234
F H++ M + K Y + W
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297
Query: 235 --------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKT 279
+ L+ R+L+ +P+ RI++A+ + +P+F + + +
Sbjct: 298 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTS 350
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 18 LGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTK----REISVMRLIQHPN 71
LG GNF V + + VAIK +LK G RE +M + +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++++ V ++ + VME A GG L F + ++ + Q+ + + +
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGT--P-AYVAPEVISRR 186
HR+L N+LL K++DFGLS D P + APE I+ R
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 187 GYDGDKADIWSCGVILY-VLLAGYLPFHD 214
+ ++D+WS GV ++ L G P+
Sbjct: 515 KFSS-RSDVWSYGVTMWEALSYGQKPYKK 542
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 82/342 (23%), Positives = 127/342 (37%), Gaps = 92/342 (26%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYAR-HLGTGQSVAIKAI-DKDKILKVGLVDQTKREI 61
G VL +YE+ LG+G F KV H G+ VA+K + + D+ + + EI
Sbjct: 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-----YCEAARSEI 62
Query: 62 SVMRLIQHP------NVMQIYEVMASKTKIYFVME------YAKGGELFKKVSKGKLKED 109
V+ + +Q+ E I V E Y + K+ + D
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLD 118
Query: 110 TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-------------------MLKV 150
RK Q+ +++F HS + H DLKPEN+L ++ +KV
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL 210
DFG SA + D T T Y APEVI G+ D+WS G IL G+
Sbjct: 179 VDFG-SA---T-YDDEHHSTLVSTRHYRAPEVILALGWSQ-PCDVWSIGCILIEYYLGFT 232
Query: 211 PF--HDSNLM-------------AMYRKIAKADY---KFPTW------------------ 234
F HDS M +K K Y W
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 235 --------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ L+ ++L+ +P+ RI++ + +++P+F
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 13 ELGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTK----REISVMR 65
++G+G+F VY+ + G A+K+ L E +M+
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 145
Query: 66 LIQHPNVMQIYEVMA-SKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAI 122
HPNV+ + + S+ V+ Y K G+L F + + Q+ +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 123 DFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG------TPA 176
F S+ HRDL N +LDE +KV DFGL+ K D + + T
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-- 263
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
A E + + + K+D+WS GV+L+ ++ G P+
Sbjct: 264 --ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 45/230 (19%)
Query: 13 ELGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTK-----REISVM 64
LGR+LG+G F V A+ G+ VA+K LK ++ + RE + M
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM------LKADIIASSDIEEFLREAACM 79
Query: 65 RLIQHPNVMQIYEV------MASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQL 118
+ HP+V ++ V ++ + K G+L + ++ E+ Q L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 119 IS-AIDFCH------SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK-----CKHQDG 166
+ +D SR HRDL N +L E+ + V DFGLS +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 167 LLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
L P V A E ++ Y +D+W+ GV ++ ++ G P+
Sbjct: 200 KL------P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 14 LGRLLGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTK----REISVM-RL 66
++G+GNF +V AR G AIK +K E+ V+ +L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIK------RMKEYASKDDHRDFAGELEVLCKL 82
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--F---KKVSKGKLKEDTARKYFQQLISA 121
HPN++ + + +Y +EYA G L F +V + A L S
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 --IDFCH----------SRGVYHRDLKPENLLLDENGMLKVTDFGLS--ALAKCKHQDGL 167
+ F + HRDL N+L+ EN + K+ DFGLS K G
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 168 LHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
L P V A E ++ Y +D+WS GV+L+
Sbjct: 203 L------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 39/224 (17%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTK---REIS 62
LGQG F K++ G V +K +L + ++ S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK------VLDKAHRNYSESFFEAAS 64
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLIS 120
+M + H +++ Y V + V E+ K G L + K +K + + +QL +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 121 AIDFCHSRGVYHRDLKPENLLLD--------ENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
A+ F + H ++ +N+LL +K++D G+S +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT---------VLPKD 175
Query: 173 GTPAYV---APEVISRRGYDGDKADIWSCGVILY-VLLAGYLPF 212
+ PE I D WS G L+ + G P
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 43/219 (19%)
Query: 13 ELGRLLGQGNFAKVYYAR---HLGTGQSVAIKAIDKDKILKVGLVDQTKR-----EISVM 64
LG++LG+G F V GT VA+K +K+ Q + E + M
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT------MKLDNSSQREIEEFLSEAACM 90
Query: 65 RLIQHPNVMQIYEV-----MASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLI 119
+ HPNV+++ V K ++ + K G+L + +L+ Q L+
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 120 S-AIDFCH------SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK-----CKHQDGL 167
+D +R HRDL N +L ++ + V DFGLS + +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 168 LHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ P V A E ++ R Y K+D+W+ GV ++
Sbjct: 211 M------P--VKWIAIESLADRVYT-SKSDVWAFGVTMW 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 57/228 (25%), Positives = 86/228 (37%), Gaps = 52/228 (22%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTK----REISV 63
G+ LG G F KV A G +S VA+K +LK + E+ V
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK------MLKPSAHLTEREALMSELKV 79
Query: 64 M-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL------------FKKVSKGKLKEDT 110
+ L H N++ + + EY G+L K S +++D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 111 ARKYFQQLIS-AID------FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-- 161
+ L+S + F S+ HRDL N+LL + K+ DFGL+ K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 162 ---KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ L P V APE I Y ++D+WS G+ L+
Sbjct: 200 NYVVKGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 48/224 (21%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTK----REISV 63
+ G+ LG G F KV A G G+ VA+K +LK K E+ +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK------MLKSTAHADEKEALMSELKI 102
Query: 64 M-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLIS 120
M L QH N++ + + + EY G+L F + L+ D A S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 121 A---IDFCH----------SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-----K 162
+ F S+ HRD+ N+LL + K+ DFGL+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 163 HQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ L P V APE I Y ++D+WS G++L+
Sbjct: 223 KGNARL------P--VKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 13 ELGRLLGQGNFAKVY--YARHLGTGQS---VAIKAIDKDKILKVGLVDQTK----REISV 63
+ R LGQG+F VY A+ + + VAIK + + + E SV
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK------TVNEAASMRERIEFLNEASV 81
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKY--FQQLI 119
M+ +V+++ V++ +ME G+L + + + + + ++I
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 120 S-AID------FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-----KHQDGL 167
A + + ++ HRDL N ++ E+ +K+ DFG++ K GL
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 168 LHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
L P V +PE + + +D+WS GV+L+
Sbjct: 202 L------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLW 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 53/225 (23%), Positives = 83/225 (36%), Gaps = 49/225 (21%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTK----REISV 63
LG+ F KVY G Q+VAIK LK + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK------TLKDKAEGPLREEFRHEAML 65
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--F--KKVSKGKLKEDTARKYFQQLI 119
+QHPNV+ + V+ + + Y G+L F + + + + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 120 SAIDFCH-------------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-ALAKC---- 161
DF H S V H+DL N+L+ + +K++D GL +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 162 KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ LL P + APE I + +DIWS GV+L+
Sbjct: 186 LLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLW 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 51/250 (20%), Positives = 93/250 (37%), Gaps = 39/250 (15%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
M + V+ Y++GR +G+G+F ++ +L Q VAIK + + L + E
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQL----RDE 55
Query: 61 ISVMRLIQH-PNVMQIYEVMASKTKIYFVMEYAKG---GELFKKVSKGKLKEDTARKYFQ 116
+L+ + +Y V++ G +L + K T +
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAK 113
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLK-----VTDFGLSALAKCKHQDGLLH-- 169
Q+++ + H + + +RD+KP+N L+ V DFG+ + H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIP 171
Query: 170 -----TTCGTPAYVAP-----EVISRRGYDGDKADIWSCGVILYVLLAGYLP---FHDSN 216
GT Y++ SRR D D+ + G + L G LP +
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRR--D----DLEALGHVFMYFLRGSLPWQGLKAAT 225
Query: 217 LMAMYRKIAK 226
Y +I +
Sbjct: 226 NKQKYERIGE 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTK----REI 61
LG+ LG+G F +V A +G + VA+K +LK ++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK------MLKDDATEKDLSDLVSEM 91
Query: 62 SVM-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL----------FKKVSKGKLKEDT 110
+M + +H N++ + +Y ++EYA G L + S +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 111 ARKYFQQLIS-AID------FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-- 161
+ F+ L+S + S+ HRDL N+L+ EN ++K+ DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 162 ---KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
K +G L P V APE + R Y ++D+WS GV+++
Sbjct: 212 YYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 48/224 (21%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTK---REISVM 64
L R LG+G F KV+ A VA+KA LK + K RE ++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA------LKDPTLAARKDFQREAELL 71
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL----------FKKVSKGKLKEDTARKY 114
+QH ++++ Y V + V EY K G+L + G+ ++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 115 FQQLIS-AIDFCH------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-ALAKC----K 162
Q++ A S+ HRDL N L+ N ++K+ DFG+S +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 163 HQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+L P + PE I R + ++D+WS GVIL+
Sbjct: 192 GGHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTK----REI 61
LG+ LG+G F +V A +G + VA+K +LK ++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------MLKSDATEKDLSDLISEM 125
Query: 62 SVM-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL----------FKKVSKGKLKEDT 110
+M + +H N++ + +Y ++EYA G L + S
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 111 ARKYFQQLIS-AIDFCH------SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-- 161
+ + L+S A S+ HRDL N+L+ E+ ++K+ DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 162 ---KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
K +G L P V APE + R Y ++D+WS GV+L+
Sbjct: 246 YYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 57/233 (24%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTK----REISV 63
LG+ LG+G F KV A +VA+K +LK E +V
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK------MLKENASPSELRDLLSEFNV 79
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISA 121
++ + HP+V+++Y + + ++EYAK G L F + S+ + S
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 122 -------------IDFCH----------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-- 156
I F + HRDL N+L+ E +K++DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 157 ---ALAKCKHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ K G + P V A E + Y ++D+WS GV+L+
Sbjct: 200 VYEEDSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 51/227 (22%)
Query: 13 ELGRLLGQGNFAKVYYAR-----HLGTGQSVAIKAIDKDKILKVGLVDQTK----REISV 63
+LG+ LG+G F +V A T ++VA+K +LK G E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------MLKEGATHSEHRALMSELKI 83
Query: 64 M-RLIQHPNVMQIYEV-MASKTKIYFVMEYAKGGEL--F---KKVSKGKLKEDTARKYFQ 116
+ + H NV+ + + ++E+ K G L + K+ K Y
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 117 QLISA--IDFCH----------SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC--- 161
L I + SR HRDL N+LL E ++K+ DFGL+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 162 --KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ D L P + APE I R Y ++D+WS GV+L+
Sbjct: 204 YVRKGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 57/233 (24%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTK----REISV 63
E G++LG G F KV A G ++ VA+K LK + E+ +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM------LKEKADSSEREALMSELKM 101
Query: 64 M-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLIS 120
M +L H N++ + IY + EY G+L + + + K ED Q+ +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 121 A------------IDFCH----------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-- 156
+ F + + HRDL N+L+ ++K+ DFGL+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 157 ---ALAKCKHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ L P V APE + Y K+D+WS G++L+
Sbjct: 222 IMSDSNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 13 ELGRLLGQGNFAKVYYAR-------HLGTGQSVAIKAIDKDKILKVGLVDQTK----REI 61
LG+ LG+G F +V A +VA+K +LK ++ E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK------MLKDDATEKDLSDLVSEM 137
Query: 62 SVM-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL----------FKKVSKGKLKEDT 110
+M + +H N++ + +Y ++EYA G L + S +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 111 ARKYFQQLIS-AID------FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC-- 161
+ F+ L+S + S+ HRDL N+L+ EN ++K+ DFGL+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 162 ---KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
K +G L P V APE + R Y ++D+WS GV+++
Sbjct: 258 YYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 37/216 (17%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTK----REISV 63
L R LG G F +VY + G VA+K L +Q + E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT------LPEVCSEQDELDFLMEALI 86
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISA 121
+ H N+++ V + +ME GG+L F + ++ + + ++ L A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 122 IDFCH------SRGVYHRDLKPENLLLD---ENGMLKVTDFGLSALAKCKHQDGLLHTTC 172
D HRD+ N LL + K+ DFG+ A+ ++ +
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM---ARDIYRAS--YYRK 201
Query: 173 GTPAYV-----APEVISRRGYDGDKADIWSCGVILY 203
G A + PE + K D WS GV+L+
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLW 236
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH- 69
+Y LGR +G G+F +Y + G+ VAIK ++ K L E + +++Q
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL----HIESKIYKMMQGG 64
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKG---GELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
+ I A VME G +LF S+ K T Q+IS I++ H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH 122
Query: 127 SRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTT-------CGTPA 176
S+ HRD+KP+N L+ + ++ + DFGL+ K + H GT
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTAR 180
Query: 177 YV---APEVI--SRRGYDGDKADIWSCGVILYVLLAGYLP---FHDSNLMAMYRKIAK 226
Y I SRR D D+ S G +L G LP + Y +I++
Sbjct: 181 YASINTHLGIEQSRR--D----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 63/270 (23%), Positives = 96/270 (35%), Gaps = 75/270 (27%)
Query: 15 GRLLGQGNFAKVYYARHLGT--GQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQ 68
G +G+G F VY G +VA+K + + + K+ EI VM Q
Sbjct: 36 GNKMGEGGFGVVYK----GYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQ 88
Query: 69 HPNV-------------MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK-------- 107
H N+ +Y M + + + L L
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGS-----LLDR----LSCLDGTPPLSWHMRCKIA 139
Query: 108 EDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167
+ A I+F H HRD+K N+LLDE K++DFG LA+ +
Sbjct: 140 QGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFG---LARASEKFAQ 188
Query: 168 LHTT---CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF----HDSNLMAM 220
T GT AY+APE + RG K+DI+S GV+L ++ G L+ +
Sbjct: 189 TVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 221 YRKIAKADYKFPTWFSADVRKLLSRILDPN 250
+I K + +D
Sbjct: 247 KEEIEDE------------EKTIEDYIDKK 264
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 51/233 (21%), Positives = 84/233 (36%), Gaps = 57/233 (24%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTG-----QSVAIKAIDKDKILKVGLVDQTK----REISV 63
E R +G+G F +V+ AR G VA+K +LK + RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK------MLKEEASADMQADFQREAAL 103
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL------------FKKVSKGKLKEDTA 111
M +PN++++ V A + + EY G+L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 112 RKYFQQLISAIDFCH-------------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-A 157
+S + R HRDL N L+ EN ++K+ DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 158 LAKC----KHQDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+ + + P + PE I Y ++D+W+ GV+L+
Sbjct: 224 IYSADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 41/241 (17%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH- 69
+ +G+ +G GNF ++ ++L T + VAIK ++ K L E + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQL----HLEYRFYKQLGSG 64
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGG----ELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
+ Q+Y V+E G +LF + T QLIS +++
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEYV 121
Query: 126 HSRGVYHRDLKPENLLLDENGMLK-----VTDFGLSALAKCKHQDGLLH-------TTCG 173
HS+ + +RD+KPEN L+ G + DF L+ + + H + G
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYREHKSLTG 179
Query: 174 TPAYVAP-----EVISRRGYDGDKADIWSCGVILYVLLAGYLP---FHDSNLMAMYRKIA 225
T Y++ + SRR D D+ + G + L G LP L Y+KI
Sbjct: 180 TARYMSINTHLGKEQSRR--D----DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
Query: 226 K 226
Sbjct: 234 D 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 43/219 (19%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTK----REISV 63
L R LG G F +VY + G VA+K L +Q + E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT------LPEVCSEQDELDFLMEALI 127
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISA 121
+ H N+++ V + ++E GG+L F + ++ + + ++ L A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 122 IDFCH------SRGVYHRDLKPENLLLDENG---MLKVTDFGLS-ALAKC----KHQDGL 167
D HRD+ N LL G + K+ DFG++ + + K +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 168 LHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
L P V PE + K D WS GV+L+
Sbjct: 248 L------P--VKWMPPEAFMEGIFTS-KTDTWSFGVLLW 277
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 37/238 (15%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-H 69
K+ LGR +G G+F ++Y ++ T + VAIK + Q E + R++Q
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGG 62
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKG---GELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
+ + VM+ G +LF S+ KL T Q+I+ ++F H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVH 120
Query: 127 SRGVYHRDLKPENLLLDENG---MLKVTDFGLSALAKCKHQDGLLHTT-------CGTPA 176
S+ HRD+KP+N L+ + + DFGL+ K + H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA--KKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 177 YVAPEV-----ISRRGYDGDKADIWSCGVILYVLLAGYLPFHD---SNLMAMYRKIAK 226
Y + SRR D D+ S G +L L G LP+ Y KI++
Sbjct: 179 YASVNTHLGIEQSRR--D----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 48/223 (21%), Positives = 82/223 (36%), Gaps = 47/223 (21%)
Query: 13 ELGRLLGQGNFAKVY--YARHLGTGQS---VAIKAIDKDKILKVGLVDQTK---REISVM 64
L LG+G F KV+ +L Q VA+KA LK + RE ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA------LKEASESARQDFQREAELL 97
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL---FKKVSKGKLKEDTARKYFQQLISA 121
++QH ++++ + V + V EY + G+L + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 122 IDFCH-------------SRGVYHRDLKPENLLLDENGMLKVTDFGLS-ALAKC----KH 163
HRDL N L+ + ++K+ DFG+S +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 164 QDGLLHTTCGTPAYV---APEVISRRGYDGDKADIWSCGVILY 203
+L P + PE I R + ++D+WS GV+L+
Sbjct: 218 GRTML------P--IRWMPPESILYRKFT-TESDVWSFGVVLW 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 58/222 (26%)
Query: 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLIQHPN 71
L+G G F KVY L G VA+K + Q EI + +HP+
Sbjct: 45 FLIGHGVFGKVYKG-VLRDGAKVALKRRTPESS-------QGIEEFETEIETLSFCRHPH 96
Query: 72 V-------------MQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-------LK--ED 109
+ + IY+ M + ++ L+ L+
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGN-----LKRH----LYGSDLPTMSMSWEQRLEICIG 147
Query: 110 TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169
AR + + H+R + HRD+K N+LLDEN + K+TDFG+S K + H
Sbjct: 148 AAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTH 196
Query: 170 TT---CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG 208
+ GT Y+ PE +G +K+D++S GV+L+ +L
Sbjct: 197 LSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCA 237
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 69/387 (17%), Positives = 122/387 (31%), Gaps = 146/387 (37%)
Query: 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLV--DQTKREIS 62
G + +Y + R LG G+F+ V+ + + + VA+K ++K + EI
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEIR 85
Query: 63 VMRLIQ-----HPN---VMQIYEVMASKTKIYF------------VMEYAKGGE---LFK 99
+++ ++ PN V+Q+ + F V E G +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLD--------DFKISGVNGTHICMVFEVL--GHHLLKWI 135
Query: 100 KVSKGK-LKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLL--------------- 142
S + L +K QQ++ +D+ H++ + H D+KPEN+LL
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 143 ----------------------------------DENGMLKVTDFGLSALAKCKHQDGLL 168
E +K+ D G + +
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE--- 252
Query: 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH---------DSNLMA 219
T Y + EV+ GY+ ADIWS + + L G F D + +A
Sbjct: 253 --DIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309
Query: 220 MY---------RKIAKADY---------------KFPTWFSADVR--------------- 240
+ + I Y K W +V
Sbjct: 310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT 369
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFR 267
L +L+ P R + A+ + +PW
Sbjct: 370 DFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 43/242 (17%), Positives = 78/242 (32%), Gaps = 59/242 (24%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
++ LG+ +G G F +Y A + A + K + + G E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAK 92
Query: 70 PNVMQIYEVMASKTK------IYFVMEYAKGGE---------------LFKKVSKGKLKE 108
+ ++ + + KG + + G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKK 150
Query: 109 DTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT--DFGLSALAKCKHQDG 166
T + +++ +++ H H D+K NLLL +V D+GLS ++
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS----YRYCPN 206
Query: 167 LLHTT---------CGTPAY--------VAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209
H GT + VA SRR D+ G + L G
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVAL---SRRS------DVEILGYCMLRWLCGK 257
Query: 210 LP 211
LP
Sbjct: 258 LP 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 43/215 (20%)
Query: 17 LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQ-- 74
+LG+G F KVY R L G VA+K + +++ G Q + E+ ++ + H N+++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 75 -----------IYEVMASKTKIYFVMEYAKGGELF-----KKVSKGKLKEDTAR--KYFQ 116
+Y MA+ + + E + ++++ G +AR Y
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG-----SARGLAYLH 148
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CG 173
D C + + HRD+K N+LLDE V DFGL+ L H T G
Sbjct: 149 ------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRG 197
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG 208
T ++APE +S G +K D++ GV+L L+ G
Sbjct: 198 TIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 48/258 (18%), Positives = 87/258 (33%), Gaps = 59/258 (22%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+++G +GQG F +Y A + +SV A K+ E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 70 PNVMQIYEVMASKTKI------YFVMEYAKGGE---------------LFKKVSKGKLKE 108
P +Q + + + G +++ +K +
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-RFSR 151
Query: 109 DTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT--DFGLSALAKCKHQDG 166
T + +++ +++ H H D+K NLLL+ +V D+GL+ ++
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA----YRYCPE 207
Query: 167 LLHTT---------CGTPAY--------VAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209
+H GT + VAP SRRG D+ G + L G+
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAP---SRRG------DLEILGYCMIQWLTGH 258
Query: 210 LPFHD---SNLMAMYRKI 224
LP+ D KI
Sbjct: 259 LPWEDNLKDPKYVRDSKI 276
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 47/256 (18%), Positives = 80/256 (31%), Gaps = 55/256 (21%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTG--------QSVAIKAIDKDKIL--------KVGL 53
++++L + N +Y A T Q ++K KD L +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 54 VDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF-VMEYAKG---GELFKKVSKGKLKED 109
Q + + + + K F V+ G K L E
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 110 TARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT--DFGLSALAKC-----K 162
+ + +L+ A++F H H ++ EN+ +D +VT +G A K
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FAFRYCPSGK 216
Query: 163 H---QDGLLHTTCGTPAY--------VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP 211
H +G G + P SRR D+ S G + L G+LP
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGP---SRRS------DLQSLGYCMLKWLYGFLP 267
Query: 212 ---FHDSNLMAMYRKI 224
+ M +K
Sbjct: 268 WTNCLPNTEDIMKQKQ 283
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 8e-15
Identities = 31/192 (16%), Positives = 60/192 (31%), Gaps = 47/192 (24%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTK-----REISVM 64
+K + +G+G F +V+ VAIK I + V Q EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 65 RLIQ---------HPNVMQIYEV------------------------------MASKTKI 85
+ + + + V ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDE 144
+ V+E+ GG +++ TA+ QL +++ + HRDL N+LL +
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 145 NGMLKVTDFGLS 156
+ K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR----EISVMRLI- 67
+LG+ LG+G F +V A G ++ + + K+LK G R E+ ++ I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 68 QHPNVMQIYEVM-ASKTKIYFVMEYAKGGEL 97
H NV+ + + ++E+ K G L
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
Q+ ++F SR HRDL N+LL E ++K+ DFG LA+ ++D
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYVRKGDARL 257
Query: 177 YV---APEVISRRGYDGDKADIWSCGVILY 203
+ APE I R Y ++D+WS GV+L+
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 33/168 (19%), Positives = 57/168 (33%), Gaps = 27/168 (16%)
Query: 12 YELGRLLGQGNFAKVYYARHL--GTGQSVAIK-------AIDKDKILKVGLVDQTKREIS 62
+G ++ G A V+YA + G ++A+K DK G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 63 VMRLIQ------HPNVMQIYEVMASKTKIYF------VMEYAKGGELFK---KVSKGKLK 107
+ N+ + E S + Y +ME+ EL +LK
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 108 EDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFG 154
E F ++ + + + H DL N++ + + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 25/158 (15%), Positives = 55/158 (34%), Gaps = 27/158 (17%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKA---------------IDKDKILKVGLVDQ 56
+G+L+G+G + V+ +K D V +
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 57 TKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ 116
+ E ++ +Q V ++Y +ME EL++ ++ + +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYR------VRVENPDEVLD 200
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFG 154
++ + + RG+ H DL N+L+ + + DF
Sbjct: 201 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 66/439 (15%), Positives = 124/439 (28%), Gaps = 151/439 (34%)
Query: 11 KYELGRLLGQGNFAK-------VYYARHLGTGQSVAIKAID-KDKILKVGLVDQTKREIS 62
+ EL RLL + V A+ A + KIL + T R
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKA--------WNAFNLSCKIL----L--TTRFKQ 276
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK----------------- 105
V + I S T + K L K +
Sbjct: 277 VTDFLSAATTTHISLDHHSMT---LTPDEVK--SLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 106 -----LKEDTAR-KYFQQ-----LISAIDFCHS-------RGVYHR------DLK-PENL 140
+++ A ++ L + I+ + R ++ R P L
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 141 L-------LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKA 193
L + + M+ V +L + + ++ +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-----------------PS---- 430
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPST 253
+Y+ L N A++R I Y P + S L P
Sbjct: 431 --------IYLELKV----KLENEYALHRSIVDH-YNIP-------KTFDSDDLIPPY-- 468
Query: 254 RISIAKIMENPWFRK-GLNSKSAKSKTAIKESSLVDVDAAFGPIENSASTEAPRPMTKPD 312
++ ++ G + K+ + + +V +D F +E ++
Sbjct: 469 -------LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF--LEQKIRHDSTAWNASGS 519
Query: 313 NLNAFHIISLSSGFDL---SGFFVEHDQKEE------VKFTSKYSASVIISKLEDIARHL 363
LN L + ++D K E + F K ++I SK D+ L
Sbjct: 520 ILNTLQ--------QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL---L 568
Query: 364 KMKLTKKDGGLLKFEKSDK 382
++ L +D + FE++ K
Sbjct: 569 RIALMAEDEAI--FEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 36/252 (14%), Positives = 75/252 (29%), Gaps = 67/252 (26%)
Query: 100 KVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLK-PENLL-------LDENGMLKVT 151
+ S L+ RK F +L V+ P LL + + M+ V
Sbjct: 360 ESSLNVLEPAEYRKMFDRL----------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVN 409
Query: 152 DFGLSALAKCKHQDGL--LH-------TTCGTPAYVAPEVISR----RGYDG-DKADIWS 197
+L + + ++ + + ++ + +D D +
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469
Query: 198 CGVILYVLLAGYLPFHDSNL-----MAMYRKIAKADYKF---------PTWFS------- 236
Y ++ H N+ M ++R + D++F W +
Sbjct: 470 DQ---YF--YSHIGHHLKNIEHPERMTLFRMVF-LDFRFLEQKIRHDSTAWNASGSILNT 523
Query: 237 -ADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK-TAIKESSLVDVDAAFG 294
++ I D +P + I++ F + SK T + +L+ D
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILD---FLPKIEENLICSKYTDLLRIALMAED---E 577
Query: 295 PIENSASTEAPR 306
I A + R
Sbjct: 578 AIFEEAHKQVQR 589
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.6 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.57 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.2 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.2 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.44 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.86 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-68 Score=515.54 Aligned_cols=260 Identities=34% Similarity=0.663 Sum_probs=242.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+++|+.++|||||++++++.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999998776666667889999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||||+||+|++++.+ +.++|..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.........
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999976 789999999999999999999999999999999999999999999999999998665444445
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
...+.||||.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++....+.+|..+|+++++||.+|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 56678999999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHH------HhcCccccc
Q 045214 247 LDPNPSTRISIAK------IMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s~~e------il~hp~f~~ 268 (450)
|++||++|||++| |++||||+.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999988 689999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-67 Score=505.16 Aligned_cols=261 Identities=45% Similarity=0.851 Sum_probs=222.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+|+.+ ++|++++.||+|+||+||+|++..+|+.||||++++....+.....++.+|+.+|+.++|||||++++++.+++
T Consensus 8 ~G~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 8 DGAHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45544 78999999999999999999999999999999999877666666788999999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+||||+ +|+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999999999 6799998865 6899999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
.....+.+||+.|+|||++.+..|++.++|||||||++|+|++|..||.+.+...+++.+..+..++|..+|+++++|
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 233456799999999999999888888999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|.+||++||++|||++|+++||||+..
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-66 Score=507.65 Aligned_cols=259 Identities=29% Similarity=0.597 Sum_probs=228.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+++.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999998765433 3467889999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 89 MEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||+||+|.+++.. ..++|..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 999999999999954 357999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCCcHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLS 244 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~ 244 (450)
....+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+..+++.++..+.+ +.+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 123456899999999999988875 899999999999999999999999999999999888776 456779999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccccccCC
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
+||++||++|||++|+|+||||++...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-65 Score=502.23 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=231.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|++++.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999998664332 35678999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
||||+||+|.+++.++++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... .....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999875432 22345
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ll~~ 245 (450)
.+.|||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+..+..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999988885 899999999999999999999999998888888876533 2334589999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||++||++|||++|+|+||||++..
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-65 Score=491.88 Aligned_cols=255 Identities=34% Similarity=0.641 Sum_probs=226.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+.+|+.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999984 4688999999987654332 2346788999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+|||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999975432 22
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++.+....+|..+|+++++||.+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 344577999999999999988876 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCC-----HHHHhcCccccc
Q 045214 246 ILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
||++||++||| ++|+++||||+.
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 589999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=503.39 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=231.3
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++++.||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998764332 356789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 90 EYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
|||+||+|.+++..+++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ......
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccc
Confidence 999999999999989999999999999999999999999999999999999999999999999999875432 223456
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHc
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVRKLLSRI 246 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ll~~~ 246 (450)
+.|||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..... ..+..+|+++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 78999999999999988885 899999999999999999999999998888888876532 34456899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccccC
Q 045214 247 LDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
|+.||++|||++|+|+||||++..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-62 Score=501.55 Aligned_cols=405 Identities=33% Similarity=0.593 Sum_probs=315.8
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..|.+..++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35778899999999999999999999999999999999999876654445567899999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+.+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~- 167 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS- 167 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc-
Confidence 999999999999999999976 579999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (450)
......+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+
T Consensus 168 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 168 --DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp --TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred --ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 223445678999999999999887777899999999999999999999999998899999998888899999999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccccCCCccccch----------hhcccCc-c-----cccccc------CCCCC--
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK----------TAIKESS-L-----VDVDAA------FGPIE-- 297 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~~~~----------~~~~~~~-~-----~~~~~~------~~~~~-- 297 (450)
||.+||+.||.+|||++++++||||+........... ....+.. . .+.... ..+..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 325 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVA 325 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------------
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHH
Confidence 9999999999999999999999999865322110000 0000000 0 000000 00000
Q ss_pred ------C------------------------CCCCCCCCCC-----CCCCCCcHHHHhhhc--CCCCCCCccccccceee
Q 045214 298 ------N------------------------SASTEAPRPM-----TKPDNLNAFHIISLS--SGFDLSGFFVEHDQKEE 340 (450)
Q Consensus 298 ------~------------------------~~~~~~~~~~-----~~~~~~~~~~~~~~s--~~~~ls~~~~~~~~~~~ 340 (450)
+ ..+...|... ..|... .+.+ .+......+ .+..+++
T Consensus 326 y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~w~ 399 (476)
T 2y94_A 326 YHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRAR-----HTLDELNPQKSKHQG-VRKAKWH 399 (476)
T ss_dssp -------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCS-----TTCTTTSSSTTTCSC-CCCCCEE
T ss_pred HHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCccc-----ccccccccccccccc-cccceee
Confidence 0 0000000000 000000 0000 000011111 2345789
Q ss_pred eeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEecCCCcHHH
Q 045214 341 VKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEY 416 (450)
Q Consensus 341 ~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le~ 416 (450)
.++.|+..+.+||..|..+++.|||.|++.+...|++..........+.|.+++|++.++.+||||++..|+.++|
T Consensus 400 lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 400 LGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp ESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred ecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 9999999999999999999999999999888888988654433345677999999999999999999999999887
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-63 Score=475.01 Aligned_cols=256 Identities=24% Similarity=0.488 Sum_probs=221.8
Q ss_pred cccccCe-eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe---
Q 045214 6 KVLMQKY-ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--- 81 (450)
Q Consensus 6 ~~l~~~y-~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 81 (450)
....++| ++.+.||+|+||+||+|.+..+++.||+|++....... ...+++.+|+.+|+.++|||||++++++.+
T Consensus 21 ~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp ECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred cCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 3445677 78889999999999999999999999999998765433 345778999999999999999999999865
Q ss_pred -CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEec-CCCCeEEeecCch
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLD-ENGMLKVTDFGLS 156 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~-~~~~vkl~DFGls 156 (450)
+..+|+|||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+||||+ .+|.+||+|||+|
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 4568999999999999999976 68999999999999999999999999 99999999999998 4799999999999
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHHHHHhhcCC--CCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIAKADY--KFPT 233 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~p~ 233 (450)
+... .....+.+|||.|||||++.+ .| +.++|||||||+||+|+||..||.+. +...++..+..+.. .++.
T Consensus 180 ~~~~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 180 TLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp GGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred EeCC----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence 7532 334567799999999999865 46 48999999999999999999999764 45566666665543 2455
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..++++++||.+||++||++|||++|+|+||||++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 68899999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=479.99 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=220.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|+.++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35689999999999999999999999999999999875432 3799999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~~~ 166 (450)
||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 7899999999999999999999999999999999999999988 69999999997654322111
Q ss_pred ---CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHH
Q 045214 167 ---LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVR 240 (450)
Q Consensus 167 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 240 (450)
.....+||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+...++.++..... .+|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 12346899999999999988875 899999999999999999999998877777777776654 35778999999
Q ss_pred HHHHHccCCCCCCCCCHHHH-------------hcCccccc
Q 045214 241 KLLSRILDPNPSTRISIAKI-------------MENPWFRK 268 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~ei-------------l~hp~f~~ 268 (450)
+||.+||++||.+|||+.|+ ++|||+.+
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 99999999999999999998 56888865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-60 Score=479.01 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=223.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------ 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (450)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+++.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 456899999999999999999999999999999999765432 2345678899999999999999999999754
Q ss_pred CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+.+|+|||||+ |+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 579999876 689999999999999999999999999999999999999999999999999997543
Q ss_pred cc--cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC------
Q 045214 161 CK--HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP------ 232 (450)
Q Consensus 161 ~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p------ 232 (450)
.. .......+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+..+.+..|......++
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 1233455779999999999998877777999999999999999999999999988888777754322111
Q ss_pred -------------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 -------------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 -------------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.+|+++.+||.+||++||++|||++|+|+||||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 2368899999999999999999999999999999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=491.98 Aligned_cols=259 Identities=29% Similarity=0.519 Sum_probs=228.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHH---HHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT---KREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
.+-+++|++++.||+|+||+||+|+++.+|+.||||++++...........+ ++++.+++.++|||||++++++.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 3456789999999999999999999999999999999987665433333333 3446677788999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+.+|+||||++||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~- 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC-
Confidence 999999999999999999976 789999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHHhhcCCCCCCCCcHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKIAKADYKFPTWFSAD 238 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~ 238 (450)
.....+.||||.|||||++.+...++.++|||||||+||+|++|..||.+. +...+...+......+|..+|++
T Consensus 344 ---~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 ---KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp ---SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ---CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 233567899999999999975443458999999999999999999999764 34567778888888999999999
Q ss_pred HHHHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
+++||.+||+.||.+|++ ++||++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 799999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-59 Score=461.96 Aligned_cols=254 Identities=25% Similarity=0.462 Sum_probs=210.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+++|+.+ +||||+++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 6789999999999999999999975 467899999986543 235678999999988 6999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFGls~~~~~~ 162 (450)
++|+||||++||+|.+++. .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999999999995 59999999999999999999999999999999999999876 79999999998643211
Q ss_pred c--------------------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-
Q 045214 163 H--------------------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS- 215 (450)
Q Consensus 163 ~--------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~- 215 (450)
. ......+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 1112345689999999999988776679999999999999999999999643
Q ss_pred cHHHHHHHHhh--------------------------------------cCC----------------CCCCCCcHHHHH
Q 045214 216 NLMAMYRKIAK--------------------------------------ADY----------------KFPTWFSADVRK 241 (450)
Q Consensus 216 ~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~~ 241 (450)
+..+.+..|.. ... .....+|++++|
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333332211 000 111247899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
||.+||++||++|+|++|+|+||||++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-59 Score=451.09 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=201.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT----- 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (450)
.+.|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 456999999999999999999999999999999997654 2234567899999999999999999999986544
Q ss_pred -------EEEEEEeecCCCChhhHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 84 -------KIYFVMEYAKGGELFKKVSKG-K---LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 84 -------~~~lv~E~~~gg~L~~~i~~~-~---l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
.+|+|||||+||+|.+++... . .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 479999999999999999763 2 45667899999999999999999999999999999999999999999
Q ss_pred cCchhhhhcccCC----------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHH
Q 045214 153 FGLSALAKCKHQD----------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMY 221 (450)
Q Consensus 153 FGls~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~ 221 (450)
||+|+........ ....+.+||+.|||||++.+..|+ .++|||||||++|+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999765432221 112346899999999999988875 89999999999999996 8865322 2333
Q ss_pred HHHhhcCCCCCC---CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 222 RKIAKADYKFPT---WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 222 ~~i~~~~~~~p~---~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+... .+|+ ..++++.+||.+||++||++|||+.|+++||||+.
T Consensus 238 ~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333333 3443 24677899999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=483.35 Aligned_cols=261 Identities=29% Similarity=0.555 Sum_probs=235.2
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.+.+.++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ..+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 152 ~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred CCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 345678999999999999999999999999999999999765432 34678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC--CCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN--GMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~--~~vkl~DFGls~~~~ 160 (450)
+|+|||||+||+|++++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999954 579999999999999999999999999999999999999854 899999999997543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCc
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFS 236 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (450)
......+.|||+.|||||++.+.+|. .++|||||||+||+|++|..||.+.+..+.+..+....+.++ ..+|
T Consensus 309 ---~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 309 ---PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp ---TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred ---CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC
Confidence 23345677999999999999998875 899999999999999999999999999999999988877665 3589
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 999999999999999999999999999999876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=446.31 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=221.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.++|.+.+.||+|+||+||+|++. .++..||||+++... ....+++.+|+++|++++|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 457999999999999999999875 357889999997543 234578899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeE
Q 045214 84 KIYFVMEYAKGGELFKKVSK--------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLK 149 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vk 149 (450)
.+|+|||||+||+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||||+.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 99999999999999999964 2599999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD 228 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 228 (450)
|+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865443332233445799999999999988875 89999999999999998 999999999888888887765
Q ss_pred -CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+.|..+|+++.+|+.+||+.||++|||+++|+ +|+++
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 467888999999999999999999999999994 57653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=445.70 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=212.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
++|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+++.+|+.+|++++|||||++++++.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46889999999999999999865 368899999997543 2345788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCe
Q 045214 85 IYFVMEYAKGGELFKKVSK----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~v 148 (450)
+|+|||||+||+|.+++.+ +++++.++..++.|++.||+|||+++|+||||||+||||+.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 9999999999999999854 358999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 227 (450)
||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..+....+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999765443333334457899999999999988775 89999999999999999 99999998888888887665
Q ss_pred -CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 228 -DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 228 -~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+.|..+++++.+|+.+||+.||++|||++||++
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 46678889999999999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=439.57 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=222.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
+-.+.+++.+.||+|+||+||+|+.. .+++.||||+++... .....+++.+|+.++++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34567899999999999999999864 367899999997543 22446789999999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE 144 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~ 144 (450)
++.+|+|||||++|+|.+++.. +.+++..+..++.|++.||+|||+++|+||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999843 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHH
Q 045214 145 NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRK 223 (450)
Q Consensus 145 ~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 223 (450)
++.+||+|||+|+..............+||+.|||||++.+..|+ .++||||+||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999866544444445567899999999999988775 89999999999999998 8999999988888888
Q ss_pred HhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 224 IAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 224 i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+..+. .+.|+.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87654 45788899999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=438.68 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=203.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+++++++.||+|+||+||+|+.. ..||||+++..... ....+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 457889999999999999999864 35999999754432 2446789999999999999999999998754 568999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||+||+|.+++.. +++++..+..++.|++.||+|||++||+||||||+||||++++.+||+|||+|+.........
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999964 579999999999999999999999999999999999999999999999999997654433334
Q ss_pred CcccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------CCCCCCcHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------KFPTWFSAD 238 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------~~p~~~s~~ 238 (450)
...+.+||+.|||||++.+.. .++.++|||||||+||||+||..||.+.+.......+..... ..+..+|++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 455679999999999996432 234799999999999999999999998665444433333322 234568899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+.+|+.+||+.||++|||+.||+++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=434.16 Aligned_cols=261 Identities=41% Similarity=0.803 Sum_probs=239.6
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.....++|++.+.||+|+||.||+|++..+|+.||||++.+.... ....+++.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 345678999999999999999999999999999999999876543 2345778899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||||++||+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999999999865 7899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+.......+..+....|..+++++.+||
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2345567899999999999988887789999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+||+.||.+|||++|+++||||+..
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-55 Score=432.99 Aligned_cols=261 Identities=34% Similarity=0.669 Sum_probs=231.4
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
..+-.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999877655555667788999999988 7999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999999999976 6899999999999999999999999999999999999999999999999999864221
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++.++......+|.++++++.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 22234567899999999999887774 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCH------HHHhcCccccc
Q 045214 243 LSRILDPNPSTRISI------AKIMENPWFRK 268 (450)
Q Consensus 243 l~~~L~~dP~~R~s~------~eil~hp~f~~ 268 (450)
|.+||+.||.+||++ +++++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=426.02 Aligned_cols=259 Identities=35% Similarity=0.655 Sum_probs=236.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34689999999999999999999999999999999998765544455678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~--~~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC--CTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc--cCC
Confidence 99999999999999976 689999999999999999999999999999999999999999999999999986422 122
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 334567899999999999887774 8999999999999999999999999999999999989999999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 045214 246 ILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
||+.||.+|| +++|+++||||+.
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 9999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=435.37 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=214.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCccEEEEEEEe-
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH-PNVMQIYEVMAS- 81 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~- 81 (450)
.++|++++.||+|+||+||+|++..+ ++.||||.+...... ...+.+.+|+.+|+.++| ||||++++++..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 36899999999999999999998654 368999999765432 335678999999999965 899999999865
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE 144 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~ 144 (450)
++.+|+|||||+||+|.+++.. ..+++..+..|+.|++.||+|||+++|+||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 4679999999999999999853 24889999999999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcH-HHHHH
Q 045214 145 NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNL-MAMYR 222 (450)
Q Consensus 145 ~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~-~~~~~ 222 (450)
++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+. ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999755332222223456899999999999988775 89999999999999998 9999998654 34445
Q ss_pred HHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 223 KIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 223 ~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+..+ ..+.|..+++++.+|+.+||+.||++|||++||++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55443 456788899999999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=431.33 Aligned_cols=260 Identities=42% Similarity=0.826 Sum_probs=233.8
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999999876554444456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+ +|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 6789888854 7899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++......+|..+|+++.+||.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 23345678999999999999888767899999999999999999999998776666666666777888999999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccc
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||++||.+|||++|+++||||+..
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=419.04 Aligned_cols=256 Identities=36% Similarity=0.757 Sum_probs=236.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-.++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765544455678889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 99999999999999976 579999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++......+|+.+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 223467899999999999887775 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 045214 246 ILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
||+.||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-54 Score=424.26 Aligned_cols=260 Identities=34% Similarity=0.664 Sum_probs=235.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
.+-.++|++.+.||+|+||.||+|++..+|+.||||++++...........+.+|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876554444567788999999877 99999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
......+.+||+.|+|||++.+..+. .++|+|||||++|+|++|..||.+.+...++..+......+|.++++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 22334567899999999999887774 89999999999999999999999999999999999998899999999999999
Q ss_pred HHccCCCCCCCCCHH-HHhcCccccc
Q 045214 244 SRILDPNPSTRISIA-KIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~-eil~hp~f~~ 268 (450)
.+||+.||++||++. ++++||||+.
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999998 9999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=421.88 Aligned_cols=261 Identities=30% Similarity=0.576 Sum_probs=234.0
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
+...+.++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 345688899999999999999999999999999999999987654321 23577899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCc
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGL 155 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGl 155 (450)
+.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999999976 5799999999999999999999999999999999999998877 799999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC---
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP--- 232 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (450)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+....+.++
T Consensus 166 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 865432 223456789999999999988776 4899999999999999999999999999999999988877765
Q ss_pred -CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 -TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 -~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++++++||.+||.+||.+|||++|+++||||+.
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 458999999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=421.28 Aligned_cols=257 Identities=33% Similarity=0.698 Sum_probs=237.8
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999877655555667889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999865421
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++..+...+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23456899999999999887775 899999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCC-----HHHHhcCccccc
Q 045214 245 RILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 245 ~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
+||+.||.+||+ ++++++||||+.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=421.52 Aligned_cols=260 Identities=30% Similarity=0.584 Sum_probs=235.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
.+-.++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999887654445567788999999988 89999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.... .
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--W 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--C
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc--c
Confidence 9999999999999999976 789999999999999999999999999999999999999999999999999986422 1
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
......+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...++.++......+|..+++++.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 22234567899999999999887774 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 244 SRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
.+||..||.+||+ ++++++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999995 699999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=427.05 Aligned_cols=259 Identities=30% Similarity=0.586 Sum_probs=229.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+-.++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4467899999999999999999999999999999999887655444456688999999877 899999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RP 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--CT
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--cC
Confidence 999999999999999976 689999999999999999999999999999999999999999999999999986421 22
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---------cHHHHHHHHhhcCCCCCCCC
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---------NLMAMYRKIAKADYKFPTWF 235 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~ 235 (450)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....+++.+......+|..+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 3345677999999999999988774 8999999999999999999999632 23456778888889999999
Q ss_pred cHHHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISI------AKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~------~eil~hp~f~~ 268 (450)
++++.+||.+||+.||.+||++ +|+++||||+.
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999985 89999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=417.64 Aligned_cols=263 Identities=34% Similarity=0.663 Sum_probs=225.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++++.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3788999999999999999999999999999999999765432 22356789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++|++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999976 47999999999999999999999999999999999999999999999999999765444333
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCCCCC--CCCcHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFP--TWFSADVRKL 242 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 242 (450)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 44556789999999999988877667899999999999999999999875543 33444443333333 4589999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
|.+||+.||.+|||++|+++||||++...
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=416.73 Aligned_cols=260 Identities=30% Similarity=0.595 Sum_probs=232.5
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
.+-.++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34567899999999999999999999999999999999887655555667788999999988 89999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~--~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--R 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC--C
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc--C
Confidence 9999999999999999976 689999999999999999999999999999999999999999999999999986422 1
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC---------CcHHHHHHHHhhcCCCCCCC
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD---------SNLMAMYRKIAKADYKFPTW 234 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~p~~ 234 (450)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .....+++.+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2233456789999999999988777 4899999999999999999999975 23455677788888889999
Q ss_pred CcHHHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISI------AKIMENPWFRK 268 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~------~eil~hp~f~~ 268 (450)
+++++.+||.+||+.||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=406.23 Aligned_cols=256 Identities=31% Similarity=0.504 Sum_probs=227.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 567899999999999999999999999999999999765432 24678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||||++||+|.+++....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--ccc
Confidence 999999999999999888999999999999999999999999999999999999999999999999998654322 223
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~ 244 (450)
....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+... ....|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 3456899999999999888774 8999999999999999999999988776655555433 23456678999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccc
Q 045214 245 RILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||++||++|||++|+++||||+..
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=417.91 Aligned_cols=261 Identities=34% Similarity=0.674 Sum_probs=231.4
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..+..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp --CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 345567789999999999999999999999999999999998765432 3456788999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSAL 158 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~ 158 (450)
+..|+||||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999999999875 5799999999999999999999999999999999999998654 599999999865
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----C
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----W 234 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~ 234 (450)
... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|. .
T Consensus 181 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 181 VND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp CTT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred ecC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 432 2234457899999999999887765 8999999999999999999999999988888888887776653 4
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+++++.+||.+||++||.+|||+.++++||||..
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 7999999999999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=420.32 Aligned_cols=263 Identities=28% Similarity=0.557 Sum_probs=235.9
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..+.+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45677889999999999999999999999999999999999877655555678889999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 166 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP- 166 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc-
Confidence 999999999999999999986 579999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCcccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCC---CcHHHHHHHHhhcCCCCCCCCc
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHD---SNLMAMYRKIAKADYKFPTWFS 236 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s 236 (450)
......+.+||+.|+|||++.... ..+.++|||||||++|+|++|..||.. ......+..+......+|..++
T Consensus 167 --~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 167 --RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp --TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred --CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 233445678999999999997422 235899999999999999999999974 3455677777788888999999
Q ss_pred HHHHHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 045214 237 ADVRKLLSRILDPNPSTRIS-IAKIMENPWFRK 268 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s-~~eil~hp~f~~ 268 (450)
+++.+||.+||++||.+||+ ++++++||||+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=423.82 Aligned_cols=262 Identities=32% Similarity=0.562 Sum_probs=230.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998755433333456789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+||||++||+|.+++.+..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....... ..
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999986533211 11
Q ss_pred CcccccCCCcccCchhcccCC---CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCC--CCCcHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRG---YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFP--TWFSADV 239 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~ 239 (450)
...+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+| ..+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234678999999999998655 13589999999999999999999999999988888886542 4444 4689999
Q ss_pred HHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPST--RISIAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~--R~s~~eil~hp~f~~~ 269 (450)
++||.+||..+|.+ |++++||++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=418.37 Aligned_cols=260 Identities=32% Similarity=0.576 Sum_probs=226.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV-MRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 84 (450)
....++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3556789999999999999999999999999999999988766544445666777776 577899999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~--~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--E 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB--C
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc--c
Confidence 9999999999999999976 689999999999999999999999999999999999999999999999999987432 1
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
......+.+||+.|+|||++.+..|. .++|+|||||++|+|++|..||.+.+..+++.++......+|+.++.++++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 22345567999999999999887765 89999999999999999999999999999999999998899999999999999
Q ss_pred HHccCCCCCCCCCH----HHHhcCccccc
Q 045214 244 SRILDPNPSTRISI----AKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s~----~eil~hp~f~~ 268 (450)
.+||+.||.+||++ +++++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999986 69999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=410.67 Aligned_cols=255 Identities=25% Similarity=0.488 Sum_probs=229.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 36789999999999999999999999999999999997543 23456889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC--CCCeEEeecCchhhhhcc
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE--NGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~--~~~vkl~DFGls~~~~~~ 162 (450)
+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 99999999999999976 36999999999999999999999999999999999999987 78999999999865432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 238 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++. .+|++
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 223345679999999999987655 48999999999999999999999999988888888888777663 58999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.+||.+||.+||.+|||+.|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=426.23 Aligned_cols=261 Identities=33% Similarity=0.668 Sum_probs=230.7
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.+..+.++|++++.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 35678899999999999999999999999999999999998765432 33567899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec---CCCCeEEeecCchhhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD---ENGMLKVTDFGLSALA 159 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~---~~~~vkl~DFGls~~~ 159 (450)
..|+||||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999998865 6799999999999999999999999999999999999998 4678999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CC
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WF 235 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 235 (450)
.. ........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+..+...+|. .+
T Consensus 164 ~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 164 EG--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CT--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cC--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 32 22233457899999999999887774 8999999999999999999999999999999999888776653 47
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=405.14 Aligned_cols=262 Identities=35% Similarity=0.680 Sum_probs=223.5
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----------------------chHHHHHHHH
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----------------------GLVDQTKREI 61 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----------------------~~~~~~~~Ei 61 (450)
+.+..++|++.+.||+|+||.||+|++..+++.||||++.+...... ...+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 34667899999999999999999999999999999999986543211 1235688999
Q ss_pred HHHHhCCCCCccEEEEEEEe--CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 045214 62 SVMRLIQHPNVMQIYEVMAS--KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPEN 139 (450)
Q Consensus 62 ~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~N 139 (450)
.+++.++||||+++++++.+ .+.+|+||||+++++|.+++..+.+++..++.++.|++.||+|||++||+||||||+|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999999986 6789999999999999998877889999999999999999999999999999999999
Q ss_pred EEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCC--CCCccchhhHHHHHHHHhhCCCCCCCCcH
Q 045214 140 LLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY--DGDKADIWSCGVILYVLLAGYLPFHDSNL 217 (450)
Q Consensus 140 ILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~ 217 (450)
||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999865432 1223345689999999999976542 35789999999999999999999999888
Q ss_pred HHHHHHHhhcCCCCC--CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 218 MAMYRKIAKADYKFP--TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 218 ~~~~~~i~~~~~~~p--~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
......+......+| +.+++++.+||.+||++||++|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 888777777666555 458999999999999999999999999999999963
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=414.19 Aligned_cols=263 Identities=30% Similarity=0.621 Sum_probs=225.1
Q ss_pred cccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc--chHHHHHHHHHHHHhCCCCCccEEEEEE
Q 045214 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV--GLVDQTKREISVMRLIQHPNVMQIYEVM 79 (450)
Q Consensus 2 ~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (450)
...+..+.++|++.+.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 16 ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp ----CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34456778899999999999999999999999999999999976543221 2357789999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---eEEe
Q 045214 80 ASKTKIYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---LKVT 151 (450)
Q Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~---vkl~ 151 (450)
.+.+.+|+||||++|++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 999999999999999999887753 24899999999999999999999999999999999999987665 9999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF 231 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 231 (450)
|||++...... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+ ...+..+.......
T Consensus 176 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 176 GFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp CCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred cCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99998654321 2223456899999999999887764 89999999999999999999998754 45666666666655
Q ss_pred C----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 232 P----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 232 p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+ ..+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 4 358999999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=426.18 Aligned_cols=262 Identities=28% Similarity=0.514 Sum_probs=227.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998755443333455789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence 99999999999999976 68999999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCCcccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCCCC---C
Q 045214 165 DGLLHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFPTW---F 235 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 235 (450)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+..+.+.++... .+.+|.. +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 112234689999999999972 233358999999999999999999999999998888888643 3555554 8
Q ss_pred cHHHHHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 045214 236 SADVRKLLSRILDPNPST--RISIAKIMENPWFRKG 269 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~--R~s~~eil~hp~f~~~ 269 (450)
|+++++||.+||..+|++ |++++|+++||||+..
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 999999999999998888 9999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=406.22 Aligned_cols=260 Identities=32% Similarity=0.588 Sum_probs=230.8
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567889999999999999999999999999999999987543221 2357789999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCchh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGLSA 157 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGls~ 157 (450)
+..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999976 5799999999999999999999999999999999999999887 89999999986
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----C
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----T 233 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (450)
.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......++ .
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 5432 2223456899999999999877664 899999999999999999999999888888888877766655 4
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+++++.+||.+||++||.+|||++|+++||||+..
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 578999999999999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=396.64 Aligned_cols=265 Identities=44% Similarity=0.836 Sum_probs=230.7
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..|.+..++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 46788999999999999999999999999999999999999876554445567889999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999975 6899999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (450)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+....+..+.......|..++.++.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22234567999999999998877656799999999999999999999999888888888888888889999999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+|.+||+.||.+|||++++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=408.90 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=196.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----E
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT----K 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (450)
..+|.+.+.||+|+||+||+|++ +|+.||||+++..... ....++|+..+..++|||||++++++.+++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46799999999999999999988 6899999999754321 123345777778899999999999987653 6
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR--------GVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+||||||++||+|.+++.+.+++++.+..++.|++.||+|||++ ||+||||||+||||+.++.+||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999998999999999999999999999987 9999999999999999999999999998
Q ss_pred hhhhcccC--CCCcccccCCCcccCchhcccCCC-----CCCccchhhHHHHHHHHhhCCCCCCCC--------------
Q 045214 157 ALAKCKHQ--DGLLHTTCGTPAYVAPEVISRRGY-----DGDKADIWSCGVILYVLLAGYLPFHDS-------------- 215 (450)
Q Consensus 157 ~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~-------------- 215 (450)
+....... .......+||+.|||||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 75432221 112234689999999999976421 236899999999999999997665321
Q ss_pred -cHHHHHHHHhhcCC--CCCCC-----CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 216 -NLMAMYRKIAKADY--KFPTW-----FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 216 -~~~~~~~~i~~~~~--~~p~~-----~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....+...+..... .+|.. .+..+.+|+.+||+.||++|||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22344444433332 33332 2246889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=406.78 Aligned_cols=261 Identities=34% Similarity=0.655 Sum_probs=223.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILK-VGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
..+..++|++.+.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3566789999999999999999999986 589999999998764322 223456789999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
+.+.+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999975 67999999999999999999999999999999999999999999999999998643
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHH
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......+|+.+++++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 172 IH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred cc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 22 1223445689999999999987776 48999999999999999999999999988888999888899999999999
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 240 RKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.+||.+||+.||.+|| +++++++||||+.
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999999999 8999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=426.60 Aligned_cols=260 Identities=36% Similarity=0.650 Sum_probs=225.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 35578899999999999999999999999999999999876544444556778999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 999999999999999876 679999999999999999999998 9999999999999999999999999999864321
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22234567899999999999887774 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 244 SRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
.+||++||.+|| |++|+++||||+.
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=397.07 Aligned_cols=261 Identities=36% Similarity=0.731 Sum_probs=234.1
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+.....++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 34567789999999999999999999999999999999998765554455678899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
..|+||||+++++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999999999876 6899999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKL 242 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (450)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+......+|..+++++.+|
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 22335579999999999987665 48999999999999999999999999999999999888889999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|.+||++||.+|||++|+++||||+..
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=411.75 Aligned_cols=257 Identities=41% Similarity=0.730 Sum_probs=215.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++.+.||+|+||.||+|++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3467999999999999999999999999999999999765432 256789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC--eEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--LKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--vkl~DFGls~~~~~~~ 163 (450)
+||||++||+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999999999865 68999999999999999999999999999999999999987765 99999999864321
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCCC--CCcH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFPT--WFSA 237 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~ 237 (450)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+. ......+......+|. .+++
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22234567999999999998888876669999999999999999999987433 4555556666666655 4799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++.+||.+||++||.+|||++|+++||||.+..
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 999999999999999999999999999997654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=397.36 Aligned_cols=257 Identities=31% Similarity=0.506 Sum_probs=217.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 46899999999999999999999999999999999876532 34457788999999999999999999999999999999
Q ss_pred EeecCCCChhhHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKV-S-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i-~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++| +|.+.+ . .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 455554 3 36899999999999999999999999999999999999999999999999999865432 222
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCC-CCCCcHHHHHHHHhhcCC----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAKADY---------------- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~~~---------------- 229 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..| |...+.......+.....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 334568999999999998777556999999999999999988777 555665555555533110
Q ss_pred -------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 -------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 -------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..++.+++++++||.+||++||++|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123478899999999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=403.07 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=216.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.+..+.++|++++.||+|+||.||+|++. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 46678999999999999999999999995 589999999976543 2344577889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+|+||||++| +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999986 78777765 3599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-C----------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-K---------- 230 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~---------- 230 (450)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..... +
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 2 22334567999999999998755556899999999999999999999988665554444432100 0
Q ss_pred -------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 -------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 -------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+.+++++.+||.+||++||++|||++|+++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 11236789999999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=393.06 Aligned_cols=259 Identities=36% Similarity=0.738 Sum_probs=235.2
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.....++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 45667899999999999999999999999999999999987655444556788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
.|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 9999999999999999875 6899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLL 243 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll 243 (450)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+......+|..++.++.++|
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred --cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence 223456799999999999887664 89999999999999999999999988888888888888889999999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+||+.||.+|||++++++||||+.
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 9999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=393.95 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=214.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||.||+|++ .+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 67999999999765432 23346778999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+++ +|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 89888865 57999999999999999999999999999999999999999999999999998765322 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------------- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 234557899999999997765556899999999999999999999998877665555432100
Q ss_pred ------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 ------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 ------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.++..+++++.+||.+||++||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347899999999999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=414.27 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=212.6
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKT 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (450)
+..+.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+..+|+.+++.+. ||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 45678999999999999999999999999999999999865432 2234567789999999997 999999999997544
Q ss_pred --EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 --KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 --~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+|+||||++| +|.+.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 79999999984 899999888999999999999999999999999999999999999999999999999999865422
Q ss_pred c-------------------cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH
Q 045214 162 K-------------------HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222 (450)
Q Consensus 162 ~-------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 222 (450)
. .........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 111223456899999999999875555689999999999999999999999988776666
Q ss_pred HHhhcCC-----------------------------------------------CCCCCCcHHHHHHHHHccCCCCCCCC
Q 045214 223 KIAKADY-----------------------------------------------KFPTWFSADVRKLLSRILDPNPSTRI 255 (450)
Q Consensus 223 ~i~~~~~-----------------------------------------------~~p~~~s~~~~~ll~~~L~~dP~~R~ 255 (450)
.+..... ..+..+++++.+||.+||+.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 5542110 01124688999999999999999999
Q ss_pred CHHHHhcCcccccc
Q 045214 256 SIAKIMENPWFRKG 269 (450)
Q Consensus 256 s~~eil~hp~f~~~ 269 (450)
|++|+++||||+..
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=425.09 Aligned_cols=261 Identities=34% Similarity=0.645 Sum_probs=234.0
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.+..+.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678889999999999999999999999999999999998776554455788999999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALA 159 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~ 159 (450)
.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998865 689999999999999999999999999999999999999 56789999999998754
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCC
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWF 235 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 235 (450)
.. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+.++ ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EA---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CC---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 32 233455689999999999876 44 5899999999999999999999999999898888888766543 348
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|+++++||.+||++||.+|||++|+++||||+..
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=387.93 Aligned_cols=259 Identities=34% Similarity=0.674 Sum_probs=230.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 567899999999999999999999999999999999998765432 3456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---eEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---LKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~---vkl~DFGls~~~~~ 161 (450)
|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888865 67999999999999999999999999999999999999987665 99999999864432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (450)
........||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+.......| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2223456799999999999887764 899999999999999999999999988888888877766555 35789
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++.+||.+||++||++|||++|+++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=406.64 Aligned_cols=255 Identities=33% Similarity=0.639 Sum_probs=221.5
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ..+|+.++.++ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 4456788999999999999999999999999999999999875422 24688888877 799999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-C---CeEEeecCchh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-G---MLKVTDFGLSA 157 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~---~vkl~DFGls~ 157 (450)
+.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999999876 579999999999999999999999999999999999998543 3 49999999987
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC---CcHHHHHHHHhhcCCCCC--
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD---SNLMAMYRKIAKADYKFP-- 232 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~p-- 232 (450)
.... ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.. .+..++...+..+.+.++
T Consensus 169 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 169 QLRA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ECBC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred cCcC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 5432 22344567899999999999877664 799999999999999999999986 456677788887777655
Q ss_pred --CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 --TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 --~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+|+++.+||.+||.+||++|||++++++||||..
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 458999999999999999999999999999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=410.18 Aligned_cols=259 Identities=22% Similarity=0.393 Sum_probs=217.0
Q ss_pred ccCeeeeceEeec--CCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 9 MQKYELGRLLGQG--NFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.++|++++.||+| +||.||+|++..+++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 5689999999999 9999999999999999999999876543 245677889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999999999865 579999999999999999999999999999999999999999999999999875332111
Q ss_pred -----CCCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--------
Q 045214 164 -----QDGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------- 228 (450)
Q Consensus 164 -----~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 228 (450)
........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1122234589999999999987 344 589999999999999999999998765443332222111
Q ss_pred --------------------------------------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 229 --------------------------------------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 229 --------------------------------------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+.+..+++++.+||.+||++||++|||++|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 12345578999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=416.68 Aligned_cols=261 Identities=30% Similarity=0.508 Sum_probs=225.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+.+|..++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 44678999999999999999999999999999999998755433344456789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++||+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 99999999999999976 379999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCcccccCCCcccCchhccc------CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CCCCC---C
Q 045214 165 DGLLHTTCGTPAYVAPEVISR------RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DYKFP---T 233 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p---~ 233 (450)
.......+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+.++... ...+| .
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 111234689999999999973 122358999999999999999999999999988888887653 23444 5
Q ss_pred CCcHHHHHHHHHccCCCCCCC---CCHHHHhcCcccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTR---ISIAKIMENPWFRKG 269 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R---~s~~eil~hp~f~~~ 269 (450)
.+|+++++||.+||. +|.+| ++++|+++||||+.-
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 699999999999999 99998 599999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=427.20 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=232.5
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 45667899999999999999999999999999999999876655445567788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 86 YFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~-- 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-- 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--
Confidence 9999999999999998752 49999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc----HHHHHHHHhhcCCCCCCCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKADYKFPTWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~ 238 (450)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+ ...+...+......+|..+|++
T Consensus 338 -~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 -EGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp -TTCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred -cCccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 22234456899999999999887765 89999999999999999999998753 4567777777778888999999
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
+++||.+||+.||.+|| +++|+++||||+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 8999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=388.33 Aligned_cols=257 Identities=38% Similarity=0.675 Sum_probs=230.1
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
..+.++|++.+.||+|+||.||+|.+..++..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 34778999999999999999999999999999999999765432 356789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~~~ 161 (450)
|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999999998865 679999999999999999999999999999999999999 7889999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 237 (450)
........||+.|+|||++.+. .+.++||||||+++|+|++|..||...+.......+......+|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2334556899999999998654 458999999999999999999999999888888888888777765 5899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++.+||.+||++||.+|||+.++++||||++..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.12 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=213.3
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCC---CCCccEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQ---HPNVMQIYEVM 79 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 79 (450)
|+++.++|++.+.||+|+||+||+|++..+++.||+|++...... .........+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 678899999999999999999999999999999999999754321 1122345667888777664 99999999999
Q ss_pred EeCC-----EEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEe
Q 045214 80 ASKT-----KIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 80 ~~~~-----~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~ 151 (450)
.... .+|+||||+.| +|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 7765 68999999975 999998763 39999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK- 230 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~- 230 (450)
|||+|..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+......++......
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999875432 2234566899999999999887764 8999999999999999999999998887776666432110
Q ss_pred --------------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 --------------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 --------------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+.+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012468899999999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=420.86 Aligned_cols=263 Identities=33% Similarity=0.629 Sum_probs=229.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc----------chHHHHHHHHHHHHhCCCCCcc
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV----------GLVDQTKREISVMRLIQHPNVM 73 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv 73 (450)
.+..+.++|++++.||+|+||+||+|++..+++.||+|++.+...... ...+.+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 345678899999999999999999999999999999999987653321 3457789999999999999999
Q ss_pred EEEEEEEeCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeE
Q 045214 74 QIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLK 149 (450)
Q Consensus 74 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vk 149 (450)
++++++.+...+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999999998865 6899999999999999999999999999999999999999876 699
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY 229 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 229 (450)
|+|||+|..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+..+.+
T Consensus 190 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp ECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999875432 223456689999999999874 45 5899999999999999999999999999999999988877
Q ss_pred CCC----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 230 KFP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 230 ~~p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.++ ..+|+++++||.+||++||.+|||++|+|+||||++...
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 665 458999999999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=406.77 Aligned_cols=257 Identities=26% Similarity=0.552 Sum_probs=227.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 4568999999999999999999999999999999999765422 2357889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC--CCCeEEeecCchhhhhcc
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE--NGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~--~~~vkl~DFGls~~~~~~ 162 (450)
+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~-- 202 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 202 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC--
Confidence 99999999999999975 36999999999999999999999999999999999999974 4679999999986543
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (450)
........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......++ ..++++
T Consensus 203 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 203 -PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp -TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred -CCcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 22334456899999999999887664 899999999999999999999999888888888877765544 357999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+.+||.+||+.||.+|||++|+++||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=391.96 Aligned_cols=259 Identities=34% Similarity=0.714 Sum_probs=207.4
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 34679999999999999999999999999999999987655444556788999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999999976 479999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 12234679999999999987665 48999999999999999999999987766666666666777888899999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccc
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||+.||++|||++++++||||...
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=390.09 Aligned_cols=261 Identities=31% Similarity=0.568 Sum_probs=236.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998776555555678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++|++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999876 67999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+.+..+.......|..+++++.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22345679999999999987766 48999999999999999999999999888888888888888899999999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||+.||++|||++++++||||....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=437.02 Aligned_cols=259 Identities=31% Similarity=0.585 Sum_probs=236.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
+-.++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||+|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999876554445567788999999987 799999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|..... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999864221 2
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~ 244 (450)
.....+.+||+.|+|||++.+..|. .++|||||||+||+|++|..||.+.+..++++.+......+|..+++++.+||.
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 2334567999999999999888774 899999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCCH-----HHHhcCccccc
Q 045214 245 RILDPNPSTRISI-----AKIMENPWFRK 268 (450)
Q Consensus 245 ~~L~~dP~~R~s~-----~eil~hp~f~~ 268 (450)
+||+.||.+||++ +||++||||+.
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999997 99999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=399.72 Aligned_cols=258 Identities=29% Similarity=0.495 Sum_probs=206.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 46899999999999999999999999999999999765422 2346778999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 89 MEYAKGGELFKKVSK-------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
|||++| +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 89888853 2589999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------ 229 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------ 229 (450)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 P--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred C--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 2 22334568999999999998755456899999999999999999999999887766665533100
Q ss_pred ----------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 230 ----------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 230 ----------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
..+..+++++.+||.+||++||++|||++|+++||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 012246889999999999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=397.57 Aligned_cols=262 Identities=31% Similarity=0.566 Sum_probs=237.4
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|.+++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999987765555566788999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999998654321 12
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 2345679999999999987766 489999999999999999999999988888888888888889999999999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccccCCC
Q 045214 247 LDPNPSTRISIAKIMENPWFRKGLNS 272 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~~~~~ 272 (450)
|+.||++|||++|+++||||+....+
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=387.33 Aligned_cols=262 Identities=34% Similarity=0.660 Sum_probs=226.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3678999999999999999999999999999999999765432 34577899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999976 47999999999999999999999999999999999999999999999999998755433333
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCCCC--CCCCcHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKF--PTWFSADVRKL 242 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~l 242 (450)
......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+....... +..+++++.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 33456689999999999988777667899999999999999999999875542 3334443333222 34589999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 243 LSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
|.+||+.||.+|||++|+++||||++..
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=402.97 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=220.8
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CCCccEEEE
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-----HPNVMQIYE 77 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~ 77 (450)
.+|.++.++|++.+.||+|+||.||+|++..+++.||||++.... .......+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 467889999999999999999999999999999999999997532 23456788999999996 999999999
Q ss_pred EEEeCCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC----------
Q 045214 78 VMASKTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---------- 144 (450)
Q Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---------- 144 (450)
++...+..|+||||+ |++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 89999999763 4999999999999999999999999999999999999975
Q ss_pred ---------------CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCC
Q 045214 145 ---------------NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY 209 (450)
Q Consensus 145 ---------------~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~ 209 (450)
++.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCC
Confidence 78999999999865322 23456799999999999887765 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhhcCCCCCCC----------------------------------------------CcHHHHHHH
Q 045214 210 LPFHDSNLMAMYRKIAKADYKFPTW----------------------------------------------FSADVRKLL 243 (450)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~~~~~p~~----------------------------------------------~s~~~~~ll 243 (450)
.||...+..+....+.....++|.. .++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9999888777666655443333311 236788999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccc
Q 045214 244 SRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
.+||++||.+|||++|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=394.77 Aligned_cols=261 Identities=30% Similarity=0.568 Sum_probs=231.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
++..+.++|++.+.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp BCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678899999999999999999999999999999999987543321 13577899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCc
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGL 155 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGl 155 (450)
+.+..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999999999976 5799999999999999999999999999999999999999888 799999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC---
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP--- 232 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (450)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++
T Consensus 166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 865432 222345679999999999987766 4899999999999999999999999888888888877766655
Q ss_pred -CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 -TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 -~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++.+.+||.+||++||++|||++|+++||||+.
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 458899999999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=421.93 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=232.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-.++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998776555455678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 87 FVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999999864 2599999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC----cHHHHHHHHhhcCCCCCCCCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS----NLMAMYRKIAKADYKFPTWFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 237 (450)
. .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....+.+.+......+|..+++
T Consensus 342 ~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 G--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp T--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1 2223456899999999999887775 8999999999999999999999875 3467778888888889999999
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 238 DVRKLLSRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
++.+||.+||++||.+||+ ++++++||||+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 589999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=392.58 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=214.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
++++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 46899999999999999999999999999999999876542 22345677899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||+++++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--ccc
Confidence 9999999999998875 5799999999999999999999999999999999999999999999999999865432 122
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------- 227 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 227 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3345689999999999987555568999999999999999999999988766554443321
Q ss_pred --CCCCC----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 --DYKFP----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 --~~~~p----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+.+ +.+++++.+||.+||++||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 2478899999999999999999999999999999763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=419.05 Aligned_cols=258 Identities=27% Similarity=0.491 Sum_probs=213.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++++.||+|+||.||+|++..+++.||||++.+... ......++.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 457899999999999999999999999999999999986532 234457788999999999999999999999654
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..+|+||||++++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 4689999999875 6666654 59999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
. .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+.++.....
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2334567899999999999988775 899999999999999999999999887776666543211
Q ss_pred ----------------CCCCCC---------------cHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 230 ----------------KFPTWF---------------SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 230 ----------------~~p~~~---------------s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
.+|..+ ++++++||.+||++||++|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 001001 567999999999999999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=397.97 Aligned_cols=261 Identities=29% Similarity=0.455 Sum_probs=211.6
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+....++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 456778999999999999999999999999999999999765432 2334567799999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-----CCCCeEEeecCchhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-----ENGMLKVTDFGLSAL 158 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-----~~~~vkl~DFGls~~ 158 (450)
+|+||||++| +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 89999876 5799999999999999999999999999999999999995 445599999999976
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CC------
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KF------ 231 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~------ 231 (450)
.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+..... +.
T Consensus 187 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 5322 22234567899999999998766556899999999999999999999998877666665543211 00
Q ss_pred ----C-------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 232 ----P-------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 232 ----p-------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+ ..+++++.+||.+||++||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0 1167899999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=391.73 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=224.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48889999999999999999999999999999976542 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccc
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT 170 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 170 (450)
|++|++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999998654321 122345
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHcc
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---FPTWFSADVRKLLSRIL 247 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~ll~~~L 247 (450)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.....+ .+..+++++.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6899999999999877664 8999999999999999999999988887777766654332 23457899999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccC
Q 045214 248 DPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 248 ~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+.||++|||++++++||||.+..
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGCC
T ss_pred cCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=418.36 Aligned_cols=259 Identities=36% Similarity=0.658 Sum_probs=223.9
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+..+.++|++++.||+|+||.||+|++..++..||+|++.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3456778999999999999999999999999999999998765432 234678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC---CCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN---GMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~---~~vkl~DFGls~~~~ 160 (450)
+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999998865 689999999999999999999999999999999999999764 459999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCc
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFS 236 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (450)
.. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..+....+..+...++. .+|
T Consensus 191 ~~---~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 191 NQ---KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp TT---BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred CC---ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 22 23445689999999999864 45 58999999999999999999999999999999988887766542 479
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++++||.+||++||.+|||+.|+|+||||++.
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999999999763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=398.60 Aligned_cols=256 Identities=34% Similarity=0.664 Sum_probs=209.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
...+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 3567788999999999999999999999999999999997653 13567789999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFGls~~~~ 160 (450)
+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999999976 57999999999999999999999999999999999999975 8899999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCCCCC----CCC
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYKFP----TWF 235 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~ 235 (450)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+......++ ..+
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 203 H---QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp -------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred c---ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 2 222345689999999999988766 48999999999999999999999876544 46666766655433 357
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+.++.+||.+||+.||++|||+.|+++||||+..
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 8999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=417.94 Aligned_cols=258 Identities=34% Similarity=0.655 Sum_probs=227.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 47789999999999999999999999999999999997654332 34577899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec---CCCCeEEeecCchhhhhcc
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD---ENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~---~~~~vkl~DFGls~~~~~~ 162 (450)
+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 99999999999998865 6899999999999999999999999999999999999995 456799999999875432
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (450)
.......+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..+|++
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred --CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 2234456899999999998763 4 5899999999999999999999999999888888887766543 247999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+++||.+||++||.+|||+.++|+||||++..
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999999998644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=385.24 Aligned_cols=255 Identities=33% Similarity=0.625 Sum_probs=219.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++.+.||+|+||.||+|++..+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++.+....|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 4778999999999999999999999999999999999876532 33578899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhh
Q 045214 87 FVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSAL 158 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~ 158 (450)
+||||++|++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999998843 579999999999999999999999999999999999999 4567899999999865
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC---CCC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP---TWF 235 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p---~~~ 235 (450)
.... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cCCc---ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 4322 22345679999999999864 34 5899999999999999999999999888877777665554433 237
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++++.+||.+||++||++|||++|+++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=397.98 Aligned_cols=254 Identities=35% Similarity=0.700 Sum_probs=203.7
Q ss_pred ccccCeeee---ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeC
Q 045214 7 VLMQKYELG---RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASK 82 (450)
Q Consensus 7 ~l~~~y~~~---~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (450)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.+. ......+|+.+++.+. ||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 467889986 8899999999999999999999999999654 2356789999999997 99999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSAL 158 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~ 158 (450)
...|+||||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999976 5799999999999999999999999999999999999998766 799999999865
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-------HHHHHHHHhhcCCCC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-------LMAMYRKIAKADYKF 231 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~ 231 (450)
... ........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+ ..+....+..+.+.+
T Consensus 159 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 432 22234566899999999999887765 89999999999999999999998643 356677777777666
Q ss_pred CC----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 232 PT----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 232 p~----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+. .+++++.+||.+||++||.+|||++|+++||||+..
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 53 479999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=398.01 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=221.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------ 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (450)
..++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3579999999999999999999999999999999997654332 334567899999999999999999999877
Q ss_pred --CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+.+|+||||++| +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999986 67777654 579999999999999999999999999999999999999999999999999987
Q ss_pred hhhccc--CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCC-
Q 045214 158 LAKCKH--QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW- 234 (450)
Q Consensus 158 ~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~- 234 (450)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 543221 12233456799999999999875555689999999999999999999999988877766665432222211
Q ss_pred -------------------------------CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCCc
Q 045214 235 -------------------------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273 (450)
Q Consensus 235 -------------------------------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 273 (450)
.++++.+||.+||+.||++|||++|+++||||+....+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 267799999999999999999999999999998755443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=398.05 Aligned_cols=263 Identities=34% Similarity=0.549 Sum_probs=222.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--KVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3567999999999999999999999999999999999876432 23456788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 045214 85 IYFVMEYAKGGELFKKVSK-----------------------------------------GKLKEDTARKYFQQLISAID 123 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~~~~qll~aL~ 123 (450)
.|+||||++||+|.+++.. ..+++..++.++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998851 12467889999999999999
Q ss_pred HHHHCCCeecCCCCCcEEecCCC--CeEEeecCchhhhhcccCCC--CcccccCCCcccCchhcccC-CCCCCccchhhH
Q 045214 124 FCHSRGVYHRDLKPENLLLDENG--MLKVTDFGLSALAKCKHQDG--LLHTTCGTPAYVAPEVISRR-GYDGDKADIWSC 198 (450)
Q Consensus 124 ~LH~~gi~HrDikp~NILl~~~~--~vkl~DFGls~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSl 198 (450)
|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998777 89999999987553322211 23456799999999999752 334589999999
Q ss_pred HHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 199 GVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 199 Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||++|+|++|..||.+.+..+....+......++. .+++++.+||.+||++||.+|||+.++++||||+..
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999998888887777766654432 378999999999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=390.56 Aligned_cols=259 Identities=33% Similarity=0.618 Sum_probs=217.3
Q ss_pred cccccCeeee-ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 6 KVLMQKYELG-RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 6 ~~l~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
..+.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3567899995 78999999999999999999999999997653 23457788999999885 7999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---eEEeecCchhhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---LKVTDFGLSALA 159 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~---vkl~DFGls~~~ 159 (450)
.+|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999976 67999999999999999999999999999999999999998776 999999998654
Q ss_pred hcccC-----CCCcccccCCCcccCchhccc-----CCCCCCccchhhHHHHHHHHhhCCCCCCCCc-------------
Q 045214 160 KCKHQ-----DGLLHTTCGTPAYVAPEVISR-----RGYDGDKADIWSCGVILYVLLAGYLPFHDSN------------- 216 (450)
Q Consensus 160 ~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------------- 216 (450)
..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 32211 112234579999999999875 334 489999999999999999999998753
Q ss_pred --HHHHHHHHhhcCCCCCC----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 217 --LMAMYRKIAKADYKFPT----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 217 --~~~~~~~i~~~~~~~p~----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....+..+......+|. .+++++.+||.+||++||.+|||++|+++||||+.
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 23456667777776663 58999999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=402.14 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=214.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 456899999999999999999999999999999999966432 223457788999999999999999999999765
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..+|+||||+ |++|.+++..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988899999999999999999999999999999999999999999999999999986532
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 180 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 1234568999999999998744456899999999999999999999998877666655533211
Q ss_pred --------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 --------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 --------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..++..++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 112346899999999999999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=397.85 Aligned_cols=266 Identities=28% Similarity=0.462 Sum_probs=223.1
Q ss_pred cccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 2 ETKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 2 ~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
.+....+.++|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 34567889999999999999999999999999999999999987665555556788999999999999999999999865
Q ss_pred CC----EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 82 KT----KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 82 ~~----~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.. ..|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 44 45999999999999999975 68999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC---
Q 045214 157 ALAKCKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP--- 232 (450)
Q Consensus 157 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (450)
......... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...............+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 754332211 122345799999999999887664 899999999999999999999999887776666555544332
Q ss_pred -CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 -TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 -~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++++.++|.+||+.||.+||++.+++.|+|++.
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 348999999999999999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=400.87 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=222.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----GLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
.+.++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 466799999999999999999999999999999999987653221 123456789999999999999999999999
Q ss_pred CCEEEEEEeecCCC-ChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 82 KTKIYFVMEYAKGG-ELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 82 ~~~~~lv~E~~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
.+.+|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999766 99999977 47999999999999999999999999999999999999999999999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHH
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
. ........+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++
T Consensus 181 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 E---RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL 251 (335)
T ss_dssp C---TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred C---CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence 3 223344668999999999999888767899999999999999999999986332 2344456677799999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+||.+||++||++|||++++++||||++..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999999999998644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=390.83 Aligned_cols=263 Identities=34% Similarity=0.615 Sum_probs=226.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCccEEEEEE--EeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-VGLVDQTKREISVMRLIQHPNVMQIYEVM--ASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 83 (450)
.+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 36789999999999999999999999999999999998764332 23457789999999999999999999998 4456
Q ss_pred EEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..|+||||++++ |.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999987 6666643 579999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+......+|..+++++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 322333344567999999999987643 2356899999999999999999999999988888899888888999999999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+||.+||+.||.+|||++++++||||++..
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=391.90 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=226.0
Q ss_pred cccccccCeeee-ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe
Q 045214 4 KGKVLMQKYELG-RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS 81 (450)
Q Consensus 4 ~g~~l~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (450)
.++.+.++|.+. +.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.+ .||||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 345678899998 89999999999999999999999999998765332 3457788999999999 56999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecCc
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFGL 155 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFGl 155 (450)
.+..|+||||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 9999999999999999999854 57999999999999999999999999999999999999987 78999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC---
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP--- 232 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (450)
+...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......++
T Consensus 181 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 181 SRKIGHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccccCCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 8654322 223456899999999999877764 899999999999999999999999888888777766555443
Q ss_pred -CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 -TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 -~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+++.+.+||.+||++||.+|||++++++||||+..
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3478999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=386.56 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=221.0
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
-|+++.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 47889999999999999999999999999999999999997765555556678999999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.+|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999976 67999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-----CCCCCcH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-----FPTWFSA 237 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~ 237 (450)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......+......+ .++.+++
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred c-ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 1 122334579999999999988766 48999999999999999999999988776655444433322 2456889
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
.+.++|.+||++||.+||+..+.+.+.|.
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999999966666666664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=397.96 Aligned_cols=263 Identities=27% Similarity=0.438 Sum_probs=221.7
Q ss_pred ccccc--cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 5 GKVLM--QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 5 g~~l~--~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
|+++. ++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 45544 79999999999999999999999999999999997543 223457788999999999999999999999665
Q ss_pred -----CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 83 -----TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 83 -----~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
...|+||||+.| +|.+++..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp STTTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CccccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 479999999975 89999988899999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC------
Q 045214 158 LAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK------ 230 (450)
Q Consensus 158 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------ 230 (450)
....... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 5543322 222345689999999999876554568999999999999999999999987765555544321000
Q ss_pred -------------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 231 -------------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 231 -------------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.++.+++++.+||.+||++||++|||++|+++||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 1134689999999999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=396.10 Aligned_cols=259 Identities=32% Similarity=0.636 Sum_probs=226.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-----KVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4567899999999999999999999999999999999765421 112346778999999999 8999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
..+..|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999999976 58999999999999999999999999999999999999999999999999988654
Q ss_pred hcccCCCCcccccCCCcccCchhcccC-----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC--
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRR-----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP-- 232 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p-- 232 (450)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+......++
T Consensus 251 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 251 EP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred CC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 32 2234457899999999998642 1235799999999999999999999999888888888877766554
Q ss_pred --CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 --TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 --~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++++.+||.+||+.||++|||++++++||||++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=394.90 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=210.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||.||+|++..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 478999999999999999999999999999999997554221 112345799999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++| +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999985 88888865 35999999999999999999999999999999999999999999999999998643322 22
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---------------- 230 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 230 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2345578999999999987555568999999999999999999999998877766655432110
Q ss_pred --------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 231 --------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 231 --------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.++.+++++.+||.+||++||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0123678999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=386.43 Aligned_cols=257 Identities=35% Similarity=0.705 Sum_probs=225.3
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+..+.++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 345888999999999999999999999999999999999865432 23567899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~~ 160 (450)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999998865 689999999999999999999999999999999999999 788899999999986432
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCc
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFS 236 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (450)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......++ ..++
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 161 ----NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp ----CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred ----CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 1223456799999999999877664 899999999999999999999999888888888877765443 4578
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++.+||.+||++||.+|||++++++||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=403.21 Aligned_cols=251 Identities=35% Similarity=0.660 Sum_probs=208.7
Q ss_pred ccccCeeee-ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCccEEEEEEEe---
Q 045214 7 VLMQKYELG-RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQIYEVMAS--- 81 (450)
Q Consensus 7 ~l~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--- 81 (450)
.+.++|.+. +.||+|+||+||+|.+..+++.||||++... ....+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456678876 7999999999999999999999999999642 3456888887 45589999999999876
Q ss_pred -CCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecC
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFG 154 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFG 154 (450)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 66899999999999999999763 5999999999999999999999999999999999999997 7899999999
Q ss_pred chhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH----HHHHHHhhcCCC
Q 045214 155 LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM----AMYRKIAKADYK 230 (450)
Q Consensus 155 ls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~ 230 (450)
++.... ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.. .+...+..+.+.
T Consensus 210 ~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccC---CCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 986432 22234567899999999999877775 8999999999999999999999875432 244556566555
Q ss_pred CC----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 FP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ~p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+| ..++.++.+||.+||+.||.+|||++|+++||||...
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 54 3589999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=380.80 Aligned_cols=258 Identities=33% Similarity=0.641 Sum_probs=225.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
++.++|++.+.||+|+||.||+|++..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 467899999999999999999999999999999999987643321 23578899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCchhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGLSAL 158 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGls~~ 158 (450)
..|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999965 6899999999999999999999999999999999999998877 899999999865
Q ss_pred hhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TW 234 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 234 (450)
.... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++ ..
T Consensus 162 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEAG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccCC---CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 4321 22334579999999999987766 4899999999999999999999999888888887776665554 45
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++..+.+||.+||++||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 7899999999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=400.14 Aligned_cols=254 Identities=33% Similarity=0.551 Sum_probs=218.6
Q ss_pred cccCeee--eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 8 LMQKYEL--GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 8 l~~~y~~--~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3445666 6789999999999999999999999999987543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe--cCCCCeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl--~~~~~vkl~DFGls~~~~~ 161 (450)
|+||||++|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998864 369999999999999999999999999999999999999 5677899999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (450)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......++ ..+++
T Consensus 242 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 ---REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ---TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ---ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 223345679999999999977655 4899999999999999999999999988888888877766554 35899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++.+||.+||++||.+|||++|+++||||+.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=410.89 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=198.0
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (450)
.+.++|++++.||+|+||.||+|++..+++.||||++..... .....+++.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 456899999999999999999999999999999999975432 22345778899999999999999999999843
Q ss_pred CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 357999999985 689998876 579999999999999999999999999999999999999999999999999997653
Q ss_pred cccCC-------------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh--------
Q 045214 161 CKHQD-------------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-------- 207 (450)
Q Consensus 161 ~~~~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-------- 207 (450)
..... ......+||+.|+|||++.....++.++|||||||+||+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22110 123456899999999987554444689999999999999998
Q ss_pred ---CCCCCCCCcH--------------------HHHHHHHhhc----------------------CC---------CCCC
Q 045214 208 ---GYLPFHDSNL--------------------MAMYRKIAKA----------------------DY---------KFPT 233 (450)
Q Consensus 208 ---g~~Pf~~~~~--------------------~~~~~~i~~~----------------------~~---------~~p~ 233 (450)
|.++|.+.+. ...+..+... .+ ...+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777765431 1111111100 00 0112
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..++++.+||.+||.+||++|||++|+|+||||+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 358999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=403.98 Aligned_cols=262 Identities=28% Similarity=0.440 Sum_probs=209.5
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC---
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK--- 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 82 (450)
-.+.++|++++.||+|+||.||+|++..+++.||||++..... .....+++.+|+.+|+.++||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3567899999999999999999999999999999999976432 223457789999999999999999999999766
Q ss_pred --CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
..+|+||||+.| +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 101 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 579999999875 99999987 46999999999999999999999999999999999999999999999999998754
Q ss_pred hcccCC--------------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-----------
Q 045214 160 KCKHQD--------------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG----------- 208 (450)
Q Consensus 160 ~~~~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g----------- 208 (450)
...... ......+||+.|+|||++......+.++|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 332211 1235678999999999975555456899999999999999984
Q ss_pred CCCCCCCcH-----------------HHHHHHH------------------------hhcCCCCC-------CCCcHHHH
Q 045214 209 YLPFHDSNL-----------------MAMYRKI------------------------AKADYKFP-------TWFSADVR 240 (450)
Q Consensus 209 ~~Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~p-------~~~s~~~~ 240 (450)
.++|.+.+. ......+ .......+ +.+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444443320 1111111 11111111 34789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+||.+||++||.+|||++|+|+||||+..
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.07 Aligned_cols=266 Identities=28% Similarity=0.430 Sum_probs=213.6
Q ss_pred CcccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCccEEEEE
Q 045214 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK--VGLVDQTKREISVMRLIQHPNVMQIYEV 78 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (450)
|.-.-....++|++++.||+|+||.||+|++..+|+.||+|++....... ......+.+|+.+++.++||||++++++
T Consensus 1 m~l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp ------------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CchhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34444556789999999999999999999999999999999997643321 1223467899999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+.+.+..|+||||+++ +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp ECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999999999987 78888865 36899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-----C
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-----F 231 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~ 231 (450)
...... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+...... +
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 755322 223445689999999999976654568999999999999999999999998877776665432110 0
Q ss_pred -----------------------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 232 -----------------------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 232 -----------------------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13357899999999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=404.14 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=215.6
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC------CCCCccEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI------QHPNVMQIYEV 78 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~ 78 (450)
++.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....++.+|+.+++.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 4567889999999999999999999999999999999997643 2345677888888877 57799999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC--eEEeec
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--LKVTDF 153 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--vkl~DF 153 (450)
+...+.+|+||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 5899988653 4999999999999999999999999999999999999999987 999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--- 230 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--- 230 (450)
|+|.... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 247 G~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TTCEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9986432 22345689999999999988777 48999999999999999999999988776655544321000
Q ss_pred --------------------------------------------------------CCCCCcHHHHHHHHHccCCCCCCC
Q 045214 231 --------------------------------------------------------FPTWFSADVRKLLSRILDPNPSTR 254 (450)
Q Consensus 231 --------------------------------------------------------~p~~~s~~~~~ll~~~L~~dP~~R 254 (450)
++...++++.+||.+||++||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 011236789999999999999999
Q ss_pred CCHHHHhcCccccccC
Q 045214 255 ISIAKIMENPWFRKGL 270 (450)
Q Consensus 255 ~s~~eil~hp~f~~~~ 270 (450)
||++|+|+||||++..
T Consensus 401 pta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCHHHHHTSTTTC---
T ss_pred CCHHHHhCChhhccCC
Confidence 9999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=380.71 Aligned_cols=262 Identities=35% Similarity=0.577 Sum_probs=226.8
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc------ccchHHHHHHHHHHHHhCC-CCCccEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL------KVGLVDQTKREISVMRLIQ-HPNVMQIYE 77 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 77 (450)
...+.++|++.+.||+|+||.||+|.+..+++.||||+++..... .....+.+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 346789999999999999999999999999999999999765321 1123467789999999995 999999999
Q ss_pred EEEeCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 78 VMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
++...+..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999976 58999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhccc-----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISR-----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF 231 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 231 (450)
..... .......+||+.|+|||++.. ....+.++||||||+++|+|++|..||...+.......+......+
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 65432 223345679999999999852 2223589999999999999999999999988888888877766554
Q ss_pred C----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 232 P----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 232 p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+ ..++.++.+||.+||+.||.+|||++++++||||++.
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 4 2478999999999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=387.22 Aligned_cols=265 Identities=27% Similarity=0.438 Sum_probs=216.0
Q ss_pred CcccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
|+..|..+.++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 67788999999999999999999999999999999999999987543 234577889999999999999999999873
Q ss_pred --------------eCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CC
Q 045214 81 --------------SKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-EN 145 (450)
Q Consensus 81 --------------~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~ 145 (450)
.....|+||||++ |+|.+++..+.+++..++.++.|++.||+|||++||+||||||+|||++ .+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4478999999998 5999999988999999999999999999999999999999999999997 56
Q ss_pred CCeEEeecCchhhhhccc-CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHH
Q 045214 146 GMLKVTDFGLSALAKCKH-QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI 224 (450)
Q Consensus 146 ~~vkl~DFGls~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i 224 (450)
+.+||+|||++....... .........+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 799999999987543221 1222345578999999999876444568999999999999999999999988776665555
Q ss_pred hhcCCC------------------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 225 AKADYK------------------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 225 ~~~~~~------------------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...... .++.++.++.+||.+||++||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 432110 123578999999999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.85 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=208.4
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH-hCCCCCccEEEEEEEeC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHPNVMQIYEVMASK 82 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~ 82 (450)
.++.+.++|++.+.||+|+||+||+|++..+++.||||++......... ..+..+|+..+. ..+||||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3567778999999999999999999999999999999998765433222 234445555554 44999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
+..|+||||+ +++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999999 6688888765 469999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC--CCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY--KFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~ 238 (450)
. .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ...+..... .++..++++
T Consensus 209 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 280 (311)
T 3p1a_A 209 T---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSE 280 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHH
T ss_pred c---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHH
Confidence 2 223345679999999999876 44 5899999999999999999766654332 223333222 234568999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.+||.+||++||++|||++|+++||||++
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=390.86 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=216.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 467999999999999999999999999999999999765432 2345667899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--cc
Confidence 9999999999888764 67999999999999999999999999999999999999999999999999998654322 22
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-------------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------- 227 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 227 (450)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 3345679999999999987655568999999999999999999999987765554443321
Q ss_pred CCCCC------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 DYKFP------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 ~~~~p------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....| +.+++++.+||.+||++||.+|||++|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 246899999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=377.99 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=214.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....++.+|+..+..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 46789999999999999999999999999999999998654332 3356778899999999 999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC--------------
Q 045214 86 YFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-------------- 146 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-------------- 146 (450)
|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999864 5699999999999999999999999999999999999998544
Q ss_pred -----CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHH
Q 045214 147 -----MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY 221 (450)
Q Consensus 147 -----~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 221 (450)
.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+..... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 799999998865432 12346999999999998764555799999999999999999988765543 2
Q ss_pred HHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 222 RKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 222 ~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+.... ...|..+++++.+||.+||++||++|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3333333 35677899999999999999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.13 Aligned_cols=258 Identities=24% Similarity=0.442 Sum_probs=210.1
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-- 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (450)
..+.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 346789999999999999999999999999999999997654 2234578899999999999999999999885543
Q ss_pred -------------------------------------------------------EEEEEEeecCCCChhhHHhcC----
Q 045214 84 -------------------------------------------------------KIYFVMEYAKGGELFKKVSKG---- 104 (450)
Q Consensus 84 -------------------------------------------------------~~~lv~E~~~gg~L~~~i~~~---- 104 (450)
..|+||||++|++|.+++...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 489999999999999999763
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC----------CCcccccCC
Q 045214 105 KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD----------GLLHTTCGT 174 (450)
Q Consensus 105 ~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~----------~~~~~~~gt 174 (450)
..++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......... ......+||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 3566779999999999999999999999999999999999999999999998754432111 122345799
Q ss_pred CcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHccCCCCCC
Q 045214 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF-PTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 175 ~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
+.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+. +...++++.+||.+||++||.+
T Consensus 240 ~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 99999999988776 4899999999999999998777532 222233333322221 1235688999999999999999
Q ss_pred CCCHHHHhcCccccc
Q 045214 254 RISIAKIMENPWFRK 268 (450)
Q Consensus 254 R~s~~eil~hp~f~~ 268 (450)
|||++|+++||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=395.31 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=209.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--- 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (450)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 467899999999999999999999999999999999976532 2234567889999999999999999999997665
Q ss_pred ---EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 ---KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 ---~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+|+||||++| +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999986 6888775 469999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC---------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--------- 231 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 231 (450)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 1223456899999999999887765 89999999999999999999999988776666654321110
Q ss_pred ---------------------------CC------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 232 ---------------------------PT------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 232 ---------------------------p~------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
|. ..++++++||.+||++||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0156899999999999999999999999999998644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=396.93 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=202.0
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK---- 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (450)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 456899999999999999999999999999999999976432 223456788999999999999999999998654
Q ss_pred --CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 --TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 --~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..+|+++|++ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999988889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------- 229 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 229 (450)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 233568999999999998744556899999999999999999999999887666555433110
Q ss_pred ------------CC--------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 ------------KF--------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ------------~~--------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.. .+..++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 12357889999999999999999999999999999763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=391.76 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=221.5
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.|.+..++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 36677899999999999999999999999999999999998653 2244577899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999999976 6899999999999999999999996 999999999999999999999999999865532
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH------------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK------------------ 223 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~------------------ 223 (450)
. .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 2 22345799999999999887664 899999999999999999999987665433221
Q ss_pred ------------------------HhhcCC-CC-CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 224 ------------------------IAKADY-KF-PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 224 ------------------------i~~~~~-~~-p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+..... .. +..++.++.+||.+||++||.+|||++|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 11 22378899999999999999999999999999999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=378.88 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=229.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 3457899999999999999999999999999999999866432 34678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
+||||++|++|.+++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~ 245 (450)
......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...+..++.++.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999887765 89999999999999999999999887776666655443 34566789999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||++||.+|||++++++||||....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=388.90 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=220.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999876544444557789999999999999999999999999999999
Q ss_pred EeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+.| +|.+.+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999984 7877774 36799999999999999999999999999999999999999999999999999865421
Q ss_pred CcccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC--CCCCCcHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK--FPTWFSADVRK 241 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 241 (450)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.......+.....+ .+..+++.+.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 23457999999999985 3344 58999999999999999999999988776666665554432 24568999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 242 LLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||.+||+.||++|||++++++||||....
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999999999999999999999997643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=389.59 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=212.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCccEEEEEEEeCCE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH--PNVMQIYEVMASKTK 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 84 (450)
+..++|++++.||+|+||.||+|.+ .+++.||||++...... ....+.+.+|+.+++.++| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999998 46899999999866432 2345778999999999976 999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+|+||| +.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||+|.......
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 567899999976 5799999999999999999999999999999999999996 6789999999987654333
Q ss_pred CCCCcccccCCCcccCchhccc----------CCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhh--cCCC
Q 045214 164 QDGLLHTTCGTPAYVAPEVISR----------RGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAK--ADYK 230 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~--~~~~ 230 (450)
........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+.. ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 3333446689999999999864 1233579999999999999999999998743 3333333332 3345
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+|...+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 6777889999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=392.83 Aligned_cols=260 Identities=25% Similarity=0.511 Sum_probs=228.0
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc--------------hHHHHHHHHHHHHhCCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG--------------LVDQTKREISVMRLIQH 69 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~h 69 (450)
.++.+.++|++.+.||+|+||.||+|.+ +++.||+|++......... ..+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3567789999999999999999999999 8999999999865443221 12788999999999999
Q ss_pred CCccEEEEEEEeCCEEEEEEeecCCCChhhH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCc
Q 045214 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKK------VSK---GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPEN 139 (450)
Q Consensus 70 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~---~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~N 139 (450)
|||+++++++.+.+..|+||||++|++|.++ +.. +.+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 654 579999999999999999999999 999999999999
Q ss_pred EEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCCCCCCCcH-
Q 045214 140 LLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYLPFHDSNL- 217 (450)
Q Consensus 140 ILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~- 217 (450)
|+++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+.
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998654321 33456799999999999876 4443489999999999999999999998766
Q ss_pred HHHHHHHhhcCCCCC-------------------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 218 MAMYRKIAKADYKFP-------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 218 ~~~~~~i~~~~~~~p-------------------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
......+......+| ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777778877777666 5689999999999999999999999999999999763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=394.78 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=210.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (450)
...++|++++.||+|+||.||+|++..+|+.||||++..+... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567999999999999999999999999999999999765422 2379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEeecCCCChhhHHh----c-CCCCHHHHHHHHHHHHHHHH
Q 045214 82 ---------------------------------KTKIYFVMEYAKGGELFKKVS----K-GKLKEDTARKYFQQLISAID 123 (450)
Q Consensus 82 ---------------------------------~~~~~lv~E~~~gg~L~~~i~----~-~~l~e~~~~~~~~qll~aL~ 123 (450)
...+|+||||++| +|.+.+. . +.+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7666654 2 57999999999999999999
Q ss_pred HHHHCCCeecCCCCCcEEec-CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHH
Q 045214 124 FCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVIL 202 (450)
Q Consensus 124 ~LH~~gi~HrDikp~NILl~-~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil 202 (450)
|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++|||||||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 688999999999865432 22334567899999999998766556899999999999
Q ss_pred HHHhhCCCCCCCCcHHHHHHHHhhc-----------------CCC------------CCCCCcHHHHHHHHHccCCCCCC
Q 045214 203 YVLLAGYLPFHDSNLMAMYRKIAKA-----------------DYK------------FPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 203 ~~ll~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
|+|++|..||.+.+..+....+... ... +|..+++++.+||.+||++||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998776666555321 011 34557899999999999999999
Q ss_pred CCCHHHHhcCccccc
Q 045214 254 RISIAKIMENPWFRK 268 (450)
Q Consensus 254 R~s~~eil~hp~f~~ 268 (450)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=400.38 Aligned_cols=259 Identities=34% Similarity=0.635 Sum_probs=209.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----GLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+...... .....+.+|+.+|+.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467899999999999999999999999999999999987643211 12235789999999999999999999985
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCch
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLS 156 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls 156 (450)
.+..|+||||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4558999999999999999875 6799999999999999999999999999999999999997654 5999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcCCCCC-
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYKFP- 232 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~p- 232 (450)
..... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ......+......++
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 75432 233456789999999999864 22234799999999999999999999986543 234445555555443
Q ss_pred ---CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 233 ---TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 233 ---~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+++++.+||.+||++||.+|||++|+++||||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 347899999999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=374.20 Aligned_cols=252 Identities=24% Similarity=0.497 Sum_probs=216.6
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----KTKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~ 85 (450)
..|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 45899999999999999999999999999999998655432 345778999999999999999999999865 4679
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEec-CCCCeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLD-ENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~-~~~~vkl~DFGls~~~~~ 161 (450)
|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~- 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence 999999999999999987 68999999999999999999999999 99999999999998 78999999999986432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhcCC--CCCCCCcHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKADY--KFPTWFSAD 238 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~--~~p~~~s~~ 238 (450)
........||+.|+|||++.+. + +.++|||||||++|+|++|..||.... ....+..+..... .++...+++
T Consensus 184 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ---ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ---ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 2233456799999999988643 4 589999999999999999999998844 4455555544322 234557899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.+||.+||+.||.+|||++++++||||+.
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=394.81 Aligned_cols=257 Identities=26% Similarity=0.469 Sum_probs=213.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--CCCccEEEEEEEeCCEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ--HPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 86 (450)
..+|++++.||+|+||.||+|.+.. ++.||||++...... ....+.+.+|+.+++.++ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3469999999999999999999865 899999999876532 234577899999999996 599999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 568899999976 5799999999999999999999999999999999999995 689999999999765433322
Q ss_pred CCcccccCCCcccCchhcccC----------CCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhc--CCCCC
Q 045214 166 GLLHTTCGTPAYVAPEVISRR----------GYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA--DYKFP 232 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~p 232 (450)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...+|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 234566899999999998652 234579999999999999999999998743 33444444433 34567
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+.+.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 7889999999999999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.02 Aligned_cols=262 Identities=29% Similarity=0.434 Sum_probs=218.3
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC--
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK-- 82 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 82 (450)
+..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 4567889999999999999999999999999999999996532 223456778999999999999999999987654
Q ss_pred ---CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 83 ---TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 83 ---~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
...|+||||+. ++|.+++..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999997 48999998889999999999999999999999999999999999999999999999999998654
Q ss_pred hcccCCC--------CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---
Q 045214 160 KCKHQDG--------LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--- 228 (450)
Q Consensus 160 ~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 228 (450)
....... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 3221110 12245789999999998764555689999999999999999999999887655444332110
Q ss_pred ---------------------CC--------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 229 ---------------------YK--------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 229 ---------------------~~--------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.. .++.+++++.+||.+||++||++|||++|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 113578999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=390.67 Aligned_cols=260 Identities=32% Similarity=0.583 Sum_probs=222.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
-.++|++.+.||+|+||.||+|++. .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3479999999999999999999985 48999999999765432 122335567899999999 699999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 83 TKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
+.+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 999999999999999999975 6899999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCCCCCCC----cHHHHHHHHhhcCCCCCCCCc
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYLPFHDS----NLMAMYRKIAKADYKFPTWFS 236 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s 236 (450)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+......+|..++
T Consensus 212 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 212 DE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 21 1223356899999999999753 23358999999999999999999999743 345566666677778888899
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 237 ADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
..+.+||.+||+.||.+|| |++++++||||++
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999999999999 9999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=381.42 Aligned_cols=250 Identities=23% Similarity=0.463 Sum_probs=211.2
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEe--CCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMAS--KTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 85 (450)
.++|++++.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999987432 367889999999997 9999999999988 6789
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~ 164 (450)
++||||+++++|.+++.. +++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--- 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 183 (330)
T ss_dssp EEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT---
T ss_pred EEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---
Confidence 999999999999998865 89999999999999999999999999999999999999777 899999999865432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHH-------------HHHhhcCCC
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMY-------------RKIAKADYK 230 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~-------------~~i~~~~~~ 230 (450)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ..... ..+......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2234456899999999999875555689999999999999999999995432 21111 111111111
Q ss_pred C------------------------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 F------------------------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ~------------------------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
. +..+++++.+||.+||++||.+|||++|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1 12278999999999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=385.53 Aligned_cols=265 Identities=34% Similarity=0.623 Sum_probs=216.9
Q ss_pred CcccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhCCCCCccEE
Q 045214 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-----KVGLVDQTKREISVMRLIQHPNVMQI 75 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l 75 (450)
|..-+..+.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++
T Consensus 1 M~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp -CCCCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred CccchhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 5555677889999999999999999999999999999999999765431 11223457899999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---eEEe
Q 045214 76 YEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---LKVT 151 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~---vkl~ 151 (450)
++++.... .|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 99997766 8999999999999999876 57999999999999999999999999999999999999987665 9999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcC
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKAD 228 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~ 228 (450)
|||++..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+....
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 9999865421 112234579999999999742 233358999999999999999999999865432 3344444454
Q ss_pred CCCC----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 229 YKFP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 229 ~~~p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..++ ..++.++.+||.+||+.||++|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 4432 3578999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=377.04 Aligned_cols=260 Identities=31% Similarity=0.469 Sum_probs=219.8
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 4567899999999999999999999999999999999976532 3357788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998864 579999999999999999999999999999999999999999999999999876432221
Q ss_pred CCCCcccccCCCcccCchhcc----cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC---CCCCCc
Q 045214 164 QDGLLHTTCGTPAYVAPEVIS----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---FPTWFS 236 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 236 (450)
. ......||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+.....+ .+..++
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 1 123457999999999984 2233358999999999999999999999998877776666555432 355689
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.++.+||.+||+.||.+|||++++++||||+...
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=383.64 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=216.6
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEE-cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC------CccEE
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARH-LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP------NVMQI 75 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l 75 (450)
..|+++.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 56889999999999999999999999998 5588999999997542 2346778999999988665 49999
Q ss_pred EEEEEeCCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC--------
Q 045214 76 YEVMASKTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-------- 144 (450)
Q Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-------- 144 (450)
++++...+..|+||||+ +++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999998753 5899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCC
Q 045214 145 -----------NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH 213 (450)
Q Consensus 145 -----------~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 213 (450)
++.+||+|||++.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999986532 123356799999999999887764 89999999999999999999999
Q ss_pred CCcHHHHHHHHhhcCCCCC--------------------------------------------CCCcHHHHHHHHHccCC
Q 045214 214 DSNLMAMYRKIAKADYKFP--------------------------------------------TWFSADVRKLLSRILDP 249 (450)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~ll~~~L~~ 249 (450)
..+..+....+.....+.| ...++++.+||.+||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 8776655544432221111 12356789999999999
Q ss_pred CCCCCCCHHHHhcCccccc
Q 045214 250 NPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 250 dP~~R~s~~eil~hp~f~~ 268 (450)
||.+|||++|+++||||+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDL 334 (339)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred CcccccCHHHHhcCHHHHH
Confidence 9999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=375.38 Aligned_cols=258 Identities=34% Similarity=0.649 Sum_probs=226.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
..+.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 35678999999999999999999999999999999999765433 23457789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vkl~DFGls~~~~~ 161 (450)
|+||||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999999998865 6899999999999999999999999999999999999997644 699999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (450)
. .......||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+...++ ..+++
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 N---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp C---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred C---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2 223345689999999998764 4 5899999999999999999999999888888888877765443 35789
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++.++|.+||++||.+|||++++++||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=395.81 Aligned_cols=255 Identities=30% Similarity=0.485 Sum_probs=210.5
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.|.....+|++.+.||+|+||.||+|++..+++ +|+|.+....... .+|+.+++.++||||+++++++...+
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~-------~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC-------CHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH-------HHHHHHHHhCCCCCcceEEEEEEecC
Confidence 356677899999999999999999999987766 8888876543222 37999999999999999999985443
Q ss_pred ------EEEEEEeecCCCChhhHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CCCCeEEee
Q 045214 84 ------KIYFVMEYAKGGELFKKVS----KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTD 152 (450)
Q Consensus 84 ------~~~lv~E~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~~~vkl~D 152 (450)
.+|+||||++++.+..... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 4889999998854433321 35799999999999999999999999999999999999999 799999999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc-----
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA----- 227 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----- 227 (450)
||+|..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 186 FG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999865432 222345678999999999977665568999999999999999999999998776655554331
Q ss_pred ------------CCC------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ------------DYK------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ------------~~~------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
... +++.+++++.+||.+||++||.+|||+.|+++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 233478999999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=379.64 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=214.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
++..++|++.+.||+|+||.||+|++ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45567999999999999999999987 6889999999765432 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 86 YFVMEYAKGGELFKKVSKGK----LKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~----l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
|+||||++||+|.+++.... +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997643 999999999999999999999999 999999999999999999999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHh--hcCCCCCCCCcH
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIA--KADYKFPTWFSA 237 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 237 (450)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ......|..+++
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred ccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 322 122345679999999999988776 489999999999999999999999988877766653 344567888999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc--Ccccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME--NPWFR 267 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~--hp~f~ 267 (450)
++.+||.+||+.||.+|||++++++ +++++
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999997 44443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=376.21 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=202.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
++..++|++.+.||+|+||.||+|++..+|+.||+|++....... .....+.++...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356789999999999999999999999999999999997653222 2234445556668889999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 86 YFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
|+||||++| +|.+++.. ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 77766542 5799999999999999999999998 9999999999999999999999999998754
Q ss_pred hcccCCCCcccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHH-HHHhhcCCCCC-C
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMY-RKIAKADYKFP-T 233 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~-~~i~~~~~~~p-~ 233 (450)
... .......||+.|+|||++. .....+.++|||||||++|+|++|..||... ...... ..+.......+ .
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 322 2233457999999999972 2333458999999999999999999999863 333333 33333333333 4
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+++++.+||.+||++||++|||++|+++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 68999999999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=382.65 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=214.0
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..+.++.++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CcccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 34577889999999999999999999999999999999999865433 2356778999999999999999999999876
Q ss_pred C--EEEEEEeecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe----cCCCCeEEee
Q 045214 83 T--KIYFVMEYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTD 152 (450)
Q Consensus 83 ~--~~~lv~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----~~~~~vkl~D 152 (450)
+ ..|+||||++|++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 889999999999999999752 39999999999999999999999999999999999999 7788899999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhccc-------CCCCCCccchhhHHHHHHHHhhCCCCCCCCc----HHHHH
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR-------RGYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMY 221 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~ 221 (450)
||++..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.... .....
T Consensus 160 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 160 FGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCCceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 999865432 223345679999999999862 2333589999999999999999999997422 23444
Q ss_pred HHHhhcCC---------------------C----CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 222 RKIAKADY---------------------K----FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 222 ~~i~~~~~---------------------~----~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.++..... + ++..++..+.+||.+||+.||++|||++|+++||=
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 44433321 1 11224567899999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=374.32 Aligned_cols=258 Identities=31% Similarity=0.582 Sum_probs=223.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA--SKTKI 85 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 85 (450)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 357899999999999999999999999999999999876533 234577899999999999999999999874 46789
Q ss_pred EEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEecCCCCeEEeecCc
Q 045214 86 YFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRG-----VYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~g-----i~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999864 24999999999999999999999999 99999999999999999999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTW 234 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 234 (450)
+...... ........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+.. .+|..
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 8754321 1112345799999999999877664 899999999999999999999999888887777776655 56778
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++.++.++|.+||+.||.+|||++|+++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=387.22 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=214.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE-
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI- 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 85 (450)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 467899999999999999999999999999999999976542 223457788999999999999999999999877654
Q ss_pred -----EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 86 -----YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 86 -----~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
|+||||+. ++|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 478777754 59999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC----------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK---------- 230 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (450)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 2335678999999999987444568999999999999999999999988776666555331100
Q ss_pred ---------------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 231 ---------------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 231 ---------------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.++.+++++.+||.+||++||++|||++|+++||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 123468999999999999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=375.26 Aligned_cols=257 Identities=29% Similarity=0.501 Sum_probs=217.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3456789999999999999999999999999999999976532 35678999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||++|++|.+++. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 99999999999999986 367999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---CCCCCCCcHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD---YKFPTWFSADVR 240 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 240 (450)
........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...|..++.++.
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred -ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 1123455799999999999887765 89999999999999999999999877665555444432 233556899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 241 KLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=392.32 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=209.5
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--------CCCccEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ--------HPNVMQI 75 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l 75 (450)
.|+++.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 46788899999999999999999999999999999999997543 23467889999999885 7889999
Q ss_pred EEEEE----eCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCC-
Q 045214 76 YEVMA----SKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENG- 146 (450)
Q Consensus 76 ~~~~~----~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~- 146 (450)
++++. ....+|+||||+ +++|.+.+.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 566899999999 5566666543 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------------CeEEeecCchhhhhcccCCCCcccccCCCccc
Q 045214 147 ------------------------------------------------MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178 (450)
Q Consensus 147 ------------------------------------------------~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~ 178 (450)
.+||+|||+|..... .....+||+.|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCccc
Confidence 799999999865432 134557999999
Q ss_pred CchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc------HHHHHHHHhhc-------------------------
Q 045214 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN------LMAMYRKIAKA------------------------- 227 (450)
Q Consensus 179 aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~~~i~~~------------------------- 227 (450)
|||++.+..+. .++|||||||++|+|++|..||...+ .......+...
T Consensus 261 aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 261 SLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred CChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999887765 89999999999999999999998643 12222222110
Q ss_pred -----------------CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 228 -----------------DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 228 -----------------~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
....+...++++.+||.+||++||++|||++|+++||||+
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 1112233456789999999999999999999999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=401.72 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=204.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHH---HHHhCCCCCccEEE-------EE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS---VMRLIQHPNVMQIY-------EV 78 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~ 78 (450)
.++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998765555556788899995 45555899999998 77
Q ss_pred EEeCCE-----------------EEEEEeecCCCChhhHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHHCCCeec
Q 045214 79 MASKTK-----------------IYFVMEYAKGGELFKKVSK-GKLKE-------DTARKYFQQLISAIDFCHSRGVYHR 133 (450)
Q Consensus 79 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~-~~l~e-------~~~~~~~~qll~aL~~LH~~gi~Hr 133 (450)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..+..++.|++.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6799999975 34555 7888899999999999999999999
Q ss_pred CCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccC-----------CCCCCccchhhHHHHH
Q 045214 134 DLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR-----------GYDGDKADIWSCGVIL 202 (450)
Q Consensus 134 Dikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~~DiwSlGvil 202 (450)
||||+|||++.+|.+||+|||+|.... ......+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 999999999999999999999986422 23345678 999999999876 55 4899999999999
Q ss_pred HHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 203 YVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 203 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|+|++|..||.+.+.......+. ..+..+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998765443332222 234568999999999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=380.15 Aligned_cols=262 Identities=29% Similarity=0.510 Sum_probs=197.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+..++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 35578999999999999999999999989999999998765432 2346778999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 86 YFVMEYAKGGELFKKVSK---------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999852 45999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccc---CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC----
Q 045214 157 ALAKCKH---QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---- 229 (450)
Q Consensus 157 ~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---- 229 (450)
....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7543221 111233457999999999987633345899999999999999999999998665544433332221
Q ss_pred ------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 ------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+..++.++.+||.+||+.||.+|||++++++||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1224578999999999999999999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=376.80 Aligned_cols=263 Identities=33% Similarity=0.505 Sum_probs=215.2
Q ss_pred Ccccccc-cccCeeeeceEeecCCeEEEEEEEc-CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEE
Q 045214 1 METKGKV-LMQKYELGRLLGQGNFAKVYYARHL-GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQI 75 (450)
Q Consensus 1 m~~~g~~-l~~~y~~~~~LG~G~fg~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l 75 (450)
|+..|.. ..++|++.+.||+|+||.||+|++. .+++.||+|++....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 4555533 4589999999999999999999996 678999999997654321 1123455777777666 89999999
Q ss_pred EEEEE-----eCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC
Q 045214 76 YEVMA-----SKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM 147 (450)
Q Consensus 76 ~~~~~-----~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~ 147 (450)
++++. .....|+||||+. |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999998 599999865 34999999999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc
Q 045214 148 LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 148 vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 227 (450)
+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999998654322 12345679999999999987766 48999999999999999999999998877666655431
Q ss_pred C---------------------------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 D---------------------------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ~---------------------------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
. ..++..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01234578999999999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=393.31 Aligned_cols=251 Identities=28% Similarity=0.456 Sum_probs=207.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------ 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (450)
...+|++.+.||+|+||.||+|++..+|+.||||++..+... ..+|+.+++.++||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 445799999999999999999999999999999999765322 2479999999999999999998843
Q ss_pred CCEEEEEEeecCCCChhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecCc
Q 045214 82 KTKIYFVMEYAKGGELFKKVS-----KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGL 155 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFGl 155 (450)
...+++||||+++ +|.+.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 2247799999987 5555543 2579999999999999999999999999999999999999965 5689999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--------
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------- 227 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 227 (450)
+..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+.++...
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432 122345689999999999977644568999999999999999999999988766555444321
Q ss_pred ---------CCC------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ---------DYK------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ---------~~~------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+. +++.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 233468999999999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.63 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=223.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEE-----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYAR-----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
.+..++|++++.||+|+||.||+|+ +..+++.||||++..... .....++.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456789999999999999999999 445788999999965432 233457889999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC---CeE
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK--------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG---MLK 149 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~---~vk 149 (450)
+....|+||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999864 2489999999999999999999999999999999999999655 499
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD 228 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 228 (450)
|+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999765444333344456789999999999887765 89999999999999998 999999998888887776654
Q ss_pred -CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
...|..+++++.+||.+||+.||.+|||+++++++.++..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4567778999999999999999999999999999988743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=381.12 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=201.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
.+..++|++++.||+|+||.||+|++..++. .||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4556789999999999999999999877765 89999997654332 3467889999999999999999999999877
Q ss_pred CEE------EEEEeecCCCChhhHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeE
Q 045214 83 TKI------YFVMEYAKGGELFKKVSKG-------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLK 149 (450)
Q Consensus 83 ~~~------~lv~E~~~gg~L~~~i~~~-------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vk 149 (450)
... |+||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 9999999999999998531 599999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA- 227 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 227 (450)
|+|||+|................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999998765433322223345678899999999887664 89999999999999999 99999998877777766554
Q ss_pred CCCCCCCCcHHHHHHHHHccCCCCCCCCC-------HHHHhcCccccc
Q 045214 228 DYKFPTWFSADVRKLLSRILDPNPSTRIS-------IAKIMENPWFRK 268 (450)
Q Consensus 228 ~~~~p~~~s~~~~~ll~~~L~~dP~~R~s-------~~eil~hp~f~~ 268 (450)
....|..+++++.+||.+||+.||.+||| +++++.|||+..
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 35667789999999999999999999999 788889999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=375.30 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=215.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS---- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 81 (450)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 457899999999999999999999999999999999976532 236788999999998 89999999999977
Q ss_pred --CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
.+.+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5689999999999999999975 46999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC--
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK-- 230 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-- 230 (450)
...... ........||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 177 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 654322 122345579999999999862 223358999999999999999999999988776666555544332
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+..++.++.+||.+||..||.+|||++++++||||+...
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 2455899999999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=394.40 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=197.8
Q ss_pred ccccccCeee-eceEeecCCeEEEEEEEc--CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 5 GKVLMQKYEL-GRLLGQGNFAKVYYARHL--GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 5 g~~l~~~y~~-~~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
...+.+.|++ +++||+|+||.||+|++. .+++.||||++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 3456778988 668999999999999976 4689999999975432 2467899999999999999999999954
Q ss_pred --CCEEEEEEeecCCCChhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe----cCC
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSK----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DEN 145 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----~~~ 145 (450)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 7799999999975 78777642 149999999999999999999999999999999999999 678
Q ss_pred CCeEEeecCchhhhhcccC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-------
Q 045214 146 GMLKVTDFGLSALAKCKHQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL------- 217 (450)
Q Consensus 146 ~~vkl~DFGls~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~------- 217 (450)
+.+||+|||+|........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 8999999999976543211 12334568999999999998766556899999999999999999999976443
Q ss_pred --HHHHHHHhhc-CCCCC-------------------------------------CCCcHHHHHHHHHccCCCCCCCCCH
Q 045214 218 --MAMYRKIAKA-DYKFP-------------------------------------TWFSADVRKLLSRILDPNPSTRISI 257 (450)
Q Consensus 218 --~~~~~~i~~~-~~~~p-------------------------------------~~~s~~~~~ll~~~L~~dP~~R~s~ 257 (450)
.+....+... ..+.+ ...++++.+||.+||++||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 1222222211 11100 0126789999999999999999999
Q ss_pred HHHhcCccccccC
Q 045214 258 AKIMENPWFRKGL 270 (450)
Q Consensus 258 ~eil~hp~f~~~~ 270 (450)
+|+|+||||+...
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=386.68 Aligned_cols=253 Identities=23% Similarity=0.426 Sum_probs=218.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
.-.++|++++.||+|+||.||+|++.. ++..||+|++..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345789999999999999999999753 456799999976532 23457789999999999 89999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+.+.+.+|+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 99999999999999999999998652 3789999999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999998754433222233445678899999999887764 89999999999999999 9999999887777
Q ss_pred HHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.... ...|..++.++.++|.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 76665543 4567789999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=386.82 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=214.5
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CC-----CccEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HP-----NVMQIYE 77 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~ 77 (450)
.|+.+.++|++.+.||+|+||+||+|++..+++.||||++.... ....++.+|+.+++.++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 46778899999999999999999999999999999999997543 33466788999988885 55 4999999
Q ss_pred EEEeCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEec--CCCCeEE
Q 045214 78 VMASKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCH--SRGVYHRDLKPENLLLD--ENGMLKV 150 (450)
Q Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH--~~gi~HrDikp~NILl~--~~~~vkl 150 (450)
++...+.+|+||||+.| +|.+++.. +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999965 99999865 35999999999999999999999 57999999999999995 4778999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK 230 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 230 (450)
+|||+|.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 203 ~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 203 VDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccCceecc-----cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999986543 223456899999999999887765 8999999999999999999999998877666655432111
Q ss_pred CC-------------------------------------CC---------------------------CcHHHHHHHHHc
Q 045214 231 FP-------------------------------------TW---------------------------FSADVRKLLSRI 246 (450)
Q Consensus 231 ~p-------------------------------------~~---------------------------~s~~~~~ll~~~ 246 (450)
.| .. .++++.+||.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 00 00 013789999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccc
Q 045214 247 LDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
|++||++|||++|+|+||||++.
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=380.66 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=213.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE--
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK-- 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (450)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 456899999999999999999999999999999999976432 22345678899999999999999999999987654
Q ss_pred ----EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 85 ----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 85 ----~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.|+||||+. ++|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 488877754 59999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC------------
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD------------ 228 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 228 (450)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 12345789999999999874445689999999999999999999999887665555443210
Q ss_pred -------------------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -------------------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -------------------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
...++.+++++.+||.+||+.||++|||++++++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1123457899999999999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=380.48 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=213.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC------ccEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTG-QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN------VMQIY 76 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~ 76 (450)
.|+.+.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 47789999999999999999999999998876 689999997543 23467788999999987665 99999
Q ss_pred EEEEeCCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe-----------
Q 045214 77 EVMASKTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----------- 142 (450)
Q Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----------- 142 (450)
+++...+..|+||||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 5567776654 369999999999999999999999999999999999999
Q ss_pred --------cCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC
Q 045214 143 --------DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD 214 (450)
Q Consensus 143 --------~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 214 (450)
+.++.+||+|||++.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999986432 122356899999999999887764 899999999999999999999998
Q ss_pred CcHHHHHHHHhhcCCCCCC--------------------------------------------CCcHHHHHHHHHccCCC
Q 045214 215 SNLMAMYRKIAKADYKFPT--------------------------------------------WFSADVRKLLSRILDPN 250 (450)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p~--------------------------------------------~~s~~~~~ll~~~L~~d 250 (450)
.+.......+.....+.|. ..+.++.+||.+||++|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 7766554444332222221 12457899999999999
Q ss_pred CCCCCCHHHHhcCccccc
Q 045214 251 PSTRISIAKIMENPWFRK 268 (450)
Q Consensus 251 P~~R~s~~eil~hp~f~~ 268 (450)
|.+|||++|+++||||+.
T Consensus 322 P~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTTSCCHHHHTTSGGGGG
T ss_pred hhhCcCHHHHhcChhhcC
Confidence 999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=381.90 Aligned_cols=258 Identities=31% Similarity=0.584 Sum_probs=222.2
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCC--CCCccEEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLIQ--HPNVMQIYEV 78 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~ 78 (450)
.+..+.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 356788999999999999999999999999999999999987643321 11234568999999996 5999999999
Q ss_pred EEeCCEEEEEEeecCC-CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CCCCeEEeecCc
Q 045214 79 MASKTKIYFVMEYAKG-GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDFGL 155 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~~~vkl~DFGl 155 (450)
+...+..|+|||++.+ ++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999986 899999875 6899999999999999999999999999999999999999 788999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF 235 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 235 (450)
+..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .+......++..+
T Consensus 197 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~ 266 (320)
T 3a99_A 197 GALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 266 (320)
T ss_dssp CEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC
T ss_pred cccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccC
Confidence 865432 223456799999999999887776688999999999999999999997643 2344556677889
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
++++.+||.+||+.||.+|||++++++||||+....
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 999999999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=382.74 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=210.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc--------ccchHHHHHHHHHHHHhCCCCCccEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL--------KVGLVDQTKREISVMRLIQHPNVMQIYE 77 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 77 (450)
..+.++|++++.||+|+||.||+|.+.. |+.||||++...... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 4678899999999999999999999854 999999999654322 1223478899999999999999999999
Q ss_pred EEEe-----CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEE
Q 045214 78 VMAS-----KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 78 ~~~~-----~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl 150 (450)
++.. ...+|+||||+.| +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9843 3479999999984 78887765 36999999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-
Q 045214 151 TDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY- 229 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 229 (450)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999864332 22234567999999999998744456899999999999999999999999877666655532110
Q ss_pred -----------------------C--------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 045214 230 -----------------------K--------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLN 271 (450)
Q Consensus 230 -----------------------~--------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~~ 271 (450)
. .++..++.+.+||.+||++||.+|||++|+++||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0 12346888999999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=376.84 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=218.4
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
+.+..++|++.+.||+|+||.||+|++..+++ .||||++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 35567899999999999999999999986655 499999976432 2345678899999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
.+..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999964 57999999999999999999999999999999999999999999999999998755
Q ss_pred hcccCCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCc
Q 045214 160 KCKHQDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFS 236 (450)
Q Consensus 160 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 236 (450)
....... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 3322111 12234567889999999877764 89999999999999999 99999998888877777655 445677899
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||.+||+.||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=371.44 Aligned_cols=255 Identities=27% Similarity=0.504 Sum_probs=209.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------ 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (450)
+.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 5678999999999999999999999999999999996532 335678899999999999999999998754
Q ss_pred -------CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 82 -------KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 82 -------~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
.+..|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4678999999999999999975 3578899999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccc------------CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHHH
Q 045214 153 FGLSALAKCKH------------QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMA 219 (450)
Q Consensus 153 FGls~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~ 219 (450)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99986543211 01223456799999999999876555689999999999999998 66542 3345
Q ss_pred HHHHHhhcCCCCCC----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 220 MYRKIAKADYKFPT----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 220 ~~~~i~~~~~~~p~----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
....+......+|+ ..+..+.++|.+||++||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55566555554444 356779999999999999999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=378.38 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=221.0
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
....++|++.+.||+|+||.||+|++.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3456799999999999999999999973 558999999976532 234577899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-------------------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDi 135 (450)
+.+..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999865 46899999999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCC
Q 045214 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHD 214 (450)
Q Consensus 136 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~ 214 (450)
||+|||++.++.+||+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999765433322333455789999999999877764 89999999999999999 9999999
Q ss_pred CcHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 215 SNLMAMYRKIAKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 215 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+.......+..... ..|..+++++.+||.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 888887777766554 567789999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=364.27 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=217.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 5778999999865432 35688999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 999999999999965 4699999999999999999999999999999999999999999999999999875432211 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~ 244 (450)
......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++++.+++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 22344578899999999877764 89999999999999999 99999998888888777665 44556778999999999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q 045214 245 RILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~h 263 (450)
+||+.||++|||+.++++|
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=381.34 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=201.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT--- 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (450)
...++|++.+.||+|+||.||+|++..+|+.||||++..+... ..+..+|+..++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4567999999999999999999999999999999998665432 234567888888999999999999986543
Q ss_pred ----EEEEEEeecCCCChhhHH----hc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEecC-CCCeEEe
Q 045214 84 ----KIYFVMEYAKGGELFKKV----SK-GKLKEDTARKYFQQLISAIDFCH--SRGVYHRDLKPENLLLDE-NGMLKVT 151 (450)
Q Consensus 84 ----~~~lv~E~~~gg~L~~~i----~~-~~l~e~~~~~~~~qll~aL~~LH--~~gi~HrDikp~NILl~~-~~~vkl~ 151 (450)
.+|+||||++++ |.+.+ .. ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 389999999875 43332 23 57999999999999999999999 999999999999999996 8999999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC--
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-- 229 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-- 229 (450)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 175 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999875432 22234567899999999997766556899999999999999999999999887766666543110
Q ss_pred ------------------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 ------------------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ------------------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+...++++.+||.+||++||.+|||+.|+++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 1112256889999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.89 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=193.8
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC--CCCCccEEE-------EEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI--QHPNVMQIY-------EVMAS 81 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~ 81 (450)
.|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 499999999999999999999999999999999987654444566778886555544 699988865 55544
Q ss_pred C-----------------CEEEEEEeecCCCChhhHHhc--CCCCHHHH------HHHHHHHHHHHHHHHHCCCeecCCC
Q 045214 82 K-----------------TKIYFVMEYAKGGELFKKVSK--GKLKEDTA------RKYFQQLISAIDFCHSRGVYHRDLK 136 (450)
Q Consensus 82 ~-----------------~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~------~~~~~qll~aL~~LH~~gi~HrDik 136 (450)
. ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||+|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3 34899999999 799999975 24444444 5667999999999999999999999
Q ss_pred CCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCCC
Q 045214 137 PENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFHD 214 (450)
Q Consensus 137 p~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 214 (450)
|+|||++.+|.+||+|||+|..... ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999875431 1224567799999999976 445 5899999999999999999999987
Q ss_pred CcHHH--HHHH-----HhhcCCCCC--CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 215 SNLMA--MYRK-----IAKADYKFP--TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 215 ~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..... .+.. .......+| ..+++++.+||.+||++||++|||++++++||||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 64321 1110 011122233 468999999999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=366.19 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=213.9
Q ss_pred CcccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 045214 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVM 79 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (450)
|...++++.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+ +|+||+++++++
T Consensus 1 Ms~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp -----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 6778899999999999999999999999999999999999998754322 3467899999999 899999999999
Q ss_pred EeCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC-----eEEee
Q 045214 80 ASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM-----LKVTD 152 (450)
Q Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~-----vkl~D 152 (450)
.+....|+||||+ |++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999999999 9999999975 46999999999999999999999999999999999999987776 99999
Q ss_pred cCchhhhhcccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHH
Q 045214 153 FGLSALAKCKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKI 224 (450)
Q Consensus 153 FGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i 224 (450)
||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... +....+..+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 9998755432221 12345679999999999988776 48999999999999999999999874 334444444
Q ss_pred hhcCCC-----CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 225 AKADYK-----FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 225 ~~~~~~-----~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...... .+..+++++.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 333221 22457899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=381.57 Aligned_cols=255 Identities=22% Similarity=0.428 Sum_probs=221.7
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGT-------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYE 77 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (450)
.+..++|++++.||+|+||.||+|++..+ +..||+|++..... .....++.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45567999999999999999999998643 35799999976532 23457788999999999 9999999999
Q ss_pred EEEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 045214 78 VMASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENL 140 (450)
Q Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NI 140 (450)
++.+.+..|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999999999999753 389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHH
Q 045214 141 LLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA 219 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 219 (450)
|++.++.+||+|||+|................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998755433322334455688999999999877664 89999999999999999 999999988888
Q ss_pred HHHHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 220 MYRKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
....+... ....|..+++++.+||.+||++||++|||+++++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777655 445677899999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=366.70 Aligned_cols=250 Identities=27% Similarity=0.479 Sum_probs=208.9
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecCC
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
...||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 349999999999999999999999999997653 23356788999999999999999999999999999999999999
Q ss_pred CChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-CCCeEEeecCchhhhhcccCCCCcc
Q 045214 95 GELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-NGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 95 g~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...... .....
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 181 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTE 181 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCccc
Confidence 9999998753 4678999999999999999999999999999999999987 899999999998654321 12234
Q ss_pred cccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcHH-H-HHH-HHhhcCCCCCCCCcHHHHHHHHH
Q 045214 170 TTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNLM-A-MYR-KIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~-~~~-~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
...||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... . ... ........+|..+++++.+||.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 567999999999997643 2357999999999999999999999764322 2 222 12233456677899999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccc
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
||++||++|||++++++||||+..
T Consensus 262 ~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=382.41 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=213.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEE-----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYAR-----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
.-.++|++++.||+|+||.||+|+ +..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 446799999999999999999999 455678999999976532 23356789999999999 7999999999987
Q ss_pred eCC-EEEEEEeecCCCChhhHHhcCC------------------------------------------------------
Q 045214 81 SKT-KIYFVMEYAKGGELFKKVSKGK------------------------------------------------------ 105 (450)
Q Consensus 81 ~~~-~~~lv~E~~~gg~L~~~i~~~~------------------------------------------------------ 105 (450)
+.+ .+|+||||++||+|.+++....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 4999999999999999996531
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 106 -------------LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 106 -------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999987543322222334557
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHH-HHHHHhh-cCCCCCCCCcHHHHHHHHHccCC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA-MYRKIAK-ADYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~-~~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+... ....+.. .....|..+++++.+++.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999887765 89999999999999998 999998865433 3333333 34567788999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 045214 250 NPSTRISIAKIMEN 263 (450)
Q Consensus 250 dP~~R~s~~eil~h 263 (450)
||.+|||++|+++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=376.63 Aligned_cols=256 Identities=34% Similarity=0.636 Sum_probs=210.8
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhC----CCCCccEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---GLVDQTKREISVMRLI----QHPNVMQIY 76 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~ 76 (450)
.+..+.++|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 456788999999999999999999999999999999999976543221 1123356799999988 899999999
Q ss_pred EEEEeCCEEEEEEee-cCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec-CCCCeEEeec
Q 045214 77 EVMASKTKIYFVMEY-AKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD-ENGMLKVTDF 153 (450)
Q Consensus 77 ~~~~~~~~~~lv~E~-~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~-~~~~vkl~DF 153 (450)
+++.+.+..|+|||+ +.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999999975 6799999999999999999999999999999999999999 8899999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT 233 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (450)
|++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+......++.
T Consensus 185 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254 (312)
T ss_dssp SSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred chhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence 99865432 223456799999999999887776568999999999999999999997642 23455667888
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.++.++.+||.+||+.||++|||++|+++||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 899999999999999999999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=360.82 Aligned_cols=249 Identities=29% Similarity=0.536 Sum_probs=205.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
-.++|++.+.||+|+||.||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 357899999999999999999998 58899999997654332 234577889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEecC--------CCCeEEeecCc
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG---VYHRDLKPENLLLDE--------NGMLKVTDFGL 155 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~g---i~HrDikp~NILl~~--------~~~vkl~DFGl 155 (450)
+||||++|++|.+++..+.+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999998889999999999999999999999999 999999999999986 77899999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--CCCCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--YKFPT 233 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~ 233 (450)
+...... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+.... .+.|.
T Consensus 163 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 163 AREWHRT----TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred ccccccc----cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 8754322 22345799999999999877664 89999999999999999999999887776666555443 45567
Q ss_pred CCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 234 WFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 234 ~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+++++.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 789999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=376.58 Aligned_cols=253 Identities=34% Similarity=0.632 Sum_probs=185.7
Q ss_pred ccccccCeeeec-eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--
Q 045214 5 GKVLMQKYELGR-LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-- 81 (450)
Q Consensus 5 g~~l~~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (450)
+..+.++|++.+ .||+|+||.||+|++..+++.||||++.... ....+....++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 456889999965 6999999999999999999999999996542 111223334677799999999999876
Q ss_pred --CCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC---CCeEEeec
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN---GMLKVTDF 153 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~---~~vkl~DF 153 (450)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 55699999999999999999763 59999999999999999999999999999999999999864 45999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH----HHHHhhcCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM----YRKIAKADY 229 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~ 229 (450)
|++.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||........ ...+.....
T Consensus 176 g~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp TTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 9986433 2223456889999999999776664 799999999999999999999987654332 222333333
Q ss_pred CCC----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 KFP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ~~p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+| ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 332 3589999999999999999999999999999999763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=371.55 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=218.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
+...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 345678999999999999999999984 456899999997543 2234577899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSKG-------------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDi 135 (450)
+.+..|+||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999999999999652 2889999999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCC
Q 045214 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHD 214 (450)
Q Consensus 136 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~ 214 (450)
||+|||++.++.+||+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998654322221122345678899999999877664 89999999999999999 9999998
Q ss_pred CcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 215 SNLMAMYRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 215 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+.......+.... ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88777776665543 45677899999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=365.80 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=209.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
...++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45689999999999999999999999999999999998765544455678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-L 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-c
Confidence 99999999999999976 679999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVRKL 242 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 242 (450)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...+...+..... ..++.+++++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 22335579999999999987665 4899999999999999999999998877655554443322 2356689999999
Q ss_pred HHHccCCCCCCCC-CHHHHhc
Q 045214 243 LSRILDPNPSTRI-SIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~-s~~eil~ 262 (450)
|.+||++||++|| |++++++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 7888775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=369.79 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=210.4
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 3579999999999999999999999999999999985432 2345778999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||++|++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999976 57999999999999999999999999999999999999999999999999998654322111
Q ss_pred ------------CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH-----HHHHHhhcC
Q 045214 166 ------------GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA-----MYRKIAKAD 228 (450)
Q Consensus 166 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-----~~~~i~~~~ 228 (450)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||....... ...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~ 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--D 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--H
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--c
Confidence 111256799999999999887764 89999999999999999999987532210 001111 1
Q ss_pred CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 229 YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 229 ~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...|+.+++++.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2346778899999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=378.90 Aligned_cols=253 Identities=25% Similarity=0.474 Sum_probs=207.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----------CCCccEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-----------HPNVMQI 75 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l 75 (450)
...++|++.+.||+|+||.||+|++..+++.||||++..+.. ....+.+|+.+++.++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 346799999999999999999999999999999999975432 3456788999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecC---
Q 045214 76 YEVMASKT----KIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDE--- 144 (450)
Q Consensus 76 ~~~~~~~~----~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~--- 144 (450)
++++...+ .++++|||+ |++|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 899999999 8899999865 4699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH----
Q 045214 145 ---NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---- 217 (450)
Q Consensus 145 ---~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---- 217 (450)
.+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999865432 2234579999999999988776 4899999999999999999999986541
Q ss_pred --HHHHHHHh------------------------------------------hcCCCCCCCCcHHHHHHHHHccCCCCCC
Q 045214 218 --MAMYRKIA------------------------------------------KADYKFPTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 218 --~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
......+. .....++..++.++.+||.+||++||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111 1222344456788999999999999999
Q ss_pred CCCHHHHhcCccccccC
Q 045214 254 RISIAKIMENPWFRKGL 270 (450)
Q Consensus 254 R~s~~eil~hp~f~~~~ 270 (450)
|||++|+++||||+...
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.37 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=216.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+++.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45679999999999999999999875 5678999999765432 356889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999999999975 3599999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (450)
.......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|...++++.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 112234567789999999877664 89999999999999999 999999988877777766554 34566789999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 045214 243 LSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~h 263 (450)
|.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=359.97 Aligned_cols=252 Identities=20% Similarity=0.354 Sum_probs=217.5
Q ss_pred CcccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
|.....+-.++|++.+.||+|+||.||+|++ +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp ---CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 6677778889999999999999999999998 48899999998754322 34567899999999999999999999998
Q ss_pred eC--CEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEeec
Q 045214 81 SK--TKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 81 ~~--~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~DF 153 (450)
+. +..|+||||++||+|.+++... .+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 77 7899999999999999999864 4899999999999999999999999 999999999999999999999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCC--ccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--CC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGD--KADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA--DY 229 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~ 229 (450)
|++... ......||+.|+|||++.+..+... ++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 158 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 158 DVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp GSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 876432 1234578999999999987655433 799999999999999999999988877766665544 34
Q ss_pred CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 ~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..|..+++++.++|.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567789999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.95 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=215.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-.++|++++.||+|+||.||+|.+. ++..||+|++...... .+++.+|+.+++.++||||+++++++.+.+..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 44578999999999999999999885 6778999999865432 356889999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999976 5799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (450)
.......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...|...++++.++
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 11233457889999999987776 489999999999999998 999999988887777776653 44567789999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 045214 243 LSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~h 263 (450)
|.+||+.||.+|||++++++|
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=374.38 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=211.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (450)
.++.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 35667899999999999999999999999999999998765322 3477899999999 99999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC-----eEEeecCchh
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM-----LKVTDFGLSA 157 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~-----vkl~DFGls~ 157 (450)
.|+||||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999974 68999999999999999999999999999999999999998887 9999999987
Q ss_pred hhhcccCCC-----CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC---cHHHHHHHHhhcCC
Q 045214 158 LAKCKHQDG-----LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS---NLMAMYRKIAKADY 229 (450)
Q Consensus 158 ~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~ 229 (450)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 543322111 1245689999999999988776 48999999999999999999999873 44555556544433
Q ss_pred CCC-----CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 KFP-----TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 ~~p-----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..| ..++ ++.+++.+||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 333 2244 9999999999999999999998876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=371.48 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=208.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEE----EEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSV----AIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
...++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 34578999999999999999999998887765 677665432 223457789999999999999999999999876
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
. .++++||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7889999999999999865 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
............+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 44333333445678899999999887764 89999999999999999 99999988776666665544 34567778999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=382.72 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=215.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987542 123345678999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999999975 369999999999999999999999999999999999999999999999999986432211111
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~ 244 (450)
......+++.|+|||++....+. .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.+||.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 11122356789999999877664 89999999999999998 99999998877766666544 45667789999999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 045214 245 RILDPNPSTRISIAKIME 262 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~ 262 (450)
+||+.||++|||++++++
T Consensus 350 ~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=372.98 Aligned_cols=252 Identities=20% Similarity=0.341 Sum_probs=212.6
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
..++|++.+.||+|+||.||+|++..+++. ||+|.+...... .....+.+|+.+++.++||||+++++++. ++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 356899999999999999999999888876 677766443211 22245678999999999999999999886 45
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|+||||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 68999999999999999975 4799999999999999999999999999999999999999999999999999986644
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADV 239 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (450)
...........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..++.++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 4333344556788899999999877764 89999999999999999 99999988777776666554 455677789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=369.47 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=220.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|++...... .....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 456789999999999999999999986 35788999999754322 23456889999999999999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeE
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLK 149 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vk 149 (450)
+.+..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999999864 3579999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC
Q 045214 150 VTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD 228 (450)
Q Consensus 150 l~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 228 (450)
|+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999998755433222223345678999999999877664 89999999999999999 899999988887777776554
Q ss_pred -CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 229 -YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 229 -~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
...|..+++++.+||.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 34677799999999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=364.90 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=211.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCC-------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTG-------QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEV 78 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (450)
++..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998877 479999997543 2345778999999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC--------e
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--------L 148 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--------v 148 (450)
+.+.+..|+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999764 3999999999999999999999999999999999999998887 9
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~ 227 (450)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| ..||...+.... ......
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYED 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhc
Confidence 9999998854321 12346889999999998744456899999999999999995 555555554433 334445
Q ss_pred CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 228 DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 228 ~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....|...++++.+||.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66677778999999999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=371.38 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=217.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEE-----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYAR-----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM 79 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (450)
.++..++|++++.||+|+||.||+|+ +..+++.||||++..... .....++.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 45678899999999999999999999 556788999999965432 23346788999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCChhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC---CCe
Q 045214 80 ASKTKIYFVMEYAKGGELFKKVSKG--------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN---GML 148 (450)
Q Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~---~~v 148 (450)
.+.+..|+||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999753 38999999999999999999999999999999999999854 469
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 227 (450)
||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 99999998765433322333455789999999999877664 89999999999999998 99999988877777766554
Q ss_pred -CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 228 -DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 228 -~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
....+..+++++.++|.+||+.||.+|||+.++++|.|+..
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 34566779999999999999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=366.08 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=210.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--CCCccEEEEEEEeCCE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ--HPNVMQIYEVMASKTK 84 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~ 84 (450)
+..++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 45568999999999999999999985 5899999999765432 234577899999999997 5999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
.|+||| +.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 999999 567899999976 5799999999999999999999999999999999999996 4899999999987654333
Q ss_pred CCCCcccccCCCcccCchhcccC----------CCCCCccchhhHHHHHHHHhhCCCCCCCCc-HHHHHHHHhhc--CCC
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRR----------GYDGDKADIWSCGVILYVLLAGYLPFHDSN-LMAMYRKIAKA--DYK 230 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~ 230 (450)
........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 22233456799999999998652 233579999999999999999999998753 23333333332 345
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
+|...+.++.++|.+||+.||.+|||++|+++||||+...
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 6777889999999999999999999999999999998643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=374.02 Aligned_cols=255 Identities=21% Similarity=0.362 Sum_probs=213.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (450)
-.++|++++.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 3568999999999999999999973 4567899999975432 23346789999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKG------------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKP 137 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp 137 (450)
.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 99999999999999999999752 278999999999999999999999999999999
Q ss_pred CcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCc
Q 045214 138 ENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSN 216 (450)
Q Consensus 138 ~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~ 216 (450)
+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999998765433222223345678899999999877664 89999999999999998 999998866
Q ss_pred HHHHHHHHhhc--CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 217 LMAMYRKIAKA--DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 217 ~~~~~~~i~~~--~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.......+... ....|..+++++.+||.+||+.||.+|||+.++++|..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 54443333333 34557778999999999999999999999999998554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=362.57 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=205.9
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
.+..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 46678999999999999999999998654 4579999987543 2234567889999999999999999999984 5
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
+..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 678999999999999999975 369999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
.... .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+... ..+.|+.++++
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2211 112334578899999999877664 89999999999999996 99999988777666666554 34577789999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.++|.+||+.||++|||+.++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=368.45 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=214.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEE-----cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARH-----LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
...++|++.+.||+|+||.||+|.+ ..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3457999999999999999999995 457789999999765422 3357789999999999 9999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSKG-------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+.+..|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 999999999999999999998653 3899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999998765433222223345678899999999877664 89999999999999999 9999988665433
Q ss_pred HHHHhhc--CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAKA--DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~~--~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....... ....+..+++++.++|.+||++||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3333322 23346678999999999999999999999999997
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=364.15 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=208.6
Q ss_pred cccccccCeeeeceEeecCCeEEEEEE----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEE
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM 79 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (450)
.++...++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456778999999999999999999999 56689999999997543 23456788999999999999999999998
Q ss_pred Ee--CCEEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 80 AS--KTKIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 80 ~~--~~~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
.. ...+|+||||++|++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 45689999999999999999763 599999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH----------------
Q 045214 156 SALAKCKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---------------- 218 (450)
Q Consensus 156 s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------- 218 (450)
+......... .......+|+.|+|||++.+..+. .++|||||||++|+|++|..||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 8765432211 122344577889999999887764 8999999999999999999998754321
Q ss_pred HHHHHHh-hcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 219 AMYRKIA-KADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 219 ~~~~~i~-~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.....+. ....+.|..+++++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1122222 2345567789999999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=369.01 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=216.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc-------CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL-------GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEV 78 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (450)
+-.++|++++.||+|+||.||+|++. .++..||+|++..... ......+.+|+.+++.+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34579999999999999999999986 3577899999976532 23456788999999999 89999999999
Q ss_pred EEeCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 045214 79 MASKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLL 141 (450)
Q Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NIL 141 (450)
+.+.+..|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 99999999999999999999999753 3889999999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHH
Q 045214 142 LDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAM 220 (450)
Q Consensus 142 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 220 (450)
++.++.+||+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999998654332211122344678899999999876664 89999999999999999 9999999888877
Q ss_pred HHHHhhcC-CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAKAD-YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.... ...|..+++++.++|.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77766553 4567779999999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=369.59 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=208.5
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEE----EEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSV----AIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
...++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34578999999999999999999998888766 555554322 223467889999999999999999999999876
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
. .++++||+.+|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999865 579999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
............+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887764 89999999999999999 99999988777766666554 35567779999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.++|.+||+.||.+|||+.|+++
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=361.44 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=220.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
.++..++|++.+.||+|+||.||+|.+..+++.||+|++..+. ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4566789999999999999999999999999999999997643 235678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 85 IYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999999975 3599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADV 239 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (450)
.. ........+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++++
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 21 1122334578899999999877764 89999999999999999 99999988877766666554 445677899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 045214 240 RKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+||.+||++||.+|||++++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=361.84 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=197.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.++..+++.++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 3568999999999999999999999999999999998654322 223344555567888899999999999999999999
Q ss_pred EEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||||+ ++.+..+.. .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-- 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--
Confidence 99999 555555554 36799999999999999999999995 9999999999999999999999999998654322
Q ss_pred CCCcccccCCCcccCchhccc----CCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHHHHHhhcCCC-CC--CCCc
Q 045214 165 DGLLHTTCGTPAYVAPEVISR----RGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIAKADYK-FP--TWFS 236 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~-~p--~~~s 236 (450)
.......||+.|+|||++.. ....+.++|||||||++|+|++|..||... +.......+...... .| ..++
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence 22334579999999999852 223358999999999999999999999873 444555555444332 33 3478
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 237 ADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 237 ~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+++.+||.+||+.||.+|||++++++||||+.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 99999999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=368.87 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=202.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----E
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT----K 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (450)
.++|++.+.||+|+||.||+|++. ++.||||++.... ....+..+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 458999999999999999999884 7999999997543 22345667999999999999999999997743 4
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCcEEecCCCCeEEeecC
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR----------GVYHRDLKPENLLLDENGMLKVTDFG 154 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~----------gi~HrDikp~NILl~~~~~vkl~DFG 154 (450)
+|+||||+++|+|.+++..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 79999999999999999988899999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhcccCCCCcccccCCCcccCchhcccCCC----CCCccchhhHHHHHHHHhhCCCCCCCCc--------------
Q 045214 155 LSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY----DGDKADIWSCGVILYVLLAGYLPFHDSN-------------- 216 (450)
Q Consensus 155 ls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------------- 216 (450)
+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9976544333333445689999999999976322 2357899999999999999999997532
Q ss_pred --HHHHHHHHhhcCCC--CCCC-----CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 217 --LMAMYRKIAKADYK--FPTW-----FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 217 --~~~~~~~i~~~~~~--~p~~-----~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.......+...... .+.. .++++.+||.+||+.||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222222222211 1111 2345999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=360.58 Aligned_cols=253 Identities=22% Similarity=0.434 Sum_probs=200.1
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
.+++..++|++.+.||+|+||.||+|++. ..||+|++...... ....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 46788899999999999999999999864 35999999765432 23457789999999999999999999965 556
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..++||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999954 4799999999999999999999999999999999999999999999999999875543
Q ss_pred ccCCCCcccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCCC-----CC
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADYK-----FP 232 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~-----~p 232 (450)
...........||+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.. .....+...... .+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 33333344567999999999986 3333 47899999999999999999999885544 444444443332 23
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+++++.+||.+||+.||.+|||++++++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 357899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=354.20 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=216.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999986 6788999999875432 36788999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 999999999999975 4699999999999999999999999999999999999999999999999999875432111 1
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLS 244 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~ 244 (450)
......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|..+++++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 12334678899999999877664 89999999999999999 899999988887777776653 3456678999999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 045214 245 RILDPNPSTRISIAKIME 262 (450)
Q Consensus 245 ~~L~~dP~~R~s~~eil~ 262 (450)
+||+.||.+|||+.++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=356.69 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=210.3
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccch----HHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGL----VDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
+....++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3456789999999999999999999999999999999997654332211 267889999999999999999999997
Q ss_pred eCCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCC-----eEEe
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGM-----LKVT 151 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~-----vkl~ 151 (450)
+.. ++||||++|++|.+.+.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 699999999999998854 47999999999999999999999999 999999999999988876 9999
Q ss_pred ecCchhhhhcccCCCCcccccCCCcccCchhcccC-CCCCCccchhhHHHHHHHHhhCCCCCCCCcHH--HHHHHHhhc-
Q 045214 152 DFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR-GYDGDKADIWSCGVILYVLLAGYLPFHDSNLM--AMYRKIAKA- 227 (450)
Q Consensus 152 DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~- 227 (450)
|||++.... .......||+.|+|||++... ...+.++|||||||++|+|++|..||...+.. .....+...
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 999886322 223456799999999998432 22357899999999999999999999875432 223333333
Q ss_pred -CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 228 -DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 228 -~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
....|..+++++.+||.+||+.||.+|||++++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33567779999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=358.10 Aligned_cols=255 Identities=32% Similarity=0.612 Sum_probs=207.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
|....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34567799999999999999999999999999999999987554444556788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
.|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999998853 46999999999999999999999999999999999999999999999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC--cHHHHHHHHhhcCCCC--CCCC
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS--NLMAMYRKIAKADYKF--PTWF 235 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~ 235 (450)
... ........||+.|+|||++.+..+. .++||||||+++|+|++|..||.+. +.......+.....+. +..+
T Consensus 187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred cCC--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 322 1223345799999999999877664 8999999999999999999999764 3344555555544332 2458
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=367.14 Aligned_cols=253 Identities=21% Similarity=0.386 Sum_probs=214.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQ-----SVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
...++|++.+.||+|+||.||+|.+..+++ .||+|++..... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345789999999999999999999987664 799999976542 23456788999999999 8999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK---------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN 145 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~ 145 (450)
+.+..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 99999999999999999999853 357999999999999999999999999999999999999999
Q ss_pred CCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHH
Q 045214 146 GMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKI 224 (450)
Q Consensus 146 ~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 224 (450)
+.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999998755433222223345678899999999877664 89999999999999998 99999886554444343
Q ss_pred hhc--CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 225 AKA--DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 225 ~~~--~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
... ....|...++++.++|.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 333 33456778999999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=365.56 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=214.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEE--EEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSV--AIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
.-.++|++.+.||+|+||.||+|++..++..+ |+|.+..... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34578999999999999999999998888865 9998875332 23346788999999999 9999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC
Q 045214 84 KIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~ 146 (450)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999999653 589999999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHh
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIA 225 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 225 (450)
.+||+|||++...... .......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998633221 112334678899999999876664 89999999999999998 999999988888877776
Q ss_pred hc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 226 KA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 226 ~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.. ....|..+++++.+||.+||+.||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55 345667789999999999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=356.97 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=216.3
Q ss_pred cccCeeeec-eEeecCCeEEEEEEEc--CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 8 LMQKYELGR-LLGQGNFAKVYYARHL--GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 8 l~~~y~~~~-~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
-.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 356788887 9999999999999864 468889999997653 223457789999999999999999999999 4556
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999999964 46999999999999999999999999999999999999999999999999998754322
Q ss_pred cC-CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHH
Q 045214 163 HQ-DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADV 239 (450)
Q Consensus 163 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (450)
.. ........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+.... ..+|..+++++
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 11 1112334578999999999876664 89999999999999998 999999888777777766543 45678899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
.++|.+||+.||.+|||+.+++++.+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999998655
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=362.30 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=204.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT- 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (450)
-.++|.+++.||+|+||.||+|.+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35689999999999999999998765 5568999999765432 234567889999999999999999999987655
Q ss_pred ----EEEEEEeecCCCChhhHHh------c-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 84 ----KIYFVMEYAKGGELFKKVS------K-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 84 ----~~~lv~E~~~gg~L~~~i~------~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
..|+||||+++++|.+++. . ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 3599999999999999983 2 4699999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCC
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYK 230 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~ 230 (450)
||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 9998765433222223345678899999999877664 89999999999999999 99999988777777666554 345
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.|..+++++.++|.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67779999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=365.13 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=213.0
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
...++|++.+.||+|+||.||+|++. .+++.||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 34578999999999999999999953 4678999999976532 23346788999999999 7999999999987
Q ss_pred eCC-EEEEEEeecCCCChhhHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe
Q 045214 81 SKT-KIYFVMEYAKGGELFKKVSKGK-----------------LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL 142 (450)
Q Consensus 81 ~~~-~~~lv~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl 142 (450)
..+ .+|+||||++|++|.+++.... +++..++.++.|++.||.|||++||+||||||+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 5999999999999999997632 8899999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHH-HH
Q 045214 143 DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLM-AM 220 (450)
Q Consensus 143 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~ 220 (450)
+.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.. ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999998754332222222345688999999999877764 89999999999999998 99999876543 33
Q ss_pred HHHHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 221 YRKIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 221 ~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
...+... ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3344333 345677899999999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=372.48 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=206.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+-.++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 44568999999999999999999987 467789999997643 2234567899999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999999976 3699999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 162 KHQDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 162 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
..... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278 (373)
T ss_dssp --------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 22111 11223457889999999877765 89999999999999998 99999988887777766544 34556678999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.+++.+||+.||.+|||++++++
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=365.59 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=191.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS-VMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
...++|++++.||+|+||.||+|.+..+|+.||||++...... ....++.+|+. +++.++||||+++++++.+.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 4467999999999999999999999999999999999765322 22345556665 77788999999999999999999
Q ss_pred EEEEeecCCCChhhHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 86 YFVMEYAKGGELFKKVS------KGKLKEDTARKYFQQLISAIDFCHSR-GVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
|+||||++| +|.+++. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999986 7777765 46799999999999999999999999 999999999999999999999999999865
Q ss_pred hhcccCCCCcccccCCCcccCchhcc----cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH-HHHHHHhhcCC-CCC
Q 045214 159 AKCKHQDGLLHTTCGTPAYVAPEVIS----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM-AMYRKIAKADY-KFP 232 (450)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~-~~p 232 (450)
.... .......||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.. .....+..... .++
T Consensus 176 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp ---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred cccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 4322 1223447999999999983 3344 58999999999999999999999875432 22222222221 122
Q ss_pred ----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 233 ----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 233 ----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 3478999999999999999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=356.54 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=215.1
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS- 81 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (450)
+-+..+.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 346678899999999999999999999999999999999997653 245689999999999999999998854
Q ss_pred ---------------CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec
Q 045214 82 ---------------KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD 143 (450)
Q Consensus 82 ---------------~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~ 143 (450)
...+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 4568999999999999999954 4799999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH
Q 045214 144 ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK 223 (450)
Q Consensus 144 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 223 (450)
.++.+||+|||++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~ 230 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTD 230 (284)
T ss_dssp ETTEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHH
T ss_pred CCCCEEECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHH
Confidence 9999999999998654322 22345579999999999987766 48999999999999999999987532 233333
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 224 IAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 224 i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+.. ...+..++.++.++|.+||+.||.+|||+.|+++|.|.-+
T Consensus 231 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 LRD--GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHT--TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hhc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 333 2356778999999999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=358.62 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=209.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEE----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
+....++|++++.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34556789999999999999999999 566899999999976542 234578899999999999999999999998
Q ss_pred eC--CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 81 SK--TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 81 ~~--~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+. ..+|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 679999999999999999954 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---------------HHHH
Q 045214 157 ALAKCKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---------------LMAM 220 (450)
Q Consensus 157 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~ 220 (450)
......... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 654322211 123345688899999999887765 89999999999999999998864321 1122
Q ss_pred HHHHhh-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 221 YRKIAK-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 221 ~~~i~~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
...+.. ...+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222222 244567789999999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.29 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=211.5
Q ss_pred ccCeeeec-eEeecCCeEEEEEEE--cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGR-LLGQGNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~-~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 45799998 999999999999954 55788999999976542 234467889999999999999999999999 56678
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 999999999999999976 4699999999999999999999999999999999999999999999999999865432211
Q ss_pred C-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHH
Q 045214 165 D-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRK 241 (450)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (450)
. .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|..+++++.+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 111233567899999999877664 79999999999999999 999999988877777766543 4567789999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
+|.+||+.||.+|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.17 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=209.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
..++|++.+.||+|+||.||+|++ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 567999999999999999999996 4689999999876532 345778999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 88 VMEYAKGGELFKKVSKG-----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999998653 4899999999999999999999999999999999999999999999999998654333
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH-------HHHHhhcCC------
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM-------YRKIAKADY------ 229 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~------ 229 (450)
..........||+.|+|||++.+..+. .++|||||||++|+|++|..||........ .........
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 333333455689999999999877664 899999999999999999999976432111 111111111
Q ss_pred ----CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 230 ----KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 230 ----~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
..++..+.++.+++.+||+.||++|||+.|++++..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 112234567899999999999999999999997654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=361.07 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=210.6
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTG----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
+..++|++.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 44568999999999999999999987653 4599999976432 23346788999999999999999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
+..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999999965 579999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcH
Q 045214 161 CKHQDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSA 237 (450)
Q Consensus 161 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (450)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 322111 12233568899999999877664 89999999999999999 99999988887777777655 4456677899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+++.+||+.||.+|||+.++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=354.74 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=207.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEE-EEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE-VMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~ 85 (450)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... .++.+|+.+++.++|++++..+. +.......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 4678999999999999999999999999999999998765422 35789999999999887665554 45778889
Q ss_pred EEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhhh
Q 045214 86 YFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAK 160 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~~ 160 (450)
|+||||+ +++|.+++. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 899999997 3579999999999999999999999999999999999999 488999999999987544
Q ss_pred cccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---HHHHHHHHhhcCCCCC
Q 045214 161 CKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADYKFP 232 (450)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~p 232 (450)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ....+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 32211 11245679999999999988776 489999999999999999999998633 2233334333333333
Q ss_pred -----CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 233 -----TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 233 -----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+++++.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 568999999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=376.47 Aligned_cols=255 Identities=24% Similarity=0.425 Sum_probs=209.7
Q ss_pred ccccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 3 ~~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
..+.++.++|++.+.||+|+||.||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 35678889999999999999999999999999999999999765433 2356778999999999999999999999876
Q ss_pred C--EEEEEEeecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe----cCCCCeEEee
Q 045214 83 T--KIYFVMEYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL----DENGMLKVTD 152 (450)
Q Consensus 83 ~--~~~lv~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl----~~~~~vkl~D 152 (450)
+ ..|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 789999999999999999752 39999999999999999999999999999999999999 7778899999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccC-------CCCCCccchhhHHHHHHHHhhCCCCCCCC----cHHHHH
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR-------GYDGDKADIWSCGVILYVLLAGYLPFHDS----NLMAMY 221 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~ 221 (450)
||++...... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ...+..
T Consensus 160 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 160 FGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 9998654322 223456799999999998652 12247899999999999999999999742 223444
Q ss_pred HHHhhcCC---------------------CC----CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 222 RKIAKADY---------------------KF----PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 222 ~~i~~~~~---------------------~~----p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++..+.. +. +..++..+.++|.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 44443321 11 1124567889999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=353.40 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=202.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEE-EEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYE-VMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~ 85 (450)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... .++.+|+.+++.++|++++..+. ++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 4678999999999999999999999999999999987655432 34678999999998877666555 45778899
Q ss_pred EEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhhh
Q 045214 86 YFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAK 160 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~~ 160 (450)
|+||||+ +++|.+++. .+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 999999997 3579999999999999999999999999999999999999 789999999999987544
Q ss_pred cccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---HHHHHHHhhcCCCCC
Q 045214 161 CKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---MAMYRKIAKADYKFP 232 (450)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~p 232 (450)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+. ...+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 32221 12235679999999999988776 4899999999999999999999986432 223333333333333
Q ss_pred -----CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 233 -----TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 233 -----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..+++++.+||.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567899999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.40 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=211.1
Q ss_pred cccccCe-eeeceEeecCCeEEEEEEE----cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 6 KVLMQKY-ELGRLLGQGNFAKVYYARH----LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 6 ~~l~~~y-~~~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
.++.++| ++++.||+|+||.||+|.. ..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 5688888 9999999999999988754 44789999999986532 234577899999999999999999999998
Q ss_pred e--CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhh
Q 045214 81 S--KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 81 ~--~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~ 158 (450)
+ ...+|+||||+++++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7 46899999999999999999988899999999999999999999999999999999999999999999999999875
Q ss_pred hhcccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH---------------HHHH
Q 045214 159 AKCKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---------------AMYR 222 (450)
Q Consensus 159 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~ 222 (450)
....... .......+|+.|+|||++.+..+. .++|||||||++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 4322110 122345688899999999877665 8999999999999999999999764321 1112
Q ss_pred HHhh-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAK-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+.. ...+.|..+++++.+||.+||+.||.+|||++++++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222 234567779999999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.63 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=211.2
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 3456799999999999999999999754 345699999986532 23457789999999999999999999998654
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 56899999999999999965 469999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
.... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.|..+++.
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 2211 112344678899999999877664 89999999999999998 99999876666555555443 44567778999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
+.++|.+||+.||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=366.52 Aligned_cols=252 Identities=16% Similarity=0.224 Sum_probs=199.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC---CCcEEEEEEeecccccccc--------hHHHHHHHHHHHHhCCCCCccEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG---TGQSVAIKAIDKDKILKVG--------LVDQTKREISVMRLIQHPNVMQIYE 77 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~ 77 (450)
.++|++++.||+|+||.||+|++.. ++..+|+|++......... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999999865321100 1133567889999999999999999
Q ss_pred EEEe----CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC--CeEE
Q 045214 78 VMAS----KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG--MLKV 150 (450)
Q Consensus 78 ~~~~----~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~--~vkl 150 (450)
++.. ....|+||||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9987 78999999999 9999999976 4799999999999999999999999999999999999999887 9999
Q ss_pred eecCchhhhhcccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC--CcHHHHHHH
Q 045214 151 TDFGLSALAKCKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD--SNLMAMYRK 223 (450)
Q Consensus 151 ~DFGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--~~~~~~~~~ 223 (450)
+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .+.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999998755332211 11245589999999999987765 4899999999999999999999965 232222222
Q ss_pred HhhcCCCCCC---------CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 224 IAKADYKFPT---------WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 224 i~~~~~~~p~---------~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
........|. .+++++.++|.+||+.||++|||++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2111112222 68899999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.57 Aligned_cols=249 Identities=22% Similarity=0.392 Sum_probs=213.6
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+..++|++++.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.. +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 455689999999999999999999975 567899999976542 24678899999999999999999999864 458
Q ss_pred EEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 86 YFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
|+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999999752 6999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
.. .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+....+... ....|..++.++.
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cc-ccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 11 112234578899999999876664 89999999999999999 99999998887777776554 3445677899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+.||++|||++++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=353.48 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=200.3
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCccEEEEEEEe-
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL--IQHPNVMQIYEVMAS- 81 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~- 81 (450)
++++.++|++.+.||+|+||.||+|++ +++.||||++.... .....+|.+++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 467889999999999999999999988 78999999986542 2445566666666 799999999998643
Q ss_pred ---CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEecCCCCeEE
Q 045214 82 ---KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH--------SRGVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 82 ---~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH--------~~gi~HrDikp~NILl~~~~~vkl 150 (450)
...+|+||||+++|+|.+++....+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999998889999999999999999999999 999999999999999999999999
Q ss_pred eecCchhhhhcccCC--CCcccccCCCcccCchhcccCCCC-----CCccchhhHHHHHHHHhhC----------CCCCC
Q 045214 151 TDFGLSALAKCKHQD--GLLHTTCGTPAYVAPEVISRRGYD-----GDKADIWSCGVILYVLLAG----------YLPFH 213 (450)
Q Consensus 151 ~DFGls~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~ 213 (450)
+|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998654322111 112344799999999999775322 2589999999999999999 88886
Q ss_pred CCc----HHHHHHHHhhcC---CCCCC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 214 DSN----LMAMYRKIAKAD---YKFPT-----WFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 214 ~~~----~~~~~~~i~~~~---~~~p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
... ............ ...|. ..++++.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 532 122222322221 22222 14567999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=374.49 Aligned_cols=242 Identities=26% Similarity=0.471 Sum_probs=209.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-EEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-KIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 86 (450)
-.++|++.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.+|+.++||||+++++++.... .+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 356899999999999999999998 47899999997653 2367889999999999999999999986655 799
Q ss_pred EEEeecCCCChhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK-G--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|.+++.. + .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence 99999999999999975 3 379999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++.+
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ---cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 12234678899999999887764 89999999999999998 99999987776666666554 45677889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||.+|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=351.48 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=209.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE-E
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI-Y 86 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 86 (450)
.|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57778999999999999999766554 79999987533 223457788999999999999999999999766655 9
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc-
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH- 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~- 163 (450)
++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 568999999999999999999999999999999999999999999999999986543222
Q ss_pred -CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHH
Q 045214 164 -QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVR 240 (450)
Q Consensus 164 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (450)
.........+|+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...|..+++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 12223345788999999999877664 89999999999999999 556666666666665555443 456777899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+.||.+|||+.++++
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.59 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=208.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEE-EeCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVM-ASKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 84 (450)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+.... .....+++.+|+.+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34799999999999999999997543 3468999987543 223457788999999999999999999985 55678
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
.|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999975 46899999999999999999999999999999999999999999999999998654322
Q ss_pred cC--CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHH
Q 045214 163 HQ--DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSAD 238 (450)
Q Consensus 163 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (450)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...|..++++
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 1122345678899999999877764 89999999999999999 677888776665555555444 3456778999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.+++.+||++||.+|||+.++++
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=374.38 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=213.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-.++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.+|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34568999999999999999999985 467899999986542 3577899999999999999999999986 56789
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999999975 268999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred e-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 111234567889999999877664 89999999999999999 99999998887777776554 34567789999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||++|||+++|++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=381.75 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=217.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34579999999999999999999998999999999976532 24678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999999975 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
.......+++.|+|||++....+. .++|||||||++|+|++ |..||.+.+....+..+... ....|..+++++.+|
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -eecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112234567889999999877764 89999999999999999 99999988877776666544 345677899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
|.+||+.||.+|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.32 Aligned_cols=252 Identities=15% Similarity=0.207 Sum_probs=199.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCC-----CcEEEEEEeecccccccc--------hHHHHHHHHHHHHhCCCCCccEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGT-----GQSVAIKAIDKDKILKVG--------LVDQTKREISVMRLIQHPNVMQI 75 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l 75 (450)
.++|++++.||+|+||.||+|.+..+ ++.||||++......... ......+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34999999999999999999998764 588999998765421100 01223456677788899999999
Q ss_pred EEEEEeC----CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec--CCCC
Q 045214 76 YEVMASK----TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD--ENGM 147 (450)
Q Consensus 76 ~~~~~~~----~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~--~~~~ 147 (450)
++++... ...|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5689999999 9999999975 5799999999999999999999999999999999999999 8899
Q ss_pred eEEeecCchhhhhcccCCC-----CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH
Q 045214 148 LKVTDFGLSALAKCKHQDG-----LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222 (450)
Q Consensus 148 vkl~DFGls~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 222 (450)
+||+|||+|.......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999996554332211 1234569999999999988776 489999999999999999999998632211111
Q ss_pred HHhh----cC-------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAK----AD-------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~----~~-------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.... .. .-.+..++.++.+++.+||..||.+|||+.+|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1100 00 0012457899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.00 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=206.1
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcC-CCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLG-TGQ--SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+..++|++.+.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 445689999999999999999998644 333 69999998765544556678899999999999999999999998766
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999999865 5699999999999999999999999999999999999999999999999999865432
Q ss_pred ccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC--CCCCCCCcH
Q 045214 162 KHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD--YKFPTWFSA 237 (450)
Q Consensus 162 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~ 237 (450)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... .+.+..++.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2111 112344678899999999877664 89999999999999999 999999988888877776554 344567899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.++|.+||+.||.+|||+.++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=358.89 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=203.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE----eCCE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA----SKTK 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 84 (450)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 468999999999999999999999999999999986543 234567889999999999999999999986 3457
Q ss_pred EEEEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
.|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999998864 56999999999999999999999999999999999999999999999999987543
Q ss_pred hcccCCC-------CcccccCCCcccCchhcccCCC--CCCccchhhHHHHHHHHhhCCCCCCCCcH--HHHHHHHh-hc
Q 045214 160 KCKHQDG-------LLHTTCGTPAYVAPEVISRRGY--DGDKADIWSCGVILYVLLAGYLPFHDSNL--MAMYRKIA-KA 227 (450)
Q Consensus 160 ~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~-~~ 227 (450)
....... ......||+.|+|||++..... .+.++|||||||++|+|++|..||..... ......+. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 2211100 0123457999999999875442 25799999999999999999999964211 01111111 12
Q ss_pred CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 228 DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 228 ~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
..+.+..+++++.++|.+||+.||.+|||+++++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 233445689999999999999999999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=349.96 Aligned_cols=243 Identities=26% Similarity=0.462 Sum_probs=204.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-KTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 85 (450)
+..++|++.+.||+|+||.||+|.+ +|+.||+|++..+. ..+.+.+|+.+++.++||||+++++++.. .+..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 4467999999999999999999988 58899999997543 34678899999999999999999998754 4579
Q ss_pred EEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 86 YFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
|+||||++|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999999999753 3899999999999999999999999999999999999999999999999998644321
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVR 240 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (450)
.....+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++++.
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred -----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 2234678999999999877664 89999999999999998 99999988777666666544 3456778999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++|.+||+.||.+|||+.++++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=359.36 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=209.8
Q ss_pred ccCeeeeceEeecCCeEEEEEE----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE--eC
Q 045214 9 MQKYELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA--SK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~ 82 (450)
.++|++.+.||+|+||.||+|+ +..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4689999999999999999999 466899999999976532 33467899999999999999999999886 56
Q ss_pred CEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 83 TKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 779999999999999999975 469999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH---------------HHHHHH
Q 045214 161 CKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM---------------AMYRKI 224 (450)
Q Consensus 161 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~~i 224 (450)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 22211 12234568889999999987766 48999999999999999999998754322 222222
Q ss_pred hh-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 225 AK-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 225 ~~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.. ...+.|..+++++.+||.+||++||.+|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 234567779999999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=361.92 Aligned_cols=249 Identities=17% Similarity=0.243 Sum_probs=204.4
Q ss_pred ccccc----ccCeeeeceEeecCCeEEEEEEEcCC--------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC
Q 045214 4 KGKVL----MQKYELGRLLGQGNFAKVYYARHLGT--------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71 (450)
Q Consensus 4 ~g~~l----~~~y~~~~~LG~G~fg~Vy~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (450)
.|+++ .++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.+++.++|||
T Consensus 32 ~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~n 103 (352)
T 2jii_A 32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPL 103 (352)
T ss_dssp TTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHH
T ss_pred CCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccc
Confidence 35556 47999999999999999999999874 889999999754 24678999999999999
Q ss_pred ccE---------------EEEEEEe-CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 045214 72 VMQ---------------IYEVMAS-KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYH 132 (450)
Q Consensus 72 Iv~---------------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~H 132 (450)
|++ +++++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+|
T Consensus 104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 182 (352)
T 2jii_A 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182 (352)
T ss_dssp HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 887 6777765 78999999999 9999999975 57999999999999999999999999999
Q ss_pred cCCCCCcEEecCCC--CeEEeecCchhhhhcccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHH
Q 045214 133 RDLKPENLLLDENG--MLKVTDFGLSALAKCKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVL 205 (450)
Q Consensus 133 rDikp~NILl~~~~--~vkl~DFGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~l 205 (450)
|||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el 261 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKW 261 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHH
Confidence 99999999999998 9999999998655432211 12234589999999999988766 4899999999999999
Q ss_pred hhCCCCCCCCc--HHHHHHHH---hhcCCCCC------CCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 206 LAGYLPFHDSN--LMAMYRKI---AKADYKFP------TWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 206 l~g~~Pf~~~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++|..||.... ........ ......++ ..+++++.+||.+||+.||.+|||++++++
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99999998753 33332222 22222222 246899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=370.69 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=196.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+|.+.+.||+|+||+|+. ....+++.||||++...... ...+|+.+++.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999764 44468999999999765432 235899999999 8999999999999999999999
Q ss_pred eecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---C--CCeEEeecCchhhhhcc
Q 045214 90 EYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---N--GMLKVTDFGLSALAKCK 162 (450)
Q Consensus 90 E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~--~~vkl~DFGls~~~~~~ 162 (450)
||+.| +|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++. + ..+||+|||+|......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99975 999999764 4666678899999999999999999999999999999953 2 35789999998754322
Q ss_pred cC-CCCcccccCCCcccCchhcccC--CCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCCCC---CCCC
Q 045214 163 HQ-DGLLHTTCGTPAYVAPEVISRR--GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF---PTWF 235 (450)
Q Consensus 163 ~~-~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~---p~~~ 235 (450)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 1223456799999999999742 223478999999999999999 999997765544433332222221 2234
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+..+.+||.+||+.||.+|||++++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 567899999999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.44 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=198.1
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
...+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+..+. .+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 34577788999999999999998754 4689999999986542 34568899999876 8999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC----------
Q 045214 84 KIYFVMEYAKGGELFKKVSKGKL--------KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN---------- 145 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~l--------~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~---------- 145 (450)
.+|+||||+. |+|.+++..... ++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 599999976432 223457799999999999999999999999999999754
Q ss_pred ---CCeEEeecCchhhhhcccCC--CCcccccCCCcccCchhccc------CCCCCCccchhhHHHHHHHHhh-CCCCCC
Q 045214 146 ---GMLKVTDFGLSALAKCKHQD--GLLHTTCGTPAYVAPEVISR------RGYDGDKADIWSCGVILYVLLA-GYLPFH 213 (450)
Q Consensus 146 ---~~vkl~DFGls~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlGvil~~ll~-g~~Pf~ 213 (450)
+.+||+|||+|......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 47999999998754332211 12235689999999999965 1334589999999999999999 999998
Q ss_pred CCcHHHHHHHHhhcCCCCCC-------CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 214 DSNLMAMYRKIAKADYKFPT-------WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
+..... ..+.......+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 754433 233333333221 24688999999999999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=349.97 Aligned_cols=231 Identities=32% Similarity=0.630 Sum_probs=191.7
Q ss_pred cccccCeeee-ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCccEEEEEEEe--
Q 045214 6 KVLMQKYELG-RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHPNVMQIYEVMAS-- 81 (450)
Q Consensus 6 ~~l~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-- 81 (450)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3466778887 8899999999999999999999999999642 3456888887 66699999999999987
Q ss_pred --CCEEEEEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeec
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDF 153 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DF 153 (450)
...+|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 77899999999999999999753 5999999999999999999999999999999999999998 788999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH----HhhcCC
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK----IAKADY 229 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~----i~~~~~ 229 (450)
|++.... +..+ +.++|||||||++|+|++|..||...+....... +.....
T Consensus 165 g~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 165 GFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp TTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 9874321 1223 3789999999999999999999987654433211 122233
Q ss_pred CCC----CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 KFP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 ~~p----~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.+| ..+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 333 4589999999999999999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.33 Aligned_cols=251 Identities=23% Similarity=0.425 Sum_probs=199.7
Q ss_pred ccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCccEEEEEEEeC
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL--IQHPNVMQIYEVMASK 82 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~ 82 (450)
+..+.++|++.+.||+|+||.||+|++ +++.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 346778999999999999999999998 48999999986543 2334455555554 4999999999999887
Q ss_pred ----CEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEecCCCCeEE
Q 045214 83 ----TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR--------GVYHRDLKPENLLLDENGMLKV 150 (450)
Q Consensus 83 ----~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDikp~NILl~~~~~vkl 150 (450)
..+|+||||++||+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999988999999999999999999999999 9999999999999999999999
Q ss_pred eecCchhhhhcccCCC--CcccccCCCcccCchhcccCCCCCC-----ccchhhHHHHHHHHhhC----------CCCCC
Q 045214 151 TDFGLSALAKCKHQDG--LLHTTCGTPAYVAPEVISRRGYDGD-----KADIWSCGVILYVLLAG----------YLPFH 213 (450)
Q Consensus 151 ~DFGls~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~-----~~DiwSlGvil~~ll~g----------~~Pf~ 213 (450)
+|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999986443222111 1235589999999999987665422 38999999999999999 77776
Q ss_pred CCc-----HHHHHHHHhhc--CCCCCC-----CCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 214 DSN-----LMAMYRKIAKA--DYKFPT-----WFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 214 ~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
... .......+... ...+|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 532 12222222222 222333 345679999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.36 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=209.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +.+|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345689999999999999999999865 46699999986542 23678899999999999999999999876 6789
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999964 469999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
........+++.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112234577899999999877664 89999999999999999 99999998887777776554 34567789999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||++|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=362.33 Aligned_cols=243 Identities=17% Similarity=0.248 Sum_probs=199.9
Q ss_pred cccCeeeeceEeecCCeEEEEE-----EEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCccEEEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYA-----RHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ---HPNVMQIYEVM 79 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 79 (450)
-.++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3567999999999999999999 467789999999997543 345678888888886 99999999999
Q ss_pred EeCCEEEEEEeecCCCChhhHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---------
Q 045214 80 ASKTKIYFVMEYAKGGELFKKVS------KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE--------- 144 (450)
Q Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~--------- 144 (450)
...+..|+||||++||+|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 99999999999999999999995 356999999999999999999999999999999999999998
Q ss_pred --CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH
Q 045214 145 --NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR 222 (450)
Q Consensus 145 --~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 222 (450)
++.+||+|||+|...............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 899999999999655433333445567899999999999888765 89999999999999999999996543211
Q ss_pred HHhhcCCCC-CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAKADYKF-PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~~~~~~-p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
......+ ..+.+..+.+++.+||+.+|.+|++..+.+.
T Consensus 293 --~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp --EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred --eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0011111 1235778999999999999999976544444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=353.25 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=203.1
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc-cccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-LKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55569999999999999986 688999999976432 223456788999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 91 YAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999863 369999999999999999999999999999999999999999999999999986543322222
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH----HHHHHHhhcC-----------CCC
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM----AMYRKIAKAD-----------YKF 231 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~-----------~~~ 231 (450)
......||+.|+|||++.+. + +.++|||||||++|+|++|..||...+.. .....+.... ...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23345799999999998753 4 58999999999999999999999875432 2222221111 112
Q ss_pred CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 232 PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 232 p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+...+..+.+++.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2334577999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=348.62 Aligned_cols=239 Identities=28% Similarity=0.511 Sum_probs=197.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||.||+|++ .++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 46899999999999999999998 4789999998643 234678899999999999999999998764 47999
Q ss_pred EeecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCcEEecCCCC-eEEeecCchhhhh
Q 045214 89 MEYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHS---RGVYHRDLKPENLLLDENGM-LKVTDFGLSALAK 160 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~---~gi~HrDikp~NILl~~~~~-vkl~DFGls~~~~ 160 (450)
|||++|++|.+++... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999999999763 37899999999999999999999 89999999999999998887 7999999986443
Q ss_pred cccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc--HHHHHHHHh-hcCCCCCCCCcH
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--LMAMYRKIA-KADYKFPTWFSA 237 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~-~~~~~~p~~~s~ 237 (450)
. ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+. ......+..+++
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 158 T-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCH
T ss_pred c-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCH
Confidence 2 12344699999999999877664 89999999999999999999998643 222222222 233455667899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.+++.+||+.||.+|||++++++
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=363.13 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=200.5
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEEE
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTG---QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA-SKTKIY 86 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 86 (450)
.|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+++.+|+.+++.++||||+++++++. .++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5889999999999999999976433 468999986532 2344678899999999999999999999864 556889
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999976 4689999999999999999999999999999999999999999999999999875432221
Q ss_pred CC--CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHH
Q 045214 165 DG--LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVR 240 (450)
Q Consensus 165 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (450)
.. ......+|+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+..+. ...|..++.++.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 12234678899999999877664 89999999999999999 788998766655555554443 445677899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 045214 241 KLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 241 ~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++.+||+.||++|||+.++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=354.45 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=187.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEE-------
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMA------- 80 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~------- 80 (450)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 458999999999999999999999999999999986543 233467889999999995 999999999983
Q ss_pred -eCCEEEEEEeecCCCChhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEecCCCCeEEeec
Q 045214 81 -SKTKIYFVMEYAKGGELFKKVSK----GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLDENGMLKVTDF 153 (450)
Q Consensus 81 -~~~~~~lv~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~~~~~vkl~DF 153 (450)
....+|++|||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 4456899999996 588887753 57999999999999999999999999 999999999999999999999999
Q ss_pred CchhhhhcccCC----------CCcccccCCCcccCchhcc---cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHH
Q 045214 154 GLSALAKCKHQD----------GLLHTTCGTPAYVAPEVIS---RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAM 220 (450)
Q Consensus 154 Gls~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~ 220 (450)
|++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 998654322111 0112456999999999983 3333 4799999999999999999999987654433
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 221 YRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 221 ~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
... ....+.+...+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 262 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcC--cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222 1223344557889999999999999999999999998755
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=357.68 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=205.4
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
....++|++.+.||+|+||.||+|++ .+++.||||++........ ..++.+|+.+++.++||||+++++++.+.+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 34567999999999999999999985 4689999999976543322 23678999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 86 YFVMEYAKGGELFKKVSKG-----KLKEDTARKYFQQLISAIDFCHSR---GVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~~LH~~---gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
|+||||++||+|.+++... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 9999999999999999752 399999999999999999999999 99999999999999999999999999987
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc--------HHHHHHHHhhc-C
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--------LMAMYRKIAKA-D 228 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~-~ 228 (450)
..... .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ........... .
T Consensus 183 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 183 LMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp ECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 54322 1222344569999999999987766 489999999999999999999996211 11111111000 0
Q ss_pred ----------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 045214 229 ----------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 229 ----------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
..++...+.++.+++.+||+.||.+|||+.++++|-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0112223477999999999999999999999998665
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.65 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=207.1
Q ss_pred eceEeecCCeEEEEEEE--cCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeec
Q 045214 15 GRLLGQGNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (450)
.+.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++..+ ..|+||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEcc
Confidence 34799999999999965 45678999999976543 234567899999999999999999999999654 588999999
Q ss_pred CCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-CCccc
Q 045214 93 KGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD-GLLHT 170 (450)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~~~ 170 (450)
+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......... .....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 99999999976 57999999999999999999999999999999999999999999999999999765432211 12223
Q ss_pred ccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHccC
Q 045214 171 TCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSRILD 248 (450)
Q Consensus 171 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~~L~ 248 (450)
..+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+||.+||+
T Consensus 532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4578899999999887765 89999999999999998 999999988888777776553 45778899999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 045214 249 PNPSTRISIAKIME 262 (450)
Q Consensus 249 ~dP~~R~s~~eil~ 262 (450)
.||++|||++++++
T Consensus 611 ~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPGFAAVEL 624 (635)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.45 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=208.0
Q ss_pred cCeeeec-eEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGR-LLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~-~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
++|.+.+ .||+|+||.||+|.+.. ++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3456666 89999999999998764 56679999997653 22346788999999999999999999999976 5599
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999964 4699999999999999999999999999999999999999999999999999975432211
Q ss_pred C-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHH
Q 045214 165 D-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRK 241 (450)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (450)
. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 111233467899999999877765 89999999999999998 999999988878777776553 4677889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||++|||++++++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=353.33 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=195.1
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe----
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS---- 81 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 81 (450)
..-.++|++++.||+|+||.||+|++ +++.||||++...... ......|+..+..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45678999999999999999999987 7899999999754321 1122344444556899999999986532
Q ss_pred -CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCcEEecCCCCeEEe
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR---------GVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~---------gi~HrDikp~NILl~~~~~vkl~ 151 (450)
...+|+||||++||+|.+++.....++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 33689999999999999999888889999999999999999999999 99999999999999999999999
Q ss_pred ecCchhhhhccc------CCCCcccccCCCcccCchhcccC------CCCCCccchhhHHHHHHHHhhCCCCCCCCc---
Q 045214 152 DFGLSALAKCKH------QDGLLHTTCGTPAYVAPEVISRR------GYDGDKADIWSCGVILYVLLAGYLPFHDSN--- 216 (450)
Q Consensus 152 DFGls~~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--- 216 (450)
|||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999986543211 11222355799999999999762 122368999999999999999977654211
Q ss_pred ---------------HHHHHHHHhh--cCCCCCCC------CcHHHHHHHHHccCCCCCCCCCHHHHhc------Ccccc
Q 045214 217 ---------------LMAMYRKIAK--ADYKFPTW------FSADVRKLLSRILDPNPSTRISIAKIME------NPWFR 267 (450)
Q Consensus 217 ---------------~~~~~~~i~~--~~~~~p~~------~s~~~~~ll~~~L~~dP~~R~s~~eil~------hp~f~ 267 (450)
.......+.. ....+|.. .++++.+||.+||+.||++|||++|+++ ++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 1111111111 12223332 3457999999999999999999999954 66665
Q ss_pred cc
Q 045214 268 KG 269 (450)
Q Consensus 268 ~~ 269 (450)
+.
T Consensus 323 ~~ 324 (336)
T 3g2f_A 323 NK 324 (336)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=364.77 Aligned_cols=244 Identities=18% Similarity=0.266 Sum_probs=198.8
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhCC---------CCCcc
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL-----KVGLVDQTKREISVMRLIQ---------HPNVM 73 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv 73 (450)
..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 7899999999876432 2334577889999999885 88888
Q ss_pred EEEEEEE------------------------------eCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHH
Q 045214 74 QIYEVMA------------------------------SKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAID 123 (450)
Q Consensus 74 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ 123 (450)
++.+++. +.+.+|+||||+++|++.+.+.++.+++..++.++.||+.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 8877653 2678999999999998888887778999999999999999999
Q ss_pred HHH-HCCCeecCCCCCcEEecCCC--------------------CeEEeecCchhhhhcccCCCCcccccCCCcccCchh
Q 045214 124 FCH-SRGVYHRDLKPENLLLDENG--------------------MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182 (450)
Q Consensus 124 ~LH-~~gi~HrDikp~NILl~~~~--------------------~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~ 182 (450)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999875432 24589999999999
Q ss_pred cccCCCCCCccchhhHHHH-HHHHhhCCCCCCCCcH-HHHHHHHhhc-CCC--C----CCCCcHHHHHHHHHccCCCCCC
Q 045214 183 ISRRGYDGDKADIWSCGVI-LYVLLAGYLPFHDSNL-MAMYRKIAKA-DYK--F----PTWFSADVRKLLSRILDPNPST 253 (450)
Q Consensus 183 l~~~~~~~~~~DiwSlGvi-l~~ll~g~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~ll~~~L~~dP~~ 253 (450)
+.+.. +.++||||||++ .+++++|..||.+... ......+... ... . ++.+++++++||.+||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 98765 579999998777 7788999999864321 1122232211 111 1 1236889999999999977
Q ss_pred CCCHHHHh-cCcccc
Q 045214 254 RISIAKIM-ENPWFR 267 (450)
Q Consensus 254 R~s~~eil-~hp~f~ 267 (450)
|++|+| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=364.94 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=208.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH-PNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 85 (450)
.+.++|++++.||+|+||.||+|++..+++.||||++...... .++.+|+.+++.++| ++|..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 5778999999999999999999999999999999998765432 346789999999976 5666777777888999
Q ss_pred EEEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEe---cCCCCeEEeecCchhhhh
Q 045214 86 YFVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAK 160 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl---~~~~~vkl~DFGls~~~~ 160 (450)
|+||||+ |++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 999999997 4689999999999999999999999999999999999999 688999999999987554
Q ss_pred cccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---HHHHHHHHhhcCC---
Q 045214 161 CKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADY--- 229 (450)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~--- 229 (450)
..... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32221 112256899999999999887764 89999999999999999999998743 3344444433222
Q ss_pred --CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 --KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 --~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.++..++.++.+||.+||+.||++||++++|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123557899999999999999999999988764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=350.73 Aligned_cols=254 Identities=21% Similarity=0.359 Sum_probs=208.4
Q ss_pred ccccccCeeeeceEeecCCeEEEEEE----EcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 045214 5 GKVLMQKYELGRLLGQGNFAKVYYAR----HLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA 80 (450)
Q Consensus 5 g~~l~~~y~~~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (450)
.....++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34556789999999999999999999 45689999999997643 234577899999999999999999999986
Q ss_pred eCC--EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 81 SKT--KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 81 ~~~--~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
..+ .+|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 544 78999999999999999976 45999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH----------------H
Q 045214 157 ALAKCKHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM----------------A 219 (450)
Q Consensus 157 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~ 219 (450)
......... .......+++.|+|||++.+..+. .++|||||||++|+|++|..||...... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 754322111 112234578889999999877664 8999999999999999999998743211 1
Q ss_pred HHHHHhh-cCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 220 MYRKIAK-ADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 220 ~~~~i~~-~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+...+.. ...+.|..+++++.+||.+||+.||++|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122221 234567779999999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=351.12 Aligned_cols=250 Identities=21% Similarity=0.386 Sum_probs=205.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCccEEEEEEEeCC
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL--IQHPNVMQIYEVMASKT 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~ 83 (450)
..+.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 45678999999999999999999998 68999999996532 3556788888887 79999999999998876
Q ss_pred ----EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEecCCCCeEEe
Q 045214 84 ----KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH--------SRGVYHRDLKPENLLLDENGMLKVT 151 (450)
Q Consensus 84 ----~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH--------~~gi~HrDikp~NILl~~~~~vkl~ 151 (450)
.+|+||||+++|+|.+++.+..+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999999889999999999999999999999 8999999999999999999999999
Q ss_pred ecCchhhhhcccCC--CCcccccCCCcccCchhcccCCCC-----CCccchhhHHHHHHHHhhC----------CCCCCC
Q 045214 152 DFGLSALAKCKHQD--GLLHTTCGTPAYVAPEVISRRGYD-----GDKADIWSCGVILYVLLAG----------YLPFHD 214 (450)
Q Consensus 152 DFGls~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~~ 214 (450)
|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99998654322110 022455799999999999765322 1579999999999999999 889876
Q ss_pred C-----cHHHHHHHHhhcCC--CCCCC-----CcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 215 S-----NLMAMYRKIAKADY--KFPTW-----FSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 215 ~-----~~~~~~~~i~~~~~--~~p~~-----~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
. ........+..... .+|.. .+..+.+|+.+||+.||++|||++++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4 23344444433322 23322 23578999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=373.76 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=213.3
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +.+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345689999999999999999999865 46799999986542 23678899999999999999999999866 6789
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999964 469999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
. .......+++.|+|||++....+. .++|||||||+||+|++ |..||.+....+....+..+ ..+.|..++.++.+
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred e-ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 111234567899999999877664 89999999999999999 99999998887777776554 34567789999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||++|||+++|++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=351.41 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=208.1
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.+..++|++.+.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3456899999999999999999999854 49999997654221 2234567899999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||++|++|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++ ++.+||+|||++.......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999999999763 599999999999999999999999999999999999998 7899999999976543211
Q ss_pred ---CCCCcccccCCCcccCchhcccC--------CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC-
Q 045214 164 ---QDGLLHTTCGTPAYVAPEVISRR--------GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF- 231 (450)
Q Consensus 164 ---~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~- 231 (450)
.........||+.|+|||++... ...+.++|||||||++|+|++|..||...+.......+.....+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 12233445799999999998752 223578999999999999999999999988877777766554332
Q ss_pred -CCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 232 -PTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 232 -p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+..++.++.++|.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2357899999999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=366.06 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=193.2
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCc-----------------
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH-PNV----------------- 72 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI----------------- 72 (450)
.|.+++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++| +|.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48899999999999999999999999999999985544333445778999999999987 221
Q ss_pred ----cEEEEEEEe-----CCEEEEEEeecCCCChhhHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 045214 73 ----MQIYEVMAS-----KTKIYFVMEYAKGGELFKKVS--------KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDL 135 (450)
Q Consensus 73 ----v~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~--------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDi 135 (450)
..+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.|++.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111111111 22467777765 578998884 234778889999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcc----------cCCCCCCccchhhHHHHHHHH
Q 045214 136 KPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS----------RRGYDGDKADIWSCGVILYVL 205 (450)
Q Consensus 136 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~----------~~~~~~~~~DiwSlGvil~~l 205 (450)
||+|||++.++.+||+|||++...... ....+| +.|+|||++. ...+ +.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 999999999999999999998654322 345678 9999999993 3334 4799999999999999
Q ss_pred hhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 206 LAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 206 l~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
++|..||...+.......+. .....+|+++.+||.+||++||++|||+.++++||||+.
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999998876544333322 223457899999999999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.07 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=205.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (450)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 34589999999999999999999999999999999987643 22345778899999999999999999998755
Q ss_pred -CCEEEEEEeecCCCChhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---eEEeec
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSKG----KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM---LKVTDF 153 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~---vkl~DF 153 (450)
.+..|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 67889999999999999999762 5999999999999999999999999999999999999997775 999999
Q ss_pred CchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH---------HH
Q 045214 154 GLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR---------KI 224 (450)
Q Consensus 154 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---------~i 224 (450)
|++..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||........+. .+
T Consensus 169 G~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 169 GYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99875432 2233456899999999999877764 89999999999999999999997653322110 00
Q ss_pred -----hhcCC------C----CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 225 -----AKADY------K----FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 225 -----~~~~~------~----~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+.. + ++..+++.+.+||.+||.+||++|||++++++||||+.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00111 1 11235688999999999999999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=340.45 Aligned_cols=228 Identities=18% Similarity=0.235 Sum_probs=194.1
Q ss_pred cccc-ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe
Q 045214 3 TKGK-VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS 81 (450)
Q Consensus 3 ~~g~-~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (450)
..|+ ++.++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3466 788999999999999999999999999999999999987765544556788999999999999999999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+..|+||||++|++|.+++..+ .....+..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CCcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999999999999765 4666788999999999999999999999999999999999999998554
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHH---HHhhcCCC----CCCC
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYR---KIAKADYK----FPTW 234 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----~p~~ 234 (450)
|++| .+.++|||||||++|+|++|..||.+.+...... +....... .+..
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 2332 2479999999999999999999998765422110 11111111 2345
Q ss_pred CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 235 FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 235 ~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+++++.+||.+||+.||.+| |++|+++
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 88999999999999999999 9999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=374.32 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=212.0
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGT---GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+..++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4467899999999999999999998654 4579999986543 2234577889999999999999999999985 45
Q ss_pred EEEEEEeecCCCChhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSKG--KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 689999999999999999753 689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADV 239 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (450)
.. ........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... .+.|+.+++++
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1112234578899999999877664 89999999999999997 999999988887777776543 56788899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 045214 240 RKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+||.+||+.||.+|||+.++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=379.53 Aligned_cols=246 Identities=25% Similarity=0.413 Sum_probs=203.8
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcC-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLG-TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK 82 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (450)
.|+++.++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 467888999999999999999999999986 78999999987543 223456788999999999999999999999876
Q ss_pred CE-----EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 83 TK-----IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 83 ~~-----~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
+. .|+||||++|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 65 7999999999999988766 79999999999999999999999999999999999999875 99999999986
Q ss_pred hhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcH
Q 045214 158 LAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSA 237 (450)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 237 (450)
.... ....+||+.|+|||++.+.. +.++|||||||++|+|++|..||.+...... .........++
T Consensus 230 ~~~~------~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINS------FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYD 295 (681)
T ss_dssp ETTC------CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCH
T ss_pred hccc------CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCH
Confidence 5432 14567999999999987643 5899999999999999999999875321100 00000011357
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999999974
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=274.74 Aligned_cols=132 Identities=27% Similarity=0.538 Sum_probs=115.9
Q ss_pred CCCCCcHHHHhhhcCCCCCCCcccccc--ceeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCccee
Q 045214 310 KPDNLNAFHIISLSSGFDLSGFFVEHD--QKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGT 387 (450)
Q Consensus 310 ~~~~~~~~~~~~~s~~~~ls~~~~~~~--~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 387 (450)
.|..+|||++||+|+|||||+||+... .+|+|||+|+.||++|+++||++|+++||+|+++++ .|++++..+|+||.
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~-~vkl~~~~~grkG~ 81 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNF-KTRLEGLSSIKAGQ 81 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSS-EEEEEECCSSGGGC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCc-EEEEEEecCCCcce
Confidence 456799999999999999999997654 478999999999999999999999999999998886 59999999999999
Q ss_pred EEEEEEEEEEeCceEEEEEEecCCCcHHHHHHHHHhhhhhcccceeeccccccccc
Q 045214 388 FSIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPALKDIVWAWQGDQHQVQ 443 (450)
Q Consensus 388 l~~~~~v~~~~~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l~div~~~~~~~~~~~ 443 (450)
|+|.+|||||+|+++||||||++||++||++||++ |+++|+||||+|+++..+.+
T Consensus 82 l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~-Lr~~L~diV~~~~~~~~~~~ 136 (143)
T 2ehb_D 82 LAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATEGIPKSE 136 (143)
T ss_dssp CEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHH-HHHHSTTTBCC---------
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHH-HHHHhhcceecCCCCCchhh
Confidence 99999999999999999999999999999998885 99999999999999775443
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=255.05 Aligned_cols=121 Identities=25% Similarity=0.448 Sum_probs=106.5
Q ss_pred CCCCCcHHHHhhhcCCCCCCCcccccc-ceeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeE
Q 045214 310 KPDNLNAFHIISLSSGFDLSGFFVEHD-QKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTF 388 (450)
Q Consensus 310 ~~~~~~~~~~~~~s~~~~ls~~~~~~~-~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l 388 (450)
.|..+|||++||+|+|||||+||+++. .+|+|||+|+.||++|+++||++|+++||+|++++++ ++..+|+||.|
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~----~~~~~g~kG~l 77 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW----GMKIEGQKGNF 77 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT----EEEEEEGGGTE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc----cccccCCCccE
Confidence 356799999999999999999997533 3689999999999999999999999999999988875 55567799999
Q ss_pred EEEEEEEEEeCceEEEEEEecCCCcHHHHHHHHHhhhhhcccceee
Q 045214 389 SIDVQLFEFNPSIHLVELTKSSGDNLEYQKMLKQEIRPALKDIVWA 434 (450)
Q Consensus 389 ~~~~~v~~~~~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l~div~~ 434 (450)
+|.+|||||+|+++||||||++||++||++||.++|+++|+||||+
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999887799999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.20 Aligned_cols=232 Identities=13% Similarity=0.082 Sum_probs=159.0
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-------cchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEE
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-------VGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (450)
..++.|++|.+..++....|+.||+|++.++.... ....+++.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34667888888888888889999999998753221 12346689999999999 79999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++|++|.++|.+ +.+++. .|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 9999999999999987 467664 58899999999999999999999999999999999999999998754322 23
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
...+.+||+.|+|||++.+.. ..++|+||+|++++.|.++..||. ..+.. .|. ....+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~-~~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPV-ERWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCG-GGCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCC-CCCcHHHHHHHH
Confidence 345678999999999997653 368999999999988876654421 11111 111 011245666677
Q ss_pred cCCCCCCCCCHHHHhcCcccc
Q 045214 247 LDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~ 267 (450)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 777777777776666666653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=266.83 Aligned_cols=189 Identities=19% Similarity=0.205 Sum_probs=144.7
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV-----GLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
...+.||+|+||.||+|. ..++.+++|.......... ...+++.+|+.+++.++||||+++..+....+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346789999999999994 4678999998765433221 124567999999999999999955444446677799
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC-
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG- 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~- 166 (450)
||||++|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999887 6689999999999999999999999999999998 99999999997653321111
Q ss_pred ----CcccccCCCcccCchhccc--CCCCCCccchhhHHHHHHHHhhCCCCCC
Q 045214 167 ----LLHTTCGTPAYVAPEVISR--RGYDGDKADIWSCGVILYVLLAGYLPFH 213 (450)
Q Consensus 167 ----~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 213 (450)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+...++-+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1235689999999999976 5554 67899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=221.59 Aligned_cols=147 Identities=18% Similarity=0.257 Sum_probs=116.9
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc---------------chHHHHHHHHHHHHhCCCCCccEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV---------------GLVDQTKREISVMRLIQHPNVMQIY 76 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~ 76 (450)
|.+++.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+++.++| ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 45569999999999999999 8899999999975432111 124568899999999984 4444
Q ss_pred EEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 77 EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 44433 44699999999999988 422 23557999999999999999999999999999999 999999999987
Q ss_pred hhhhcccCCCCcccccCCCcccCchhccc
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISR 185 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 185 (450)
. .+..+.|||.+.+
T Consensus 240 ~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 240 V---------------EVGEEGWREILER 253 (282)
T ss_dssp E---------------ETTSTTHHHHHHH
T ss_pred e---------------ECCCCCHHHHHHH
Confidence 4 3446789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=190.94 Aligned_cols=139 Identities=20% Similarity=0.264 Sum_probs=109.3
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcE--EEEEEeecccccc---------------------cchHHHHHHHHHHHHhCC
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILK---------------------VGLVDQTKREISVMRLIQ 68 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 68 (450)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 9999986542110 011236789999999998
Q ss_pred CCCc--cEEEEEEEeCCEEEEEEeecCC-C----ChhhHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcE
Q 045214 69 HPNV--MQIYEVMASKTKIYFVMEYAKG-G----ELFKKVSKGKLKEDTARKYFQQLISAIDFCH-SRGVYHRDLKPENL 140 (450)
Q Consensus 69 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDikp~NI 140 (450)
|++| +.+++. +..|+||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8754 445543 246899999942 3 56655432 345678899999999999999 99999999999999
Q ss_pred EecCCCCeEEeecCchhh
Q 045214 141 LLDENGMLKVTDFGLSAL 158 (450)
Q Consensus 141 Ll~~~~~vkl~DFGls~~ 158 (450)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9988 999999998853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=177.78 Aligned_cols=135 Identities=17% Similarity=0.192 Sum_probs=102.3
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc-----------c----c----hHHHHHHHHHHHHhCCCCCc
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK-----------V----G----LVDQTKREISVMRLIQHPNV 72 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-----------~----~----~~~~~~~Ei~il~~l~hpnI 72 (450)
|++++.||.|+||.||+|.+. +|+.||||+++.....- . . ......+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999984 69999999986532110 0 0 01123567888888865554
Q ss_pred c--EEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC---
Q 045214 73 M--QIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM--- 147 (450)
Q Consensus 73 v--~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~--- 147 (450)
. ..++. .. .++||||++|++|.++... +.+..++.|++.+|.|||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~~-----~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSSV-----PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCCCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhccc-----HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3 33332 22 3799999999888665432 245678999999999999999999999999999988773
Q ss_pred -------eEEeecCch
Q 045214 148 -------LKVTDFGLS 156 (450)
Q Consensus 148 -------vkl~DFGls 156 (450)
+.|+||+.+
T Consensus 247 ~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQM 262 (397)
T ss_dssp TTSEEEEEEECCCTTC
T ss_pred ccccccceEEEEeCCc
Confidence 899999965
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=128.02 Aligned_cols=140 Identities=19% Similarity=0.191 Sum_probs=113.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (450)
.+.|++...++.|+.+.||++.. .++.+++|+........ ...+.+|+.+++.+. +..+++++++..+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 45799999999999999999975 46889999987532111 235788999999884 6778899999999999999
Q ss_pred EEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 045214 88 VMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS---------------------------------------- 127 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~---------------------------------------- 127 (450)
||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999999877632 122344788899999999998
Q ss_pred -------------------CCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 128 -------------------RGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 128 -------------------~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.7e-12 Score=120.26 Aligned_cols=135 Identities=13% Similarity=0.181 Sum_probs=101.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEEEEEEeCCEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIYEVMASKTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 86 (450)
...|.+....+.|..+.||++.. .+|+.+++|+..... ...+.+|+.+++.+.+.+ +++++.+....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34577665555677799999964 467789999976531 134678999999885444 567899888888899
Q ss_pred EEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 045214 87 FVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG------------------------------------- 129 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~g------------------------------------- 129 (450)
+||||++|.+|. ... .. ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TSC--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cCc--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999998884 211 22 2356777888888888753
Q ss_pred ---------------------CeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 130 ---------------------VYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 130 ---------------------i~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=121.03 Aligned_cols=141 Identities=21% Similarity=0.349 Sum_probs=107.5
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEee--cccccccchHHHHHHHHHHHHhCC--CCCccEEEEEEEeC---CEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAID--KDKILKVGLVDQTKREISVMRLIQ--HPNVMQIYEVMASK---TKI 85 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~ 85 (450)
.-.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999998763 4678898876 33211 11346788999999996 45688899988776 458
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS-------------------------------------- 127 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~-------------------------------------- 127 (450)
|+||||++|..+.+... ..+++.....++.++...|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999988754322 247888889999999999999997
Q ss_pred --------------------CCCeecCCCCCcEEecCCCC--eEEeecCchhh
Q 045214 128 --------------------RGVYHRDLKPENLLLDENGM--LKVTDFGLSAL 158 (450)
Q Consensus 128 --------------------~gi~HrDikp~NILl~~~~~--vkl~DFGls~~ 158 (450)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997764 68999998753
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.24 E-value=7.4e-11 Score=96.91 Aligned_cols=87 Identities=16% Similarity=0.243 Sum_probs=75.7
Q ss_pred eeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEe-CceEEEEEEecCCCcHHHHHHH
Q 045214 342 KFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFN-PSIHLVELTKSSGDNLEYQKML 420 (450)
Q Consensus 342 rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~ 420 (450)
.-+|..+|++|+..|++|++.+|+.+++++...+++.......++.+.|.+||+++. +++++|+|+|.+||.+.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 346889999999999999999999999887666888765444567899999999996 8999999999999999999999
Q ss_pred HHhhhhhcc
Q 045214 421 KQEIRPALK 429 (450)
Q Consensus 421 ~~~l~~~l~ 429 (450)
.+ |...|+
T Consensus 112 ~~-il~~L~ 119 (120)
T 3ose_A 112 SK-IANELK 119 (120)
T ss_dssp HH-HHHHCC
T ss_pred HH-HHHHhc
Confidence 97 776664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-11 Score=119.43 Aligned_cols=185 Identities=18% Similarity=0.251 Sum_probs=123.2
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCC--ccEEEEEEEeCC---EEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPN--VMQIYEVMASKT---KIYFV 88 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lv 88 (450)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+ .+.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 5669999999999863 46899986533 2346788999999887 3333 455555543333 45899
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS----------------------------------------- 127 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~----------------------------------------- 127 (450)
||+++|.+|.+... ..++.++...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988875433 347888888899999999999996
Q ss_pred -----------------CCCeecCCCCCcEEecC--CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhccc--C
Q 045214 128 -----------------RGVYHRDLKPENLLLDE--NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR--R 186 (450)
Q Consensus 128 -----------------~gi~HrDikp~NILl~~--~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~ 186 (450)
..++|+|++|.||+++. .+.+.|+||+.+........ .. .......-..|+.... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~-~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--FI-SLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--HH-TTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--HH-HHHhhccccCHHHHHHHHH
Confidence 13699999999999998 45678999998753211000 00 0000000022222110 0
Q ss_pred CCCC-----------CccchhhHHHHHHHHhhCCCCCC
Q 045214 187 GYDG-----------DKADIWSCGVILYVLLAGYLPFH 213 (450)
Q Consensus 187 ~~~~-----------~~~DiwSlGvil~~ll~g~~Pf~ 213 (450)
.|.. ...+.|++|.++|.+.+|..+|-
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1110 12589999999999999987763
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.76 E-value=1.6e-08 Score=82.90 Aligned_cols=86 Identities=14% Similarity=0.198 Sum_probs=72.8
Q ss_pred eecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEe-CceEEEEEEecCCCcHHHHHHHH
Q 045214 343 FTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFN-PSIHLVELTKSSGDNLEYQKMLK 421 (450)
Q Consensus 343 f~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~~ 421 (450)
-+|..+|++|+..|..+++++|+.++.++...+++..........+.|.+||+++. .+++.|+|+|.+||...|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 45678999999999999999999999867666887653333456799999999994 78999999999999999999999
Q ss_pred Hhhhhhcc
Q 045214 422 QEIRPALK 429 (450)
Q Consensus 422 ~~l~~~l~ 429 (450)
+ |-..|+
T Consensus 113 ~-IL~eLk 119 (126)
T 1v5s_A 113 K-IANELK 119 (126)
T ss_dssp H-HHHHTT
T ss_pred H-HHHHHh
Confidence 8 666665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2e-07 Score=89.87 Aligned_cols=133 Identities=20% Similarity=0.207 Sum_probs=97.3
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC---CccEEEEEEE-eCCEEEEEEe
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP---NVMQIYEVMA-SKTKIYFVME 90 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 90 (450)
.+.++.|....||+. +..+++|+.... .....+.+|..+|+.+.+. .+.+++.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 566889999999987 567899985321 2346789999999999642 3667777764 4566889999
Q ss_pred ecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 045214 91 YAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR------------------------------------------ 128 (450)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~------------------------------------------ 128 (450)
+++|..+.+..- ..++......+..++...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988866322 2355666666666666666666642
Q ss_pred ------------------CCeecCCCCCcEEecC---CCCe-EEeecCchhh
Q 045214 129 ------------------GVYHRDLKPENLLLDE---NGML-KVTDFGLSAL 158 (450)
Q Consensus 129 ------------------gi~HrDikp~NILl~~---~~~v-kl~DFGls~~ 158 (450)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3499999999999987 4554 8999997643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=4.3e-07 Score=85.42 Aligned_cols=131 Identities=15% Similarity=0.216 Sum_probs=97.0
Q ss_pred EeecCCe-EEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEeecCCC
Q 045214 18 LGQGNFA-KVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 18 LG~G~fg-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (450)
+..|..+ .||+......+..+++|+-... ....+.+|...|+.+. +--+.+++.+..+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445444 6998887767788999986543 2456788999998884 334778899999999999999999998
Q ss_pred ChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 045214 96 ELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR----------------------------------------------- 128 (450)
Q Consensus 96 ~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~----------------------------------------------- 128 (450)
++.+..... ......+..++...|..||+.
T Consensus 106 ~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 106 TAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp EHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 877665432 122334566677777777741
Q ss_pred -----------CCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 129 -----------GVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 129 -----------gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.++|+|++|.|||++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15899999999999987777899999764
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=6.9e-07 Score=70.62 Aligned_cols=90 Identities=12% Similarity=0.196 Sum_probs=74.6
Q ss_pred eeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEecCCC-----
Q 045214 338 KEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGD----- 412 (450)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd----- 412 (450)
++.--..|...+.+||..|..+++.+|+.|+..+...|++..........+.|.+++|++.+..+|+||++..||
T Consensus 7 kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~ 86 (106)
T 4eai_A 7 KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGG 86 (106)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSS
T ss_pred cceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCC
Confidence 455567788899999999999999999999988777788875433233568999999999999999999999994
Q ss_pred ---cHHHHHHHHHhhhhhc
Q 045214 413 ---NLEYQKMLKQEIRPAL 428 (450)
Q Consensus 413 ---~le~~~~~~~~l~~~l 428 (450)
+++|-.+|.. +-..|
T Consensus 87 ~~~~~~F~d~ca~-li~~l 104 (106)
T 4eai_A 87 GSHTIEFFEMCAN-LIKIL 104 (106)
T ss_dssp SCHHHHHHHHHHH-HHHHC
T ss_pred CcCcEeHHHHHHH-HHHHH
Confidence 8999999998 44333
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=1e-06 Score=74.69 Aligned_cols=87 Identities=11% Similarity=0.162 Sum_probs=66.4
Q ss_pred CCccccccceeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEe
Q 045214 329 SGFFVEHDQKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTK 408 (450)
Q Consensus 329 s~~~~~~~~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k 408 (450)
||+-..+..++.-...|+..+.+||..|..+++.||+.|++.+...|++..........+.|.+++|++.++.+||||++
T Consensus 9 ~~~~~~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~ 88 (173)
T 2y8l_A 9 SGLVPRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRS 88 (173)
T ss_dssp -------CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEE
T ss_pred cCCcccccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEe
Confidence 34544445677788889999999999999999999999999888888887543222236899999999999999999999
Q ss_pred cCCCcHH
Q 045214 409 SSGDNLE 415 (450)
Q Consensus 409 ~~Gd~le 415 (450)
..||+-|
T Consensus 89 l~Gd~~e 95 (173)
T 2y8l_A 89 IDDEITE 95 (173)
T ss_dssp ECCC---
T ss_pred cCCCccc
Confidence 9999866
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=5.7e-07 Score=89.72 Aligned_cols=80 Identities=18% Similarity=0.125 Sum_probs=51.7
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc-cc---cchHHHHHHHHHHHHhCCC--C-CccEEEEEEEeCCEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI-LK---VGLVDQTKREISVMRLIQH--P-NVMQIYEVMASKTKIY 86 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~ 86 (450)
-.+.||.|..+.||++....+++.+++|....... .. .....+...|..+++.+.. | .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997665678999998753211 00 0123456789989887732 3 45566654 344568
Q ss_pred EEEeecCCC
Q 045214 87 FVMEYAKGG 95 (450)
Q Consensus 87 lv~E~~~gg 95 (450)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=4.4e-07 Score=89.04 Aligned_cols=86 Identities=13% Similarity=0.118 Sum_probs=57.4
Q ss_pred eeeceE-eecCCeEEEEEEEc--C----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-C--CCccEEEEEEEeC
Q 045214 13 ELGRLL-GQGNFAKVYYARHL--G----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-H--PNVMQIYEVMASK 82 (450)
Q Consensus 13 ~~~~~L-G~G~fg~Vy~a~~~--~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 82 (450)
...+.| +.|....+|+.... . +++.+++|+..............+.+|..+++.+. + ..+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88989999998753 1 26679999875433100000134678888888774 2 3577888877655
Q ss_pred ---CEEEEEEeecCCCChh
Q 045214 83 ---TKIYFVMEYAKGGELF 98 (450)
Q Consensus 83 ---~~~~lv~E~~~gg~L~ 98 (450)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.2e-06 Score=70.79 Aligned_cols=78 Identities=10% Similarity=0.148 Sum_probs=63.8
Q ss_pred eeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEecCCCcHH
Q 045214 338 KEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLE 415 (450)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le 415 (450)
++.-...|+..+.+||..|..+++.||+.|++.+...|++.-........+.|.+++|+|.++.+||||++..||+-|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 455667788899999999999999999999998888888875433222368999999999999999999999999866
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.20 E-value=7.6e-06 Score=79.28 Aligned_cols=133 Identities=15% Similarity=0.186 Sum_probs=77.2
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CCCccEEE-E--EEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-----HPNVMQIY-E--VMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 86 (450)
.+.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.+. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34566678899999876 33459999987521 23344555555442 34444310 0 123467889
Q ss_pred EEEeecCCCChh-----------h---HHhc--CCC--C-----------HH--------H-------------------
Q 045214 87 FVMEYAKGGELF-----------K---KVSK--GKL--K-----------ED--------T------------------- 110 (450)
Q Consensus 87 lv~E~~~gg~L~-----------~---~i~~--~~l--~-----------e~--------~------------------- 110 (450)
++|+|++|..+. . .+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 0 1110 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 111 ----ARKYFQQLISAIDFCHS-------------RGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 111 ----~~~~~~qll~aL~~LH~-------------~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+..+..++..++.+|++ .+++|+|++|.|||++.++.+.|+||+.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11122233445666652 57999999999999988889999999965
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.20 E-value=2.4e-05 Score=63.39 Aligned_cols=80 Identities=11% Similarity=0.141 Sum_probs=61.1
Q ss_pred eeeeeeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEecCCCcHHHH
Q 045214 338 KEEVKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLEYQ 417 (450)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le~~ 417 (450)
++.--..|...|.+||..|..+++.+|+.|++.+...|++..........+.|.+++|++.+..+|+||+...||-.|..
T Consensus 7 kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 7 KWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp CEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred ceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 44555677888999999999999999999998877778887544433345889999999999999999999999976653
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=6.8e-06 Score=68.24 Aligned_cols=91 Identities=13% Similarity=0.096 Sum_probs=71.6
Q ss_pred ceeeeeeecccCHHHHHHHHHHHHHHcCcEEEEe---------cCceEEEEEecCCc-----ceeEEEEEEEEEEeCceE
Q 045214 337 QKEEVKFTSKYSASVIISKLEDIARHLKMKLTKK---------DGGLLKFEKSDKGR-----LGTFSIDVQLFEFNPSIH 402 (450)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~-----~g~l~~~~~v~~~~~~~~ 402 (450)
.++.-...|+..+.+||..|..|++.||+.|++. +...|++.-....- ...+.|.+++|+|.++.+
T Consensus 11 ~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~Y 90 (137)
T 2qrd_A 11 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCF 90 (137)
T ss_dssp CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEE
T ss_pred CccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcE
Confidence 3566677888899999999999999999999977 66667775532210 135889999999999999
Q ss_pred EEEEEecCCC---------------c----HHHHHHHHHhhhhhc
Q 045214 403 LVELTKSSGD---------------N----LEYQKMLKQEIRPAL 428 (450)
Q Consensus 403 lVe~~k~~Gd---------------~----le~~~~~~~~l~~~l 428 (450)
||||+...|+ . ++|-.+|.. |-..|
T Consensus 91 LlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~-Li~eL 134 (137)
T 2qrd_A 91 MLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAM-LVCKL 134 (137)
T ss_dssp EEEEEEEEEEESCC-------------CCCTTHHHHHHH-HHHHH
T ss_pred EEEEEecCCccccccCccccccCCccccccccHHHHHHH-HHHHH
Confidence 9999999998 4 788888887 44444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=8.9e-05 Score=71.34 Aligned_cols=76 Identities=16% Similarity=0.232 Sum_probs=60.9
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCccEEEEEEEeCCEEEEEEe
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ---HPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E 90 (450)
-.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.+. ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999875 5678899987643 2456788998888873 3568899998888889999999
Q ss_pred ecCCCCh
Q 045214 91 YAKGGEL 97 (450)
Q Consensus 91 ~~~gg~L 97 (450)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.2e-05 Score=77.61 Aligned_cols=77 Identities=16% Similarity=0.089 Sum_probs=46.6
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccc--ccc----chHHHHHHHHHHHH-hCCCCCccEEEEEEEeCCEEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI--LKV----GLVDQTKREISVMR-LIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~--~~~----~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~ 86 (450)
-.+.||.|..+.||++.. +++.+++|....... ... .....++.|+..+. ......+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467789999999999964 567899994332110 000 01223333433222 22334677777765 56679
Q ss_pred EEEeec-CC
Q 045214 87 FVMEYA-KG 94 (450)
Q Consensus 87 lv~E~~-~g 94 (450)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00012 Score=62.84 Aligned_cols=89 Identities=12% Similarity=0.137 Sum_probs=69.4
Q ss_pred eeeeeeecccCHHHHHHHHHHHHHHcCcEEEEec---CceEEEEEecC---------CcceeEEEEEEEEEEeCceEEEE
Q 045214 338 KEEVKFTSKYSASVIISKLEDIARHLKMKLTKKD---GGLLKFEKSDK---------GRLGTFSIDVQLFEFNPSIHLVE 405 (450)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~g~l~~~~~v~~~~~~~~lVe 405 (450)
++.--..|+..+.+||..|..+++.+|+.|++.+ ...|++..... +....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 4555567889999999999999999999999865 56688763211 11235899999999999999999
Q ss_pred EEecCC----------------------CcHHHHHHHHHhhhhhc
Q 045214 406 LTKSSG----------------------DNLEYQKMLKQEIRPAL 428 (450)
Q Consensus 406 ~~k~~G----------------------d~le~~~~~~~~l~~~l 428 (450)
|+ ..| ....|-.+|.+ |--+|
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~-LI~eL 172 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK-LIMEL 172 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHH-HHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHH-HHHHH
Confidence 99 778 66888888887 54444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.70 E-value=6.1e-05 Score=71.90 Aligned_cols=74 Identities=15% Similarity=0.068 Sum_probs=46.5
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEEEe
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFVME 90 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E 90 (450)
+.-.+.|+.|....+|++ +.+++|+........ ....+|..+++.+...++ .+++.. +.+.-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence 333788999999999998 568999886532111 122468877777642222 466654 3333578999
Q ss_pred ec-CCCCh
Q 045214 91 YA-KGGEL 97 (450)
Q Consensus 91 ~~-~gg~L 97 (450)
|+ +|.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.69 E-value=9.7e-05 Score=71.50 Aligned_cols=134 Identities=15% Similarity=0.191 Sum_probs=70.9
Q ss_pred eceEeecCCeE-EEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCccEEEEEEEeCCEEEEEEee
Q 045214 15 GRLLGQGNFAK-VYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH--PNVMQIYEVMASKTKIYFVMEY 91 (450)
Q Consensus 15 ~~~LG~G~fg~-Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 91 (450)
.+.|+.|+... +|+... .+++.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45566665554 666643 2366787876543321 223467777776632 23566776643333 789999
Q ss_pred cCCCChhhHHhcC---------------------------CCCHHHHH-------H-HH------------HHHHHHHHH
Q 045214 92 AKGGELFKKVSKG---------------------------KLKEDTAR-------K-YF------------QQLISAIDF 124 (450)
Q Consensus 92 ~~gg~L~~~i~~~---------------------------~l~e~~~~-------~-~~------------~qll~aL~~ 124 (450)
+.|..+.+.+... .+...... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776664433211 11121110 0 00 011112222
Q ss_pred H------HHCCCeecCCCCCcEEecCC----CCeEEeecCchh
Q 045214 125 C------HSRGVYHRDLKPENLLLDEN----GMLKVTDFGLSA 157 (450)
Q Consensus 125 L------H~~gi~HrDikp~NILl~~~----~~vkl~DFGls~ 157 (450)
+ +...++|+|+.|.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 2 13479999999999999874 679999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00034 Score=62.95 Aligned_cols=120 Identities=18% Similarity=0.150 Sum_probs=79.6
Q ss_pred ChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCccccc
Q 045214 96 ELFKKVSK--GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC 172 (450)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 172 (450)
+|.+.+.. .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 68888864 689999999999999999877622 2222344557899999999998874 2110 1
Q ss_pred CCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHccCC
Q 045214 173 GTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 173 gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
....+.|||... ...+.+.=|||||+++|..+--.+|= .-+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 233577888763 12235678999999999887633331 12345899999999999866
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00018 Score=69.08 Aligned_cols=136 Identities=13% Similarity=0.146 Sum_probs=76.4
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--ccEEEE------EEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN--VMQIYE------VMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (450)
.+.|+.|....+|+.... +..+++|+..... . ...+..|+.+++.+...+ +.+++. +....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 456777888999998763 3368899887531 1 124456777776663211 233331 122356789
Q ss_pred EEEeecCCCChhh--------------HHhc--CCC--------CHHHHHHH---------------HHHHHHHHHHHHH
Q 045214 87 FVMEYAKGGELFK--------------KVSK--GKL--------KEDTARKY---------------FQQLISAIDFCHS 127 (450)
Q Consensus 87 lv~E~~~gg~L~~--------------~i~~--~~l--------~e~~~~~~---------------~~qll~aL~~LH~ 127 (450)
++++|++|..+.. .+.. ..+ ....-... -..+...++.+++
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865311 0110 011 11000000 0113344555553
Q ss_pred -------CCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 128 -------RGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 128 -------~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999877666899998653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00025 Score=70.12 Aligned_cols=135 Identities=19% Similarity=0.172 Sum_probs=82.3
Q ss_pred eceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (450)
++.|..|-...+|++.... +++.+++|+..... .......+|..+++.+. +.-..+++..+.+ -
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4567778888999988642 35789999863311 12355668999998874 3334667766543 2
Q ss_pred EEEeecCCCChhh--------------HH---hc-----CC-CC--HHHHHHHHHHHHH-------------------HH
Q 045214 87 FVMEYAKGGELFK--------------KV---SK-----GK-LK--EDTARKYFQQLIS-------------------AI 122 (450)
Q Consensus 87 lv~E~~~gg~L~~--------------~i---~~-----~~-l~--e~~~~~~~~qll~-------------------aL 122 (450)
+||||++|..|.. .+ .. ++ .. ...+..++.++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999855421 11 11 11 11 3456666655422 23
Q ss_pred HHHH----H----CCCeecCCCCCcEEecCC----CCeEEeecCchh
Q 045214 123 DFCH----S----RGVYHRDLKPENLLLDEN----GMLKVTDFGLSA 157 (450)
Q Consensus 123 ~~LH----~----~gi~HrDikp~NILl~~~----~~vkl~DFGls~ 157 (450)
..|. + ..++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3333 2 258999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00026 Score=71.29 Aligned_cols=75 Identities=12% Similarity=0.122 Sum_probs=50.8
Q ss_pred eeceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEE
Q 045214 14 LGRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKI 85 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 85 (450)
-++.|+.|....+|++.... +++.+++|+..... ....+.+|..+++.+...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888899999998753 35789999884321 1134457898888884333 3677766542
Q ss_pred EEEEeecCCCCh
Q 045214 86 YFVMEYAKGGEL 97 (450)
Q Consensus 86 ~lv~E~~~gg~L 97 (450)
.+|+||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0025 Score=60.08 Aligned_cols=81 Identities=15% Similarity=0.091 Sum_probs=57.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC---CCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH---PNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~ 85 (450)
..+..-++.+|.|..+.||+.+. .+|+.|++|+....... ....+.+|...|+.+.. --+++++.+. . -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 34566788999999999999986 57899999986544322 12356789999988842 2355666542 2 3
Q ss_pred EEEEeecCCCCh
Q 045214 86 YFVMEYAKGGEL 97 (450)
Q Consensus 86 ~lv~E~~~gg~L 97 (450)
+++|||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00043 Score=67.97 Aligned_cols=75 Identities=15% Similarity=0.100 Sum_probs=45.5
Q ss_pred eceEeecCCeEEEEEEEcC--------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEE
Q 045214 15 GRLLGQGNFAKVYYARHLG--------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKI 85 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 85 (450)
.+.|+.|....+|++.... .++.+++|+....... . .....|..+++.+...+ .++++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5567888889999998643 1368999987643211 1 12357888888774333 45666554 22
Q ss_pred EEEEeecCCCCh
Q 045214 86 YFVMEYAKGGEL 97 (450)
Q Consensus 86 ~lv~E~~~gg~L 97 (450)
+++|||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00086 Score=64.44 Aligned_cols=75 Identities=13% Similarity=0.115 Sum_probs=47.9
Q ss_pred ceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CccEEEEE-----EEeCCEEEEE
Q 045214 16 RLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP--NVMQIYEV-----MASKTKIYFV 88 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lv 88 (450)
+.|+ |....||++.. .+|+.+++|+...... ....+..|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998764 3466799999864321 134566788887766321 23333332 2335677899
Q ss_pred EeecCCCC
Q 045214 89 MEYAKGGE 96 (450)
Q Consensus 89 ~E~~~gg~ 96 (450)
|++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99999854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0021 Score=65.03 Aligned_cols=76 Identities=13% Similarity=0.219 Sum_probs=49.8
Q ss_pred eeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-cEEEEEEEeCCEEEEEEeec
Q 045214 14 LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNV-MQIYEVMASKTKIYFVMEYA 92 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 92 (450)
-++.|+.|-...+|++.....++.+++|+...... ... ...+|..+++.+...++ +++++.+. +. +||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence 35678889999999998754457899998754321 111 12589999998865444 57777663 32 499999
Q ss_pred CCCCh
Q 045214 93 KGGEL 97 (450)
Q Consensus 93 ~gg~L 97 (450)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.002 Score=62.47 Aligned_cols=30 Identities=17% Similarity=0.326 Sum_probs=26.8
Q ss_pred CCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 128 ~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 469999999999999988899999998664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0084 Score=59.96 Aligned_cols=76 Identities=13% Similarity=0.123 Sum_probs=49.5
Q ss_pred eeceEeecCCeEEEEEEEcCC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEE
Q 045214 14 LGRLLGQGNFAKVYYARHLGT-------GQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKI 85 (450)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (450)
-++.|..|-...+|++..... ++.+++++...... .. -...+|..+++.+. +.-..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KF-YDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 356677788899999987521 57899998654321 11 12357888888774 33345666533 22
Q ss_pred EEEEeecCCCCh
Q 045214 86 YFVMEYAKGGEL 97 (450)
Q Consensus 86 ~lv~E~~~gg~L 97 (450)
+.||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.44 E-value=0.043 Score=54.30 Aligned_cols=29 Identities=34% Similarity=0.473 Sum_probs=24.6
Q ss_pred CCeecCCCCCcEEe------cCCCCeEEeecCchh
Q 045214 129 GVYHRDLKPENLLL------DENGMLKVTDFGLSA 157 (450)
Q Consensus 129 gi~HrDikp~NILl------~~~~~vkl~DFGls~ 157 (450)
.++|+|+.+.|||+ ++++.+.++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 456789999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.75 E-value=1.6 Score=39.02 Aligned_cols=114 Identities=15% Similarity=0.175 Sum_probs=80.7
Q ss_pred CCCCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCeecCCCCCcEEecCCC
Q 045214 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAID-FCHSRGVYHRDLKPENLLLDENG 146 (450)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~-~LH~~gi~HrDikp~NILl~~~~ 146 (450)
.||++ -..+-.+++.+.+.++.-+++.=+..+.. ++....++++.+|+.... ++ ..-+|--|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~--~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK--TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT--SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh--cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 68888 55666888888888887766655666644 788888888888877655 33 4567888999999999999
Q ss_pred CeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchh-hHHHHHHHHhhCCCCCC
Q 045214 147 MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW-SCGVILYVLLAGYLPFH 213 (450)
Q Consensus 147 ~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw-SlGvil~~ll~g~~Pf~ 213 (450)
.+++.-.|+-. -++|.- -...|.| .+=|++..++.++..|.
T Consensus 122 ~p~i~hRGi~~-------------------~lpP~e-------~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 122 EPFFLHVGVKE-------------------SLPPDE-------WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CEEESCCEETT-------------------TBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred cEEEEEcCCcc-------------------cCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999887521 122321 1233433 36678888888877654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.86 E-value=1.1 Score=39.96 Aligned_cols=115 Identities=14% Similarity=0.282 Sum_probs=80.9
Q ss_pred CCCCccEEEEEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCC
Q 045214 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGM 147 (450)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~ 147 (450)
.||+++.. .+-.+.+.+.+.++.-+.+.=+..+.. ++....++++.+|+....++ ..-+|--|+|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~--~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS--FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG--SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh--cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 68989877 677788877777776654444444554 78888899999998877444 44578889999999999999
Q ss_pred eEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchh-hHHHHHHHHhhCCCCCC
Q 045214 148 LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIW-SCGVILYVLLAGYLPFH 213 (450)
Q Consensus 148 vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw-SlGvil~~ll~g~~Pf~ 213 (450)
+++.--|+... ++|. .-...|.| .+=|++..+++++..|.
T Consensus 118 p~i~~RGik~~-------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 118 PIAKTRGLQNV-------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEESCCEETTT-------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEEccCccC-------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99987775211 1221 11233433 36688889999888764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 450 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-87 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-86 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-82 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-80 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-79 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-79 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-78 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-78 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-74 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-73 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-72 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-71 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-71 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-64 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-23 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 4e-11 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 275 bits (705), Expect = 2e-91
Identities = 93/261 (35%), Positives = 152/261 (58%), Gaps = 6/261 (2%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
++ +E+GR LG+G F VY AR + +A+K + K ++ K G+ Q +RE+ + ++
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS 127
HPN++++Y T++Y ++EYA G +++++ K K E Y +L +A+ +CHS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
+ V HRD+KPENLLL G LK+ DFG S T CGT Y+ PE+I R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
+D +K D+WS GV+ Y L G PF + Y++I++ ++ FP + + R L+SR+L
Sbjct: 181 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 248 DPNPSTRISIAKIMENPWFRK 268
NPS R + +++E+PW
Sbjct: 240 KHNPSQRPMLREVLEHPWITA 260
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (683), Expect = 1e-87
Identities = 88/264 (33%), Positives = 150/264 (56%), Gaps = 8/264 (3%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
++ G++LG+G+F+ V AR L T + AIK ++K I+K V RE VM + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG 129
+++Y K+YF + YAK GEL K + K G E R Y +++SA+++ H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
+ HRDLKPEN+LL+E+ +++TDFG + + + + ++ GT YV+PE+++ +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRILDP 249
+D+W+ G I+Y L+AG PF N +++KI K +Y FP F R L+ ++L
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 250 NPSTRISIAK------IMENPWFR 267
+ + R+ + + +P+F
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (671), Expect = 4e-86
Identities = 91/269 (33%), Positives = 153/269 (56%), Gaps = 6/269 (2%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ ++L + LG+G + +V A + T ++VA+K +D + + + K+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNH 62
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSR 128
NV++ Y Y +EY GGELF ++ + E A+++F QL++ + + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
G+ HRD+KPENLLLDE LK++DFGL+ + + +++ LL+ CGT YVAPE++ RR +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 189 DGDKADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKADYKFPTW--FSADVRKLLSR 245
+ D+WSCG++L +LAG LP+ S+ Y + W + LL +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 246 ILDPNPSTRISIAKIMENPWFRKGLNSKS 274
IL NPS RI+I I ++ W+ K L +
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKKGA 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 7e-84
Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 9/268 (3%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+KY +GQG VY A + TGQ VAI+ ++ + K + EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
PN++ + +++ VMEY GG L V++ + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRD+K +N+LL +G +K+TDFG A+ + T GTP ++APEV++R+ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLSRI 246
K DIWS G++ ++ G P+ + N + IA + + P SA R L+R
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 247 LDPNPSTRISIAKIMENPWFRKGLNSKS 274
LD + R S +++++ + + S
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (654), Expect = 2e-82
Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 15/277 (5%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E K ++ Y++ LG G F V+ TG + A K + + ++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKE 73
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQL 118
I M +++HP ++ +++ ++ + E+ GGELF+KV+ K+ ED A +Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 119 ISAIDFCHSRGVYHRDLKPENLLL--DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
+ H H DLKPEN++ + LK+ DFGL+A K + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAE 190
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP---- 232
+ APEV + G D+WS GV+ Y+LL+G PF N R + D+
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269
+ S D + + ++L +P+TR++I + +E+PW G
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 254 bits (649), Expect = 9e-82
Identities = 80/325 (24%), Positives = 146/325 (44%), Gaps = 25/325 (7%)
Query: 1 METKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKRE 60
+E K + Y++ LG G F V+ TG+ K I+ L K E
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNE 76
Query: 61 ISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQL 118
IS+M + HP ++ +++ K ++ ++E+ GGELF +++ K+ E Y +Q
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLD--ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
+ H + H D+KPEN++ + + +K+ DFG LA + D ++ T T
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAE 193
Query: 177 YVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP---- 232
+ APE++ R D+W+ GV+ YVLL+G PF + + + + + D++F
Sbjct: 194 FAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252
Query: 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS----------KSAKSKTAIK 282
+ S + + + +L P R+++ +E+PW + ++ + K K
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312
Query: 283 ESSLVDVDAAFGPIENSASTEAPRP 307
+ A G I N +S RP
Sbjct: 313 YADWPAPQPAIGRIANFSSLRKHRP 337
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 2e-80
Identities = 73/269 (27%), Positives = 135/269 (50%), Gaps = 14/269 (5%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+E+ LG G F KVY A++ T A K ID ++ + EI ++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 70
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRG 129
++++ + + ++ ++E+ GG + + + L E + +Q + A+++ H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI----SR 185
+ HRDLK N+L +G +K+ DFG+S AK + GTP ++APEV+ S+
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADVRKL 242
KAD+WS G+ L + P H+ N M + KIAK++ P+ +S++ +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 243 LSRILDPNPSTRISIAKIMENPWFRKGLN 271
L + L+ N R + ++++++P+ N
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (633), Expect = 6e-80
Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 11/264 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ + R +G G+F VY+AR + + VAIK + +E+ ++ ++H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELF-KKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
PN +Q + + VMEY G +V K L+E + + + HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI--SRR 186
+ HRD+K N+LL E G++K+ DFG + ++ GTP ++APEVI
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDE 188
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW--FSADVRKLLS 244
G K D+WS G+ L P + N M+ IA+ + +S R +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 245 RILDPNPSTRISIAKIMENPWFRK 268
L P R + ++++ + +
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 1e-79
Identities = 88/263 (33%), Positives = 145/263 (55%), Gaps = 6/263 (2%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLI 67
++ + L ++LG+G+F KV+ A T Q AIKA+ KD +L V+ T E V+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCH 126
+HP + ++ +K ++FVMEY GG+L + S K A Y ++I + F H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
S+G+ +RDLK +N+LLD++G +K+ DFG+ + D +T CGTP Y+APE++ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246
Y+ D WS GV+LY +L G PFH + ++ I + +P W + + LL ++
Sbjct: 179 KYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 247 LDPNPSTRISIAK-IMENPWFRK 268
P R+ + I ++P FR+
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (624), Expect = 5e-79
Identities = 95/276 (34%), Positives = 141/276 (51%), Gaps = 20/276 (7%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV------GLVDQTKREISV 63
+ YE +LG+G + V H T + A+K ID L + T +E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 64 MRLIQ-HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISA 121
+R + HPN++Q+ + + T + V + K GELF + K L E RK + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I H + HRDLKPEN+LLD++ +K+TDFG S L CGTP+Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPE 179
Query: 182 VISRRGYD-----GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTW 234
+I D G + D+WS GVI+Y LLAG PF M M R I +Y+F P W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 235 --FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+S V+ L+SR L P R + + + +P+F++
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 244 bits (624), Expect = 1e-78
Identities = 93/266 (34%), Positives = 162/266 (60%), Gaps = 12/266 (4%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+Q +++ R LG G+F +V+ R G+ A+K + K+ ++++ V+ T E ++ ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFK-KVSKGKLKEDTARKYFQQLISAIDFCHS 127
HP +++++ +I+ +M+Y +GGELF + A+ Y ++ A+++ HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
+ + +RDLKPEN+LLD+NG +K+TDFG K+ + +T CGTP Y+APEV+S +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFG-----FAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247
Y+ D WS G+++Y +LAGY PF+DSN M Y KI A+ +FP +F+ DV+ LLSR++
Sbjct: 178 YN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236
Query: 248 DPNPSTRI-----SIAKIMENPWFRK 268
+ S R+ + +PWF++
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 2e-78
Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 17/268 (6%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
YE+ +G G++ + R G+ + K +D + + E++++R ++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 71 NVMQIYEVMASKT--KIYFVMEYAKGGELFKKVSKGK-----LKEDTARKYFQQLISAID 123
N+++ Y+ + +T +Y VMEY +GG+L ++KG L E+ + QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 124 FCHSRG-----VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
CH R V HRDLKP N+ LD +K+ DFGL+ + H GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYM 181
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSA 237
+PE ++R Y+ K+DIWS G +LY L A PF + + KI + + + P +S
Sbjct: 182 SPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENPW 265
++ ++++R+L+ R S+ +I+ENP
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 243 bits (620), Expect = 5e-78
Identities = 93/273 (34%), Positives = 152/273 (55%), Gaps = 14/273 (5%)
Query: 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISV 63
+ + + Y+ +LG G F++V A T + VAIK I K + G + EI+V
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAV 60
Query: 64 MRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAI 122
+ I+HPN++ + ++ S +Y +M+ GGELF ++ KG E A + Q++ A+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 123 DFCHSRGVYHRDLKPENLLL---DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
+ H G+ HRDLKPENLL DE+ + ++DFGL +K + +L T CGTP YVA
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL---SKMEDPGSVLSTACGTPGYVA 177
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WF 235
PEV++++ Y D WS GVI Y+LL GY PF+D N ++ +I KA+Y+F +
Sbjct: 178 PEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
S + + +++ +P R + + +++PW
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (620), Expect = 8e-78
Identities = 70/286 (24%), Positives = 131/286 (45%), Gaps = 16/286 (5%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
K L +KY + LG+G F V+ + ++ K + +V K+EIS++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILN 56
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLISAID 123
+ +H N++ ++E S ++ + E+ G ++F+++ S +L E Y Q+ A+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 124 FCHSRGVYHRDLKPENLLLD--ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
F HS + H D++PEN++ + +K+ +FG + K P Y APE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPE 173
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSA 237
V D+WS G ++YVLL+G PF + I A+Y F S
Sbjct: 174 VHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKTAIKE 283
+ + R+L +R++ ++ +++PW ++ + S K +K
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKH 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 2e-76
Identities = 92/268 (34%), Positives = 149/268 (55%), Gaps = 9/268 (3%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
KV M ++ +LLG+G F KV R TG+ A+K + K+ I+ V T E V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLISAIDF 124
+HP + + + ++ FVMEYA GGELF +S+ E+ AR Y +++SA+++
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HSR V +RD+K ENL+LD++G +K+TDFGL + T CGTP Y+APEV+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLS 244
Y D W GV++Y ++ G LPF++ + ++ I + +FP S + + LL+
Sbjct: 179 DNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 245 RILDPNPSTRIS-----IAKIMENPWFR 267
+L +P R+ ++ME+ +F
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-74
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 18/274 (6%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVD---QTKREISVM 64
L +Y++G LLG G F VY + VAIK ++KD+I G + + E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 65 RLIQ--HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV--SKGKLKEDTARKYFQQLIS 120
+ + V+++ + ++E + + +G L+E+ AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 121 AIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
A+ CH+ GV HRD+K EN+L+D N G LK+ DFG AL K GT Y
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239
PE I Y G A +WS G++LY ++ G +PF +I + F S++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231
Query: 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGLNSK 273
+ L+ L PS R + +I +PW + L +
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 4e-74
Identities = 63/267 (23%), Positives = 121/267 (45%), Gaps = 18/267 (6%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+ +G+G+F VY T VA + K+ K + K E +++ +QHPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 72 VMQIYEVMASKTK----IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCH 126
+++ Y+ S K I V E G L + + +K R + +Q++ + F H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 127 SRG--VYHRDLKPENLLL-DENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+R + HRDLK +N+ + G +K+ D GL+ L + GTP ++APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY 185
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIAKADY--KFPTWFSADVR 240
YD + D+++ G+ + + P+ + N +YR++ F +V+
Sbjct: 186 -EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 241 KLLSRILDPNPSTRISIAKIMENPWFR 267
+++ + N R SI ++ + +F+
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 6e-74
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 53/304 (17%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+E LG GN V+ H +G +A K I + +K + +Q RE+ V+ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSR- 128
++ Y S +I ME+ GG L + + K G++ E K +I + + +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 189 DGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADYKF-------------- 231
++DIWS G+ L + G P + L M+ + D
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 232 ---------------------------PTWFSADVRKLLSRILDPNPSTRISIAKIMENP 264
FS + + +++ L NP+ R + ++M +
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 265 WFRK 268
+ ++
Sbjct: 300 FIKR 303
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 231 bits (589), Expect = 7e-74
Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 11/272 (4%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
L +YELG +LG G ++V+ AR L + VA+K + D + +RE
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 66 LIQHPNVMQIYEVMASKTK----IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLIS 120
+ HP ++ +Y+ ++T Y VMEY G L V G + A +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSA-LAKCKHQDGLLHTTCGTPAYVA 179
A++F H G+ HRD+KP N+++ +KV DFG++ +A + GT Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WF 235
PE D ++D++S G +LY +L G PF + +++ + + D P+
Sbjct: 183 PEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
SAD+ ++ + L NP R A M R
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 3e-73
Identities = 87/280 (31%), Positives = 145/280 (51%), Gaps = 16/280 (5%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKIL---KVGLVDQTKREISVMRLI 67
Y+ G LG G FA V R TG A K I K + + + +RE+S+++ I
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCH 126
QHPNV+ ++EV +KT + ++E GGELF + K L E+ A ++ +Q+++ + + H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 127 SRGVYHRDLKPENLLLDENGM----LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEV 182
S + H DLKPEN++L + + +K+ DFGL A GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 183 ISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSAD 238
++ +AD+WS GVI Y+LL+G PF ++ +Y+F + SA
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSK 278
+ + R+L +P R++I +++PW + ++ S
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 8e-73
Identities = 58/262 (22%), Positives = 117/262 (44%), Gaps = 15/262 (5%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+ +G+ +G G+F VY + G VA+K ++ L K E+ V+R +H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRHV 64
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSR 128
N++ + ++ V ++ +G L+ + + K + +Q +D+ H++
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 129 GVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGY 188
+ HRDLK N+ L E+ +K+ DFGL+ + G+ ++APEVI +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 189 D--GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW------FSADVR 240
+ ++D+++ G++LY L+ G LP+ + N + Y P ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 241 KLLSRILDPNPSTRISIAKIME 262
+L++ L R +I+
Sbjct: 244 RLMAECLKKKRDERPLFPQILA 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 231 bits (589), Expect = 1e-72
Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 16/271 (5%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M + + R++G+G F +VY R TG+ A+K +DK +I E ++ L+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 69 ---HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDF 124
P ++ + + K+ F+++ GG+L +S+ G E R Y ++I ++
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
H+R V +RDLKP N+LLDE+G ++++D GL+ C H + GT Y+APEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQ 178
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADYKFPTWFSADVRK 241
+ AD +S G +L+ LL G+ PF + R + P FS ++R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 242 LLSRILDPNPSTRISIAK-----IMENPWFR 267
LL +L + + R+ + E+P+FR
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-71
Identities = 93/299 (31%), Positives = 146/299 (48%), Gaps = 32/299 (10%)
Query: 1 METKGKVLMQKYE-LGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKR 59
++ K ++ Y+ ++LG G KV + T + A+K + + +R
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARR 53
Query: 60 EISVM-RLIQHPNVMQIYEV----MASKTKIYFVMEYAKGGELFKKVSK---GKLKEDTA 111
E+ + R Q P++++I +V A + + VME GGELF ++ E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 112 RKYFQQLISAIDFCHSRGVYHRDLKPENLLLD---ENGMLKVTDFGLSALAKCKHQDGLL 168
+ + + AI + HS + HRD+KPENLL N +LK+TDFG AK L
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSL 170
Query: 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKI 224
T C TP YVAPEV+ YD D+WS GVI+Y+LL GY PF+ ++ +A M +I
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 225 AKADYKFP----TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAKSKT 279
Y+FP + S +V+ L+ +L P+ R++I + M +PW + T
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 228 bits (581), Expect = 1e-71
Identities = 87/272 (31%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 3 TKGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREIS 62
++ + +++ + LG G+F +V +H +G A+K +DK K++K+ ++ T E
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISA 121
+++ + P ++++ + +Y VMEY GGE+F + + G+ E AR Y Q++
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
++ HS + +RDLKPENLL+D+ G ++VTDFG + K G T CGTP +APE
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPE 208
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRK 241
+I +GY+ D W+ GV++Y + AGY PF + +Y KI +FP+ FS+D++
Sbjct: 209 IILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
Query: 242 LLSRILDPNPSTRI-----SIAKIMENPWFRK 268
LL +L + + R + I + WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-68
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 9/261 (3%)
Query: 10 QKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
+ L LG G+F V G SVA+K + D + + +D RE++ M
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 67 IQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDF 124
+ H N++++Y V+ + + V E A G L ++ K G T +Y Q+ + +
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
S+ HRDL NLLL ++K+ DFGL ++ P
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 185 RRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKF--PTWFSADVRK 241
+ +D W GV L+ + G P+ N + KI K + P D+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 242 LLSRILDPNPSTRISIAKIME 262
++ + P R + + +
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 63/260 (24%), Positives = 114/260 (43%), Gaps = 19/260 (7%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M++ +L + +G+G F V + G VA+K I D + E SVM ++
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLR 58
Query: 69 HPNVMQIYEVMA-SKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDF 124
H N++Q+ V+ K +Y V EY G L + + L D K+ + A+++
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HRDL N+L+ E+ + KV+DFG K T + APE +
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFG-----LTKEASSTQDTGKLPVKWTAPEALR 173
Query: 185 RRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242
+ + K+D+WS G++L+ + + G +P+ L + ++ K P V ++
Sbjct: 174 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 243 LSRILDPNPSTRISIAKIME 262
+ + + R S ++ E
Sbjct: 233 MKNCWHLDAAMRPSFLQLRE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-67
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 38/300 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y +G+G + V A VAIK I + +T REI ++ +H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66
Query: 71 NVMQIYEVMASKT----KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
N++ I +++ + T K +++ + G +L+K + L D + Q++ + + H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISR 185
S V HRDLKP NLLL+ LK+ DFGL+ +A H T T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP------------- 232
DIWS G IL +L+ F + + I
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 233 ------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKS 274
+ LL ++L NP RI + + + +P+ + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-66
Identities = 72/286 (25%), Positives = 113/286 (39%), Gaps = 33/286 (11%)
Query: 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI--LKVGLVDQTKREISVMRLIQHP 70
E LG+G FA VY AR T Q VAIK I K G+ REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGK-LKEDTARKYFQQLISAIDFCHSRG 129
N++ + + K+ I V ++ + L + Y + +++ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
+ HRDLKP NLLLDENG+LK+ DFGL+ + T Y APE++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 190 GDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----------------- 232
G D+W+ G IL LL + + +I +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 233 -----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
+ D+ L+ + NP RI+ + ++ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 64/303 (21%), Positives = 113/303 (37%), Gaps = 44/303 (14%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
+ KYE +GQG F +V+ ARH TGQ VA+K + + K G REI +++L++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLK 67
Query: 69 HPNVMQIYEVMASKT--------KIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLI 119
H NV+ + E+ +K IY V ++ + K ++ Q L+
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD--GLLHTTCGTPAY 177
+ + + H + HRD+K N+L+ +G+LK+ DFGL+ T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----- 232
PE++ G D+W G I+ + + I++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 233 ---------------------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPW 265
L+ ++L +P+ RI + + +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 266 FRK 268
F
Sbjct: 308 FWS 310
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 45/318 (14%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
Y + +G G + V A TG VAIK + + + + RE+ +++ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRH 76
Query: 70 PNVMQIYEVMASK------TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAID 123
NV+ + +V T Y VM + G +L K + KL ED + Q++ +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 124 FCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVI 183
+ H+ G+ HRDLKP NL ++E+ LK+ DFGL+ + D + T Y APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 184 SRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF-------- 235
DIWS G I+ ++ G F S+ + ++I K P F
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 236 -----------------------SADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNS 272
S LL ++L + R++ + + +P+F + L+
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLHD 309
Query: 273 KSAKSKTAIKESSLVDVD 290
+ + + S DVD
Sbjct: 310 TEDEPQVQKYDDSFDDVD 327
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 7e-64
Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 34/291 (11%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+ ++ +G+G + VY AR+ TG+ VA+K I D + G+ REIS+++ +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELN 59
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
HPN++++ +V+ ++ K+Y V E+ + + + + Y QL+ + FCH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
S V HRDLKP+NLL++ G +K+ DFGL+ + T Y APE++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 187 GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA------------------D 228
Y DIWS G I ++ F + + +I +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 229 YKFPTW-----------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
FP W D R LLS++L +P+ RIS + +P+F+
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-63
Identities = 56/285 (19%), Positives = 110/285 (38%), Gaps = 36/285 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQS-----VAIKAIDKDKILKVGLVDQTKREISVM- 64
E G++LG G F KV A G ++ VA+K + + + E+ +M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--------------------- 103
+L H N++ + IY + EY G+L +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 104 ---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160
L + + Q+ ++F + HRDL N+L+ ++K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMA 219
+ ++APE + Y K+D+WS G++L+ + + G P+ + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 220 MYRKIAKADYKF--PTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ K+ + +K P + + ++ ++ + R S +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 50/297 (16%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
Y +++G G+F VY A+ +G+ VAIK + +DK K RE+ +MR + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 72 VMQIYEVMAS------KTKIYFVMEYAKGGEL----FKKVSKGKLKEDTARKYFQQLISA 121
++++ S + + V++Y +K L + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 122 IDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAP 180
+ + HS G+ HRD+KP+NLLLD + +LK+ DFG AK + + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---AKQLVRGEPNVSYICSRYYRAP 191
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAK-------------- 226
E+I D+WS G +L LL G F + + +I K
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 227 ---ADYKFPTW------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
++KFP + L SR+L+ P+ R++ + + +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-63
Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 11/264 (4%)
Query: 16 RLLGQGNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM 73
+ LG GNF V + ++VA+K + + L D+ E +VM+ + +P ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 74 QIYEVMASKTKIYFVMEYAKGGELFKKV-SKGKLKEDTARKYFQQLISAIDFCHSRGVYH 132
++ + ++ VME A+ G L K + +K+ + Q+ + + H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 133 RDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT-CGTPAYVAPEVISRRGYDGD 191
RDL N+LL K++DFGLS + T + APE I+ +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS- 189
Query: 192 KADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSRILDP 249
K+D+WS GV+++ + G P+ + + K + P ++ L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 250 NPSTRISIAKIME--NPWFRKGLN 271
+ R A + ++ +N
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-63
Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 11/256 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+ LG G F V Y + VAIK I + + + D+ E VM + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++Q+Y V + I+ + EY G L + + + + + + + A+++ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
HRDL N L+++ G++KV+DFGLS + + + PEV+ +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 190 GDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRIL 247
K+DIW+ GV+++ + + G +P+ IA+ P S V ++
Sbjct: 180 S-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 248 DPNPSTRISIAKIMEN 263
R + ++ N
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 203 bits (516), Expect = 7e-63
Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 34/290 (11%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
M+KY +G+G + VY A++ G++ A+K I +K G+ T REIS+++ ++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFK-KVSKGKLKEDTARKYFQQLISAIDFCHS 127
H N++++Y+V+ +K ++ V E+ V +G L+ TA+ + QL++ I +CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
R V HRDLKP+NLL++ G LK+ DFGL+ T Y AP+V+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 188 YDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------------ 229
DIWS G I ++ G F + +I +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 230 -----------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
F LLS++L +P+ RI+ + +E+ +F++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-62
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 14/259 (5%)
Query: 18 LGQGNFAKVYYARH--LGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQI 75
LG GNF V + VAIK + + + ++ RE +M + +P ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 76 YEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHR 133
V + VME A GG L K + ++ + Q+ + + + HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 134 DLKPENLLLDENGMLKVTDFGLS-ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDK 192
DL N+LL K++DFGLS AL + APE I+ R + +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS-R 192
Query: 193 ADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSRILDPN 250
+D+WS GV ++ L+ G P+ + I + + P ++ L+S
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 251 PSTRIS---IAKIMENPWF 266
R + + M ++
Sbjct: 253 WEDRPDFLTVEQRMRACYY 271
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-62
Identities = 79/278 (28%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREI 61
KV ++ +EL ++LG G + KV+ R + TG+ A+K + K I+ K + T+ E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 62 SVMRLIQH-PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKG-KLKEDTARKYFQQLI 119
V+ I+ P ++ ++ ++TK++ +++Y GGELF +S+ + E + Y +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 120 SAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVA 179
A++ H G+ +RD+K EN+LLD NG + +TDFGLS +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 180 PEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN----LMAMYRKIAKADYKFPTWF 235
V D WS GV++Y LL G PF + R+I K++ +P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 236 SADVRKLLSRILDPNPSTRISIAK-----IMENPWFRK 268
SA + L+ R+L +P R+ I E+ +F+K
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-62
Identities = 64/294 (21%), Positives = 120/294 (40%), Gaps = 42/294 (14%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y+ +G G + V A TG VA+K + + + +T RE+ +++ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 71 NVMQIYEVMASKTKI-----YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
NV+ + +V + +++ + G +L V KL +D + Q++ + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISR 185
HS + HRDLKP NL ++E+ LK+ DFGL+ + T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 186 RGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF---------- 235
+ DIWS G I+ LL G F ++ + + I +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 236 ---------------------SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+ LL ++L + RI+ A+ + + +F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 8e-62
Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 11/257 (4%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+ LG G + +VY +VA+K + +D + V++ +E +VM+ I+HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK---KVSKGKLKEDTARKYFQQLISAIDFCHS 127
N++Q+ V + Y + E+ G L + ++ ++ Q+ SA+++
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
+ HRDL N L+ EN ++KV DFGLS L + APE ++
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 188 YDGDKADIWSCGVILYVLL-AGYLPFHDSNLMAMYRKIAK-ADYKFPTWFSADVRKLLSR 245
+ K+D+W+ GV+L+ + G P+ +L +Y + K + P V +L+
Sbjct: 193 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 246 ILDPNPSTRISIAKIME 262
NPS R S A+I +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-61
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 11/255 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN 71
+ +G G F V+ L VAIK I + + + + E VM + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 72 VMQIYEVMASKTKIYFVMEYAKGGELFK--KVSKGKLKEDTARKYFQQLISAIDFCHSRG 129
++Q+Y V + I V E+ + G L + +G +T + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 130 VYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYD 189
V HRDL N L+ EN ++KV+DFG++ Q T + +PEV S Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 190 GDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRIL 247
K+D+WS GV+++ + + G +P+ + + + I+ P S V ++++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 248 DPNPSTRISIAKIME 262
P R + ++++
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 1e-61
Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 22/278 (7%)
Query: 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQS---VAIKAIDKDKILKVGLVDQTKREIS 62
++ + ++ +++G G F +V G+ VAIK + K E S
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEAS 79
Query: 63 VMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLIS 120
+M HPNV+ + V+ T + + E+ + G L F + + G+ + + +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 121 AIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT---CGTPAY 177
+ + HRDL N+L++ N + KV+DFGLS + D + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 178 VAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADYKFPTW-- 234
APE I R + +D+WS G++++ +++ G P+ D + I + DY+ P
Sbjct: 200 TAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257
Query: 235 FSADVRKLLSRILDPNPSTRISIA-------KIMENPW 265
+ + +L+ + + R K++ NP
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-61
Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 43/296 (14%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGT-GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI- 67
Q+YE +G+G + KV+ AR L G+ VA+K + + G+ T RE++V+R +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLE 65
Query: 68 --QHPNVMQIYEVMAS-----KTKIYFVMEYAKGG--ELFKKVSKGKLKEDTARKYFQQL 118
+HPNV+++++V +TK+ V E+ KV + + +T + QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 119 ISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYV 178
+ +DF HS V HRDLKP+N+L+ +G +K+ DFG LA+ L + T Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQMALTSVVVTLWYR 182
Query: 179 APEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKI-------------- 224
APEV+ + Y D+WS G I + F S+ + KI
Sbjct: 183 APEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 225 -------------AKADYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267
A+ KF T + LL + L NP+ RIS + +P+F+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-61
Identities = 58/258 (22%), Positives = 112/258 (43%), Gaps = 13/258 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ +L LG G F +V+ + VA+K++ + + D E ++M+ +QH
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELF---KKVSKGKLKEDTARKYFQQLISAIDFCH 126
++++Y V+ ++ IY + EY + G L K S KL + Q+ + F
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
R HRDL+ N+L+ + K+ DFGL+ L + ++ + APE I
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI-NY 184
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244
G K+D+WS G++L ++ G +P+ + + + + P ++ +L+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 245 RILDPNPSTRISIAKIME 262
P R + +
Sbjct: 245 LCWKERPEDRPTFDYLRS 262
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (505), Expect = 4e-61
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ 68
MQKYE +G+G + V+ A++ T + VA+K + D G+ REI +++ ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGEL-FKKVSKGKLKEDTARKYFQQLISAIDFCHS 127
H N++++++V+ S K+ V E+ + G L + + + QL+ + FCHS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
R V HRDLKP+NLL++ NG LK+ +FGL+ T Y P+V+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 188 YDGDKADIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAKADYKFP-------------- 232
D+WS G I L P F +++ ++I +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 233 ---------------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268
+A R LL +L NP RIS + +++P+F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 6e-61
Identities = 63/264 (23%), Positives = 109/264 (41%), Gaps = 15/264 (5%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH 69
+ L LGQG F +V+ GT + VAIK + + + +E VM+ ++H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRH 71
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK---EDTARKYFQQLISAIDFCH 126
++Q+Y V+ S+ IY V EY G L + K Q+ S + +
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRR 186
HRDL+ N+L+ EN + KV DFGL+ L + ++ + APE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 189
Query: 187 GYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLS 244
+ K+D+WS G++L L G +P+ + ++ + P + L+
Sbjct: 190 RFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 245 RILDPNPSTRISIAKIME--NPWF 266
+ P R + + +F
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-60
Identities = 53/257 (20%), Positives = 107/257 (41%), Gaps = 8/257 (3%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK--DKILKVGLVDQTKREISVMRLIQH 69
++ ++LG G F VY + G+ V I K + + E VM + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 70 PNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLK--EDTARKYFQQLISAIDFCHS 127
P+V ++ + + T + + + G L V + K + Q+ +++
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 128 RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRG 187
R + HRDL N+L+ +K+TDFGL+ L + ++ ++A E I R
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 188 YDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKLLSR 245
Y ++D+WS GV ++ L+ G P+ + + K + P + DV ++ +
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 246 ILDPNPSTRISIAKIME 262
+ +R +++
Sbjct: 249 CWMIDADSRPKFRELII 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-60
Identities = 56/271 (20%), Positives = 106/271 (39%), Gaps = 24/271 (8%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLIQHP 70
+ ++G+GNF +V AR G + + E+ V+ +L HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 71 NVMQIYEVMASKTKIYFVMEYAKGGELFK-----------------KVSKGKLKEDTARK 113
N++ + + +Y +EYA G L + L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
+ + +D+ + HRDL N+L+ EN + K+ DFG L++ +
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 188
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKF 231
++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K+ + +
Sbjct: 189 PVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKIME 262
P +V L+ + P R S A+I+
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 8e-60
Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 11 KYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
E R +G+G F +V+ AR G VA+K + ++ + +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 66 LIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFK-------------------------K 100
+PN++++ V A + + EY G+L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 101 VSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160
L +Q+ + + + R HRDL N L+ EN ++K+ DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 161 CKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYL-PFHDSNLMA 219
++ PE I Y ++D+W+ GV+L+ + + L P++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 220 MYRKIAKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ + + P ++ L+ P+ R S I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-59
Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 12/260 (4%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDK-DKILKVGLVDQTKREISVMRLIQ 68
++ ELGR +G+G F V+ ++ AI + ++ +E MR
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 69 HPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCH 126
HP+++++ V+ ++ ++ +ME GEL + L + Y QL +A+ +
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 127 SRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTC--GTPAYVAPEVIS 184
S+ HRD+ N+L+ N +K+ DFGLS + + ++APE I+
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 185 RRGYDGDKADIWSCGVILY-VLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVRKL 242
R + +D+W GV ++ +L+ G PF + +I + P + L
Sbjct: 183 FRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
Query: 243 LSRILDPNPSTRISIAKIME 262
+++ +PS R ++
Sbjct: 242 MTKCWAYDPSRRPRFTELKA 261
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 194 bits (493), Expect = 7e-59
Identities = 64/301 (21%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVM-RLI 67
Y+L R LG+G +++V+ A ++ + V +K + K + KREI ++ L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLR 87
Query: 68 QHPNVMQIYEVMASKTK--IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFC 125
PN++ + +++ V E+ + + L + R Y +++ A+D+C
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYC 145
Query: 126 HSRGVYHRDLKPENLLLD-ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVIS 184
HS G+ HRD+KP N+++D E+ L++ D+G LA+ H + + + PE++
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 185 RRGYDGDKADIWSCGVILYVLLAGYLPFHDSN--------------LMAMYRKIAKADYK 230
D+WS G +L ++ PF + +Y I K + +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 231 FPTWF------------------------SADVRKLLSRILDPNPSTRISIAKIMENPWF 266
F S + L ++L + +R++ + ME+P+F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 267 R 267
Sbjct: 323 Y 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-57
Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 31/281 (11%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
+ G+ LG G F KV A G +VA+K + L + E+ V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVL 80
Query: 65 -RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK-------------------G 104
L H N++ + + EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 105 KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164
L + + Q+ + F S+ HRDL N+LL + K+ DFGL+ K
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRK 223
+ ++APE I ++D+WS G+ L+ L + G P+ + + + K
Sbjct: 201 YVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 224 IAKADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ K ++ P A++ ++ D +P R + +I++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 9e-57
Identities = 63/262 (24%), Positives = 116/262 (44%), Gaps = 13/262 (4%)
Query: 11 KYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++G+G+F VY+ L G A+K++++ +G V Q E +M+
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDF 85
Query: 68 QHPNVMQIYEV-MASKTKIYFVMEYAKGGEL--FKKVSKGKLKEDTARKYFQQLISAIDF 124
HPNV+ + + + S+ V+ Y K G+L F + + Q+ + F
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 125 CHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTT--CGTPAYVAPEV 182
S+ HRDL N +LDE +KV DFGL+ K D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 183 ISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY-KFPTWFSADVR 240
+ + K+D+WS GV+L+ L+ G P+ D N + + + P + +
Sbjct: 206 L-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 241 KLLSRILDPNPSTRISIAKIME 262
+++ + P R S ++++
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-56
Identities = 57/279 (20%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQS-------VAIKAIDKDKILKVGLVDQTKREISV 63
+ LG+ LG+G F +V A +G + VA+K + D K + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEM 71
Query: 64 M-RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFK-----------------KVSKGK 105
M + +H N++ + +Y ++EYA G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 106 LKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165
L Q+ +++ S+ HRDL N+L+ E+ ++K+ DFGL+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKI 224
++APE + R Y ++D+WS GV+L+ + G P+ + +++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 225 AKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
+ P+ + ++ ++ PS R + +++E
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 5e-56
Identities = 57/282 (20%), Positives = 99/282 (35%), Gaps = 27/282 (9%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y LGR +G G+F +Y + G+ VAIK Q E + +++Q
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGG 62
Query: 71 N-VMQIYEVMASKTKIYFVMEYAKGGELF-KKVSKGKLKEDTARKYFQQLISAIDFCHSR 128
+ I A VME K T Q+IS I++ HS+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 129 GVYHRDLKPENLLLDENGM---LKVTDFGLSALAK-----CKHQDGLLHTTCGTPAYVAP 180
HRD+KP+N L+ + + DFGL+ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 181 EVISRRGYDGDKADIWSCGVILYVLLAGYLPF---HDSNLMAMYRKIAKADYKFPTW--- 234
+ D+ S G +L G LP+ + Y +I++ P
Sbjct: 183 NTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 235 --FSADVRKLLSRILDPNPSTRIS---IAKIMENPWFRKGLN 271
+ ++ L+ + + ++ N + R+G +
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-56
Identities = 53/260 (20%), Positives = 109/260 (41%), Gaps = 12/260 (4%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQS----VAIKAIDKDKILKVGLVDQTKREISVMRLI 67
+++G G F +VY + VAIK + K E +M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQF 66
Query: 68 QHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFC 125
H N++++ V++ + + EY + G L K + + G+ + + + + +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 126 HSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHT-TCGTPAYVAPEVIS 184
+ HRDL N+L++ N + KV+DFGLS + + + + + APE IS
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 185 RRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242
R + +D+WS G++++ ++ G P+ + + + + I P + + +L
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 243 LSRILDPNPSTRISIAKIME 262
+ + + R A I+
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (460), Expect = 1e-54
Identities = 53/290 (18%), Positives = 99/290 (34%), Gaps = 28/290 (9%)
Query: 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRL 66
V+ Y++GR +G+G+F ++ +L Q VAIK + Q + E +L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKL 56
Query: 67 IQH-PNVMQIYEVMASKTKIYFVMEYA-KGGELFKKVSKGKLKEDTARKYFQQLISAIDF 124
+ + +Y V++ E + K T +Q+++ +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 125 CHSRGVYHRDLKPENLLLDE-----NGMLKVTDFGLSALA-----KCKHQDGLLHTTCGT 174
H + + +RD+KP+N L+ M+ V DFG+ K GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 175 PAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPF---HDSNLMAMYRKIAKADYKF 231
Y++ R + D+ + G + L G LP+ + Y +I +
Sbjct: 177 ARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 232 PTW-----FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
P F + K + + + F K L +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTT 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 54/283 (19%), Positives = 107/283 (37%), Gaps = 27/283 (9%)
Query: 10 QKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVM 64
+K + R LGQG+F VY G VAIK +++ ++ + E SVM
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 65 RLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELF-----------KKVSKGKLKEDTARK 113
+ +V+++ V++ +ME G+L +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 114 YFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCG 173
++ + + ++ HRDL N ++ E+ +K+ DFG++
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 174 TPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKADY-KF 231
+++PE + + +D+WS GV+L+ + P+ + + R + +
Sbjct: 198 PVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 232 PTWFSADVRKLLSRILDPNPSTRISIAKIME------NPWFRK 268
P + +L+ NP R S +I+ P FR+
Sbjct: 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-54
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 55/309 (17%)
Query: 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI 67
++++Y+ + +G G V A ++VAIK + + + RE+ +M+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 68 QHPNVMQIYEVMASK------TKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISA 121
H N++ + V + +Y VME +V + +L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 122 IDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPE 181
I HS G+ HRDLKP N+++ + LK+ DFG LA+ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 188
Query: 182 VISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWF------ 235
VI GY + DIWS G I+ ++ + F + + + K+ + F
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 236 ------------------------------------SADVRKLLSRILDPNPSTRISIAK 259
++ R LLS++L +P+ RIS+
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 260 IMENPWFRK 268
+++P+
Sbjct: 308 ALQHPYINV 316
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-52
Identities = 54/293 (18%), Positives = 113/293 (38%), Gaps = 47/293 (16%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
L +G+G F +V+ + G+ VA+K + + EI +++H
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRHE 57
Query: 71 NVMQIYEVM----ASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCH 126
N++ + T+++ V +Y + G LF +++ + + K S + H
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 127 S--------RGVYHRDLKPENLLLDENGMLKVTDFGLSAL--AKCKHQDGLLHTTCGTPA 176
+ HRDLK +N+L+ +NG + D GL+ + D + GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 177 YVAPEVIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFH---------------DSN 216
Y+APEV+ + +ADI++ G++ + + D +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 217 LMAMYRKIA--KADYKFPTWFSA-----DVRKLLSRILDPNPSTRISIAKIME 262
+ M + + K P + + + K++ N + R++ +I +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-51
Identities = 60/279 (21%), Positives = 113/279 (40%), Gaps = 30/279 (10%)
Query: 11 KYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMR 65
+ +LG+ LG+G F +V A G T ++VA+K + + E+ ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILI 71
Query: 66 LIQHPN--VMQIYEVMASKTKIYFVMEYAKGGELFK-----------------KVSKGKL 106
I H V + + ++E+ K G L + K L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 107 KEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166
+ Y Q+ ++F SR HRDL N+LL E ++K+ DFGL+
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY-LPFHDSNLMAMYRKIA 225
++APE I R Y ++D+WS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 226 KADYK--FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262
K + P + + ++ + + PS R + ++++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (391), Expect = 1e-43
Identities = 59/333 (17%), Positives = 116/333 (34%), Gaps = 72/333 (21%)
Query: 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHP 70
+Y L R LG G+F+ V+ A+ + VA+K + DK+ + + EI +++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 71 NV-------------MQIYEVMASKTKIYFVMEYAKGG----ELFKKVSKGKLKEDTARK 113
+ + + ++ VM + G L KK + ++
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 114 YFQQLISAIDFC-HSRGVYHRDLKPENLLLDENGM-LKVTDFGLSALAKCKHQDGLLHTT 171
+QL+ +D+ G+ H D+KPEN+L++ + ++ L D +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY---------- 221
T Y +PEV+ + ADIWS +++ L+ G F +
Sbjct: 190 IQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 222 --------------------------------------RKIAKADYKFPTWFSADVRKLL 243
+ YKF + ++ L
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 244 SRILDPNPSTRISIAKIMENPWFRKGLNSKSAK 276
S +L +P R ++ +PW + L + +
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 7e-23
Identities = 36/212 (16%), Positives = 69/212 (32%), Gaps = 41/212 (19%)
Query: 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKI---------------LKVGLVDQ 56
+G+L+G+G + V+ +K V +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 57 TKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQ 116
+ E ++ +Q V ++Y +ME EL++ + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRV------RVENPDEVLD 110
Query: 117 QLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPA 176
++ + + RG+ H DL N+L+ E G + + DF S + +L
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV---- 165
Query: 177 YVAPEVIS---RRGYDGDKADIWSCGVILYVL 205
I R Y + DI S I +L
Sbjct: 166 ----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.5 bits (139), Expect = 4e-11
Identities = 11/83 (13%), Positives = 34/83 (40%), Gaps = 1/83 (1%)
Query: 341 VKFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEF-NP 399
+K TS S ++ ++ + +++ LL D ++++ +
Sbjct: 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRL 72
Query: 400 SIHLVELTKSSGDNLEYQKMLKQ 422
S++ V + SG ++ ++ + +
Sbjct: 73 SLNGVRFKRISGTSIAFKNIASK 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.09 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.72 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-64 Score=480.02 Aligned_cols=256 Identities=37% Similarity=0.753 Sum_probs=238.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++++.||+|+||+||+|+++.+++.||+|++.+....+....+++.+|+.+++.++||||+++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999988766655667889999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence 9999999999999976 689999999999999999999999999999999999999999999999999986432 23
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++....+.+|+.+|+++++||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 34567899999999999988775 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 045214 247 LDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|++||++|||++|+|+||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-64 Score=480.73 Aligned_cols=261 Identities=34% Similarity=0.665 Sum_probs=226.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+.++|++++.||+|+||+||+|+++.+|+.||||+++..... ...+++.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 567899999999999999999999999999999999876432 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999998665444444
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhhcCCCC--CCCCcHHHHHHH
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAKADYKF--PTWFSADVRKLL 243 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~--p~~~s~~~~~ll 243 (450)
...+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||...+. ...+..+....... +..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 556778999999999999888877889999999999999999999987543 33334443333322 245899999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccccccC
Q 045214 244 SRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 244 ~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+||++||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-64 Score=481.16 Aligned_cols=261 Identities=34% Similarity=0.665 Sum_probs=235.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
..-++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34468999999999999999999999999999999998876655566788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999875 78999999999999999999999999999999999999999999999999999766544444
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+++.++....+.+|..+|+++++||.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 445567899999999999888775 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHH------HhcCccccc
Q 045214 246 ILDPNPSTRISIAK------IMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~s~~e------il~hp~f~~ 268 (450)
||++||++|||++| +++||||+.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999988 578999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-62 Score=472.96 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=227.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 45899999999999999999999999999999999865432 346789999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCc
Q 045214 89 MEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLL 168 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 168 (450)
|||++||+|.+++.++.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 22334
Q ss_pred ccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc---CCCCCCCCcHHHHHHHHH
Q 045214 169 HTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA---DYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 169 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ll~~ 245 (450)
...+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.......+... ....|+.+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999988775 8999999999999999999999988876666555443 234567799999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccc
Q 045214 246 ILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
||++||++|||++|+|+||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-62 Score=479.30 Aligned_cols=259 Identities=35% Similarity=0.655 Sum_probs=240.2
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+-+++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 34678999999999999999999999999999999999876655566788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||++||+|.+++.+ +.++|+.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 99999999999999976 6899999999999999999999999999999999999999999999999999875432 22
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+..++++++......+|..+|+++++||.+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 345567999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCC-----HHHHhcCccccc
Q 045214 246 ILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
||++||.+|++ ++|+++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-61 Score=470.16 Aligned_cols=259 Identities=35% Similarity=0.690 Sum_probs=216.3
Q ss_pred cccccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 4 KGKVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 4 ~g~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
+.+-+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34557889999999999999999999999999999999998765432 2356789999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec---CCCCeEEeecCchhhh
Q 045214 84 KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD---ENGMLKVTDFGLSALA 159 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~---~~~~vkl~DFGls~~~ 159 (450)
.+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||+. ++|.+||+|||+|...
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999966 6899999999999999999999999999999999999995 5789999999999754
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCC
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWF 235 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 235 (450)
.. .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+......++ +.+
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 32 2334567899999999999988775 899999999999999999999999998888888887766543 458
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|+++.+||.+||++||++|||++|+++||||+.
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-61 Score=468.96 Aligned_cols=254 Identities=37% Similarity=0.768 Sum_probs=236.4
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
.+.|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999877665556678899999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
|||++||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~-----~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DV 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----SC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec-----cc
Confidence 999999999999876 578999999999999999999999999999999999999999999999999987543 23
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHcc
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRIL 247 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~L 247 (450)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+...+|+.+|++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467899999999999888876 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----CHHHHhcCccccc
Q 045214 248 DPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 248 ~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
++||.+|+ |++++++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 9999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-61 Score=462.53 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=224.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++++.||+|+||+||+|++..+|+.||||++++... ...+.+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 579999999999999999999999999999999986532 23466789999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999998754 569999999999999999999999999999999999999999999999999986443221 12
Q ss_pred cccccCCCcccCchhcc-----cCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC---CCCCCCcHHH
Q 045214 168 LHTTCGTPAYVAPEVIS-----RRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY---KFPTWFSADV 239 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (450)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+.+.++..... ..|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34568999999999984 3334 5899999999999999999999999888888877777653 3456789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
++||.+||++||++|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-61 Score=457.71 Aligned_cols=254 Identities=31% Similarity=0.598 Sum_probs=216.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS--KTKIY 86 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 86 (450)
.+.|++++.||+|+||+||+|+++.+|+.||+|+++.....+ ...+.+.+|+++|+.++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 467999999999999999999999999999999998765432 345778999999999999999999999854 55789
Q ss_pred EEEeecCCCChhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEecCCCCeEEeecCch
Q 045214 87 FVMEYAKGGELFKKVSK-----GKLKEDTARKYFQQLISAIDFCHSRG-----VYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~~LH~~g-----i~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 46999999999999999999999976 999999999999999999999999999
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-CCCCCC
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY-KFPTWF 235 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 235 (450)
..... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++..++..+.. .+|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 76542 22334567899999999999887775 899999999999999999999999999998888887765 467789
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWF 266 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f 266 (450)
|+++.+||.+||++||.+|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-60 Score=470.59 Aligned_cols=258 Identities=29% Similarity=0.566 Sum_probs=231.9
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+.+.++|++++.||+|+||+||+|++..+|+.||||++.+... ...+.+.+|+.+|+.++||||+++++++.+++.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467899999999999999999999999999999999976543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec--CCCCeEEeecCchhhhhc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD--ENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~--~~~~vkl~DFGls~~~~~ 161 (450)
|+||||++||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~- 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence 999999999999999953 5799999999999999999999999999999999999996 46789999999987543
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCcH
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSA 237 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 237 (450)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+......++. .+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 23344567899999999999988875 8999999999999999999999999999999999888776553 5899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++++||.+||++||++|||++|+|+||||+...
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-60 Score=457.90 Aligned_cols=257 Identities=33% Similarity=0.603 Sum_probs=232.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 6789999999999999999999999999999999998765432 2246788999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC----CeEEeecCchhhh
Q 045214 85 IYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG----MLKVTDFGLSALA 159 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~----~vkl~DFGls~~~ 159 (450)
+|+|||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+| .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999966 6899999999999999999999999999999999999998776 5999999998654
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCC
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWF 235 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 235 (450)
.. .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......++ +.+
T Consensus 168 ~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 168 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred CC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 32 233456789999999999988766 4899999999999999999999999999999999888877665 468
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
|+++++||.+||++||++|||++|+++||||+.
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-60 Score=469.51 Aligned_cols=256 Identities=34% Similarity=0.712 Sum_probs=237.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.-+++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34689999999999999999999999999999999998876655566788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
+||||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~----- 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----
Confidence 99999999999999876 689999999999999999999999999999999999999999999999999987543
Q ss_pred CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~ 245 (450)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+.++......+|..+|+++.+||.+
T Consensus 193 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 193 GRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp SCBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred cccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 223467899999999999988875 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 045214 246 ILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 246 ~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
||++||.+|+ |++++++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=450.35 Aligned_cols=256 Identities=25% Similarity=0.495 Sum_probs=221.1
Q ss_pred ccccccCe-eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe--
Q 045214 5 GKVLMQKY-ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-- 81 (450)
Q Consensus 5 g~~l~~~y-~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (450)
|....+|| ++.+.||+|+||+||+|++..+++.||+|.+....... ...+++.+|+++|++++||||+++++++.+
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 44566777 78889999999999999999999999999998765432 345678999999999999999999999865
Q ss_pred --CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEec-CCCCeEEeecCc
Q 045214 82 --KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRG--VYHRDLKPENLLLD-ENGMLKVTDFGL 155 (450)
Q Consensus 82 --~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDikp~NILl~-~~~~vkl~DFGl 155 (450)
+..+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 4578999999999999999976 68999999999999999999999999 99999999999996 578999999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCC-cHHHHHHHHhhcCC--CCC
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDS-NLMAMYRKIAKADY--KFP 232 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~p 232 (450)
|+... .....+.+||+.|+|||++.+ +| +.++|||||||++|+|++|..||.+. +...+++.+..+.. .++
T Consensus 162 a~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 162 ATLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp GGGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred ceecc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC
Confidence 97532 233456789999999999865 45 58999999999999999999999865 45566666655433 234
Q ss_pred CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 233 TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 233 ~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
...++++.+||.+||++||++|||++|+++||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 55789999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-60 Score=467.78 Aligned_cols=256 Identities=27% Similarity=0.557 Sum_probs=231.0
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+.++|++++.||+|+||+||+|++..+|+.||||++++.... ....+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999999999999999999875432 24577899999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec--CCCCeEEeecCchhhhhccc
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD--ENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~--~~~~vkl~DFGls~~~~~~~ 163 (450)
|||||+||+|.+++.. .++++.+++.++.||+.||+|||++||+||||||+||||+ .+|.+||+|||+|....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~--- 180 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--- 180 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC---
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC---
Confidence 9999999999998765 3699999999999999999999999999999999999998 67899999999987543
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCCcHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWFSADV 239 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (450)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+......+| +.+|+++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 23445667899999999999888775 899999999999999999999999999999999888877655 4589999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.+||.+||++||.+|||++|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-60 Score=460.90 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=225.4
Q ss_pred CeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 11 KYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999988765555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 91 YAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
||.||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 9999999876654 6899999999999999999999999999999999999999999999999999864321 24
Q ss_pred cccCCCcccCchhcccC--CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC--CCCCcHHHHHHHHH
Q 045214 170 TTCGTPAYVAPEVISRR--GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF--PTWFSADVRKLLSR 245 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ll~~ 245 (450)
..+||+.|+|||++.+. +.++.++|||||||++|+|++|..||.+.+..+...++.....+. +..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999998642 223479999999999999999999999988877777776655432 34589999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccccC
Q 045214 246 ILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
||++||.+|||++|+|+||||++..
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-60 Score=461.02 Aligned_cols=257 Identities=34% Similarity=0.660 Sum_probs=233.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH-hCCCCCccEEEEEEEeCCEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 87 (450)
+++|++++.||+|+||+||+|+++.+|+.||||+++++........+.+.+|..++. .++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998776544455566677777665 6899999999999999999999
Q ss_pred EEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 88 VMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 9999999999999976 6899999999999999999999999999999999999999999999999999864332 223
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHHHHHHHHc
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADVRKLLSRI 246 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ll~~~ 246 (450)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+++.++......+|+.+|+++.+||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34457899999999999988876 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHH-HHhcCccccc
Q 045214 247 LDPNPSTRISIA-KIMENPWFRK 268 (450)
Q Consensus 247 L~~dP~~R~s~~-eil~hp~f~~ 268 (450)
|++||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-60 Score=464.97 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=217.8
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+..++|++++.||+|+||+||+|++..+|+.||+|+++++. .....+++.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998653 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++||+|.+++.+ +.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 99999999999999965 689999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHH-----------------------
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMY----------------------- 221 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~----------------------- 221 (450)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23456899999999999988775 8999999999999999999999765432110
Q ss_pred -------------------HHHhhcC-CCCCC-CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 222 -------------------RKIAKAD-YKFPT-WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 222 -------------------~~i~~~~-~~~p~-~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+.... ...|. .+|.++.+||.+||++||.+|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0011111 11121 25889999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-59 Score=447.43 Aligned_cols=258 Identities=35% Similarity=0.601 Sum_probs=228.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeeccccccc------chHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKV------GLVDQTKREISVMRLIQ-HPNVMQIYEVMA 80 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 80 (450)
+.++|++.+.||+|+||+||+|++..+|+.||||++++...... ...+++.+|+.+++.++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 46899999999999999999999999999999999987654321 23456889999999997 999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
+++.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999965 78999999999999999999999999999999999999999999999999998754
Q ss_pred hcccCCCCcccccCCCcccCchhcccC-----CCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC-
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRR-----GYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT- 233 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~- 233 (450)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+.......+..+...++.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 32 2234557899999999998632 22357999999999999999999999999998888888877665443
Q ss_pred ---CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 234 ---WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 234 ---~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.+|+++++||.+||++||++|||++|+++||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=458.52 Aligned_cols=255 Identities=25% Similarity=0.499 Sum_probs=230.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4789999999999999999999999999999999999875432 356789999999999999999999999999999
Q ss_pred EEEeecCCCChhhHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC--CCeEEeecCchhhhhcc
Q 045214 87 FVMEYAKGGELFKKVSK-G-KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN--GMLKVTDFGLSALAKCK 162 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~--~~vkl~DFGls~~~~~~ 162 (450)
+|||||+||+|.+++.. + .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999999975 3 69999999999999999999999999999999999999854 489999999986542
Q ss_pred cCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCC----CCcHH
Q 045214 163 HQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPT----WFSAD 238 (450)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 238 (450)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+.++....+.+|. .+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 22334567899999999999887775 8999999999999999999999999999999999988877764 58999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
+++||.+||++||++|||++|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-59 Score=462.89 Aligned_cols=256 Identities=30% Similarity=0.519 Sum_probs=222.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHH---HHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQT---KREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
+++|++++.||+|+||+||+|++..+|+.||||++.+...........+ .+|+++++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 5789999999999999999999999999999999987654333323333 3457777888999999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
|+||||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999975 6899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH---HHHHHHHhhcCCCCCCCCcHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL---MAMYRKIAKADYKFPTWFSADVRK 241 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~ 241 (450)
......+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+. ......+......+|..+|+++++
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 2345678999999999997655456899999999999999999999987543 344555556667788889999999
Q ss_pred HHHHccCCCCCCCCC-----HHHHhcCccccc
Q 045214 242 LLSRILDPNPSTRIS-----IAKIMENPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s-----~~eil~hp~f~~ 268 (450)
||.+||++||++||| ++|+++||||+.
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999999999 799999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-59 Score=446.52 Aligned_cols=253 Identities=33% Similarity=0.621 Sum_probs=222.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccc---hHHHHHHHHHHHHhCC--CCCccEEEEEEEeC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVG---LVDQTKREISVMRLIQ--HPNVMQIYEVMASK 82 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 82 (450)
|.++|++++.||+|+||+||+|++..+|+.||||++++....... ...++.+|+.+|+.++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 678999999999999999999999999999999999876543221 1234568999999986 89999999999999
Q ss_pred CEEEEEEeecCC-CChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCC-CCeEEeecCchhhh
Q 045214 83 TKIYFVMEYAKG-GELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDEN-GMLKVTDFGLSALA 159 (450)
Q Consensus 83 ~~~~lv~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~-~~vkl~DFGls~~~ 159 (450)
+..|+||||+.+ +++.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 577888765 689999999999999999999999999999999999999854 79999999998653
Q ss_pred hcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCCCcHHH
Q 045214 160 KCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTWFSADV 239 (450)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (450)
. .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||...+ .+......+++.+|+++
T Consensus 162 ~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 K----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp C----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred c----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 2 2334567899999999999888887778999999999999999999998642 35667788899999999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 240 RKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
++||.+||++||++|||++|+++||||++..
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999999999998644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=439.33 Aligned_cols=258 Identities=30% Similarity=0.502 Sum_probs=217.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||+||+|++..+|+.||||+++..... ....+++.+|+++|++++||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 47899999999999999999999999999999999765432 23457889999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCC
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDG 166 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 166 (450)
|||+.|+.+...... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 999987544433332 5799999999999999999999999999999999999999999999999999976532 223
Q ss_pred CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC-----------------
Q 045214 167 LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY----------------- 229 (450)
Q Consensus 167 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (450)
.....+||+.|+|||++....+.+.++|||||||++|+|++|..||.+.+..+...++.....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 345668999999999998888888999999999999999999999998877665555432100
Q ss_pred -CCC-----------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 230 -KFP-----------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 230 -~~p-----------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
..+ +.+|+++.+||.+||++||++|||++|+++||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 011 1357899999999999999999999999999999763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=442.67 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=214.2
Q ss_pred eeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK--VGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVME 90 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (450)
+.++.||+|+||+||+|++..+|+.||||+++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997654322 1223568899999999999999999999999999999999
Q ss_pred ecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCCcc
Q 045214 91 YAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGLLH 169 (450)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 169 (450)
|+.|+++..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--ccccc
Confidence 9999887777765 57999999999999999999999999999999999999999999999999998654322 23345
Q ss_pred cccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCC-------------------
Q 045214 170 TTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYK------------------- 230 (450)
Q Consensus 170 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------------------- 230 (450)
+.+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+...++.+....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999977666668999999999999999999999998887777666432100
Q ss_pred -C--------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 231 -F--------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 231 -~--------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
. .+.+++++.+||.+||++||++|||++|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 1236789999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-58 Score=448.69 Aligned_cols=258 Identities=34% Similarity=0.640 Sum_probs=217.9
Q ss_pred CcccccccccCeeeec-eEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHH-hCCCCCccEEEEE
Q 045214 1 METKGKVLMQKYELGR-LLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMR-LIQHPNVMQIYEV 78 (450)
Q Consensus 1 m~~~g~~l~~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~ 78 (450)
|+-+...+.++|++.. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++. ..+||||++++++
T Consensus 2 ~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~ 73 (335)
T d2ozaa1 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDV 73 (335)
T ss_dssp CCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 3445566788999875 699999999999999999999999998643 35678999865 4589999999999
Q ss_pred EEe----CCEEEEEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCe
Q 045214 79 MAS----KTKIYFVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGML 148 (450)
Q Consensus 79 ~~~----~~~~~lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~v 148 (450)
+.+ +..+|+|||||+||+|++++.+ .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence 876 4679999999999999999975 26999999999999999999999999999999999999985 4579
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHH----HHHHH
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMA----MYRKI 224 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i 224 (450)
||+|||+|+.... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+... +...+
T Consensus 154 Kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 154 KLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp EECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred cccccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 9999999875432 2334567899999999999888775 89999999999999999999998765433 33344
Q ss_pred hhcCCCCCC----CCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 225 AKADYKFPT----WFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 225 ~~~~~~~p~----~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
......+|. .+|+++.+||.+||++||++|||++|+++||||++..
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 445555553 3799999999999999999999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-56 Score=430.62 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=218.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||+||+|+++ +|+.||||+++..... ....+++.+|+.+|+.++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999995 7899999999776543 34457889999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||++.++.+..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998877777764 68999999999999999999999999999999999999999999999999998765322 222
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------------ 229 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (450)
.....|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..+...++.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 34557999999999998877778999999999999999999999998877666555432100
Q ss_pred -----------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 -----------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 -----------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..++.+++++.+||.+||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-57 Score=431.17 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=218.9
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT-- 83 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (450)
..|.++|++.+.||+|+||+||+|++..+|+.||||++.++...+.....++.+|+.+++.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 568899999999999999999999999999999999998876665566778999999999999999999999987654
Q ss_pred --EEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 84 --KIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 84 --~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
.+|+||||++|++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999998865 689999999999999999999999999999999999999999999999999875443
Q ss_pred ccc-CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCC----CCC
Q 045214 161 CKH-QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFP----TWF 235 (450)
Q Consensus 161 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 235 (450)
... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++.......| +.+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 222 22234456899999999999887775 899999999999999999999999888887777766654433 458
Q ss_pred cHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 045214 236 SADVRKLLSRILDPNPSTRISIAKIMENPWFR 267 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~ 267 (450)
|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999544445577764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=428.91 Aligned_cols=256 Identities=32% Similarity=0.476 Sum_probs=213.4
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCC-CcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCccEEEEEEEe--
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGT-GQSVAIKAIDKDKILKVGLVDQTKREISVMRLI---QHPNVMQIYEVMAS-- 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-- 81 (450)
..++|++++.||+|+||+||+|++..+ ++.||||++....... .......+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 357999999999999999999999765 6789999997654322 2223456777777665 89999999999853
Q ss_pred ---CCEEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 82 ---KTKIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 82 ---~~~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
...+|++|||++++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3579999999999876554433 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC--------
Q 045214 157 ALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD-------- 228 (450)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 228 (450)
...... ......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++....
T Consensus 164 ~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhccc---ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 654322 234567899999999999988875 89999999999999999999999988877766654310
Q ss_pred -------------------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -------------------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -------------------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..++..+++++.+||.+||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123447899999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=434.73 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=215.2
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT---- 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (450)
+.++|++++.||+|+||+||+|++..+|+.||||++++... .....+++.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 78899999999999999999999999999999999976543 3345678899999999999999999999997654
Q ss_pred --EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 --KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 --~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+|+||||+ |.+|...+..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6688888888899999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------ 229 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------ 229 (450)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2334678999999999998877777999999999999999999999998876655444332111
Q ss_pred -------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 -------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 -------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
..+..+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 122346899999999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=426.83 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=214.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-------
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------- 81 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 81 (450)
.++|++++.||+|+||+||+|++..+|+.||||++..+... .....++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 58999999999999999999999999999999999776543 2445778899999999999999999998754
Q ss_pred -CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhh
Q 045214 82 -KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALA 159 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~ 159 (450)
.+.+|+||||+.++.+...... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999988766655544 57999999999999999999999999999999999999999999999999998654
Q ss_pred hccc--CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCCCCC---
Q 045214 160 KCKH--QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKFPTW--- 234 (450)
Q Consensus 160 ~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--- 234 (450)
.... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+......+++.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4222 12234456899999999999876555689999999999999999999999888776666654432221110
Q ss_pred -----------------------------CcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 235 -----------------------------FSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 235 -----------------------------~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
.++++.+||.+||++||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 26788999999999999999999999999999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=431.97 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=215.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----E
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT----K 84 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (450)
..||++++.||+|+||+||+|++..+|+.||||++++.. .....+++.+|+.+|+.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 379999999999999999999999999999999997654 2244567889999999999999999999987653 2
Q ss_pred EEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 85 IYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
.+++++++.||+|.+++..+++++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 34445566799999999988999999999999999999999999999999999999999999999999999875433322
Q ss_pred -CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcC---------------
Q 045214 165 -DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKAD--------------- 228 (450)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------- 228 (450)
.......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2334567899999999999776666789999999999999999999999877654443332110
Q ss_pred -------C---------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 229 -------Y---------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 229 -------~---------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
. ...+.+|+++++||.+||++||.+|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 01234688999999999999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=431.91 Aligned_cols=251 Identities=22% Similarity=0.383 Sum_probs=213.7
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCC
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQ-----SVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKT 83 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (450)
++|++++.||+|+||+||+|++..+++ .||+|.+...... .....+.+|+.+++.+ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 679999999999999999999876554 6999998765422 2346788999999988 8999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 045214 84 KIYFVMEYAKGGELFKKVSKG------------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPEN 139 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~N 139 (450)
.+|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999998642 37899999999999999999999999999999999
Q ss_pred EEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHH
Q 045214 140 LLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (450)
Q Consensus 140 ILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~ 218 (450)
||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999765443333233456789999999999887775 89999999999999998 89999987665
Q ss_pred HHHHHHhhc--CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 219 AMYRKIAKA--DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 219 ~~~~~i~~~--~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
..+.++... ..+.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555555444 345677899999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=421.83 Aligned_cols=251 Identities=22% Similarity=0.401 Sum_probs=205.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++++.||+|+||+||+|+.. ..||||+++...... ...+.+.+|+.+|++++||||++++++.. .+.+|+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 3578999999999999999999753 369999997654332 45678899999999999999999999865 456899
Q ss_pred EEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC
Q 045214 88 VMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD 165 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~ 165 (450)
||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|.........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999999964 56999999999999999999999999999999999999999999999999999765543333
Q ss_pred CCcccccCCCcccCchhcccCC--CCCCccchhhHHHHHHHHhhCCCCCCCCcHHH-HHHHHhhcCC-----CCCCCCcH
Q 045214 166 GLLHTTCGTPAYVAPEVISRRG--YDGDKADIWSCGVILYVLLAGYLPFHDSNLMA-MYRKIAKADY-----KFPTWFSA 237 (450)
Q Consensus 166 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s~ 237 (450)
....+.+||+.|+|||++.... ..+.++||||+||+||+|+||..||.+.+... ....+..+.. ..+..+|+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 4455678999999999996532 23579999999999999999999999866544 3334433322 23456889
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
++.+|+.+||+.||++|||++||+++
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=415.16 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=221.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFV 88 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (450)
+++|++++.||+|+||+||+|++..+++.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999987653 335678899999999999999999999999999999999
Q ss_pred EeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 89 MEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999888876 58999999999999999999999999999999999999999999999999998654322 223
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCC-CCcHHHHHHHHhhcC------------------
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFH-DSNLMAMYRKIAKAD------------------ 228 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~------------------ 228 (450)
.....+++.|+|||++....+.+.++|||||||++|+|++|..||. +.+..+...++....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 3345678899999999887776799999999999999999999854 455555555543211
Q ss_pred -----------CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 229 -----------YKFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 229 -----------~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
...+..+++++.+||.+||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1122346889999999999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-55 Score=421.98 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=216.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++.+.||+|+||+||+|++..+++.||||+++.+.. ..+++.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 34689999999999999999999999999999999976542 24678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 9999999999999864 468999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCC-CCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLP-FHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
........||+.|+|||++.+..|+ .++||||+||++|+|++|..| |.+.+...+++.+..+ ..+.|..+|+++.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence 1122334589999999999888775 899999999999999996555 5566666666666544 356778899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 045214 243 LSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~ 262 (450)
|.+||+.||++|||++|+++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=413.98 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=208.2
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
++|++++.||+|+||+||+|++. +++.||||+++..... .+++.+|+++++.++||||+++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999985 5678999999765432 367889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++|+|.+++.. ..++++.+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999976543222 22
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ll~~ 245 (450)
.....||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||...+..+++..+..+. ...|..+++++.+|+.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999988775 89999999999999999 577788888888888876653 45677789999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 045214 246 ILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~h 263 (450)
||++||++|||++||++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=420.01 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=208.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQ---SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
-.++|++.+.||+|+||+||+|++..+++ .||||.+..... ....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 35789999999999999999999987765 588998865432 2345678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcc
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCK 162 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~ 162 (450)
+|+||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999999998865 46999999999999999999999999999999999999999999999999999765432
Q ss_pred cCCCC---cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcH
Q 045214 163 HQDGL---LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSA 237 (450)
Q Consensus 163 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (450)
..... .....||+.|+|||++.+..|+ .++|||||||++|+|+| |..||.+.+..+....+..+ ..+.|..+++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 22111 1124579999999999887775 89999999999999998 89999998888888877654 3456777999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 238 DVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 238 ~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
++.+|+.+||+.||++|||+.||+++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=419.29 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=209.4
Q ss_pred ceEeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEeecC
Q 045214 16 RLLGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVMEYAK 93 (450)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (450)
+.||+|+||+||+|.+.. +++.||||+++.... +....+++.+|+.+|++++||||+++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 479999999999998643 567899999976543 334567899999999999999999999998655 5789999999
Q ss_pred CCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC-CCCcccc
Q 045214 94 GGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ-DGLLHTT 171 (450)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~-~~~~~~~ 171 (450)
||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999976 5799999999999999999999999999999999999999999999999999875432211 1122345
Q ss_pred cCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHccCC
Q 045214 172 CGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSRILDP 249 (450)
Q Consensus 172 ~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~~L~~ 249 (450)
.||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+ ..+.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 789999999999887764 89999999999999998 89999998888888777665 3567888999999999999999
Q ss_pred CCCCCCCHHHHh---cCccc
Q 045214 250 NPSTRISIAKIM---ENPWF 266 (450)
Q Consensus 250 dP~~R~s~~eil---~hp~f 266 (450)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-55 Score=417.54 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=217.7
Q ss_pred cCeeeece-EeecCCeEEEEEEEcC--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 10 QKYELGRL-LGQGNFAKVYYARHLG--TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 10 ~~y~~~~~-LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.... ....+++.+|+++|++++|||||++++++.++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 46888885 9999999999998764 455799999976532 23457789999999999999999999998754 589
Q ss_pred EEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 87 FVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
+||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998754 5799999999999999999999999999999999999999999999999999976543221
Q ss_pred -CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHH
Q 045214 165 -DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRK 241 (450)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (450)
.......+||+.|+|||++....++ .++|||||||++|||+| |..||.+.+..++...+..+. .+.|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223345789999999999887765 89999999999999998 999999988888888776654 5678889999999
Q ss_pred HHHHccCCCCCCCCCHHHH---hcCcccc
Q 045214 242 LLSRILDPNPSTRISIAKI---MENPWFR 267 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~ei---l~hp~f~ 267 (450)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 5678874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=409.13 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=219.9
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYFVM 89 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (450)
+.|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 47999999999999999999984 7889999999876533 367889999999999999999999999999999999
Q ss_pred eecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCCCC
Q 045214 90 EYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQDGL 167 (450)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 167 (450)
||+++|+|.+++.. ..+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+|....... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999998754 579999999999999999999999999999999999999999999999999987543322 222
Q ss_pred cccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHHHHH
Q 045214 168 LHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKLLSR 245 (450)
Q Consensus 168 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ll~~ 245 (450)
.....||+.|+|||++.+..++ .++||||+||++|+|+| |..||.+.+..++..++..+ ....|...++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999988875 89999999999999998 89999999988888888765 345677889999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 045214 246 ILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 246 ~L~~dP~~R~s~~eil~h 263 (450)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=414.07 Aligned_cols=252 Identities=22% Similarity=0.380 Sum_probs=216.7
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (450)
-.++|++++.||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++|||||++++++.+ +.+|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3578999999999999999999985 577899999976542 24678999999999999999999998754 56799
Q ss_pred EEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccC
Q 045214 88 VMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 88 v~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~ 164 (450)
||||+++|+|.+++.. .++++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-
Confidence 9999999999998754 369999999999999999999999999999999999999999999999999997653221
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
........||+.|+|||++.+..++ .++||||+||++|+|+|| .+||...+..+....+..+ ....|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 1223345799999999999877765 899999999999999995 5667777777777777654 345678899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc--Ccccc
Q 045214 243 LSRILDPNPSTRISIAKIME--NPWFR 267 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~--hp~f~ 267 (450)
+.+||+.||++|||++++++ |+||.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999998 78885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=424.82 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=210.7
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-----
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS----- 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (450)
...-+|..+++||+|+||+||+|++..+|+.||||++.++... ..+|+.+|++++||||+++++++..
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 3344799999999999999999999999999999999775432 2479999999999999999999843
Q ss_pred -CCEEEEEEeecCCCChhhHH---h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCc
Q 045214 82 -KTKIYFVMEYAKGGELFKKV---S-KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGL 155 (450)
Q Consensus 82 -~~~~~lv~E~~~gg~L~~~i---~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGl 155 (450)
..++|+||||++++.+.... . ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence 34689999999876433332 2 24799999999999999999999999999999999999999775 899999999
Q ss_pred hhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhc--------
Q 045214 156 SALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKA-------- 227 (450)
Q Consensus 156 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 227 (450)
|..... .....+.+||+.|+|||++.+...++.++||||+||++|+|++|..||...+..+.+.++.+.
T Consensus 170 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 170 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 865432 233456789999999999887666679999999999999999999999988776665554321
Q ss_pred ---------CCC------------CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 228 ---------DYK------------FPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 228 ---------~~~------------~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
... ..+.+++++.+||.+||++||++|||++|+|+||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 123478999999999999999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=421.27 Aligned_cols=261 Identities=32% Similarity=0.583 Sum_probs=223.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCCC-CCccEEEEEEEe
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHL---GTGQSVAIKAIDKDKIL-KVGLVDQTKREISVMRLIQH-PNVMQIYEVMAS 81 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 81 (450)
+-.++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+++.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 44588999999999999999999984 46899999999876542 22334667899999999976 899999999999
Q ss_pred CCEEEEEEeecCCCChhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhh
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAK 160 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~ 160 (450)
...+|++|||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999999999976 689999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCCcccccCCCcccCchhcccCC-CCCCccchhhHHHHHHHHhhCCCCCCCCcH----HHHHHHHhhcCCCCCCCC
Q 045214 161 CKHQDGLLHTTCGTPAYVAPEVISRRG-YDGDKADIWSCGVILYVLLAGYLPFHDSNL----MAMYRKIAKADYKFPTWF 235 (450)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~p~~~ 235 (450)
... .....+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+. ..+.+.......++|..+
T Consensus 181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 322 22345678999999999997654 345799999999999999999999987543 344455556677788889
Q ss_pred cHHHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 045214 236 SADVRKLLSRILDPNPSTRI-----SIAKIMENPWFRK 268 (450)
Q Consensus 236 s~~~~~ll~~~L~~dP~~R~-----s~~eil~hp~f~~ 268 (450)
|+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999999 5899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=428.12 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=216.8
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----C
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASK-----T 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 83 (450)
.+||++++.||+|+||+||+|++..+|+.||||++.+.... ....+++.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 57999999999999999999999999999999999865432 23456788999999999999999999998533 3
Q ss_pred EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 84 KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
..+++|+++.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 346667778899999999888999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCCCC------------
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADYKF------------ 231 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 231 (450)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23456799999999998887777799999999999999999999999888766666554322111
Q ss_pred -------------------CCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 045214 232 -------------------PTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 232 -------------------p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~ 269 (450)
...+++++++||.+||++||.+|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12368899999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=416.91 Aligned_cols=249 Identities=24% Similarity=0.467 Sum_probs=208.6
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEe--CCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMAS--KTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 85 (450)
.++|++++.||+|+||+||+|++..+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999997543 367889999999995 9999999999974 4579
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCC-CeEEeecCchhhhhcccC
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENG-MLKVTDFGLSALAKCKHQ 164 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~-~vkl~DFGls~~~~~~~~ 164 (450)
|+||||+.+++|.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~--- 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 182 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT---
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC---
Confidence 9999999999998764 3599999999999999999999999999999999999998665 599999999875432
Q ss_pred CCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcH-HHHHHHHhh-------------cCC-
Q 045214 165 DGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNL-MAMYRKIAK-------------ADY- 229 (450)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~-------------~~~- 229 (450)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||...+. ......+.. ...
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23345678999999999998776666899999999999999999999976432 111111110 000
Q ss_pred -----------------------CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 045214 230 -----------------------KFPTWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRK 268 (450)
Q Consensus 230 -----------------------~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~ 268 (450)
.....+++++.+||.+||++||++|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011236889999999999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=420.88 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=205.5
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe------
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS------ 81 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (450)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.... .....++.+|+.+++.++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 568999999999999999999999999999999999876532 3445678999999999999999999999953
Q ss_pred CCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 82 KTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
.+.+|+||||+.|+.+ +.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHH-Hhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 4789999999977544 4443 4699999999999999999999999999999999999999999999999998765443
Q ss_pred ccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHHHhhcCC------------
Q 045214 162 KHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRKIAKADY------------ 229 (450)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------ 229 (450)
. ......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+......++.....
T Consensus 172 ~---~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 S---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred c---cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 2 233456899999999999887764 899999999999999999999998776655544422110
Q ss_pred ----------CC--------------C------CCCcHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 045214 230 ----------KF--------------P------TWFSADVRKLLSRILDPNPSTRISIAKIMENPWFRKGL 270 (450)
Q Consensus 230 ----------~~--------------p------~~~s~~~~~ll~~~L~~dP~~R~s~~eil~hp~f~~~~ 270 (450)
.. + ...|+++.+||.+||++||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 00 0 01367899999999999999999999999999998744
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=412.49 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=211.0
Q ss_pred cCeeeeceEeecCCeEEEEEEEcCCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLGTGQ----SVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
..|++++.||+|+||+||+|++..+|+ .||+|.++... .....+++.+|+.++++++|||||++++++.+++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 469999999999999999999988876 47777776433 2234678899999999999999999999998654 6
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
++++|++.+|+|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999988764 479999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (450)
.........||+.|+|||++.+..|+ .++|||||||++|+|+| |..||.+.+..++...+..+. .+.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33334455789999999999888774 89999999999999998 899999888777777776654 5677889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcc
Q 045214 242 LLSRILDPNPSTRISIAKIMENPW 265 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~hp~ 265 (450)
|+.+||+.||.+|||+.||++|..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999998743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=406.00 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=206.5
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTG---QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++++.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|++++||||+++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999987643 468888886433 2234577899999999999999999999985 5678
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999998754 479999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcC-CCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKAD-YKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (450)
........||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+++.++..+. .+.|+.+|+++.+
T Consensus 163 -~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 163 -YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2223455789999999999887775 89999999999999998 899999988888888877654 5678889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcC
Q 045214 242 LLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~h 263 (450)
||.+||+.||++|||++||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=404.35 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=211.9
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (450)
+=.++|++++.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.++++++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3357899999999999999999999655 56999999765432 3678999999999999999999999854 5579
Q ss_pred EEEeecCCCChhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSK---GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|..++.. ..+++.++..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999988753 569999999999999999999999999999999999999999999999999997653222
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
........||+.|+|||++.+..++ .++||||+||++|+|++| .+||...+..+.+..+..+ ..+.|..+++++.+
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 1223346799999999999887775 899999999999999995 5566667777777776654 45678889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc--Cccccc
Q 045214 242 LLSRILDPNPSTRISIAKIME--NPWFRK 268 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~--hp~f~~ 268 (450)
||.+||+.||++|||+++|++ ++||..
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999999999999999987 778754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=401.61 Aligned_cols=252 Identities=20% Similarity=0.318 Sum_probs=207.9
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTG----QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
--+.|++.++||+|+||+||+|.+..++ ..||||.++..... ....++.+|+.+++.++|||||++++++.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999987654 47999999765432 33467889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhc
Q 045214 84 KIYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKC 161 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~ 161 (450)
..|+||||+.++++.+.+.. +.+++..+..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999998765 5799999999999999999999999999999999999999999999999999976543
Q ss_pred ccCC-CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhc-CCCCCCCCcHH
Q 045214 162 KHQD-GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKA-DYKFPTWFSAD 238 (450)
Q Consensus 162 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (450)
.... .......||+.|+|||++.+..++ .++|||||||++|+|++| .+||...+..+++..+..+ ..+.|..++.+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 2221 123345789999999999887775 899999999999999995 5556666777777776654 34567779999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 045214 239 VRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 239 ~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+.+||.+||+.||++|||+.||++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-52 Score=404.02 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=218.8
Q ss_pred cCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Q 045214 10 QKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTK 84 (450)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (450)
++|++++.||+|+||+||+|+... +++.||||+++.... .....++.+|+.+|+.++||||+++++++.+.+.
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 579999999999999999999753 567899999976542 2345778999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 045214 85 IYFVMEYAKGGELFKKVSKG-------------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPEN 139 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~N 139 (450)
.+++|||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 99999999999999988531 37889999999999999999999999999999999
Q ss_pred EEecCCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCC-CCCCCCcHH
Q 045214 140 LLLDENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGY-LPFHDSNLM 218 (450)
Q Consensus 140 ILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~~ 218 (450)
||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. .||.+.+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999866554444445567899999999999988775 8999999999999999985 689998888
Q ss_pred HHHHHHhhcCC-CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 219 AMYRKIAKADY-KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 219 ~~~~~i~~~~~-~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
+....+..+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus 250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888877654 467789999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=403.39 Aligned_cols=251 Identities=23% Similarity=0.434 Sum_probs=216.9
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCC-------cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTG-------QSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMA 80 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (450)
.++|++++.||+|+||.||+|++..++ ..||||+++++... .....+.+|...+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 579999999999999999999987654 36999999765432 3356778888888888 8999999999999
Q ss_pred eCCEEEEEEeecCCCChhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec
Q 045214 81 SKTKIYFVMEYAKGGELFKKVSKG-----------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD 143 (450)
Q Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~ 143 (450)
+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999642 489999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHH
Q 045214 144 ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYR 222 (450)
Q Consensus 144 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 222 (450)
.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+++.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999877655554555667899999999999888775 89999999999999998 799999999888888
Q ss_pred HHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+..+ ..+.|.++++++.+||.+||++||++|||+.||++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77654 45678889999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=401.19 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=205.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-CC--cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-TG--QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++.+.||+|+||+||+|+... ++ ..||||++.++........+++.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998654 33 3689999988766666667889999999999999999999999966 467
Q ss_pred EEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 86 YFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
|+||||+++|++.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988754 579999999999999999999999999999999999999999999999999987653322
Q ss_pred CCC-CcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhcCC--CCCCCCcHHH
Q 045214 164 QDG-LLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKADY--KFPTWFSADV 239 (450)
Q Consensus 164 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 239 (450)
... ......||+.|+|||++.+..++ .++|||||||++|+|+| |..||.+.+..+...++..... +.|+.+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 211 22344678899999999887664 88999999999999998 8999999999988888876654 4566789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 045214 240 RKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 240 ~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.+||.+||++||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=403.69 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=201.7
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEe-
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMAS- 81 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 81 (450)
.++|++++.||+|+||+||+|++.. +++.||||+++..... ...+.+.+|..++.++ +||||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 4689999999999999999999764 4578999999754422 2345667777777766 78999999998765
Q ss_pred CCEEEEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC
Q 045214 82 KTKIYFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE 144 (450)
Q Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~ 144 (450)
+..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4578999999999999999853 24889999999999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHH-HHH
Q 045214 145 NGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMA-MYR 222 (450)
Q Consensus 145 ~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~-~~~ 222 (450)
++.+||+|||+|+..............+||+.|+|||++.+..++ .++||||+||++|+|++| ..||.+.+... ...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999765443333344556899999999999887764 899999999999999986 56888765443 334
Q ss_pred HHhhc-CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 223 KIAKA-DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 223 ~i~~~-~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
.+..+ ..+.|..+++++.+||.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44333 456678899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=393.81 Aligned_cols=242 Identities=26% Similarity=0.459 Sum_probs=206.3
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMA-SKTKIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 86 (450)
-.++|++++.||+|+||.||+|++ +|..||||+++++. ..+.+.+|+.++++++||||+++++++. +.+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 356899999999999999999998 57789999997543 3467889999999999999999999884 456789
Q ss_pred EEEeecCCCChhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhccc
Q 045214 87 FVMEYAKGGELFKKVSKG---KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKH 163 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~ 163 (450)
+||||+++|+|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 999999999999998652 489999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHHHHhhc-CCCCCCCCcHHHHH
Q 045214 164 QDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYRKIAKA-DYKFPTWFSADVRK 241 (450)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (450)
......+|+.|+|||++.+..++ .++||||+||++|+|+| |.+||...+..+....+..+ ..++|..+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 23455789999999999887764 89999999999999998 79999988888888777653 45678889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 045214 242 LLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 242 ll~~~L~~dP~~R~s~~eil~ 262 (450)
||.+||+.||.+|||+.++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHH
Confidence 999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=401.01 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=213.3
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcCCCcE--EEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEE
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLGTGQS--VAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASKTKI 85 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (450)
.++|++.+.||+|+||+||+|+++.+|.. ||||.+..... ....+.+.+|+.+|+++ +||||+++++++.+++.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 46899999999999999999999888875 67777654332 23346789999999998 799999999999999999
Q ss_pred EEEEeecCCCChhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCe
Q 045214 86 YFVMEYAKGGELFKKVSK-----------------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGML 148 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~v 148 (450)
|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 999999999999999853 368999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhc
Q 045214 149 KVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKA 227 (450)
Q Consensus 149 kl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~ 227 (450)
||+|||+|....... .....+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 999999986543222 22355799999999999888775 899999999999999996 4689999998988887664
Q ss_pred -CCCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 045214 228 -DYKFPTWFSADVRKLLSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 228 -~~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~h 263 (450)
..+.|..+++++.+||.+||+.||++|||++||++|
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456677899999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=396.98 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=219.1
Q ss_pred ccCeeeeceEeecCCeEEEEEEEcC-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHLG-----TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT 83 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (450)
-++|++++.||+|+||+||+|.+.. ++..||||+++..... .....+.+|+.++++++||||+++++++..++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 4789999999999999999999853 3578999999765422 33457889999999999999999999999999
Q ss_pred EEEEEEeecCCCChhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEee
Q 045214 84 KIYFVMEYAKGGELFKKVSK-----------GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTD 152 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~D 152 (450)
..++||||+++|+|.+++.. ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 99999999999999998743 2368899999999999999999999999999999999999999999999
Q ss_pred cCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhC-CCCCCCCcHHHHHHHHhhcC-CC
Q 045214 153 FGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAG-YLPFHDSNLMAMYRKIAKAD-YK 230 (450)
Q Consensus 153 FGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~-~~ 230 (450)
||+|...............+||+.|+|||.+.+..+. .++||||+||++|+|+|| ..||.+.+..+.+..+..+. .+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999766544433334455799999999999887775 799999999999999998 58899988888888876654 34
Q ss_pred CCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 231 FPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 231 ~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.|+.+++.+.+||.+||+.||++|||+++|++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67789999999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=395.87 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=214.0
Q ss_pred ccCeeeeceEeecCCeEEEEEEEc-----CCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCccEEEEEEEeC
Q 045214 9 MQKYELGRLLGQGNFAKVYYARHL-----GTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLI-QHPNVMQIYEVMASK 82 (450)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (450)
.++|++++.||+|+||.||+|+.. .+++.||||++++.... .....+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 478999999999999999999863 46778999999865432 3356788999999999 699999999999999
Q ss_pred CEEEEEEeecCCCChhhHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEec
Q 045214 83 TKIYFVMEYAKGGELFKKVSKG-------------------KLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLD 143 (450)
Q Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~ 143 (450)
..+|+||||++||+|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 9999999999999999998542 488999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhh-CCCCCCCCcHHHHHH
Q 045214 144 ENGMLKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLA-GYLPFHDSNLMAMYR 222 (450)
Q Consensus 144 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 222 (450)
.++.+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999976554333333345689999999999987766 489999999999999998 677777766655555
Q ss_pred HHhhcC--CCCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 223 KIAKAD--YKFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 223 ~i~~~~--~~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
++.... ...|..+++++.+||.+||++||++|||++||++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 544333 3456678999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=381.19 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=204.1
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEE
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPN-VMQIYEVMASKTKIY 86 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (450)
+.++|++++.||+|+||+||+|++..+|+.||||++..+... .++.+|+++++.++|+| |+.++.++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 567899999999999999999999999999999998765422 34678999999997665 556667778899999
Q ss_pred EEEeecCCCChhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC---CCCeEEeecCchhhhhc
Q 045214 87 FVMEYAKGGELFKKVS--KGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE---NGMLKVTDFGLSALAKC 161 (450)
Q Consensus 87 lv~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~---~~~vkl~DFGls~~~~~ 161 (450)
+||||+.+ +|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999954 5666554 357999999999999999999999999999999999999863 45799999999976543
Q ss_pred ccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHHHHHHH---HhhcCC----
Q 045214 162 KHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLMAMYRK---IAKADY---- 229 (450)
Q Consensus 162 ~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~~~---- 229 (450)
.... ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||........... ......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 2211 123355899999999999988775 899999999999999999999987654333222 211111
Q ss_pred -CCCCCCcHHHHHHHHHccCCCCCCCCCHH---HHhcCccccccCC
Q 045214 230 -KFPTWFSADVRKLLSRILDPNPSTRISIA---KIMENPWFRKGLN 271 (450)
Q Consensus 230 -~~p~~~s~~~~~ll~~~L~~dP~~R~s~~---eil~hp~f~~~~~ 271 (450)
..++.+|+++.+|+.+||+.||++||+++ ++|+|+|.+.++.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 12346889999999999999999999986 4567887765443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=379.81 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=203.6
Q ss_pred eeeceEeecCCeEEEEEEEcCCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEE
Q 045214 13 ELGRLLGQGNFAKVYYARHLGTG---QSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMAS-KTKIYFV 88 (450)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv 88 (450)
.+.++||+|+||+||+|++..++ ..||||.+++.. .....+++.+|+++|++++||||+++++++.. ++..|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987643 368999997533 23446789999999999999999999999765 5689999
Q ss_pred EeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCchhhhhcccCC-
Q 045214 89 MEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLSALAKCKHQD- 165 (450)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls~~~~~~~~~- 165 (450)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999999875 35788899999999999999999999999999999999999999999999999765433221
Q ss_pred -CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCC-CcHHHHHHHHhhc-CCCCCCCCcHHHHHH
Q 045214 166 -GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHD-SNLMAMYRKIAKA-DYKFPTWFSADVRKL 242 (450)
Q Consensus 166 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (450)
.......||+.|+|||++....++ .++||||||+++|+|++|..||.. .+..+....+..+ ....|+.+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 122235689999999999887764 899999999999999997777654 3444455555444 445678899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 045214 243 LSRILDPNPSTRISIAKIMEN 263 (450)
Q Consensus 243 l~~~L~~dP~~R~s~~eil~h 263 (450)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-48 Score=375.00 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=208.3
Q ss_pred cccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCE
Q 045214 6 KVLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH-PNVMQIYEVMASKTK 84 (450)
Q Consensus 6 ~~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 84 (450)
+++.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.+.| +||+.+++++..+..
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 46789999999999999999999999999999999998765422 346789999999965 899999999999999
Q ss_pred EEEEEeecCCCChhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecC-----CCCeEEeecCchh
Q 045214 85 IYFVMEYAKGGELFKKVSK--GKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDE-----NGMLKVTDFGLSA 157 (450)
Q Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~-----~~~vkl~DFGls~ 157 (450)
.|+||||+ |++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999 6799988865 47999999999999999999999999999999999999974 5789999999997
Q ss_pred hhhcccCC-----CCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCc---HHHHHHHHhhcCC
Q 045214 158 LAKCKHQD-----GLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSN---LMAMYRKIAKADY 229 (450)
Q Consensus 158 ~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~ 229 (450)
........ ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+ ....+.++.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 65432211 123456899999999999987765 89999999999999999999998543 3333444332211
Q ss_pred -----CCCCCCcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 230 -----KFPTWFSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 230 -----~~p~~~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
..++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123458899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=374.54 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=195.6
Q ss_pred cccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----
Q 045214 8 LMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVMQIYEVMASKT---- 83 (450)
Q Consensus 8 l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (450)
+..+|.+.+.||+|+||.||+|+. +|+.||||+++.+... ....++|+..++.++||||+++++++.+.+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 357899999999999999999987 7899999999754321 122345666667889999999999987654
Q ss_pred EEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCcEEecCCCCeEEeecCc
Q 045214 84 KIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHS--------RGVYHRDLKPENLLLDENGMLKVTDFGL 155 (450)
Q Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~--------~gi~HrDikp~NILl~~~~~vkl~DFGl 155 (450)
.+|+||||+++|+|.+++.+.++++.....++.|++.||+|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999999999999998889999999999999999999996 5999999999999999999999999999
Q ss_pred hhhhhcccC--CCCcccccCCCcccCchhcccCCC-----CCCccchhhHHHHHHHHhhCCCCCCCC-------------
Q 045214 156 SALAKCKHQ--DGLLHTTCGTPAYVAPEVISRRGY-----DGDKADIWSCGVILYVLLAGYLPFHDS------------- 215 (450)
Q Consensus 156 s~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~------------- 215 (450)
+........ .......+||+.|+|||++.+... .+.++|||||||+||+|+||..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 876533221 112345689999999999876431 235899999999999999998876421
Q ss_pred --cHHHHHHHHhhcCC--CCCCC-----CcHHHHHHHHHccCCCCCCCCCHHHHhc
Q 045214 216 --NLMAMYRKIAKADY--KFPTW-----FSADVRKLLSRILDPNPSTRISIAKIME 262 (450)
Q Consensus 216 --~~~~~~~~i~~~~~--~~p~~-----~s~~~~~ll~~~L~~dP~~R~s~~eil~ 262 (450)
.............. .+|.. ....+.+|+.+||+.||++|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22333333333332 22222 2245889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-47 Score=377.50 Aligned_cols=256 Identities=24% Similarity=0.455 Sum_probs=201.1
Q ss_pred cccccc-cCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----------CCC
Q 045214 4 KGKVLM-QKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-----------HPN 71 (450)
Q Consensus 4 ~g~~l~-~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpn 71 (450)
.|+++. +||++++.||+|+||+||+|++..+|+.||||+++++.. ..+...+|+.+++.++ |||
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 478776 579999999999999999999999999999999987542 2356778998888775 578
Q ss_pred ccEEEEEEE--eCCEEEEEEeecCCCChhhHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEecC
Q 045214 72 VMQIYEVMA--SKTKIYFVMEYAKGGELFKKV----SKGKLKEDTARKYFQQLISAIDFCHS-RGVYHRDLKPENLLLDE 144 (450)
Q Consensus 72 Iv~l~~~~~--~~~~~~lv~E~~~gg~L~~~i----~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDikp~NILl~~ 144 (450)
|+++++++. .....+++++++..+...... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 999998875 446777888777665443332 12579999999999999999999998 89999999999999987
Q ss_pred CCC------eEEeecCchhhhhcccCCCCcccccCCCcccCchhcccCCCCCCccchhhHHHHHHHHhhCCCCCCCCcHH
Q 045214 145 NGM------LKVTDFGLSALAKCKHQDGLLHTTCGTPAYVAPEVISRRGYDGDKADIWSCGVILYVLLAGYLPFHDSNLM 218 (450)
Q Consensus 145 ~~~------vkl~DFGls~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~ 218 (450)
++. ++++|||.|..... .....+||+.|+|||++....|+ .++||||+||++++|++|+.||...+..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccc
Confidence 664 99999999864432 23456899999999999988875 8999999999999999999999754321
Q ss_pred ------HHHHHHhh------------------------------------------cCCCCCCCCcHHHHHHHHHccCCC
Q 045214 219 ------AMYRKIAK------------------------------------------ADYKFPTWFSADVRKLLSRILDPN 250 (450)
Q Consensus 219 ------~~~~~i~~------------------------------------------~~~~~p~~~s~~~~~ll~~~L~~d 250 (450)
........ ....++...++++.+||.+||++|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 11111000 011112234678999999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 045214 251 PSTRISIAKIMENPWFRKG 269 (450)
Q Consensus 251 P~~R~s~~eil~hp~f~~~ 269 (450)
|.+|||++|+|+||||++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.8e-27 Score=209.96 Aligned_cols=135 Identities=19% Similarity=0.295 Sum_probs=107.9
Q ss_pred eeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccc---------------cchHHHHHHHHHHHHhCCCCCccEEE
Q 045214 12 YELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILK---------------VGLVDQTKREISVMRLIQHPNVMQIY 76 (450)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~---------------~~~~~~~~~Ei~il~~l~hpnIv~l~ 76 (450)
|.+++.||+|+||+||+|++. +|+.||||+++...... ........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999984 78999999986432110 01123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEecCCCCeEEeecCch
Q 045214 77 EVMASKTKIYFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGMLKVTDFGLS 156 (450)
Q Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDikp~NILl~~~~~vkl~DFGls 156 (450)
++.. .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 7642 279999999865533 4556677899999999999999999999999999999865 4999999988
Q ss_pred hh
Q 045214 157 AL 158 (450)
Q Consensus 157 ~~ 158 (450)
..
T Consensus 150 ~~ 151 (191)
T d1zara2 150 VE 151 (191)
T ss_dssp EE
T ss_pred cc
Confidence 54
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.50 E-value=6.2e-14 Score=109.59 Aligned_cols=87 Identities=16% Similarity=0.235 Sum_probs=78.6
Q ss_pred eeecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEe-CceEEEEEEecCCCcHHHHHHH
Q 045214 342 KFTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFN-PSIHLVELTKSSGDNLEYQKML 420 (450)
Q Consensus 342 rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~ 420 (450)
.-+|..+|++|+..|+++++.+|+.+++++...+++.....+.++.+.|.+||+++. +++++|+|+|.+||+++|+++|
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~ 93 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 93 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHH
Confidence 457899999999999999999999998876666999998888999999999999995 7999999999999999999999
Q ss_pred HHhhhhhcc
Q 045214 421 KQEIRPALK 429 (450)
Q Consensus 421 ~~~l~~~l~ 429 (450)
.+ |-..|+
T Consensus 94 ~~-il~~l~ 101 (102)
T d1ul7a_ 94 SK-IANELK 101 (102)
T ss_dssp HH-HHHHCC
T ss_pred HH-HHHhcc
Confidence 98 655553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=6e-08 Score=88.56 Aligned_cols=142 Identities=20% Similarity=0.195 Sum_probs=98.4
Q ss_pred ccccCeeeeceEeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEE
Q 045214 7 VLMQKYELGRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKI 85 (450)
Q Consensus 7 ~l~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (450)
.+.+.|++.+..+.++.+.||+.. ..++.+++|......... ...+.+|...++.+. +--+.+++.+..+++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 356788888887767778999875 366678888876543222 234678888887773 43467888888889999
Q ss_pred EEEEeecCCCChhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 045214 86 YFVMEYAKGGELFKKVSKGKLKEDTARKYFQQLISAIDFCHSR------------------------------------- 128 (450)
Q Consensus 86 ~lv~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~~LH~~------------------------------------- 128 (450)
|+||++++|.++.+......- ...++.++...+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999999877554332211 222334444444455531
Q ss_pred ----------------------CCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 129 ----------------------GVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 129 ----------------------gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 25899999999999877666799998654
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.33 E-value=1.9e-06 Score=69.57 Aligned_cols=73 Identities=11% Similarity=0.175 Sum_probs=62.1
Q ss_pred eecccCHHHHHHHHHHHHHHcCcEEEEecCceEEEEEecCCcceeEEEEEEEEEEeCceEEEEEEecCCCcHH
Q 045214 343 FTSKYSASVIISKLEDIARHLKMKLTKKDGGLLKFEKSDKGRLGTFSIDVQLFEFNPSIHLVELTKSSGDNLE 415 (450)
Q Consensus 343 f~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le 415 (450)
..|+..+.+||..+..++++||+.|++.+...|++..........+.|.+++|+|.++.+||||+...|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 5678899999999999999999999998888899877554444578999999999999999999999998766
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=5.4e-06 Score=74.70 Aligned_cols=73 Identities=11% Similarity=0.155 Sum_probs=51.8
Q ss_pred EeecC-CeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCccEEEEEEEeCCEEEEEEeecCC
Q 045214 18 LGQGN-FAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH--PNVMQIYEVMASKTKIYFVMEYAKG 94 (450)
Q Consensus 18 LG~G~-fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~g 94 (450)
+..|. .+.||+... ..+..+++|....... ..+.+|...++.+.. -.+.+++.+..+++..|+||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 468998875 4566788897654432 235678888877632 3367788888888899999999998
Q ss_pred CCh
Q 045214 95 GEL 97 (450)
Q Consensus 95 g~L 97 (450)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.09 E-value=3.9e-06 Score=81.29 Aligned_cols=81 Identities=17% Similarity=0.138 Sum_probs=51.8
Q ss_pred eceEeecCCeEEEEEEEcCCCcEEEEEEeeccc-c-cc--cchHHHHHHHHHHHHhCC-C--CCccEEEEEEEeCCEEEE
Q 045214 15 GRLLGQGNFAKVYYARHLGTGQSVAIKAIDKDK-I-LK--VGLVDQTKREISVMRLIQ-H--PNVMQIYEVMASKTKIYF 87 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~-~-~~--~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 87 (450)
.+.||.|....||++.+..+++.+++|.-.... . .. .....+...|...|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999987788999999754321 0 00 112345667888887662 2 346667654 4445678
Q ss_pred EEeecCCCCh
Q 045214 88 VMEYAKGGEL 97 (450)
Q Consensus 88 v~E~~~gg~L 97 (450)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.72 E-value=9.9e-05 Score=58.10 Aligned_cols=69 Identities=14% Similarity=0.151 Sum_probs=54.0
Q ss_pred eeeeeecccCHHHHHHHHHHHHHHcCcEEEEecC---------ceEEEEEe-----cCCcceeEEEEEEEEEEeCceEEE
Q 045214 339 EEVKFTSKYSASVIISKLEDIARHLKMKLTKKDG---------GLLKFEKS-----DKGRLGTFSIDVQLFEFNPSIHLV 404 (450)
Q Consensus 339 ~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~---------~~~~~~~~-----~~~~~g~l~~~~~v~~~~~~~~lV 404 (450)
+.--..|+..|-+||..|..|+++||+.|++-+. ..|++.-. ..+...-+.|.+++|+|.++.+||
T Consensus 3 WhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 3 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred ceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEE
Confidence 3445668899999999999999999999987554 45776522 122234578899999999999999
Q ss_pred EEE
Q 045214 405 ELT 407 (450)
Q Consensus 405 e~~ 407 (450)
||+
T Consensus 83 DFK 85 (127)
T d2qrda1 83 DVK 85 (127)
T ss_dssp EEE
T ss_pred EEc
Confidence 997
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.29 E-value=0.00052 Score=56.75 Aligned_cols=72 Identities=13% Similarity=0.092 Sum_probs=52.6
Q ss_pred ceeeeeeecccCHHHHHHHHHHHHHHcCcEEEEec---CceEEEEEecC---------CcceeEEEEEEEEEEeCceEEE
Q 045214 337 QKEEVKFTSKYSASVIISKLEDIARHLKMKLTKKD---GGLLKFEKSDK---------GRLGTFSIDVQLFEFNPSIHLV 404 (450)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~g~l~~~~~v~~~~~~~~lV 404 (450)
.|+.--..|+..+-+||..|..|+++||+.|++.+ ...|++.-... .....+.|.+++|+|.++.+||
T Consensus 44 ~kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLl 123 (171)
T d2qlva1 44 TRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLV 123 (171)
T ss_dssp CCCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEE
T ss_pred ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEE
Confidence 35677788999999999999999999999998654 34577653211 1112478999999999999999
Q ss_pred EEEe
Q 045214 405 ELTK 408 (450)
Q Consensus 405 e~~k 408 (450)
||+-
T Consensus 124 DFK~ 127 (171)
T d2qlva1 124 DFKF 127 (171)
T ss_dssp EEEE
T ss_pred EEec
Confidence 9973
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.15 E-value=0.00062 Score=65.19 Aligned_cols=74 Identities=12% Similarity=0.116 Sum_probs=51.1
Q ss_pred eceEeecCCeEEEEEEEcC-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Q 045214 15 GRLLGQGNFAKVYYARHLG-------TGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQ-HPNVMQIYEVMASKTKIY 86 (450)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (450)
++.|+.|-.-.+|++.... .++.|.+++.-... . .....+|..+++.+. +.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 5678889999999998753 24567787764211 1 234568999999884 4334578777643 5
Q ss_pred EEEeecCCCCh
Q 045214 87 FVMEYAKGGEL 97 (450)
Q Consensus 87 lv~E~~~gg~L 97 (450)
+|+||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999988544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.00059 Score=63.53 Aligned_cols=69 Identities=13% Similarity=0.129 Sum_probs=46.0
Q ss_pred CeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcc--EEE-----EEEEeCCEEEEEEeecCCC
Q 045214 23 FAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQHPNVM--QIY-----EVMASKTKIYFVMEYAKGG 95 (450)
Q Consensus 23 fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv--~l~-----~~~~~~~~~~lv~E~~~gg 95 (450)
--.||++.. .+|..|++|+.++..- ..+++..|...+..|...+|. ... ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 458999886 5788899999876432 246677888888777422221 111 1235577899999999874
Q ss_pred C
Q 045214 96 E 96 (450)
Q Consensus 96 ~ 96 (450)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.0022 Score=59.01 Aligned_cols=142 Identities=15% Similarity=0.222 Sum_probs=75.1
Q ss_pred ccCeeeece-----EeecCCeEEEEEEEcCCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-----CCccEEE--
Q 045214 9 MQKYELGRL-----LGQGNFAKVYYARHLGTGQSVAIKAIDKDKILKVGLVDQTKREISVMRLIQH-----PNVMQIY-- 76 (450)
Q Consensus 9 ~~~y~~~~~-----LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~-- 76 (450)
..+|.+++. |..|---+.|+.... +| .+++|++..... .+.+..|+.++..+.. |..+...
T Consensus 12 l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g 84 (316)
T d2ppqa1 12 LTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDG 84 (316)
T ss_dssp HTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTC
T ss_pred HHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCC
Confidence 345766444 445666788998763 34 589999865421 1344566666666632 2222110
Q ss_pred -EEEEeCCEEEEEEeecCCCChhh--------------HHh---cC-------CCCH------------------HHHHH
Q 045214 77 -EVMASKTKIYFVMEYAKGGELFK--------------KVS---KG-------KLKE------------------DTARK 113 (450)
Q Consensus 77 -~~~~~~~~~~lv~E~~~gg~L~~--------------~i~---~~-------~l~e------------------~~~~~ 113 (450)
.+.......+.++.+..|..... .+. .. .... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (316)
T d2ppqa1 85 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 164 (316)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHH
Confidence 12233566777777777643210 000 00 0000 11112
Q ss_pred HHHHHHHHHHHHH----HCCCeecCCCCCcEEecCCCCeEEeecCchh
Q 045214 114 YFQQLISAIDFCH----SRGVYHRDLKPENLLLDENGMLKVTDFGLSA 157 (450)
Q Consensus 114 ~~~qll~aL~~LH----~~gi~HrDikp~NILl~~~~~vkl~DFGls~ 157 (450)
.+..+...+.-.+ ..|++|+|+.++||+++.+...-|.||+.++
T Consensus 165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2223333333322 2579999999999999988777899999753
|